

  2  1
$MOL
Dehydroepiandrosterone
C19H28O2
53-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6026 3.7975 0.0 0
M  V30 2 C 8.1632 6.1516 0.0 0
M  V30 3 O 9.9426 6.5605 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 6 C 5.3348 3.0800 0.0 0 CFG=2
M  V30 7 C 8.0022 3.0800 0.0 0 CFG=2
M  V30 8 C 6.6684 0.7700 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 10 C 5.3348 4.6200 0.0 0
M  V30 11 C 8.0022 4.6200 0.0 0 CFG=2
M  V30 12 C 9.4668 2.6040 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 6.6684 5.3901 0.0 0
M  V30 17 C 9.4668 5.0959 0.0 0
M  V30 18 C 10.3720 3.8500 0.0 0
M  V30 19 C 2.6675 0.0000 0.0 0
M  V30 20 C 1.3337 2.3100 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0 CFG=1
M  V30 22 H 7.5518 1.0484 0.0 0
M  V30 23 H 4.2458 4.1690 0.0 0
M  V30 24 H 8.5540 1.6423 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 11 2 CFG=1
M  V30 3 2 3 17
M  V30 4 1 21 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 23 CFG=3
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 24 CFG=3
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 10 16
M  V30 19 1 11 16
M  V30 20 1 11 17
M  V30 21 1 12 18
M  V30 22 2 13 14
M  V30 23 1 14 19
M  V30 24 1 15 20
M  V30 25 1 17 18
M  V30 26 1 19 21
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 5 6 7 9 11 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3β-Formyloxy-5-androstene-17-one
C20H28O3
29163-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0177 3.7058 0.0 0
M  V30 2 C 10.8306 6.1517 0.0 0
M  V30 3 O 12.6103 6.5605 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 0.7700 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0 CFG=2
M  V30 8 C 9.3360 2.3101 0.0 0 CFG=1
M  V30 9 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 10.6697 3.0801 0.0 0 CFG=2
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0 CFG=2
M  V30 17 C 12.1342 2.6040 0.0 0
M  V30 18 C 8.0022 0.0000 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 4.0012 2.3101 0.0 0
M  V30 21 C 12.1342 5.0960 0.0 0
M  V30 22 C 13.0395 3.8501 0.0 0
M  V30 23 C 4.0012 0.7700 0.0 0 CFG=1
M  V30 24 H 7.1190 4.3415 0.0 0
M  V30 25 H 10.2192 1.0485 0.0 0
M  V30 26 H 11.4628 1.7600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 16 2 CFG=1
M  V30 3 2 3 21
M  V30 4 1 4 5
M  V30 5 1 23 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 24 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 25 CFG=1
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 1 11 26 CFG=3
M  V30 20 1 12 18
M  V30 21 2 13 18
M  V30 22 1 13 19
M  V30 23 1 14 20
M  V30 24 1 15 16
M  V30 25 1 16 21
M  V30 26 1 17 22
M  V30 27 1 19 23
M  V30 28 1 20 23
M  V30 29 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 7 8 9 11 16 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53-43-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29163-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-12661978
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of dehydroisoandrosterone-3-formate (DHEA formate) A solution
of 45 g (156 mmol) of dehydroisoandrosterone in 225 ml (51/kg) of formic
acid 80% was maintained 7 hours at 20-25°C. The end of the reaction was
monitored by HPLC (area% of DHEA). The mixture was extracted with 90 ml
of dichloromethane. The aqueous layer was then washed twice with 45 ml of
dichloromethane. The organic layer was washed with 180 ml of saturated
sodium bicarbonate solution and then with 45 ml of water. The organic
layer was concentrated to give DHEA formate. Yield 49 g, yield 99.2%.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction monitored by HPLC; second stage quench
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing 17-substituted steroids from
dehydroepisoandrosterone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Derrien, Yvon; Poirier, Patricia; Forcato, Massimiliano; Pintus, Tony;
Cotarca, Livius; Meunier, Sebastien; Graindorge, Laurence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013053691 A1 2013-04-18

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-1,2-phenylenediamine
C6H6Cl2N2
5348-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dichlorobenzimidazole
C7H4Cl2N2
6478-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 0.0000 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5348-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6478-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-19753392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nucleoside analogs regulating mammalian circadian clock
rhythm
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Erquan; Qi, Xiangbing; Ju, Dapeng; Zhou, Guanshen; Zhao, Haijiao;
Mei, Long; Wang, Zhiqiang; Liang, Leiming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018133835 A1 2018-07-26

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-1,2-phenylenediamine
C6H6Cl2N2
5348-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dichlorobenzimidazole
C7H4Cl2N2
6478-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 0.0000 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5348-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6478-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-20875625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of adenosine analogs and its use in regulating the circadian
clock rhythm
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Erquan; Qi, Xiangbing; Ju, Dapeng; Zhao, Haijiao; Mei, Long; Wang,
Zhiqiang; Wu, Qingcui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018133854 A1 2018-07-26

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-1,2-phenylenediamine
C6H6Cl2N2
5348-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dichlorobenzimidazole
C7H4Cl2N2
6478-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 0.0000 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5348-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6478-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1486015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of benzo[d]imidazole derivatives as
potential anti-cancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alkahtani, Hamad M.; Abbas, Abdullahi Y.; Wang, Shudong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(3), 1317-1321

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Hydroxysuccinimide
C4H5NO3
6066-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Formyloxy)-2,5-pyrrolidinedione
C5H5NO4
17592-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7710 1.3628 0.0 0
M  V30 2 C 5.1048 2.1328 0.0 0
M  V30 3 O 6.4385 1.3628 0.0 0
M  V30 4 O 3.4208 4.6949 0.0 0
M  V30 5 O 0.7103 0.0000 0.0 0
M  V30 6 N 2.4374 2.1328 0.0 0
M  V30 7 C 2.2764 3.6643 0.0 0
M  V30 8 C 1.0306 1.5064 0.0 0
M  V30 9 C 0.7700 3.9845 0.0 0
M  V30 10 C 0.0000 2.6508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 7
M  V30 5 2 5 8
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17592-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30824961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Carbonylation of (Hetero)Aryl, Alkenyl and Allyl
Halides by Means of N-Hydroxysuccinimidyl Formate as CO Surrogate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barre, Anais; Tintas, Mihaela-Liliana; Alix, Florent; Gembus, Vincent;
Papamicael, Cyril; Levacher, Vincent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(13), 6537-6544

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Hydroxysuccinimide
C4H5NO3
6066-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Formyloxy)-2,5-pyrrolidinedione
C5H5NO4
17592-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7710 1.3628 0.0 0
M  V30 2 C 5.1048 2.1328 0.0 0
M  V30 3 O 6.4385 1.3628 0.0 0
M  V30 4 O 3.4208 4.6949 0.0 0
M  V30 5 O 0.7103 0.0000 0.0 0
M  V30 6 N 2.4374 2.1328 0.0 0
M  V30 7 C 2.2764 3.6643 0.0 0
M  V30 8 C 1.0306 1.5064 0.0 0
M  V30 9 C 0.7700 3.9845 0.0 0
M  V30 10 C 0.0000 2.6508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 7
M  V30 5 2 5 8
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17592-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33647029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Synthesis of Esters from Arenes through C-H
Thianthrenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Mengning; Zhang, Xiaomei; Ma, Mengtao; Zhao, Binlin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(32), 6031-6036

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Deoxycholic acid
C24H40O4
83-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.9216 0.0 0
M  V30 2 C 3.3503 4.4757 0.0 0
M  V30 3 C 10.8005 6.6359 0.0 0 CFG=2
M  V30 4 C 12.1342 5.8659 0.0 0
M  V30 5 C 10.8005 8.1759 0.0 0
M  V30 6 C 13.4678 6.6359 0.0 0
M  V30 7 C 14.8015 5.8659 0.0 0
M  V30 8 O 16.1353 6.6359 0.0 0
M  V30 9 O 14.8015 4.3259 0.0 0
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 14 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0022 5.3900 0.0 0 CFG=1
M  V30 17 C 9.4667 3.3742 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 19 C 5.3347 5.3900 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 22 C 6.6685 6.1600 0.0 0 CFG=1
M  V30 23 C 10.3719 4.6200 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 2.6674 0.7700 0.0 0
M  V30 27 C 1.3338 3.0800 0.0 0
M  V30 28 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 29 H 7.5517 1.8184 0.0 0
M  V30 30 H 8.7953 2.5299 0.0 0
M  V30 31 H 4.4515 5.1114 0.0 0
M  V30 32 H 8.8404 7.2728 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 10 CFG=3
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 19 22
M  V30 29 1 20 24
M  V30 30 1 21 23
M  V30 31 1 21 32 CFG=3
M  V30 32 1 24 26
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 12 13 14 16 18 21 22 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,12α)-3,12-Bis(formyloxy)cholan-24-oic acid
C26H40O6
2287-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.9216 0.0 0
M  V30 2 O 9.3358 7.7000 0.0 0
M  V30 3 C 8.0022 8.4700 0.0 0
M  V30 4 O 8.0022 10.0101 0.0 0
M  V30 5 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 6 C 14.8015 5.8659 0.0 0
M  V30 7 C 13.4678 8.1759 0.0 0
M  V30 8 C 16.1351 6.6359 0.0 0
M  V30 9 C 17.4689 5.8659 0.0 0
M  V30 10 O 18.8026 6.6359 0.0 0
M  V30 11 O 17.4689 4.3259 0.0 0
M  V30 12 C 6.2698 4.5675 0.0 0
M  V30 13 O 2.6674 0.7700 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 O 0.0000 0.7700 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 17 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 18 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 19 C 12.1342 3.3742 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0 CFG=1
M  V30 21 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 22 C 8.0022 3.8500 0.0 0 CFG=1
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 13.0394 4.6200 0.0 0
M  V30 25 C 8.0022 5.3900 0.0 0
M  V30 26 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 4.0011 3.0800 0.0 0
M  V30 32 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 33 H 11.2214 2.4123 0.0 0
M  V30 34 H 10.4248 1.9911 0.0 0
M  V30 35 H 11.5077 7.2728 0.0 0
M  V30 36 H 7.1188 5.1116 0.0 0
M  V30 37 H 6.6684 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 26 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 34 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 35 CFG=3
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 22 36 CFG=3
M  V30 32 1 23 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 1 28 37 CFG=1
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 5 16 17 18 20 21 22 26 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-11387493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 7-deoxycholic amides or cholanes containing distinctive
ion-recognizing groups at C3 and C12 and evaluation for ion-selective
ionophores
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM On, Jeung Hoon; Cho, Kui Tae; Park, Youngjin; Hahm, Sunmi; Kim, Wook;
Cho, Joo Young; Hwang, Ji Hyeon; Jun, Young Moo; Cha, Guen Sig; Nam,
Hakhyun; Kim, Byeong Hyo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(7), 1415-1423

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Deoxycholic acid
C24H40O4
83-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.9216 0.0 0
M  V30 2 C 3.3503 4.4757 0.0 0
M  V30 3 C 10.8005 6.6359 0.0 0 CFG=2
M  V30 4 C 12.1342 5.8659 0.0 0
M  V30 5 C 10.8005 8.1759 0.0 0
M  V30 6 C 13.4678 6.6359 0.0 0
M  V30 7 C 14.8015 5.8659 0.0 0
M  V30 8 O 16.1353 6.6359 0.0 0
M  V30 9 O 14.8015 4.3259 0.0 0
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 14 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0022 5.3900 0.0 0 CFG=1
M  V30 17 C 9.4667 3.3742 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 19 C 5.3347 5.3900 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 22 C 6.6685 6.1600 0.0 0 CFG=1
M  V30 23 C 10.3719 4.6200 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 2.6674 0.7700 0.0 0
M  V30 27 C 1.3338 3.0800 0.0 0
M  V30 28 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 29 H 7.5517 1.8184 0.0 0
M  V30 30 H 8.7953 2.5299 0.0 0
M  V30 31 H 4.4515 5.1114 0.0 0
M  V30 32 H 8.8404 7.2728 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 10 CFG=3
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 19 22
M  V30 29 1 20 24
M  V30 30 1 21 23
M  V30 31 1 21 32 CFG=3
M  V30 32 1 24 26
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 12 13 14 16 18 21 22 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,12α)-3,12-Bis(formyloxy)cholan-24-oic acid
C26H40O6
2287-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.9216 0.0 0
M  V30 2 O 9.3358 7.7000 0.0 0
M  V30 3 C 8.0022 8.4700 0.0 0
M  V30 4 O 8.0022 10.0101 0.0 0
M  V30 5 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 6 C 14.8015 5.8659 0.0 0
M  V30 7 C 13.4678 8.1759 0.0 0
M  V30 8 C 16.1351 6.6359 0.0 0
M  V30 9 C 17.4689 5.8659 0.0 0
M  V30 10 O 18.8026 6.6359 0.0 0
M  V30 11 O 17.4689 4.3259 0.0 0
M  V30 12 C 6.2698 4.5675 0.0 0
M  V30 13 O 2.6674 0.7700 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 O 0.0000 0.7700 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 17 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 18 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 19 C 12.1342 3.3742 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0 CFG=1
M  V30 21 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 22 C 8.0022 3.8500 0.0 0 CFG=1
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 13.0394 4.6200 0.0 0
M  V30 25 C 8.0022 5.3900 0.0 0
M  V30 26 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 4.0011 3.0800 0.0 0
M  V30 32 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 33 H 11.2214 2.4123 0.0 0
M  V30 34 H 10.4248 1.9911 0.0 0
M  V30 35 H 11.5077 7.2728 0.0 0
M  V30 36 H 7.1188 5.1116 0.0 0
M  V30 37 H 6.6684 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 26 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 34 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 35 CFG=3
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 22 36 CFG=3
M  V30 32 1 23 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 1 28 37 CFG=1
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 5 16 17 18 20 21 22 26 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-21434565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tweezer-type neutral carrier-based calcium-selective membrane electrode
with drastically reduced anionic interference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Min Hyung; Yoo, Choong Leol; Lee, Jae Seon; Cho, In-Sook; Kim,
Byeong Hyo; Cha, Geun Sig; Nam, Hakhyun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Analytical Chemistry (2002), 74(11), 2603-2607

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Deoxycholic acid
C24H40O4
83-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.9216 0.0 0
M  V30 2 C 3.3503 4.4757 0.0 0
M  V30 3 C 10.8005 6.6359 0.0 0 CFG=2
M  V30 4 C 12.1342 5.8659 0.0 0
M  V30 5 C 10.8005 8.1759 0.0 0
M  V30 6 C 13.4678 6.6359 0.0 0
M  V30 7 C 14.8015 5.8659 0.0 0
M  V30 8 O 16.1353 6.6359 0.0 0
M  V30 9 O 14.8015 4.3259 0.0 0
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 14 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0022 5.3900 0.0 0 CFG=1
M  V30 17 C 9.4667 3.3742 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 19 C 5.3347 5.3900 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 22 C 6.6685 6.1600 0.0 0 CFG=1
M  V30 23 C 10.3719 4.6200 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 2.6674 0.7700 0.0 0
M  V30 27 C 1.3338 3.0800 0.0 0
M  V30 28 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 29 H 7.5517 1.8184 0.0 0
M  V30 30 H 8.7953 2.5299 0.0 0
M  V30 31 H 4.4515 5.1114 0.0 0
M  V30 32 H 8.8404 7.2728 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 10 CFG=3
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 19 22
M  V30 29 1 20 24
M  V30 30 1 21 23
M  V30 31 1 21 32 CFG=3
M  V30 32 1 24 26
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 12 13 14 16 18 21 22 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,12α)-3,12-Bis(formyloxy)cholan-24-oic acid
C26H40O6
2287-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.9216 0.0 0
M  V30 2 O 9.3358 7.7000 0.0 0
M  V30 3 C 8.0022 8.4700 0.0 0
M  V30 4 O 8.0022 10.0101 0.0 0
M  V30 5 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 6 C 14.8015 5.8659 0.0 0
M  V30 7 C 13.4678 8.1759 0.0 0
M  V30 8 C 16.1351 6.6359 0.0 0
M  V30 9 C 17.4689 5.8659 0.0 0
M  V30 10 O 18.8026 6.6359 0.0 0
M  V30 11 O 17.4689 4.3259 0.0 0
M  V30 12 C 6.2698 4.5675 0.0 0
M  V30 13 O 2.6674 0.7700 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 O 0.0000 0.7700 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 17 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 18 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 19 C 12.1342 3.3742 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0 CFG=1
M  V30 21 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 22 C 8.0022 3.8500 0.0 0 CFG=1
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 13.0394 4.6200 0.0 0
M  V30 25 C 8.0022 5.3900 0.0 0
M  V30 26 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 4.0011 3.0800 0.0 0
M  V30 32 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 33 H 11.2214 2.4123 0.0 0
M  V30 34 H 10.4248 1.9911 0.0 0
M  V30 35 H 11.5077 7.2728 0.0 0
M  V30 36 H 7.1188 5.1116 0.0 0
M  V30 37 H 6.6684 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 26 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 34 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 35 CFG=3
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 22 36 CFG=3
M  V30 32 1 23 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 1 28 37 CFG=1
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 5 16 17 18 20 21 22 26 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-4019054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Step 1) Preparation of 3 α ,12 α -diformyloxy-5 β -cholic acid A mixture
of 5.00 g (12.7 mmol) of deoxycholic acid and 4 drops of 70% HClO4 in 20
mL of 98% formic acid was stirred at 55°C. for 1.5 h. After the mixture
was allowed to cool to 40°C, Ac2O was added slowly to let the temperature
of the solution maintained between 55-60°C. until a large quantity of
bubbles appeared. After the solution was allowed to cool to rt and poured
into 200 mL of water, the precipitate was filtered, washed with water,
and dried to give 5.63 g (99%) of the desired compound as a white powder.
3 α ,12 α -diformyloxy-5 β -cholic acid, yield 5.63 g, 99%. C26H40O6; TLC
(acetone:n-hexane=3:7) Rf, 0.61; m.p 197-198°C.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of cholanic acid ring based 4-(trifluoroacetyl)phenyl
derivatives for use as host material in host-guest chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chu, Junho; Pyun, Hyung Jung; Yoon, In Jun; Shin, Jae Ho; Nam, Hakhyun;
Cha, Geun Sig
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6177417 B1 2001-01-23

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Deoxycholic acid
C24H40O4
83-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.9216 0.0 0
M  V30 2 C 3.3503 4.4757 0.0 0
M  V30 3 C 10.8005 6.6359 0.0 0 CFG=2
M  V30 4 C 12.1342 5.8659 0.0 0
M  V30 5 C 10.8005 8.1759 0.0 0
M  V30 6 C 13.4678 6.6359 0.0 0
M  V30 7 C 14.8015 5.8659 0.0 0
M  V30 8 O 16.1353 6.6359 0.0 0
M  V30 9 O 14.8015 4.3259 0.0 0
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 14 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0022 5.3900 0.0 0 CFG=1
M  V30 17 C 9.4667 3.3742 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 19 C 5.3347 5.3900 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 22 C 6.6685 6.1600 0.0 0 CFG=1
M  V30 23 C 10.3719 4.6200 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 2.6674 0.7700 0.0 0
M  V30 27 C 1.3338 3.0800 0.0 0
M  V30 28 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 29 H 7.5517 1.8184 0.0 0
M  V30 30 H 8.7953 2.5299 0.0 0
M  V30 31 H 4.4515 5.1114 0.0 0
M  V30 32 H 8.8404 7.2728 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 10 CFG=3
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 19 22
M  V30 29 1 20 24
M  V30 30 1 21 23
M  V30 31 1 21 32 CFG=3
M  V30 32 1 24 26
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 12 13 14 16 18 21 22 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,12α)-3,12-Bis(formyloxy)cholan-24-oic acid
C26H40O6
2287-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.9216 0.0 0
M  V30 2 O 9.3358 7.7000 0.0 0
M  V30 3 C 8.0022 8.4700 0.0 0
M  V30 4 O 8.0022 10.0101 0.0 0
M  V30 5 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 6 C 14.8015 5.8659 0.0 0
M  V30 7 C 13.4678 8.1759 0.0 0
M  V30 8 C 16.1351 6.6359 0.0 0
M  V30 9 C 17.4689 5.8659 0.0 0
M  V30 10 O 18.8026 6.6359 0.0 0
M  V30 11 O 17.4689 4.3259 0.0 0
M  V30 12 C 6.2698 4.5675 0.0 0
M  V30 13 O 2.6674 0.7700 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 O 0.0000 0.7700 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 17 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 18 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 19 C 12.1342 3.3742 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0 CFG=1
M  V30 21 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 22 C 8.0022 3.8500 0.0 0 CFG=1
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 13.0394 4.6200 0.0 0
M  V30 25 C 8.0022 5.3900 0.0 0
M  V30 26 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 4.0011 3.0800 0.0 0
M  V30 32 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 33 H 11.2214 2.4123 0.0 0
M  V30 34 H 10.4248 1.9911 0.0 0
M  V30 35 H 11.5077 7.2728 0.0 0
M  V30 36 H 7.1188 5.1116 0.0 0
M  V30 37 H 6.6684 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 26 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 34 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 35 CFG=3
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 22 36 CFG=3
M  V30 32 1 23 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 1 28 37 CFG=1
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 5 16 17 18 20 21 22 26 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-6030366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recognition Properties of Flavin Analogues with Bile Acid-Based
Receptors: Role of Steric Effects in Hydrogen Bond Based Molecular
Recognition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Prosenjit; Nagpal, Rekha; Pandey, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2008), 61(3), 216-222

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Deoxycholic acid
C24H40O4
83-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.9216 0.0 0
M  V30 2 C 3.3503 4.4757 0.0 0
M  V30 3 C 10.8005 6.6359 0.0 0 CFG=2
M  V30 4 C 12.1342 5.8659 0.0 0
M  V30 5 C 10.8005 8.1759 0.0 0
M  V30 6 C 13.4678 6.6359 0.0 0
M  V30 7 C 14.8015 5.8659 0.0 0
M  V30 8 O 16.1353 6.6359 0.0 0
M  V30 9 O 14.8015 4.3259 0.0 0
M  V30 10 O 6.6685 7.7000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 14 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 8.0022 5.3900 0.0 0 CFG=1
M  V30 17 C 9.4667 3.3742 0.0 0
M  V30 18 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 19 C 5.3347 5.3900 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 22 C 6.6685 6.1600 0.0 0 CFG=1
M  V30 23 C 10.3719 4.6200 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 2.6674 0.7700 0.0 0
M  V30 27 C 1.3338 3.0800 0.0 0
M  V30 28 C 1.3338 1.5400 0.0 0 CFG=2
M  V30 29 H 7.5517 1.8184 0.0 0
M  V30 30 H 8.7953 2.5299 0.0 0
M  V30 31 H 4.4515 5.1114 0.0 0
M  V30 32 H 8.8404 7.2728 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 10 CFG=3
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 19 22
M  V30 29 1 20 24
M  V30 30 1 21 23
M  V30 31 1 21 32 CFG=3
M  V30 32 1 24 26
M  V30 33 1 24 33 CFG=1
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 3 12 13 14 16 18 21 22 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,12α)-3,12-Bis(formyloxy)cholan-24-oic acid
C26H40O6
2287-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.9216 0.0 0
M  V30 2 O 9.3358 7.7000 0.0 0
M  V30 3 C 8.0022 8.4700 0.0 0
M  V30 4 O 8.0022 10.0101 0.0 0
M  V30 5 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 6 C 14.8015 5.8659 0.0 0
M  V30 7 C 13.4678 8.1759 0.0 0
M  V30 8 C 16.1351 6.6359 0.0 0
M  V30 9 C 17.4689 5.8659 0.0 0
M  V30 10 O 18.8026 6.6359 0.0 0
M  V30 11 O 17.4689 4.3259 0.0 0
M  V30 12 C 6.2698 4.5675 0.0 0
M  V30 13 O 2.6674 0.7700 0.0 0
M  V30 14 C 1.3336 1.5400 0.0 0
M  V30 15 O 0.0000 0.7700 0.0 0
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=1
M  V30 17 C 10.6695 5.3900 0.0 0 CFG=2
M  V30 18 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 19 C 12.1342 3.3742 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0 CFG=1
M  V30 21 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 22 C 8.0022 3.8500 0.0 0 CFG=1
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 13.0394 4.6200 0.0 0
M  V30 25 C 8.0022 5.3900 0.0 0
M  V30 26 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 29 C 5.3347 3.8500 0.0 0
M  V30 30 C 5.3347 0.7700 0.0 0
M  V30 31 C 4.0011 3.0800 0.0 0
M  V30 32 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 33 H 11.2214 2.4123 0.0 0
M  V30 34 H 10.4248 1.9911 0.0 0
M  V30 35 H 11.5077 7.2728 0.0 0
M  V30 36 H 7.1188 5.1116 0.0 0
M  V30 37 H 6.6684 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 26 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 32 13 CFG=3
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 33 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 34 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 1 21 24
M  V30 28 1 21 35 CFG=3
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 22 36 CFG=3
M  V30 32 1 23 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 1 28 37 CFG=1
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 5 16 17 18 20 21 22 26 28 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2287-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-518390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and binding ability of bile acid-based receptors for
recognition of flavin analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Prosenjit; Pandey, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(36), 8620-8624

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Phenylglycine
C8H9NO2
875-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0 CFG=1
M  V30 2 C 1.3337 5.3901 0.0 0
M  V30 3 N 4.0010 5.3901 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 O 1.3337 6.9302 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(Formylamino)benzeneacetic acid
C9H9NO3
10419-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 C 6.6687 3.0801 0.0 0
M  V30 5 O 2.6675 5.3901 0.0 0
M  V30 6 O 5.3348 5.3901 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 875-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10419-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8369070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (R)-N-Formylaminophenylglycine (17) A mixture of 8 (1.40 g, 9.28 mmol)
and acetic anhydride (9 ml, 95.4 mmol) in formic acid (8.5 ml, 226 mmol)
was stirred at room temperature for 22.5 h. After addition of H2O (10 mL)
the solvent was evaporated. The residue was washed with cold MeOH-H2O
(1:1, 3 × 20 mL) to give 17. Colorless plates, yield (1.64 g, 99%). mp
185-187°C (lit. [19] mp 188- 189°C); 1H NMR (DMSO-d6) δ: 5.37 (1H, d, J =
7.6 Hz), 7.32-7.37 (5H, m), 8.06 (1H, s), 8.91 (1H, d, J = 7.6 Hz); IR
(KBr) λmax cm-1: 3157 (OH), 1775 and 1671 (C=O).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported and polymeric chiral guanidines: Preparation and
application to the asymmetric Michael reaction of iminoacetate with
methyl vinyl ketone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wannaporn, Disadee; Ishikawa, Tsutomu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2005), 9(4), 321-331

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitroaniline
C6H6N2O2
100-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)formamide
C7H6N2O3
16135-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-01-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16135-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34127896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant in stage 1,Ac2O also used as solvent in stage
1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazo[1,2-a]pyrazine and imidazo[1,2-a]pyridine based
tyrosyl-DNA phosphodiesterase 1 (TPD1) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Xuezhi; Wang, Wenjie; Lountos, George Themistoclis; Kiselev, Evgeny
Anatolyevich; Waugh, David Spencer; Pommier, Yves Georges; Burke,
Terrence Richard, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022164934 A1 2022-08-04

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35104982
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, catalyst prepared and used, recyclable
catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid-based periodic mesoporous organosilicas: Metal/solvent-free
synthesis of formamides and formamidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Seyed Mehran Hoseini; Haghighat, Mahdieh; Shirini, Farhad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1274(Part_1), 134473

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35267148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lewis Acid Mediated Conjugate Addition of Isocyanides to
β-Hydroxy-α-diazo Carbonyls: Synthesis of β-Carboxamido-α-diazo Carbonyl
Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Yong-Xin; Wang, Jie; Xu, Xue-Cen; Gong, Yue; Zhao, Yu-Long
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(1), 200-204

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36298717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12027-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst supported on
silica prepared and used,recyclable catalyst,no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Magnetically Recyclable Silica-Coated Magnetite-Molybdate Nanocatalyst
and its Applications in N-Formylation Reactions Under Solvent-Free
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Runjhun; Patil, Shripad; Tandon, Nitin; Kumar, Pushpendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2022), 19(8), 616-626

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24209094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, solid-supported catalyst
(Fe3O4 immobilized CuO nanoparticles catalyst used), click chemistry,
catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile N-Formylation of Amines on Magnetic Fe3O4-CuO Nanocomposites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mishra, Kanchan; Datta Khanal, Hari; Rok Lee, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(31), 4477-4484

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19065993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 26851-55-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfatedsulfonic acid functionalizedsulfonic acid functionalizedsulfonic
acid functionalized
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, no solvent, recyclable
catalyst upto 5 cycles without loss its activity, optimization study,
optimized on stoichiometry of catalyst, optimized on solvent, optimized
on temperature, optimized on time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated polyborate-catalyzed N-formylation of amines: a rapid, green and
efficient protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khatri, Chetan K.; Chaturbhuj, Ganesh U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2017), 14(12), 2513-2519

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17598433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM catalyst with sulfamic acid on zeolite NaY
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 5329-14-6
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM catalyst with Cu(OAc)2 on zeolite NaY
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, green chemistry-catalyst,
solid-supported catalyst, no solvent, catalyst prepared and used,
recyclable catalyst, zeolite NaY support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NaY zeolite functionalized by sulfamic acid/Cu(OAc)2 as a new and
reusable heterogeneous hybrid catalyst for efficient solvent-free
formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazemi, Samira; Mobinikhaledi, Akbar; Zendehdel, Mojgan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(8), 1767-1772

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11497437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1616058-17-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, solid state, molten conditions, ionic
liquid used (catalyst), reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteropolyanion-based sulfated ionic liquid catalyzed formamides
synthesis by grindstone chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satasia, Shailesh P.; Kalaria, Piyush N.; Raval, Dipak K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2014), 39141-47

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6128091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction products with chlorosulfonic acid
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sulfated tungstate used as catalyst, optimized on
catalyst amount,temperature, no solvent, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate catalyzed highly accelerated N-formylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Sawant, Ravindra V.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(26), 3259-3263

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2858084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, 5 wt% sulfated
titania [TiO2 - SO4(2-)] used as catalyst, other catalyst (TiO2-P25) gave
lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient method for the N-formylation of amines at room temperature
using TiO2-P25 or sulfated titania
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krishnakumar, B.; Swaminathan, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2011), 334(1-2), 98-102

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29583656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 9003-39-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfonated, bisulfate salt
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sulfonated poly(vinylpyrrolidonium) hydrogen sulfate
catalyst used, reusable catalyst, optimization study, optimized on
temperature, time, catalyst and formic acid stoichiometry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [PVP-SO3H] HSO4: An Efficient Polymeric Solid Acid Catalyst for the
Formylation and N-Boc Protection Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pakpour-Roudsari, Fatemeh; Seddighi, Mohadeseh; Shirini, Farhad; Tajik,
Hassan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2019), 4(20), 6382-6389

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10218051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-74-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical procedure for the formylation of
amines: A mixture of amine (2 mmol), formic acid (purity = 99%; 226 mL, 6
mmol), and In metal (23 mg, 0.2 mmol) was stirred at 70 °C, and the
reaction was monitored by TLC. After completion of the reaction, the
mixture was diluted with CH2Cl2 and filtered through Celite. The filtrate
was washed with saturated NaHCO3 and brine, then dried over anhydrous
MgSO4. After filtration and evaporation of the solvent, the residue was
purified by column chromatography on silica gel. Entry 2 Yield: 97%
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indium-catalyzed N-formylation of amines under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joong-Gon; Jang, Doo Ok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2010), (8), 1231-1234

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9796745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2: N-(4-Chloro-phenyl)-formamide (Intermediate compound).
4-Chloroaniline (15 g, 117 mmol) and formic acid (25 mL, 663 mL) were
heated to reflux for 2 hours. The mixture was concentrated in vacuo.
Saturated aqueous sodium hydrogen carbonate was added and the aqueous
phase was extracted twice with ethyl acetate. The combined organic phases
were dried over magnesium sulphate, filtered and concentrated in vacuo to
give N-(4-chloro-phenyl)-formamide (17.6 g, 97%) as a grey crystalline
compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted purinyl-pyrazole derivatives and their use as
potassium channel modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eriksen, Birgitte L.; Hougaard, Charlotte; Peters, Dan; Christophersen,
Palle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010034707 A1 2010-04-01

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3610050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(4-Chloro-phenyl)-formamide. 4-Chloroaniline (15 g, 117 mmol) and
formic acid (25 mL, 663 mmol) were heated to reflux for 2 hours. The
mixture was concentrated in vacuo. Saturated aqueous sodium hydrogen
carbonate was added and the aqueous phase was extracted twice with ethyl
acetate. The combined organic phases were dried over magnesium sulphate,
filtered and concentrated in vacuo to give N-(4-chloro-phenyl)-formamide
(17.6 g, 97%) as a grey crystalline compound.
N-(4-chloro-phenyl)-formamide, yield (17.6 g, 97%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of purine derivatives and their use as potassium channel
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eriksen, Birgitte L.; Soerensen, Ulrik Svane; Hougaard, Charlotte;
Peters, Dan; Johansen, Tina Holm; Christophersen, Palle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008116909 A1 2008-10-02

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7426313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 2. N-(4-Chloro-phenyl)-formamide.
4-Chloroaniline (15 g, 117 mmol) and formic acid (25 mL, 663 mL) were
heated to reflux for 2 hours. The mixture was concentrated in vacuo.
Saturated aqueous sodium hydrogencarbonate was added and the aqueous
phase was extracted twice with ethyl acetate. The combined organic phases
were dried over magnesium sulphate, filtered and concentrated in vacuo.
N-(4-chloro-phenyl)-formamide (17.6 g, 97%) grey crystalline compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of purine derivatives and their use as potassium channel
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eriksen, Birgitte L.; Soerensen, Ulrik Svane; Hougaard, Charlotte;
Peters, Dan; Johansen, Tina Holm; Christophersen, Palle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008116910 A1 2008-10-02

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9793425
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 5. N-(4-Chloro-phenyl)-formamide. 4-Chloroaniline (15 g, 117
mmol) and formic acid (25 mL, 663 mL) were heated to reflux for 2 hours.
The mixture was concentrated in vacuo. Saturated aqueous sodium hydrogen
carbonate was added and the aqueous phase was extracted twice with ethyl
acetate. The combined organic phases were dried over magnesium sulphate,
filtered and concentrated in vacuo to give N-(4-chloro-phenyl)-formamide
(17.6 g, 97%) as a grey crystalline compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of purine derivatives and their use as potassium channel
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eriksen, Birgitte L.; Soerensen, Ulrik Svane; Hougaard, Charlotte;
Peters, Dan; Johansen, Tina Holm; Christophersen, Palle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008116911 A1 2008-10-02

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylmorpholine
C5H9NO2
4394-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4394-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40257818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid boosting N-formylation of amines on
polyoxometalate-stabilizing iridium single-atom catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Xinjia; Zhang, Xianyang; Jiang, Yongjun; Liao, Huiying; Lai, Wenkai;
Dai, Sheng; An, Pengfei; Wang, Zhi-Qiang; Hou, Zhenshan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2024), 433115493

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylmorpholine
C5H9NO2
4394-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4394-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13112754
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Experimental procedure. In a typical
experimental procedure, aniline (1 mmol) and formic acid (1.2 mmol) or
ethyl formate (3 mmol) were carefully added to a sealed glass vial
without any additional solvent or catalyst and were magnetically stirred
at 60°C. The progress of the reaction was monitored by TLC. After
completion of the reaction, the reaction mixture was diluted by using DCM
or EtOAc. The obtained organic mixture was then washed with water (2 x 10
ml) and a saturated solution of NaHCO3 and was then dried over anhydrous
Na2SO4. The solvent was evaporated in vacuo and the residue obtained was
then subjected to recrystallization with a suitable solvent or was
isolated through column chromatography to obtain pure N-formylated
products. Morpholine-4-carbaldehyde, yield 98%. MS (70 eV, EI): m/z (%):
115 (95) (M+), 100 (70), 86 (50), 72 (25), 57 (90), 56 (95), 42 (100).
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, sealed glass vial used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient, catalyst- and solvent-free N-formylation of aromatic and
aliphatic amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dhake, Kishor P.; Tambade, Pawan J.; Singhal, Rekha S.; Bhanage,
Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry Letters and Reviews (2011), 4(2), 151-157

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylmorpholine
C5H9NO2
4394-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4394-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9921423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylmorpholine
C5H9NO2
4394-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 N 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4394-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19066003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 26851-55-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfatedsulfonic acid functionalizedsulfonic acid functionalizedsulfonic
acid functionalized
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, no solvent, recyclable
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated polyborate-catalyzed N-formylation of amines: a rapid, green and
efficient protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khatri, Chetan K.; Chaturbhuj, Ganesh U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2017), 14(12), 2513-2519

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,2-benzenediamine
C6H7BrN2
1575-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Br 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1H-benzimidazole
C7H5BrN2
4887-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1575-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4887-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-12981304
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of selected benzimidazole derivatives as
potential antimicrobial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alasmary, Fatmah A. S.; Snelling, Anna M.; Zain, Mohammed E.; Alafeefy,
Ahmed M.; Awaad, Amani S.; Karodia, Nazira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2015), 20(8), 15206-15223

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lithocholic acid
C24H40O3
434-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1630 6.9216 0.0 0
M  V30 2 C 10.8005 6.6360 0.0 0 CFG=2
M  V30 3 C 10.8005 8.1760 0.0 0
M  V30 4 C 12.1341 5.8659 0.0 0
M  V30 5 C 12.1341 8.9460 0.0 0
M  V30 6 C 12.1341 10.4860 0.0 0
M  V30 7 O 13.4678 11.2560 0.0 0
M  V30 8 O 10.8005 11.2560 0.0 0
M  V30 9 C 3.3502 4.4758 0.0 0
M  V30 10 O 0.0000 0.7700 0.0 0
M  V30 11 C 8.0021 3.8501 0.0 0 CFG=2
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0021 5.3901 0.0 0 CFG=1
M  V30 14 C 9.4668 3.3742 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 9.4668 5.8659 0.0 0 CFG=1
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 10.3721 4.6201 0.0 0
M  V30 20 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0010 1.5400 0.0 0 CFG=1
M  V30 24 C 2.6673 3.8501 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 1.3337 3.0800 0.0 0
M  V30 27 C 1.3337 1.5400 0.0 0 CFG=2
M  V30 28 H 8.7952 2.5299 0.0 0
M  V30 29 H 7.5518 1.8185 0.0 0
M  V30 30 H 4.4514 5.1115 0.0 0
M  V30 31 H 8.8403 7.2729 0.0 0
M  V30 32 H 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 20 9 CFG=1
M  V30 10 1 27 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 28 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 29 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 21
M  V30 23 1 15 30 CFG=3
M  V30 24 1 16 22
M  V30 25 1 17 19
M  V30 26 1 17 31 CFG=3
M  V30 27 1 18 21
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 22 23
M  V30 31 1 23 25
M  V30 32 1 23 32 CFG=1
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 11 12 13 15 17 20 23 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β)-3-(Formyloxy)cholan-24-oic acid
C25H40O4
5015-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8306 6.9216 0.0 0
M  V30 2 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 3 C 13.4678 8.1759 0.0 0
M  V30 4 C 14.8015 5.8659 0.0 0
M  V30 5 C 14.8015 8.9459 0.0 0
M  V30 6 C 14.8015 10.4859 0.0 0
M  V30 7 O 16.1353 11.2559 0.0 0
M  V30 8 O 13.4678 11.2559 0.0 0
M  V30 9 C 6.2698 4.5675 0.0 0
M  V30 10 O 2.6674 0.7700 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 10.6695 3.8500 0.0 0 CFG=2
M  V30 14 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 15 C 10.6695 5.3900 0.0 0 CFG=1
M  V30 16 C 12.1342 3.3742 0.0 0
M  V30 17 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 18 C 9.3358 1.5400 0.0 0
M  V30 19 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 20 C 9.3358 6.1600 0.0 0
M  V30 21 C 13.0394 4.6200 0.0 0
M  V30 22 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 23 C 8.0022 5.3900 0.0 0
M  V30 24 C 8.0022 0.7700 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0 CFG=1
M  V30 26 C 5.3347 3.8500 0.0 0
M  V30 27 C 5.3347 0.7700 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 30 H 11.2214 2.4123 0.0 0
M  V30 31 H 10.4248 1.9911 0.0 0
M  V30 32 H 7.1188 5.1114 0.0 0
M  V30 33 H 11.5079 7.2728 0.0 0
M  V30 34 H 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 22 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 29 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=1
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 17 23
M  V30 25 1 17 32 CFG=3
M  V30 26 1 18 24
M  V30 27 1 19 21
M  V30 28 1 19 33 CFG=3
M  V30 29 1 20 23
M  V30 30 1 22 25
M  V30 31 1 22 26
M  V30 32 1 24 25
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 13 14 15 17 19 22 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5015-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-3881015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recognition Properties of Flavin Analogues with Bile Acid-Based
Receptors: Role of Steric Effects in Hydrogen Bond Based Molecular
Recognition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Prosenjit; Nagpal, Rekha; Pandey, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2008), 61(3), 216-222

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lithocholic acid
C24H40O3
434-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1630 6.9216 0.0 0
M  V30 2 C 10.8005 6.6360 0.0 0 CFG=2
M  V30 3 C 10.8005 8.1760 0.0 0
M  V30 4 C 12.1341 5.8659 0.0 0
M  V30 5 C 12.1341 8.9460 0.0 0
M  V30 6 C 12.1341 10.4860 0.0 0
M  V30 7 O 13.4678 11.2560 0.0 0
M  V30 8 O 10.8005 11.2560 0.0 0
M  V30 9 C 3.3502 4.4758 0.0 0
M  V30 10 O 0.0000 0.7700 0.0 0
M  V30 11 C 8.0021 3.8501 0.0 0 CFG=2
M  V30 12 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 13 C 8.0021 5.3901 0.0 0 CFG=1
M  V30 14 C 9.4668 3.3742 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 9.4668 5.8659 0.0 0 CFG=1
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 10.3721 4.6201 0.0 0
M  V30 20 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0010 1.5400 0.0 0 CFG=1
M  V30 24 C 2.6673 3.8501 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 1.3337 3.0800 0.0 0
M  V30 27 C 1.3337 1.5400 0.0 0 CFG=2
M  V30 28 H 8.7952 2.5299 0.0 0
M  V30 29 H 7.5518 1.8185 0.0 0
M  V30 30 H 4.4514 5.1115 0.0 0
M  V30 31 H 8.8403 7.2729 0.0 0
M  V30 32 H 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 20 9 CFG=1
M  V30 10 1 27 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 28 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 29 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 21
M  V30 23 1 15 30 CFG=3
M  V30 24 1 16 22
M  V30 25 1 17 19
M  V30 26 1 17 31 CFG=3
M  V30 27 1 18 21
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 22 23
M  V30 31 1 23 25
M  V30 32 1 23 32 CFG=1
M  V30 33 1 24 26
M  V30 34 1 25 27
M  V30 35 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 11 12 13 15 17 20 23 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β)-3-(Formyloxy)cholan-24-oic acid
C25H40O4
5015-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8306 6.9216 0.0 0
M  V30 2 C 13.4678 6.6359 0.0 0 CFG=2
M  V30 3 C 13.4678 8.1759 0.0 0
M  V30 4 C 14.8015 5.8659 0.0 0
M  V30 5 C 14.8015 8.9459 0.0 0
M  V30 6 C 14.8015 10.4859 0.0 0
M  V30 7 O 16.1353 11.2559 0.0 0
M  V30 8 O 13.4678 11.2559 0.0 0
M  V30 9 C 6.2698 4.5675 0.0 0
M  V30 10 O 2.6674 0.7700 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 10.6695 3.8500 0.0 0 CFG=2
M  V30 14 C 9.3358 3.0800 0.0 0 CFG=2
M  V30 15 C 10.6695 5.3900 0.0 0 CFG=1
M  V30 16 C 12.1342 3.3742 0.0 0
M  V30 17 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 18 C 9.3358 1.5400 0.0 0
M  V30 19 C 12.1342 5.8659 0.0 0 CFG=1
M  V30 20 C 9.3358 6.1600 0.0 0
M  V30 21 C 13.0394 4.6200 0.0 0
M  V30 22 C 6.6685 3.0800 0.0 0 CFG=2
M  V30 23 C 8.0022 5.3900 0.0 0
M  V30 24 C 8.0022 0.7700 0.0 0
M  V30 25 C 6.6685 1.5400 0.0 0 CFG=1
M  V30 26 C 5.3347 3.8500 0.0 0
M  V30 27 C 5.3347 0.7700 0.0 0
M  V30 28 C 4.0011 3.0800 0.0 0
M  V30 29 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 30 H 11.2214 2.4123 0.0 0
M  V30 31 H 10.4248 1.9911 0.0 0
M  V30 32 H 7.1188 5.1114 0.0 0
M  V30 33 H 11.5079 7.2728 0.0 0
M  V30 34 H 6.6685 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 22 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 29 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=1
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 17 23
M  V30 25 1 17 32 CFG=3
M  V30 26 1 18 24
M  V30 27 1 19 21
M  V30 28 1 19 33 CFG=3
M  V30 29 1 20 23
M  V30 30 1 22 25
M  V30 31 1 22 26
M  V30 32 1 24 25
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 2 13 14 15 17 19 22 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5015-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-5415582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and binding ability of bile acid-based receptors for
recognition of flavin analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Prosenjit; Pandey, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(36), 8620-8624

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
1-Aminocyclopentanecarboxylic acid
C6H11NO2
52-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8119 1.5400 0.0 0
M  V30 2 O 5.1456 2.3101 0.0 0
M  V30 3 O 3.8119 0.0000 0.0 0
M  V30 4 N 3.3833 3.5559 0.0 0
M  V30 5 C 2.4782 2.3101 0.0 0
M  V30 6 C 1.8517 0.9031 0.0 0
M  V30 7 C 1.3337 3.3405 0.0 0
M  V30 8 C 0.3202 1.0642 0.0 0
M  V30 9 C 0.0000 2.5705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 5
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Formylamino)cyclopentanecarboxylic acid
C7H11NO3
15026-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.4916 3.2617 0.0 0
M  V30 2 C 4.8253 2.4917 0.0 0
M  V30 3 O 6.1591 3.2617 0.0 0
M  V30 4 C 1.5317 3.8987 0.0 0
M  V30 5 O 2.4367 5.1445 0.0 0
M  V30 6 O 0.0000 4.0596 0.0 0
M  V30 7 C 2.1580 2.4917 0.0 0
M  V30 8 C 0.6933 2.0159 0.0 0
M  V30 9 C 3.0632 1.2459 0.0 0
M  V30 10 C 0.6933 0.4759 0.0 0
M  V30 11 C 2.1580 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 52-52-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15026-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22063357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formation of Imidazolones by Ring Closure of α-Isocyanoamides: Exploring
New Reactivities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frippiat, Steven; Leterrier, Claire; Baudequin, Christine; Hoarau,
Christophe; Bischoff, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2020), 31(12), 1211-1215

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Glycine
C2H5NO2
56-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formylglycine
C3H5NO3
2491-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 N 4.0011 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-40-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2491-15-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5975640
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 39377-45-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable catalyst, exothermic, nano rod-shaped basic
Al2O3 catalyst used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nano rod-shaped and reusable basic Al2O3 catalyst for N-formylation of
amines under solvent-free conditions: A novel, practical and convenient
NOSE' approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Vijay Kumar; Devi, Rashmi Rekha; Raul, Prasanta Kumar; Thakur, Ashim
Jyoti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2012), 14(3), 847-854

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodoaniline
C6H6IN
615-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)formamide
C7H6INO
10113-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 I 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10113-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodoaniline
C6H6IN
615-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)formamide
C7H6INO
10113-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 I 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10113-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11297492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(2-(Phenylethynyl)phenyl)formamide (S1): To formic acid (2.41 mL, 63.9
mmol) was added acetic anhydride (2.16 mL, 22.8 mmol) and the mixure was
stirred at room temperature. After stirring for 10 min, to the mixture
was added the solution of o-iodoaniline (3.99 g, 18.3 mmol) in CH2Cl2 (60
mL) and the mixture was stirred at room temperature. After stirring for 2
h, the mixture was concentrated under reduced pressure to give product.
o-iodoformanilide as a white solid, yield 4.42 g, 98%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Acyl-2-arylindole via Palladium-catalyzed Isocyanide
Insertion and Oxypalladation of Alkyne
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nanjo, Takeshi; Yamamoto, Sho; Tsukano, Chihiro; Takemoto, Yoshiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2013), 15(14), 3754-3757

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Difluoro-1,2-phenylenediamine
C6H6F2N2
76179-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6674 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 N 4.6200 5.3349 0.0 0
M  V30 4 N 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Difluoro-1H-benzimidazole
C7H4F2N2
78581-99-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 0.0000 0.0 0
M  V30 2 F 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 N 5.4658 0.2941 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 5.4658 2.7859 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 10 C 6.3710 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76179-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 78581-99-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13838863
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of benzo[d]imidazole derivatives as
potential anti-cancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alkahtani, Hamad M.; Abbas, Abdullahi Y.; Wang, Shudong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(3), 1317-1321

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,3,3-Tetramethylguanidine
C5H13N3
80-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 N 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,3,3-Tetramethylguanidine formate
C5H13N3.CH2O2
56580-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 N 1.3338 4.6200 0.0 0
M  V30 4 N 2.6674 2.3100 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0
M  V30 6 C 5.3349 3.8500 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 1.3338 6.1600 0.0 0
M  V30 9 C 2.6674 0.0000 0.0 0
M  V30 10 O 1.3338 0.7700 0.0 0
M  V30 11 O 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 9 10
M  V30 9 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56580-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25329238
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1,1,3,3-Tetramethylguanidine was purchased
from Baigui Chemical Company (Shijiaihuang, China). All acids and
solvents (analytical grade) were purchased from Beijing Chemical Reagent
Plant (Beijing, China). We only describe the procedures to synthesize
1,1,3,3-tetramethylguanidinium trifluoroacetate (1), because those to
prepare the other four ILs (2-4) are similar. The main difference was
that the corresponding acids were used. In a typical experiment, 100 mL
ethanol and 2.30 g TMG (20.0 mmol) were loaded into a 250-mL flask in a
water bath of 25°C. Then 20.0 mmol CF3COOH in 35 mL ethanol was charged
into the flask under stirring. The reaction lasted for 2 hours. The
reaction mixture was. evaporated under reduced pressure. The crude oily
residue was dissolved in 100 mL ethanol, treated with active carbon,
filtered, and evaporated under vacuum, and 3.8 g colorless product was
obtained with a yield of 92.6%. The ILs were characterized by
differential scanning calorimetry (DSC, Perkin-Elmer DSC-7),
thermogravimetric analysis (TGA, Perkin-Elmer TDA-7), DDS-307
Conductivity Meter (Shanghai). Infrared spectra were determined using a
Perkin-Elmer 83. 1H NMR spectra were recorded on a Bruker AM 300
spectrometer with TMS as the internal standard. Fast atom
bombardment-mass spectrometry (FAB-MS) were carried on LCMS-2010 mass
spectrometer (Shimadzu, Japan), and the results are as follow.
1,1,3,3-Tetramethylguanidinium formate (4) (yield 97.6%). 1H NMR (300
MHz, D2O) 2.70(s, 12H), 8.20(s, 1H). IR 3281, 3107, 1648, 1608, 1566,
1411, 1085, 1064, 1038, 623 cm-1. Positive ion FAB-MS: m/z: 116 (M + H+)
negative ion FAB-MS: m/z: 137 (M+CH2(OH)CH(OH)CH2OH-H-).
$DTYPE RXN:VAR(1):NOTES
$DATUM product is ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of room-temperature ionic liquids by neutralization of
1,1,3,3-tetramethylguanidine with acids and their use as media for
Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Haixiang; Han, Buxing; Li, Junchun; Jiang, Tao; Liu, Zhimin; Wu,
Weize; Chang, Yanhong; Zhang, Jianmin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2004), 34(17), 3083-3089

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cholic acid
C24H40O5
81-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 8.1631 6.9216 0.0 0
M  V30 3 C 3.3501 4.4757 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 6.6684 7.7000 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 16 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 17 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 18 C 9.4667 3.3740 0.0 0
M  V30 19 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 20 C 5.3347 5.3900 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 10.3720 4.6200 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 26 C 2.6673 3.8500 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3336 3.0800 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 30 H 7.7573 1.9909 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 4.2458 4.9390 0.0 0
M  V30 33 H 10.8004 6.6359 0.0 0
M  V30 34 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 17 2 CFG=1
M  V30 3 1 19 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 11 CFG=3
M  V30 12 1 29 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=3
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 15 32 CFG=3
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 19 26
M  V30 29 1 20 23
M  V30 30 1 21 25
M  V30 31 1 22 24
M  V30 32 1 22 33 CFG=3
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 13 14 15 16 17 19 22 23 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,7α,12α)-3,7,12-Tris(formyloxy)cholan-24-oic acid
C27H40O8
2097-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 10.6695 0.7700 0.0 0
M  V30 3 O 12.0032 0.0000 0.0 0
M  V30 4 C 10.8305 8.4616 0.0 0
M  V30 5 C 6.0176 6.0158 0.0 0
M  V30 6 O 9.3357 9.2401 0.0 0
M  V30 7 C 8.0021 10.0101 0.0 0
M  V30 8 O 8.0021 11.5501 0.0 0
M  V30 9 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 10 C 12.4130 10.0586 0.0 0
M  V30 11 C 9.9762 8.9737 0.0 0
M  V30 12 C 11.7865 11.4656 0.0 0
M  V30 13 C 12.6917 12.7114 0.0 0
M  V30 14 O 12.0654 14.1182 0.0 0
M  V30 15 O 14.2233 12.5505 0.0 0
M  V30 16 O 2.6673 2.3100 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 O 0.0000 2.3100 0.0 0
M  V30 19 C 9.3357 4.6200 0.0 0 CFG=2
M  V30 20 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 21 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 22 C 9.3357 3.0800 0.0 0 CFG=2
M  V30 23 C 10.6695 6.9301 0.0 0 CFG=2
M  V30 24 C 12.1341 4.9140 0.0 0
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 26 C 8.0021 6.9301 0.0 0
M  V30 27 C 8.0021 2.3100 0.0 0
M  V30 28 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 29 C 12.1341 7.4059 0.0 0 CFG=1
M  V30 30 C 13.0393 6.1601 0.0 0
M  V30 31 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 32 C 5.3348 5.3901 0.0 0
M  V30 33 C 5.3348 2.3100 0.0 0
M  V30 34 C 4.0010 4.6200 0.0 0
M  V30 35 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 36 H 10.4247 3.5309 0.0 0
M  V30 37 H 11.2213 3.9523 0.0 0
M  V30 38 H 6.9131 6.4790 0.0 0
M  V30 39 H 13.4677 8.1759 0.0 0
M  V30 40 H 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 23 4 CFG=1
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 28 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 35 16 CFG=3
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 37 CFG=3
M  V30 26 1 21 25
M  V30 27 1 21 26
M  V30 28 1 21 38 CFG=3
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 1 26 28
M  V30 36 1 27 31
M  V30 37 1 29 30
M  V30 38 1 29 39 CFG=3
M  V30 39 1 31 33
M  V30 40 1 31 40 CFG=1
M  V30 41 1 32 34
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 9 19 20 21 22 23 25 28 29 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-10295284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recognition Properties of Flavin Analogues with Bile Acid-Based
Receptors: Role of Steric Effects in Hydrogen Bond Based Molecular
Recognition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Prosenjit; Nagpal, Rekha; Pandey, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2008), 61(3), 216-222

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cholic acid
C24H40O5
81-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 8.1631 6.9216 0.0 0
M  V30 3 C 3.3501 4.4757 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 6.6684 7.7000 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 16 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 17 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 18 C 9.4667 3.3740 0.0 0
M  V30 19 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 20 C 5.3347 5.3900 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 10.3720 4.6200 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 26 C 2.6673 3.8500 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3336 3.0800 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 30 H 7.7573 1.9909 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 4.2458 4.9390 0.0 0
M  V30 33 H 10.8004 6.6359 0.0 0
M  V30 34 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 17 2 CFG=1
M  V30 3 1 19 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 11 CFG=3
M  V30 12 1 29 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=3
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 15 32 CFG=3
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 19 26
M  V30 29 1 20 23
M  V30 30 1 21 25
M  V30 31 1 22 24
M  V30 32 1 22 33 CFG=3
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 13 14 15 16 17 19 22 23 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,7α,12α)-3,7,12-Tris(formyloxy)cholan-24-oic acid
C27H40O8
2097-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 10.6695 0.7700 0.0 0
M  V30 3 O 12.0032 0.0000 0.0 0
M  V30 4 C 10.8305 8.4616 0.0 0
M  V30 5 C 6.0176 6.0158 0.0 0
M  V30 6 O 9.3357 9.2401 0.0 0
M  V30 7 C 8.0021 10.0101 0.0 0
M  V30 8 O 8.0021 11.5501 0.0 0
M  V30 9 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 10 C 12.4130 10.0586 0.0 0
M  V30 11 C 9.9762 8.9737 0.0 0
M  V30 12 C 11.7865 11.4656 0.0 0
M  V30 13 C 12.6917 12.7114 0.0 0
M  V30 14 O 12.0654 14.1182 0.0 0
M  V30 15 O 14.2233 12.5505 0.0 0
M  V30 16 O 2.6673 2.3100 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 O 0.0000 2.3100 0.0 0
M  V30 19 C 9.3357 4.6200 0.0 0 CFG=2
M  V30 20 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 21 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 22 C 9.3357 3.0800 0.0 0 CFG=2
M  V30 23 C 10.6695 6.9301 0.0 0 CFG=2
M  V30 24 C 12.1341 4.9140 0.0 0
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 26 C 8.0021 6.9301 0.0 0
M  V30 27 C 8.0021 2.3100 0.0 0
M  V30 28 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 29 C 12.1341 7.4059 0.0 0 CFG=1
M  V30 30 C 13.0393 6.1601 0.0 0
M  V30 31 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 32 C 5.3348 5.3901 0.0 0
M  V30 33 C 5.3348 2.3100 0.0 0
M  V30 34 C 4.0010 4.6200 0.0 0
M  V30 35 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 36 H 10.4247 3.5309 0.0 0
M  V30 37 H 11.2213 3.9523 0.0 0
M  V30 38 H 6.9131 6.4790 0.0 0
M  V30 39 H 13.4677 8.1759 0.0 0
M  V30 40 H 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 23 4 CFG=1
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 28 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 35 16 CFG=3
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 37 CFG=3
M  V30 26 1 21 25
M  V30 27 1 21 26
M  V30 28 1 21 38 CFG=3
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 1 26 28
M  V30 36 1 27 31
M  V30 37 1 29 30
M  V30 38 1 29 39 CFG=3
M  V30 39 1 31 33
M  V30 40 1 31 40 CFG=1
M  V30 41 1 32 34
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 9 19 20 21 22 23 25 28 29 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-13177878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bile acid-based receptors containing 2,6-bis(acylamino)pyridine for
recognition of uracil derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Prosenjit; Pandey, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(6), 1553-1557

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cholic acid
C24H40O5
81-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 8.1631 6.9216 0.0 0
M  V30 3 C 3.3501 4.4757 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 6.6684 7.7000 0.0 0
M  V30 12 O 0.0000 0.7700 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 16 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 17 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 18 C 9.4667 3.3740 0.0 0
M  V30 19 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 20 C 5.3347 5.3900 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 9.4667 5.8659 0.0 0 CFG=1
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 10.3720 4.6200 0.0 0
M  V30 25 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 26 C 2.6673 3.8500 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3336 3.0800 0.0 0
M  V30 29 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 30 H 7.7573 1.9909 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 4.2458 4.9390 0.0 0
M  V30 33 H 10.8004 6.6359 0.0 0
M  V30 34 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 1 17 2 CFG=1
M  V30 3 1 19 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 11 CFG=3
M  V30 12 1 29 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 30 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 31 CFG=3
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 15 32 CFG=3
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 19 26
M  V30 29 1 20 23
M  V30 30 1 21 25
M  V30 31 1 22 24
M  V30 32 1 22 33 CFG=3
M  V30 33 1 25 27
M  V30 34 1 25 34 CFG=1
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 13 14 15 16 17 19 22 23 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α,5β,7α,12α)-3,7,12-Tris(formyloxy)cholan-24-oic acid
C27H40O8
2097-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 2.3100 0.0 0
M  V30 2 C 10.6695 0.7700 0.0 0
M  V30 3 O 12.0032 0.0000 0.0 0
M  V30 4 C 10.8305 8.4616 0.0 0
M  V30 5 C 6.0176 6.0158 0.0 0
M  V30 6 O 9.3357 9.2401 0.0 0
M  V30 7 C 8.0021 10.0101 0.0 0
M  V30 8 O 8.0021 11.5501 0.0 0
M  V30 9 C 11.5078 8.8127 0.0 0 CFG=2
M  V30 10 C 12.4130 10.0586 0.0 0
M  V30 11 C 9.9762 8.9737 0.0 0
M  V30 12 C 11.7865 11.4656 0.0 0
M  V30 13 C 12.6917 12.7114 0.0 0
M  V30 14 O 12.0654 14.1182 0.0 0
M  V30 15 O 14.2233 12.5505 0.0 0
M  V30 16 O 2.6673 2.3100 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 O 0.0000 2.3100 0.0 0
M  V30 19 C 9.3357 4.6200 0.0 0 CFG=2
M  V30 20 C 10.6695 5.3901 0.0 0 CFG=2
M  V30 21 C 8.0021 5.3901 0.0 0 CFG=2
M  V30 22 C 9.3357 3.0800 0.0 0 CFG=2
M  V30 23 C 10.6695 6.9301 0.0 0 CFG=2
M  V30 24 C 12.1341 4.9140 0.0 0
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 26 C 8.0021 6.9301 0.0 0
M  V30 27 C 8.0021 2.3100 0.0 0
M  V30 28 C 9.3357 7.7001 0.0 0 CFG=1
M  V30 29 C 12.1341 7.4059 0.0 0 CFG=1
M  V30 30 C 13.0393 6.1601 0.0 0
M  V30 31 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 32 C 5.3348 5.3901 0.0 0
M  V30 33 C 5.3348 2.3100 0.0 0
M  V30 34 C 4.0010 4.6200 0.0 0
M  V30 35 C 4.0010 3.0800 0.0 0 CFG=2
M  V30 36 H 10.4247 3.5309 0.0 0
M  V30 37 H 11.2213 3.9523 0.0 0
M  V30 38 H 6.9131 6.4790 0.0 0
M  V30 39 H 13.4677 8.1759 0.0 0
M  V30 40 H 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 23 4 CFG=1
M  V30 5 1 25 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 28 6 CFG=3
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 35 16 CFG=3
M  V30 18 2 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 36 CFG=1
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 20 37 CFG=3
M  V30 26 1 21 25
M  V30 27 1 21 26
M  V30 28 1 21 38 CFG=3
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 1 23 29
M  V30 32 1 24 30
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 1 26 28
M  V30 36 1 27 31
M  V30 37 1 29 30
M  V30 38 1 29 39 CFG=3
M  V30 39 1 31 33
M  V30 40 1 31 40 CFG=1
M  V30 41 1 32 34
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 9 19 20 21 22 23 25 28 29 31 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-5859888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Scalable Stereoselective Synthesis of Scymnol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adhikari, Raju; Cundy, Darren J.; Francis, Craig L.; Gebara-Coghlan,
Mariana; Krywult, Beata; Lubin, Carolyn; Simpson, Gregory W.; Yang, Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2005), 58(1), 34-38

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[2-[(1R,3R,4S,5S)-3-chloro-4-ethenyl-5-(methoxyamino)...
C25H35ClN2O3
878006-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.1079 2.5135 0.0 0
M  V30 2 O 1.6204 2.1149 0.0 0
M  V30 3 C 1.2218 0.6274 0.0 0
M  V30 4 C 7.2787 6.9761 0.0 0
M  V30 5 C 8.3677 5.0901 0.0 0
M  V30 6 C 1.5342 3.8285 0.0 0
M  V30 7 C 0.0000 3.9628 0.0 0
M  V30 8 C 1.0218 5.7409 0.0 0
M  V30 9 N 9.5616 4.0011 0.0 0
M  V30 10 C 11.1017 4.0011 0.0 0
M  V30 11 O 11.8717 5.3348 0.0 0
M  V30 12 O 11.8717 2.6673 0.0 0
M  V30 13 C 13.4117 5.3348 0.0 0
M  V30 14 C 13.4117 6.8748 0.0 0
M  V30 15 C 14.9517 5.3348 0.0 0
M  V30 16 C 13.4117 3.7948 0.0 0
M  V30 17 Cl 1.7271 7.6665 0.0 0
M  V30 18 C 4.9940 4.3997 0.0 0
M  V30 19 C 6.4816 4.0011 0.0 0
M  V30 20 C 5.3927 5.8872 0.0 0 CFG=2
M  V30 21 C 3.5065 4.0011 0.0 0 CFG=2
M  V30 22 C 6.8802 5.4886 0.0 0
M  V30 23 C 4.3037 6.9761 0.0 0
M  V30 24 C 2.4175 5.0901 0.0 0 CFG=2
M  V30 25 C 2.8161 6.5776 0.0 0 CFG=1
M  V30 26 C 7.2516 2.6673 0.0 0
M  V30 27 C 8.7916 2.6673 0.0 0
M  V30 28 C 6.4816 1.3337 0.0 0
M  V30 29 C 9.5616 1.3337 0.0 0
M  V30 30 C 7.2516 0.0000 0.0 0
M  V30 31 C 8.7916 0.0000 0.0 0
M  V30 32 H 6.1627 7.2208 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 4 22
M  V30 5 1 5 22
M  V30 6 2 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 24 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 25 17 CFG=3
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 26
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 20 32 CFG=1
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[2-[(1R,3R,4S,5S)-3-chloro-4-ethenyl-5-(formylmethoxy...
C26H35ClN2O4
878006-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6268 5.3348 0.0 0
M  V30 2 C 3.3969 6.6685 0.0 0
M  V30 3 O 1.0868 5.3348 0.0 0
M  V30 4 O 2.6268 8.0022 0.0 0
M  V30 5 C 0.3168 6.6685 0.0 0
M  V30 6 C 7.8106 2.1037 0.0 0
M  V30 7 C 8.3742 4.2074 0.0 0
M  V30 8 C 1.4470 3.6573 0.0 0
M  V30 9 C 0.0000 3.1306 0.0 0
M  V30 10 C 1.4470 1.6774 0.0 0
M  V30 11 N 9.2457 5.5683 0.0 0
M  V30 12 C 10.7333 5.9669 0.0 0
M  V30 13 O 11.8222 4.8779 0.0 0
M  V30 14 O 11.1318 7.4544 0.0 0
M  V30 15 C 13.3097 5.2765 0.0 0
M  V30 16 C 12.9112 6.7640 0.0 0
M  V30 17 C 14.7973 5.6750 0.0 0
M  V30 18 C 13.7083 3.7889 0.0 0
M  V30 19 Cl 2.6268 0.0000 0.0 0
M  V30 20 C 4.9369 4.0010 0.0 0
M  V30 21 C 6.2706 4.7710 0.0 0
M  V30 22 C 3.3969 4.0010 0.0 0 CFG=2
M  V30 23 C 5.7069 2.6673 0.0 0 CFG=2
M  V30 24 C 7.0406 3.4374 0.0 0
M  V30 25 C 2.6268 2.6673 0.0 0 CFG=2
M  V30 26 C 4.9369 1.3337 0.0 0
M  V30 27 C 3.3969 1.3337 0.0 0 CFG=2
M  V30 28 C 6.6691 6.2587 0.0 0
M  V30 29 C 8.1568 6.6573 0.0 0
M  V30 30 C 5.5802 7.3477 0.0 0
M  V30 31 C 8.5554 8.1448 0.0 0
M  V30 32 C 5.9787 8.8352 0.0 0
M  V30 33 C 7.4664 9.2337 0.0 0
M  V30 34 H 6.7959 1.5784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 22 1 CFG=1
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 24
M  V30 7 1 7 24
M  V30 8 2 8 9
M  V30 9 1 25 8 CFG=1
M  V30 10 1 25 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 27 19 CFG=1
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 1 21 28
M  V30 25 1 22 25
M  V30 26 1 23 24
M  V30 27 1 23 26
M  V30 28 1 23 34 CFG=3
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 22 23 25 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 878006-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878006-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9194404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of methoxyamide 126. To a solution of 125 (54.0 mg, 0.121
mmol) in 6 mL of CH2Cl2 at under N2 was added 100.0 μL of acetic formic
anhydride (prepared from heating 0.4 mL HCOOH and 0.8 mL of (CH3CO)2O to
65 °C for 45 min under N2). The resulting solution was stirred for 1 hour
at room temperature, then concentrated under reduced pressure. The
residue was purified by silica gel chromatography (gradient elution,
0→30% EtOAc/Hexanes) to give 56.0 mg (98% yield) of 126 as a colorless
oil. 1H NMR spectra shows two sets of broad peaks for 126 due to rotamers
(see attached spectra). The material was generally used immediately in
the subsequent reaction. Methoxy Amide 126: FTIR (NaCl/thin film) 3421
(m), 2976 (m), 2877 (m), 1731 (s), 1689 (s), 1516 (s), 1446 (s), 1367
(m), 1236 (m), 1158 (s), 734 (m); LRMS (ES+) calc’d for C26H36ClN2O4
[M+H] 475.24, found 475.47.
$DTYPE RXN:VAR(1):NOTES
$DATUM formic acetic anhydride generated first stage, product used immediately
for subsequent reaction, in-situ generated reagent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evolution of a Synthetic Strategy: Total Synthesis of
(±)-Welwitindolinone A Isonitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reisman, Sarah E.; Ready, Joseph M.; Weiss, Matthew M.; Hasuoka, Atsushi;
Hirata, Makoto; Tamaki, Kazuhiko; Ovaska, Timo V.; Smith, Catherine J.;
Wood, John L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(6), 2087-2100

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Dimethylamino)ethanol
C4H11NO
108-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 O 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-(dimethylamino)ethanol (1:1)
C4H11NO.CH2O2
59101-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 N 1.3338 3.8500 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 O 5.3349 4.6200 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 O 1.3338 0.7700 0.0 0
M  V30 9 O 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 7 8
M  V30 7 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59101-30-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30116933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, product is an ionic liquid, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyl ammonium ionic liquids as media for biocatalytic oxidations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Papadopoulou, Athena A.; Tzani, Andromachi; Alivertis, Dimitrios;
Katsoura, Maria H.; Polydera, Angeliki C.; Detsi, Anastasia; Stamatis,
Haralambos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(4), 1147-1158

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanolamine
C2H7NO
141-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxyethylammonium formate
C2H7NO.CH2O2
53226-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3100 0.0 0
M  V30 2 C 2.6673 3.0800 0.0 0
M  V30 3 N 0.0000 3.0800 0.0 0
M  V30 4 O 4.0010 2.3100 0.0 0
M  V30 5 C 2.0005 0.0000 0.0 0
M  V30 6 O 0.6668 0.7700 0.0 0
M  V30 7 O 3.3342 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53226-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29757717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, product is an ionic liquid, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyl ammonium ionic liquids as media for biocatalytic oxidations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Papadopoulou, Athena A.; Tzani, Andromachi; Alivertis, Dimitrios;
Katsoura, Maria H.; Polydera, Angeliki C.; Detsi, Anastasia; Stamatis,
Haralambos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(4), 1147-1158

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
1-Piperidinecarboxylic acid, 4-[3-(2,6-dioxo-3-piperidinyl)-1-ethyl-1H-indazo...
C24H30F2N4O4
2912305-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.6486 3.7430 0.0 0
M  V30 2 C 6.1438 1.0304 0.0 0
M  V30 3 C 4.9995 0.0000 0.0 0
M  V30 4 O 0.0000 8.8165 0.0 0
M  V30 5 F 11.7416 7.8652 0.0 0
M  V30 6 F 10.0271 6.8753 0.0 0
M  V30 7 C 15.3242 5.0149 0.0 0
M  V30 8 O 16.0942 3.6812 0.0 0
M  V30 9 O 16.0942 6.3485 0.0 0
M  V30 10 C 17.6342 3.6812 0.0 0
M  V30 11 C 17.6342 2.1412 0.0 0
M  V30 12 C 19.1742 3.6812 0.0 0
M  V30 13 C 17.6342 5.2212 0.0 0
M  V30 14 C 4.5778 4.6947 0.0 0
M  V30 15 C 6.0842 5.0149 0.0 0
M  V30 16 N 4.4169 3.1632 0.0 0
M  V30 17 C 6.8542 3.6812 0.0 0
M  V30 18 C 6.8542 6.3485 0.0 0
M  V30 19 N 5.8237 2.5367 0.0 0
M  V30 20 C 8.3942 3.6812 0.0 0
M  V30 21 C 8.3942 6.3485 0.0 0
M  V30 22 C 9.1642 5.0149 0.0 0
M  V30 23 C 3.4334 5.7251 0.0 0
M  V30 24 C 1.9687 5.2492 0.0 0
M  V30 25 C 3.7536 7.2315 0.0 0
M  V30 26 N 0.8244 6.2798 0.0 0
M  V30 27 C 2.6091 8.2619 0.0 0
M  V30 28 C 1.1445 7.7861 0.0 0
M  V30 29 C 10.7042 5.0149 0.0 0
M  V30 30 C 11.4742 6.3485 0.0 0
M  V30 31 C 11.4742 3.6812 0.0 0
M  V30 32 C 13.0142 6.3485 0.0 0
M  V30 33 C 13.0142 3.6812 0.0 0
M  V30 34 N 13.7842 5.0149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 2 4 28
M  V30 5 1 5 30
M  V30 6 1 6 30
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 34
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 22 29
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 3-[6-(3,3-difluoro-4-piperidinyl)-1-ethyl-1H-indazol...
C19H22F2N4O2.CH2O2
2912305-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6246 3.7746 0.0 0
M  V30 2 C 5.1004 2.3100 0.0 0
M  V30 3 O 9.8739 3.8761 0.0 0
M  V30 4 O 13.8384 7.4457 0.0 0
M  V30 5 F 3.1940 12.4927 0.0 0
M  V30 6 F 4.1840 10.7782 0.0 0
M  V30 7 C 6.6685 7.1955 0.0 0
M  V30 8 C 7.8129 6.1650 0.0 0
M  V30 9 C 5.3348 6.4254 0.0 0
M  V30 10 C 6.6685 8.7355 0.0 0
M  V30 11 N 7.1865 4.7582 0.0 0
M  V30 12 N 5.6550 4.9191 0.0 0
M  V30 13 C 4.0010 7.1955 0.0 0
M  V30 14 C 5.3348 9.5055 0.0 0
M  V30 15 C 4.0010 8.7355 0.0 0
M  V30 16 C 9.3193 6.4852 0.0 0
M  V30 17 C 10.3498 5.3408 0.0 0
M  V30 18 C 9.7952 7.9499 0.0 0
M  V30 19 N 11.8562 5.6610 0.0 0
M  V30 20 C 11.3017 8.2701 0.0 0
M  V30 21 C 12.3321 7.1255 0.0 0
M  V30 22 C 2.6673 9.5055 0.0 0
M  V30 23 C 2.6673 11.0455 0.0 0
M  V30 24 C 1.3337 8.7355 0.0 0
M  V30 25 C 1.3337 11.8155 0.0 0
M  V30 26 C 0.0000 9.5055 0.0 0
M  V30 27 N 0.0000 11.0455 0.0 0
M  V30 28 C 6.9192 0.0000 0.0 0
M  V30 29 O 5.5855 0.7700 0.0 0
M  V30 30 O 8.2529 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 17
M  V30 4 2 4 21
M  V30 5 1 5 23
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 16
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 15 22
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2912305-06-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2912305-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36098118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carried out using reverse phase column chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of protein tyrosine phosphatase targeting ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veits, Gesine Kerstin; Fitzgerald, Mark E.; Hird, Alexander W.;
Henderson, James A.; Vora, Harit U.; Sweis, Ramzi F.; Kort, Michael E.;
Matulenko, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023019166 A1 2023-02-16

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenoxy)ethanol
C8H9FO2
2924-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 F 0.0000 0.0000 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(4-fluorophenoxy)-, 1-formate
C9H9FO3
2417431-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 O 12.0033 2.3101 0.0 0
M  V30 7 F 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2924-66-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-38-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24470071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[6-[[[3-[[6-chloro-3-[(methylamino)carbonyl]-4-pyridazinyl]a...
C28H32ClN9O5
2941179-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.1557 0.0 0
M  V30 2 C 4.0010 5.9257 0.0 0
M  V30 3 N 5.3348 8.2358 0.0 0
M  V30 4 C 10.6697 8.2358 0.0 0
M  V30 5 O 12.0033 7.4658 0.0 0
M  V30 6 C 13.3370 8.2358 0.0 0
M  V30 7 C 6.3269 0.0000 0.0 0
M  V30 8 C 2.6673 9.7758 0.0 0
M  V30 9 N 1.3337 10.5458 0.0 0
M  V30 10 O 2.6673 8.2358 0.0 0
M  V30 11 C 0.0000 9.7758 0.0 0
M  V30 12 Cl 8.0022 12.8559 0.0 0
M  V30 13 N 18.6718 8.2358 0.0 0
M  V30 14 C 20.0057 7.4658 0.0 0
M  V30 15 O 21.3393 8.2358 0.0 0
M  V30 16 O 20.0057 5.9257 0.0 0
M  V30 17 C 22.6730 7.4658 0.0 0
M  V30 18 C 23.4430 8.7996 0.0 0
M  V30 19 C 24.0067 6.6958 0.0 0
M  V30 20 C 21.9030 6.1321 0.0 0
M  V30 21 C 8.0022 5.1557 0.0 0
M  V30 22 C 6.6685 5.9257 0.0 0
M  V30 23 C 9.3358 5.9257 0.0 0
M  V30 24 C 6.6685 7.4658 0.0 0
M  V30 25 C 9.3358 7.4658 0.0 0
M  V30 26 C 8.0022 8.2358 0.0 0
M  V30 27 C 8.0022 3.6157 0.0 0
M  V30 28 N 6.7563 2.7105 0.0 0
M  V30 29 N 9.2481 2.7105 0.0 0
M  V30 30 N 7.2322 1.2459 0.0 0
M  V30 31 C 8.7722 1.2459 0.0 0
M  V30 32 C 5.3348 9.7758 0.0 0
M  V30 33 C 4.0010 10.5458 0.0 0
M  V30 34 C 6.6685 10.5458 0.0 0
M  V30 35 N 4.0010 12.0859 0.0 0
M  V30 36 C 6.6685 12.0859 0.0 0
M  V30 37 N 5.3348 12.8559 0.0 0
M  V30 38 C 14.6708 7.4658 0.0 0
M  V30 39 N 16.0045 8.2358 0.0 0
M  V30 40 C 14.6708 5.9257 0.0 0
M  V30 41 C 17.3382 7.4658 0.0 0
M  V30 42 C 16.0045 5.1557 0.0 0
M  V30 43 C 17.3382 5.9257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 24
M  V30 4 1 3 32
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 5 6
M  V30 8 1 6 38
M  V30 9 1 7 30
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 33
M  V30 13 1 9 11
M  V30 14 1 12 36
M  V30 15 1 13 14
M  V30 16 1 13 41
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 21 27
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-[[5-[[(6-amino-2-pyridinyl)methoxy]methyl]-2-metho...
C23H24ClN9O3.CH2O2
2941179-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 7.4657 0.0 0
M  V30 2 C 4.0011 8.2357 0.0 0
M  V30 3 N 5.3347 10.5457 0.0 0
M  V30 4 C 10.6695 10.5457 0.0 0
M  V30 5 O 12.0033 9.7757 0.0 0
M  V30 6 C 13.3369 10.5457 0.0 0
M  V30 7 C 9.6774 2.3100 0.0 0
M  V30 8 C 2.6674 12.0857 0.0 0
M  V30 9 N 1.3336 12.8557 0.0 0
M  V30 10 O 2.6674 10.5457 0.0 0
M  V30 11 C 0.0000 12.0857 0.0 0
M  V30 12 Cl 8.0022 15.1657 0.0 0
M  V30 13 N 18.6717 10.5457 0.0 0
M  V30 14 C 8.0022 7.4657 0.0 0
M  V30 15 C 6.6684 8.2357 0.0 0
M  V30 16 C 9.3358 8.2357 0.0 0
M  V30 17 C 6.6684 9.7757 0.0 0
M  V30 18 C 9.3358 9.7757 0.0 0
M  V30 19 C 8.0022 10.5457 0.0 0
M  V30 20 C 8.0022 5.9256 0.0 0
M  V30 21 N 6.7563 5.0204 0.0 0
M  V30 22 N 9.2481 5.0204 0.0 0
M  V30 23 C 7.2322 3.5559 0.0 0
M  V30 24 N 8.7722 3.5559 0.0 0
M  V30 25 C 5.3347 12.0857 0.0 0
M  V30 26 C 4.0011 12.8557 0.0 0
M  V30 27 C 6.6684 12.8557 0.0 0
M  V30 28 N 4.0011 14.3957 0.0 0
M  V30 29 C 6.6684 14.3957 0.0 0
M  V30 30 N 5.3347 15.1657 0.0 0
M  V30 31 C 14.6706 9.7757 0.0 0
M  V30 32 N 16.0042 10.5457 0.0 0
M  V30 33 C 14.6706 8.2357 0.0 0
M  V30 34 C 17.3380 9.7757 0.0 0
M  V30 35 C 16.0042 7.4657 0.0 0
M  V30 36 C 17.3380 8.2357 0.0 0
M  V30 37 C 9.3358 0.0000 0.0 0
M  V30 38 O 8.0022 0.7700 0.0 0
M  V30 39 O 10.6695 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 17
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 31
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 26
M  V30 13 1 9 11
M  V30 14 1 12 29
M  V30 15 1 13 34
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 40 1 37 38
M  V30 41 2 37 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2941179-05-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2941179-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37884821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylamines as TYK2 inhibitors and compositions and methods for
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wan, Zhaokui; Vazquez, Michael Lawrence; Grewal, Gurmit; Li, Xiaodong;
Su, Lin; Wu, Jingyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023109954 A1 2023-06-22

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[6-[[[3-[[6-chloro-3-[(methylamino)carbonyl]-4-pyridazinyl]a...
C28H32ClN9O5
2941179-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.1557 0.0 0
M  V30 2 C 4.0010 5.9257 0.0 0
M  V30 3 N 5.3348 8.2358 0.0 0
M  V30 4 C 10.6697 8.2358 0.0 0
M  V30 5 O 12.0033 7.4658 0.0 0
M  V30 6 C 13.3370 8.2358 0.0 0
M  V30 7 C 6.3269 0.0000 0.0 0
M  V30 8 C 2.6673 9.7758 0.0 0
M  V30 9 N 1.3337 10.5458 0.0 0
M  V30 10 O 2.6673 8.2358 0.0 0
M  V30 11 C 0.0000 9.7758 0.0 0
M  V30 12 Cl 8.0022 12.8559 0.0 0
M  V30 13 N 18.6718 8.2358 0.0 0
M  V30 14 C 20.0057 7.4658 0.0 0
M  V30 15 O 21.3393 8.2358 0.0 0
M  V30 16 O 20.0057 5.9257 0.0 0
M  V30 17 C 22.6730 7.4658 0.0 0
M  V30 18 C 23.4430 8.7996 0.0 0
M  V30 19 C 24.0067 6.6958 0.0 0
M  V30 20 C 21.9030 6.1321 0.0 0
M  V30 21 C 8.0022 5.1557 0.0 0
M  V30 22 C 6.6685 5.9257 0.0 0
M  V30 23 C 9.3358 5.9257 0.0 0
M  V30 24 C 6.6685 7.4658 0.0 0
M  V30 25 C 9.3358 7.4658 0.0 0
M  V30 26 C 8.0022 8.2358 0.0 0
M  V30 27 C 8.0022 3.6157 0.0 0
M  V30 28 N 6.7563 2.7105 0.0 0
M  V30 29 N 9.2481 2.7105 0.0 0
M  V30 30 N 7.2322 1.2459 0.0 0
M  V30 31 C 8.7722 1.2459 0.0 0
M  V30 32 C 5.3348 9.7758 0.0 0
M  V30 33 C 4.0010 10.5458 0.0 0
M  V30 34 C 6.6685 10.5458 0.0 0
M  V30 35 N 4.0010 12.0859 0.0 0
M  V30 36 C 6.6685 12.0859 0.0 0
M  V30 37 N 5.3348 12.8559 0.0 0
M  V30 38 C 14.6708 7.4658 0.0 0
M  V30 39 N 16.0045 8.2358 0.0 0
M  V30 40 C 14.6708 5.9257 0.0 0
M  V30 41 C 17.3382 7.4658 0.0 0
M  V30 42 C 16.0045 5.1557 0.0 0
M  V30 43 C 17.3382 5.9257 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 3 24
M  V30 4 1 3 32
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 5 6
M  V30 8 1 6 38
M  V30 9 1 7 30
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 33
M  V30 13 1 9 11
M  V30 14 1 12 36
M  V30 15 1 13 14
M  V30 16 1 13 41
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 21 27
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-[[5-[[(6-amino-2-pyridinyl)methoxy]methyl]-2-metho...
C23H24ClN9O3.CH2O2
2941179-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 7.4657 0.0 0
M  V30 2 C 4.0011 8.2357 0.0 0
M  V30 3 N 5.3347 10.5457 0.0 0
M  V30 4 C 10.6695 10.5457 0.0 0
M  V30 5 O 12.0033 9.7757 0.0 0
M  V30 6 C 13.3369 10.5457 0.0 0
M  V30 7 C 9.6774 2.3100 0.0 0
M  V30 8 C 2.6674 12.0857 0.0 0
M  V30 9 N 1.3336 12.8557 0.0 0
M  V30 10 O 2.6674 10.5457 0.0 0
M  V30 11 C 0.0000 12.0857 0.0 0
M  V30 12 Cl 8.0022 15.1657 0.0 0
M  V30 13 N 18.6717 10.5457 0.0 0
M  V30 14 C 8.0022 7.4657 0.0 0
M  V30 15 C 6.6684 8.2357 0.0 0
M  V30 16 C 9.3358 8.2357 0.0 0
M  V30 17 C 6.6684 9.7757 0.0 0
M  V30 18 C 9.3358 9.7757 0.0 0
M  V30 19 C 8.0022 10.5457 0.0 0
M  V30 20 C 8.0022 5.9256 0.0 0
M  V30 21 N 6.7563 5.0204 0.0 0
M  V30 22 N 9.2481 5.0204 0.0 0
M  V30 23 C 7.2322 3.5559 0.0 0
M  V30 24 N 8.7722 3.5559 0.0 0
M  V30 25 C 5.3347 12.0857 0.0 0
M  V30 26 C 4.0011 12.8557 0.0 0
M  V30 27 C 6.6684 12.8557 0.0 0
M  V30 28 N 4.0011 14.3957 0.0 0
M  V30 29 C 6.6684 14.3957 0.0 0
M  V30 30 N 5.3347 15.1657 0.0 0
M  V30 31 C 14.6706 9.7757 0.0 0
M  V30 32 N 16.0042 10.5457 0.0 0
M  V30 33 C 14.6706 8.2357 0.0 0
M  V30 34 C 17.3380 9.7757 0.0 0
M  V30 35 C 16.0042 7.4657 0.0 0
M  V30 36 C 17.3380 8.2357 0.0 0
M  V30 37 C 9.3358 0.0000 0.0 0
M  V30 38 O 8.0022 0.7700 0.0 0
M  V30 39 O 10.6695 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 17
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 31
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 26
M  V30 13 1 9 11
M  V30 14 1 12 29
M  V30 15 1 13 34
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 40 1 37 38
M  V30 41 2 37 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2941179-05-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2941179-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37279256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carrried out using preparative HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylamines as TYK2 inhibitors and compositions and methods for
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wan, Zhaokui; Li, Xiaodong; Vazquez, Michael Lawrence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023108536 A1 2023-06-22

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 2-[(4-bromophenyl)amino]-1-cyclopropyl-
C11H12BrNO
2959485-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 8.0023 0.0000 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 Br 0.0000 4.6201 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 10.8760 2.3101 0.0 0
M  V30 8 C 10.1060 3.6437 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 9
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-(4-bromophenyl)-N-(2-cyclopropyl-2-oxoethyl)-
C12H12BrNO2
2959485-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 Br 0.0000 5.3901 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 10.1060 4.4137 0.0 0
M  V30 16 C 10.8760 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 7 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2959485-77-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2959485-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37674533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazole derivatives as modulators of Rho-associated
protein kinase (ROCK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guisot, Nicolas E.S.; Jones, Clifford D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023139379 A1 2023-07-27

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Piperidinedione, 3-[4-[4-(dimethoxymethyl)-1-piperidinyl]-5-fluoro-2,3-di...
C29H35FN4O6
3030284-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6256 1.9692 0.0 0
M  V30 2 F 6.6685 7.7002 0.0 0
M  V30 3 O 11.9577 1.6190 0.0 0
M  V30 4 O 13.8751 2.0707 0.0 0
M  V30 5 C 16.8879 2.7111 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 O 1.3337 3.0801 0.0 0
M  V30 8 O 2.6673 0.7700 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 O 17.8396 5.6404 0.0 0
M  V30 12 O 22.9134 3.9918 0.0 0
M  V30 13 C 23.9438 2.8474 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 10.6697 5.3901 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 N 9.6562 3.1138 0.0 0
M  V30 18 N 11.8141 4.3597 0.0 0
M  V30 19 C 10.6697 6.9302 0.0 0
M  V30 20 C 8.0022 6.9302 0.0 0
M  V30 21 C 11.1877 2.9527 0.0 0
M  V30 22 C 9.3360 7.7002 0.0 0
M  V30 23 N 6.6685 4.6201 0.0 0
M  V30 24 C 5.3348 5.3901 0.0 0
M  V30 25 C 6.6685 3.0801 0.0 0
M  V30 26 C 4.0012 4.6201 0.0 0
M  V30 27 C 5.3348 2.3101 0.0 0
M  V30 28 C 4.0012 3.0801 0.0 0
M  V30 29 C 13.3205 4.6799 0.0 0
M  V30 30 C 14.3510 3.5353 0.0 0
M  V30 31 C 13.7964 6.1444 0.0 0
M  V30 32 N 15.8574 3.8555 0.0 0
M  V30 33 C 15.3027 6.4646 0.0 0
M  V30 34 C 16.3333 5.3202 0.0 0
M  V30 35 C 18.3942 3.0312 0.0 0
M  V30 36 C 18.8702 4.4960 0.0 0
M  V30 37 C 19.4248 1.8868 0.0 0
M  V30 38 C 20.3765 4.8161 0.0 0
M  V30 39 C 20.9311 2.2070 0.0 0
M  V30 40 C 21.4069 3.6716 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 20
M  V30 3 2 3 21
M  V30 4 2 4 30
M  V30 5 1 5 32
M  V30 6 1 5 35
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 28
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 11 34
M  V30 13 1 12 13
M  V30 14 1 12 40
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 16 23
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 1 18 29
M  V30 25 1 19 22
M  V30 26 2 20 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1-[5-fluoro-2,3-dihydro-1-[1-[(4-methoxyphenyl)methy...
C27H29FN4O5.CH2O2
3030284-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9015 8.3225 0.0 0
M  V30 2 F 6.1788 2.3100 0.0 0
M  V30 3 O 10.0879 9.3577 0.0 0
M  V30 4 O 12.0573 9.3146 0.0 0
M  V30 5 C 15.1373 9.3146 0.0 0
M  V30 6 C 1.1445 6.7503 0.0 0
M  V30 7 O 0.0000 5.7199 0.0 0
M  V30 8 O 16.6773 6.6473 0.0 0
M  V30 9 O 21.2973 9.3146 0.0 0
M  V30 10 C 22.0673 10.6482 0.0 0
M  V30 11 C 8.1474 5.8773 0.0 0
M  V30 12 C 9.6121 5.4013 0.0 0
M  V30 13 C 7.0030 4.8467 0.0 0
M  V30 14 N 8.1474 7.4173 0.0 0
M  V30 15 N 10.5173 6.6473 0.0 0
M  V30 16 C 9.9322 3.8950 0.0 0
M  V30 17 C 7.3232 3.3404 0.0 0
M  V30 18 C 9.6121 7.8931 0.0 0
M  V30 19 C 8.7879 2.8646 0.0 0
M  V30 20 N 5.5383 5.3227 0.0 0
M  V30 21 C 5.2181 6.8290 0.0 0
M  V30 22 C 4.3939 4.2922 0.0 0
M  V30 23 C 3.7536 7.3049 0.0 0
M  V30 24 C 2.9292 4.7680 0.0 0
M  V30 25 C 2.6091 6.2744 0.0 0
M  V30 26 C 12.0573 6.6473 0.0 0
M  V30 27 C 12.8273 7.9809 0.0 0
M  V30 28 C 12.8273 5.3135 0.0 0
M  V30 29 N 14.3673 7.9809 0.0 0
M  V30 30 C 14.3673 5.3135 0.0 0
M  V30 31 C 15.1373 6.6473 0.0 0
M  V30 32 C 16.6773 9.3146 0.0 0
M  V30 33 C 17.4473 7.9809 0.0 0
M  V30 34 C 17.4473 10.6482 0.0 0
M  V30 35 C 18.9873 7.9809 0.0 0
M  V30 36 C 18.9873 10.6482 0.0 0
M  V30 37 C 19.7573 9.3146 0.0 0
M  V30 38 C 11.0336 0.0000 0.0 0
M  V30 39 O 9.7000 0.7700 0.0 0
M  V30 40 O 12.3673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 17
M  V30 3 2 3 18
M  V30 4 2 4 27
M  V30 5 1 5 29
M  V30 6 1 5 32
M  V30 7 2 6 7
M  V30 8 1 6 25
M  V30 9 2 8 31
M  V30 10 1 9 10
M  V30 11 1 9 37
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 13 20
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 1 15 26
M  V30 22 1 16 19
M  V30 23 2 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 2 38 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3030284-04-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3030284-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40336541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and related heterocyclic compounds as CDK2
degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collier, Philip; Zheng, Xiaozhang; Zhu, Xiao; Ford, Melissa; Weiss,
Matthew M.; Aversa, Robert; Pennington, Lewis Dale; Comer, Eamon;
Mahasenan, Kiran Vijayakumari; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024039901 A2 2024-02-22

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 4-[[[4-[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]-2-nitroph...
C26H27N3O5
3036768-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 14.6300 4.0011 0.0 0
M  V30 2 C 15.4000 5.3349 0.0 0
M  V30 3 N 13.0900 1.3338 0.0 0 VAL=5
M  V30 4 O 14.6300 1.3338 0.0 0
M  V30 5 O 12.3200 0.0000 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 N 7.7000 5.3349 0.0 0
M  V30 8 O 7.7000 2.6674 0.0 0
M  V30 9 C 21.5600 5.3349 0.0 0
M  V30 10 O 22.3300 6.6685 0.0 0
M  V30 11 O 22.3300 4.0011 0.0 0
M  V30 12 C 23.8700 6.6685 0.0 0
M  V30 13 C 1.5400 5.3349 0.0 0
M  V30 14 C 1.5400 3.7949 0.0 0
M  V30 15 C 0.0000 5.3349 0.0 0
M  V30 16 C 1.5400 6.8749 0.0 0
M  V30 17 C 13.0900 4.0011 0.0 0
M  V30 18 C 12.3200 2.6674 0.0 0
M  V30 19 C 12.3200 5.3349 0.0 0
M  V30 20 C 10.7800 2.6674 0.0 0
M  V30 21 C 10.7800 5.3349 0.0 0
M  V30 22 C 10.0100 4.0011 0.0 0
M  V30 23 C 16.9400 5.3349 0.0 0
M  V30 24 C 17.7100 6.6685 0.0 0
M  V30 25 C 17.7100 4.0011 0.0 0
M  V30 26 C 19.2500 6.6685 0.0 0
M  V30 27 C 19.2500 4.0011 0.0 0
M  V30 28 C 20.0200 5.3349 0.0 0
M  V30 29 C 6.1600 5.3349 0.0 0
M  V30 30 C 5.3900 4.0011 0.0 0
M  V30 31 C 5.3900 6.6685 0.0 0
M  V30 32 C 3.8500 4.0011 0.0 0
M  V30 33 C 3.8500 6.6685 0.0 0
M  V30 34 C 3.0800 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 23
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 22
M  V30 10 1 7 29
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 28
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 34
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C27H27N3O3
3036768-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.7408 3.4099 0.0 0
M  V30 2 C 8.4700 2.6996 0.0 0
M  V30 3 N 7.7000 4.0333 0.0 0
M  V30 4 O 7.7000 1.3660 0.0 0
M  V30 5 C 21.5994 1.5063 0.0 0
M  V30 6 O 22.7438 2.5368 0.0 0
M  V30 7 O 21.9196 0.0000 0.0 0
M  V30 8 C 24.2085 2.0608 0.0 0
M  V30 9 C 1.5400 4.0333 0.0 0
M  V30 10 C 1.5400 5.5733 0.0 0
M  V30 11 C 0.0000 4.0333 0.0 0
M  V30 12 C 1.5400 2.4933 0.0 0
M  V30 13 C 13.0900 2.6996 0.0 0
M  V30 14 C 12.3200 1.3660 0.0 0
M  V30 15 N 14.5964 2.3795 0.0 0
M  V30 16 C 12.3200 4.0333 0.0 0
M  V30 17 C 10.7800 1.3660 0.0 0
M  V30 18 N 13.3506 0.2215 0.0 0
M  V30 19 C 14.7574 0.8479 0.0 0
M  V30 20 C 10.7800 4.0333 0.0 0
M  V30 21 C 10.0100 2.6996 0.0 0
M  V30 22 C 17.2055 2.9340 0.0 0
M  V30 23 C 17.5257 1.4276 0.0 0
M  V30 24 C 18.3499 3.9644 0.0 0
M  V30 25 C 18.9904 0.9517 0.0 0
M  V30 26 C 19.8146 3.4886 0.0 0
M  V30 27 C 20.1347 1.9823 0.0 0
M  V30 28 C 6.1600 4.0333 0.0 0
M  V30 29 C 5.3900 2.6996 0.0 0
M  V30 30 C 5.3900 5.3669 0.0 0
M  V30 31 C 3.8500 2.6996 0.0 0
M  V30 32 C 3.8500 5.3669 0.0 0
M  V30 33 C 3.0800 4.0333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 3 28
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 5 27
M  V30 10 1 6 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 33
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 19
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3036768-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036768-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36515424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of FXR/PPARγ dual partial agonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamashita, Yukiko; Gohda, Keigo; Iguchi, Yusuke; Fujimori, Ko; Oda,
Keisuke; Masuda, Arisa; Une, Mizuho; Teno, Naoki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 85117238

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Quinolinecarboxylic acid, 2-hydrazinyl-, ethyl ester
C12H13N3O2
3039771-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 7.7000 5.3347 0.0 0
M  V30 3 O 7.7000 2.6674 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 C 10.0100 6.6685 0.0 0
M  V30 6 N 5.3900 1.3338 0.0 0
M  V30 7 N 4.6200 0.0000 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 N 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 9 CFG=2
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,2,4]Triazolo[4,3-a]quinoline-4-carboxylic acid, ethyl ester
C13H11N3O2
3039771-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7035 0.0 0
M  V30 2 O 7.7000 5.0372 0.0 0
M  V30 3 O 7.7000 2.3699 0.0 0
M  V30 4 C 9.2400 5.0372 0.0 0
M  V30 5 C 10.0100 6.3710 0.0 0
M  V30 6 N 3.0800 2.3699 0.0 0
M  V30 7 C 4.6200 2.3699 0.0 0
M  V30 8 C 2.3100 3.7035 0.0 0
M  V30 9 C 2.6041 0.9052 0.0 0
M  V30 10 C 5.3900 3.7035 0.0 0
M  V30 11 N 5.0959 0.9052 0.0 0
M  V30 12 C 3.0800 5.0372 0.0 0
M  V30 13 C 0.7700 3.7035 0.0 0
M  V30 14 N 3.8500 0.0000 0.0 0
M  V30 15 C 4.6200 5.0372 0.0 0
M  V30 16 C 2.3100 6.3710 0.0 0
M  V30 17 C 0.0000 5.0372 0.0 0
M  V30 18 C 0.7700 6.3710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 2 10 15
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3039771-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3039771-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41530390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heterocycles as AHR agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bell, Michael; Calvin, Joel; Carson, Cheryl; Chauvigne-Hines, Lacie;
Clarke, Christian; Dorsey, Frank; Gernert, Douglas; Green, Steven;
Mcmillen, William; Navarro, Antonio; Rizzo, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024107555 A1 2024-05-23

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-[2-(phenylthio)ethyl]benzeneethanamine
C18H23NO2S
304011-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3336 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3347 0.0 0
M  V30 7 N 9.2400 5.3347 0.0 0
M  V30 8 C 10.0100 6.6684 0.0 0
M  V30 9 C 11.5500 6.6684 0.0 0
M  V30 10 S 12.3200 8.0021 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 13.8600 8.0021 0.0 0
M  V30 18 C 14.6300 9.3358 0.0 0
M  V30 19 C 14.6300 6.6684 0.0 0
M  V30 20 C 16.1700 9.3358 0.0 0
M  V30 21 C 16.1700 6.6684 0.0 0
M  V30 22 C 16.9400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(3,4-Dimethoxyphenyl)ethyl]-N-[2-(phenylthio)ethyl]formamide
C19H23NO3S
304011-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 6.6685 0.0 0
M  V30 2 C 3.0800 8.0021 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 2.6674 0.0 0
M  V30 7 N 9.2400 2.6674 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 10.0100 1.3336 0.0 0
M  V30 10 C 11.5500 4.0011 0.0 0
M  V30 11 O 9.2400 0.0000 0.0 0
M  V30 12 S 12.3200 5.3347 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 5.3900 4.0011 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 13.8600 5.3347 0.0 0
M  V30 20 C 14.6300 6.6685 0.0 0
M  V30 21 C 14.6300 4.0011 0.0 0
M  V30 22 C 16.1700 6.6685 0.0 0
M  V30 23 C 16.1700 4.0011 0.0 0
M  V30 24 C 16.9400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 19
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 304011-18-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 304011-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15336014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthesis of 2,3,4,5-tetrahydro-1H-3-benzazepines via Pummerer-type
cyclization of N-(2-arylethyl)-N-(2-phenylsulfinylethyl)formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Toda, Jun; Ichikawa, Tsuyoshi; Saitoh, Toshiaki; Horiguchi, Yoshie; Sano,
Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2000), 53(9), 2009-2018

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(Phenylthio)ethyl]benzeneethanamine
C16H19NS
304011-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 6.6685 2.3101 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 C 9.3358 2.3101 0.0 0
M  V30 6 S 10.6697 3.0801 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 C 12.0033 2.3101 0.0 0
M  V30 14 C 13.3370 3.0801 0.0 0
M  V30 15 C 12.0033 0.7700 0.0 0
M  V30 16 C 14.6707 2.3101 0.0 0
M  V30 17 C 13.3370 0.0000 0.0 0
M  V30 18 C 14.6707 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Phenylethyl)-N-[2-(phenylthio)ethyl]formamide
C17H19NOS
304011-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 N 6.9300 2.6674 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 7.7000 1.3338 0.0 0
M  V30 6 C 9.2400 4.0011 0.0 0
M  V30 7 O 6.9300 0.0000 0.0 0
M  V30 8 S 10.0100 5.3347 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 11.5500 5.3347 0.0 0
M  V30 16 C 12.3200 4.0011 0.0 0
M  V30 17 C 12.3200 6.6685 0.0 0
M  V30 18 C 13.8600 4.0011 0.0 0
M  V30 19 C 13.8600 6.6685 0.0 0
M  V30 20 C 14.6300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 15
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 304011-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 304011-24-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1946231
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthesis of 2,3,4,5-tetrahydro-1H-3-benzazepines via Pummerer-type
cyclization of N-(2-arylethyl)-N-(2-phenylsulfinylethyl)formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Toda, Jun; Ichikawa, Tsuyoshi; Saitoh, Toshiaki; Horiguchi, Yoshie; Sano,
Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2000), 53(9), 2009-2018

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azaspiro[3.3]heptane-2-carboxylic acid, 6-[(1,2-dihydro-2,8-dimethyl-1-oxo-...
C21H28N4O3
3055848-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.3659 5.3348 0.0 0
M  V30 2 O 15.1359 6.6686 0.0 0
M  V30 3 O 15.1359 4.0011 0.0 0
M  V30 4 C 16.6759 6.6686 0.0 0
M  V30 5 C 16.6759 5.1286 0.0 0
M  V30 6 C 18.2159 6.6686 0.0 0
M  V30 7 C 16.6759 8.2086 0.0 0
M  V30 8 N 6.9301 5.3348 0.0 0
M  V30 9 O 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 10.6480 5.3348 0.0 0
M  V30 13 C 11.7369 4.2458 0.0 0
M  V30 14 C 11.7369 6.4237 0.0 0
M  V30 15 C 9.5590 6.4237 0.0 0
M  V30 16 C 9.5590 4.2458 0.0 0
M  V30 17 N 12.8259 5.3348 0.0 0
M  V30 18 C 8.4701 5.3348 0.0 0
M  V30 19 C 6.1601 4.0011 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 6.9301 2.6675 0.0 0
M  V30 22 C 3.8500 2.6675 0.0 0
M  V30 23 C 3.8500 5.3348 0.0 0
M  V30 24 C 6.1601 1.3338 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6200 1.3338 0.0 0
M  V30 27 N 2.3100 5.3348 0.0 0
M  V30 28 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 18
M  V30 9 1 8 19
M  V30 10 2 9 25
M  V30 11 1 10 26
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 2 23 27
M  V30 29 1 24 26
M  V30 30 1 25 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azaspiro[3.3]heptane-2-carboxylic acid, 6-[(1,2-dihydro-2,8-dimethyl-1-oxo-...
C22H28N4O4
3055849-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 5.3348 0.0 0
M  V30 2 C 6.1601 6.6686 0.0 0
M  V30 3 O 6.9301 8.0022 0.0 0
M  V30 4 C 14.3659 5.3348 0.0 0
M  V30 5 O 15.1359 6.6686 0.0 0
M  V30 6 O 15.1359 4.0011 0.0 0
M  V30 7 C 16.6759 6.6686 0.0 0
M  V30 8 C 16.6759 8.2086 0.0 0
M  V30 9 C 18.2159 6.6686 0.0 0
M  V30 10 C 16.6759 5.1286 0.0 0
M  V30 11 O 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 10.6480 5.3348 0.0 0
M  V30 15 C 9.5590 4.2458 0.0 0
M  V30 16 C 9.5590 6.4237 0.0 0
M  V30 17 C 11.7369 4.2458 0.0 0
M  V30 18 C 11.7369 6.4237 0.0 0
M  V30 19 C 8.4701 5.3348 0.0 0
M  V30 20 N 12.8259 5.3348 0.0 0
M  V30 21 C 6.1601 4.0011 0.0 0
M  V30 22 C 4.6200 4.0011 0.0 0
M  V30 23 C 6.9301 2.6675 0.0 0
M  V30 24 C 3.8500 2.6675 0.0 0
M  V30 25 C 3.8500 5.3348 0.0 0
M  V30 26 C 6.1601 1.3338 0.0 0
M  V30 27 C 2.3100 2.6675 0.0 0
M  V30 28 C 4.6200 1.3338 0.0 0
M  V30 29 N 2.3100 5.3348 0.0 0
M  V30 30 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 21
M  V30 4 2 2 3
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 27
M  V30 13 1 12 28
M  V30 14 1 13 30
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 24 28
M  V30 30 2 25 29
M  V30 31 1 26 28
M  V30 32 1 27 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3055848-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055849-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42897094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-azaspiro[3.3]heptane derivatives as STAT3 inhibitors for
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Qingfeng; Cook, Brian; Wallace, Michael; Pollack, Jonathan; Snead,
Aaron; Lee, Bryan; Malmstrom, Robert; Hammersley, Gabriel; Urbano,
Mariangela; Green, Jason; Alabi, Philip
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024182693 A1 2024-09-06

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-Phenylethenyl]-1H-isoindole-1,3(2H)-dione
C16H11NO2
32150-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 C 7.3470 4.0442 0.0 0
M  V30 5 C 2.6673 1.9406 0.0 0
M  V30 6 C 2.6673 3.4806 0.0 0
M  V30 7 C 4.1320 1.4647 0.0 0
M  V30 8 C 1.3336 1.1706 0.0 0
M  V30 9 C 4.1320 3.9564 0.0 0
M  V30 10 C 1.3336 4.2506 0.0 0
M  V30 11 N 5.0370 2.7106 0.0 0
M  V30 12 C 0.0000 1.9406 0.0 0
M  V30 13 C 0.0000 3.4806 0.0 0
M  V30 14 C 8.8870 4.0442 0.0 0
M  V30 15 C 9.6570 2.7106 0.0 0
M  V30 16 C 9.6570 5.3780 0.0 0
M  V30 17 C 11.1970 2.7106 0.0 0
M  V30 18 C 11.1970 5.3780 0.0 0
M  V30 19 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-1,3-dioxo-α-phenyl-2H-isoindole-2-propanoic acid
C17H13NO4
54373-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 5.8172 6.2291 0.0 0
M  V30 5 O 8.4743 6.4615 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 N 5.0370 2.7104 0.0 0
M  V30 9 C 4.1320 3.9564 0.0 0
M  V30 10 C 4.1320 1.4645 0.0 0
M  V30 11 C 2.6673 3.4804 0.0 0
M  V30 12 C 2.6673 1.9404 0.0 0
M  V30 13 C 1.3336 4.2504 0.0 0
M  V30 14 C 1.3336 1.1704 0.0 0
M  V30 15 C 0.0000 3.4804 0.0 0
M  V30 16 C 0.0000 1.9404 0.0 0
M  V30 17 C 8.8870 4.0442 0.0 0
M  V30 18 C 9.6570 2.7104 0.0 0
M  V30 19 C 9.6570 5.3778 0.0 0
M  V30 20 C 11.1970 2.7104 0.0 0
M  V30 21 C 11.1970 5.3778 0.0 0
M  V30 22 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32150-95-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54373-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used, optimization study, optimized on
catalyst, optimized on ligand, optimized on solvent, alternative
preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2,4-Dimethylphenoxy)ethanol
C10H14O2
34135-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(2,4-dimethylphenoxy)-, 1-formate
C11H14O3
2417431-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 1.5400 0.0 0
M  V30 6 O 12.0033 2.3101 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 10
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34135-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24444255
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Thioproline
C4H7NO2S
34592-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 2.6217 0.0 0
M  V30 2 O 0.0000 1.8517 0.0 0
M  V30 3 O 1.3338 4.1617 0.0 0
M  V30 4 C 2.6675 1.8517 0.0 0 CFG=1
M  V30 5 C 2.8284 0.3202 0.0 0
M  V30 6 N 4.0743 2.4782 0.0 0
M  V30 7 S 4.3348 0.0000 0.0 0
M  V30 8 C 5.1048 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 4 1 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R)-3-Formyl-4-thiazolidinecarboxylic acid
C5H7NO3S
1307126-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8722 3.4208 0.0 0
M  V30 2 O 6.3784 3.1007 0.0 0
M  V30 3 C 1.5400 3.7710 0.0 0
M  V30 4 O 2.3100 5.1048 0.0 0
M  V30 5 O 0.0000 3.7710 0.0 0
M  V30 6 N 3.8416 2.2765 0.0 0
M  V30 7 C 2.3100 2.4374 0.0 0 CFG=2
M  V30 8 C 4.1617 0.7700 0.0 0
M  V30 9 C 1.6837 1.0306 0.0 0
M  V30 10 S 2.8281 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 7 3 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34592-47-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1307126-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13388138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrogen-bridged heterocycles via cycloaddition of non-classical
heterocyclic-fused-[c]thiazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soares, Maria I. L.; Gomes, Clara S. B.; Pinho e Melo, Teresa M. V. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(43), 8392-8403

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hexen-1-amine
C6H13N
34825-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-5-Hexen-1-ylformamide
C7H13NO
1314905-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 C 2.6673 0.7700 0.0 0
M  V30 5 N 8.0023 0.7700 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 9.3360 0.0000 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 O 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34825-70-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1314905-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17767469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on catalyst, time and reactant
stoichiometry, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A titanium dioxide supported gold nanoparticle catalyst for the selective
N-formylation of functionalized amines with carbon dioxide and hydrogen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mitsudome, Takato; Urayama, Teppei; Fujita, Shu; Maeno, Zen; Mizugaki,
Tomoo; Jitsukawa, Koichiro; Kaneda, Kiyotomi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2017), 9(19), 3632-3636

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(4-bromophenyl)-2-(cyanoamino)-1,4-dihydro-6-methyl-5-pyrimidinecarbo...
C15H15BrN4O2
359450-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 5.3900 2.6674 0.0 0
M  V30 3 O 7.7000 4.0011 0.0 0
M  V30 4 C 6.1600 1.3336 0.0 0
M  V30 5 C 5.3900 0.0000 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 N 3.0800 9.3358 0.0 0
M  V30 8 C 1.5400 9.3358 0.0 0
M  V30 9 N 0.0000 9.3358 0.0 0
M  V30 10 Br 12.3200 6.6684 0.0 0
M  V30 11 C 6.1600 6.6684 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 N 5.3900 8.0021 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 3.8500 8.0021 0.0 0
M  V30 16 N 3.0800 6.6684 0.0 0
M  V30 17 C 7.7000 6.6684 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 10.0100 8.0021 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.7800 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 3 8 9
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 2-amino-4-(4-bromophenyl)-1,4-dihydro-6-methyl-,...
C14H16BrN3O2.CH2O2
2087929-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 8.4700 0.0 0
M  V30 2 O 6.6684 9.2400 0.0 0
M  V30 3 O 5.3347 6.9300 0.0 0
M  V30 4 C 8.0021 8.4700 0.0 0
M  V30 5 C 9.3358 9.2400 0.0 0
M  V30 6 C 5.3347 11.5500 0.0 0
M  V30 7 N 0.0000 11.5500 0.0 0
M  V30 8 Br 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 8.4700 0.0 0
M  V30 10 C 4.0011 9.2400 0.0 0
M  V30 11 N 1.3336 9.2400 0.0 0
M  V30 12 C 4.0011 10.7800 0.0 0
M  V30 13 C 1.3336 10.7800 0.0 0
M  V30 14 N 2.6674 11.5500 0.0 0
M  V30 15 C 2.6674 6.9300 0.0 0
M  V30 16 C 4.0011 6.1600 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 4.0011 4.6200 0.0 0
M  V30 19 C 1.3336 4.6200 0.0 0
M  V30 20 C 2.6674 3.8500 0.0 0
M  V30 21 C 4.6679 0.0000 0.0 0
M  V30 22 O 3.3342 0.7700 0.0 0
M  V30 23 O 6.0016 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 359450-59-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2087929-59-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26280290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Biginelli reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the synthesis of deceptively simple Biginelli products through
N-CN bond cleavage
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fidencio, Juan Jesus Nolasco; Rios-Guerra, Hulme; Gonzalez-Villanueva,
Gilberto; Penieres-Carrillo, Jose Guillermo; Balcazar, Gustavo Guevara;
Nicolas-Vazquez, Ma. Ines; Delgado, Francisco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2016), 92(10), 1803-1809

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminodeoxopteroic acid
C14H13N7O2
36093-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.5500 0.0000 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 N 16.1700 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 O 0.0000 6.6685 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 11.5500 2.6674 0.0 0
M  V30 9 C 12.3200 4.0011 0.0 0
M  V30 10 N 10.0100 2.6674 0.0 0
M  V30 11 C 12.3200 1.3338 0.0 0
M  V30 12 N 11.5500 5.3347 0.0 0
M  V30 13 N 13.8600 4.0011 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 N 13.8600 1.3338 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 14.6300 2.6674 0.0 0
M  V30 18 C 5.3900 5.3347 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 4.6200 6.6685 0.0 0
M  V30 21 C 3.0800 4.0011 0.0 0
M  V30 22 C 3.0800 6.6685 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 18
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(2,4-Diamino-6-pteridinyl)methyl]formylamino]benzoic acid
C15H13N7O3
89043-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.5500 0.0000 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 7.7000 6.6685 0.0 0
M  V30 5 O 6.9300 8.0021 0.0 0
M  V30 6 N 16.1700 2.6674 0.0 0
M  V30 7 C 0.7700 5.3347 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 O 0.0000 6.6685 0.0 0
M  V30 10 C 11.5500 2.6674 0.0 0
M  V30 11 C 12.3200 4.0011 0.0 0
M  V30 12 N 10.0100 2.6674 0.0 0
M  V30 13 C 12.3200 1.3336 0.0 0
M  V30 14 N 13.8600 4.0011 0.0 0
M  V30 15 N 11.5500 5.3347 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 N 13.8600 1.3336 0.0 0
M  V30 18 C 14.6300 2.6674 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 5.3900 5.3347 0.0 0
M  V30 21 C 4.6200 6.6685 0.0 0
M  V30 22 C 4.6200 4.0011 0.0 0
M  V30 23 C 3.0800 6.6685 0.0 0
M  V30 24 C 3.0800 4.0011 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 2 4 5
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 25
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36093-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89043-75-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9762822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and enzymatic activation of
N-[Nα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-L-ornithiny]-L-phenylalanine,
a candidate for antibody-directed enzyme prodrug therapy (ADEPT)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wright, Joel E.; Rosowsky, Andre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2002), 10(3), 493-500

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-[(1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo[3.1.0]...
C23H35N3O5
361442-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 5.5213 0.0 0 CFG=2
M  V30 2 C 7.7002 5.5213 0.0 0
M  V30 3 N 5.3901 6.8550 0.0 0
M  V30 4 O 8.4702 4.1875 0.0 0
M  V30 5 C 3.8501 6.8550 0.0 0
M  V30 6 O 3.0801 8.1887 0.0 0
M  V30 7 O 3.0801 5.5213 0.0 0
M  V30 8 C 1.5400 8.1887 0.0 0
M  V30 9 C 1.5400 6.6486 0.0 0
M  V30 10 C 0.0000 8.1887 0.0 0
M  V30 11 C 1.5400 9.7287 0.0 0
M  V30 12 O 1.6728 3.4674 0.0 0
M  V30 13 C 11.0323 5.8715 0.0 0
M  V30 14 N 10.5563 4.4068 0.0 0
M  V30 15 O 12.5386 6.1917 0.0 0
M  V30 16 C 5.3901 4.1875 0.0 0
M  V30 17 C 3.8553 4.2697 0.0 0
M  V30 18 C 6.2287 2.8994 0.0 0
M  V30 19 C 5.3792 2.4938 0.0 0
M  V30 20 C 3.1591 3.0639 0.0 0
M  V30 21 C 5.5326 1.6936 0.0 0
M  V30 22 C 4.6831 1.2879 0.0 0
M  V30 23 C 3.1481 1.3703 0.0 0
M  V30 24 C 3.9978 1.7760 0.0 0
M  V30 25 C 5.5215 0.0000 0.0 0
M  V30 26 N 8.4702 6.8550 0.0 0
M  V30 27 C 7.8439 8.2618 0.0 0 CFG=1
M  V30 28 C 10.0017 7.0159 0.0 0 CFG=2
M  V30 29 C 8.9883 9.2924 0.0 0 CFG=2
M  V30 30 C 7.5237 9.7683 0.0 0
M  V30 31 C 10.3219 8.5224 0.0 0
M  V30 32 H 6.3791 7.7859 0.0 0
M  V30 33 H 9.6146 10.6992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 26
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 20
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 28 13 CFG=1
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 1 22 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 27 32 CFG=3
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 1 29 31
M  V30 37 1 29 33 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 27 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(1S)-2-[(1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo[3.1.0]hex...
C24H35N3O6
2173145-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 5.8592 0.0 0 CFG=2
M  V30 2 C 6.7238 4.5255 0.0 0
M  V30 3 N 4.4137 5.8592 0.0 0
M  V30 4 O 8.2638 4.5255 0.0 0
M  V30 5 C 3.6437 7.1929 0.0 0
M  V30 6 O 2.1037 7.1929 0.0 0
M  V30 7 O 4.4137 8.5267 0.0 0
M  V30 8 C 1.3337 8.5267 0.0 0
M  V30 9 C 0.0000 7.7567 0.0 0
M  V30 10 C 0.5637 9.8604 0.0 0
M  V30 11 C 2.6673 9.2967 0.0 0
M  V30 12 O 10.4411 7.9132 0.0 0
M  V30 13 C 11.5336 8.9986 0.0 0
M  V30 14 O 13.0198 8.5951 0.0 0
M  V30 15 C 8.0866 1.4647 0.0 0
M  V30 16 N 8.5624 0.0000 0.0 0
M  V30 17 O 9.1170 2.6091 0.0 0
M  V30 18 C 6.7238 7.1929 0.0 0
M  V30 19 C 8.2586 7.1108 0.0 0
M  V30 20 C 5.8851 8.4811 0.0 0
M  V30 21 C 6.7346 8.8868 0.0 0
M  V30 22 C 8.9548 8.3165 0.0 0
M  V30 23 C 6.5813 9.6868 0.0 0
M  V30 24 C 7.4308 10.0925 0.0 0
M  V30 25 C 8.9658 10.0102 0.0 0
M  V30 26 C 8.1161 9.6046 0.0 0
M  V30 27 C 6.5924 11.3805 0.0 0
M  V30 28 N 5.9538 3.1919 0.0 0
M  V30 29 C 4.4222 3.0308 0.0 0 CFG=1
M  V30 30 C 6.5801 1.7849 0.0 0 CFG=2
M  V30 31 C 4.1020 1.5245 0.0 0 CFG=2
M  V30 32 C 2.9575 2.5549 0.0 0
M  V30 33 C 5.4357 0.7545 0.0 0
M  V30 34 H 4.1020 4.5372 0.0 0
M  V30 35 H 3.1968 0.2786 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 18
M  V30 4 2 2 4
M  V30 5 1 2 28
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 22
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 30 15 CFG=3
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 22 26
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 1 24 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 34 CFG=1
M  V30 36 1 30 33
M  V30 37 1 31 32
M  V30 38 1 31 33
M  V30 39 1 31 35 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 29 30 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 361442-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173145-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-22145885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for the preparation of saxagliptin or hydrates thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Panda, Atulya Kumar; Gupta, Ashish Kumar; Gupta, Nitin Kumar; Vaghasia,
Shailesh J.; Singh, Biswajit; Jamshad, Danish; Biswas, Sujay; Vir, Dharam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN201611035865 A 2018-04-27

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-[(1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo[3.1.0]...
C23H35N3O5
361442-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 5.5213 0.0 0 CFG=2
M  V30 2 C 7.7002 5.5213 0.0 0
M  V30 3 N 5.3901 6.8550 0.0 0
M  V30 4 O 8.4702 4.1875 0.0 0
M  V30 5 C 3.8501 6.8550 0.0 0
M  V30 6 O 3.0801 8.1887 0.0 0
M  V30 7 O 3.0801 5.5213 0.0 0
M  V30 8 C 1.5400 8.1887 0.0 0
M  V30 9 C 1.5400 6.6486 0.0 0
M  V30 10 C 0.0000 8.1887 0.0 0
M  V30 11 C 1.5400 9.7287 0.0 0
M  V30 12 O 1.6728 3.4674 0.0 0
M  V30 13 C 11.0323 5.8715 0.0 0
M  V30 14 N 10.5563 4.4068 0.0 0
M  V30 15 O 12.5386 6.1917 0.0 0
M  V30 16 C 5.3901 4.1875 0.0 0
M  V30 17 C 3.8553 4.2697 0.0 0
M  V30 18 C 6.2287 2.8994 0.0 0
M  V30 19 C 5.3792 2.4938 0.0 0
M  V30 20 C 3.1591 3.0639 0.0 0
M  V30 21 C 5.5326 1.6936 0.0 0
M  V30 22 C 4.6831 1.2879 0.0 0
M  V30 23 C 3.1481 1.3703 0.0 0
M  V30 24 C 3.9978 1.7760 0.0 0
M  V30 25 C 5.5215 0.0000 0.0 0
M  V30 26 N 8.4702 6.8550 0.0 0
M  V30 27 C 7.8439 8.2618 0.0 0 CFG=1
M  V30 28 C 10.0017 7.0159 0.0 0 CFG=2
M  V30 29 C 8.9883 9.2924 0.0 0 CFG=2
M  V30 30 C 7.5237 9.7683 0.0 0
M  V30 31 C 10.3219 8.5224 0.0 0
M  V30 32 H 6.3791 7.7859 0.0 0
M  V30 33 H 9.6146 10.6992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 26
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 20
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 28 13 CFG=1
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 1 22 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 27 32 CFG=3
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 1 29 31
M  V30 37 1 29 33 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 27 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(1S)-2-[(1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo[3.1.0]hex...
C24H35N3O6
2173145-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 5.8592 0.0 0 CFG=2
M  V30 2 C 6.7238 4.5255 0.0 0
M  V30 3 N 4.4137 5.8592 0.0 0
M  V30 4 O 8.2638 4.5255 0.0 0
M  V30 5 C 3.6437 7.1929 0.0 0
M  V30 6 O 2.1037 7.1929 0.0 0
M  V30 7 O 4.4137 8.5267 0.0 0
M  V30 8 C 1.3337 8.5267 0.0 0
M  V30 9 C 0.0000 7.7567 0.0 0
M  V30 10 C 0.5637 9.8604 0.0 0
M  V30 11 C 2.6673 9.2967 0.0 0
M  V30 12 O 10.4411 7.9132 0.0 0
M  V30 13 C 11.5336 8.9986 0.0 0
M  V30 14 O 13.0198 8.5951 0.0 0
M  V30 15 C 8.0866 1.4647 0.0 0
M  V30 16 N 8.5624 0.0000 0.0 0
M  V30 17 O 9.1170 2.6091 0.0 0
M  V30 18 C 6.7238 7.1929 0.0 0
M  V30 19 C 8.2586 7.1108 0.0 0
M  V30 20 C 5.8851 8.4811 0.0 0
M  V30 21 C 6.7346 8.8868 0.0 0
M  V30 22 C 8.9548 8.3165 0.0 0
M  V30 23 C 6.5813 9.6868 0.0 0
M  V30 24 C 7.4308 10.0925 0.0 0
M  V30 25 C 8.9658 10.0102 0.0 0
M  V30 26 C 8.1161 9.6046 0.0 0
M  V30 27 C 6.5924 11.3805 0.0 0
M  V30 28 N 5.9538 3.1919 0.0 0
M  V30 29 C 4.4222 3.0308 0.0 0 CFG=1
M  V30 30 C 6.5801 1.7849 0.0 0 CFG=2
M  V30 31 C 4.1020 1.5245 0.0 0 CFG=2
M  V30 32 C 2.9575 2.5549 0.0 0
M  V30 33 C 5.4357 0.7545 0.0 0
M  V30 34 H 4.1020 4.5372 0.0 0
M  V30 35 H 3.1968 0.2786 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 18
M  V30 4 2 2 4
M  V30 5 1 2 28
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 22
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 30 15 CFG=3
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 22 26
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 1 24 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 34 CFG=1
M  V30 36 1 30 33
M  V30 37 1 31 32
M  V30 38 1 31 33
M  V30 39 1 31 35 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 29 30 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 361442-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173145-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-22121658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also acts as a solvent,alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of saxagliptin, its pharmaceutically
acceptable salts or hydrates thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Biswas, Sujay; Gupta, Ashish Kumar; Singh, Biswajit Kumar; Vaghasia,
Shailesh J.; Biswas, Bidyut; Panda, Atulya Kumar; Vir, Dharam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2014DE01779 A 2016-08-31

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-[1-phenyl-2-(phenylthio)ethyl]benzeneethanamine
C24H27NO2S
371156-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0102 6.6685 0.0 0
M  V30 2 C 11.5503 6.6685 0.0 0
M  V30 3 N 9.2402 5.3348 0.0 0
M  V30 4 S 12.3203 5.3348 0.0 0
M  V30 5 C 7.7002 5.3348 0.0 0
M  V30 6 C 6.9302 4.0012 0.0 0
M  V30 7 O 2.3101 1.3337 0.0 0
M  V30 8 C 3.0801 0.0000 0.0 0
M  V30 9 O 0.7700 4.0012 0.0 0
M  V30 10 C 0.0000 5.3348 0.0 0
M  V30 11 C 9.2402 8.0023 0.0 0
M  V30 12 C 10.0102 9.3360 0.0 0
M  V30 13 C 7.7002 8.0023 0.0 0
M  V30 14 C 9.2402 10.6697 0.0 0
M  V30 15 C 6.9302 9.3360 0.0 0
M  V30 16 C 7.7002 10.6697 0.0 0
M  V30 17 C 13.8603 5.3348 0.0 0
M  V30 18 C 14.6303 4.0012 0.0 0
M  V30 19 C 14.6303 6.6685 0.0 0
M  V30 20 C 16.1704 4.0012 0.0 0
M  V30 21 C 16.1704 6.6685 0.0 0
M  V30 22 C 16.9404 5.3348 0.0 0
M  V30 23 C 5.3901 4.0012 0.0 0
M  V30 24 C 4.6201 2.6673 0.0 0
M  V30 25 C 4.6201 5.3348 0.0 0
M  V30 26 C 3.0801 2.6673 0.0 0
M  V30 27 C 3.0801 5.3348 0.0 0
M  V30 28 C 2.3101 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 1 6 23
M  V30 9 1 7 8
M  V30 10 1 7 26
M  V30 11 1 9 10
M  V30 12 1 9 28
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(3,4-Dimethoxyphenyl)ethyl]-N-[1-phenyl-2-(phenylthio)ethyl]formamide
C25H27NO3S
371156-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.6684 0.0 0
M  V30 2 N 5.3901 8.0021 0.0 0
M  V30 3 C 5.3901 5.3348 0.0 0
M  V30 4 C 6.9301 8.0021 0.0 0
M  V30 5 C 4.6201 9.3359 0.0 0
M  V30 6 S 4.6201 4.0010 0.0 0
M  V30 7 C 7.7001 9.3359 0.0 0
M  V30 8 O 5.3901 10.6695 0.0 0
M  V30 9 O 12.3201 12.0032 0.0 0
M  V30 10 C 11.5501 13.3369 0.0 0
M  V30 11 O 13.8602 9.3359 0.0 0
M  V30 12 C 14.6302 8.0021 0.0 0
M  V30 13 C 3.0800 6.6684 0.0 0
M  V30 14 C 2.3100 5.3348 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 0.7700 5.3348 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 0.0000 6.6684 0.0 0
M  V30 19 C 5.3901 2.6673 0.0 0
M  V30 20 C 6.9301 2.6673 0.0 0
M  V30 21 C 4.6201 1.3337 0.0 0
M  V30 22 C 7.7001 1.3337 0.0 0
M  V30 23 C 5.3901 0.0000 0.0 0
M  V30 24 C 6.9301 0.0000 0.0 0
M  V30 25 C 9.2401 9.3359 0.0 0
M  V30 26 C 10.0101 10.6695 0.0 0
M  V30 27 C 10.0101 8.0021 0.0 0
M  V30 28 C 11.5501 10.6695 0.0 0
M  V30 29 C 11.5501 8.0021 0.0 0
M  V30 30 C 12.3201 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 19
M  V30 10 1 7 25
M  V30 11 1 9 10
M  V30 12 1 9 28
M  V30 13 1 11 12
M  V30 14 1 11 30
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371156-84-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 371156-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15258619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthesis of 3-phenyl-1,2,3,4-tetrahydroisoquinoline and
2-phenyl-1,2,4,5-tetrahydro-3H-3-benzazepine via Pummerer-type
cyclization: enhancing effect of boron trifluoride diethyl etherate on
the cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Ichikawa, Tsuyoshi; Horiguchi, Yoshie; Toda, Jun; Sano,
Takehiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2001), 49(8), 979-984

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24209080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, solid-supported catalyst
(Fe3O4 immobilized CuO nanoparticles catalyst used), click chemistry,
catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile N-Formylation of Amines on Magnetic Fe3O4-CuO Nanocomposites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mishra, Kanchan; Datta Khanal, Hari; Rok Lee, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(31), 4477-4484

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4971585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, 5 wt% sulfated
titania [TiO2 - SO4(2-)] used as catalyst, other catalyst (TiO2-P25) gave
lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient method for the N-formylation of amines at room temperature
using TiO2-P25 or sulfated titania
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krishnakumar, B.; Swaminathan, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2011), 334(1-2), 98-102

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1383847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, silica gel used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Formylation of anilines with silica sulfuric acid under solvent-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Habibi, Davood; Rahmani, Payam; Akbaripanah, Ziba
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemistry (2013), 972960, 6 pp.

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14109247
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure: To a mixture of HCO2H (3
mmol, 0.11 mL) and ZnO (0.5 mmol, 0.04 g) an amine (1 mmol) was added and
then the reaction mixture was heated in an oil bath at 70 °C and stirred
with a magnetic stirrer. The progress of the reaction was monitored by
TLC. After the reaction was complete, CH2Cl2 or EtOAc was added to the
reaction mixture and ZnO was removed by filtration. The organic solvent
was then washed with H2O (2x10 mL), saturated solution of NaHCO3, and
dried over anhydrous Na2SO4. After removal of the solvent, the pure
product was obtained. This was further purified by recrystallization with
suitable solvent (ether or CHCl3). The structure of the products was
confirmed by 1H NMR, IR and comparison with authentic samples obtained
commercially or prepared by reported methods. N-(4-Flourophenyl)
formamide (8) 1H NMR (250 MHz, CDCl3) δ 9.06 (brs, 1H, trans), 8.46 (d,
1H, J=11.32, trans), 8.23 (s, 1H, cis), 8.15 (brs, 1H cis), 7.39-7.45 (m,
2H, Ar-H), 6.93-6.99 (m, 2H, Ar- H); 13C NMR (62.9 MHz, CDCl3) δ 115.4,
115.8, 116.3, 116.6, 120.9, 121.1, 132.7, 158.4, 163.3.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry (- catalyst), no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zinc oxide as a new catalyst for N-formylation of amines under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hosseini-Sarvari, Mona; Sharghi, Hashem
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2006), 71(17), 6652-6654

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6807441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thermal oligomerization of aryl isocyanides: formation of
pyrazino[1,2-a:4,5-a']diindoles and indigo diarylimines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boeyens, Jan C. A.; Cook, Leanne M.; Ding, Yunxiang; Fernandes, Manuel
A.; Reid, David H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2003), 1(12), 2168-2172

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36298693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12027-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst supported on
silica prepared and used,recyclable catalyst,no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Magnetically Recyclable Silica-Coated Magnetite-Molybdate Nanocatalyst
and its Applications in N-Formylation Reactions Under Solvent-Free
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Runjhun; Patil, Shripad; Tandon, Nitin; Kumar, Pushpendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2022), 19(8), 616-626

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-[4-(dimethylamino)phenyl]ethanone
C10H12BrNO
37904-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 Br 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Dimethylamino)phenyl]-2-(formyloxy)ethanone
C11H13NO3
1262974-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 O 12.0033 4.6201 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37904-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262974-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-7315895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 595-91-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 102-71-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Labeling Reaction. Figure 1 shows the reaction
scheme for labeling carboxylic acids using the isotope reagents, 13C- or
12CDmPABr. For labeling human urine samples, urine in 50% (v: v) of
acetonitrile was centrifuged for 10 min at 12 000 rpm. About 50 μL of
human urine in acetonitrile (v:v) or 50 μL of carboxylic acid standards
in acetonitrile (1.2 mM each) were mixed with an equal volume of 750 mM
of triethanolamine (TEOA) in a reaction vial. The solutions were
vortexed, spun down, and then mixed with 50 μL of freshly prepared
13C-DmPA (20 mg/mL) (for heavy labeling) or 12C-DmPA (20 mg/mL) (for
light labeling). The derivatization reaction proceeded for 60 min at 90
°C in a water bath. After 60 min, the mixtures were vortexed, spun down,
and 100 μL of triphenylacetic acid (30 mg/mL) was added to consume the
excess labeling reagent, 12C-/13C-DmPA, at 90 °C in TEOA for 30 min. The
solutions were vortexed and spun down. The labeling reactions were
carried out in sealed glass vials with Teflon lined caps. After labeling,
the 13C-labeled mixtures were combined with their 12C-labeled mixtures
for LC-MS analysis. We note that the labeled sample was usually analyzed
within 2 weeks. No degradation products for the labeled standards were
observed after storing the labeled samples in -20 °C for up to 2 weeks.
Yield 99%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed vial used, alternate solvents (acetone, DMF) may be
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM High-Performance Isotope Labeling for Profiling Carboxylic
Acid-Containing Metabolites in Biofluids by Mass Spectrometry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Kevin; Li, Liang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Analytical Chemistry (Washington, DC, United States) (2010), 82(21),
8789-8793

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
17-Hydroxypregnenolone
C21H32O3
387-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1632 6.1516 0.0 0
M  V30 2 C 3.3501 3.7057 0.0 0
M  V30 3 C 10.8004 5.8659 0.0 0
M  V30 4 C 12.1341 5.0959 0.0 0
M  V30 5 O 10.8004 7.4059 0.0 0
M  V30 6 O 8.8403 6.5029 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 C 6.6684 2.3100 0.0 0 CFG=2
M  V30 9 C 8.0021 3.0800 0.0 0 CFG=2
M  V30 10 C 5.3348 3.0800 0.0 0 CFG=2
M  V30 11 C 6.6684 0.7700 0.0 0
M  V30 12 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 13 C 9.4668 2.6042 0.0 0
M  V30 14 C 4.0010 2.3100 0.0 0 CFG=2
M  V30 15 C 5.3348 4.6200 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 17 C 9.4668 5.0959 0.0 0 CFG=1
M  V30 18 C 6.6684 5.3901 0.0 0
M  V30 19 C 10.3720 3.8500 0.0 0
M  V30 20 C 4.0010 0.7700 0.0 0
M  V30 21 C 2.6673 3.0800 0.0 0
M  V30 22 C 2.6673 0.0000 0.0 0
M  V30 23 C 1.3337 2.3100 0.0 0
M  V30 24 C 1.3337 0.7700 0.0 0 CFG=1
M  V30 25 H 7.5518 1.0484 0.0 0
M  V30 26 H 8.7953 1.7599 0.0 0
M  V30 27 H 4.4514 4.3415 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 14 2 CFG=1
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 17 3 CFG=1
M  V30 6 1 17 6 CFG=3
M  V30 7 1 24 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 25 CFG=1
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 26 CFG=3
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 10 27 CFG=3
M  V30 18 1 11 16
M  V30 19 1 12 17
M  V30 20 1 12 18
M  V30 21 1 13 19
M  V30 22 1 14 20
M  V30 23 1 14 21
M  V30 24 1 15 18
M  V30 25 2 16 20
M  V30 26 1 17 19
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 8 9 10 12 14 17 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pregn-5-en-20-one, 3-(formyloxy)-17-hydroxy-, (3β)-
C22H32O4
20867-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8306 6.1516 0.0 0
M  V30 2 C 13.4678 5.8659 0.0 0
M  V30 3 C 13.4678 7.4059 0.0 0
M  V30 4 O 14.8016 5.0959 0.0 0
M  V30 5 O 11.5079 6.5028 0.0 0
M  V30 6 C 6.0177 3.7057 0.0 0
M  V30 7 O 2.6674 0.0000 0.0 0
M  V30 8 C 1.3338 0.7700 0.0 0
M  V30 9 O 0.0000 0.0000 0.0 0
M  V30 10 C 10.6695 3.0800 0.0 0 CFG=2
M  V30 11 C 9.3358 2.3100 0.0 0 CFG=2
M  V30 12 C 10.6695 4.6200 0.0 0 CFG=1
M  V30 13 C 12.1342 2.6042 0.0 0
M  V30 14 C 8.0022 3.0800 0.0 0 CFG=2
M  V30 15 C 9.3358 0.7700 0.0 0
M  V30 16 C 12.1342 5.0959 0.0 0 CFG=1
M  V30 17 C 9.3358 5.3900 0.0 0
M  V30 18 C 13.0394 3.8500 0.0 0
M  V30 19 C 6.6685 2.3100 0.0 0 CFG=2
M  V30 20 C 8.0022 4.6200 0.0 0
M  V30 21 C 8.0022 0.0000 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3347 3.0800 0.0 0
M  V30 24 C 5.3347 0.0000 0.0 0
M  V30 25 C 4.0011 2.3100 0.0 0
M  V30 26 C 4.0011 0.7700 0.0 0 CFG=1
M  V30 27 H 11.4627 1.7599 0.0 0
M  V30 28 H 10.2192 1.0484 0.0 0
M  V30 29 H 7.1188 4.3414 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 16 2 CFG=1
M  V30 5 1 16 5 CFG=3
M  V30 6 1 19 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 26 7 CFG=1
M  V30 9 2 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 27 CFG=3
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 28 CFG=1
M  V30 17 1 12 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 14 20
M  V30 22 1 14 29 CFG=3
M  V30 23 1 15 21
M  V30 24 1 16 18
M  V30 25 1 17 20
M  V30 26 1 19 22
M  V30 27 1 19 23
M  V30 28 2 21 22
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 10 11 12 14 16 19 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 387-79-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20867-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-12844939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM process for the preparation of cyproterone acetate from solasodine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manosroi, Aranya; Manosroi, Jiradej; Buddhasukh, Duang; Sripalakit,
Pattana; Maier, Roland; Werner, Rolf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1359154 A1 2003-11-05

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenylmethyl)leucine
C13H19NO2
40297-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 O 3.0800 0.0000 0.0 0
M  V30 8 O 0.7700 1.3338 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 11
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-N-(phenylmethyl)leucine
C14H19NO3
2211040-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 C 6.6685 0.7700 0.0 0
M  V30 7 O 6.6685 5.3901 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 5.3348 0.0000 0.0 0
M  V30 10 O 8.0023 0.0000 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 10.6697 3.0801 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 13
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40297-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211040-91-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19113112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-4-chloro-, methyl ester
C8H8ClNO2
40872-87-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-3-(formylamino)benzoate
C9H8ClNO3
1486677-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 2.3100 0.0 0
M  V30 2 O 8.0022 3.0800 0.0 0
M  V30 3 O 6.6684 0.7700 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 N 1.3337 2.3100 0.0 0
M  V30 6 C 1.3337 0.7700 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 Cl 1.3337 5.3901 0.0 0
M  V30 9 C 5.3348 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40872-87-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1486677-77-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(4-Methoxyphenyl)ethenyl]-1H-isoindole-1,3(2H)-dione
C17H13NO3
41314-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 C 7.3470 4.0442 0.0 0
M  V30 5 O 13.5070 4.0442 0.0 0
M  V30 6 C 14.2770 5.3780 0.0 0
M  V30 7 C 2.6673 1.9406 0.0 0
M  V30 8 C 2.6673 3.4806 0.0 0
M  V30 9 C 4.1320 1.4647 0.0 0
M  V30 10 C 1.3336 1.1706 0.0 0
M  V30 11 C 4.1320 3.9564 0.0 0
M  V30 12 C 1.3336 4.2506 0.0 0
M  V30 13 N 5.0370 2.7106 0.0 0
M  V30 14 C 0.0000 1.9406 0.0 0
M  V30 15 C 0.0000 3.4806 0.0 0
M  V30 16 C 8.8870 4.0442 0.0 0
M  V30 17 C 9.6570 2.7106 0.0 0
M  V30 18 C 9.6570 5.3780 0.0 0
M  V30 19 C 11.1970 2.7106 0.0 0
M  V30 20 C 11.1970 5.3780 0.0 0
M  V30 21 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 2 3 4
M  V30 4 1 3 13
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-α-(4-methoxyphenyl)-1,3-dioxo-2H-isoindole-2-propanoic acid
C18H15NO5
293731-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7104 0.0 0
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.2129 5.5783 0.0 0
M  V30 4 O 5.8172 6.2291 0.0 0
M  V30 5 O 8.4743 6.4615 0.0 0
M  V30 6 O 4.6078 5.4210 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 O 13.5070 4.0442 0.0 0
M  V30 9 C 14.2770 2.7104 0.0 0
M  V30 10 N 5.0370 2.7104 0.0 0
M  V30 11 C 4.1320 3.9564 0.0 0
M  V30 12 C 4.1320 1.4645 0.0 0
M  V30 13 C 2.6673 3.4804 0.0 0
M  V30 14 C 2.6673 1.9404 0.0 0
M  V30 15 C 1.3336 4.2504 0.0 0
M  V30 16 C 1.3336 1.1704 0.0 0
M  V30 17 C 0.0000 3.4804 0.0 0
M  V30 18 C 0.0000 1.9404 0.0 0
M  V30 19 C 8.8870 4.0442 0.0 0
M  V30 20 C 9.6570 2.7104 0.0 0
M  V30 21 C 9.6570 5.3778 0.0 0
M  V30 22 C 11.1970 2.7104 0.0 0
M  V30 23 C 11.1970 5.3778 0.0 0
M  V30 24 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 11
M  V30 8 2 7 12
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41314-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 293731-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-18517789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1864-94-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vial used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An effective route to β2-amino acid derivatives via Pd-catalyzed
regioselective hydrocarboxylation of 1,2-disubstituted enimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Chang, Wenju; Zhang, Ping; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2017), 4(2), 297-302

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Proline phenylmethyl ester
C12H15NO2
41324-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0 CFG=1
M  V30 6 C 8.1633 3.8416 0.0 0
M  V30 7 N 9.4091 1.6837 0.0 0
M  V30 8 C 9.6696 4.1618 0.0 0
M  V30 9 C 10.4396 2.8281 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Formyl-L-proline phenylmethyl ester
C13H15NO3
144222-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 O 5.3900 3.7710 0.0 0
M  V30 3 O 7.7000 5.1048 0.0 0
M  V30 4 C 4.6200 5.1048 0.0 0
M  V30 5 C 10.2621 3.4208 0.0 0
M  V30 6 O 11.7684 3.1006 0.0 0
M  V30 7 C 7.7000 2.4374 0.0 0 CFG=2
M  V30 8 N 9.2315 2.2764 0.0 0
M  V30 9 C 7.0737 1.0306 0.0 0
M  V30 10 C 9.5517 0.7700 0.0 0
M  V30 11 C 8.2181 0.0000 0.0 0
M  V30 12 C 3.0800 5.1048 0.0 0
M  V30 13 C 2.3100 6.4384 0.0 0
M  V30 14 C 2.3100 3.7710 0.0 0
M  V30 15 C 0.7700 6.4384 0.0 0
M  V30 16 C 0.7700 3.7710 0.0 0
M  V30 17 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 1 5 8
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41324-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 144222-39-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2914833
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, optimization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A practical and convenient procedure for the N-formylation of amines
using formic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Sun Ho; Ahn, Jin Hee; Park, Sang Kyu; Choi, Joong-Kwon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2002), 23(1), 149-150

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-bromo-6-[(3-chlorophenyl)methoxy]-2-pyrazinyl]-1-piper...
C20H24BrClN4O3
479684-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3372 3.0801 0.0 0
M  V30 2 C 14.6708 2.3101 0.0 0
M  V30 3 Br 13.3372 0.0000 0.0 0
M  V30 4 C 4.0012 5.3901 0.0 0
M  V30 5 O 2.6675 4.6201 0.0 0
M  V30 6 O 4.0012 6.9302 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 C 0.5637 4.0564 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 C 2.1037 6.7238 0.0 0
M  V30 11 Cl 20.0057 2.3101 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 N 10.6697 3.0801 0.0 0
M  V30 14 C 9.3360 0.7700 0.0 0
M  V30 15 C 12.0033 2.3101 0.0 0
M  V30 16 N 10.6697 0.0000 0.0 0
M  V30 17 C 12.0033 0.7700 0.0 0
M  V30 18 N 8.0023 3.0801 0.0 0
M  V30 19 C 8.0023 4.6201 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 6.6685 5.3901 0.0 0
M  V30 22 C 5.3348 3.0801 0.0 0
M  V30 23 N 5.3348 4.6201 0.0 0
M  V30 24 C 16.0045 3.0801 0.0 0
M  V30 25 C 17.3382 2.3101 0.0 0
M  V30 26 C 16.0045 4.6201 0.0 0
M  V30 27 C 18.6720 3.0801 0.0 0
M  V30 28 C 17.3382 5.3901 0.0 0
M  V30 29 C 18.6720 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 24
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 27
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-(3-bromo-1-piperazinyl)-6-[(3-chlorophenyl)methoxy...
C15H16BrClN4O.xCH2O2
479685-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 5.3901 0.0 0
M  V30 2 C 10.6698 4.6201 0.0 0
M  V30 3 Br 0.0000 4.6201 0.0 0
M  V30 4 Cl 16.0046 4.6201 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 N 6.6687 5.3901 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 C 8.0023 4.6201 0.0 0
M  V30 9 N 6.6687 2.3100 0.0 0
M  V30 10 C 8.0023 3.0800 0.0 0
M  V30 11 N 4.0012 5.3901 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 6.9301 0.0 0
M  V30 14 C 1.3338 5.3901 0.0 0
M  V30 15 C 2.6675 7.7001 0.0 0
M  V30 16 N 1.3338 6.9301 0.0 0
M  V30 17 C 12.0035 5.3901 0.0 0
M  V30 18 C 13.3372 4.6201 0.0 0
M  V30 19 C 12.0035 6.9301 0.0 0
M  V30 20 C 14.6708 5.3901 0.0 0
M  V30 21 C 13.3372 7.7001 0.0 0
M  V30 22 C 14.6708 6.9301 0.0 0
M  V30 23 C 8.0023 0.0000 0.0 0
M  V30 24 O 6.6687 0.7700 0.0 0
M  V30 25 O 9.3360 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 17
M  V30 4 1 3 14
M  V30 5 1 4 20
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 479684-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479685-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-113-CAS-6592183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of [1,2']bipyrazinyl 5-HT2 receptor ligands for treatment of
sexual dysfunction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chiang, Yuan-Ching Phoebe; Dasilva-Jardine, Paul Andrew; Garigipati, Ravi
S.; Guzman-Perez, Angel; Novomisle, William Albert; Welch, Willard
Mckowan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003000666 A1 2003-01-03

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-Bis[2-(amino-κN)-4-[(difluoromethyl)sulfonyl]benzenethiolato-κS]zinc
C14H12F4N2O4S4Zn
494776-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 5.3901 0.0 0 VAL=6
M  V30 2 C 1.3338 6.1601 0.0 0
M  V30 3 O 1.8975 4.0564 0.0 0
M  V30 4 O 3.4375 6.7237 0.0 0
M  V30 5 F 1.3338 7.7001 0.0 0
M  V30 6 F 0.0000 5.3901 0.0 0
M  V30 7 S 15.4093 2.3100 0.0 0 VAL=6
M  V30 8 C 16.7430 1.5400 0.0 0
M  V30 9 O 16.1793 3.6437 0.0 0
M  V30 10 O 14.6393 0.9764 0.0 0
M  V30 11 F 18.0768 2.3100 0.0 0
M  V30 12 F 16.7430 0.0000 0.0 0
M  V30 13 Zn 9.0384 3.8501 0.0 0 CHG=2 VAL=4
M  V30 14 N 8.1332 5.0959 0.0 0 VAL=4
M  V30 15 N 9.9436 2.6042 0.0 0 VAL=4
M  V30 16 S 9.9436 5.0959 0.0 0 CHG=-1 VAL=2
M  V30 17 S 8.1332 2.6042 0.0 0 CHG=-1 VAL=2
M  V30 18 C 6.6686 4.6201 0.0 0
M  V30 19 C 11.4082 3.0800 0.0 0
M  V30 20 C 11.4082 4.6201 0.0 0
M  V30 21 C 6.6686 3.0800 0.0 0
M  V30 22 C 5.3348 5.3901 0.0 0
M  V30 23 C 12.7420 2.3100 0.0 0
M  V30 24 C 12.7420 5.3901 0.0 0
M  V30 25 C 5.3348 2.3100 0.0 0
M  V30 26 C 4.0011 4.6201 0.0 0
M  V30 27 C 14.0756 3.0800 0.0 0
M  V30 28 C 14.0756 4.6201 0.0 0
M  V30 29 C 4.0011 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 26
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 27
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 20
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 26 29
M  V30 32 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(Difluoromethyl)sulfonyl]benzothiazole
C8H5F2NO2S2
494775-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.3709 2.3100 0.0 0 VAL=6
M  V30 2 C 7.7047 1.5400 0.0 0
M  V30 3 O 7.1409 3.6437 0.0 0
M  V30 4 O 5.6009 0.9764 0.0 0
M  V30 5 F 7.7047 0.0000 0.0 0
M  V30 6 F 9.0384 2.3100 0.0 0
M  V30 7 C 2.3699 3.0800 0.0 0
M  V30 8 C 2.3699 4.6201 0.0 0
M  V30 9 C 3.7036 2.3100 0.0 0
M  V30 10 N 0.9052 2.6042 0.0 0
M  V30 11 C 3.7036 5.3901 0.0 0
M  V30 12 S 0.9052 5.0959 0.0 0
M  V30 13 C 5.0373 3.0800 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 5.0373 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 494776-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 494775-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-361451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothiazole derivatives containing fluoro-, difluoro- and
trifluoromethylsulfonyl groups as new compounds with potential biological
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizerski, Arkadiusz; Ochal, Zbigniew; Felis, Albert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pestycydy (Warsaw) (2001), (3-4), 11-18

$RFMT $RIREG SCHEME47 STEP1
$RXN



  3  1
$MOL
3-Methoxyaniline
C7H9NO
536-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 N 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-nitropyridine
C5H2BrClN2O2
67443-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-3-(3-methoxyphenyl)-3H-imidazo[4,5-b]pyridine
C13H10BrN3O
329280-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.2608 1.8517 0.0 0
M  V30 2 C 12.5947 2.6217 0.0 0
M  V30 3 Br 0.0000 3.4387 0.0 0
M  V30 4 N 5.9260 1.8517 0.0 0
M  V30 5 C 4.5192 2.4782 0.0 0
M  V30 6 C 5.7651 0.3202 0.0 0
M  V30 7 C 3.4888 1.3337 0.0 0
M  V30 8 N 4.0433 3.9428 0.0 0
M  V30 9 N 4.2588 0.0000 0.0 0
M  V30 10 C 1.9823 1.6538 0.0 0
M  V30 11 C 2.5369 4.2630 0.0 0
M  V30 12 C 1.5065 3.1186 0.0 0
M  V30 13 C 7.2599 2.6217 0.0 0
M  V30 14 C 8.5935 1.8517 0.0 0
M  V30 15 C 7.2599 4.1618 0.0 0
M  V30 16 C 9.9272 2.6217 0.0 0
M  V30 17 C 8.5935 4.9318 0.0 0
M  V30 18 C 9.9272 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 536-90-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67443-38-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 329280-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17874332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1313-82-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridines as GABAA receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hallett, David James; Rowley, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001018000 A1 2001-03-15

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,4-diamino-2-methoxybenzoate
C9H12N2O3
538372-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 5.3349 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 N 1.5400 1.3338 0.0 0
M  V30 8 N 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 7-methoxy-1H-benzimidazole-6-carboxylate
C10H10N2O3
907190-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.7700 0.0 0
M  V30 2 C 2.3699 0.0000 0.0 0
M  V30 3 C 6.3709 2.3100 0.0 0
M  V30 4 O 7.7047 3.0800 0.0 0
M  V30 5 O 6.3709 0.7700 0.0 0
M  V30 6 C 9.0383 2.3100 0.0 0
M  V30 7 C 2.3699 3.0800 0.0 0
M  V30 8 C 3.7036 2.3100 0.0 0
M  V30 9 C 2.3699 4.6200 0.0 0
M  V30 10 N 0.9052 2.6042 0.0 0
M  V30 11 C 5.0372 3.0800 0.0 0
M  V30 12 C 3.7036 5.3900 0.0 0
M  V30 13 N 0.9052 5.0959 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 5.0372 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 538372-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 907190-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24646683
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl and heteroaryl-carboxamide substituted heteroaryl compounds as TYK2
inhibitors and preparation thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Puig Duran, Carlos; Gomez Castillo, Elena; Caturla Javaloyes, Juan
Francisco; Pages Santacana, Lluis Miquel; Erra Sola, Montserrat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021204626 A1 2021-10-14

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Methoxyphenoxy)ethanol
C9H12O3
5394-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(4-methoxyphenoxy)-, 1-formate
C10H12O4
2417431-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 O 13.3370 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 4.0010 0.0000 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5394-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-40-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24457858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitro-N1-phenyl-1,2-benzenediamine
C12H11N3O2
55315-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 N 6.6684 0.0000 0.0 0
M  V30 3 N 9.3359 4.6201 0.0 0 VAL=5
M  V30 4 O 10.6695 3.8500 0.0 0
M  V30 5 O 9.3359 6.1601 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 10 C 6.6684 4.6201 0.0 0
M  V30 11 C 8.0022 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 7
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-1-phenyl-1H-benzimidazole
C13H9N3O2
15127-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.6646 1.5400 0.0 0 VAL=5
M  V30 2 O 9.6646 0.0000 0.0 0
M  V30 3 O 10.9983 2.3101 0.0 0
M  V30 4 C 5.6635 3.8501 0.0 0
M  V30 5 N 4.5191 4.8805 0.0 0
M  V30 6 C 6.9973 4.6201 0.0 0
M  V30 7 C 5.6635 2.3101 0.0 0
M  V30 8 C 5.1454 6.2873 0.0 0
M  V30 9 C 8.3310 3.8501 0.0 0
M  V30 10 N 6.6771 6.1264 0.0 0
M  V30 11 C 6.9973 1.5400 0.0 0
M  V30 12 C 8.3310 2.3101 0.0 0
M  V30 13 C 3.0128 4.5603 0.0 0
M  V30 14 C 2.5367 3.0956 0.0 0
M  V30 15 C 1.9822 5.7047 0.0 0
M  V30 16 C 1.0304 2.7754 0.0 0
M  V30 17 C 0.4759 5.3846 0.0 0
M  V30 18 C 0.0000 3.9200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 10
M  V30 13 1 9 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55315-12-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15127-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33756055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Neutral Cyclometalated Iridium(III) Complexes Bearing Substituted
N-Heterocyclic Carbene (NHC) Ligands for High-Performance Yellow OLED
Application
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Bingqing; Jabed, Mohammed A.; Guo, Jiali; Xu, Wan; Brown, Samuel L.;
Ugrinov, Angel; Hobbie, Erik K.; Kilina, Svetlana; Qin, Anjun; Sun,
Wenfang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2019), 58(21), 14377-14388

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodobenzene
C6H5I
591-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid
C7H6O2
65-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28571296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM optimized on ligand, catalyst, base, solvent, time, temperature and
formic acid stoichiometry, optimization study, sealed tube used,
selective carboxylation, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Ligand-Controlled Selective Synthesis of Aldehydes
and Acids from Aryl Halides and Formic Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Fu-Peng; Peng, Jin-Bao; Meng, Ling-Shen; Qi, Xinxin; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2017), 9(16), 3121-3124

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
DL-Proline
C5H9NO2
609-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 2.6217 0.0 0
M  V30 2 O 0.0000 1.8517 0.0 0
M  V30 3 O 1.3338 4.1617 0.0 0
M  V30 4 C 2.6675 1.8517 0.0 0
M  V30 5 C 2.8284 0.3202 0.0 0
M  V30 6 N 4.0743 2.4782 0.0 0
M  V30 7 C 4.3348 0.0000 0.0 0
M  V30 8 C 5.1048 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Formylproline
C6H9NO3
67985-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8722 3.4208 0.0 0
M  V30 2 O 6.3784 3.1007 0.0 0
M  V30 3 C 1.5400 3.7710 0.0 0
M  V30 4 O 2.3100 5.1048 0.0 0
M  V30 5 O 0.0000 3.7710 0.0 0
M  V30 6 N 3.8416 2.2765 0.0 0
M  V30 7 C 2.3100 2.4374 0.0 0
M  V30 8 C 4.1617 0.7700 0.0 0
M  V30 9 C 1.6837 1.0306 0.0 0
M  V30 10 C 2.8281 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 609-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67985-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22681391
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of Punicagranine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Perry, Charles K.; Lindsley, Craig W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2019), 60(35), 150989

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzyl chloride
C7H6Cl2
611-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 Cl 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Chlorophenyl)acetic acid
C8H7ClO2
2444-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2444-36-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28422405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed carbonylation of benzyl chlorides:
Additive-controlled divergent synthesis of benzyl arylacetates and
arylacetic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Jin-Bao; Wang, Wei-Feng; Wu, Fu-Peng; Ying, Jun; Qi, Xinxin; Wu,
Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2018), 368275-278

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tryptamine
C10H12N2
61-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 C 7.1955 2.7126 0.0 0
M  V30 3 N 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(1H-Indol-3-yl)ethyl]formamide
C11H12N2O
6502-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7532 2.6218 0.0 0
M  V30 2 C 7.0868 1.8518 0.0 0
M  V30 3 N 8.4204 2.6218 0.0 0
M  V30 4 C 9.7542 1.8518 0.0 0
M  V30 5 O 11.0878 2.6218 0.0 0
M  V30 6 C 3.0126 2.4781 0.0 0
M  V30 7 C 4.4196 1.8518 0.0 0
M  V30 8 C 1.9822 1.3338 0.0 0
M  V30 9 C 2.5368 3.9428 0.0 0
M  V30 10 C 4.2585 0.3202 0.0 0
M  V30 11 N 2.7522 0.0000 0.0 0
M  V30 12 C 0.4759 1.6539 0.0 0
M  V30 13 C 1.0304 4.2629 0.0 0
M  V30 14 C 0.0000 3.1184 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6502-82-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23301127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Continuous-flow synthesis of thioureas, enabled by aqueous polysulfide
solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nemeth, Andras Gy.; Szabo, Renata; Orsy, Gyorgy; Mandity, Istvan M.;
Keseru, Gyorgy M.; Abranyi-Balogh, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(2), 303

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Methylphenoxy)ethanol
C9H12O2
6161-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(2-methylphenoxy)-, 1-formate
C10H12O3
2417431-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6161-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24466731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Furanmethanamine
C5H7NO
617-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Furanylmethyl)formamide
C6H7NO2
72693-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 N 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 O 7.7722 1.8517 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 C 1.0304 2.4782 0.0 0
M  V30 7 O 2.2765 0.3202 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 617-89-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72693-10-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23015422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-83-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1610891-42-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, catalyst prepared and used,
reusable catalyst, 91% isolated yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalysed efficient N-formylation of amines with a recyclable
polyoxometalate-supported green catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dan, Demin; Chen, Fubo; Zhao, Whenshu; Yu, Han; Han, Sheng; Wei, Yongge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2021), 50(1), 90-94

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzyl chloride
C7H6Cl2
620-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 Cl 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Chlorophenyl)acetic acid
C8H7ClO2
1878-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 O 8.0021 3.0800 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1878-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28194361
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed carbonylation of benzyl chlorides:
Additive-controlled divergent synthesis of benzyl arylacetates and
arylacetic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Jin-Bao; Wang, Wei-Feng; Wu, Fu-Peng; Ying, Jun; Qi, Xinxin; Wu,
Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2018), 368275-278

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Aminoisobutyric acid
C4H9NO2
62-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 C 2.1037 3.6437 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 N 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-2-methylalanine
C5H9NO3
60421-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 3.6437 1.8973 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 3.0801 4.0010 0.0 0
M  V30 5 C 0.9762 3.4374 0.0 0
M  V30 6 C 4.9774 2.6673 0.0 0
M  V30 7 O 2.3101 0.0000 0.0 0
M  V30 8 O 0.0000 1.3337 0.0 0
M  V30 9 O 6.3111 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-57-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60421-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7688021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thioester-isocyanides: versatile reagents for the synthesis of cycle-tail
peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rotstein, Benjamin H.; Winternheimer, David J.; Yin, Lois M.; Deber,
Charles M.; Yudin, Andrei K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(31),
3775-3777

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
L-Phenylalanine
C9H11NO2
63-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 2.6674 4.6200 0.0 0 CFG=2
M  V30 3 C 1.3338 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 1.3338 6.9300 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-phenylalanine
C10H11NO3
13200-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 2 C 4.0011 4.6200 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 1.3336 6.1600 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 O 1.3336 0.0000 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 6.6685 4.6200 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13200-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17912619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An aryne-based three-component access to α-aroylamino amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serafini, Marta; Griglio, Alessia; Viarengo, Sara; Aprile, Silvio;
Pirali, Tracey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(31), 6604-6612

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Trifluoromethoxybenzene-1,2-diamine
C7H7F3N2O
658-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 2.6674 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 F 2.3100 5.3349 0.0 0
M  V30 4 F 0.7700 5.3349 0.0 0
M  V30 5 F 0.0000 4.0011 0.0 0
M  V30 6 N 6.9300 0.0000 0.0 0
M  V30 7 N 8.4700 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 6.1600 1.3338 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Trifluoromethoxy)-1H-benzimidazole
C8H5F3N2O
911825-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 3.0800 0.0 0
M  V30 2 C 1.3336 2.3100 0.0 0
M  V30 3 F 1.3336 0.7700 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 6.6684 0.7700 0.0 0
M  V30 7 C 6.6684 2.3100 0.0 0
M  V30 8 C 5.3347 0.0000 0.0 0
M  V30 9 N 8.1331 0.2941 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 N 8.1331 2.7859 0.0 0
M  V30 12 C 4.0011 0.7700 0.0 0
M  V30 13 C 9.0383 1.5400 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 658-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911825-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-23644888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzimidazole carboxamides and their use in the treatment of
medical disorders and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Ray, Soumya; Lansbury,
Peter T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021055591 A1 2021-03-25

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-(methylamino)benzoic acid
C8H10N2O2
66315-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 N 4.0011 0.0000 0.0 0
M  V30 5 N 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-benzimidazole-5-carboxylic acid
C9H8N2O2
53484-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0407 3.1885 0.0 0
M  V30 2 C 0.7700 2.4782 0.0 0
M  V30 3 O 0.0000 1.1444 0.0 0
M  V30 4 O 0.0000 3.8118 0.0 0
M  V30 5 C 4.6201 1.1444 0.0 0
M  V30 6 C 5.3901 2.4782 0.0 0
M  V30 7 C 3.0800 1.1444 0.0 0
M  V30 8 N 5.6505 0.0000 0.0 0
M  V30 9 N 6.8963 2.1580 0.0 0
M  V30 10 C 4.6201 3.8118 0.0 0
M  V30 11 C 2.3100 2.4782 0.0 0
M  V30 12 C 7.0573 0.6263 0.0 0
M  V30 13 C 3.0800 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66315-15-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-8234818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3: 1-Methyl-1H-benzo[d]imidazole-5-carboxylic acid (281). A solution
of the di-amino compound 280 (678mg; 4.1mmol) (or an o-aminophenol) in
50% HCO2H (or any other carboxylic acid or an ortho-ester) in water (or
anhydrous solvent if an orthoester is used) was stirred at 85°C for 13h,
concentrated, the residue was re-dissolved in water and lyophillized to
afford the title compound 281 (712mg, 99% yield).
1-Methyl-1H-benzo[d]imidazole-5-carboxylic acid (281), yield (712mg,
99%). 1H NMR: (400.2 MHz, DMSO) δ (ppm): 12.9 (bs; 1H); 8.80 (s; 1H);
8.26 (d, J= 1.6 Hz; 1H); 7.96 (dd, J= 1.6, 8.6 Hz; 1H); 7.79 (d, J= 8.6
Hz; 1H); 3.95 (s, 3H). MS: calc: 176.2; found: 177.1 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide derivatives as inhibitors of histone deacetylase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moradei, Oscar; Paquin, Isabelle; Leit, Silvana; Frechette, Sylvie;
Vaisburg, Arkadii; Besterman, Jeffrey M.; Tessier, Pierre; Mallais, Tammy
C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005030704 A1 2005-04-07

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)-1,2-benzenediamine
C7H10N2S
67469-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylthio)-1H-benzimidazole
C8H8N2S
121537-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67469-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121537-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11909427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step C-8-(Methylthio)-1H-benzimidazole 4-(Methylthio)benzene-1,2-diamine
(10.7 g, 69.2 mmol) was dissolved in 230 mL of aqueous 4N HCl with
stirring. Formic acid (7.85 mL, 208 mmol) was added and the reaction was
refluxed for 1 h. The reaction was cooled to rt then concentrated in
vacuo to a dark solid. The dark solid was dissolved In 500 mL of MeOH
with stirring, NaHCO3 (51.0 g, 607 mmol) was added and the reaction was
stirred for 1 h. The reaction was then filtered, and the filtrate
concentrated in vacuo to a solid. The solid was stirred in 400 mL of
EtOAc and heated to reflux, then filtered. The filtrate was concentrated
in vacuo to a solid. The solid dissolved in 400 mL of DCM with stirring,
then dried over MgSO4, and filtered. The filtrate was concentrated in
vacuo. 11.3 g (99%) of the crude 6-(methylthio)-1H-benzimidazole as a
dark oil. 1H NMR (400 MHz, CD3OD) δ 8.12 (s, 1H), 7.52 (m, 2H), 7.24 (m,
1H), 2.50 (s, 3H). MS m/z 165 (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole thiophene compounds and their preparation, pharmaceutical
compositions and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuntz, Kevin; Emmitte, Kyle Allen; Rheault, Tara Renae; Smith, Stephon;
Hornberger, Keith; Dickson, Hamilton; Cheung, Mui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080300247 A1 2008-12-04

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)-1,2-benzenediamine
C7H10N2S
67469-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylthio)-1H-benzimidazole
C8H8N2S
121537-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67469-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121537-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-10773945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step C - 6-(Methylthio)-1H-benzimidazole
4-(Methylthio)benzene-1,2-diamine (10.7 g, 69.2 mmol) was dissolved in
230 mL. of aqueous 4N HCl with stirring. Formic acid (7.85 mL, 208 mmol)
was added and the reaction was refluxed for 1 h. The reaction was cooled
to rt then concentrated in vacuo to a dark solid. The dark solid was
dissolved in 500 mL of MeOH with stirring. NaHCO3 (51.0 g, 607 mmol) was
added and the reaction was stirred for 1 h. The reaction was then
filtered, and the filtrate concentrated in vacuo to a solid. The soiid
was stirred in 400 mL of EtOAc and heated to reflux, then filtered. The
filtrate was concentrated in vacuo to a solid. The solid dissolved in 400
mL of DCM with stirring, then dried over MgSO4, and filtered. The
filtrate was concentrated in vacuo to give 11.3 g (99%) of the crude
6-(methylthio)-1H-benzimidazole as a dark oil.
6-(Methylthio)-1H-benzimidazole, yield 11.3 g (99%). 1H NMR (400 MHz,
CD3OD) δ 8.12 (s, 1 H), 7.52 (m, 2 H), 7.24 (m, 1 H), 2.50 (s, 3H). MS
m/z 165 (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole thiophene compounds and their preparation, pharmaceutical
compositions and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuntz, Kevin; Emmitte, Kyle Allen; Rheault, Tara Renae; Smith, Stephon;
Hornberger, Keith; Dickson, Hamilton; Cheung, Mui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007143456 A2 2007-12-13

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Hydroxymethyl)furfural
C6H6O3
67-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 O 7.5415 1.8517 0.0 0
M  V30 3 C 0.9052 1.4946 0.0 0
M  V30 4 O 0.0000 0.2487 0.0 0
M  V30 5 C 4.8742 1.8517 0.0 0
M  V30 6 O 3.4672 2.4782 0.0 0
M  V30 7 C 4.7131 0.3202 0.0 0
M  V30 8 C 2.4368 1.3337 0.0 0
M  V30 9 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(Formyloxy)methyl]-2-furancarboxaldehyde
C7H6O4
102390-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 O 7.5415 1.8517 0.0 0
M  V30 3 C 8.8752 2.6218 0.0 0
M  V30 4 O 10.2089 1.8517 0.0 0
M  V30 5 C 0.9051 1.4946 0.0 0
M  V30 6 O 0.0000 0.2487 0.0 0
M  V30 7 C 4.8741 1.8517 0.0 0
M  V30 8 O 3.4672 2.4782 0.0 0
M  V30 9 C 4.7131 0.3202 0.0 0
M  V30 10 C 2.4368 1.3337 0.0 0
M  V30 11 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-47-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 102390-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-21088041
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple efficient one-pot synthesis of 5-hydroxymethylfurfural and
2,5-diformylfuran from carbohydrates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Girka, Quentin; Estrine, Boris; Hoffmann, Norbert; Le Bras, Jean;
Marinkovic, Sinisa; Muzart, Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Reaction Chemistry & Engineering (2016), 1(2), 176-182

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Isocyanobenzenamine
C7H6N2
69236-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 1.3336 0.0 0 CHG=1 VAL=4
M  V30 2 C 7.7000 1.3336 0.0 0 CHG=-1
M  V30 3 N 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Diisocyanobenzene
C8H4N2
935-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3336 0.0 0 CHG=1 VAL=4
M  V30 2 C 0.0000 1.3336 0.0 0 CHG=-1
M  V30 3 N 7.7000 1.3336 0.0 0 CHG=1 VAL=4
M  V30 4 C 9.2400 1.3336 0.0 0 CHG=-1
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 5.3900 0.0000 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 3 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69236-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 935-16-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30059092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild C-F Activation in Perfluorinated Arenes through Photosensitized
Insertion of Isonitriles at 350 nm
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weidlich, Frauke; Esumi, Naoto; Chen, Dongyang; Mueck-Lichtenfeld,
Christian; Zysman-Colman, Eli; Studer, Armido
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2020), 362(2), 376-383

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-1′-methylspiro[3H-indole-3,4′-piperidine]
C13H18N2
69584-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4207 4.1618 0.0 0
M  V30 2 C 4.4196 1.8518 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2587 0.3202 0.0 0
M  V30 5 C 4.4196 3.3918 0.0 0
M  V30 6 C 5.7533 1.0818 0.0 0
M  V30 7 C 1.9823 1.3338 0.0 0
M  V30 8 C 2.5368 3.9429 0.0 0
M  V30 9 N 2.7523 0.0000 0.0 0
M  V30 10 C 5.7533 4.1618 0.0 0
M  V30 11 C 7.0869 1.8518 0.0 0
M  V30 12 C 0.4760 1.6540 0.0 0
M  V30 13 C 1.0306 4.2630 0.0 0
M  V30 14 N 7.0869 3.3918 0.0 0
M  V30 15 C 0.0000 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-Methylspiro[3H-indole-3,4′-piperidine]-1(2H)-carboxaldehyde
C14H18N2O
1025687-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 4.1036 0.0 0
M  V30 2 O 8.5963 5.5106 0.0 0
M  V30 3 C 0.0000 6.7708 0.0 0
M  V30 4 C 4.0011 4.4608 0.0 0
M  V30 5 C 4.1620 2.9292 0.0 0
M  V30 6 C 5.4079 5.0872 0.0 0
M  V30 7 C 2.6673 3.6908 0.0 0
M  V30 8 C 4.0011 6.0008 0.0 0
M  V30 9 C 5.6683 2.6091 0.0 0
M  V30 10 C 3.1316 1.7849 0.0 0
M  V30 11 N 6.4383 3.9427 0.0 0
M  V30 12 C 1.3336 4.4608 0.0 0
M  V30 13 C 2.6673 6.7708 0.0 0
M  V30 14 C 6.1443 1.1444 0.0 0
M  V30 15 C 3.6074 0.3202 0.0 0
M  V30 16 N 1.3336 6.0008 0.0 0
M  V30 17 C 5.1137 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69584-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1025687-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13761200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A. 1-methyl-1'-formyl-spiro[piperidine-4,3'-(2H)-indole] A solution
of 1,2-dihydro-1'-methyl-spiro[3H-indole-3,4'-piperidine] (29.8 g, 0.148
mol; CAS# 69584-91-4; J. Med Chem. 1983, 26, 981-986) in toluene (737 mL)
was treated with formic acid (27.8 mL, 0.737 mol). The reaction vessel
was fitted with a Dean-Stark trap and the reaction mixture, which appears
as two layers, was heated at reflux under nitrogen with azeotropic
removal of water for 16 h. The reaction mixture was coole to room
temperature and concentrated invacuo. The residue was partitioned between
chloroform (500 mL) and 3N aq. NaOH (300 mL). The organic layer was
extracted three more times with N aq. NaOH (300 mL), dried over anhydrous
K2CO3, and filtered. The filtrate was concentrated in vacuo to furnish 6a
(33.5 g, 99%) as a beige solid.
1-methyl-1'-formyl-spiro[piperidine-4,3'-(2H)-indole] 6a, yield (33.5 g,
99%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spiropiperidines as tryptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Costanzo, Michael J.; Yabut, Stephen C.; Tounge, Brett; Maryanoff, Bruce
E.; Zhang, Han-Cheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009067202 A1 2009-05-28

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-1′-methylspiro[3H-indole-3,4′-piperidine]
C13H18N2
69584-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4207 4.1618 0.0 0
M  V30 2 C 4.4196 1.8518 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2587 0.3202 0.0 0
M  V30 5 C 4.4196 3.3918 0.0 0
M  V30 6 C 5.7533 1.0818 0.0 0
M  V30 7 C 1.9823 1.3338 0.0 0
M  V30 8 C 2.5368 3.9429 0.0 0
M  V30 9 N 2.7523 0.0000 0.0 0
M  V30 10 C 5.7533 4.1618 0.0 0
M  V30 11 C 7.0869 1.8518 0.0 0
M  V30 12 C 0.4760 1.6540 0.0 0
M  V30 13 C 1.0306 4.2630 0.0 0
M  V30 14 N 7.0869 3.3918 0.0 0
M  V30 15 C 0.0000 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-Methylspiro[3H-indole-3,4′-piperidine]-1(2H)-carboxaldehyde
C14H18N2O
1025687-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 4.1036 0.0 0
M  V30 2 O 8.5963 5.5106 0.0 0
M  V30 3 C 0.0000 6.7708 0.0 0
M  V30 4 C 4.0011 4.4608 0.0 0
M  V30 5 C 4.1620 2.9292 0.0 0
M  V30 6 C 5.4079 5.0872 0.0 0
M  V30 7 C 2.6673 3.6908 0.0 0
M  V30 8 C 4.0011 6.0008 0.0 0
M  V30 9 C 5.6683 2.6091 0.0 0
M  V30 10 C 3.1316 1.7849 0.0 0
M  V30 11 N 6.4383 3.9427 0.0 0
M  V30 12 C 1.3336 4.4608 0.0 0
M  V30 13 C 2.6673 6.7708 0.0 0
M  V30 14 C 6.1443 1.1444 0.0 0
M  V30 15 C 3.6074 0.3202 0.0 0
M  V30 16 N 1.3336 6.0008 0.0 0
M  V30 17 C 5.1137 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 11
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69584-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1025687-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5611578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and
biological evaluation of novel spirocyclic piperidine amide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Costanzo, Michael J.; Yabut, Stephen C.; Zhang, Han-Cheng; White,
Kimberley B.; de Garavilla, Lawrence; Wang, Yuanping; Minor, Lisa K.;
Tounge, Brett A.; Barnakov, Alexander N.; Lewandowski, Frank; Milligan,
Cynthia; Spurlino, John C.; Abraham, William M.; Boswell-Smith, Victoria;
Page, Clive P.; Maryanoff, Bruce E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(6), 2114-2121

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fmoc-Lys(Boc)-OH
C26H32N2O6
71989-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0870 7.5408 0.0 0
M  V30 4 N 7.0870 9.0808 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 8.4206 9.8508 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0808 0.0 0
M  V30 8 C 8.4206 11.3908 0.0 0
M  V30 9 C 11.0881 9.8508 0.0 0
M  V30 10 O 7.0870 12.1609 0.0 0
M  V30 11 O 9.7544 12.1609 0.0 0
M  V30 12 C 12.4217 9.0808 0.0 0
M  V30 13 C 13.7554 9.8508 0.0 0
M  V30 14 N 15.0892 9.0808 0.0 0
M  V30 15 C 16.4228 9.8508 0.0 0
M  V30 16 O 17.7565 9.0808 0.0 0
M  V30 17 O 16.4228 11.3908 0.0 0
M  V30 18 C 19.0901 9.8508 0.0 0
M  V30 19 C 18.3201 11.1846 0.0 0
M  V30 20 C 20.4239 10.6208 0.0 0
M  V30 21 C 19.8603 8.5172 0.0 0
M  V30 22 C 4.4197 4.4608 0.0 0
M  V30 23 C 4.2586 2.9293 0.0 0
M  V30 24 C 3.0127 5.0873 0.0 0
M  V30 25 C 2.7523 2.6091 0.0 0
M  V30 26 C 5.2892 1.7847 0.0 0
M  V30 27 C 1.9823 3.9427 0.0 0
M  V30 28 C 2.5369 6.5518 0.0 0
M  V30 29 C 2.2764 1.1444 0.0 0
M  V30 30 C 4.8133 0.3202 0.0 0
M  V30 31 C 0.4759 4.2629 0.0 0
M  V30 32 C 1.0306 6.8720 0.0 0
M  V30 33 C 3.3069 0.0000 0.0 0
M  V30 34 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 23 26
M  V30 26 1 24 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 2 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 33
M  V30 35 1 31 34
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Lysine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-, formate (1:1)
C21H24N2O4.CH2O2
1235989-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 7.5409 0.0 0
M  V30 2 O 5.7533 9.0809 0.0 0
M  V30 3 C 7.0871 9.8509 0.0 0
M  V30 4 N 7.0871 11.3910 0.0 0
M  V30 5 O 8.4208 9.0809 0.0 0
M  V30 6 C 8.4208 12.1610 0.0 0 CFG=2
M  V30 7 C 9.7544 11.3910 0.0 0
M  V30 8 C 8.4208 13.7010 0.0 0
M  V30 9 C 11.0881 12.1610 0.0 0
M  V30 10 O 7.0871 14.4710 0.0 0
M  V30 11 O 9.7544 14.4710 0.0 0
M  V30 12 C 12.4219 11.3910 0.0 0
M  V30 13 C 13.7556 12.1610 0.0 0
M  V30 14 N 15.0893 11.3910 0.0 0
M  V30 15 C 4.4196 6.7709 0.0 0
M  V30 16 C 3.0128 7.3974 0.0 0
M  V30 17 C 4.2587 5.2393 0.0 0
M  V30 18 C 1.9822 6.2528 0.0 0
M  V30 19 C 2.5369 8.8619 0.0 0
M  V30 20 C 2.7522 4.9191 0.0 0
M  V30 21 C 5.2891 4.0949 0.0 0
M  V30 22 C 0.4759 6.5730 0.0 0
M  V30 23 C 1.0304 9.1821 0.0 0
M  V30 24 C 2.2763 3.4544 0.0 0
M  V30 25 C 4.8132 2.6302 0.0 0
M  V30 26 C 0.0000 8.0377 0.0 0
M  V30 27 C 3.3069 2.3100 0.0 0
M  V30 28 C 7.5446 0.0000 0.0 0
M  V30 29 O 6.2110 0.7700 0.0 0
M  V30 30 O 8.8783 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 20
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71989-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235989-95-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-6633860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Monitoring the Activity of 2-Oxoglutarate Dependent Histone Demethylases
by NMR Spectroscopy: Direct Observation of Formaldehyde
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hopkinson, Richard J.; Hamed, Refaat B.; Rose, Nathan R.; Claridge,
Timothy D. W.; Schofield, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemBioChem (2010), 11(4), 506-510

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[(phenylmethoxy)amino]methyl]-2-hexenoate
C15H21NO3
752258-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 O 5.3900 5.3347 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 C 10.0100 2.6674 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 O 9.2400 1.3336 0.0 0
M  V30 10 O 11.5500 2.6674 0.0 0
M  V30 11 C 12.3200 6.6685 0.0 0
M  V30 12 C 10.0100 0.0000 0.0 0
M  V30 13 C 13.8600 6.6685 0.0 0
M  V30 14 C 3.0800 6.6685 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[formyl(phenylmethoxy)amino]methyl]-2-hexenoate
C16H21NO4
1000393-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0
M  V30 5 N 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 O 8.4700 5.3347 0.0 0
M  V30 10 C 6.1600 6.6685 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 1.5400 6.6685 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 O 6.9300 8.0021 0.0 0
M  V30 15 C 0.0000 6.6685 0.0 0
M  V30 16 C 10.7800 4.0011 0.0 0
M  V30 17 C 11.5500 2.6674 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 13.0900 2.6674 0.0 0
M  V30 20 C 13.0900 5.3347 0.0 0
M  V30 21 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4 CFG=2
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 752258-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000393-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3271223
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM E:Z = 1:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective hydrogenation of α-aminomethylacrylates containing a
free N-H group for the synthesis of β-amino acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiu, Liqin; Prashad, Mahavir; Hu, Bin; Prasad, Kapa; Repic, Oljan;
Blacklock, Thomas J.; Kwong, Fuk Yee; Kok, Stanton H. L.; Lee, Hang Wai;
Chan, Albert S. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2007), 104(43), 16787-16792

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butylamine
C4H11N
75-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-methyl-2-propanamine (1:1)
C4H11N.CH2O2
63302-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 3.8500 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 1.5400 5.3900 0.0 0
M  V30 4 C 3.0800 3.8500 0.0 0
M  V30 5 N 1.5400 2.3100 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 0.2063 0.7700 0.0 0
M  V30 8 O 2.8737 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 6 7
M  V30 6 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63302-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29864851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid prepd.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Hydroxyethylammonium carboxylates - highly biodegradable and slightly
toxic ionic liquids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zicmanis, A.; Pavlovica, S.; Gzibovska, E.; Mekss, P.; Klavins, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Latvijas Kimijas Zurnals (2010), (3/4), 269-276

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
C14H18I3N3O6
76801-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 4.6200 0.0 0
M  V30 2 N 13.3369 3.8500 0.0 0
M  V30 3 O 12.0032 6.1600 0.0 0
M  V30 4 C 14.6705 4.6200 0.0 0
M  V30 5 C 16.0041 3.8500 0.0 0
M  V30 6 C 17.3379 4.6200 0.0 0
M  V30 7 O 16.0041 2.3100 0.0 0
M  V30 8 O 18.6716 3.8500 0.0 0
M  V30 9 I 9.3358 6.1600 0.0 0
M  V30 10 I 12.0032 1.5400 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 N 5.3347 3.8500 0.0 0
M  V30 13 O 6.6684 6.1600 0.0 0
M  V30 14 C 4.0011 4.6200 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 O 2.6674 2.3100 0.0 0
M  V30 18 O 0.0000 3.8500 0.0 0
M  V30 19 N 9.3358 0.0000 0.0 0
M  V30 20 I 6.6684 1.5400 0.0 0
M  V30 21 C 10.6694 3.8500 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6694 2.3100 0.0 0
M  V30 24 C 8.0021 3.8500 0.0 0
M  V30 25 C 9.3358 1.5400 0.0 0
M  V30 26 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 22
M  V30 10 1 10 23
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 24
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 19 25
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N3-Bis[2,3-bis(formyloxy)propyl]-5-(formylamino)-2,4,6-triiodo-1,3-benzene...
C19H18I3N3O11
1096689-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6685 0.0 0
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 O 7.7000 5.3347 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 O 0.0000 8.0021 0.0 0
M  V30 12 O 3.0800 0.0000 0.0 0
M  V30 13 I 10.0100 6.6685 0.0 0
M  V30 14 I 5.3900 9.3358 0.0 0
M  V30 15 C 11.5500 9.3358 0.0 0
M  V30 16 N 12.3200 10.6696 0.0 0
M  V30 17 O 12.3200 8.0021 0.0 0
M  V30 18 C 13.8600 10.6696 0.0 0
M  V30 19 C 14.6300 12.0032 0.0 0
M  V30 20 C 16.1700 12.0032 0.0 0
M  V30 21 O 13.8600 13.3369 0.0 0
M  V30 22 O 16.9400 10.6694 0.0 0
M  V30 23 C 14.6300 14.6705 0.0 0
M  V30 24 C 18.4800 10.6694 0.0 0
M  V30 25 O 13.8600 16.0043 0.0 0
M  V30 26 O 19.2500 9.3358 0.0 0
M  V30 27 N 6.9300 12.0032 0.0 0
M  V30 28 C 5.3900 12.0032 0.0 0
M  V30 29 O 4.6200 13.3369 0.0 0
M  V30 30 I 10.0100 12.0032 0.0 0
M  V30 31 C 7.7000 8.0021 0.0 0
M  V30 32 C 9.2400 8.0021 0.0 0
M  V30 33 C 6.9300 9.3358 0.0 0
M  V30 34 C 10.0100 9.3358 0.0 0
M  V30 35 C 7.7000 10.6696 0.0 0
M  V30 36 C 9.2400 10.6696 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 31
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 13 32
M  V30 14 1 14 33
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 34
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 27 28
M  V30 28 1 27 35
M  V30 29 2 28 29
M  V30 30 1 30 36
M  V30 31 2 31 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 2 33 35
M  V30 35 2 34 36
M  V30 36 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76801-93-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1096689-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8417538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2a)
1-formylamino-3,5-bis(2,3-bis(formyloxy)propan-1-ylcarbamoyl)-2,4,6-triiodo-benzene
Formic acid (4 L) was charged in a dry 5000 ml jacketed reactor on
cryostat was fitted with a dropping funnel, mechanical stirring,
thermometer and a gas inlet. The acid was cooled with a cryostat under a
nitrogen blanket. Acetic anhydride (1.98 L, 21.0 mol) was added drop wise
at a rate so that the temperature did not exceed 12.0 °C. After 7.5 h the
addition was completed and the mixture was cooled to 3.8 °C and
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-isophthalamide (1.481
kg, 2.1 mol) was added over 20 minutes and the mixture was left stirring
over night attaining ambient temperature. The reaction mixture was
evaporated in vacuo at 40 °C to a moist mass, this was further dried in a
vacuum oven at 40 °C to yield 1754 g (98.8 %) of
1-formylamino-3,5-bis(2,3-bis(formyloxy)propan-1-ylcarbamoyl)-2,4,6-triiodo-benzene.
The product was used in the next step without purification. The obtained
product does contain some minor fraction of O-acetyl esters, as the
product is used directly in the next step without purification this can
be disregarded.
1-formylamino-3,5-bis(2,3-bis(formyloxy)propan-1-ylcarbamoyl)-2,4,6-triiodo-benzene,
yield 1754 g (98.8 %)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM X-ray contrast media compositions containing non-ionic monomeric and
non-ionic dimeric triiodo-compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wistrand, Lars-Goeran; Thaning, Mikkel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010079201 A1 2010-07-15

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dicyclopentadiene
C10H12
77-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6590 2.3100 0.0 0
M  V30 2 C 2.6590 0.7700 0.0 0
M  V30 3 C 1.3346 3.0800 0.0 0
M  V30 4 C 4.1235 2.7859 0.0 0
M  V30 5 C 1.3346 0.0000 0.0 0
M  V30 6 C 4.1235 0.2941 0.0 0
M  V30 7 C 0.8624 1.5400 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 5.0287 1.5400 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 7
M  V30 10 1 5 10
M  V30 11 2 6 9
M  V30 12 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Methano-1H-inden-6-ol, 3a,4,5,6,7,7a-hexahydro-, 6-formate
C11H14O2
17383-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0243 3.6198 0.0 0
M  V30 2 C 7.3580 2.8498 0.0 0
M  V30 3 O 8.6916 3.6198 0.0 0
M  V30 4 C 3.2432 2.5201 0.0 0
M  V30 5 C 2.4086 3.7118 0.0 0
M  V30 6 C 4.6905 2.8498 0.0 0
M  V30 7 C 2.4970 0.0000 0.0 0
M  V30 8 C 1.4362 2.5173 0.0 0
M  V30 9 C 1.5731 5.0054 0.0 0
M  V30 10 C 3.8133 1.9035 0.0 0
M  V30 11 C 2.5659 1.4188 0.0 0
M  V30 12 C 0.0000 3.0730 0.0 0
M  V30 13 C 0.0845 4.6107 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77-73-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17383-78-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-237-CAS-17765662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 8-(formyloxy)tricyclo[5.2.1.02.6]dec-3-yl (meth)acrylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, M. K.; Makhmudova, E. G.; Rasulova, R. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2017), 53(5), 785-786

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(4-fluorophenyl)-5,6,7,8-tetrahydrocycloocta[b]pyridine
C17H15ClFN
848301-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.5912 0.0000 0.0 0
M  V30 2 F 10.2597 6.9302 0.0 0
M  V30 3 C 4.9249 3.8501 0.0 0
M  V30 4 C 3.5912 4.6201 0.0 0
M  V30 5 C 4.9249 2.3101 0.0 0
M  V30 6 C 2.2575 3.8501 0.0 0
M  V30 7 C 3.9898 6.1076 0.0 0
M  V30 8 C 3.5912 1.5400 0.0 0
M  V30 9 N 2.2575 2.3101 0.0 0
M  V30 10 C 0.7700 4.2486 0.0 0
M  V30 11 C 3.2197 7.4414 0.0 0
M  V30 12 C 0.0000 5.5825 0.0 0
M  V30 13 C 1.7322 7.8400 0.0 0
M  V30 14 C 0.3986 7.0700 0.0 0
M  V30 15 C 6.2587 4.6201 0.0 0
M  V30 16 C 7.5924 3.8501 0.0 0
M  V30 17 C 6.2587 6.1601 0.0 0
M  V30 18 C 8.9260 4.6201 0.0 0
M  V30 19 C 7.5924 6.9302 0.0 0
M  V30 20 C 8.9260 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 20
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cycloocta[b]pyridin-8-ol, 2-chloro-4-(4-fluorophenyl)-5,6,7,8-tetrahydro-, 8-...
C18H15ClFNO2
848301-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.6685 0.0000 0.0 0
M  V30 2 F 0.0000 6.9301 0.0 0
M  V30 3 O 11.0830 8.0074 0.0 0
M  V30 4 C 12.5058 7.4180 0.0 0
M  V30 5 O 13.7275 8.3556 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 8.0021 3.8501 0.0 0
M  V30 10 C 6.2699 6.1076 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 9.4898 4.2486 0.0 0
M  V30 13 N 8.0021 2.3100 0.0 0
M  V30 14 C 7.0399 7.4413 0.0 0
M  V30 15 C 10.2598 5.5823 0.0 0
M  V30 16 C 8.5274 7.8400 0.0 0
M  V30 17 C 9.8611 7.0700 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 C 4.0011 6.1601 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 C 2.6673 6.9301 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848301-78-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 848301-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-209-CAS-9320794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7446-08-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses and properties of the major hydroxy metabolites in humans of
blonanserin AD-5423, a novel antipsychotic agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ochi, Takeshi; Sakamoto, Masato; Minamida, Akira; Suzuki, Kenji; Ueda,
Tomohiko; Une, Teruaki; Toda, Hiroshi; Matsumoto, Kazuya; Terauchi,
Yoshiaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(4), 1055-1059

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(8α,9S)-Cinchonan-9-amine
C19H23N3
850409-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0 CFG=1
M  V30 2 N 5.3347 4.6200 0.0 0
M  V30 3 C 12.0822 3.1037 0.0 0
M  V30 4 C 12.7934 1.7377 0.0 0
M  V30 5 C 6.6685 2.3100 0.0 0 CFG=2
M  V30 6 N 7.9612 3.3249 0.0 0 CFG=1
M  V30 7 C 7.8315 2.5943 0.0 0
M  V30 8 C 9.2455 2.5815 0.0 0
M  V30 9 C 7.6247 4.8967 0.0 0
M  V30 10 C 9.2271 3.9131 0.0 0 CFG=2
M  V30 11 C 10.5436 3.1709 0.0 0 CFG=2
M  V30 12 C 8.8630 5.5455 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 2.6674 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 2.6674 4.6200 0.0 0
M  V30 18 C 2.6674 0.0000 0.0 0
M  V30 19 N 1.3338 0.7700 0.0 0
M  V30 20 C 0.0000 3.0800 0.0 0
M  V30 21 C 1.3338 5.3900 0.0 0
M  V30 22 C 0.0000 4.6200 0.0 0
M  V30 23 H 6.4506 0.7856 0.0 0
M  V30 24 H 10.4637 4.8308 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 5
M  V30 3 1 1 13
M  V30 4 2 3 4
M  V30 5 1 11 3 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 5 23 CFG=3
M  V30 9 1 6 8 CFG=1
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 10 11
M  V30 15 1 10 12
M  V30 16 1 10 24 CFG=1
M  V30 17 1 13 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 14 17
M  V30 21 1 15 18
M  V30 22 1 16 19
M  V30 23 1 16 20
M  V30 24 2 17 21
M  V30 25 2 18 19
M  V30 26 2 20 22
M  V30 27 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 5 6 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(8α,9S)-Cinchonan-9-ylformamide
C20H23N3O
1620137-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 2 N 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 12.0822 3.8263 0.0 0
M  V30 6 C 12.7934 5.1923 0.0 0
M  V30 7 C 6.6685 4.6200 0.0 0 CFG=2
M  V30 8 N 7.9612 3.6051 0.0 0 CFG=1
M  V30 9 C 7.8315 4.3357 0.0 0
M  V30 10 C 9.2455 4.3485 0.0 0
M  V30 11 C 7.6247 2.0333 0.0 0
M  V30 12 C 9.2271 3.0169 0.0 0 CFG=2
M  V30 13 C 10.5436 3.7591 0.0 0 CFG=2
M  V30 14 C 8.8630 1.3845 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 4.0011 6.1600 0.0 0
M  V30 18 C 1.3338 4.6200 0.0 0
M  V30 19 C 2.6674 2.3100 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 N 1.3338 6.1600 0.0 0
M  V30 22 C 0.0000 3.8500 0.0 0
M  V30 23 C 1.3338 1.5400 0.0 0
M  V30 24 C 0.0000 2.3100 0.0 0
M  V30 25 H 6.4506 6.1444 0.0 0
M  V30 26 H 10.4637 2.0992 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 2 5 6
M  V30 7 1 13 5 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=3
M  V30 10 1 7 25 CFG=1
M  V30 11 1 8 10 CFG=3
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 12 26 CFG=3
M  V30 19 1 15 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 18 21
M  V30 25 1 18 22
M  V30 26 2 19 23
M  V30 27 2 20 21
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 7 8 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 850409-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620137-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11859183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, literature preparation, 87% global yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel cinchona-amino acid hybrid organocatalysts for
asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrulas, Pedro; Benaglia, Maurizio; Burke, Anthony J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2014), 25(12), 923-935

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Stereoisomer of 2-bromo-N-(5-hydroxytricyclo[3.3.1.13,7]dec-2-yl)propanamide
C13H20BrNO2
868604-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6589 1.8920 0.0 0
M  V30 2 C 7.4289 3.2258 0.0 0
M  V30 3 C 8.9691 3.2258 0.0 0 CFG=3
M  V30 4 O 6.6589 4.5597 0.0 0
M  V30 5 Br 9.7391 4.5597 0.0 0
M  V30 6 C 9.7391 1.8920 0.0 0
M  V30 7 O 0.0000 4.0585 0.0 0
M  V30 8 C 5.1188 1.8920 0.0 0 CFG=1
M  V30 9 C 3.4967 2.3793 0.0 0 CFG=2
M  V30 10 C 3.6469 1.4500 0.0 0 CFG=1
M  V30 11 C 2.5354 3.3867 0.0 0
M  V30 12 C 2.9857 0.9296 0.0 0
M  V30 13 C 2.6855 2.4573 0.0 0
M  V30 14 C 3.1360 0.0000 0.0 0
M  V30 15 C 1.0631 2.9444 0.0 0
M  V30 16 C 1.5138 0.4871 0.0 0
M  V30 17 C 0.5524 1.4945 0.0 0
M  V30 18 H 4.3020 3.6920 0.0 0
M  V30 19 H 4.7100 0.3356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18 CFG=1
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 19 CFG=3
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 8 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Stereoisomer of 4-[(2-bromo-1-oxopropyl)amino]tricyclo[3.3.1.13,7]decane-1-ca...
C14H20BrNO3
868623-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.2208 0.0 0
M  V30 2 O 0.0000 3.9909 0.0 0
M  V30 3 O 1.3337 1.6808 0.0 0
M  V30 4 N 8.3329 3.4263 0.0 0
M  V30 5 C 8.6965 1.9298 0.0 0
M  V30 6 C 10.1743 1.4965 0.0 0 CFG=3
M  V30 7 O 7.5822 0.8666 0.0 0
M  V30 8 Br 10.5379 0.0000 0.0 0
M  V30 9 C 11.2885 2.5596 0.0 0
M  V30 10 C 2.6675 3.9909 0.0 0
M  V30 11 C 3.9556 3.1523 0.0 0
M  V30 12 C 4.3612 4.0018 0.0 0
M  V30 13 C 2.5853 5.5257 0.0 0
M  V30 14 C 5.1615 3.8484 0.0 0 CFG=2
M  V30 15 C 5.5671 4.6979 0.0 0 CFG=1
M  V30 16 C 3.7911 6.2219 0.0 0
M  V30 17 C 6.8550 3.8595 0.0 0 CFG=2
M  V30 18 C 5.0791 5.3832 0.0 0
M  V30 19 C 5.4847 6.2329 0.0 0
M  V30 20 H 5.5649 2.3621 0.0 0
M  V30 21 H 6.9006 5.4681 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 17 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 20 CFG=1
M  V30 19 1 15 17
M  V30 20 1 15 19
M  V30 21 1 15 21 CFG=3
M  V30 22 1 16 18
M  V30 23 1 16 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 868604-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 868623-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-075-CAS-10988322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 8014-95-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM E-4-(2-Bromo-propionylamino)-adamantane-1-carboxylic acid A solution of
E-2-bromo-N-(5-hydroxy-adamantan-2-yl)-propionamide from Example 13B (4.0
g, 13.25mmol) in 99% formic acid (13 mL) was added dropwise with vigorous
gas evolution over 40 minutes to a rapidly stirred 30% oleum solution (40
mL) heated to 60° C. (W. J. le Noble, S. Srivastava, C. K. Cheung, J.
Org. Chem. 48: 1099-1101,1983).Upon completion of addition, more 99%
formic acid (13 mL) was slowly added over the next 40 minutes. The
mixture was stirred another 60 minutes at 60° C. and then slowly poured
into vigorously stirred iced water (100 mL) cooled to 0° C. The mixture
was allowed to slowly warm to 23° C. while stirring, filtered and washed
with water to neutral pH (1L). The precipitate was dried in a vacuum oven
to provide the title compound as a white solid (4.3 g, 99% crude).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of adamantyl amide derivatives as inhibitors of the
11β-hydroxysteroid dehydrogenase type 1 enzyme
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Link, James T.; Pliushchev, Marina A.; Rohde, Jeffrey J.; Wodka, Dariusz;
Patel, Jyoti R.; Shuai, Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050245534 A1 2005-11-03

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-(Phenylmethyl)-3,7-dioxa-9-azabicyclo[3.3.1]nonane
C13H17NO2
873336-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0176 3.5630 0.0 0
M  V30 2 N 3.6839 2.7930 0.0 0
M  V30 3 C 2.4061 2.5942 0.0 0
M  V30 4 C 2.7430 1.6244 0.0 0
M  V30 5 C 0.9328 3.4289 0.0 0
M  V30 6 C 1.6380 1.0109 0.0 0
M  V30 7 C 1.9207 0.0000 0.0 0
M  V30 8 C 1.1946 2.4804 0.0 0
M  V30 9 O 0.0000 2.2589 0.0 0
M  V30 10 O 0.4492 0.4546 0.0 0
M  V30 11 C 6.3514 2.7930 0.0 0
M  V30 12 C 6.3514 1.2530 0.0 0
M  V30 13 C 7.6851 3.5630 0.0 0
M  V30 14 C 7.6851 0.4830 0.0 0
M  V30 15 C 9.0187 2.7930 0.0 0
M  V30 16 C 9.0187 1.2530 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 10
M  V30 12 1 8 9
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 3,7-dioxa-9-azabicyclo[3.3.1]nonane (1:1)
C6H11NO2.CH2O2
873336-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4028 3.0800 0.0 0
M  V30 2 N 1.5223 4.9169 0.0 0
M  V30 3 C 0.0000 4.5565 0.0 0
M  V30 4 C 1.7365 2.3100 0.0 0
M  V30 5 C 3.5820 5.5375 0.0 0
M  V30 6 O 0.7637 5.8983 0.0 0
M  V30 7 O 3.2212 2.7192 0.0 0
M  V30 8 C 3.9912 4.0528 0.0 0
M  V30 9 C 2.2547 6.2993 0.0 0
M  V30 10 C 1.9956 0.0000 0.0 0
M  V30 11 O 0.6619 0.7700 0.0 0
M  V30 12 O 3.3293 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 9
M  V30 10 1 7 8
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 873336-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 873336-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-14274841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3,7-Dioxa-9-aza-bicyclo[3,3,1]nonane Formic Acid Salt (1-HCO2H). To a
solution of 12 (87 mg, 0.397 mmol) in 5% HCO2HMeOH (4 mL) was added Pd
black (9 mg), and the mixture was stirred for 2 h. After filtration, the
solution was concentrated to give 64 mg of 1 as a formic acid salt (99%):
1H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 4.12 (dd, J = 12.0, 2.2 Hz, 4H),
4.07 (dd, J = 12.0, 2.2 Hz, 4H), 3.25 (s, 2H); 13C NMR (100 MHz, CDCl3) δ
168.0, 69.0, 49.2; HRMS (ESI) calcd for C6H12NO2 (M + H) 130.0863, found
130.0859
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concise Synthesis of 3,7-Dioxa-9-aza-bicyclo[3,3,1]-nonane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Cheol-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2006), 71(1), 413-415

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzonitrile
C7H6N2
873-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 N 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyanophenyl)formamide
C8H6N2O
6321-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 N 10.0100 1.3336 0.0 0
M  V30 6 C 3.8500 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 6.1600 0.0000 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 873-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6321-94-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5586442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM capped vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Keto Phenylamides as P1'-Extended Proteasome Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Voss, Constantin; Scholz, Christoph; Knorr, Sabine; Beck, Philipp; Stein,
Martin L.; Zall, Andrea; Kuckelkorn, Ulrike; Kloetzel, Peter-Michael;
Groll, Michael; Hamacher, Kay; Schmidt, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2014), 9(11), 2557-2564

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
(2S)-N-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-L-valyl-N-(3,5-dimethylphenyl)...
C27H37N3O4
876366-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 2 N 9.3358 5.3900 0.0 0
M  V30 3 C 6.6684 5.3900 0.0 0
M  V30 4 C 10.6694 4.6200 0.0 0
M  V30 5 N 5.3347 4.6200 0.0 0
M  V30 6 O 6.6684 6.9300 0.0 0
M  V30 7 C 12.0032 5.3900 0.0 0 CFG=2
M  V30 8 O 10.6694 3.0800 0.0 0
M  V30 9 N 13.3369 4.6200 0.0 0
M  V30 10 C 12.0032 6.9300 0.0 0
M  V30 11 C 14.6705 5.3900 0.0 0
M  V30 12 C 13.3369 3.0800 0.0 0
M  V30 13 C 10.6694 7.7000 0.0 0
M  V30 14 C 13.3369 7.7000 0.0 0
M  V30 15 O 16.0041 4.6200 0.0 0
M  V30 16 O 14.6705 6.9300 0.0 0
M  V30 17 C 17.3379 5.3900 0.0 0
M  V30 18 C 18.1079 4.0564 0.0 0
M  V30 19 C 18.6716 6.1600 0.0 0
M  V30 20 C 16.5679 6.7236 0.0 0
M  V30 21 C 2.6674 9.2400 0.0 0
M  V30 22 C 0.0000 4.6200 0.0 0
M  V30 23 C 8.0021 3.0800 0.0 0
M  V30 24 C 9.3358 2.3100 0.0 0
M  V30 25 C 6.6684 2.3100 0.0 0
M  V30 26 C 9.3358 0.7700 0.0 0
M  V30 27 C 6.6684 0.7700 0.0 0
M  V30 28 C 8.0021 0.0000 0.0 0
M  V30 29 C 4.0011 5.3900 0.0 0
M  V30 30 C 4.0011 6.9300 0.0 0
M  V30 31 C 2.6674 4.6200 0.0 0
M  V30 32 C 2.6674 7.7000 0.0 0
M  V30 33 C 1.3336 5.3900 0.0 0
M  V30 34 C 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 29
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 32
M  V30 23 1 22 33
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycinamide, N-formyl-N-methyl-L-valyl-N-(3,5-dimethylphenyl)-2-phenyl-, (2S)-
C23H29N3O3
876366-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 N 8.0022 6.1601 0.0 0
M  V30 4 N 5.3348 4.6201 0.0 0
M  V30 5 O 4.0010 6.9302 0.0 0
M  V30 6 C 9.3358 6.9302 0.0 0
M  V30 7 C 10.6697 6.1601 0.0 0 CFG=2
M  V30 8 O 9.3358 8.4702 0.0 0
M  V30 9 N 12.0033 6.9302 0.0 0
M  V30 10 C 10.6697 4.6201 0.0 0
M  V30 11 C 13.3370 6.1601 0.0 0
M  V30 12 C 12.0033 8.4702 0.0 0
M  V30 13 C 9.3358 3.8501 0.0 0
M  V30 14 C 12.0033 3.8501 0.0 0
M  V30 15 O 14.6707 6.9302 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 6.6685 8.4702 0.0 0
M  V30 19 C 5.3348 9.2402 0.0 0
M  V30 20 C 8.0022 9.2402 0.0 0
M  V30 21 C 5.3348 10.7802 0.0 0
M  V30 22 C 8.0022 10.7802 0.0 0
M  V30 23 C 6.6685 11.5503 0.0 0
M  V30 24 C 4.0010 3.8501 0.0 0
M  V30 25 C 4.0010 2.3101 0.0 0
M  V30 26 C 2.6673 4.6201 0.0 0
M  V30 27 C 2.6673 1.5400 0.0 0
M  V30 28 C 1.3337 3.8501 0.0 0
M  V30 29 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 24
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 16 27
M  V30 18 1 17 28
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 876366-47-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876366-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-7496137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamides derived from N-methyl amino acids serve as new chiral
organocatalysts in the enantioselective reduction of aromatic ketimines
with trichlorosilane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malkov, Andrei V.; Stoncius, Sigitas; MacDougall, Kenneth N.; Mariani,
Andrea; McGeoch, Grant D.; Kocovsky, Pavel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(2-3), 264-284

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
L-Phenylalaninamide, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-L-valyl-N-(3,5...
C28H39N3O4
876366-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 6.9302 0.0 0 CFG=1
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 C 6.6687 8.4702 0.0 0
M  V30 4 N 8.0023 6.1601 0.0 0
M  V30 5 N 5.3348 4.6201 0.0 0
M  V30 6 O 4.0012 6.9302 0.0 0
M  V30 7 C 9.3360 6.9302 0.0 0
M  V30 8 C 10.6697 6.1601 0.0 0 CFG=2
M  V30 9 O 9.3360 8.4702 0.0 0
M  V30 10 N 12.0035 6.9302 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 13.3372 6.1601 0.0 0
M  V30 13 C 12.0035 8.4702 0.0 0
M  V30 14 C 12.0035 3.8501 0.0 0
M  V30 15 C 9.3360 3.8501 0.0 0
M  V30 16 O 14.6708 6.9302 0.0 0
M  V30 17 O 13.3372 4.6201 0.0 0
M  V30 18 C 16.0045 6.1601 0.0 0
M  V30 19 C 16.7745 7.4938 0.0 0
M  V30 20 C 17.3383 5.3901 0.0 0
M  V30 21 C 15.2345 4.8265 0.0 0
M  V30 22 C 2.6675 0.0000 0.0 0
M  V30 23 C 0.0000 4.6201 0.0 0
M  V30 24 C 5.3348 9.2402 0.0 0
M  V30 25 C 4.0012 8.4702 0.0 0
M  V30 26 C 5.3348 10.7802 0.0 0
M  V30 27 C 2.6675 9.2402 0.0 0
M  V30 28 C 4.0012 11.5503 0.0 0
M  V30 29 C 2.6675 10.7802 0.0 0
M  V30 30 C 4.0012 3.8501 0.0 0
M  V30 31 C 4.0012 2.3101 0.0 0
M  V30 32 C 2.6675 4.6201 0.0 0
M  V30 33 C 2.6675 1.5400 0.0 0
M  V30 34 C 1.3338 3.8501 0.0 0
M  V30 35 C 1.3338 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 24
M  V30 7 1 4 7
M  V30 8 1 5 30
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 8 11 CFG=1
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 33
M  V30 24 1 23 34
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalaninamide, N-formyl-N-methyl-L-valyl-N-(3,5-dimethylphenyl)-
C24H31N3O3
876366-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.9300 0.0 0 CFG=2
M  V30 2 C 6.6684 8.4700 0.0 0
M  V30 3 C 5.3347 6.1600 0.0 0
M  V30 4 N 8.0020 6.1600 0.0 0
M  V30 5 N 5.3347 4.6200 0.0 0
M  V30 6 O 4.0009 6.9300 0.0 0
M  V30 7 C 9.3356 6.9300 0.0 0
M  V30 8 C 10.6694 6.1600 0.0 0 CFG=2
M  V30 9 O 9.3356 8.4700 0.0 0
M  V30 10 N 12.0031 6.9300 0.0 0
M  V30 11 C 10.6694 4.6200 0.0 0
M  V30 12 C 13.3367 6.1600 0.0 0
M  V30 13 C 12.0031 8.4700 0.0 0
M  V30 14 C 12.0031 3.8500 0.0 0
M  V30 15 C 9.3356 3.8500 0.0 0
M  V30 16 O 14.6703 6.9300 0.0 0
M  V30 17 C 2.6673 0.0000 0.0 0
M  V30 18 C 0.0000 4.6200 0.0 0
M  V30 19 C 5.3347 9.2400 0.0 0
M  V30 20 C 4.0009 8.4700 0.0 0
M  V30 21 C 5.3347 10.7800 0.0 0
M  V30 22 C 2.6673 9.2400 0.0 0
M  V30 23 C 4.0009 11.5500 0.0 0
M  V30 24 C 2.6673 10.7800 0.0 0
M  V30 25 C 4.0009 3.8500 0.0 0
M  V30 26 C 4.0009 2.3100 0.0 0
M  V30 27 C 2.6673 4.6200 0.0 0
M  V30 28 C 2.6673 1.5400 0.0 0
M  V30 29 C 1.3336 3.8500 0.0 0
M  V30 30 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 25
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 8 11 CFG=1
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 17 28
M  V30 19 1 18 29
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 876366-48-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876366-64-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-6571893
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamides derived from N-methyl amino acids serve as new chiral
organocatalysts in the enantioselective reduction of aromatic ketimines
with trichlorosilane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malkov, Andrei V.; Stoncius, Sigitas; MacDougall, Kenneth N.; Mariani,
Andrea; McGeoch, Grant D.; Kocovsky, Pavel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(2-3), 264-284

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, (4S)-1-[(1,1-dimethylethoxy)carbonyl]-4-(methylthio)-L-proly...
C27H41N3O6S
876953-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0132 6.2079 0.0 0
M  V30 2 N 8.5532 6.2079 0.0 0
M  V30 3 O 6.2432 7.5416 0.0 0
M  V30 4 C 9.3232 7.5416 0.0 0 CFG=1
M  V30 5 C 10.8632 7.5416 0.0 0
M  V30 6 C 8.5532 8.8752 0.0 0
M  V30 7 N 11.6333 6.2079 0.0 0
M  V30 8 O 11.6333 8.8752 0.0 0
M  V30 9 C 9.3232 10.2089 0.0 0
M  V30 10 C 13.1733 6.2079 0.0 0 CFG=2
M  V30 11 C 8.5532 11.5427 0.0 0
M  V30 12 C 10.8632 10.2089 0.0 0
M  V30 13 C 13.9433 7.5416 0.0 0
M  V30 14 C 13.9433 4.8741 0.0 0
M  V30 15 O 13.1733 3.5405 0.0 0
M  V30 16 O 15.4833 4.8741 0.0 0
M  V30 17 C 13.9433 2.2068 0.0 0
M  V30 18 C 3.6812 5.8576 0.0 0
M  V30 19 O 2.1748 5.5374 0.0 0
M  V30 20 O 4.1571 7.3223 0.0 0
M  V30 21 C 1.1444 6.6820 0.0 0
M  V30 22 C 0.0000 5.6514 0.0 0
M  V30 23 C 0.1140 7.8263 0.0 0
M  V30 24 C 2.2889 7.7124 0.0 0
M  V30 25 S 5.8862 0.9052 0.0 0
M  V30 26 C 4.6402 0.0000 0.0 0
M  V30 27 C 6.2432 4.8741 0.0 0 CFG=2
M  V30 28 N 4.7117 4.7132 0.0 0
M  V30 29 C 6.8697 3.4673 0.0 0
M  V30 30 C 4.3915 3.2069 0.0 0
M  V30 31 C 5.7251 2.4369 0.0 0 CFG=2
M  V30 32 C 15.4833 7.5416 0.0 0
M  V30 33 C 16.2533 6.2079 0.0 0
M  V30 34 C 16.2533 8.8752 0.0 0
M  V30 35 C 17.7933 6.2079 0.0 0
M  V30 36 C 17.7933 8.8752 0.0 0
M  V30 37 C 18.5633 7.5416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 27 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13 CFG=1
M  V30 14 1 10 14
M  V30 15 1 13 32
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 28
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 26
M  V30 27 1 31 25 CFG=3
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 33 2 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 34 36
M  V30 37 2 35 37
M  V30 38 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 10 27 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, (4S)-1-formyl-4-(methylthio)-L-prolyl-L-leucyl-, methyl ester
C23H33N3O5S
876953-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 6.2080 0.0 0
M  V30 2 N 10.0102 6.2080 0.0 0
M  V30 3 O 12.3203 7.5417 0.0 0
M  V30 4 C 9.2402 7.5417 0.0 0 CFG=1
M  V30 5 C 7.7002 7.5417 0.0 0
M  V30 6 C 10.0102 8.8754 0.0 0
M  V30 7 N 6.9302 6.2080 0.0 0
M  V30 8 O 6.9302 8.8754 0.0 0
M  V30 9 C 9.2402 10.2090 0.0 0
M  V30 10 C 5.3901 6.2080 0.0 0 CFG=2
M  V30 11 C 10.0102 11.5429 0.0 0
M  V30 12 C 7.7002 10.2090 0.0 0
M  V30 13 C 4.6201 7.5417 0.0 0
M  V30 14 C 4.6201 4.8742 0.0 0
M  V30 15 O 5.3901 3.5405 0.0 0
M  V30 16 O 3.0801 4.8742 0.0 0
M  V30 17 C 4.6201 2.2069 0.0 0
M  V30 18 C 14.8824 5.8577 0.0 0
M  V30 19 O 16.3887 5.5375 0.0 0
M  V30 20 S 12.6774 0.9052 0.0 0
M  V30 21 C 13.9233 0.0000 0.0 0
M  V30 22 C 12.3203 4.8742 0.0 0 CFG=2
M  V30 23 N 13.8518 4.7133 0.0 0
M  V30 24 C 11.6939 3.4674 0.0 0
M  V30 25 C 14.1720 3.2070 0.0 0
M  V30 26 C 12.8383 2.4369 0.0 0 CFG=2
M  V30 27 C 3.0801 7.5417 0.0 0
M  V30 28 C 2.3101 8.8754 0.0 0
M  V30 29 C 2.3101 6.2080 0.0 0
M  V30 30 C 0.7700 8.8754 0.0 0
M  V30 31 C 0.7700 6.2080 0.0 0
M  V30 32 C 0.0000 7.5417 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 22 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13 CFG=3
M  V30 14 1 10 14
M  V30 15 1 13 27
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 23
M  V30 21 1 20 21
M  V30 22 1 26 20 CFG=1
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 10 22 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 876953-54-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876953-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-2047441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16357-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine
chimeras as N-terminal residue
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mollica, Adriano; Paradisi, Mario Paglialunga; Varani, Katia; Spisani,
Susanna; Lucente, Gino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(7), 2253-2265

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βR)-β-Amino-α-phenylbenzeneethanol
C14H15NO
88082-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=1
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=1
M  V30 3 N 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 5
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R)-2-Hydroxy-1,2-diphenylethyl]formamide
C15H15NO2
1380325-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88082-66-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380325-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2657855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM mixed anhydride solution (prepared in stage 1) added in stage 2, 23.6 g
scale
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales, Marvin R.; Mellem, Kevin T.; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(19), 4568-4571,
S4568/1-S4568/112

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Phenylmethoxy)-2-pyridinemethanamine
C13H14N2O
88423-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 2.3100 5.3347 0.0 0
M  V30 8 N 0.7700 2.6674 0.0 0
M  V30 9 C 0.7700 5.3347 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 6.6685 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 3 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[3-(Phenylmethoxy)-2-pyridinyl]methyl]formamide
C14H14N2O2
952024-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 N 9.2400 4.0011 0.0 0
M  V30 5 C 10.0100 5.3347 0.0 0
M  V30 6 O 11.5500 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 N 7.7000 1.3336 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88423-14-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 952024-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11100478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2B) Process for preparing
N-(3-benzyloxypyridin-2-ylmethyl)formamide (Formula X) A solution of
52.300 mmol of C-(3-benzyloxypyridin-2-yl)methylamine [88423-14-7]
(Example 2A) in 35 ml of formic acid is heated to reflux for 3 hours. The
reaction mixture is cooled and adjusted cautiously to pH 8 with approx.
100 ml of ammonium hydroxide solution (25% in water) with ice bath
cooling. The mixture is diluted with 100 ml of water and the aqueous
phase is extracted repeatedly with dichloromethane (3×250 ml). The
combined organic phases are dried over sodium sulphate and concentrated
by evaporation. 51.590 mmol (99% crude yield) of the title compound are
obtained from the residue as a brown oil. The material is used in the
next step without further purification. Rf=0.16 (ethyl acetate), Rt=4.58.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of 6,7-dihydro-5H-imidazo[1,5-a]pyridin-8-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martin, Pierre; Boudier, Andreas; Quirmbach, Michael; Mah, Robert;
Jotterand, Nathalie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007113235 A1 2007-10-11

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Ethyl-N-[2-(phenylthio)ethyl]benzenemethanamine
C17H21NS
886759-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 N 5.3348 3.0801 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 C 8.0022 3.0801 0.0 0
M  V30 7 S 9.3358 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 10.6697 3.0801 0.0 0
M  V30 15 C 12.0033 2.3101 0.0 0
M  V30 16 C 10.6697 4.6201 0.0 0
M  V30 17 C 13.3370 3.0801 0.0 0
M  V30 18 C 12.0033 5.3901 0.0 0
M  V30 19 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Phenylpropyl)-N-[2-(phenylthio)ethyl]formamide
C18H21NOS
886759-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 N 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 C 5.3900 1.3338 0.0 0
M  V30 6 C 0.7700 1.3338 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 O 4.6200 0.0000 0.0 0
M  V30 9 S 7.7000 5.3347 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 16
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886759-13-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886759-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6633406
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Abe, Kenji; Ishikawa, Masami; Nakatani, Masanao;
Shimazu, Seiichiro; Satoh, Noriyuki; Yoneda, Fumio; Taguchi, Kyoji;
Horiguchi, Yoshie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2006), 41(2), 241-252

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(Phenylthio)ethyl]-α-propylbenzenemethanamine
C18H23NS
886759-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 N 5.3348 4.6201 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 8.0022 4.6201 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 S 9.3360 3.8501 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 6.1601 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 C 12.0033 3.8501 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 13.3370 4.6201 0.0 0
M  V30 19 C 12.0033 6.9302 0.0 0
M  V30 20 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 8 15
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Phenylbutyl)-N-[2-(phenylthio)ethyl]formamide
C19H23NOS
886759-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 N 5.3348 4.6201 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 5.3348 6.1601 0.0 0
M  V30 6 C 2.6673 1.5400 0.0 0
M  V30 7 C 8.0022 4.6201 0.0 0
M  V30 8 O 6.6685 6.9302 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 S 9.3360 3.8501 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 1.3337 6.9302 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 10.6697 6.1601 0.0 0
M  V30 20 C 13.3370 4.6201 0.0 0
M  V30 21 C 12.0033 6.9302 0.0 0
M  V30 22 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886759-14-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886759-20-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8769505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Abe, Kenji; Ishikawa, Masami; Nakatani, Masanao;
Shimazu, Seiichiro; Satoh, Noriyuki; Yoneda, Fumio; Taguchi, Kyoji;
Horiguchi, Yoshie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2006), 41(2), 241-252

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Cyclopropyl-N-[2-(phenylthio)ethyl]benzenemethanamine
C18H21NS
886759-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.8737 0.0 0
M  V30 2 N 5.3348 3.6437 0.0 0
M  V30 3 C 6.6685 2.8737 0.0 0
M  V30 4 C 8.0022 3.6437 0.0 0
M  V30 5 S 9.3360 2.8737 0.0 0
M  V30 6 C 4.0010 1.3337 0.0 0
M  V30 7 C 3.2310 0.0000 0.0 0
M  V30 8 C 4.7710 0.0000 0.0 0
M  V30 9 C 2.6673 3.6437 0.0 0
M  V30 10 C 2.6673 5.1838 0.0 0
M  V30 11 C 1.3337 2.8737 0.0 0
M  V30 12 C 1.3337 5.9538 0.0 0
M  V30 13 C 0.0000 3.6437 0.0 0
M  V30 14 C 0.0000 5.1838 0.0 0
M  V30 15 C 10.6697 3.6437 0.0 0
M  V30 16 C 12.0033 2.8737 0.0 0
M  V30 17 C 10.6697 5.1838 0.0 0
M  V30 18 C 13.3370 3.6437 0.0 0
M  V30 19 C 12.0033 5.9538 0.0 0
M  V30 20 C 13.3370 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 9
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 15
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclopropylphenylmethyl)-N-[2-(phenylthio)ethyl]formamide
C19H21NOS
886759-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.8737 0.0 0
M  V30 2 N 5.3348 3.6437 0.0 0
M  V30 3 C 6.6685 2.8737 0.0 0
M  V30 4 C 5.3348 5.1838 0.0 0
M  V30 5 C 8.0022 3.6437 0.0 0
M  V30 6 O 6.6685 5.9538 0.0 0
M  V30 7 S 9.3360 2.8737 0.0 0
M  V30 8 C 4.0010 1.3337 0.0 0
M  V30 9 C 3.2310 0.0000 0.0 0
M  V30 10 C 4.7710 0.0000 0.0 0
M  V30 11 C 2.6673 3.6437 0.0 0
M  V30 12 C 1.3337 2.8737 0.0 0
M  V30 13 C 2.6673 5.1838 0.0 0
M  V30 14 C 0.0000 3.6437 0.0 0
M  V30 15 C 1.3337 5.9538 0.0 0
M  V30 16 C 0.0000 5.1838 0.0 0
M  V30 17 C 10.6697 3.6437 0.0 0
M  V30 18 C 12.0033 2.8737 0.0 0
M  V30 19 C 10.6697 5.1838 0.0 0
M  V30 20 C 13.3370 3.6437 0.0 0
M  V30 21 C 12.0033 5.9538 0.0 0
M  V30 22 C 13.3370 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 11
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 17
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886759-15-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886759-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2652141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Abe, Kenji; Ishikawa, Masami; Nakatani, Masanao;
Shimazu, Seiichiro; Satoh, Noriyuki; Yoneda, Fumio; Taguchi, Kyoji;
Horiguchi, Yoshie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2006), 41(2), 241-252

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Cyclobutyl-N-[2-(phenylthio)ethyl]benzenemethanamine
C19H23NS
886759-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.7179 0.0 0
M  V30 2 N 5.3348 4.4880 0.0 0
M  V30 3 C 6.6685 3.7179 0.0 0
M  V30 4 C 8.0022 4.4880 0.0 0
M  V30 5 S 9.3360 3.7179 0.0 0
M  V30 6 C 4.0010 2.1779 0.0 0
M  V30 7 C 2.9120 1.0890 0.0 0
M  V30 8 C 5.0901 1.0890 0.0 0
M  V30 9 C 4.0010 0.0000 0.0 0
M  V30 10 C 2.6673 4.4880 0.0 0
M  V30 11 C 2.6673 6.0280 0.0 0
M  V30 12 C 1.3337 3.7179 0.0 0
M  V30 13 C 1.3337 6.7980 0.0 0
M  V30 14 C 0.0000 4.4880 0.0 0
M  V30 15 C 0.0000 6.0280 0.0 0
M  V30 16 C 10.6697 4.4880 0.0 0
M  V30 17 C 12.0033 3.7179 0.0 0
M  V30 18 C 10.6697 6.0280 0.0 0
M  V30 19 C 13.3370 4.4880 0.0 0
M  V30 20 C 12.0033 6.7980 0.0 0
M  V30 21 C 13.3370 6.0280 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 10
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 16
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclobutylphenylmethyl)-N-[2-(phenylthio)ethyl]formamide
C20H23NOS
886759-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.7179 0.0 0
M  V30 2 N 5.3348 4.4880 0.0 0
M  V30 3 C 6.6685 3.7179 0.0 0
M  V30 4 C 5.3348 6.0280 0.0 0
M  V30 5 C 8.0022 4.4880 0.0 0
M  V30 6 O 6.6685 6.7980 0.0 0
M  V30 7 S 9.3360 3.7179 0.0 0
M  V30 8 C 4.0010 2.1779 0.0 0
M  V30 9 C 5.0901 1.0890 0.0 0
M  V30 10 C 2.9120 1.0890 0.0 0
M  V30 11 C 4.0010 0.0000 0.0 0
M  V30 12 C 2.6673 4.4880 0.0 0
M  V30 13 C 1.3337 3.7179 0.0 0
M  V30 14 C 2.6673 6.0280 0.0 0
M  V30 15 C 0.0000 4.4880 0.0 0
M  V30 16 C 1.3337 6.7980 0.0 0
M  V30 17 C 0.0000 6.0280 0.0 0
M  V30 18 C 10.6697 4.4880 0.0 0
M  V30 19 C 12.0033 3.7179 0.0 0
M  V30 20 C 10.6697 6.0280 0.0 0
M  V30 21 C 13.3370 4.4880 0.0 0
M  V30 22 C 12.0033 6.7980 0.0 0
M  V30 23 C 13.3370 6.0280 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886759-16-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886759-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4977599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Abe, Kenji; Ishikawa, Masami; Nakatani, Masanao;
Shimazu, Seiichiro; Satoh, Noriyuki; Yoneda, Fumio; Taguchi, Kyoji;
Horiguchi, Yoshie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2006), 41(2), 241-252

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Cyclohexyl-N-[2-(phenylthio)ethyl]benzenemethanamine
C21H27NS
886759-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 S 9.3360 4.6201 0.0 0
M  V30 6 C 2.6673 5.3901 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 C 2.6673 6.9302 0.0 0
M  V30 9 C 0.0000 5.3901 0.0 0
M  V30 10 C 1.3337 7.7002 0.0 0
M  V30 11 C 0.0000 6.9302 0.0 0
M  V30 12 C 4.0010 3.0801 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 4.0010 0.0000 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 10.6697 6.9302 0.0 0
M  V30 21 C 13.3370 5.3901 0.0 0
M  V30 22 C 12.0033 7.7002 0.0 0
M  V30 23 C 13.3370 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 18
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclohexylphenylmethyl)-N-[2-(phenylthio)ethyl]formamide
C22H27NOS
886759-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 8.0022 5.3901 0.0 0
M  V30 6 O 6.6685 7.7002 0.0 0
M  V30 7 S 9.3360 4.6201 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 4.0010 0.0000 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 2.6673 6.9302 0.0 0
M  V30 17 C 0.0000 5.3901 0.0 0
M  V30 18 C 1.3337 7.7002 0.0 0
M  V30 19 C 0.0000 6.9302 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 10.6697 6.9302 0.0 0
M  V30 22 C 12.0033 4.6201 0.0 0
M  V30 23 C 12.0033 7.7002 0.0 0
M  V30 24 C 13.3370 5.3901 0.0 0
M  V30 25 C 13.3370 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 20
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886759-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886759-23-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6914625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Abe, Kenji; Ishikawa, Masami; Nakatani, Masanao;
Shimazu, Seiichiro; Satoh, Noriyuki; Yoneda, Fumio; Taguchi, Kyoji;
Horiguchi, Yoshie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2006), 41(2), 241-252

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-α-methyl-N-[2-(phenylthio)ethyl]benzenemethanamine
C16H18FNS
886759-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 1.5400 0.0 0
M  V30 2 N 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 S 4.0010 1.5400 0.0 0
M  V30 7 F 14.6707 4.6201 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 10.6697 3.8501 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 C 12.0033 4.6201 0.0 0
M  V30 12 C 13.3370 2.3101 0.0 0
M  V30 13 C 13.3370 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 14
M  V30 8 1 7 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Fluorophenyl)ethyl]-N-[2-(phenylthio)ethyl]formamide
C17H18FNOS
886759-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 1.5400 0.0 0
M  V30 2 N 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 O 6.6685 4.6201 0.0 0
M  V30 8 S 4.0010 1.5400 0.0 0
M  V30 9 F 14.6707 4.6201 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 13.3370 2.3101 0.0 0
M  V30 14 C 12.0033 4.6201 0.0 0
M  V30 15 C 13.3370 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 16
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886759-18-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886759-24-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9051161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saitoh, Toshiaki; Abe, Kenji; Ishikawa, Masami; Nakatani, Masanao;
Shimazu, Seiichiro; Satoh, Noriyuki; Yoneda, Fumio; Taguchi, Kyoji;
Horiguchi, Yoshie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2006), 41(2), 241-252

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(Phenylsulfinyl)methyl]thio]benzenamine
C13H13NOS2
889877-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0 VAL=4
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 N 1.3337 0.0000 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 12
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[[(Phenylsulfinyl)methyl]thio]phenyl]formamide
C14H13NO2S2
889877-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0011 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 S 4.6200 5.3347 0.0 0 VAL=4
M  V30 4 O 5.3900 6.6685 0.0 0
M  V30 5 N 10.0100 4.0011 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0
M  V30 7 O 12.3200 5.3347 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0
M  V30 9 C 9.2400 2.6674 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 10.0100 1.3338 0.0 0
M  V30 12 C 7.7000 0.0000 0.0 0
M  V30 13 C 9.2400 0.0000 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 1 5 9
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 889877-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889877-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12632356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 2-[(Formylamino)phenylthio]acetonitrile A
solution of (2-aminophenylthio)acetonitrile3 (2.2 g, 13 mmol) in toluene
(13 mL) containing formic acid (3.1 g, 67 mmol) was refluxed under
azeotropic conditions for 15 min. After cooling the solvent and excess
formic acid were removed under reduced pressure to give a residue, which
was purified by column chromatography on silica gel (1:1 hexane-THF) to
afford the title compound.
N-[2-(Phenylsulfinylmethylthio)phenyl]formamide This compound was
prepared from 2-(phenylsulfinylmethylthio)benzeneamine as described for
the preparation of [2-(formylamino)phenylthio]acetonitrile; yield: 99%;
pale-yellow viscous oil. Rf = 0.18 (1:1 EtOAc-hexane). IR (neat): 3244,
1693, 1084 cm-1. 1H NMR (500 MHz): δ = 4.02 (1 H, d, J = 13.7 Hz), 4.12
(1 H, d, J = 13.7 Hz), 7.03-7.66 (9 H, m), 8.36-9.83 (2 H, m). Anal.
Calcd for C14H13NO2S2: C, 57.71; H, 4.50; N, 4.81; S, 22.01. Found: C,
57.65; H, 4.51; N, 4.64; S, 22.22.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new synthesis of 4H-1,4-benzothiazine derivatives based on ring closure
of EWG-stabilized (2-isocyanophenylthio)methyl anions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Kazuhiro; Hayashi, Kazutaka; Iitsuka, Daisuke; Morikawa,
Osamu; Konishi, Hisatoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2006), (7), 1077-1082

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-methoxy-3-pyridinamine
C6H7BrN2O
89466-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 Br 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-2-methoxy-3-pyridinyl)formamide
C7H7BrN2O2
1123194-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 O 8.4700 5.3349 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Br 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 N 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89466-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123194-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22770366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel methoxypyridine-derived gamma-secretase
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rynearson, Kevin D.; Buckle, Ronald N.; Herr, R. Jason; Mayhew, Nicholas
J.; Chen, Xinchao; Paquette, William D.; Sakwa, Samuel A.; Yang, Jinhai;
Barnes, Keith D.; Nguyen, Phuong; Mobley, William C.; Johnson, Graham;
Lin, Juinn H.; Tanzi, Rudolph E.; Wagner, Steven L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(22), 115734

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-methoxy-3-pyridinamine
C6H7BrN2O
89466-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 Br 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-2-methoxy-3-pyridinyl)formamide
C7H7BrN2O2
1123194-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 O 8.4700 5.3349 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Br 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 N 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89466-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123194-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17563552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazine derivatives for use in the treatment of
neurodegenerative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burnett, Duane A.; Bursavich, Matthew Gregory; Harrison, Bryce Alden
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017031325 A1 2017-02-23

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-methoxy-3-pyridinamine
C6H7BrN2O
89466-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 Br 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-2-methoxy-3-pyridinyl)formamide
C7H7BrN2O2
1123194-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 O 8.4700 5.3349 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Br 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 N 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89466-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123194-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16890721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazine compounds for treating neurodegenerative
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Acharya, Raksha; Burnett, Duane A.; Bursavich, Matthew Gregory; Cook,
Andrew Simon; Harrison, Bryce Alden; McRiner, Andrew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016201168 A1 2016-12-15

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [1-ethyl-3-[(phenylmethoxy)amino]propyl]-, diethyl ester
C16H28NO4P
902526-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1838 0.0 0
M  V30 7 C 6.1600 2.5164 0.0 0
M  V30 8 C 1.5400 5.1838 0.0 0
M  V30 9 C 2.5164 1.5400 0.0 0
M  V30 10 C 7.7000 5.1838 0.0 0
M  V30 11 C 7.7000 2.5164 0.0 0
M  V30 12 C 0.0000 5.1838 0.0 0
M  V30 13 C 2.5164 0.0000 0.0 0
M  V30 14 N 8.4700 6.5174 0.0 0
M  V30 15 O 10.0100 6.5174 0.0 0
M  V30 16 C 10.7800 7.8511 0.0 0
M  V30 17 C 12.3200 7.8511 0.0 0
M  V30 18 C 13.0900 6.5174 0.0 0
M  V30 19 C 13.0900 9.1849 0.0 0
M  V30 20 C 14.6300 6.5174 0.0 0
M  V30 21 C 14.6300 9.1849 0.0 0
M  V30 22 C 15.4000 7.8511 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [1-ethyl-3-[formyl(phenylmethoxy)amino]propyl]-, diethyl ester
C17H28NO5P
902526-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1838 0.0 0
M  V30 7 C 6.1600 2.5164 0.0 0
M  V30 8 C 1.5400 5.1838 0.0 0
M  V30 9 C 2.5164 1.5400 0.0 0
M  V30 10 C 7.7000 5.1838 0.0 0
M  V30 11 C 7.7000 2.5164 0.0 0
M  V30 12 C 0.0000 5.1838 0.0 0
M  V30 13 C 2.5164 0.0000 0.0 0
M  V30 14 N 8.4700 6.5174 0.0 0
M  V30 15 O 10.0100 6.5174 0.0 0
M  V30 16 C 7.7000 7.8511 0.0 0
M  V30 17 C 10.7800 7.8511 0.0 0
M  V30 18 O 8.4700 9.1849 0.0 0
M  V30 19 C 12.3200 7.8511 0.0 0
M  V30 20 C 13.0900 9.1847 0.0 0
M  V30 21 C 13.0900 6.5174 0.0 0
M  V30 22 C 14.6300 9.1847 0.0 0
M  V30 23 C 14.6300 6.5174 0.0 0
M  V30 24 C 15.4000 7.8511 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 902526-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 902526-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2541034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimalarial activity of chain substituted
pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurz, Thomas; Schlueter, Katrin; Kaula, Uwe; Bergmann, Baerbel; Walter,
Rolf D.; Geffken, Detlef
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(15), 5121-5135

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-3-[2-(trimethylsilyl)ethynyl]benzoate
C13H17NO2Si
916486-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.8737 0.0 0
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 Si 1.3337 1.3337 0.0 0
M  V30 4 C 0.0000 0.5637 0.0 0
M  V30 5 C 0.5637 2.6673 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 N 4.0012 5.9538 0.0 0
M  V30 8 C 9.3360 2.8737 0.0 0
M  V30 9 O 10.6697 3.6437 0.0 0
M  V30 10 O 9.3360 1.3337 0.0 0
M  V30 11 C 12.0033 2.8737 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 13 C 6.6685 2.8737 0.0 0
M  V30 14 C 5.3348 5.1838 0.0 0
M  V30 15 C 8.0022 3.6437 0.0 0
M  V30 16 C 6.6685 5.9538 0.0 0
M  V30 17 C 8.0022 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(formylamino)-3-[2-(trimethylsilyl)ethynyl]benzoate
C14H17NO3Si
2112823-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.3901 0.0 0
M  V30 2 C 2.6673 6.1601 0.0 0
M  V30 3 Si 1.3337 6.9302 0.0 0
M  V30 4 C 0.0000 7.7002 0.0 0
M  V30 5 C 0.5637 5.5965 0.0 0
M  V30 6 C 2.1037 8.2638 0.0 0
M  V30 7 N 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 O 2.6673 0.0000 0.0 0
M  V30 10 C 9.3360 5.3901 0.0 0
M  V30 11 O 10.6697 4.6201 0.0 0
M  V30 12 O 9.3360 6.9302 0.0 0
M  V30 13 C 12.0033 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 6.6685 5.3901 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 8.0022 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916486-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2112823-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-24265330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymerization based on alternating insertion of an isocyanide and alkyne
into palladium-carbon bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kataoka, Yuki; Kanbayashi, Naoya; Okamura, Taka-aki; Onitsuka, Kiyotaka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Chemistry (2018), 9(20), 2797-2804

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-[(4-Chlorophenyl)methylene]cyclopropanemethanol
C11H11ClO
916608-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4375 4.4137 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 Cl 8.7722 1.3337 0.0 0
M  V30 5 C 2.1037 3.6437 0.0 0
M  V30 6 C 1.3337 2.3100 0.0 0 CFG=3
M  V30 7 C 0.5636 3.6437 0.0 0
M  V30 8 C 4.7711 3.6437 0.0 0
M  V30 9 C 4.7711 2.1037 0.0 0
M  V30 10 C 6.1048 4.4137 0.0 0
M  V30 11 C 6.1048 1.3337 0.0 0
M  V30 12 C 7.4386 3.6437 0.0 0
M  V30 13 C 7.4386 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 6
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanemethanol, 2-[(4-chlorophenyl)methylene]-, 1-formate
C12H11ClO2
1260428-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 9.5422 3.0801 0.0 0
M  V30 3 O 10.8760 2.3101 0.0 0
M  V30 4 C 12.2097 3.0801 0.0 0
M  V30 5 O 13.5434 2.3101 0.0 0
M  V30 6 Cl 0.0000 0.0000 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.2085 2.3101 0.0 0
M  V30 9 C 7.4385 0.9764 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7 CFG=2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916608-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1260428-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-2520275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction in presence of Pd(PPh3)4/AsPh3 catalyst gave lower
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Reactions of 3-Substituted Methylenecyclopropanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shao, Li-Xiong; Li, Jia; Wang, Bao-Yu; Shi, Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2010), (33), 6448-6453,
S6448/1-S6448/52

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[(1S)-1-[[[3,5-bis(1-methylethyl)phenyl]amino]carbonyl]-2...
C23H38N2O3
928790-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0 CFG=2
M  V30 4 O 8.0023 3.0801 0.0 0
M  V30 5 N 10.6698 4.6201 0.0 0
M  V30 6 C 9.3360 6.9302 0.0 0
M  V30 7 C 12.0035 5.3901 0.0 0
M  V30 8 C 10.6698 3.0801 0.0 0
M  V30 9 C 8.0023 7.7002 0.0 0
M  V30 10 C 10.6698 7.7002 0.0 0
M  V30 11 O 13.3372 4.6201 0.0 0
M  V30 12 O 12.0035 6.9302 0.0 0
M  V30 13 C 14.6708 5.3901 0.0 0
M  V30 14 C 15.4408 4.0564 0.0 0
M  V30 15 C 16.0046 6.1601 0.0 0
M  V30 16 C 13.9008 6.7238 0.0 0
M  V30 17 C 1.3338 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 1.3338 6.9302 0.0 0
M  V30 20 C 4.0012 0.7700 0.0 0
M  V30 21 C 5.3348 0.0000 0.0 0
M  V30 22 C 2.6675 0.0000 0.0 0
M  V30 23 C 5.3348 4.6201 0.0 0
M  V30 24 C 4.0012 5.3901 0.0 0
M  V30 25 C 5.3348 3.0801 0.0 0
M  V30 26 C 2.6675 4.6201 0.0 0
M  V30 27 C 4.0012 2.3101 0.0 0
M  V30 28 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 26
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 27
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-N-[3,5-Bis(1-methylethyl)phenyl]-2-(formylmethylamino)-3-methylbutanamide
C19H30N2O2
928789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 5.3900 0.0 0
M  V30 2 C 8.0020 4.6200 0.0 0
M  V30 3 C 9.3358 5.3900 0.0 0 CFG=2
M  V30 4 O 8.0020 3.0800 0.0 0
M  V30 5 N 10.6694 4.6200 0.0 0
M  V30 6 C 9.3358 6.9300 0.0 0
M  V30 7 C 12.0031 5.3900 0.0 0
M  V30 8 C 10.6694 3.0800 0.0 0
M  V30 9 C 8.0020 7.7000 0.0 0
M  V30 10 C 10.6694 7.7000 0.0 0
M  V30 11 O 13.3367 4.6200 0.0 0
M  V30 12 C 1.3336 5.3900 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 1.3336 6.9300 0.0 0
M  V30 15 C 4.0009 0.7700 0.0 0
M  V30 16 C 5.3347 0.0000 0.0 0
M  V30 17 C 2.6673 0.0000 0.0 0
M  V30 18 C 5.3347 4.6200 0.0 0
M  V30 19 C 4.0009 5.3900 0.0 0
M  V30 20 C 5.3347 3.0800 0.0 0
M  V30 21 C 2.6673 4.6200 0.0 0
M  V30 22 C 4.0009 2.3100 0.0 0
M  V30 23 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 22
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 928790-08-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-12289124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formamide (S)-(-)-3c. Trifluoroacetic acid (5 mL) was added dropwise to a
solution of BOC derivative 15c (380 mg, 0.97 mmol) in dichloromethane (5
mL) at 0 °C and the reaction mixture was stirred at 0 °C for 1 h. The
solvent was then removed under reduced pressure and the residue was
coevaporated with toluene (3 X 5mL) to afford a TFA salt of the
deprotected amide as a colorless solid, which was used in the following
step without further purification. The crude amide was dissolved in
formic acid (3.0 mL) and the resulting solution was cooled to 0 °C.
Acetic anhydride (1.5 mL, 15.9 mmol) was added dropwise and the reaction
mixture was allowed to stir at room temperature overnight, and then
evaporated to dryness. The traces of acids were removed by coevaporation
with toluene (3 X 5 mL) and the residue was purified by column
chromatography on silica gel with a petroleum etherethyl acetate mixture
(2:1, Rf 0.46/0.24) to afford (S)-(-)-3c (307 mg, 99%) as a colorless
solid. mp 102-104 °C; [α]D -193.6 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3,
a mixture of rotamers in ca. 6.5:1 ratio; the signals for the minor
rotamer are marked with an *) δ 0.91 (d, J = 6.6 Hz, 3H), 1.06 (d, J =
6.5 Hz, 3H), 1.22 (d, J = 6.9 Hz, 12H), 2.40-2.56 (m, 1H), 2.85 (hept, J
= 6.9 Hz, 2H), 2.93* (s, 0.4H), 3.0 (s, 2.6H), 3.54* (d, J = 10.4 Hz,
0.13H), 4.43 (d, J = 11.3 Hz, 0.87H), 6.83 (br s) and 6.86* (br s, 1H),
7.22* (d, J = 1.5 Hz) and 7.24 (d, J = 1.5 Hz, 2H), 8.0* (br s) and 8.13
(br s, 1H), 8.15 (s) and 8.28* (s, 1H); 13C NMR δ 18.53 (CH3), 18.85*
(CH3), 19.60 (CH3), 19.87* (CH3), 23.93 (CH3), 25.19 (CH3), 26.64* (CH3),
27.25* (CH), 31.47 (CH), 34.22 (CH), 63.02 (CH), 69.26* (CH), 115.43
(CH), 115.64* (CH), 120.98 (CH), 121.41* (CH), 137.24* (C), 137.59 (C),
149.84 (C), 149.91* (C), 163.53* (CHO), 163.93 (CHO), 166.77* (CO),
166.98 (CO); IR (KBr) ν 3320, 3295, 2962, 1686, 1650, 1615, 1562, 1084,
867 cm-1; MS (EI) m/z (%) 318 (M.+, 25), 177 (20), 142 (43), 114 (100),
83 (40); HRMS (EI) 318.2305 (C19H30O2N2 requires 318.2307).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalysis with a Fluorous Tag: Asymmetric Reduction of Imines with
Trichlorosilane Catalyzed by Amino Acid-Derived Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malkov, Andrei V.; Figlus, Marek; Stoncius, Sigitas; Kocovsky, Pavel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(4), 1315-1325

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[(1S)-1-[[[3,5-bis(1,1-dimethylethyl)phenyl]amino]carbony...
C25H42N2O3
928790-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 6.1601 0.0 0
M  V30 2 C 8.0023 5.3901 0.0 0
M  V30 3 C 9.3360 6.1601 0.0 0 CFG=2
M  V30 4 O 8.0023 3.8501 0.0 0
M  V30 5 N 10.6698 5.3901 0.0 0
M  V30 6 C 9.3360 7.7002 0.0 0
M  V30 7 C 12.0035 6.1601 0.0 0
M  V30 8 C 10.6698 3.8501 0.0 0
M  V30 9 C 8.0023 8.4702 0.0 0
M  V30 10 C 10.6698 8.4702 0.0 0
M  V30 11 O 13.3372 5.3901 0.0 0
M  V30 12 O 12.0035 7.7002 0.0 0
M  V30 13 C 14.6708 6.1601 0.0 0
M  V30 14 C 13.9008 7.4938 0.0 0
M  V30 15 C 16.0046 6.9302 0.0 0
M  V30 16 C 15.4408 4.8265 0.0 0
M  V30 17 C 1.3338 6.1601 0.0 0
M  V30 18 C 2.1038 7.4938 0.0 0
M  V30 19 C 0.0000 6.9302 0.0 0
M  V30 20 C 0.5638 4.8265 0.0 0
M  V30 21 C 4.0012 1.5400 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0012 0.0000 0.0 0
M  V30 24 C 2.6675 0.7700 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0012 6.1601 0.0 0
M  V30 27 C 5.3348 3.8501 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0012 3.0801 0.0 0
M  V30 30 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 28
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 21 29
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-N-[3,5-Bis(1,1-dimethylethyl)phenyl]-2-(formylmethylamino)-3-methylbutan...
C21H34N2O2
928789-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.1601 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3360 6.1601 0.0 0 CFG=2
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 N 10.6697 5.3901 0.0 0
M  V30 6 C 9.3360 7.7002 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 C 10.6697 3.8501 0.0 0
M  V30 9 C 8.0022 8.4702 0.0 0
M  V30 10 C 10.6697 8.4702 0.0 0
M  V30 11 O 13.3370 5.3901 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 2.1037 7.4938 0.0 0
M  V30 18 C 0.0000 6.9302 0.0 0
M  V30 19 C 0.5637 4.8265 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 4.0010 6.1601 0.0 0
M  V30 23 C 4.0010 3.0801 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 23
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 24
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 928790-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928789-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-6625679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of 1,2- diarylaziridines by the
organocatalytic reductive amination of α-chloroketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malkov, Andrei V.; Stoncius, Sigitas; Kocovsky, Pavel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2007), 46(20), 3722-3724

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[(1S)-1-[[[3,5-bis(1,1-dimethylethyl)phenyl]amino]carbony...
C25H42N2O3
928790-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 6.1601 0.0 0
M  V30 2 C 8.0023 5.3901 0.0 0
M  V30 3 C 9.3360 6.1601 0.0 0 CFG=2
M  V30 4 O 8.0023 3.8501 0.0 0
M  V30 5 N 10.6698 5.3901 0.0 0
M  V30 6 C 9.3360 7.7002 0.0 0
M  V30 7 C 12.0035 6.1601 0.0 0
M  V30 8 C 10.6698 3.8501 0.0 0
M  V30 9 C 8.0023 8.4702 0.0 0
M  V30 10 C 10.6698 8.4702 0.0 0
M  V30 11 O 13.3372 5.3901 0.0 0
M  V30 12 O 12.0035 7.7002 0.0 0
M  V30 13 C 14.6708 6.1601 0.0 0
M  V30 14 C 13.9008 7.4938 0.0 0
M  V30 15 C 16.0046 6.9302 0.0 0
M  V30 16 C 15.4408 4.8265 0.0 0
M  V30 17 C 1.3338 6.1601 0.0 0
M  V30 18 C 2.1038 7.4938 0.0 0
M  V30 19 C 0.0000 6.9302 0.0 0
M  V30 20 C 0.5638 4.8265 0.0 0
M  V30 21 C 4.0012 1.5400 0.0 0
M  V30 22 C 5.3348 0.7700 0.0 0
M  V30 23 C 4.0012 0.0000 0.0 0
M  V30 24 C 2.6675 0.7700 0.0 0
M  V30 25 C 5.3348 5.3901 0.0 0
M  V30 26 C 4.0012 6.1601 0.0 0
M  V30 27 C 5.3348 3.8501 0.0 0
M  V30 28 C 2.6675 5.3901 0.0 0
M  V30 29 C 4.0012 3.0801 0.0 0
M  V30 30 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 28
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 21 29
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-N-[3,5-Bis(1,1-dimethylethyl)phenyl]-2-(formylmethylamino)-3-methylbutan...
C21H34N2O2
928789-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.1601 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3360 6.1601 0.0 0 CFG=2
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 N 10.6697 5.3901 0.0 0
M  V30 6 C 9.3360 7.7002 0.0 0
M  V30 7 C 12.0033 6.1601 0.0 0
M  V30 8 C 10.6697 3.8501 0.0 0
M  V30 9 C 8.0022 8.4702 0.0 0
M  V30 10 C 10.6697 8.4702 0.0 0
M  V30 11 O 13.3370 5.3901 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 1.3337 6.1601 0.0 0
M  V30 17 C 2.1037 7.4938 0.0 0
M  V30 18 C 0.0000 6.9302 0.0 0
M  V30 19 C 0.5637 4.8265 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 4.0010 6.1601 0.0 0
M  V30 23 C 4.0010 3.0801 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 23
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 24
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 928790-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928789-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-14431698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formamide (S)-(-)-3d. Trifluoroacetic acid (14 mL) was added dropwise to
a solution of BOC derivative 15d (1.19 g, 2.85 mmol) in dichloromethane
(14 mL) at 0 °C and the reaction mixture was stirred at 0 °C for 1 h. The
solvent was then removed under reduced pressure and the residue was
coevaporated with toluene (3 X 5 mL) to afford a TFA salt of the
deprotected amide as a colorless solid, which was used in the following
step without further purification. The crude amide was dissolved in
formic acid (8.6 mL) and the resulting solution was cooled to 0 °C.
Acetic anhydride (4.3 mL, 45.5 mmol) was added dropwise and the reaction
mixture was allowed to stir at room temperature overnight, and then
evaporated to dryness. The traces of acids were removed by coevaporation
with toluene (3 X 5 mL) and the residue was purified by column
chromatography on silica gel with a petroleum etherethyl acetate mixture
(75:25, Rf 0.56/0.29) to afford (S)-(-)-3d (985 mg, 99%) as a colorless
solid. mp 167-169 °C; [α]D -178.1 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3,
a mixture of rotamers in ca. 5.7:1 ratio; the signals for the minor
rotamer are marked with an *) δ 0.92 (d, J = 6.6 Hz, 3H), 1.06 (d, J =
6.5 Hz, 3H), 1.30 (s, 18H), 2.40-2.57 (m, 1H), 2.94* (s, 0.45H), 3.0 (s,
2.55H), 3.55* (d, J = 10.4 Hz, 0.15H), 4.46 (d, J = 11.2 Hz, 0.85H), 7.18
(t, J = 1.6 Hz) and 7.20* (t, J = 1.6 Hz, 1H), 7.39* (d, J = 1.6 Hz) and
7.41 (d, J = 1.6 Hz, 2H), 8.01* (br s) and 8.13 (br s, 1H), 8.15 (s) and
8.30* (s, 1H); 13C NMR δ 18.53 (CH3), 18.86* (CH3), 19.63 (CH3), 19.92*
(CH3), 25.21 (CH3), 26.63* (CH3), 27.26* (CH), 31.35 (CH3), 31.42 (CH),
34.91 (C), 62.96 (CH), 69.33* (CH), 114.28 (CH), 114.49* (CH), 118.63
(CH), 119.03* (CH), 136.77* (C), 137.13 (C), 151.66 (C), 151.75* (C),
163.55* (CHO), 163.90 (CHO), 166.74* (CO), 166.97 (CO); IR (KBr) ν 3318,
2963, 1649, 1615, 1566, 1083, 870, 711 cm-1; MS (EI) m/z (%) 346 (M.+,
24), 205 (36), 142 (47), 114 (100), 83 (39), 57 (19); HRMS (EI) 346.2618
(C21H34O2N2 requires 346.2620).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalysis with a Fluorous Tag: Asymmetric Reduction of Imines with
Trichlorosilane Catalyzed by Amino Acid-Derived Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malkov, Andrei V.; Figlus, Marek; Stoncius, Sigitas; Kocovsky, Pavel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(4), 1315-1325

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol
C15H23NO2
93413-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3671 2.3101 0.0 0
M  V30 2 C 4.3671 0.7700 0.0 0
M  V30 3 N 5.7007 0.0000 0.0 0
M  V30 4 O 4.0232 4.2597 0.0 0
M  V30 5 O 9.7019 5.3901 0.0 0
M  V30 6 C 11.0356 4.6201 0.0 0
M  V30 7 C 3.0333 3.0801 0.0 0
M  V30 8 C 2.5066 1.6329 0.0 0
M  V30 9 C 2.0433 4.2597 0.0 0
M  V30 10 C 0.9899 1.3655 0.0 0
M  V30 11 C 0.5267 3.9924 0.0 0
M  V30 12 C 0.0000 2.5452 0.0 0
M  V30 13 C 5.7007 3.0801 0.0 0
M  V30 14 C 7.0344 2.3101 0.0 0
M  V30 15 C 5.7007 4.6201 0.0 0
M  V30 16 C 8.3681 3.0801 0.0 0
M  V30 17 C 7.0344 5.3901 0.0 0
M  V30 18 C 8.3681 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 1 4 7
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl]formamide
C16H23NO3
272788-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6644 5.3348 0.0 0
M  V30 2 C 2.8943 4.0012 0.0 0
M  V30 3 N 3.6644 2.6675 0.0 0
M  V30 4 C 2.8943 1.3337 0.0 0
M  V30 5 O 3.6644 0.0000 0.0 0
M  V30 6 O 4.3415 7.1953 0.0 0
M  V30 7 O 9.8245 5.3348 0.0 0
M  V30 8 C 10.5945 6.6685 0.0 0
M  V30 9 C 2.8943 6.6685 0.0 0
M  V30 10 C 1.7145 5.6787 0.0 0
M  V30 11 C 2.6268 8.1853 0.0 0
M  V30 12 C 0.2675 6.2054 0.0 0
M  V30 13 C 1.1798 8.7120 0.0 0
M  V30 14 C 0.0000 7.7220 0.0 0
M  V30 15 C 5.2044 5.3348 0.0 0
M  V30 16 C 5.9744 4.0012 0.0 0
M  V30 17 C 5.9744 6.6685 0.0 0
M  V30 18 C 7.5144 4.0012 0.0 0
M  V30 19 C 7.5144 6.6685 0.0 0
M  V30 20 C 8.2845 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 6 9
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93413-77-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 272788-07-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9704240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formic acid (2.2 g, 0.048 mol) was added to a solution of
1-[(RS)-2-amino-1-(4-methoxyphenyl)ethyl]cyclohexanol (free base of 4, 10
g, 0.04 mol) in toluene (60 mL), and the mixture was heated to reflux for
5 h. The reaction mass was cooled to 25-35 °C and washed with saturated
aqueous sodium bicarbonate solution (150 mL). The toluene layer was
washed with water (225 mL) and distilled off completely under reduced
pressure at less than 70 °C to afford
N-[2RS-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl]formamide 5a (11 g,
99%). N-[2RS-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl]formamide 5a,
yield 11 g, 99%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Impurity Profile Study of Venlafaxine Hydrochloride, an Antipsychotic
Drug Substance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saravanan, Mohanarangam; Kumar, Karra Suresh; Reddy, Padi Pratap;
Satyanarayana, Bollikonda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(13), 1880-1886

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Tris(4-amino-2-methylphenyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
C24H24N6O3
939971-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 10.7801 0.0 0
M  V30 2 O 4.0010 6.1601 0.0 0
M  V30 3 C 5.3348 11.5501 0.0 0
M  V30 4 O 9.3359 6.1601 0.0 0
M  V30 5 N 0.0000 11.5501 0.0 0
M  V30 6 C 10.6695 6.9301 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 N 13.3369 11.5501 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 N 5.3348 8.4701 0.0 0
M  V30 11 C 6.6684 9.2401 0.0 0
M  V30 12 C 5.3348 6.9301 0.0 0
M  V30 13 N 8.0021 8.4701 0.0 0
M  V30 14 N 6.6684 6.1601 0.0 0
M  V30 15 C 8.0021 6.9301 0.0 0
M  V30 16 C 4.0010 9.2401 0.0 0
M  V30 17 C 4.0010 10.7801 0.0 0
M  V30 18 C 2.6673 8.4701 0.0 0
M  V30 19 C 2.6673 11.5501 0.0 0
M  V30 20 C 1.3337 9.2401 0.0 0
M  V30 21 C 1.3337 10.7801 0.0 0
M  V30 22 C 9.3359 9.2401 0.0 0
M  V30 23 C 10.6695 8.4701 0.0 0
M  V30 24 C 9.3359 10.7801 0.0 0
M  V30 25 C 12.0032 9.2401 0.0 0
M  V30 26 C 10.6695 11.5501 0.0 0
M  V30 27 C 12.0032 10.7801 0.0 0
M  V30 28 C 6.6684 4.6201 0.0 0
M  V30 29 C 5.3348 3.8500 0.0 0
M  V30 30 C 8.0021 3.8500 0.0 0
M  V30 31 C 5.3348 2.3100 0.0 0
M  V30 32 C 8.0021 2.3100 0.0 0
M  V30 33 C 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 1 3 17
M  V30 4 2 4 15
M  V30 5 1 5 21
M  V30 6 1 6 23
M  V30 7 1 7 29
M  V30 8 1 8 27
M  V30 9 1 9 33
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 22
M  V30 17 1 14 15
M  V30 18 1 14 28
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′,N′′-[(2,4,6-Trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris(3-methyl-4,...
C27H24N6O6
939971-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 13.0903 0.0 0
M  V30 2 O 10.6697 8.4702 0.0 0
M  V30 3 C 9.3360 13.8603 0.0 0
M  V30 4 O 5.3348 8.4702 0.0 0
M  V30 5 N 14.6708 13.8603 0.0 0
M  V30 6 C 16.0045 13.0903 0.0 0
M  V30 7 O 17.3383 13.8603 0.0 0
M  V30 8 C 4.0012 9.2402 0.0 0
M  V30 9 C 10.6697 6.9302 0.0 0
M  V30 10 N 1.3338 13.8603 0.0 0
M  V30 11 C 1.3338 15.4003 0.0 0
M  V30 12 O 0.0000 16.1704 0.0 0
M  V30 13 N 8.0023 2.3101 0.0 0
M  V30 14 C 6.6687 1.5400 0.0 0
M  V30 15 O 6.6687 0.0000 0.0 0
M  V30 16 N 9.3360 10.7802 0.0 0
M  V30 17 C 8.0023 11.5503 0.0 0
M  V30 18 C 9.3360 9.2402 0.0 0
M  V30 19 N 6.6687 10.7802 0.0 0
M  V30 20 N 8.0023 8.4702 0.0 0
M  V30 21 C 6.6687 9.2402 0.0 0
M  V30 22 C 10.6697 11.5503 0.0 0
M  V30 23 C 10.6697 13.0903 0.0 0
M  V30 24 C 12.0035 10.7802 0.0 0
M  V30 25 C 12.0035 13.8603 0.0 0
M  V30 26 C 13.3372 11.5503 0.0 0
M  V30 27 C 13.3372 13.0903 0.0 0
M  V30 28 C 5.3348 11.5503 0.0 0
M  V30 29 C 4.0012 10.7802 0.0 0
M  V30 30 C 5.3348 13.0903 0.0 0
M  V30 31 C 2.6675 11.5503 0.0 0
M  V30 32 C 4.0012 13.8603 0.0 0
M  V30 33 C 2.6675 13.0903 0.0 0
M  V30 34 C 8.0023 6.9302 0.0 0
M  V30 35 C 9.3360 6.1601 0.0 0
M  V30 36 C 6.6687 6.1601 0.0 0
M  V30 37 C 9.3360 4.6201 0.0 0
M  V30 38 C 6.6687 4.6201 0.0 0
M  V30 39 C 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 18
M  V30 3 1 3 23
M  V30 4 2 4 21
M  V30 5 1 5 6
M  V30 6 1 5 27
M  V30 7 2 6 7
M  V30 8 1 8 29
M  V30 9 1 9 35
M  V30 10 1 10 11
M  V30 11 1 10 33
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 39
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 28
M  V30 23 1 20 21
M  V30 24 1 20 34
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 939971-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 939971-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12960539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4d) Preparation of 1, 3, 5-Tris-(4-formamido-2-methyl-phenyl)-[1, 3,
5]tri-azinane-2, 4, 6-trione (4) Formic acid (175 ml) was put in an
ice-cooled 500 ml round-bottom flask. Acetic anhydride (15 ml, 0.16 mol)
was added and the yellow solution was stirred under argon for 1 h at 0 °
C. The triamine 3 (8.7 g, 0.020 mol) was added to this solution and the
ice bath was removed. After stirring under argon at room temperature for
30 minutes HPLC showed complete reaction. The solvent was removed in
vacuo and the brown, sticky residue was suspended in H2O and filtered
off. It was then washed thoroughly with H2O to make sure all acid was
removed. The product was a pale- brown solid (10.2 g, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions of amine carboxylates, DNP agent, and paramagnetic metal ion
for producing hyperpolarized samples as MRI imaging agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thaning, Mikkel; Gram, Karl Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007069909 A2 2007-06-21

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Tris(4-amino-2-methylphenyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
C24H24N6O3
939971-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 10.7801 0.0 0
M  V30 2 O 4.0010 6.1601 0.0 0
M  V30 3 C 5.3348 11.5501 0.0 0
M  V30 4 O 9.3359 6.1601 0.0 0
M  V30 5 N 0.0000 11.5501 0.0 0
M  V30 6 C 10.6695 6.9301 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 N 13.3369 11.5501 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 N 5.3348 8.4701 0.0 0
M  V30 11 C 6.6684 9.2401 0.0 0
M  V30 12 C 5.3348 6.9301 0.0 0
M  V30 13 N 8.0021 8.4701 0.0 0
M  V30 14 N 6.6684 6.1601 0.0 0
M  V30 15 C 8.0021 6.9301 0.0 0
M  V30 16 C 4.0010 9.2401 0.0 0
M  V30 17 C 4.0010 10.7801 0.0 0
M  V30 18 C 2.6673 8.4701 0.0 0
M  V30 19 C 2.6673 11.5501 0.0 0
M  V30 20 C 1.3337 9.2401 0.0 0
M  V30 21 C 1.3337 10.7801 0.0 0
M  V30 22 C 9.3359 9.2401 0.0 0
M  V30 23 C 10.6695 8.4701 0.0 0
M  V30 24 C 9.3359 10.7801 0.0 0
M  V30 25 C 12.0032 9.2401 0.0 0
M  V30 26 C 10.6695 11.5501 0.0 0
M  V30 27 C 12.0032 10.7801 0.0 0
M  V30 28 C 6.6684 4.6201 0.0 0
M  V30 29 C 5.3348 3.8500 0.0 0
M  V30 30 C 8.0021 3.8500 0.0 0
M  V30 31 C 5.3348 2.3100 0.0 0
M  V30 32 C 8.0021 2.3100 0.0 0
M  V30 33 C 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 1 3 17
M  V30 4 2 4 15
M  V30 5 1 5 21
M  V30 6 1 6 23
M  V30 7 1 7 29
M  V30 8 1 8 27
M  V30 9 1 9 33
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 22
M  V30 17 1 14 15
M  V30 18 1 14 28
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′,N′′-[(2,4,6-Trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris(3-methyl-4,...
C27H24N6O6
939971-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 13.0903 0.0 0
M  V30 2 O 10.6697 8.4702 0.0 0
M  V30 3 C 9.3360 13.8603 0.0 0
M  V30 4 O 5.3348 8.4702 0.0 0
M  V30 5 N 14.6708 13.8603 0.0 0
M  V30 6 C 16.0045 13.0903 0.0 0
M  V30 7 O 17.3383 13.8603 0.0 0
M  V30 8 C 4.0012 9.2402 0.0 0
M  V30 9 C 10.6697 6.9302 0.0 0
M  V30 10 N 1.3338 13.8603 0.0 0
M  V30 11 C 1.3338 15.4003 0.0 0
M  V30 12 O 0.0000 16.1704 0.0 0
M  V30 13 N 8.0023 2.3101 0.0 0
M  V30 14 C 6.6687 1.5400 0.0 0
M  V30 15 O 6.6687 0.0000 0.0 0
M  V30 16 N 9.3360 10.7802 0.0 0
M  V30 17 C 8.0023 11.5503 0.0 0
M  V30 18 C 9.3360 9.2402 0.0 0
M  V30 19 N 6.6687 10.7802 0.0 0
M  V30 20 N 8.0023 8.4702 0.0 0
M  V30 21 C 6.6687 9.2402 0.0 0
M  V30 22 C 10.6697 11.5503 0.0 0
M  V30 23 C 10.6697 13.0903 0.0 0
M  V30 24 C 12.0035 10.7802 0.0 0
M  V30 25 C 12.0035 13.8603 0.0 0
M  V30 26 C 13.3372 11.5503 0.0 0
M  V30 27 C 13.3372 13.0903 0.0 0
M  V30 28 C 5.3348 11.5503 0.0 0
M  V30 29 C 4.0012 10.7802 0.0 0
M  V30 30 C 5.3348 13.0903 0.0 0
M  V30 31 C 2.6675 11.5503 0.0 0
M  V30 32 C 4.0012 13.8603 0.0 0
M  V30 33 C 2.6675 13.0903 0.0 0
M  V30 34 C 8.0023 6.9302 0.0 0
M  V30 35 C 9.3360 6.1601 0.0 0
M  V30 36 C 6.6687 6.1601 0.0 0
M  V30 37 C 9.3360 4.6201 0.0 0
M  V30 38 C 6.6687 4.6201 0.0 0
M  V30 39 C 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 18
M  V30 3 1 3 23
M  V30 4 2 4 21
M  V30 5 1 5 6
M  V30 6 1 5 27
M  V30 7 2 6 7
M  V30 8 1 8 29
M  V30 9 1 9 35
M  V30 10 1 10 11
M  V30 11 1 10 33
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 39
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 28
M  V30 23 1 20 21
M  V30 24 1 20 34
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 939971-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 939971-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7615416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1d) Preparation of
1,3,5-tris-(4-formamido-2-methyl-phenyl)-[1,3,5]triazinane-2,4,6-trione
(17). Formic acid (175 mL) was put in an ice-cooled 500 mL round-bottom
flask. Acetic anhydride (15 mL, 0.16 mol) was added and the yellow
solution was stirred under argon for 1 h at 0 °C. The triamine 16 (8.7 g,
0.020 mol) was added to this solution and the ice bath was removed. After
stirring under argon at room temperature for 30 minutes HPLC showed
complete reaction. The solvent was removed in vacuo and the brown, sticky
residue was suspended in H2O and filtered off. It was then washed
thoroughly with H2O to make sure all acid was removed. The product was a
pale-brown solid (10.2 g,99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazine gadolinium coordination compounds as multi-meric
magnetic resonance contrast agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Axelsson, Oskar; Johannesson, Haukur; Meijer, Andreas; Olsson, Andreas;
Staahlberg, Tim; Thaning, Mikkel; Wynn, Duncan; Braathe, Anders
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007064227 A1 2007-06-07

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Tris(4-amino-2-methylphenyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
C24H24N6O3
939971-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 10.7801 0.0 0
M  V30 2 O 4.0010 6.1601 0.0 0
M  V30 3 C 5.3348 11.5501 0.0 0
M  V30 4 O 9.3359 6.1601 0.0 0
M  V30 5 N 0.0000 11.5501 0.0 0
M  V30 6 C 10.6695 6.9301 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 N 13.3369 11.5501 0.0 0
M  V30 9 N 6.6684 0.0000 0.0 0
M  V30 10 N 5.3348 8.4701 0.0 0
M  V30 11 C 6.6684 9.2401 0.0 0
M  V30 12 C 5.3348 6.9301 0.0 0
M  V30 13 N 8.0021 8.4701 0.0 0
M  V30 14 N 6.6684 6.1601 0.0 0
M  V30 15 C 8.0021 6.9301 0.0 0
M  V30 16 C 4.0010 9.2401 0.0 0
M  V30 17 C 4.0010 10.7801 0.0 0
M  V30 18 C 2.6673 8.4701 0.0 0
M  V30 19 C 2.6673 11.5501 0.0 0
M  V30 20 C 1.3337 9.2401 0.0 0
M  V30 21 C 1.3337 10.7801 0.0 0
M  V30 22 C 9.3359 9.2401 0.0 0
M  V30 23 C 10.6695 8.4701 0.0 0
M  V30 24 C 9.3359 10.7801 0.0 0
M  V30 25 C 12.0032 9.2401 0.0 0
M  V30 26 C 10.6695 11.5501 0.0 0
M  V30 27 C 12.0032 10.7801 0.0 0
M  V30 28 C 6.6684 4.6201 0.0 0
M  V30 29 C 5.3348 3.8500 0.0 0
M  V30 30 C 8.0021 3.8500 0.0 0
M  V30 31 C 5.3348 2.3100 0.0 0
M  V30 32 C 8.0021 2.3100 0.0 0
M  V30 33 C 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 1 3 17
M  V30 4 2 4 15
M  V30 5 1 5 21
M  V30 6 1 6 23
M  V30 7 1 7 29
M  V30 8 1 8 27
M  V30 9 1 9 33
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 22
M  V30 17 1 14 15
M  V30 18 1 14 28
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′,N′′-[(2,4,6-Trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris(3-methyl-4,...
C27H24N6O6
939971-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 13.0903 0.0 0
M  V30 2 O 10.6697 8.4702 0.0 0
M  V30 3 C 9.3360 13.8603 0.0 0
M  V30 4 O 5.3348 8.4702 0.0 0
M  V30 5 N 14.6708 13.8603 0.0 0
M  V30 6 C 16.0045 13.0903 0.0 0
M  V30 7 O 17.3383 13.8603 0.0 0
M  V30 8 C 4.0012 9.2402 0.0 0
M  V30 9 C 10.6697 6.9302 0.0 0
M  V30 10 N 1.3338 13.8603 0.0 0
M  V30 11 C 1.3338 15.4003 0.0 0
M  V30 12 O 0.0000 16.1704 0.0 0
M  V30 13 N 8.0023 2.3101 0.0 0
M  V30 14 C 6.6687 1.5400 0.0 0
M  V30 15 O 6.6687 0.0000 0.0 0
M  V30 16 N 9.3360 10.7802 0.0 0
M  V30 17 C 8.0023 11.5503 0.0 0
M  V30 18 C 9.3360 9.2402 0.0 0
M  V30 19 N 6.6687 10.7802 0.0 0
M  V30 20 N 8.0023 8.4702 0.0 0
M  V30 21 C 6.6687 9.2402 0.0 0
M  V30 22 C 10.6697 11.5503 0.0 0
M  V30 23 C 10.6697 13.0903 0.0 0
M  V30 24 C 12.0035 10.7802 0.0 0
M  V30 25 C 12.0035 13.8603 0.0 0
M  V30 26 C 13.3372 11.5503 0.0 0
M  V30 27 C 13.3372 13.0903 0.0 0
M  V30 28 C 5.3348 11.5503 0.0 0
M  V30 29 C 4.0012 10.7802 0.0 0
M  V30 30 C 5.3348 13.0903 0.0 0
M  V30 31 C 2.6675 11.5503 0.0 0
M  V30 32 C 4.0012 13.8603 0.0 0
M  V30 33 C 2.6675 13.0903 0.0 0
M  V30 34 C 8.0023 6.9302 0.0 0
M  V30 35 C 9.3360 6.1601 0.0 0
M  V30 36 C 6.6687 6.1601 0.0 0
M  V30 37 C 9.3360 4.6201 0.0 0
M  V30 38 C 6.6687 4.6201 0.0 0
M  V30 39 C 8.0023 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 18
M  V30 3 1 3 23
M  V30 4 2 4 21
M  V30 5 1 5 6
M  V30 6 1 5 27
M  V30 7 2 6 7
M  V30 8 1 8 29
M  V30 9 1 9 35
M  V30 10 1 10 11
M  V30 11 1 10 33
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 39
M  V30 15 2 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 28
M  V30 23 1 20 21
M  V30 24 1 20 34
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 939971-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 939971-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14453197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4d) Preparation of
1,3,5-Tris-(4-formamido-2-methyl-phenyl)-[1,3,5]triazinane-2,4,6-trione
(4) Formic acid (175 ml) was put in an ice-cooled 500 ml round-bottom
flask. Acetic anhydride (15 ml, 0.16 mol) was added and the yellow
solution was stirred under argon for 1 h at 0 °C. The triamine 3 (8.7 g,
0.020 mol) was added to this solution and the ice bath was removed. After
stirring under argon at room temperature for 30 minutes HPLC showed
complete reaction. The solvent was removed in vacuo and the brown, sticky
residue was suspended in H2O and filtered off. It was then washed
thoroughly with H2O to make sure all acid was removed. The product was a
pale- brown solid (10.2 g, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method of dynamic nuclear polarization (DNP) with trityl radicals and
paramagnetic metal ions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thaning, Mikkel; Servin, Rolf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007064226 A2 2007-06-07

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloroaniline
C6H6ClN
95-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 2.6673 0.0 0
M  V30 2 N 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,N-dimethylbenzenamine
C8H10ClN
698-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-51-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25296964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-53-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6737-42-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 11057-89-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-96-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, conversion >99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM General catalytic methylation of amines with formic acid under mild
reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorribes, Ivan; Junge, Kathrin; Beller, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(26), 7878-7883

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-5-nitroaniline
C7H8N2O3
99-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 N 4.0011 0.0000 0.0 0
M  V30 5 O 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methoxy-5-nitrophenyl)formamide
C8H8N2O4
149686-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 4.0011 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 O 8.4701 5.3348 0.0 0
M  V30 4 O 4.6201 1.3337 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 N 1.5400 6.6686 0.0 0 VAL=5
M  V30 7 O 2.3100 8.0022 0.0 0
M  V30 8 O 0.0000 6.6686 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 3.8500 2.6675 0.0 0
M  V30 11 C 3.8500 5.3348 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0
M  V30 13 C 2.3100 5.3348 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-59-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149686-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11364562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM B. N-(2-methoxy-5-nitrophenyl)formamide (4) Into a 5-L, 3-neck flask
equipped with a mechanical stirrer, a temperature probe and an ice bath
was placed, acetic anhydride (367 g, 9.72 mol). Formic acid (367 g, 6.01
mol) was added with stirring and cooling. The rate of addition was such
that the temperature did not exceed 32°C. Stirring was continued for one
hour at ambient temperature. Cooling was again applied and
2-methoxy-5-nitroaniline (3) (415 g, 2.47 mol) was added in portions over
a 1.5-hour period. The temperature was kept below 32°C. during addition.
The thick-yellow slurry was stirred overnight. Water (3 L) was added and
the mixture was stirred for an additional 48 hours. The yellow product
was collected by filtration and washed with water until the pH of the
aqueous washing was neutral. A total of 9.2 L of water was used. The
product was dried at 60° C. under house vacuum and afforded 480 g (99.1%)
of the title compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrroloquinoline quinone (PQQ)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kempf, Vern J.; Gopal, Damodara; Stalzer, Walter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006102642 A1 2006-09-28

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22629819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, palladium supported on modified clinoptilolite catalyst
prepared and used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and catalytic evaluation of a palladium catalyst deposited
over modified clinoptilolite (Pd@MCP) for chemoselective N-formylation
and N-acylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amirsoleimani, Mina; Khalilzadeh, Mohammad A.; Zareyee, Daryoush
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2021), 1225129076

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17598429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM catalyst with sulfamic acid on zeolite NaY
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 5329-14-6
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM catalyst with Cu(OAc)2 on zeolite NaY
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, green chemistry-catalyst,
solid-supported catalyst, no solvent, catalyst prepared and used,
recyclable catalyst, zeolite NaY support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NaY zeolite functionalized by sulfamic acid/Cu(OAc)2 as a new and
reusable heterogeneous hybrid catalyst for efficient solvent-free
formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazemi, Samira; Mobinikhaledi, Akbar; Zendehdel, Mojgan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(8), 1767-1772

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18675092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 338741-79-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst (imidazolium based
ionic liquid supported on silica-coated ferrite nanoparticles), catalyst
prepared and used, ionic liquid used (catalyst), no solvent, recyclable
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An imidazolium based ionic liquid supported on Fe3O4@SiO2 nanoparticles
as an efficient heterogeneous catalyst for N-formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garkoti, Charu; Shabir, Javaid; Mozumdar, Subho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2017), 41(17), 9291-9298

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14971100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction products with chlorosulfonic acid
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sulfated tungstate used as catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate catalyzed highly accelerated N-formylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Sawant, Ravindra V.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(26), 3259-3263

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2377756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-74-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Typical procedure for the formylation of amines: A mixture of amine (2
mmol), formic acid (purity = 99%; 226 mL, 6 mmol), and In metal (23 mg,
0.2 mmol) was stirred at 70 °C, and the reaction was monitored by TLC.
After completion of the reaction, the mixture was diluted with CH2Cl2 and
filtered through Celite. The filtrate was washed with saturated NaHCO3
and brine, then dried over anhydrous MgSO4. After filtration and
evaporation of the solvent, the residue was purified by column
chromatography on silica gel. The formylated product.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indium-catalyzed N-formylation of amines under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joong-Gon; Jang, Doo Ok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2010), (8), 1231-1234

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35104990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, catalyst prepared and used, recyclable
catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid-based periodic mesoporous organosilicas: Metal/solvent-free
synthesis of formamides and formamidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Seyed Mehran Hoseini; Haghighat, Mahdieh; Shirini, Farhad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1274(Part_1), 134473

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24209079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, solid-supported catalyst
(Fe3O4 immobilized CuO nanoparticles catalyst used), click chemistry,
catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile N-Formylation of Amines on Magnetic Fe3O4-CuO Nanocomposites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mishra, Kanchan; Datta Khanal, Hari; Rok Lee, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(31), 4477-4484

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17922215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1715923-43-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM SBA-15 supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, no solvent, recyclable
catalyst used, SBA-15 support used, ionic liquid used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mesoporous silica SBA-15 functionalized with acidic deep eutectic
solvent: A highly active heterogeneous N-formylation catalyst under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Azizi, Najmedin; Edrisi, Mahtab; Abbasi, Faezeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2018), 32(1), n/a

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1520939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, solid-supported catalyst,
copperoxide nanoparticles supported on HZSM-5 Zeolite used as catalyst,
no solvent, recyclable catalyst, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation, characterization and application of nanosized CuO/HZSM-5 as
an efficient and heterogeneous catalyst for the N-formylation of amines
at room temperature
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tajbakhsh, Mahmood; Alinezhad, Heshmatollah; Nasrollahzadeh, Mahmoud;
Kamali, Taghi A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Colloid and Interface Science (2016), 47137-47

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-949070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Synthesis of α-Diimines from Triarylbismuthines and
Isocyanides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobiki, Yohsuke; Kawaguchi, Shin-ichi; Ogawa, Akiya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(14), 3490-3493

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16894715
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7790-94-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, reusable catalyst, no solvent, sulfonated rice husk ash
solid acid catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient method for the synthesis of formamidine and formamide
derivatives promoted by sulfonated rice husk ash (RHA-SO3H)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seddighi, Mohadeseh; Shirini, Farhad; Mamaghani, Manouchehr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2015), 12(3), 433-439

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4897474
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1616058-17-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, solid state, molten conditions, ionic
liquid used (catalyst), reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteropolyanion-based sulfated ionic liquid catalyzed formamides
synthesis by grindstone chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satasia, Shailesh P.; Kalaria, Piyush N.; Raval, Dipak K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2014), 39141-47

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11099221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 778543-37-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of 3. A
mixture of amines (1 mmol), formic acid (2 mmol), and MTSA (0.03 mmol)
was prepared and stirred at 60 °C for appropriate time (Table 1). After
completion of the reaction (TLC), the mixture was diluted with CH2Cl2 (20
mL), washed with H2O (10 mL), and then dried over anhydrous MgSO4. After
filtration and evaporation of the solvent, the residue was purified by
column chromatography on silica gel to give the formylated product. All
the compounds are known and their physical properties are the same as the
reported values. 1H NMR, IR, and mass spectral data of all the products
match the reported data. Product: 3d, Time: 60 min, Yield: 97%.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Melamine trisulfonic acid-catalyzed N-formylation of amines under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xiao Juan; Zhang, Yong Sen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2013), 39(6), 2843-2848

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10982591
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-waste reduction, choline chloride and SnCl2 based deep
eutectic solvent used both as catalyst and reaction medium, catalyst
prepared and used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deep eutectic solvent promoted highly efficient synthesis of N,
N'-diarylamidines and formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Azizi, Najmadin; Gholibeglo, Elham; Babapour, Mahbobe; Ghafuri, Hossein;
Bolourtchian, Seyed Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Comptes Rendus Chimie (2012), 15(9), 768-773

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1492163
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-06-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1309-37-1
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7790-94-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, sulfonic acid
supported on hydroxyapatite-encapsulated gamma-Fe2O3 nanocrystallites
catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfonic acid supported on hydroxyapatite-encapsulated-γ-Fe2O3
nanocrystallites as a magnetically Bronsted acid for N-formylation of
amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma'mani, Leila; Sheykhan, Mehdi; Heydari, Akbar; Faraji, Mohammad;
Yamini, Yadollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Catalysis, A: General (2010), 377(1-2), 64-69

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36298692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12027-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst supported on
silica prepared and used,recyclable catalyst,no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Magnetically Recyclable Silica-Coated Magnetite-Molybdate Nanocatalyst
and its Applications in N-Formylation Reactions Under Solvent-Free
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Runjhun; Patil, Shripad; Tandon, Nitin; Kumar, Pushpendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2022), 19(8), 616-626

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13762219
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 9002-89-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM aminated with ethanolamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, no solvent (stage 1), catalyst
prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amino group immobilized on polyvinyl alcohol as a reusable catalyst for
highly accelerated N-formylation of amines using formic acid under
solvent-free condition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rezazadeh, Soodabeh; Akhlaghinia, Batool
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Indian Chemical Society (2015), 92(8), 1277-1285

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8254921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction products with chlorosulfonic acid
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sulfated tungstate used as catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate catalyzed highly accelerated N-formylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Sawant, Ravindra V.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(26), 3259-3263

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11977657
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure: To a mixture of HCO2H (3
mmol, 0.11 mL) and ZnO (0.5 mmol, 0.04 g) an amine (1 mmol) was added and
then the reaction mixture was heated in an oil bath at 70 °C and stirred
with a magnetic stirrer. The progress of the reaction was monitored by
TLC. After the reaction was complete, CH2Cl2 or EtOAc was added to the
reaction mixture and ZnO was removed by filtration. The organic solvent
was then washed with H2O (2x10 mL), saturated solution of NaHCO3, and
dried over anhydrous Na2SO4. After removal of the solvent, the pure
product was obtained. This was further purified by recrystallization with
suitable solvent (ether or CHCl3). The structure of the products was
confirmed by 1H NMR, IR and comparison with authentic samples obtained
commercially or prepared by reported methods. N-(4-Bromophenyl) formamide
(7) 1H NMR (250 MHz, CDCl3) δ 9.21 (brs, 1H, trans), 8.46 (d, 1H,
J=11.32, trans), 8.23 (s, 1H, cis), 8.15 (brs, 1H cis), 7.39-7.45 (m, 2H,
Ar-H), 6.93-6.99 (m, 2H, Ar-H); 13C NMR (62.9 MHz, CDCl3) δ 115.4, 115.8,
116.3, 116.6, 120.9, 121.1, 132.7, 158.4, 163.3.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry (- catalyst), no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zinc oxide as a new catalyst for N-formylation of amines under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hosseini-Sarvari, Mona; Sharghi, Hashem
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2006), 71(17), 6652-6654

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19065994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 26851-55-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfatedsulfonic acid functionalizedsulfonic acid functionalizedsulfonic
acid functionalized
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, no solvent, recyclable
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated polyborate-catalyzed N-formylation of amines: a rapid, green and
efficient protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khatri, Chetan K.; Chaturbhuj, Ganesh U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2017), 14(12), 2513-2519

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17598432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM catalyst with sulfamic acid on zeolite NaY
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 5329-14-6
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM catalyst with Cu(OAc)2 on zeolite NaY
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, green chemistry-catalyst,
solid-supported catalyst, no solvent, catalyst prepared and used,
recyclable catalyst, zeolite NaY support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NaY zeolite functionalized by sulfamic acid/Cu(OAc)2 as a new and
reusable heterogeneous hybrid catalyst for efficient solvent-free
formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazemi, Samira; Mobinikhaledi, Akbar; Zendehdel, Mojgan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(8), 1767-1772

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)formamide
C7H6BrNO
2617-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16894711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7790-94-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sulfonated rice husk ash solid acid catalyst used, no
solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient method for the synthesis of formamidine and formamide
derivatives promoted by sulfonated rice husk ash (RHA-SO3H)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seddighi, Mohadeseh; Shirini, Farhad; Mamaghani, Manouchehr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2015), 12(3), 433-439

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethanolamine
C4H11NO2
111-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethanolamine formate
C4H11NO2.CH2O2
68391-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 6.6687 2.3100 0.0 0
M  V30 5 C 1.3337 2.3100 0.0 0
M  V30 6 O 8.0023 3.0800 0.0 0
M  V30 7 O 0.0000 3.0800 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 2.6675 0.7700 0.0 0
M  V30 10 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 8 9
M  V30 8 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 111-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68391-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25752590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM product is an ionic liquid, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Neoteric Solvent Systems as Sustainable Media for Dissolution and Film
Preparation of Poly-[(R)-3-hydroxybutyrate]
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sequeira, Rosy Alphons; Dubey, Sonam; Pereira, Matheus M.; Maity, Tapan
Kumar; Singh, Sanju; Mishra, Sandhya; Prasad, Kamalesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2020), 8(32), 12005-12013

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethanolamine
C4H11NO2
111-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethanolamine formate
C4H11NO2.CH2O2
68391-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 6.6687 2.3100 0.0 0
M  V30 5 C 1.3337 2.3100 0.0 0
M  V30 6 O 8.0023 3.0800 0.0 0
M  V30 7 O 0.0000 3.0800 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 2.6675 0.7700 0.0 0
M  V30 10 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 8 9
M  V30 8 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 111-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68391-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29079483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, product is an ionic liquid, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyl ammonium ionic liquids as media for biocatalytic oxidations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Papadopoulou, Athena A.; Tzani, Andromachi; Alivertis, Dimitrios;
Katsoura, Maria H.; Polydera, Angeliki C.; Detsi, Anastasia; Stamatis,
Haralambos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(4), 1147-1158

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(aminomethyl)-3-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-2-pyrazin...
C16H21FN4O2Si
1168091-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 O 0.7700 6.6684 0.0 0
M  V30 4 O 3.0800 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 N 4.6200 0.0000 0.0 0
M  V30 8 F 6.9300 9.3358 0.0 0
M  V30 9 Si 11.5500 6.6684 0.0 0
M  V30 10 C 13.0900 6.6684 0.0 0
M  V30 11 C 11.5500 5.1284 0.0 0
M  V30 12 C 11.5500 8.2084 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 5.3900 4.0011 0.0 0
M  V30 16 N 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 7.7000 8.0021 0.0 0
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 24
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[2-fluoro-4-(trimethylsilyl)phenyl]amino]-5-[(formylamino)methyl]-2...
C17H21FN4O3Si
1168091-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 9.3358 0.0 0
M  V30 2 C 2.3100 9.3358 0.0 0
M  V30 3 O 0.7700 9.3358 0.0 0
M  V30 4 O 3.0800 10.6694 0.0 0
M  V30 5 C 0.0000 10.6694 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 N 4.6200 2.6673 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 F 6.9300 12.0031 0.0 0
M  V30 11 Si 11.5500 9.3358 0.0 0
M  V30 12 C 13.0900 9.3358 0.0 0
M  V30 13 C 11.5500 10.8758 0.0 0
M  V30 14 C 11.5500 7.7958 0.0 0
M  V30 15 C 4.6200 8.0020 0.0 0
M  V30 16 C 3.0800 8.0020 0.0 0
M  V30 17 N 5.3900 6.6684 0.0 0
M  V30 18 N 2.3100 6.6684 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 7.7000 10.6694 0.0 0
M  V30 23 C 7.7000 8.0020 0.0 0
M  V30 24 C 9.2400 10.6694 0.0 0
M  V30 25 C 9.2400 8.0020 0.0 0
M  V30 26 C 10.0100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 26
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1168091-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1168091-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2830209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6:
3-(2-Fluoro-4-trimethylsilanyl-phenylamino)-5-formylaminomethyl-pyrazine-2-carboxylic
acid methyl ester A solution of
5-aminomethyl-3-(2-fluoro-4-trimethylsilanyl-phenylamino)-pyrazine-2-carboxylic
acid methyl ester (800 mg, 2.30 mmol) from above in formic acid (12 mL)
and acetic anhydride (4 mL) was stirred at ambient temperature under N2
for 1.5 hour. The reaction mixture was concentrated in vacuo, and the
residue was azeotroped with toluene. The resultant residue was diluted
with ethyl acetate. The organic layer was washed with saturated aqueous
solution of sodium bicarbonate, water and brine, dried (Na2SO4), filtered
and concentrated in vacuo to afford the title compound as a yellow foam
(850 mg, 98.3%).
3-(2-Fluoro-4-trimethylsilanyl-phenylamino)-5-formylaminomethyl-pyrazine-2-carboxylic
acid methyl ester, yield (850 mg, 98.3%). LCMS (method Dl): RT=1.09 min,
[M+H]+=377.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-anilinoimidazopyridines and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Price, Stephen; Heald, Robert; Lee, Wendy; Zak, Mark E.; Hewitt, Joanne
Frances Mary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100004269 A1 2010-01-07

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2377516
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of ZnO Nanoparticles To prepare
nanosized particles of zinc oxide,[29] we used the method of
mechanochemical synthesis from salt systems. Zinc acetate
[Zn(CH3CO2)2.2H2O] and oxalic acid [H2C2O4.2H2O] were used as the main
raw materials. Zinc acetate was dried at 120 °C in air for 24 h prior to
use. In a typical synthesis, starting materials [Zn(CH3COO)2.2H2O and
H2C2O4.2H2O] were put in an agate mortar with molar ratio of 2:3 and
mixed and milled for 45 min at room temperature. The white powders
(precursor) were calcined at 450 °C in air in a porcelain crucible for 30
min to prepare the ZnO nanoparticles. The results obtained from XRD
pattern and TEM micrograph of the ZnO nanoparticles show that the mean
particle size is 15 nm. General Procedure To a mixture of aq. 98% formic
acid (3 mmol, 0.11 mL) and ZnO nanoparticles (2 mol%, 0.0016 g) was added
an amine (1 mmol). The reaction mixture was heated in an oil bath at 70
°C with continuous stirring. The progress of the reaction was monitored
by TLC. After completion of the reaction, CH2Cl2 or EtOAc was added to
the cooled reaction mixture and then filtered to remove the ZnO
nanoparticles. The organic solvent was washed with H2O (2×10 mL) and a
saturated solution of NaHCO3 and dried over anhydrous Na2SO4. After
removal of the solvent, the pure product was obtained. This was further
purified by recrystallization with suitable solvent (Table 1). TABLE 1
N-Formylation of amines with formic acid catalyzed by ZnO-nanoparticlesa
Entry 1 TABLE 1 N-Formylation of amines with formic acid catalyzed by
ZnO-nanoparticlesa Entry 9 Yield 98%.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, green chemistry-catalyst, no solvent,
catalyst prepared and used, reusable catalyst, ZnO nanoparticles used as
catalyst, aqueous formic acid as reactant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Simple Method for Preparation of ZnO Nanoparticles as a Highly
Efficient Nanocatalyst for N-Formylation of Primary and Secondary Amines
under Solvent-Free Condition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alinezhad, Heshmatollah; Salehian, Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal
Chemistry (2013), 43(5), 532-538

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4892055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, optimization study, optimized on catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macroporous metal oxides as an efficient heterogeneous catalyst for
various organic transformations-A comparative study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thakuria, Harjyoti; Borah, Ballav Moni; Das, Gopal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2007), 274(1-2), 1-10

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3749079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11120-01-7
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction products with chlorosulfonic acid
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sulfated tungstate used as catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated tungstate catalyzed highly accelerated N-formylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pathare, Sagar P.; Sawant, Ravindra V.; Akamanchi, Krishnacharya G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(26), 3259-3263

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzoic acid
C7H7NO2
150-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)benzoic acid
C8H7NO3
28533-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28533-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21378813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rod-shaped 1D polymer-assisted anisotropic self-assembly of 0D
nanoparticles by a solution-drying method
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hayashi, Hiroki; Kikuchi, Ryosuke; Kumai, Reiji; Takeguchi, Masaki; Goto,
Hiromasa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Materials Chemistry C: Materials for Optical and Electronic
Devices (2019), 7(24), 7442-7453

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzoic acid
C7H7NO2
150-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)benzoic acid
C8H7NO3
28533-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 150-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28533-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37137514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-82-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Novel Gateway to InCl3 catalyzed N-Formylation of Amines: An Access to
2-unsubstituted, N-unsubstituted Benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Bikash; Ghosh, Anjulika; Dubey, Manoj Kumar; Bandichhor,
Rakeshwar; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(25), e202300443

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-bromopyridine
C5H5BrN2
19798-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-2-pyridinyl)formamide
C6H5BrN2O
1451186-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 Br 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19798-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1451186-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24200188
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed microwave vial in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Substituted 2-isocyanopyridines as versatile convertible isocyanides
for peptidomimetic design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hollanders, Charlie; Elsocht, Mathias; Van der Poorten, Olivier; Jida,
Mouhamad; Renders, Evelien; Maes, Bert U. W.; Ballet, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2021), 57(56),
6863-6866

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxyaniline
C8H11NO2
2735-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 4.6200 0.0000 0.0 0
M  V30 4 O 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethoxyphenyl)formamide
C9H11NO3
6639-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3349 0.0 0
M  V30 3 O 9.2400 5.3349 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2735-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6639-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8120326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Reactivity of some Activated Heterocyclic Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alamgir, Mahiuddin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2007), (20140701), No pp.

$RFMT $RIREG SCHEME106 STEP1
$RXN



  3  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Azobenzene
C12H10N2
103-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 4.0010 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 0.7700 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 7.7002 2.6673 0.0 0
M  V30 11 C 7.7002 0.0000 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 C 9.2402 0.0000 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2,6-Bis[[(1,1-dimethylethyl)imino-κN]methyl]phenyl-κC]bismuth
C16H23BiN2
1816296-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6205 5.0130 0.0 0
M  V30 2 C 6.6205 3.4730 0.0 0
M  V30 3 C 8.1605 5.0130 0.0 0
M  V30 4 C 6.6205 6.5530 0.0 0
M  V30 5 C 5.0084 1.0942 0.0 0
M  V30 6 C 3.9247 0.0000 0.0 0
M  V30 7 C 6.1026 0.0106 0.0 0
M  V30 8 C 6.0919 2.1885 0.0 0
M  V30 9 Bi 4.1526 3.7373 0.0 0 CHG=1 VAL=3
M  V30 10 C 2.8019 4.2929 0.0 0 CHG=-1 VAL=4
M  V30 11 N 5.0805 5.0130 0.0 0 VAL=4
M  V30 12 N 3.9141 2.1779 0.0 0 VAL=4
M  V30 13 C 1.6680 3.3255 0.0 0
M  V30 14 C 2.6768 5.7779 0.0 0
M  V30 15 C 4.1762 6.2566 0.0 0
M  V30 16 C 2.3965 1.9305 0.0 0
M  V30 17 C 0.2256 3.9227 0.0 0
M  V30 18 C 1.2317 6.3687 0.0 0
M  V30 19 C 0.0000 5.4454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 15
M  V30 19 1 14 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hydrazobenzene
C12H12N2
122-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 7.7002 0.0000 0.0 0
M  V30 11 C 7.7002 2.6673 0.0 0
M  V30 12 C 9.2402 0.0000 0.0 0
M  V30 13 C 9.2402 2.6673 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H24BiN2O2.CHO2
3033614-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.2224 5.4928 0.0 0 CHG=-1 VAL=2
M  V30 2 C 6.5561 6.2628 0.0 0
M  V30 3 O 7.8897 5.4928 0.0 0
M  V30 4 C 9.5570 6.7898 0.0 0
M  V30 5 C 11.0833 6.5852 0.0 0
M  V30 6 C 9.3522 5.2635 0.0 0
M  V30 7 C 9.7617 8.3161 0.0 0
M  V30 8 C 4.3854 3.5294 0.0 0
M  V30 9 C 3.1660 2.5889 0.0 0
M  V30 10 C 5.3259 2.3100 0.0 0
M  V30 11 C 5.6050 4.4699 0.0 0
M  V30 12 Bi 3.8886 6.2628 0.0 0 CHG=3 VAL=4
M  V30 13 C 2.6238 6.9931 0.0 0 CHG=-1 VAL=4
M  V30 14 N 4.9779 7.4041 0.0 0 VAL=4
M  V30 15 N 3.4449 4.7490 0.0 0 VAL=4
M  V30 16 C 1.3714 6.1851 0.0 0
M  V30 17 C 2.6974 8.4817 0.0 0
M  V30 18 C 4.2470 8.7568 0.0 0
M  V30 19 C 1.9079 4.7057 0.0 0
M  V30 20 C 0.0211 6.9688 0.0 0
M  V30 21 C 1.3435 9.2593 0.0 0
M  V30 22 C 0.0000 8.5080 0.0 0
M  V30 23 C 5.5417 0.0000 0.0 0
M  V30 24 O 4.2080 0.7700 0.0 0 CHG=-1
M  V30 25 O 6.8753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 15
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 18
M  V30 22 1 17 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-33-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1816296-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122-66-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 3033614-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40411206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1693-74-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 1,3,5-trimethoxybenzene used as an internal standard,glove box
used,reaction in a capped J. young NMR tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mechanistic Studies on the Bismuth-Catalyzed Transfer Hydrogenation of
Azoarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moon, Hye Won; Wang, Feng; Bhattacharyya, Kalishankar; Planas, Oriol;
Leutzsch, Markus; Noethling, Nils; Auer, Alexander A.; Cornella, Josep
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2023), 62(49), e202313578

$RFMT $RIREG SCHEME107 STEP1
$RXN



  3  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Azobenzene
C12H10N2
103-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 4.0010 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 0.7700 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 7.7002 2.6673 0.0 0
M  V30 11 C 7.7002 0.0000 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 C 9.2402 0.0000 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H25BiN2
3033614-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6205 5.0130 0.0 0
M  V30 2 C 6.6205 3.4730 0.0 0
M  V30 3 C 8.1605 5.0130 0.0 0
M  V30 4 C 6.6205 6.5530 0.0 0
M  V30 5 C 5.0084 1.0942 0.0 0
M  V30 6 C 3.9247 0.0000 0.0 0
M  V30 7 C 6.1026 0.0106 0.0 0
M  V30 8 C 6.0919 2.1885 0.0 0
M  V30 9 Bi 4.1526 3.7373 0.0 0 CHG=1 VAL=3
M  V30 10 C 2.8019 4.2929 0.0 0 CHG=-1 VAL=4
M  V30 11 N 5.0805 5.0130 0.0 0 VAL=4
M  V30 12 N 3.9141 2.1779 0.0 0 VAL=4
M  V30 13 C 1.6680 3.3255 0.0 0
M  V30 14 C 2.6768 5.7779 0.0 0
M  V30 15 C 4.1762 6.2566 0.0 0
M  V30 16 C 2.3965 1.9305 0.0 0
M  V30 17 C 0.2256 3.9227 0.0 0
M  V30 18 C 1.2317 6.3687 0.0 0
M  V30 19 C 0.0000 5.4454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 15
M  V30 19 1 14 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hydrazobenzene
C12H12N2
122-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 7.7002 0.0000 0.0 0
M  V30 11 C 7.7002 2.6673 0.0 0
M  V30 12 C 9.2402 0.0000 0.0 0
M  V30 13 C 9.2402 2.6673 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H24BiN2O2.CHO2
3033614-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.2224 5.4928 0.0 0 CHG=-1 VAL=2
M  V30 2 C 6.5561 6.2628 0.0 0
M  V30 3 O 7.8897 5.4928 0.0 0
M  V30 4 C 9.5570 6.7898 0.0 0
M  V30 5 C 11.0833 6.5852 0.0 0
M  V30 6 C 9.3522 5.2635 0.0 0
M  V30 7 C 9.7617 8.3161 0.0 0
M  V30 8 C 4.3854 3.5294 0.0 0
M  V30 9 C 3.1660 2.5889 0.0 0
M  V30 10 C 5.3259 2.3100 0.0 0
M  V30 11 C 5.6050 4.4699 0.0 0
M  V30 12 Bi 3.8886 6.2628 0.0 0 CHG=3 VAL=4
M  V30 13 C 2.6238 6.9931 0.0 0 CHG=-1 VAL=4
M  V30 14 N 4.9779 7.4041 0.0 0 VAL=4
M  V30 15 N 3.4449 4.7490 0.0 0 VAL=4
M  V30 16 C 1.3714 6.1851 0.0 0
M  V30 17 C 2.6974 8.4817 0.0 0
M  V30 18 C 4.2470 8.7568 0.0 0
M  V30 19 C 1.9079 4.7057 0.0 0
M  V30 20 C 0.0211 6.9688 0.0 0
M  V30 21 C 1.3435 9.2593 0.0 0
M  V30 22 C 0.0000 8.5080 0.0 0
M  V30 23 C 5.5417 0.0000 0.0 0
M  V30 24 O 4.2080 0.7700 0.0 0 CHG=-1
M  V30 25 O 6.8753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 15
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 18
M  V30 22 1 17 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-33-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3033614-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122-66-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 3033614-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40411214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1693-74-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 1,3,5-trimethoxybenzene used as an internal standard,glove box
used,reaction in a capped J. young NMR tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mechanistic Studies on the Bismuth-Catalyzed Transfer Hydrogenation of
Azoarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moon, Hye Won; Wang, Feng; Bhattacharyya, Kalishankar; Planas, Oriol;
Leutzsch, Markus; Noethling, Nils; Auer, Alexander A.; Cornella, Josep
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2023), 62(49), e202313578

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Oxo-3-(phenylmethoxy)propyl]-1H-isoindole-1,3(2H)-dione
C18H15NO4
1354657-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 0.0000 0.0 0
M  V30 2 O 5.7309 4.6949 0.0 0
M  V30 3 C 6.0811 1.3628 0.0 0
M  V30 4 C 7.4148 2.1328 0.0 0
M  V30 5 C 8.7485 1.3628 0.0 0
M  V30 6 O 7.4148 3.6728 0.0 0
M  V30 7 O 10.0821 2.1328 0.0 0
M  V30 8 C 11.4160 1.3628 0.0 0
M  V30 9 C 2.3101 2.6509 0.0 0
M  V30 10 C 3.0801 3.9845 0.0 0
M  V30 11 C 3.3405 1.5065 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 4.5864 3.6644 0.0 0
M  V30 14 C 2.3101 5.3184 0.0 0
M  V30 15 N 4.7473 2.1328 0.0 0
M  V30 16 C 0.0000 3.9845 0.0 0
M  V30 17 C 0.7700 5.3184 0.0 0
M  V30 18 C 12.7496 2.1328 0.0 0
M  V30 19 C 14.0833 1.3628 0.0 0
M  V30 20 C 12.7496 3.6728 0.0 0
M  V30 21 C 15.4170 2.1328 0.0 0
M  V30 22 C 14.0833 4.4428 0.0 0
M  V30 23 C 15.4170 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon dioxide
CO2
124-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Isoindole-1,3(2H)-dione, 2-[2-hydroxy-3-(phenylmethoxy)propyl]-, (R)-
C18H17NO4
119835-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 0.0000 0.0 0
M  V30 2 O 5.7309 4.6949 0.0 0
M  V30 3 C 6.0811 1.3628 0.0 0
M  V30 4 C 7.4148 2.1328 0.0 0 CFG=1
M  V30 5 C 8.7485 1.3628 0.0 0
M  V30 6 O 7.4148 3.6728 0.0 0
M  V30 7 O 10.0821 2.1328 0.0 0
M  V30 8 C 11.4160 1.3628 0.0 0
M  V30 9 C 2.3101 2.6509 0.0 0
M  V30 10 C 3.0801 3.9845 0.0 0
M  V30 11 C 3.3405 1.5065 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 4.5864 3.6644 0.0 0
M  V30 14 C 2.3101 5.3184 0.0 0
M  V30 15 N 4.7473 2.1328 0.0 0
M  V30 16 C 0.0000 3.9845 0.0 0
M  V30 17 C 0.7700 5.3184 0.0 0
M  V30 18 C 12.7496 2.1328 0.0 0
M  V30 19 C 14.0833 1.3628 0.0 0
M  V30 20 C 12.7496 3.6728 0.0 0
M  V30 21 C 15.4170 2.1328 0.0 0
M  V30 22 C 14.0833 4.4428 0.0 0
M  V30 23 C 15.4170 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354657-87-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124-38-9
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 119835-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-513-CAS-18573680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1192620-83-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Schlenk tube used, ee 76%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploitation of differential electronic densities for the stereoselective
reduction of ketones bearing a masked amino surrogate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chew, Renta Jonathan; Wills, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2018), 36140-44

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenylmethyl)-1,3-benzodioxol-5-amine
C14H13NO2
32932-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 10.8006 2.6042 0.0 0
M  V30 7 C 8.0022 5.3901 0.0 0
M  V30 8 O 10.8006 5.0960 0.0 0
M  V30 9 C 6.6685 3.0801 0.0 0
M  V30 10 C 11.7058 3.8501 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzodioxol-5-amine
C7H7NO2
14268-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 O 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1,3-Benzodioxol-5-ylformamide
C8H7NO3
117889-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 O 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 O 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32932-20-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14268-66-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 117889-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25695788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Pd/vulcan catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Transfer Hydrodebenzylation with Low Palladium Loading
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yakukhnov, Sergey A.; Ananikov, Valentine P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2019), 361(20), 4781-4789

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furfural
C5H4O2
98-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furfuryl alcohol
C5H6O2
98-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furfuryl formate
C6H6O3
13493-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 O 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 O 7.7722 1.8517 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 C 1.0304 2.4782 0.0 0
M  V30 7 O 2.2765 0.3202 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98-00-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 13493-97-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38634956
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3024077-18-4
$DTYPE RXN:VAR(1):NOTES
$DATUM conversion = greater than 99%, optimization study (optimized on catalyst,
solvent, reagent and temperature), Palladium iminophosphorane catalyst
prepared and used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient hydrogenation of furfural to furfuryl alcohol in
metal-catalyzed and organo-catalyzed environments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsheku, Asanda C.; Maumela, Munaka Christopher; Makhubela, Banothile C.
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Sustainability (2023), 1(6), 1471-1483

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  3
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Phenylacrylic acid
C9H8O2
492-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 C 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cinnamic acid
C9H8O2
621-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(1E)-1-Buten-3-yne-1,4-diylbis[benzene]
C16H12
13343-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 6.9302 2.6673 0.0 0
M  V30 4 C 8.4702 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 10.7802 1.3337 0.0 0
M  V30 13 C 10.7802 4.0010 0.0 0
M  V30 14 C 12.3203 1.3337 0.0 0
M  V30 15 C 12.3203 4.0010 0.0 0
M  V30 16 C 13.0903 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 492-38-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 621-82-9
$DTYPE RXN:PRO(3):CAS_RN
$DATUM 13343-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30037650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 2240160-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, sealed Teflon-lined stainless-steel
autoclave used, conversion, 61%, selectivity, 80%, optimization study,
optimized on various reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrocarboxylation of alkynes with formic acid over multifunctional
ligand modified Pd-catalyst with co-catalytic effect
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Lei; Yao, Yin-Qing; Chen, Xiao-Chao; Guo, Lin; Lu, Yong; Zhao,
Xiao-Li; Liu, Ye
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2022), 405322-332

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
4-Piperidineethanaminium, N,N,N-trimethyl-1-(2-methyl-4-nitrobenzoyl)-, forma...
C18H28N3O3.CHO2
2755310-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.8501 0.0 0
M  V30 2 O 6.6687 2.3100 0.0 0
M  V30 3 C 4.0012 2.3100 0.0 0
M  V30 4 N 1.3338 6.9301 0.0 0 VAL=5
M  V30 5 O 1.3338 8.4702 0.0 0
M  V30 6 O 0.0000 6.1601 0.0 0
M  V30 7 C 12.0035 6.9301 0.0 0
M  V30 8 C 13.3372 6.1601 0.0 0
M  V30 9 N 14.6708 6.9301 0.0 0 CHG=1 VAL=4
M  V30 10 C 16.0046 7.7001 0.0 0
M  V30 11 C 13.9008 8.2638 0.0 0
M  V30 12 C 15.4408 5.5964 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 4.0012 6.9301 0.0 0
M  V30 18 C 2.6675 6.1601 0.0 0
M  V30 19 N 8.0023 4.6201 0.0 0
M  V30 20 C 8.0023 6.1601 0.0 0
M  V30 21 C 9.3360 3.8501 0.0 0
M  V30 22 C 9.3360 6.9301 0.0 0
M  V30 23 C 10.6698 4.6201 0.0 0
M  V30 24 C 10.6698 6.1601 0.0 0
M  V30 25 C 8.0023 0.0000 0.0 0
M  V30 26 O 6.6687 0.7700 0.0 0 CHG=-1
M  V30 27 O 9.3360 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 3 14
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidineethanaminium, 1-(4-amino-2-methylbenzoyl)-N,N,N-trimethyl-, forma...
C18H30N3O.C2H4O2.CHO2
2755310-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3353 11.3438 0.0 0
M  V30 2 C 6.0017 12.1138 0.0 0
M  V30 3 O 8.6690 12.1138 0.0 0
M  V30 4 O 7.3353 9.8038 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 O 5.3348 2.3100 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 N 0.0000 6.9301 0.0 0
M  V30 9 C 10.6697 6.9301 0.0 0
M  V30 10 C 12.0033 6.1601 0.0 0
M  V30 11 N 13.3370 6.9301 0.0 0 CHG=1 VAL=4
M  V30 12 C 14.6707 7.7001 0.0 0
M  V30 13 C 12.5670 8.2638 0.0 0
M  V30 14 C 14.1070 5.5964 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 4.0010 6.1601 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 2.6673 6.9301 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 N 6.6685 4.6201 0.0 0
M  V30 22 C 6.6685 6.1601 0.0 0
M  V30 23 C 8.0022 3.8501 0.0 0
M  V30 24 C 8.0022 6.9301 0.0 0
M  V30 25 C 9.3358 4.6201 0.0 0
M  V30 26 C 9.3358 6.1601 0.0 0
M  V30 27 C 7.3353 0.0000 0.0 0
M  V30 28 O 6.0017 0.7700 0.0 0 CHG=-1
M  V30 29 O 8.6690 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 5 6
M  V30 5 1 5 15
M  V30 6 1 5 21
M  V30 7 1 7 16
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 27 1 27 28
M  V30 28 2 27 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2755310-61-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2755310-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31669672
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel imidazopyrazine derivatives as antibiotics and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Zhanling; Kramer, Christian; Lerner, Christian; Liu, Yongqiang;
Nettekoven, Matthias; Pflieger, Philippe; Schmitt, Sebastien; Stoll,
Theodor; Wang, Jianhua; Wang, Yongguang; Yang, Song; Zhou, Chengang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021249896 A1 2021-12-16

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-[2-(1,1-dimethylethoxy)-3,4-dioxo-1-cyclobuten-1-yl]-N-(phenyl...
C24H28N4O6.CH2O2
1333228-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4702 7.6448 0.0 0
M  V30 2 C 9.2402 6.3110 0.0 0
M  V30 3 C 6.9302 7.6448 0.0 0
M  V30 4 C 6.1601 8.9785 0.0 0
M  V30 5 N 4.6201 8.9785 0.0 0
M  V30 6 O 6.9302 10.3122 0.0 0
M  V30 7 C 3.8501 10.3122 0.0 0 CFG=2
M  V30 8 C 4.6201 11.6459 0.0 0
M  V30 9 C 2.3101 10.3122 0.0 0
M  V30 10 O 1.5400 8.9785 0.0 0
M  V30 11 O 1.5400 11.6459 0.0 0
M  V30 12 C 0.0000 8.9785 0.0 0
M  V30 13 O 12.0615 8.6071 0.0 0
M  V30 14 C 13.3952 9.3771 0.0 0
M  V30 15 C 14.1652 8.0434 0.0 0
M  V30 16 C 14.7289 10.1471 0.0 0
M  V30 17 C 12.6252 10.7107 0.0 0
M  V30 18 O 7.5080 11.2361 0.0 0
M  V30 19 O 11.0992 12.1984 0.0 0
M  V30 20 C 9.2402 8.9785 0.0 0
M  V30 21 C 10.7277 9.3771 0.0 0
M  V30 22 C 8.8416 10.4660 0.0 0
M  V30 23 C 10.3292 10.8646 0.0 0
M  V30 24 C 8.4702 4.9774 0.0 0
M  V30 25 C 9.2402 3.6437 0.0 0
M  V30 26 C 6.9302 4.9774 0.0 0
M  V30 27 C 8.4702 2.3100 0.0 0
M  V30 28 C 6.1601 3.6437 0.0 0
M  V30 29 C 6.9302 2.3100 0.0 0
M  V30 30 C 3.8501 12.9797 0.0 0
M  V30 31 C 2.3185 13.1406 0.0 0
M  V30 32 N 4.4764 14.3865 0.0 0
M  V30 33 N 1.9983 14.6469 0.0 0
M  V30 34 C 3.3320 15.4169 0.0 0
M  V30 35 C 7.3644 0.0000 0.0 0
M  V30 36 O 6.0308 0.7700 0.0 0
M  V30 37 O 8.6981 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 8 30
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 21
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 18 22
M  V30 21 2 19 23
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 37 1 35 36
M  V30 38 2 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(2-hydroxy-3,4-dioxo-1-cyclobuten-1-yl)-N-(phenylmethyl)glycyl...
C20H20N4O6.C2HF3O2
1333227-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2999 9.7373 0.0 0
M  V30 2 C 10.8399 9.7373 0.0 0
M  V30 3 C 8.5299 11.0711 0.0 0
M  V30 4 C 6.9898 11.0711 0.0 0
M  V30 5 N 6.2198 12.4047 0.0 0
M  V30 6 O 6.2198 9.7373 0.0 0
M  V30 7 C 4.6798 12.4047 0.0 0 CFG=2
M  V30 8 C 3.9098 11.0711 0.0 0
M  V30 9 C 3.9098 13.7384 0.0 0
M  V30 10 O 4.6798 15.0720 0.0 0
M  V30 11 O 2.3698 13.7384 0.0 0
M  V30 12 C 3.9098 16.4059 0.0 0
M  V30 13 O 5.7087 8.7750 0.0 0
M  V30 14 O 10.2622 6.1461 0.0 0
M  V30 15 O 6.6709 5.1837 0.0 0
M  V30 16 C 8.5299 8.4036 0.0 0
M  V30 17 C 7.0424 8.0050 0.0 0
M  V30 18 C 8.9284 6.9161 0.0 0
M  V30 19 C 7.4409 6.5175 0.0 0
M  V30 20 C 11.6099 11.0711 0.0 0
M  V30 21 C 10.8399 12.4047 0.0 0
M  V30 22 C 13.1499 11.0711 0.0 0
M  V30 23 C 11.6099 13.7384 0.0 0
M  V30 24 C 13.9199 12.4047 0.0 0
M  V30 25 C 13.1499 13.7384 0.0 0
M  V30 26 C 2.3698 11.0711 0.0 0
M  V30 27 C 1.4646 12.3169 0.0 0
M  V30 28 N 1.4646 9.8250 0.0 0
M  V30 29 N 0.0000 11.8411 0.0 0
M  V30 30 C 0.0000 10.3011 0.0 0
M  V30 31 C 6.2931 2.3101 0.0 0
M  V30 32 C 7.6268 1.5400 0.0 0
M  V30 33 F 7.0632 3.6437 0.0 0
M  V30 34 F 4.9595 3.0801 0.0 0
M  V30 35 F 5.5231 0.9764 0.0 0
M  V30 36 O 8.9605 2.3101 0.0 0
M  V30 37 O 7.6268 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 26
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 2 13 17
M  V30 16 1 14 18
M  V30 17 2 15 19
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 33 1 31 32
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 1 31 35
M  V30 37 1 32 36
M  V30 38 2 32 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333228-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-69-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-9314154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-2-{2-[Benzyl-(2-hydroxy-3,4-dioxo-cyclobut-1-enyl)-amino]-acetylamino}-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (81).CF3COOH was obtained from (60) as followed: (60)
was dissolved in dichloromethane (2 mL) and cooled at 4°C in an ice/water
bath. After 15 minutes of stirring, trifluoroacetic acid (2 mL) was added
and the mixture was stirred at 4°C for 30 minutes then 10μL of distilled
water were added. The reaction mixture was concentrated under reduced
pressure and the crude product was precipitated in Et2O and filtrated.
(S)-2-{2-[Benzyl-(2-hydroxy-3,4-dioxo-cyclobut-1-enyl)-amino]-acetylamino}-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (81).CF3COOH (70 mg, 99%). Purity 100%. 1H NMR (DMSO) δ
ppm: 8.97 (d, J=1.5Hz, 1H), 8.57 (d, J=8.1Hz, 1H), 7.40-7.22 (m, 5H),
4.70-4.66 (m, 1H), 4.65 (d, J= 14.7Hz, 1H), 4.58 (d, J=14.7Hz, 1H), 4.00
(d, J= 16.5Hz, 1H), 3.95 (d, J=16.5Hz, 1H), 3.67 (s, 3H), 3.16 (dd, J=
5.1 and 15.0 Hz, 1H), 3.03 (dd, J=9.0 and 15.0 Hz, 1H). LC tR=3.02 min,
MS (ESI+): m/z=413 (M+H)+. IC50: 12.5 μM. pIC50: 4.9.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-[2-(1,1-dimethylethoxy)-3,4-dioxo-1-cyclobuten-1-yl]-N-(phenyl...
C24H28N4O6.CH2O2
1333228-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4702 7.6448 0.0 0
M  V30 2 C 9.2402 6.3110 0.0 0
M  V30 3 C 6.9302 7.6448 0.0 0
M  V30 4 C 6.1601 8.9785 0.0 0
M  V30 5 N 4.6201 8.9785 0.0 0
M  V30 6 O 6.9302 10.3122 0.0 0
M  V30 7 C 3.8501 10.3122 0.0 0 CFG=2
M  V30 8 C 4.6201 11.6459 0.0 0
M  V30 9 C 2.3101 10.3122 0.0 0
M  V30 10 O 1.5400 8.9785 0.0 0
M  V30 11 O 1.5400 11.6459 0.0 0
M  V30 12 C 0.0000 8.9785 0.0 0
M  V30 13 O 12.0615 8.6071 0.0 0
M  V30 14 C 13.3952 9.3771 0.0 0
M  V30 15 C 14.1652 8.0434 0.0 0
M  V30 16 C 14.7289 10.1471 0.0 0
M  V30 17 C 12.6252 10.7107 0.0 0
M  V30 18 O 7.5080 11.2361 0.0 0
M  V30 19 O 11.0992 12.1984 0.0 0
M  V30 20 C 9.2402 8.9785 0.0 0
M  V30 21 C 10.7277 9.3771 0.0 0
M  V30 22 C 8.8416 10.4660 0.0 0
M  V30 23 C 10.3292 10.8646 0.0 0
M  V30 24 C 8.4702 4.9774 0.0 0
M  V30 25 C 9.2402 3.6437 0.0 0
M  V30 26 C 6.9302 4.9774 0.0 0
M  V30 27 C 8.4702 2.3100 0.0 0
M  V30 28 C 6.1601 3.6437 0.0 0
M  V30 29 C 6.9302 2.3100 0.0 0
M  V30 30 C 3.8501 12.9797 0.0 0
M  V30 31 C 2.3185 13.1406 0.0 0
M  V30 32 N 4.4764 14.3865 0.0 0
M  V30 33 N 1.9983 14.6469 0.0 0
M  V30 34 C 3.3320 15.4169 0.0 0
M  V30 35 C 7.3644 0.0000 0.0 0
M  V30 36 O 6.0308 0.7700 0.0 0
M  V30 37 O 8.6981 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=3
M  V30 10 1 7 9
M  V30 11 1 8 30
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 21
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 18 22
M  V30 21 2 19 23
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 37 1 35 36
M  V30 38 2 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-(2-hydroxy-3,4-dioxo-1-cyclobuten-1-yl)-N-(phenylmethyl)glycyl...
C20H20N4O6.C2HF3O2
1333227-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2999 9.7373 0.0 0
M  V30 2 C 10.8399 9.7373 0.0 0
M  V30 3 C 8.5299 11.0711 0.0 0
M  V30 4 C 6.9898 11.0711 0.0 0
M  V30 5 N 6.2198 12.4047 0.0 0
M  V30 6 O 6.2198 9.7373 0.0 0
M  V30 7 C 4.6798 12.4047 0.0 0 CFG=2
M  V30 8 C 3.9098 11.0711 0.0 0
M  V30 9 C 3.9098 13.7384 0.0 0
M  V30 10 O 4.6798 15.0720 0.0 0
M  V30 11 O 2.3698 13.7384 0.0 0
M  V30 12 C 3.9098 16.4059 0.0 0
M  V30 13 O 5.7087 8.7750 0.0 0
M  V30 14 O 10.2622 6.1461 0.0 0
M  V30 15 O 6.6709 5.1837 0.0 0
M  V30 16 C 8.5299 8.4036 0.0 0
M  V30 17 C 7.0424 8.0050 0.0 0
M  V30 18 C 8.9284 6.9161 0.0 0
M  V30 19 C 7.4409 6.5175 0.0 0
M  V30 20 C 11.6099 11.0711 0.0 0
M  V30 21 C 10.8399 12.4047 0.0 0
M  V30 22 C 13.1499 11.0711 0.0 0
M  V30 23 C 11.6099 13.7384 0.0 0
M  V30 24 C 13.9199 12.4047 0.0 0
M  V30 25 C 13.1499 13.7384 0.0 0
M  V30 26 C 2.3698 11.0711 0.0 0
M  V30 27 C 1.4646 12.3169 0.0 0
M  V30 28 N 1.4646 9.8250 0.0 0
M  V30 29 N 0.0000 11.8411 0.0 0
M  V30 30 C 0.0000 10.3011 0.0 0
M  V30 31 C 6.2931 2.3101 0.0 0
M  V30 32 C 7.6268 1.5400 0.0 0
M  V30 33 F 7.0632 3.6437 0.0 0
M  V30 34 F 4.9595 3.0801 0.0 0
M  V30 35 F 5.5231 0.9764 0.0 0
M  V30 36 O 8.9605 2.3101 0.0 0
M  V30 37 O 7.6268 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 26
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 2 13 17
M  V30 16 1 14 18
M  V30 17 2 15 19
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 33 1 31 32
M  V30 34 1 31 33
M  V30 35 1 31 34
M  V30 36 1 31 35
M  V30 37 1 32 36
M  V30 38 2 32 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333228-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-69-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-6611708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-2-{2-[Benzyl-(2-hydroxy-3,4-dioxo-cyclobut-1-enyl)-amino]-acetylamino}-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (81)•CF3COOH was obtained from (60) as followed: (60)
was dissolved in dichloromethane (2 mL) and cooled at 4°C in an ice/water
bath. After 15 minutes of stirring, trifluoroacetic acid (2 mL) was added
and the mixture was stirred at 4°C for 30 minutes then 10μL of distilled
water were added. The reaction mixture was concentrated under reduced
pressure and the crude product was precipitated in Et2O and filtrated to
give (81). Yield 70 mg, 99%. Purity 100%; 1H NMR (DMSO) δ ppm: 8.97 (d, J
= 1.5Hz, 1H), 8.57 (d, J = 8.1Hz, 1H), 7.40-7.22 (m, 5H), 4.70-4.66 (m,
1H), 4.65 (d, J = 14.7Hz, 1H), 4.58 (d, J = 14.7Hz, 1H), 4.00 (d, J =
16.5Hz, 1H), 3.95 (dr J = 16.5Hz, 1H), 3.67 (s, 3H), 3.16 (ddr J = 5.1
and 15.0 Hz, 1H), 3.03 (dd, J = 9.0 and 15.0 Hz, 1H). LC tR=3.02 min, MS
(ESI+): m/z=413 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
tert-Butyl acrylate
C7H12O2
1663-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 0.5638 2.8737 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 2.1038 0.2064 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 O 4.0012 0.0000 0.0 0
M  V30 9 C 6.6687 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1...
C14H24BN3O2.CH2O2
2945858-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 3.2022 0.0 0
M  V30 2 C 0.1272 4.7337 0.0 0
M  V30 3 C 0.0000 5.9451 0.0 0
M  V30 4 C 1.0304 7.7300 0.0 0
M  V30 5 B 3.9437 5.7472 0.0 0
M  V30 6 O 3.1737 4.4135 0.0 0
M  V30 7 O 2.9131 6.8918 0.0 0
M  V30 8 C 1.6672 4.7337 0.0 0
M  V30 9 C 1.5063 6.2653 0.0 0
M  V30 10 C 5.4753 5.9082 0.0 0
M  V30 11 C 6.5057 4.7638 0.0 0
M  V30 12 C 6.2453 7.2420 0.0 0
M  V30 13 N 7.9127 5.3901 0.0 0
M  V30 14 N 7.7516 6.9216 0.0 0
M  V30 15 C 9.2464 4.6201 0.0 0
M  V30 16 C 10.5800 5.3901 0.0 0
M  V30 17 C 9.2464 3.0800 0.0 0
M  V30 18 C 11.9137 4.6201 0.0 0
M  V30 19 C 10.5800 2.3100 0.0 0
M  V30 20 N 11.9137 3.0800 0.0 0
M  V30 21 C 5.9569 0.0000 0.0 0
M  V30 22 O 4.6232 0.7700 0.0 0
M  V30 23 O 7.2905 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinepropanoic acid, 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl...
C21H36BN3O4
2949430-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 4.5279 0.0 0
M  V30 2 C 0.1274 2.9963 0.0 0
M  V30 3 C 0.0000 1.7849 0.0 0
M  V30 4 C 1.0304 0.0000 0.0 0
M  V30 5 C 13.2475 5.4200 0.0 0
M  V30 6 C 14.5812 4.6500 0.0 0
M  V30 7 C 15.9149 5.4200 0.0 0
M  V30 8 O 17.2487 4.6500 0.0 0
M  V30 9 O 15.9149 6.9600 0.0 0
M  V30 10 C 18.5824 5.4200 0.0 0
M  V30 11 C 19.3524 4.0863 0.0 0
M  V30 12 C 19.9160 6.1900 0.0 0
M  V30 13 C 17.8123 6.7537 0.0 0
M  V30 14 B 3.9437 1.9828 0.0 0
M  V30 15 O 3.1737 3.3165 0.0 0
M  V30 16 O 2.9133 0.8382 0.0 0
M  V30 17 C 1.6674 2.9963 0.0 0
M  V30 18 C 1.5063 1.4647 0.0 0
M  V30 19 C 5.4753 1.8219 0.0 0
M  V30 20 C 6.5059 2.9663 0.0 0
M  V30 21 C 6.2453 0.4880 0.0 0
M  V30 22 N 7.9127 2.3399 0.0 0
M  V30 23 N 7.7518 0.8084 0.0 0
M  V30 24 C 9.2464 3.1099 0.0 0
M  V30 25 C 9.2464 4.6500 0.0 0
M  V30 26 C 10.5800 2.3399 0.0 0
M  V30 27 C 10.5800 5.4200 0.0 0
M  V30 28 C 11.9139 3.1099 0.0 0
M  V30 29 N 11.9139 4.6500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 17
M  V30 3 1 3 18
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 29
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1663-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2945858-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2949430-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37405213
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional arylsulfonamide compounds for treating
necroptosis and/or inhibiting and/or degrading MLKL
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garnier, Jean-Marc Daniel; Gardner, Christopher; Lessene, Guillaume
Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023115150 A1 2023-06-29

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
4-Hydroxyphenylacetaldehyde
C8H8O2
7339-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (1R,6S)-8-azabicyclo[4.3.1]dec-10-yl acetate (1:1)
C11H19NO2.CH2O2
1235966-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.5986 4.8412 0.0 0
M  V30 2 C 6.3687 6.1749 0.0 0
M  V30 3 C 7.9087 6.1749 0.0 0
M  V30 4 O 5.5986 7.5086 0.0 0
M  V30 5 C 4.0586 4.8412 0.0 0 CFG=1
M  V30 6 C 2.4517 5.0302 0.0 0 CFG=1
M  V30 7 C 1.5055 4.5408 0.0 0 CFG=2
M  V30 8 C 2.7673 6.7181 0.0 0
M  V30 9 C 2.8201 3.7869 0.0 0
M  V30 10 C 0.9106 5.7665 0.0 0
M  V30 11 C 1.4626 3.0237 0.0 0
M  V30 12 C 2.1698 7.9493 0.0 0
M  V30 13 N 2.3864 2.3100 0.0 0
M  V30 14 C 1.2342 7.4642 0.0 0
M  V30 15 H 1.9183 3.5855 0.0 0
M  V30 16 H 0.0000 4.2170 0.0 0
M  V30 17 C 3.9543 0.0000 0.0 0
M  V30 18 O 2.6207 0.7700 0.0 0
M  V30 19 O 5.2880 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9 CFG=1
M  V30 9 1 6 15 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 16 CFG=1
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 5 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
8-Azabicyclo[4.3.1]decan-10-ol, 8-[(4-hydroxyphenyl)methyl]-, 10-acetate
C18H25NO3
1235966-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.5372 4.9981 0.0 0
M  V30 2 C 1.0310 4.6772 0.0 0
M  V30 3 C 0.0000 5.8211 0.0 0
M  V30 4 O 0.5558 3.2123 0.0 0
M  V30 5 C 7.3379 5.6402 0.0 0
M  V30 6 O 13.4980 5.6402 0.0 0
M  V30 7 C 3.5682 3.8541 0.0 0 CFG=1
M  V30 8 C 5.5005 2.1587 0.0 0 CFG=2
M  V30 9 C 4.5035 2.5338 0.0 0 CFG=1
M  V30 10 C 6.6563 3.1423 0.0 0
M  V30 11 C 4.9883 0.8961 0.0 0
M  V30 12 C 5.1805 3.6398 0.0 0
M  V30 13 C 3.0385 1.6383 0.0 0
M  V30 14 N 6.5679 4.3065 0.0 0
M  V30 15 C 3.5105 0.0000 0.0 0
M  V30 16 C 2.5239 0.3701 0.0 0
M  V30 17 C 8.8779 5.6402 0.0 0
M  V30 18 C 9.6479 4.3065 0.0 0
M  V30 19 C 9.6479 6.9738 0.0 0
M  V30 20 C 11.1880 4.3065 0.0 0
M  V30 21 C 11.1880 6.9738 0.0 0
M  V30 22 C 11.9580 5.6402 0.0 0
M  V30 23 H 6.7490 1.2570 0.0 0
M  V30 24 H 5.9339 3.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 14
M  V30 6 1 5 17
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 23 CFG=3
M  V30 13 1 9 12 CFG=3
M  V30 14 1 9 13
M  V30 15 1 9 24 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 14
M  V30 19 1 13 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7339-87-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1235966-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1235966-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-18215948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Evaluation of a New Family of Constrained
Azabicyclic Homocholine Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halliday, Jill I.; Chebib, Mary; McLeod, Malcolm D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2010), 63(5), 808-812

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Formic acid, compd. with 3-bromo-4-methoxybenzenemethanamine (1:1)
C8H10BrNO.CH2O2
2897745-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.9774 0.0 0
M  V30 2 N 7.7002 6.3110 0.0 0
M  V30 3 Br 2.3101 2.3100 0.0 0
M  V30 4 O 0.7700 4.9774 0.0 0
M  V30 5 C 0.0000 6.3110 0.0 0
M  V30 6 C 5.3901 4.9774 0.0 0
M  V30 7 C 4.6201 3.6437 0.0 0
M  V30 8 C 4.6201 6.3110 0.0 0
M  V30 9 C 3.0801 3.6437 0.0 0
M  V30 10 C 3.0801 6.3110 0.0 0
M  V30 11 C 2.3101 4.9774 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 13 O 2.5164 0.7700 0.0 0
M  V30 14 O 5.1838 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H20N2O4S
2897745-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 11.5500 5.3349 0.0 0 VAL=6
M  V30 2 O 11.5500 6.8749 0.0 0
M  V30 3 O 11.5500 3.7949 0.0 0
M  V30 4 N 5.3900 5.3349 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 O 5.3900 2.6674 0.0 0
M  V30 8 C 10.0100 5.3349 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3349 0.0 0
M  V30 14 N 13.0900 5.3349 0.0 0
M  V30 15 C 13.8600 6.6685 0.0 0
M  V30 16 C 13.8600 4.0011 0.0 0
M  V30 17 C 15.4000 6.6685 0.0 0
M  V30 18 C 15.4000 4.0011 0.0 0
M  V30 19 C 16.1700 5.3349 0.0 0
M  V30 20 C 2.3100 2.6674 0.0 0
M  V30 21 C 0.7700 2.6674 0.0 0
M  V30 22 C 3.0800 1.3338 0.0 0
M  V30 23 C 0.0000 1.3338 0.0 0
M  V30 24 C 2.3100 0.0000 0.0 0
M  V30 25 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 20
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Urea, N-[(3-bromo-4-methoxyphenyl)methyl]-N′-[4-(1-piperidinylsulfonyl)phenyl]-
C20H24BrN3O4S
2897745-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.3349 0.0 0 VAL=6
M  V30 2 O 4.6200 3.7949 0.0 0
M  V30 3 O 4.6200 6.8749 0.0 0
M  V30 4 N 10.7800 5.3349 0.0 0
M  V30 5 C 11.5500 4.0011 0.0 0
M  V30 6 N 13.0900 4.0011 0.0 0
M  V30 7 O 10.7800 2.6674 0.0 0
M  V30 8 C 13.8600 2.6674 0.0 0
M  V30 9 Br 18.4800 0.0000 0.0 0
M  V30 10 O 20.0200 2.6674 0.0 0
M  V30 11 C 20.7900 4.0011 0.0 0
M  V30 12 C 6.1600 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 N 3.0800 5.3349 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 6.6685 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 6.6685 0.0 0
M  V30 23 C 0.0000 5.3349 0.0 0
M  V30 24 C 15.4000 2.6674 0.0 0
M  V30 25 C 16.1700 1.3338 0.0 0
M  V30 26 C 16.1700 4.0011 0.0 0
M  V30 27 C 17.7100 1.3338 0.0 0
M  V30 28 C 17.7100 4.0011 0.0 0
M  V30 29 C 18.4800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 24
M  V30 11 1 9 27
M  V30 12 1 10 11
M  V30 13 1 10 29
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2897745-25-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2897745-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2897745-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35891957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of naphthalene disulfonic acid ENAMPT modulators treating
cancers, diabetes, cardiovascular, inflammatory and kidney diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Butterworth, Samuel; Garzon Sanz, Miguel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023007147 A1 2023-02-02

$RFMT $RIREG SCHEME117 STEP1
$RXN



  1  1
$MOL
Formic acid, compd. with 2,2,2-trifluoro-N-(1-methyl-5-phenyl-3-piperidinyl)a...
C14H17F3N2O.CH2O2
2079881-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 6.9301 0.0 0
M  V30 2 C 9.3360 6.1601 0.0 0
M  V30 3 C 10.6697 6.9301 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 F 9.8996 8.2638 0.0 0
M  V30 6 F 12.0033 7.7001 0.0 0
M  V30 7 F 11.4397 5.5964 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0012 6.1601 0.0 0
M  V30 10 C 5.3348 6.9301 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 6.6685 6.1601 0.0 0
M  V30 13 N 5.3348 3.8501 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 2.6673 6.9301 0.0 0
M  V30 16 C 2.6673 8.4702 0.0 0
M  V30 17 C 1.3337 6.1601 0.0 0
M  V30 18 C 1.3337 9.2402 0.0 0
M  V30 19 C 0.0000 6.9301 0.0 0
M  V30 20 C 0.0000 8.4702 0.0 0
M  V30 21 C 6.0017 0.0000 0.0 0
M  V30 22 O 4.6680 0.7700 0.0 0
M  V30 23 O 7.3353 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Piperidinamine, 1-methyl-5-phenyl-
C12H18N2
1782457-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0021 4.6200 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 C 5.3347 4.6200 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 6.6685 3.8500 0.0 0
M  V30 7 N 5.3347 1.5400 0.0 0
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2079881-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1782457-98-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-16793946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated
Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain
Chemical Probe
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Humphreys, Philip G.; Bamborough, Paul; Chung, Chun-wa; Craggs, Peter D.;
Gordon, Laurie; Grandi, Paola; Hayhow, Thomas G.; Hussain, Jameed; Jones,
Katherine L.; Lindon, Matthew; Michon, Anne-Marie; Renaux, Jessica F.;
Suckling, Colin J.; Tough, David F.; Prinjha, Rab K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(2), 695-709

$RFMT $RIREG SCHEME118 STEP1
$RXN



  1  1
$MOL
Formic acid, compd. with 1,1-dimethylethyl N-[2-[4-[3-(2,6-dioxo-3-piperidiny...
C25H33F2N5O4.CH2O2
2888604-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9645 2.4115 0.0 0
M  V30 2 C 9.2140 2.3100 0.0 0
M  V30 3 O 0.0000 5.9811 0.0 0
M  V30 4 F 10.6444 11.0281 0.0 0
M  V30 5 F 9.6545 9.3136 0.0 0
M  V30 6 C 15.1723 10.3510 0.0 0
M  V30 7 C 16.5059 9.5810 0.0 0
M  V30 8 N 17.8396 10.3510 0.0 0
M  V30 9 C 19.1733 9.5810 0.0 0
M  V30 10 O 20.5071 10.3510 0.0 0
M  V30 11 O 19.1733 8.0409 0.0 0
M  V30 12 C 21.8408 9.5810 0.0 0
M  V30 13 C 21.0707 8.2473 0.0 0
M  V30 14 C 23.1744 8.8110 0.0 0
M  V30 15 C 22.6108 10.9146 0.0 0
M  V30 16 C 6.0255 4.7005 0.0 0
M  V30 17 C 7.1699 5.7309 0.0 0
M  V30 18 N 6.6519 3.2935 0.0 0
M  V30 19 C 8.5036 4.9609 0.0 0
M  V30 20 C 7.1699 7.2709 0.0 0
M  V30 21 N 8.1834 3.4546 0.0 0
M  V30 22 C 9.8374 5.7309 0.0 0
M  V30 23 C 8.5036 8.0409 0.0 0
M  V30 24 C 9.8374 7.2709 0.0 0
M  V30 25 C 4.5191 5.0206 0.0 0
M  V30 26 C 3.4886 3.8761 0.0 0
M  V30 27 C 4.0432 6.4852 0.0 0
M  V30 28 N 1.9822 4.1962 0.0 0
M  V30 29 C 2.5369 6.8055 0.0 0
M  V30 30 C 1.5063 5.6610 0.0 0
M  V30 31 C 11.1711 8.0409 0.0 0
M  V30 32 C 11.1711 9.5810 0.0 0
M  V30 33 C 12.5048 7.2709 0.0 0
M  V30 34 C 12.5048 10.3510 0.0 0
M  V30 35 C 13.8384 8.0409 0.0 0
M  V30 36 N 13.8384 9.5810 0.0 0
M  V30 37 C 11.5872 0.0000 0.0 0
M  V30 38 O 10.2535 0.7700 0.0 0
M  V30 39 O 12.9209 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 26
M  V30 2 1 2 21
M  V30 3 2 3 30
M  V30 4 1 4 32
M  V30 5 1 5 32
M  V30 6 1 6 7
M  V30 7 1 6 36
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 25
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 27 1 24 31
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 40 1 37 38
M  V30 41 2 37 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 3-[6-[1-(2-aminoethyl)-3,3-difluoro-4-piperidinyl]-1...
C20H25F2N5O2.CH2O2
2888605-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2140 2.3100 0.0 0
M  V30 2 O 3.9646 2.4115 0.0 0
M  V30 3 O 0.0000 5.9811 0.0 0
M  V30 4 F 10.6443 11.0281 0.0 0
M  V30 5 F 9.6544 9.3136 0.0 0
M  V30 6 C 15.1722 10.3509 0.0 0
M  V30 7 C 16.5058 9.5809 0.0 0
M  V30 8 N 17.8396 10.3509 0.0 0
M  V30 9 C 7.1700 5.7309 0.0 0
M  V30 10 C 6.0255 4.7004 0.0 0
M  V30 11 C 8.5037 4.9609 0.0 0
M  V30 12 C 7.1700 7.2709 0.0 0
M  V30 13 N 6.6520 3.2935 0.0 0
M  V30 14 C 9.8374 5.7309 0.0 0
M  V30 15 N 8.1835 3.4546 0.0 0
M  V30 16 C 8.5037 8.0409 0.0 0
M  V30 17 C 9.8374 7.2709 0.0 0
M  V30 18 C 4.5192 5.0206 0.0 0
M  V30 19 C 3.4886 3.8761 0.0 0
M  V30 20 C 4.0433 6.4852 0.0 0
M  V30 21 N 1.9823 4.1962 0.0 0
M  V30 22 C 2.5369 6.8053 0.0 0
M  V30 23 C 1.5065 5.6610 0.0 0
M  V30 24 C 11.1710 8.0409 0.0 0
M  V30 25 C 11.1710 9.5809 0.0 0
M  V30 26 C 12.5048 7.2709 0.0 0
M  V30 27 C 12.5048 10.3509 0.0 0
M  V30 28 C 13.8385 8.0409 0.0 0
M  V30 29 N 13.8385 9.5809 0.0 0
M  V30 30 C 8.9198 0.0000 0.0 0
M  V30 31 O 7.5861 0.7700 0.0 0
M  V30 32 O 10.2535 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 2 2 19
M  V30 3 2 3 23
M  V30 4 1 4 25
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 29
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 18
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 1 17 24
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2888604-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2888605-00-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35576237
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Degrader compounds and application
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veits, Gesine Kerstin; Fitzgerald, Mark E.; Hird, Alexander W.; Sweis,
Ramzi F.; Kort, Michael E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022271727 A1 2022-12-29

$RFMT $RIREG SCHEME119 STEP1
$RXN



  1  1
$MOL
Formic acid, compd. with N-[2-[(3R,4S)-3-fluoro-4-methoxy-1-piperidinyl]-4-py...
C25H34FN7O3.xCH2O2
1817658-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3955 11.6292 0.0 0
M  V30 2 C 7.2509 12.6597 0.0 0
M  V30 3 C 9.8600 12.1052 0.0 0
M  V30 4 C 5.3347 10.2666 0.0 0
M  V30 5 O 4.0011 9.4966 0.0 0
M  V30 6 N 12.9557 7.6447 0.0 0
M  V30 7 F 20.6557 2.3100 0.0 0
M  V30 8 O 22.1957 4.9775 0.0 0
M  V30 9 C 22.9657 6.3111 0.0 0
M  V30 10 C 9.1057 8.9785 0.0 0
M  V30 11 N 8.0753 10.1229 0.0 0
M  V30 12 C 8.3357 7.6447 0.0 0
M  V30 13 C 10.6457 8.9785 0.0 0
M  V30 14 C 6.6684 9.4966 0.0 0
M  V30 15 N 6.8294 7.9649 0.0 0
M  V30 16 C 9.1057 6.3111 0.0 0
M  V30 17 C 11.4157 7.6447 0.0 0
M  V30 18 N 10.6457 6.3111 0.0 0
M  V30 19 C 13.7257 6.3111 0.0 0
M  V30 20 N 15.2657 6.3111 0.0 0
M  V30 21 C 12.9557 4.9775 0.0 0
M  V30 22 C 16.0357 4.9775 0.0 0
M  V30 23 C 13.7257 3.6438 0.0 0
M  V30 24 N 15.2657 3.6437 0.0 0
M  V30 25 C 2.6674 10.2666 0.0 0 CFG=3
M  V30 26 C 1.3336 9.4966 0.0 0
M  V30 27 O 2.6674 11.8066 0.0 0
M  V30 28 C 0.0000 10.2666 0.0 0
M  V30 29 C 1.3336 12.5766 0.0 0
M  V30 30 C 0.0000 11.8066 0.0 0
M  V30 31 N 17.5757 4.9775 0.0 0
M  V30 32 C 18.3457 3.6437 0.0 0
M  V30 33 C 18.3457 6.3111 0.0 0
M  V30 34 C 19.8857 3.6437 0.0 0 CFG=1
M  V30 35 C 19.8857 6.3111 0.0 0
M  V30 36 C 20.6557 4.9775 0.0 0 CFG=1
M  V30 37 C 11.4829 0.0000 0.0 0
M  V30 38 O 10.1492 0.7700 0.0 0
M  V30 39 O 12.8165 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 25
M  V30 7 1 6 17
M  V30 8 1 6 19
M  V30 9 1 34 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 36 8 CFG=3
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 15
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 22 31
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 2 37 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 34 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 6-[[2-[(3R,4S)-3-fluoro-4-methoxy-1-piperidinyl]-4-p...
C20H26FN7O2.xCH2O2
1817658-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3944 3.3406 0.0 0
M  V30 2 C 3.2500 2.3100 0.0 0
M  V30 3 C 5.8591 2.8646 0.0 0
M  V30 4 C 1.3338 4.7032 0.0 0
M  V30 5 O 0.0000 5.4732 0.0 0
M  V30 6 N 8.9548 7.3250 0.0 0
M  V30 7 F 16.6548 12.6597 0.0 0
M  V30 8 O 18.1948 9.9923 0.0 0
M  V30 9 C 18.9648 8.6587 0.0 0
M  V30 10 C 5.1048 5.9912 0.0 0
M  V30 11 C 4.3348 7.3250 0.0 0
M  V30 12 N 4.0742 4.8469 0.0 0
M  V30 13 C 6.6448 5.9912 0.0 0
M  V30 14 N 2.8284 7.0049 0.0 0
M  V30 15 C 5.1048 8.6587 0.0 0
M  V30 16 C 2.6674 5.4732 0.0 0
M  V30 17 C 7.4148 7.3250 0.0 0
M  V30 18 N 6.6448 8.6587 0.0 0
M  V30 19 C 9.7248 8.6587 0.0 0
M  V30 20 N 11.2648 8.6587 0.0 0
M  V30 21 C 8.9548 9.9923 0.0 0
M  V30 22 C 12.0348 9.9923 0.0 0
M  V30 23 C 9.7248 11.3259 0.0 0
M  V30 24 N 11.2648 11.3261 0.0 0
M  V30 25 N 13.5748 9.9923 0.0 0
M  V30 26 C 14.3448 11.3261 0.0 0
M  V30 27 C 14.3448 8.6587 0.0 0
M  V30 28 C 15.8848 11.3261 0.0 0 CFG=1
M  V30 29 C 15.8848 8.6587 0.0 0
M  V30 30 C 16.6548 9.9923 0.0 0 CFG=1
M  V30 31 C 9.4824 0.0000 0.0 0
M  V30 32 O 8.1487 0.7700 0.0 0
M  V30 33 O 10.8161 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 17
M  V30 7 1 6 19
M  V30 8 1 28 7 CFG=1
M  V30 9 1 8 9
M  V30 10 1 30 8 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 22 25
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 28 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1817658-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1817658-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-3212329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors:
A Lead Optimization Case Study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heald, Robert; Bowman, Krista K.; Bryan, Marian C.; Burdick, Daniel;
Chan, Bryan; Chan, Emily; Chen, Yuan; Clausen, Saundra;
Dominguez-Fernandez, Belen; Eigenbrot, Charles; Elliott, Richard; Hanan,
Emily J.; Jackson, Philip; Knight, Jamie; La, Hank; Lainchbury, Michael;
Malek, Shiva; Mann, Sam; Merchant, Mark; Mortara, Kyle; Purkey, Hans;
Schaefer, Gabriele; Schmidt, Stephen; Seward, Eileen; Sideris, Steve;
Shao, Lily; Wang, Shumei; Yeap, Kuen; Yen, Ivana; Yu, Christine; Heffron,
Timothy P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(22), 8877-8895

$RFMT $RIREG SCHEME120 STEP1
$RXN



  1  1
$MOL
Formic acid, compd. with N-[2-[trans-4-(hydroxymethyl)cyclohexyl]-5-(1-hydrox...
C23H28N4O3S.CH2O2
2654056-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 6.3111 0.0 0
M  V30 2 C 4.6201 7.6448 0.0 0
M  V30 3 O 5.3901 8.9786 0.0 0
M  V30 4 C 6.9301 3.6438 0.0 0
M  V30 5 C 5.5964 4.4138 0.0 0
M  V30 6 C 6.1601 2.3100 0.0 0
M  V30 7 O 8.2637 2.8738 0.0 0
M  V30 8 C 17.0123 11.2430 0.0 0
M  V30 9 O 18.3459 10.4730 0.0 0
M  V30 10 C 0.0000 10.3123 0.0 0
M  V30 11 C 9.2401 7.6448 0.0 0
M  V30 12 C 10.0101 6.3111 0.0 0
M  V30 13 S 10.2705 8.7893 0.0 0
M  V30 14 C 7.7001 7.6448 0.0 0
M  V30 15 N 11.5164 6.6313 0.0 0
M  V30 16 C 9.2401 4.9775 0.0 0
M  V30 17 C 11.6775 8.1630 0.0 0
M  V30 18 C 6.9301 6.3111 0.0 0
M  V30 19 C 7.7001 4.9775 0.0 0
M  V30 20 C 13.0111 8.9330 0.0 0 CFG=1
M  V30 21 C 14.3448 8.1630 0.0 0
M  V30 22 C 13.0111 10.4730 0.0 0
M  V30 23 C 15.6786 8.9330 0.0 0
M  V30 24 C 14.3448 11.2430 0.0 0
M  V30 25 C 15.6786 10.4730 0.0 0 CFG=1
M  V30 26 C 3.0800 7.6448 0.0 0
M  V30 27 N 2.3100 8.9786 0.0 0
M  V30 28 C 2.3100 6.3111 0.0 0
M  V30 29 C 0.7700 8.9786 0.0 0
M  V30 30 N 0.7700 6.3111 0.0 0
M  V30 31 C 0.0000 7.6448 0.0 0
M  V30 32 C 9.1730 0.0000 0.0 0
M  V30 33 O 7.8393 0.7700 0.0 0
M  V30 34 O 10.5066 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 19
M  V30 9 1 8 9
M  V30 10 1 25 8 CFG=3
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 1 20 17 CFG=1
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 20 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[2-(trans-4-Formylcyclohexyl)-5-(1-hydroxy-1-methylethyl)-6-benzothiazolyl]...
C23H26N4O3S
2654056-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 4.0011 0.0 0
M  V30 2 C 4.6201 5.3348 0.0 0
M  V30 3 O 5.3901 6.6686 0.0 0
M  V30 4 C 6.9301 1.3338 0.0 0
M  V30 5 C 5.5964 2.1038 0.0 0
M  V30 6 C 6.1601 0.0000 0.0 0
M  V30 7 O 8.2637 0.5638 0.0 0
M  V30 8 C 17.0123 8.9330 0.0 0
M  V30 9 O 18.3459 8.1630 0.0 0
M  V30 10 C 0.0000 8.0022 0.0 0
M  V30 11 C 9.2401 5.3348 0.0 0
M  V30 12 C 10.0101 4.0011 0.0 0
M  V30 13 S 10.2705 6.4793 0.0 0
M  V30 14 C 7.7001 5.3348 0.0 0
M  V30 15 N 11.5164 4.3213 0.0 0
M  V30 16 C 9.2401 2.6675 0.0 0
M  V30 17 C 11.6775 5.8530 0.0 0
M  V30 18 C 6.9301 4.0011 0.0 0
M  V30 19 C 7.7001 2.6675 0.0 0
M  V30 20 C 13.0111 6.6230 0.0 0 CFG=1
M  V30 21 C 14.3448 5.8530 0.0 0
M  V30 22 C 13.0111 8.1630 0.0 0
M  V30 23 C 15.6786 6.6230 0.0 0
M  V30 24 C 14.3448 8.9330 0.0 0
M  V30 25 C 15.6786 8.1630 0.0 0 CFG=1
M  V30 26 C 3.0800 5.3348 0.0 0
M  V30 27 N 2.3100 6.6686 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 29 C 0.7700 6.6686 0.0 0
M  V30 30 N 0.7700 4.0011 0.0 0
M  V30 31 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 19
M  V30 9 2 8 9
M  V30 10 1 25 8 CFG=3
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 19
M  V30 21 1 20 17 CFG=1
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 20 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2654056-80-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2654056-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24033143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 87413-09-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM dess-Martin oxidation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzothiazole derivatives as IRAK degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021127283 A2 2021-06-24

$RFMT $RIREG SCHEME121 STEP1
$RXN



  1  1
$MOL
8,11-Iminoazepino[1,2-b]isoquinoline-10-carboxylic acid, 5,7,8,9,10,11,11a,12...
C18H22N2O5.CH2O2
1030029-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1178 4.3107 0.0 0
M  V30 2 O 9.6579 4.3107 0.0 0
M  V30 3 O 6.2709 3.0819 0.0 0
M  V30 4 C 1.1769 6.6133 0.0 0
M  V30 5 O 0.0000 5.6202 0.0 0
M  V30 6 O 0.9051 8.1293 0.0 0
M  V30 7 C 1.9967 5.2288 0.0 0
M  V30 8 O 10.4279 5.6445 0.0 0
M  V30 9 C 11.9679 5.6445 0.0 0
M  V30 10 C 5.0378 6.9782 0.0 0 CFG=1
M  V30 11 N 5.8078 5.6445 0.0 0
M  V30 12 C 3.5989 7.0428 0.0 0 CFG=2
M  V30 13 C 5.8078 8.3118 0.0 0
M  V30 14 C 7.3478 5.6445 0.0 0 CFG=1
M  V30 15 C 5.2350 4.2215 0.0 0
M  V30 16 C 2.6256 6.0908 0.0 0 CFG=2
M  V30 17 N 4.2968 5.4417 0.0 0
M  V30 18 C 7.3478 8.3118 0.0 0
M  V30 19 C 8.1178 6.9782 0.0 0
M  V30 20 C 3.9263 3.8348 0.0 0 CFG=2
M  V30 21 C 2.7847 4.5651 0.0 0
M  V30 22 C 8.1178 9.6455 0.0 0
M  V30 23 C 9.6579 6.9782 0.0 0
M  V30 24 C 9.6579 9.6455 0.0 0
M  V30 25 C 10.4279 8.3118 0.0 0
M  V30 26 H 4.2979 8.3288 0.0 0
M  V30 27 H 3.0496 8.4815 0.0 0
M  V30 28 H 3.7101 2.3100 0.0 0
M  V30 29 C 5.9840 0.0000 0.0 0
M  V30 30 O 4.6503 0.7700 0.0 0
M  V30 31 O 7.3176 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 16 4 CFG=1
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 23
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 26 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17 CFG=1
M  V30 18 1 12 27
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 20 17 CFG=1
M  V30 24 1 18 19
M  V30 25 2 18 22
M  V30 26 2 19 23
M  V30 27 1 20 21
M  V30 28 1 20 28
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 25
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 12 14 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R,8S,10R,11R,11aS)-5,7,8,9,10,11,11a,12-Octahydro-5-(hydroxymethyl)-4-metho...
C18H22N2O5
1030029-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1178 2.0007 0.0 0
M  V30 2 O 9.6579 2.0007 0.0 0
M  V30 3 O 6.2709 0.7719 0.0 0
M  V30 4 C 1.1769 4.3033 0.0 0
M  V30 5 O 0.0000 3.3101 0.0 0
M  V30 6 O 0.9051 5.8193 0.0 0
M  V30 7 C 1.9967 2.9188 0.0 0
M  V30 8 O 10.4279 3.3345 0.0 0
M  V30 9 C 11.9679 3.3345 0.0 0
M  V30 10 C 5.0378 4.6682 0.0 0 CFG=1
M  V30 11 N 5.8078 3.3345 0.0 0
M  V30 12 C 3.5989 4.7328 0.0 0 CFG=2
M  V30 13 C 5.8078 6.0018 0.0 0
M  V30 14 C 7.3478 3.3345 0.0 0 CFG=1
M  V30 15 C 5.2350 1.9115 0.0 0
M  V30 16 C 2.6256 3.7808 0.0 0 CFG=2
M  V30 17 N 4.2968 3.1317 0.0 0
M  V30 18 C 7.3478 6.0018 0.0 0
M  V30 19 C 8.1178 4.6682 0.0 0
M  V30 20 C 3.9263 1.5248 0.0 0 CFG=2
M  V30 21 C 2.7847 2.2551 0.0 0
M  V30 22 C 8.1178 7.3355 0.0 0
M  V30 23 C 9.6579 4.6682 0.0 0
M  V30 24 C 9.6579 7.3355 0.0 0
M  V30 25 C 10.4279 6.0018 0.0 0
M  V30 26 H 4.2979 6.0188 0.0 0
M  V30 27 H 3.0496 6.1715 0.0 0
M  V30 28 H 3.7101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 16 4 CFG=1
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 23
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 26 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17 CFG=1
M  V30 18 1 12 27
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 20 17 CFG=1
M  V30 24 1 18 19
M  V30 25 2 18 22
M  V30 26 2 19 23
M  V30 27 1 20 21
M  V30 28 1 20 28
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 12 14 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1030029-43-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1030029-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-855306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of (-)-quinocarcinamide (4) hydrochloride (9.6 mg, 25.2
μmol) in 1 mL of methanol (MeOH), ammonia water (NH3.H2O, 5 M, 10 μL) was
added at 0 °C. After stirring at 0 °C for 5 min, the mixture was
concentrated under vacuum, and the residue was purified by flash
reverse-phase chromatography on C18 column (elution gradient 0% ( 50%
methanol in water) to give pure (-)-quinocarcinamide (4, 8.6 mg, 99%
yield) (-)-quinocarcinamide, yield 99% foam. 1H NMR (300 MHz, D2O) δ 7.33
(t, 1H, J = 7.8 Hz, ArH), 7.04 (d, 1H, J = 7.8 Hz, ArH), 6.94 (d, 1H, J =
7.8 Hz, ArH), 5.45 (t, 1H, J = 3.9 Hz, ArCHCH2OH), 3.93 (dd, 1H, J =
11.2, 4.5 Hz, ArCHCH2OH), 3.87 (s, 1H, ArOMe), 3.83-3.74 (m, 2H, ArCH2CH
& CHCHCO2H), 3.70 (dd, 1H, J = 11.2, 4.5 Hz, ArCHCH2OH), 3.58 (d, 1H, J =
6.6 Hz, CH2CHNMe), 3.22 (dd, 1H, J = 10.2, 6.9 Hz, CHCO2H), 3.06-3.00 (m,
1H, ArCH2CH), 2.82-2.74 (m, 1H, ArCH2CH), 2.59 (ddd, 1H, J = 13.6, 6.9,
6.9 Hz, CH2CHCO2H), 2.38 (s, 3H, NMe), 2.34 (ddd, 1H, J = 13.6, 9.9 Hz,
CH2CHCO2H). HRMS (TOF MS ES+) m/z : Calcd for C18H22N2O5Na [M+Na]+:
369.1426. Found: 369.1421.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Total Synthesis of (-)-Quinocarcin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Yan-Chao; Liron, Melanie; Zhu, Jieping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(22), 7148-7152

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenol
C6H5NO3
100-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-22062815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM decorated on covalent organic framework
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1491156-89-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, solid-supported catalyst, silver
nanoparticles-decorated covalent organic framework catalyst prepared and
used, reusable catalyst, sunlight irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of Ag/TFPG-DMB COF in carbamates synthesis via CO2 fixation
reaction and one-pot reductive N-formylation of nitroarenes under
sunlight
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hazra Chowdhury, Arpita; Hazra Chowdhury, Ipsita; Biswas, Surajit; Islam,
Sk. Manirul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Catalysis (2020), 493111050

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenol
C6H5NO3
100-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxyphenyl)formamide
C7H7NO2
1693-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-5696960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 154769-61-6
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM graphitic
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, solid-supported catalyst, graphitic carbon nitride used as
support, catalyst prepared and used, 40 W domestic bulb used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A photoactive bimetallic framework for direct aminoformylation of
nitroarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasir Baig, R. B.; Verma, Sanny; Nadagouda, Mallikarjuna N.; Varma,
Rajender S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(4), 1019-1022

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitroanisole
C7H7NO3
100-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-22062812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM decorated on covalent organic framework
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1491156-89-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, solid-supported catalyst, silver
nanoparticles-decorated covalent organic framework catalyst prepared and
used, reusable catalyst, sunlight irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of Ag/TFPG-DMB COF in carbamates synthesis via CO2 fixation
reaction and one-pot reductive N-formylation of nitroarenes under
sunlight
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hazra Chowdhury, Arpita; Hazra Chowdhury, Ipsita; Biswas, Surajit; Islam,
Sk. Manirul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Catalysis (2020), 493111050

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitroanisole
C7H7NO3
100-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34878300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-37-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical (white LED lamp (11 W) used),
solid-supported catalyst (Pd nanoparticles immobilizing on
alpha-Fe2O3-decorated melamine-based COFs catalyst used), screw-capped
tube used, recyclable catalyst, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-light-induced photocatalytic reductive carbonylation of
nitroarenes using formic acid as a hydrogen source over a
water-dispersible CTF-based palladium catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nejad, Masoumeh Jadidi; Shariatipour, Monire; Salamatmanesh, Arefe;
Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Science & Technology (2022), 12(24), 7481-7493

$RFMT $RIREG SCHEME124 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethylethylenediamine
C6H16N2
100-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 2.6673 0.0 0
M  V30 2 C 3.8501 2.6673 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 C 4.6201 4.0010 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.0000 4.0010 0.0 0
M  V30 8 N 6.1601 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Iodo-4-phenyl-1-(phenylmethyl)-1H-1,2,3-triazole
C15H12IN3
860002-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 7.0619 0.0000 0.0 0
M  V30 2 C 4.0011 1.3626 0.0 0
M  V30 3 C 7.7722 2.6508 0.0 0
M  V30 4 C 6.7418 1.5063 0.0 0
M  V30 5 N 7.0022 3.9845 0.0 0
M  V30 6 N 5.3348 2.1326 0.0 0
M  V30 7 N 5.4959 3.6643 0.0 0
M  V30 8 C 9.3037 2.4898 0.0 0
M  V30 9 C 10.2090 3.7356 0.0 0
M  V30 10 C 9.9302 1.0829 0.0 0
M  V30 11 C 11.7405 3.5747 0.0 0
M  V30 12 C 11.4618 0.9219 0.0 0
M  V30 13 C 12.3670 2.1679 0.0 0
M  V30 14 C 2.6675 2.1326 0.0 0
M  V30 15 C 2.6675 3.6726 0.0 0
M  V30 16 C 1.3338 1.3626 0.0 0
M  V30 17 C 1.3338 4.4427 0.0 0
M  V30 18 C 0.0000 2.1326 0.0 0
M  V30 19 C 0.0000 3.6726 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 6
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(Diethylamino)ethyl]-4-phenyl-1-(phenylmethyl)-1H-1,2,3-triazole-5-carbo...
C22H27N5O
2379722-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.8689 0.0 0
M  V30 2 N 5.3347 7.4089 0.0 0
M  V30 3 O 4.0011 5.0989 0.0 0
M  V30 4 C 4.0011 8.1789 0.0 0
M  V30 5 C 4.0011 9.7189 0.0 0
M  V30 6 N 2.6674 10.4889 0.0 0
M  V30 7 C 1.3336 9.7189 0.0 0
M  V30 8 C 2.6674 12.0289 0.0 0
M  V30 9 C 0.0000 10.4889 0.0 0
M  V30 10 C 4.0011 12.7989 0.0 0
M  V30 11 C 8.3955 7.2317 0.0 0
M  V30 12 C 6.6685 5.0989 0.0 0
M  V30 13 C 6.8294 3.5673 0.0 0
M  V30 14 N 8.0753 5.7253 0.0 0
M  V30 15 N 8.3357 3.2471 0.0 0
M  V30 16 N 9.1057 4.5809 0.0 0
M  V30 17 C 5.6849 2.5368 0.0 0
M  V30 18 C 4.2204 3.0127 0.0 0
M  V30 19 C 6.0051 1.0306 0.0 0
M  V30 20 C 3.0758 1.9823 0.0 0
M  V30 21 C 4.8607 0.0000 0.0 0
M  V30 22 C 3.3960 0.4760 0.0 0
M  V30 23 C 9.8602 7.7075 0.0 0
M  V30 24 C 10.1803 9.2138 0.0 0
M  V30 25 C 11.0045 6.6770 0.0 0
M  V30 26 C 11.6449 9.6897 0.0 0
M  V30 27 C 12.4692 7.1530 0.0 0
M  V30 28 C 12.7894 8.6593 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 11 14
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-36-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 860002-66-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2379722-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31245747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Aminocarbonylation Reaction to Access
1,2,3-Triazole-5-carboxamides Using Dimethyl Carbonate as Sustainable
Solvent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Albuquerque, Danilo Yano; de Moraes, Juliana R.; Schwab, Ricardo S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(39), 6673-6681

$RFMT $RIREG SCHEME125 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Iodo-4-phenyl-1H-1,2,3-triazol-1-yl)methyl]pyridine
C14H11IN4
1390650-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 7.0619 0.0000 0.0 0
M  V30 2 C 4.0011 1.3626 0.0 0
M  V30 3 C 7.7722 2.6508 0.0 0
M  V30 4 C 6.7418 1.5063 0.0 0
M  V30 5 N 7.0022 3.9845 0.0 0
M  V30 6 N 5.3348 2.1326 0.0 0
M  V30 7 N 5.4959 3.6643 0.0 0
M  V30 8 C 9.3037 2.4898 0.0 0
M  V30 9 C 10.2090 3.7356 0.0 0
M  V30 10 C 9.9302 1.0829 0.0 0
M  V30 11 C 11.7405 3.5747 0.0 0
M  V30 12 C 11.4618 0.9219 0.0 0
M  V30 13 C 12.3670 2.1679 0.0 0
M  V30 14 C 2.6675 2.1326 0.0 0
M  V30 15 C 2.6675 3.6726 0.0 0
M  V30 16 N 1.3338 1.3626 0.0 0
M  V30 17 C 1.3338 4.4427 0.0 0
M  V30 18 C 0.0000 2.1326 0.0 0
M  V30 19 C 0.0000 3.6726 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 6
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Phenyl-N-(phenylmethyl)-1-(2-pyridinylmethyl)-1H-1,2,3-triazole-5-carboxamide
C22H19N5O
2379722-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 7.4548 0.0 0
M  V30 2 N 5.3901 7.4548 0.0 0
M  V30 3 O 7.7002 8.7885 0.0 0
M  V30 4 C 4.6201 8.7885 0.0 0
M  V30 5 C 5.5675 4.3940 0.0 0
M  V30 6 C 7.7002 6.1212 0.0 0
M  V30 7 C 9.2319 5.9601 0.0 0
M  V30 8 N 7.0738 4.7142 0.0 0
M  V30 9 N 9.5521 4.4538 0.0 0
M  V30 10 N 8.2182 3.6838 0.0 0
M  V30 11 C 10.2623 7.1046 0.0 0
M  V30 12 C 11.7686 6.7845 0.0 0
M  V30 13 C 9.7865 8.5692 0.0 0
M  V30 14 C 12.7992 7.9289 0.0 0
M  V30 15 C 10.8169 9.7138 0.0 0
M  V30 16 C 12.3232 9.3936 0.0 0
M  V30 17 C 5.0915 2.9295 0.0 0
M  V30 18 C 3.5852 2.6091 0.0 0
M  V30 19 N 6.1221 1.7849 0.0 0
M  V30 20 C 3.1093 1.1446 0.0 0
M  V30 21 C 5.6461 0.3203 0.0 0
M  V30 22 C 4.1398 0.0000 0.0 0
M  V30 23 C 3.0801 8.7885 0.0 0
M  V30 24 C 2.3101 7.4548 0.0 0
M  V30 25 C 2.3101 10.1223 0.0 0
M  V30 26 C 0.7700 7.4548 0.0 0
M  V30 27 C 0.7700 10.1223 0.0 0
M  V30 28 C 0.0000 8.7885 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 23
M  V30 6 1 5 8
M  V30 7 1 5 17
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 11
M  V30 12 1 8 10
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1390650-59-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2379722-41-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31245759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Aminocarbonylation Reaction to Access
1,2,3-Triazole-5-carboxamides Using Dimethyl Carbonate as Sustainable
Solvent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Albuquerque, Danilo Yano; de Moraes, Juliana R.; Schwab, Ricardo S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(39), 6673-6681

$RFMT $RIREG SCHEME126 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylamine
C7H9N
100-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Iodo-1-(phenylmethyl)-1H-1,2,3-triazole
C9H8IN3
1654724-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3320 3.7710 0.0 0
M  V30 2 I 0.0000 3.4208 0.0 0
M  V30 3 N 2.5620 2.4374 0.0 0
M  V30 4 C 1.0304 2.2764 0.0 0
M  V30 5 N 3.1884 1.0306 0.0 0
M  V30 6 C 0.7103 0.7700 0.0 0
M  V30 7 N 2.0439 0.0000 0.0 0
M  V30 8 C 4.8720 3.7710 0.0 0
M  V30 9 C 5.6420 5.1048 0.0 0
M  V30 10 C 5.6420 2.4374 0.0 0
M  V30 11 C 7.1820 5.1048 0.0 0
M  V30 12 C 7.1820 2.4374 0.0 0
M  V30 13 C 7.9520 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 8
M  V30 3 1 2 4
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Bis(phenylmethyl)-1H-1,2,3-triazole-5-carboxamide
C17H16N4O
485400-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5190 3.4208 0.0 0
M  V30 2 C 7.8509 3.7710 0.0 0
M  V30 3 N 9.3909 3.7710 0.0 0
M  V30 4 O 7.0809 5.1048 0.0 0
M  V30 5 C 10.1609 5.1048 0.0 0
M  V30 6 N 5.5494 2.2764 0.0 0
M  V30 7 C 7.0809 2.4374 0.0 0
M  V30 8 N 5.2292 0.7700 0.0 0
M  V30 9 C 7.7074 1.0306 0.0 0
M  V30 10 N 6.5629 0.0000 0.0 0
M  V30 11 C 3.0125 3.1006 0.0 0
M  V30 12 C 1.9821 4.2450 0.0 0
M  V30 13 C 2.5367 1.6359 0.0 0
M  V30 14 C 0.4759 3.9248 0.0 0
M  V30 15 C 1.0304 1.3158 0.0 0
M  V30 16 C 0.0000 2.4603 0.0 0
M  V30 17 C 11.7009 5.1048 0.0 0
M  V30 18 C 12.4709 6.4384 0.0 0
M  V30 19 C 12.4709 3.7710 0.0 0
M  V30 20 C 14.0109 6.4384 0.0 0
M  V30 21 C 14.0109 3.7710 0.0 0
M  V30 22 C 14.7809 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 7
M  V30 6 1 3 5
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-46-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1654724-21-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 485400-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31245761
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Aminocarbonylation Reaction to Access
1,2,3-Triazole-5-carboxamides Using Dimethyl Carbonate as Sustainable
Solvent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Albuquerque, Danilo Yano; de Moraes, Juliana R.; Schwab, Ricardo S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(39), 6673-6681

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenylhydroxylamine
C6H7NO
100-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Hydroxy-N-phenylformamide
C7H7NO2
31335-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 O 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31335-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-787560
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
C,C′-Bis(1,1-dimethylethyl) N,N′-[3-bromo-5-[2-[4-(2-nitrophenyl)-1-piperazin...
C28H38BrN5O6
1019198-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9536 5.3347 0.0 0
M  V30 2 C 6.7236 4.0009 0.0 0
M  V30 3 O 5.9536 2.6673 0.0 0
M  V30 4 O 8.2636 4.0009 0.0 0
M  V30 5 C 6.7236 1.3336 0.0 0
M  V30 6 C 5.3900 0.5636 0.0 0
M  V30 7 C 7.4936 0.0000 0.0 0
M  V30 8 C 8.0573 2.1036 0.0 0
M  V30 9 N 4.4136 8.0020 0.0 0
M  V30 10 C 3.6436 9.3356 0.0 0
M  V30 11 O 2.1036 9.3356 0.0 0
M  V30 12 O 4.4136 10.6694 0.0 0
M  V30 13 C 1.3336 10.6694 0.0 0
M  V30 14 C 2.6673 11.4394 0.0 0
M  V30 15 C 0.5636 12.0031 0.0 0
M  V30 16 C 0.0000 9.8994 0.0 0
M  V30 17 Br 5.9536 10.6694 0.0 0
M  V30 18 C 10.5736 8.0020 0.0 0
M  V30 19 C 11.3436 9.3358 0.0 0
M  V30 20 N 17.5036 12.0031 0.0 0 VAL=5
M  V30 21 O 15.9636 12.0031 0.0 0
M  V30 22 O 18.2736 13.3367 0.0 0
M  V30 23 C 6.7236 6.6684 0.0 0
M  V30 24 C 5.9536 8.0020 0.0 0
M  V30 25 C 8.2636 6.6684 0.0 0
M  V30 26 C 6.7236 9.3356 0.0 0
M  V30 27 C 9.0336 8.0020 0.0 0
M  V30 28 C 8.2636 9.3358 0.0 0
M  V30 29 N 12.8836 9.3358 0.0 0
M  V30 30 C 13.6536 8.0020 0.0 0
M  V30 31 C 13.6536 10.6694 0.0 0
M  V30 32 C 15.1936 8.0020 0.0 0
M  V30 33 C 15.1936 10.6694 0.0 0
M  V30 34 N 15.9636 9.3358 0.0 0
M  V30 35 C 17.5036 9.3358 0.0 0
M  V30 36 C 18.2736 10.6694 0.0 0
M  V30 37 C 18.2736 8.0020 0.0 0
M  V30 38 C 19.8136 10.6694 0.0 0
M  V30 39 C 19.8136 8.0020 0.0 0
M  V30 40 C 20.5836 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 26
M  V30 18 1 18 19
M  V30 19 1 18 27
M  V30 20 1 19 29
M  V30 21 2 20 21
M  V30 22 2 20 22
M  V30 23 1 20 36
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 34
M  V30 36 1 34 35
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-5-[2-[4-(2-nitrophenyl)-1-piperazinyl]ethyl]-1H-benzimidazole
C19H20BrN5O2
1019199-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 2 O 4.6200 1.3336 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 C 9.2400 4.0009 0.0 0
M  V30 5 C 10.0100 5.3347 0.0 0
M  V30 6 Br 14.6300 2.6673 0.0 0
M  V30 7 C 3.0800 4.0009 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0009 0.0 0
M  V30 13 N 4.6200 4.0009 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 5.3900 2.6673 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 6.9300 2.6673 0.0 0
M  V30 18 N 7.7000 4.0009 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 12.3200 6.6684 0.0 0
M  V30 21 C 12.3200 4.0009 0.0 0
M  V30 22 C 13.8600 6.6684 0.0 0
M  V30 23 C 13.8600 4.0009 0.0 0
M  V30 24 C 14.6300 5.3347 0.0 0
M  V30 25 N 14.8904 7.8127 0.0 0
M  V30 26 N 16.1363 5.6549 0.0 0
M  V30 27 C 16.2972 7.1864 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 19
M  V30 7 1 6 23
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 13
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 2 23 24
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1019198-96-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1019199-01-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26577570
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and pharmacological evaluation of several
N-(2-nitrophenyl)piperazine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andric, Deana; Tovilovic, Gordana; Roglic, Goran; Vaskovic, Durdica;
Soskic, Vukic; Tomic, Mirko; Kostic-Rajacic, Sladana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Serbian Chemical Society (2007), 72(5), 429-435

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-1,2-phenylenediamine
C7H10N2O
102-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxybenzimidazole
C8H8N2O
4887-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 102-51-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4887-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11583806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Synthesis of
Benzimidazole To a mixture of 98% aqueous formic acid (2 mmol, 0.07mL)
and NAP-ZnO (2 mol%, 0.0016 g) was added an o-phenylenediamine (1 mmol,
0.108 g). The reaction mixture was heated in an oil bath at 70°C with
continuous stirring. The progress of the reaction was monitored by TLC.
After completion of the reaction, EtOAc was added to the cooled reaction
mixture and then filtered to remove the NAP-ZnO. The organic solvent was
washed with H2O (2×10 mL) and a saturated solution of NaHCO3 and dried
over anhydrous Na2SO4. After removal of the solvent, the pure product was
obtained. This was further purified by recrystallization with EtOH. The
structures of the products was confirmed by spectral data. The product
were identified by comparison of its physical and spectral data (mp, 1H
NMR, and 13C NMR) with those reported in the literature.
5-Methoxy-1H-benzimidazole (Entry 3). 1H NMR (400 MHz, CDCl3): δ 11.20
(br, NH), 8.04 (s, 1H), 7.56 (d, 1H), 7.09 (s, 1H), 6.93 (dd, 1H), 3.81
(s, 3H); 13C NMR (400 MHz, CDCl3) 156.6 (C), 140.6 (CH), 137.7 (C), 133
(C), 116.5 (C), 112.7 (CH), 97.6 (C), 55.8 (OCH3).
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, reusable catalyst, catalyst prepared and used,
catalyst prepared from Zn(OAc)2,oxalic acid, milled and calcined,
selective reaction, no solvent, zinc oxide nanoparticles used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Benzimidazole Derivatives Using Heterogeneous ZnO
Nanoparticles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alinezhad, Heshmatollah; Salehian, Fatemeh; Biparva, Pourya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2012), 42(1), 102-108

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-L-Methionine methyl ester
C6H13NO2S
10332-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0 CFG=1
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 N 4.0012 3.8501 0.0 0
M  V30 5 O 1.3337 2.3101 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 S 8.0023 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-methionine methyl ester
C7H13NO3S
28381-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0 CFG=1
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 N 4.6200 2.6674 0.0 0
M  V30 5 O 1.5400 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 6.1600 5.3347 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 S 6.9300 6.6685 0.0 0
M  V30 11 O 4.6200 0.0000 0.0 0
M  V30 12 C 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10332-17-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28381-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5394109
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Dicyclohexylcarbodiimide (DCC) (6.5 mmol, 1.34
g) was dissolved in dichloromethane (DCM) (20 mL), and the mixture was
cooled to 0 °C. To this solution, 98% formic acid (6.5 mmol, 0.25 mL) was
added, and the mixture was allowed to stir for 10 min, over the course of
which a white precipitate formed. The amino acid methyl ester
hydrochloride (5 mmol, 0.908 g) and dimethylaminopyridine (DMAP) (1.0
mmol, 123 mg) were added directly to the solution of the O-formylisourea.
Five microliters of DCM was used to rinse residual reagent from the neck
of the flask into the reaction. Finally, N-methylmorpholine (NMM) (8
mmol, 0.88 mL) was added, and the reaction was allowed to stir for 16 h.
Upon completion, the reaction was concentrated in vacuo to near dryness
and then suspended with cold ethyl acetate and filtered through a short
silica gel column (0.5 in. × 1 in.). The filtrate was concentrated in
vacuo, and the residue was applied directly to a silica gel column (5 in.
× 2 in. column). The N-formylamino acid methyl ester product was eluted
using an ethyl acetate/hexanes mobile phase. Often times, the product was
contaminoted with dicyclohexylurea (DCU) after flash chromatog-raphy. To
remove this impurity, the concentrated residue was dissolved in ethyl
acetate (0.5-1 mL) and stored at -20 °C overnight, during which time the
contaminoting DCU precipitated. The precipitate was filtered and washed
with -20 °C ethyl acetate. The filtrate was concentrated Yielding a
colorless oil. (S)-N-Formylmethionine Methyl Ester. Yield: 939 mg (98%).
1H NMR (400 MHz, CDCl3) δ 8.25 (1 H, s), 6.35 (1 H d, J= 5.3 Hz), 4.82 (1
H, td, J= 7.85.3 Hz), 3.79 (1 H, s), 2.53 (2 H, t, J= 7.10 Hz), 2.21 (1
H, m), 2.10 (1 H, s), 2.04 (1 H, m); 13C NMR (100 MHz, CDCl3) δ 172.0,
160.7, 52.8, 50.2, 31.6, 29.8, 15.5; HRMS (FAB) calcd for [C7H13NO3S +
Na]+ 214.0514, found 214.0508.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigation of the Configurational Stabilities of Chiral
Isocyanoacetates in Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carney, Daniel W.; Truong, Jonathan V.; Sello, Jason K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(24), 10279-10285

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitroaniline
C6H5BrN2O2
10403-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromo-5-nitrophenyl)formamide
C7H5BrN2O3
98556-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10403-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98556-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8036148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM benzothiazole-5-sulfonyl chloride Step 1: A solution of
2-bromo-5-nitroaniline (5.27 g, 24.3 mmol) in 98% formic acid (30 ml) was
heated to reflux for 90 min under nitrogen. The cooled reaction mixture
was then poured into cold water (600 ml) which afforded a yellow
precipitate. The solid was isolated by filtration and the cake washed
with cold water (2×200 ml). Subsequent drying overnight under vacuum
overnight afforded N-formyl-2-bromo-5-nitroaniline (5.84 g, 98%) as a
yellow solid. 1H NMR (DMSO-d6) δ 10.14 (br s, 1H), 9.01 (d, J=2.4 Hz,
1H), 8.46 (s, 1H), 7.98 (d, J=8.8 Hz, 1H), 7.91 (dd, J=8.8, 2.S Hz, 1H);
13C NMR (DMSO-d6) δ 161.2, 146.9, 136.6, 134.0, 120.6, 119.8, 116.7.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of erythromycin macrolide antibiotics and their use as
antibacterial and antiprotozoal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chupak, Louis S.; Flanagan, Mark E.; Kaneko, Takushi; Magee, Thomas V.;
Noe, Mark C.; Reilly, Usa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060135447 A1 2006-06-22

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitroaniline
C6H5BrN2O2
10403-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromo-5-nitrophenyl)formamide
C7H5BrN2O3
98556-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10403-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98556-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18894254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds for treatment of trypanosomes and
neurological pathogens and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tidwell, Richard Ray; Patrick, Donald Alan; Buckner, Frederick S.; Gelb,
Michael H.; Gillespie, John R.; Silva, Daniel Gedder
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017127627 A1 2017-07-27

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzylethanolamine
C9H13NO
104-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyethyl)-N-(phenylmethyl)formamide
C10H13NO2
99075-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 7.7000 4.0011 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 O 9.2400 4.0011 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99075-41-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14782120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-lysine
C21H24N2O4
105047-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4219 9.0810 0.0 0
M  V30 13 C 13.7556 9.8510 0.0 0
M  V30 14 N 15.0893 9.0810 0.0 0
M  V30 15 C 4.4196 4.4609 0.0 0
M  V30 16 C 3.0128 5.0873 0.0 0
M  V30 17 C 4.2587 2.9293 0.0 0
M  V30 18 C 1.9822 3.9428 0.0 0
M  V30 19 C 2.5369 6.5519 0.0 0
M  V30 20 C 2.7522 2.6091 0.0 0
M  V30 21 C 5.2891 1.7849 0.0 0
M  V30 22 C 0.4759 4.2630 0.0 0
M  V30 23 C 1.0304 6.8721 0.0 0
M  V30 24 C 2.2763 1.1444 0.0 0
M  V30 25 C 4.8132 0.3202 0.0 0
M  V30 26 C 0.0000 5.7277 0.0 0
M  V30 27 C 3.3069 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 20
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 25 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-formyl-L-lysine
C22H24N2O5
201004-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0869 7.5409 0.0 0
M  V30 4 N 7.0869 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 C 11.0881 9.8510 0.0 0
M  V30 10 O 7.0869 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4218 9.0810 0.0 0
M  V30 13 C 13.7556 9.8510 0.0 0
M  V30 14 N 15.0893 9.0810 0.0 0
M  V30 15 C 16.4229 9.8510 0.0 0
M  V30 16 O 17.7566 9.0810 0.0 0
M  V30 17 C 4.4196 4.4609 0.0 0
M  V30 18 C 3.0126 5.0873 0.0 0
M  V30 19 C 4.2587 2.9293 0.0 0
M  V30 20 C 1.9822 3.9428 0.0 0
M  V30 21 C 2.5367 6.5519 0.0 0
M  V30 22 C 2.7522 2.6091 0.0 0
M  V30 23 C 5.2891 1.7849 0.0 0
M  V30 24 C 0.4759 4.2630 0.0 0
M  V30 25 C 1.0304 6.8721 0.0 0
M  V30 26 C 2.2763 1.1444 0.0 0
M  V30 27 C 4.8132 0.3202 0.0 0
M  V30 28 C 0.0000 5.7277 0.0 0
M  V30 29 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 22
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 28
M  V30 30 1 26 29
M  V30 31 2 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105047-45-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 201004-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10342731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of Fmoc-Formyl Lysine. Formic acid (534 μL, 14 mmol) was added
dropwise to acetic anhydride (1.086 mL, 11.4 mmol) at 0 °C, followed by
gentle heating (60 °C, 2 h).25 The resulting mixture was cooled to 0 °C
in an ice bath. Fmoc-Lys (0.384 g; 1.0 mmol) was taken up into 5 mL of
THF and added dropwise to the mixed anhydride solution. The resulting
solution was allowed to stir overnight at room temperature. After removal
of the solvent in Vacuo, the solution was taken up into ethyl acetate (25
mL) and washed with water (25 mL) and brine (25 mL). The organic layer
was dried with sodium sulfate and the solvent removed in vacuo to give
Fmoc-Formyl Lysine as a clear oil, yield 0.390 g, 0.98 mmol, 98%. ESI-MS:
calculated ) 396.169; actual ) 396.2 NMR (600 MHz, CDCl3): 8.08 (s, 1H),
7.74 (d, 1H), 7.58 (d, 2H), 7.38 (dd, 2H), 7.28 (dd, 2H), 6.07 (s,1H);
5.71 (s, 1H); 4.38 (m, 2H); 4.19 (m, 1H), 3.26 (m, 2H); 1.25-1.9 (m, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Effects of Lysine Acetylation in a β-Hairpin Peptide: Comparison of an
Amide-π and a Cation-π Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hughes, Robert M.; Waters, Marcey L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(41), 13586-13591

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-pyridinemethanamine
C6H6Cl2N2
1060815-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6686 3.8500 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4,6-Dichloro-2-pyridinyl)methyl]formamide
C7H6Cl2N2O
2064217-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6684 3.8500 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 O 9.3359 3.8500 0.0 0
M  V30 5 Cl 0.0000 4.6201 0.0 0
M  V30 6 Cl 2.6675 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3337 3.8500 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1060815-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2064217-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17031440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridine derivatives for use as TDO and/or IDO
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cowley, Phillip M.; Wise, Alan; Brown, Thomas J.; McGowan, Meredeth A.;
Zhou, Hua; Han, Yongxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017007700 A1 2017-01-12

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′-[(2,2-Dimethyl-1,3-dioxo-1,3-propanediyl)diimino]bis[ethyl 2-deoxy-4,6-O...
C35H46N2O10S2
1062080-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.0350 13.5434 0.0 0
M  V30 2 N 10.3675 12.0033 0.0 0
M  V30 3 C 9.0338 11.2333 0.0 0
M  V30 4 C 7.7002 12.0033 0.0 0
M  V30 5 O 9.0338 9.6933 0.0 0
M  V30 6 C 6.9302 10.6697 0.0 0
M  V30 7 C 6.3663 12.7733 0.0 0
M  V30 8 C 8.4702 13.3370 0.0 0
M  V30 9 N 5.3901 10.6697 0.0 0
M  V30 10 O 7.7002 9.3360 0.0 0
M  V30 11 S 10.3675 8.9233 0.0 0
M  V30 12 C 10.3675 7.3832 0.0 0
M  V30 13 C 11.7012 6.6132 0.0 0
M  V30 14 S 2.3101 10.6697 0.0 0
M  V30 15 C 0.7700 10.6697 0.0 0
M  V30 16 C 0.0000 12.0033 0.0 0
M  V30 17 O 6.9302 8.0022 0.0 0
M  V30 18 C 14.3687 11.2333 0.0 0 CFG=1
M  V30 19 C 14.3687 9.6933 0.0 0 CFG=1
M  V30 20 C 13.0350 12.0033 0.0 0 CFG=2
M  V30 21 O 15.7023 12.0033 0.0 0
M  V30 22 O 13.0350 8.9233 0.0 0
M  V30 23 C 15.7023 8.9233 0.0 0
M  V30 24 C 11.7013 11.2333 0.0 0 CFG=1
M  V30 25 C 17.0362 11.2333 0.0 0 CFG=2
M  V30 26 C 11.7013 9.6933 0.0 0 CFG=1
M  V30 27 O 17.0362 9.6933 0.0 0
M  V30 28 C 18.3698 12.0033 0.0 0
M  V30 29 C 18.3698 13.5434 0.0 0
M  V30 30 C 19.7035 11.2333 0.0 0
M  V30 31 C 19.7035 14.3134 0.0 0
M  V30 32 C 21.0372 12.0033 0.0 0
M  V30 33 C 21.0372 13.5434 0.0 0
M  V30 34 C 4.6201 9.3360 0.0 0 CFG=2
M  V30 35 C 3.0801 9.3360 0.0 0 CFG=2
M  V30 36 C 5.3901 8.0022 0.0 0 CFG=1
M  V30 37 O 2.3101 8.0022 0.0 0
M  V30 38 C 4.6201 6.6685 0.0 0 CFG=2
M  V30 39 C 3.0801 6.6685 0.0 0 CFG=2
M  V30 40 O 5.3901 5.3348 0.0 0
M  V30 41 C 2.3101 5.3348 0.0 0
M  V30 42 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 43 O 3.0801 4.0012 0.0 0
M  V30 44 C 5.3901 2.6673 0.0 0
M  V30 45 C 4.6201 1.3337 0.0 0
M  V30 46 C 6.9302 2.6673 0.0 0
M  V30 47 C 5.3901 0.0000 0.0 0
M  V30 48 C 7.7002 1.3337 0.0 0
M  V30 49 C 6.9302 0.0000 0.0 0
M  V30 50 H 14.3687 12.7733 0.0 0
M  V30 51 H 14.3687 8.1532 0.0 0
M  V30 52 H 6.1601 6.6685 0.0 0
M  V30 53 H 1.5400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 24 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 34 9 CFG=3
M  V30 12 1 11 12
M  V30 13 1 26 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 35 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 36 17 CFG=1
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 50 CFG=1
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 1 19 51 CFG=3
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 25 28 CFG=3
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 38 40
M  V30 46 1 38 52 CFG=1
M  V30 47 1 39 41
M  V30 48 1 39 53 CFG=3
M  V30 49 1 40 42
M  V30 50 1 41 43
M  V30 51 1 42 43
M  V30 52 1 42 44 CFG=3
M  V30 53 2 44 45
M  V30 54 1 44 46
M  V30 55 1 45 47
M  V30 56 2 46 48
M  V30 57 2 47 49
M  V30 58 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(12 18 19 20 24 25 26 34 35 36 38 39 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
β-D-Glucopyranoside, 2,2′-[(2,2-dimethyl-1,3-dioxo-1,3-propanediyl)diimino]bi...
C37H46N2O12S2
1221148-08-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 62 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 18.7267 5.1838 0.0 0
M  V30 2 C 17.9567 3.8500 0.0 0
M  V30 3 O 18.7267 2.5164 0.0 0
M  V30 4 N 15.6467 5.1838 0.0 0
M  V30 5 C 14.1067 5.1838 0.0 0
M  V30 6 C 13.3367 3.8500 0.0 0
M  V30 7 O 13.3367 6.5174 0.0 0
M  V30 8 C 12.0031 4.6200 0.0 0
M  V30 9 C 14.6705 3.0800 0.0 0
M  V30 10 C 12.5667 2.5164 0.0 0
M  V30 11 N 10.6694 3.8500 0.0 0
M  V30 12 O 12.0031 6.1600 0.0 0
M  V30 13 S 14.1067 7.8511 0.0 0
M  V30 14 C 13.3367 9.1847 0.0 0
M  V30 15 C 14.1067 10.5185 0.0 0
M  V30 16 O 8.0020 2.3100 0.0 0
M  V30 17 C 9.3358 1.5400 0.0 0
M  V30 18 O 9.3356 0.0000 0.0 0
M  V30 19 S 10.6694 6.9300 0.0 0
M  V30 20 C 10.6694 8.4700 0.0 0
M  V30 21 C 9.3358 9.2400 0.0 0
M  V30 22 C 18.7267 7.8511 0.0 0 CFG=2
M  V30 23 C 17.9567 6.5174 0.0 0 CFG=2
M  V30 24 C 17.9567 9.1847 0.0 0 CFG=1
M  V30 25 O 20.2667 7.8511 0.0 0
M  V30 26 C 16.4167 6.5174 0.0 0 CFG=1
M  V30 27 O 16.4167 9.1847 0.0 0
M  V30 28 C 18.7267 10.5185 0.0 0
M  V30 29 C 21.0367 9.1847 0.0 0 CFG=2
M  V30 30 C 15.6467 7.8511 0.0 0 CFG=2
M  V30 31 O 20.2667 10.5185 0.0 0
M  V30 32 C 22.5767 9.1847 0.0 0
M  V30 33 C 23.3467 7.8511 0.0 0
M  V30 34 C 23.3467 10.5185 0.0 0
M  V30 35 C 24.8867 7.8511 0.0 0
M  V30 36 C 24.8867 10.5185 0.0 0
M  V30 37 C 25.6567 9.1847 0.0 0
M  V30 38 C 9.3358 4.6200 0.0 0 CFG=1
M  V30 39 C 8.0020 3.8500 0.0 0 CFG=1
M  V30 40 C 9.3358 6.1600 0.0 0 CFG=2
M  V30 41 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 42 O 8.0020 6.9300 0.0 0
M  V30 43 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 44 O 5.3347 3.8500 0.0 0
M  V30 45 C 5.3347 6.9300 0.0 0
M  V30 46 C 4.0009 4.6200 0.0 0 CFG=2
M  V30 47 O 4.0009 6.1600 0.0 0
M  V30 48 C 2.6673 3.8500 0.0 0
M  V30 49 C 2.6673 2.3100 0.0 0
M  V30 50 C 1.3336 4.6200 0.0 0
M  V30 51 C 1.3336 1.5400 0.0 0
M  V30 52 C 0.0000 3.8500 0.0 0
M  V30 53 C 0.0000 2.3100 0.0 0
M  V30 54 H 19.4967 6.5174 0.0 0
M  V30 55 H 17.1867 10.5185 0.0 0
M  V30 56 H 6.6684 3.0800 0.0 0
M  V30 57 H 6.6684 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 26 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 38 11 CFG=3
M  V30 14 1 13 14
M  V30 15 1 30 13 CFG=3
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 39 16 CFG=1
M  V30 19 2 17 18
M  V30 20 1 19 20
M  V30 21 1 40 19 CFG=1
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 22 54 CFG=3
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 24 55 CFG=1
M  V30 31 1 25 29
M  V30 32 1 26 30
M  V30 33 1 27 30
M  V30 34 1 28 31
M  V30 35 1 29 31
M  V30 36 1 29 32 CFG=1
M  V30 37 2 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 41 44
M  V30 49 1 41 56 CFG=1
M  V30 50 1 42 43
M  V30 51 1 43 45
M  V30 52 1 43 57 CFG=3
M  V30 53 1 44 46
M  V30 54 1 45 47
M  V30 55 1 46 47
M  V30 56 1 46 48 CFG=3
M  V30 57 2 48 49
M  V30 58 1 48 50
M  V30 59 1 49 51
M  V30 60 2 50 52
M  V30 61 2 51 53
M  V30 62 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(12 22 23 24 26 29 30 38 39 40 41 43 46)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1062080-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1221148-08-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-12330963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bis(oxazolines) based on glycopyranosides - steric, configurational and
conformational influences on stereoselectivity of cyclopropanation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Minuth, Tobias; Boysen, Mike M. K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2010), 6No pp. given, No. 23

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoaniline
C6H6BrN
106-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N′,N′-dimethylaniline
C8H10BrN
586-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25335408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-53-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6737-42-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 11057-89-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-96-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, conversion >99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM General catalytic methylation of amines with formic acid under mild
reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorribes, Ivan; Junge, Kathrin; Beller, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(26), 7878-7883

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Trifluoromethyl)-3-pyridinamine
C6H5F3N2
106877-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 N 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[6-(Trifluoromethyl)-3-pyridinyl]formamide
C7H5F3N2O
1550994-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 O 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 N 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106877-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1550994-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16586690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of triazole-based TGR5 agonists towards orally available
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Futatsugi, Kentaro; Bahnck, Kevin B.; Brenner, Martin B.; Buxton, Joanne;
Chin, Janice E.; Coffey, Steven B.; Dubins, Jeffrey; Flynn, Declan;
Gautreau, Denise; Guzman-Perez, Angel; Hadcock, John R.; Hepworth, David;
Herr, Michael; Hinchey, Terri; Janssen, Ann M.; Jennings, Sandra M.;
Jiao, Wenhua; Lavergne, Sophie Y.; Li, Bryan; Li, Mei; Munchhof, Michael
J.; Orr, Suvi T. M.; Piotrowski, David W.; Roush, Nicole S.; Sammons,
Matthew; Stevens, Benjamin D.; Storer, Gregory; Wang, Jian; Warmus,
Joseph S.; Wei, Liuqing; Wolford, Angela C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2013), 4(1), 205-210

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Trifluoromethyl)-3-pyridinamine
C6H5F3N2
106877-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 N 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[6-(Trifluoromethyl)-3-pyridinyl]formamide
C7H5F3N2O
1550994-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 O 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 N 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106877-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1550994-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32118911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted
2-Nitroimidazooxazines Offer Enhanced Solubility
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thompson, Andrew M.; O'Connor, Patrick D.; Yardley, Vanessa; Maes, Louis;
Launay, Delphine; Braillard, Stephanie; Chatelain, Eric; Wan, Baojie;
Franzblau, Scott G.; Ma, Zhenkun; Cooper, Christopher B.; Denny, William
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2021), 12(2), 275-281

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethylenediamine
C2H8N2
107-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 N 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,2-ethanediamine (2:1)
C2H8N2.2CH2O2
6442-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3100 0.0 0
M  V30 2 C 2.6673 3.0800 0.0 0
M  V30 3 N 0.0000 3.0800 0.0 0
M  V30 4 N 4.0010 2.3100 0.0 0
M  V30 5 C 2.0005 0.0000 0.0 0
M  V30 6 O 0.6668 0.7700 0.0 0
M  V30 7 O 3.3342 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 5 6
M  V30 5 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6442-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26625918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ethylenediammonium diformate (EDDF) in PEG600: an efficient ambiphilic
novel catalytic system for the one-pot synthesis of 4H-pyrans via
Knoevenagel condensation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thakur, Anuj; Tripathi, Mohit; Rajesh, U. Chinna; Rawat, Diwan S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(39), 18142-18148

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethylene glycol
C2H6O2
107-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 O 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycol monoformate
C3H6O3
628-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 628-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-18234086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11118-20-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of mixed diesters of ethylene glycol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamedov, M. K.; Mekhtiyeva, G. N.; Ismailova, Dj. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Neft Kimyasi va Neft E'mali Proseslari (2014), 15(3), 223-227

$RFMT $RIREG SCHEME140 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexylamine
C6H13N
108-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Iodo-4-phenyl-1-(phenylmethyl)-1H-1,2,3-triazole
C15H12IN3
860002-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 7.0619 0.0000 0.0 0
M  V30 2 C 4.0011 1.3626 0.0 0
M  V30 3 C 7.7722 2.6508 0.0 0
M  V30 4 C 6.7418 1.5063 0.0 0
M  V30 5 N 7.0022 3.9845 0.0 0
M  V30 6 N 5.3348 2.1326 0.0 0
M  V30 7 N 5.4959 3.6643 0.0 0
M  V30 8 C 9.3037 2.4898 0.0 0
M  V30 9 C 10.2090 3.7356 0.0 0
M  V30 10 C 9.9302 1.0829 0.0 0
M  V30 11 C 11.7405 3.5747 0.0 0
M  V30 12 C 11.4618 0.9219 0.0 0
M  V30 13 C 12.3670 2.1679 0.0 0
M  V30 14 C 2.6675 2.1326 0.0 0
M  V30 15 C 2.6675 3.6726 0.0 0
M  V30 16 C 1.3338 1.3626 0.0 0
M  V30 17 C 1.3338 4.4427 0.0 0
M  V30 18 C 0.0000 2.1326 0.0 0
M  V30 19 C 0.0000 3.6726 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 6
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyclohexyl-4-phenyl-1-(phenylmethyl)-1H-1,2,3-triazole-5-carboxamide
C22H24N4O
2379722-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3753 5.3348 0.0 0
M  V30 2 N 5.1454 4.0011 0.0 0
M  V30 3 O 2.8353 5.3348 0.0 0
M  V30 4 C 7.7075 5.6850 0.0 0
M  V30 5 C 4.5190 8.0754 0.0 0
M  V30 6 C 5.1454 6.6686 0.0 0
M  V30 7 N 5.6636 9.1058 0.0 0
M  V30 8 N 6.6771 6.8295 0.0 0
M  V30 9 N 6.9972 8.3358 0.0 0
M  V30 10 C 3.0127 8.3956 0.0 0
M  V30 11 C 1.9822 7.2512 0.0 0
M  V30 12 C 2.5367 9.8603 0.0 0
M  V30 13 C 0.4759 7.5713 0.0 0
M  V30 14 C 1.0304 10.1804 0.0 0
M  V30 15 C 0.0000 9.0359 0.0 0
M  V30 16 C 9.2138 6.0051 0.0 0
M  V30 17 C 9.6898 7.4699 0.0 0
M  V30 18 C 10.2443 4.8608 0.0 0
M  V30 19 C 11.1961 7.7900 0.0 0
M  V30 20 C 11.7506 5.1809 0.0 0
M  V30 21 C 12.2265 6.6456 0.0 0
M  V30 22 C 4.3753 2.6675 0.0 0
M  V30 23 C 5.1454 1.3337 0.0 0
M  V30 24 C 2.8353 2.6675 0.0 0
M  V30 25 C 4.3753 0.0000 0.0 0
M  V30 26 C 2.0653 1.3337 0.0 0
M  V30 27 C 2.8353 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 22
M  V30 5 1 4 8
M  V30 6 1 4 16
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 2 7 9
M  V30 12 1 8 9
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-91-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 860002-66-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2379722-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31245739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Aminocarbonylation Reaction to Access
1,2,3-Triazole-5-carboxamides Using Dimethyl Carbonate as Sustainable
Solvent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Albuquerque, Danilo Yano; de Moraes, Juliana R.; Schwab, Ricardo S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(39), 6673-6681

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminopyrimidine
C4H5N3
109-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 N 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-2-Pyrimidinylformamide
C5H5N3O
31354-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 N 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31354-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20697974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7429-90-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM mesoporous silica-supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst,
aluminum-MCM-41-catalyst prepared and used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Characterization and Properties of N- Heteroaryl Formamide
Derivatives in the Presence of the Al-MCM-41-Nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi Meleh Amiri, Kianoosh; Saadati, Zohreh; Vafayi Bagheri, Zahra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Silicon (2019), 11(4), 2117-2125

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
(2R)-4-Bromo-3,3,4,4-tetrafluoro-2-(phenylmethoxy)-1-butanol
C11H11BrF4O2
1134288-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0 CFG=1
M  V30 2 C 2.6673 3.0801 0.0 0
M  V30 3 O 5.3348 3.0801 0.0 0
M  V30 4 C 4.0012 0.7700 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 F 3.4374 4.4137 0.0 0
M  V30 7 F 1.8973 1.7464 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 O 5.3348 0.0000 0.0 0
M  V30 10 Br 0.0000 4.6201 0.0 0
M  V30 11 F 2.1037 5.1838 0.0 0
M  V30 12 F 0.5637 2.5164 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 9.3360 2.3101 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 8 13
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butanol, 4-bromo-3,3,4,4-tetrafluoro-2-(phenylmethoxy)-, 1-formate, (2R)-
C12H11BrF4O3
1134288-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 2 C 2.6673 5.3901 0.0 0
M  V30 3 O 5.3348 5.3901 0.0 0
M  V30 4 C 4.0012 3.0801 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 F 1.8973 4.0564 0.0 0
M  V30 7 F 3.4374 6.7238 0.0 0
M  V30 8 C 6.6685 4.6201 0.0 0
M  V30 9 O 5.3348 2.3101 0.0 0
M  V30 10 Br 0.0000 6.9302 0.0 0
M  V30 11 F 0.5637 4.8265 0.0 0
M  V30 12 F 2.1037 7.4938 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 O 6.6685 0.0000 0.0 0
M  V30 15 C 8.0023 5.3901 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 8.0023 6.9302 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 9.3360 7.7002 0.0 0
M  V30 20 C 10.6697 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 8 15
M  V30 13 1 9 13
M  V30 14 2 13 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1134288-43-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1134288-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-18231991
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of tetrafluorinated ribose and fructose
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Linclau, Bruno; Boydell, A. James; Timofte, Roxana S.; Brown, Kylie J.;
Vinader, Victoria; Weymouth-Wilson, Alexander C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2009), 7(4), 803-814

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-methionyl-1-amino-3-cyclopentene-1-carbony...
C26H37N3O6S
1139893-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6685 0.0 0
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0 CFG=2
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 O 1.5400 6.6685 0.0 0
M  V30 8 O 1.5400 4.0011 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 N 8.1760 7.0969 0.0 0
M  V30 11 C 9.5828 7.7233 0.0 0
M  V30 12 C 10.8287 6.8182 0.0 0 CFG=2
M  V30 13 O 9.7437 9.2549 0.0 0
M  V30 14 N 12.2356 7.4445 0.0 0
M  V30 15 C 10.6677 5.2865 0.0 0
M  V30 16 C 13.4815 6.5393 0.0 0
M  V30 17 C 11.9136 4.3815 0.0 0
M  V30 18 O 14.8883 7.1656 0.0 0
M  V30 19 O 13.3205 5.0078 0.0 0
M  V30 20 S 11.7527 2.8498 0.0 0
M  V30 21 C 16.1341 6.2606 0.0 0
M  V30 22 C 12.9985 1.9446 0.0 0
M  V30 23 C 17.0393 7.5064 0.0 0
M  V30 24 C 17.3801 5.3553 0.0 0
M  V30 25 C 15.2291 5.0145 0.0 0
M  V30 26 C 6.9300 8.0021 0.0 0
M  V30 27 C 7.9606 9.1465 0.0 0
M  V30 28 C 5.5232 8.6285 0.0 0
M  V30 29 C 7.1906 10.4803 0.0 0
M  V30 30 C 5.6841 10.1600 0.0 0
M  V30 31 C 3.8500 2.6674 0.0 0
M  V30 32 C 4.6200 1.3338 0.0 0
M  V30 33 C 2.3100 2.6674 0.0 0
M  V30 34 C 3.8500 0.0000 0.0 0
M  V30 35 C 1.5400 1.3338 0.0 0
M  V30 36 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 31
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-methionyl-1-amino-3-cyclopentene-1-carbonyl-L-phenylalanine methyl...
C22H29N3O5S
1139893-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6685 0.0 0
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0 CFG=2
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 O 1.5400 6.6685 0.0 0
M  V30 8 O 1.5400 4.0011 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 N 8.1760 7.0969 0.0 0
M  V30 11 C 9.5828 7.7233 0.0 0
M  V30 12 C 10.8287 6.8182 0.0 0 CFG=1
M  V30 13 O 9.7437 9.2549 0.0 0
M  V30 14 C 12.2356 7.4445 0.0 0
M  V30 15 N 10.6677 5.2865 0.0 0
M  V30 16 C 13.4815 6.5393 0.0 0
M  V30 17 C 11.9136 4.3815 0.0 0
M  V30 18 S 14.8883 7.1656 0.0 0
M  V30 19 O 11.7527 2.8498 0.0 0
M  V30 20 C 16.1343 6.2606 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 7.9606 9.1465 0.0 0
M  V30 23 C 5.5232 8.6285 0.0 0
M  V30 24 C 7.1906 10.4803 0.0 0
M  V30 25 C 5.6841 10.1601 0.0 0
M  V30 26 C 3.8500 2.6674 0.0 0
M  V30 27 C 4.6200 1.3338 0.0 0
M  V30 28 C 2.3100 2.6674 0.0 0
M  V30 29 C 3.8500 0.0000 0.0 0
M  V30 30 C 1.5400 1.3338 0.0 0
M  V30 31 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 21
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 12 15 CFG=3
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1139893-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1139893-30-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12970646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16357-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemotactic tripeptides incorporating at position 2 α-amino acid residues
with unsaturated side chains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucente, G.; Paradisi, M. P.; Giordano, C.; Sansone, A.; Torino, D.;
Spisani, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2008), 35(2), 329-338

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2,4-Dinitrophenyl)hydrazine
C6H6N4O4
119-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2,4-Dinitrophenyl)hydrazinecarboxaldehyde
C7H6N4O5
7474-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6673 6.9301 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 N 6.6684 4.6201 0.0 0
M  V30 5 N 8.0022 3.8500 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 O 10.6695 3.8500 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7474-09-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1089482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 940-71-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of esters and amides from carboxylic acids and N-formylation
of amines promoted by
1,3,5-triazo-2,4,6-triphosphorine-2,2,4,4,6,6-hexachloride (TAPC)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bahrami, Kiumars; Khodaei, Mohammad M.; Targhan, Homa; Sheikh Arabi,
Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(37), 5064-5068

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2,4-Dinitrophenyl)hydrazine
C6H6N4O4
119-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2,4-Dinitrophenyl)hydrazinecarboxaldehyde
C7H6N4O5
7474-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6673 6.9301 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 N 6.6684 4.6201 0.0 0
M  V30 5 N 8.0022 3.8500 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 O 10.6695 3.8500 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7474-09-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16894725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7790-94-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, reusable catalyst, no solvent, sulfonated rice husk ash
solid acid catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient method for the synthesis of formamidine and formamide
derivatives promoted by sulfonated rice husk ash (RHA-SO3H)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seddighi, Mohadeseh; Shirini, Farhad; Mamaghani, Manouchehr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2015), 12(3), 433-439

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole
C8H7N
120-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 4.1321 2.7859 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 4.1321 0.2941 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 5.0371 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 7
M  V30 9 1 6 9
M  V30 10 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-1-carboxaldehyde
C9H7NO
58246-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 N 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 C 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58246-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-5640624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 39377-45-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable catalyst, nano rod-shaped basic Al2O3
catalyst used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nano rod-shaped and reusable basic Al2O3 catalyst for N-formylation of
amines under solvent-free conditions: A novel, practical and convenient
NOSE' approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Vijay Kumar; Devi, Rashmi Rekha; Raul, Prasanta Kumar; Thakur, Ashim
Jyoti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2012), 14(3), 847-854

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Zingerone
C11H14O3
122-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 8.0022 0.0000 0.0 0
M  V30 5 O 9.3359 2.3100 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(Formyloxy)-3-methoxyphenyl]-2-butanone
C12H14O4
2460598-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7001 1.3338 0.0 0
M  V30 2 C 6.9301 0.0000 0.0 0
M  V30 3 O 9.2401 4.0011 0.0 0
M  V30 4 C 10.0101 5.3348 0.0 0
M  V30 5 O 11.5501 5.3348 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 5.3348 0.0 0
M  V30 8 C 0.7700 5.3348 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 O 0.0000 6.6686 0.0 0
M  V30 11 C 6.9301 2.6675 0.0 0
M  V30 12 C 7.7001 4.0011 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 6.9301 5.3348 0.0 0
M  V30 15 C 4.6201 4.0011 0.0 0
M  V30 16 C 5.3901 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-48-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2460598-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24911004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Steglich esterification
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic Modification of Zingerone Reveals Structural Requirements for
Attraction of Jarvis's Fruit Fly
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanssen, Benjamin L.; Park, Soo Jean; Royer, Jane E.; Jamie, Joanne F.;
Taylor, Phillip W.; Jamie, Ian M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2019), 9(1), 19332

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitro-2-pyridinyl)-1H-benzimidazol-6-amine
C12H9N5O2
1262887-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2873 4.0012 0.0 0
M  V30 2 N 9.3674 4.0012 0.0 0 VAL=5
M  V30 3 O 8.5974 5.3348 0.0 0
M  V30 4 O 10.9074 4.0012 0.0 0
M  V30 5 C 2.4373 5.3348 0.0 0
M  V30 6 C 1.6672 4.0012 0.0 0
M  V30 7 C 3.9773 5.3348 0.0 0
M  V30 8 N 1.4068 6.4792 0.0 0
M  V30 9 C 2.4373 2.6673 0.0 0
M  V30 10 N 0.1609 4.3213 0.0 0
M  V30 11 C 4.7473 4.0012 0.0 0
M  V30 12 C 0.0000 5.8529 0.0 0
M  V30 13 C 3.9773 2.6673 0.0 0
M  V30 14 C 7.0574 2.6673 0.0 0
M  V30 15 C 8.5974 2.6673 0.0 0
M  V30 16 N 6.2873 1.3337 0.0 0
M  V30 17 C 9.3674 1.3337 0.0 0
M  V30 18 C 7.0574 0.0000 0.0 0
M  V30 19 C 8.5974 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1H-Benzimidazol-6-yl)-3H-imidazo[4,5-b]pyridine
C13H9N5
1262887-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4197 1.8517 0.0 0
M  V30 2 C 3.0127 2.4782 0.0 0
M  V30 3 C 4.2586 0.3202 0.0 0
M  V30 4 C 1.9823 1.3336 0.0 0
M  V30 5 N 2.5369 3.9427 0.0 0
M  V30 6 N 2.7523 0.0000 0.0 0
M  V30 7 C 0.4759 1.6538 0.0 0
M  V30 8 C 1.0306 4.2629 0.0 0
M  V30 9 C 0.0000 3.1185 0.0 0
M  V30 10 C 5.7533 2.6217 0.0 0
M  V30 11 C 7.0870 1.8517 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 8.4206 2.6217 0.0 0
M  V30 14 C 7.0870 4.9317 0.0 0
M  V30 15 C 8.4206 4.1617 0.0 0
M  V30 16 N 9.8853 2.1458 0.0 0
M  V30 17 N 9.8853 4.6376 0.0 0
M  V30 18 C 10.7905 3.3917 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 14 15
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262887-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262887-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13442321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Experimental Procedure
1H-Benzo[d]imidazole15 (1): A 40 mL glass vial was charged with
o-nitroaniline (0.138 g, 1.00 mmol), iron powder 325 mesh (0.558 g, 10.0
mmol), NH4Cl (0.535 g, 10.0 mmol), and a magnetic stir bar. 2-PrOH (5.0
mL) and formic acid (5.0 mL) were added, and the reaction vial was sealed
with a Teflon-lined cap. The reaction mixture was stirred at 80 °C for 1
h at which time LC-MS analysis indicated that conversion into the product
was complete. The reaction mixture was diluted with 2-PrOH (10 mL) and
filtered to remove insoluble materials. The filtrate was concentrated to
dryness, and the resulting residue partitioned between CH2Cl2 (20 mL) and
(5 mL) sat. aq NaHCO3. The aqueous layer was extracted with additional
CH2Cl2 (5 x 20 mL). The combined organic extracts were dried over MgSO4,
filtered, and concentrated.
3-{1H-Benzo[d]imidazol-5-yl}-3H-imidazo[4,5-b]pyridine (16), yield 98%.
ESI-MS: m/z = 250.2 [M + H]+. 1H NMR (400 MHz, DMSO): δ = 12.72 (s, 1 H),
8.83 (s, 1 H), 8.36 (s, 1 H), 8.28 (s, 1 H), 8.13 (s, 1 H), 8.02 (s, 1
H), 7.85-7.60 (m, 2 H), 2.46 (s, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and general one-pot reduction and cyclization of aromatic and
heteroaromatic 2-nitroamines to bicyclic 2H-imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanan, Emily J.; Chan, Bryan K.; Estrada, Anthony A.; Shore, Daniel G.;
Lyssikatos, Joseph P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2010), (18), 2759-2764

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2,4-difluorobenzaldehyde
C7H3BrF2O
1326714-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 F 4.6201 0.0000 0.0 0
M  V30 4 Br 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2,4-difluorobenzenepropanoic acid
C9H7BrF2O2
1785407-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 F 2.6675 0.0000 0.0 0
M  V30 7 Br 0.0000 1.5400 0.0 0
M  V30 8 F 0.0000 4.6201 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1326714-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1785407-43-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24593358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indazoles and azaindazoles as LRKK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garofalo, Albert W.; Schwarz, Jacob Bradley; Sabbatini, Fabio Maria;
Bernardi, Silvia; Migliore, Marco; Budassi, Federica; Beato, Claudia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178780 A1 2021-09-10

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N4,N4-dimethyl-1,4-benzenediamine
C8H11IN2
1369893-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 0.0000 1.3337 0.0 0
M  V30 4 I 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(Dimethylamino)-2-iodophenyl]formamide
C9H11IN2O
2055085-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 I 4.0012 6.1601 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1369893-82-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055085-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-[(4-Methylphenyl)sulfonyl]-1H-indol-2-yl]benzenamine
C21H18N2O2S
1401838-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3182 5.7282 0.0 0 VAL=6
M  V30 2 O 5.6384 4.2218 0.0 0
M  V30 3 O 4.9981 7.2345 0.0 0
M  V30 4 N 1.6455 1.3336 0.0 0
M  V30 5 C 11.3436 7.0088 0.0 0
M  V30 6 C 3.1855 4.0011 0.0 0
M  V30 7 N 3.8118 5.4079 0.0 0
M  V30 8 C 1.6540 4.1620 0.0 0
M  V30 9 C 2.6674 6.4384 0.0 0
M  V30 10 C 1.3338 5.6684 0.0 0
M  V30 11 C 2.6674 7.9784 0.0 0
M  V30 12 C 0.0000 6.4384 0.0 0
M  V30 13 C 1.3338 8.7484 0.0 0
M  V30 14 C 0.0000 7.9784 0.0 0
M  V30 15 C 3.9555 2.6674 0.0 0
M  V30 16 C 3.1855 1.3336 0.0 0
M  V30 17 C 5.4955 2.6674 0.0 0
M  V30 18 C 3.9555 0.0000 0.0 0
M  V30 19 C 6.2655 1.3336 0.0 0
M  V30 20 C 5.4955 0.0000 0.0 0
M  V30 21 C 6.8245 6.0484 0.0 0
M  V30 22 C 7.8551 4.9038 0.0 0
M  V30 23 C 7.3004 7.5129 0.0 0
M  V30 24 C 9.3614 5.2240 0.0 0
M  V30 25 C 8.8068 7.8331 0.0 0
M  V30 26 C 9.8372 6.6887 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 21
M  V30 5 1 4 16
M  V30 6 1 5 26
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[1-[(4-Methylphenyl)sulfonyl]-1H-indol-2-yl]phenyl]formamide
C22H18N2O3S
1401822-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0454 4.6079 0.0 0 VAL=6
M  V30 2 O 7.5696 6.0725 0.0 0
M  V30 3 O 8.5213 3.1432 0.0 0
M  V30 4 N 2.6675 6.5772 0.0 0
M  V30 5 C 1.3337 7.3472 0.0 0
M  V30 6 O 0.0000 6.5772 0.0 0
M  V30 7 C 13.9040 6.5114 0.0 0
M  V30 8 C 5.3348 5.0371 0.0 0
M  V30 9 N 6.5807 4.1321 0.0 0
M  V30 10 C 4.0889 4.1321 0.0 0
M  V30 11 C 6.1048 2.6673 0.0 0
M  V30 12 C 4.5648 2.6673 0.0 0
M  V30 13 C 6.8749 1.3337 0.0 0
M  V30 14 C 3.7948 1.3337 0.0 0
M  V30 15 C 6.1048 0.0000 0.0 0
M  V30 16 C 4.5648 0.0000 0.0 0
M  V30 17 C 5.3348 6.5772 0.0 0
M  V30 18 C 4.0012 7.3472 0.0 0
M  V30 19 C 6.6685 7.3472 0.0 0
M  V30 20 C 4.0012 8.8872 0.0 0
M  V30 21 C 6.6685 8.8872 0.0 0
M  V30 22 C 5.3348 9.6572 0.0 0
M  V30 23 C 9.5100 5.0838 0.0 0
M  V30 24 C 10.6546 4.0534 0.0 0
M  V30 25 C 9.8302 6.5901 0.0 0
M  V30 26 C 12.1191 4.5292 0.0 0
M  V30 27 C 11.2949 7.0661 0.0 0
M  V30 28 C 12.4393 6.0355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 23
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 2 5 6
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 17
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401838-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401822-29-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7275015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 1-tosyl-2-(o-(N-formylamino)phenyl)indole: Formic acid
(0.2 g, 4.3 mmol) was added dropwise to acetic anhydride (0.36 g, 3.6
mmol) at 0 degC and then the mixture was heated to 50 degC for 30 min.
The mixture was cooled to 0 degC and tetrahydrofuran (2.5 mL, anhydrous)
added. A solution of 1-tosyl-2-(o-aminophenyl)indole (0.5 g, 1.38 mmol)
in tetrahydrofuran (2.5 mL. anhydrous) was added dropwise and the
solution was allowed to warm to room temperature over 1 hr. The solvent
removed by distillation under vacuum and left under high vacuum for 5 hr
to afford the title compound as a cream coloured foam (0.53 g, 1.36 mmol,
98 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic Approaches Towards Debromo-Hinckdentine A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Corden, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2002), (20121004), No pp.

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(3-Amino-5-bromo-2-pyridinyl)amino]-2′,6′-difluoro[1,1′-biphenyl]-3-yl]...
C19H15BrF2N4O
1430739-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.0800 8.0021 0.0 0
M  V30 2 F 3.0800 2.6673 0.0 0
M  V30 3 N 7.7000 8.0021 0.0 0
M  V30 4 N 7.7000 2.6673 0.0 0
M  V30 5 C 6.9300 1.3336 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 O 7.7000 0.0000 0.0 0
M  V30 8 N 9.2400 10.6694 0.0 0
M  V30 9 Br 13.8600 8.0021 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 6.6684 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 6.6684 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 5.3900 6.6684 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 6.9300 4.0011 0.0 0
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 10.0100 9.3358 0.0 0
M  V30 24 N 10.0100 6.6684 0.0 0
M  V30 25 C 11.5500 9.3358 0.0 0
M  V30 26 C 11.5500 6.6684 0.0 0
M  V30 27 C 12.3200 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 19
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 8 23
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-(6-Bromo-3H-imidazo[4,5-b]pyridin-3-yl)-2′,6′-difluoro[1,1′-biphenyl]-3-...
C20H13BrF2N4O
1430729-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 O 2.6674 2.3100 0.0 0
M  V30 5 Br 13.9281 5.3430 0.0 0
M  V30 6 F 4.0011 9.2400 0.0 0
M  V30 7 F 1.3338 4.6200 0.0 0
M  V30 8 N 8.0021 6.9300 0.0 0
M  V30 9 C 9.4089 6.3037 0.0 0
M  V30 10 C 8.1631 8.4615 0.0 0
M  V30 11 C 10.4395 7.4481 0.0 0
M  V30 12 N 9.8848 4.8390 0.0 0
M  V30 13 N 9.6695 8.7817 0.0 0
M  V30 14 C 11.9458 7.1279 0.0 0
M  V30 15 C 11.3912 4.5188 0.0 0
M  V30 16 C 12.4216 5.6632 0.0 0
M  V30 17 C 6.6685 6.1600 0.0 0
M  V30 18 C 5.3347 6.9300 0.0 0
M  V30 19 C 6.6685 4.6200 0.0 0
M  V30 20 C 4.0011 6.1600 0.0 0
M  V30 21 C 5.3347 3.8500 0.0 0
M  V30 22 C 4.0011 4.6200 0.0 0
M  V30 23 C 2.6674 6.9300 0.0 0
M  V30 24 C 2.6674 8.4700 0.0 0
M  V30 25 C 1.3338 6.1600 0.0 0
M  V30 26 C 1.3338 9.2400 0.0 0
M  V30 27 C 0.0000 6.9300 0.0 0
M  V30 28 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 16
M  V30 6 1 6 24
M  V30 7 1 7 25
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1430739-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430729-11-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-5512689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c)
N-(5-(6-bromo-3H-imidazo[4,5-b]pyridin-3-yl)-2',6'-difluoro-[1,1'-biphenyl]-3-yl)acetamide.
A mixture of the compound of Example 209(b) (0.6 g, 1.38 mmol) and formic
acid (3 ml) was heated at 80 °C for 1 h. Formic acid was then distilled
off and the crude was dissolved in ethyl acetate. The ethyl acetate layer
was washed with water, brine and dried over sodium sulphate. The solvent
was distilled off and hexane washings were given to the crude material to
afford the title product. 98 % yield (0.5 g).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazoles and related compounds as protein kinase inhibitors and
their preparation and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Linnanen, Tero; Wohlfahrt, Gerd; Nanduri, Srinivas; Ujjinamatada, Ravi;
Rajagopalan, Srinivasan; Mukherjee, Subhendu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013053983 A1 2013-04-18

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N2-[(1R)-1-(4-chloro-2-fluorophenyl)ethyl]-1,2-benzenediamine
C14H13BrClFN2
1442445-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6675 0.0 0
M  V30 2 C 5.3901 4.0012 0.0 0 CFG=1
M  V30 3 C 4.6201 5.3348 0.0 0
M  V30 4 N 3.0801 0.0000 0.0 0
M  V30 5 Br 0.0000 5.3348 0.0 0
M  V30 6 F 6.9302 6.6687 0.0 0
M  V30 7 Cl 11.5503 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 1.3338 0.0 0
M  V30 10 C 2.3101 4.0012 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0012 0.0 0
M  V30 13 C 0.0000 2.6675 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 7.7002 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 14
M  V30 5 1 4 9
M  V30 6 1 5 12
M  V30 7 1 6 15
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-Bromo-1-[(1R)-1-(4-chloro-2-fluorophenyl)ethyl]-1H-benzimidazole
C15H11BrClFN2
1442445-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 2.6674 0.0 0 CFG=2
M  V30 2 C 5.2850 1.3336 0.0 0
M  V30 3 Br 0.0000 2.5770 0.0 0
M  V30 4 F 7.5950 0.0000 0.0 0
M  V30 5 Cl 12.2150 2.6674 0.0 0
M  V30 6 N 5.2850 4.0011 0.0 0
M  V30 7 C 3.7534 4.1620 0.0 0
M  V30 8 C 5.9114 5.4079 0.0 0
M  V30 9 C 3.4333 5.6684 0.0 0
M  V30 10 C 2.6091 3.1316 0.0 0
M  V30 11 N 4.7669 6.4384 0.0 0
M  V30 12 C 1.9686 6.1443 0.0 0
M  V30 13 C 1.1444 3.6074 0.0 0
M  V30 14 C 0.8242 5.1139 0.0 0
M  V30 15 C 7.5950 2.6674 0.0 0
M  V30 16 C 8.3650 1.3336 0.0 0
M  V30 17 C 8.3650 4.0011 0.0 0
M  V30 18 C 9.9050 1.3336 0.0 0
M  V30 19 C 9.9050 4.0011 0.0 0
M  V30 20 C 10.6750 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 6
M  V30 3 1 1 15
M  V30 4 1 3 13
M  V30 5 1 4 16
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1442445-27-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1442445-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-14606802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) To a solution of the crude
(R)-5-bromo-N-(1-(4-chloro-2-fluorophenyl)ethyl)benzene-1,2-diamine (0.75
g, 2.0 mmol) in formic acid (8 mL) was heated at 100 °C for 1 h. After
cooling to room temperature, excess solvent was removed in vacuo. The
residue was diluted with dichloromethane (50 mL), dried (Na2SO4), and
concentrated in vacuo. The resulting crude material was purified by flash
chromatography (SiO2, 5-15% methanol in dichloromethane) to afford the
desired product. Yield 0.70 g, 2.0 mmol, 98%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole derivatives for use as CCR4 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leleti, Manmohan Reddy; Li, Yandong; Mali, Venkat Reddy; Powers, Jay;
Yang, Ju
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013082429 A1 2013-06-06

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-α-Santalol
C15H24O
14490-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6220 0.0000 0.0 0
M  V30 2 C 5.8017 1.6780 0.0 0
M  V30 3 C 7.2487 2.2051 0.0 0
M  V30 4 C 8.4287 1.2155 0.0 0
M  V30 5 C 9.8756 1.7426 0.0 0
M  V30 6 C 11.0556 0.7531 0.0 0
M  V30 7 C 10.1427 3.2592 0.0 0
M  V30 8 O 12.5025 1.2802 0.0 0
M  V30 9 C 5.8010 3.6578 0.0 0
M  V30 10 C 3.8520 1.3336 0.0 0 CFG=2
M  V30 11 C 2.3111 1.3339 0.0 0 CFG=2
M  V30 12 C 1.5400 2.6680 0.0 0 CFG=1
M  V30 13 C 4.6218 2.6674 0.0 0 CFG=2
M  V30 14 C 2.4139 3.0526 0.0 0
M  V30 15 C 2.3097 4.0018 0.0 0
M  V30 16 C 3.8506 4.0015 0.0 0
M  V30 17 H 1.5414 0.0002 0.0 0
M  V30 18 H 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 13 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 1 11 14
M  V30 15 1 11 17 CFG=3
M  V30 16 1 12 15
M  V30 17 1 12 18 CFG=1
M  V30 18 1 13 16
M  V30 19 1 14 16
M  V30 20 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Penten-1-ol, 5-[(1R,3R,6S)-2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl]-2-met...
C16H24O2
1373929-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6220 4.0018 0.0 0
M  V30 2 C 5.8017 2.3238 0.0 0
M  V30 3 C 7.2487 1.7967 0.0 0
M  V30 4 C 8.4287 2.7863 0.0 0
M  V30 5 C 9.8756 2.2592 0.0 0
M  V30 6 C 11.0556 3.2488 0.0 0
M  V30 7 C 10.1427 0.7426 0.0 0
M  V30 8 O 12.5025 2.7216 0.0 0
M  V30 9 C 13.6825 3.7112 0.0 0
M  V30 10 O 15.1294 3.1841 0.0 0
M  V30 11 C 5.8010 0.3440 0.0 0
M  V30 12 C 3.8520 2.6682 0.0 0 CFG=2
M  V30 13 C 2.3111 2.6679 0.0 0 CFG=2
M  V30 14 C 1.5400 1.3338 0.0 0 CFG=1
M  V30 15 C 4.6217 1.3344 0.0 0 CFG=2
M  V30 16 C 2.4139 0.9492 0.0 0
M  V30 17 C 2.3097 0.0000 0.0 0
M  V30 18 C 3.8506 0.0003 0.0 0
M  V30 19 H 1.5412 4.0017 0.0 0
M  V30 20 H 0.0000 1.3344 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 15 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 15 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 14
M  V30 16 1 13 16
M  V30 17 1 13 19 CFG=1
M  V30 18 1 14 17
M  V30 19 1 14 20 CFG=3
M  V30 20 1 15 18
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14490-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1373929-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-4034110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of both formic acid and magnesium sulfate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-odor relationships of α-santalol derivatives with modified side
chains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasegawa, Toshio; Izumi, Hiroaki; Tajima, Yuji; Yamada, Hideo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 172259-2270

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
(3S,6R)-6-[(1R)-2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-methylethyl]-2-(h...
C18H33F3O5SSi
1507345-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.6437 4.6201 0.0 0
M  V30 2 S 2.3100 3.8501 0.0 0 VAL=6
M  V30 3 C 1.5400 5.1837 0.0 0
M  V30 4 O 0.9762 3.0800 0.0 0
M  V30 5 O 3.0800 2.5164 0.0 0
M  V30 6 F 2.3100 6.5175 0.0 0
M  V30 7 F 0.7700 6.5174 0.0 0
M  V30 8 F 0.0000 5.1837 0.0 0
M  V30 9 C 7.3009 5.7997 0.0 0 CFG=1
M  V30 10 C 8.8176 5.5324 0.0 0
M  V30 11 C 6.7743 7.2469 0.0 0
M  V30 12 O 9.8075 6.7120 0.0 0
M  V30 13 Si 11.3241 6.4447 0.0 0
M  V30 14 C 12.8407 6.1772 0.0 0
M  V30 15 C 11.5916 7.9613 0.0 0
M  V30 16 C 11.0568 4.9281 0.0 0
M  V30 17 C 12.5734 4.6606 0.0 0
M  V30 18 C 14.3573 5.9098 0.0 0
M  V30 19 C 13.1082 7.6940 0.0 0
M  V30 20 C 3.6437 1.5400 0.0 0
M  V30 21 O 3.6437 0.0000 0.0 0
M  V30 22 C 6.3110 0.0000 0.0 0
M  V30 23 C 4.9774 3.8501 0.0 0
M  V30 24 C 6.3110 4.6201 0.0 0 CFG=1
M  V30 25 C 4.9774 2.3100 0.0 0
M  V30 26 C 7.6448 3.8501 0.0 0
M  V30 27 C 6.3110 1.5400 0.0 0 CFG=1
M  V30 28 C 7.6448 2.3100 0.0 0
M  V30 29 H 5.3211 5.7997 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=1
M  V30 11 1 9 24
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 20 21
M  V30 21 1 20 25
M  V30 22 1 27 22 CFG=3
M  V30 23 1 23 24
M  V30 24 2 23 25
M  V30 25 1 24 26
M  V30 26 1 24 29 CFG=3
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S,7R)-7-[(1R)-2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-methylethyl]-4,5,...
C18H32O3Si
1507345-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8836 3.1447 0.0 0 CFG=1
M  V30 2 C 7.2173 3.9147 0.0 0
M  V30 3 C 5.8836 1.6047 0.0 0
M  V30 4 O 8.5509 3.1447 0.0 0
M  V30 5 Si 9.8846 3.9147 0.0 0
M  V30 6 C 11.2184 4.6847 0.0 0
M  V30 7 C 10.6546 2.5811 0.0 0
M  V30 8 C 9.1146 5.2484 0.0 0
M  V30 9 C 11.9884 3.3511 0.0 0
M  V30 10 C 12.5520 5.4547 0.0 0
M  V30 11 C 10.4484 6.0184 0.0 0
M  V30 12 O 6.2712 0.8935 0.0 0
M  V30 13 C 0.0000 3.1124 0.0 0
M  V30 14 C 4.0231 2.4676 0.0 0
M  V30 15 C 2.5065 2.2001 0.0 0
M  V30 16 C 4.5498 3.9147 0.0 0 CFG=1
M  V30 17 C 4.7462 1.1077 0.0 0
M  V30 18 C 2.2922 0.6751 0.0 0
M  V30 19 C 1.5166 3.3799 0.0 0 CFG=1
M  V30 20 C 3.5599 5.0944 0.0 0
M  V30 21 O 3.6763 0.0000 0.0 0
M  V30 22 C 2.0433 4.8270 0.0 0
M  V30 23 H 5.5397 5.0944 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 2 12 17
M  V30 13 1 19 13 CFG=1
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23 CFG=1
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 16 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1507345-74-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1507345-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26683990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 102-82-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7447-41-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2) To a solution of 2.67 g (5.98 mmol) 12 in MeCN (95 mL, previously
degassed by 3 freeze-pump-thaw cycles) in a 300 mL Schlenk tube was
subsequently added 2.80 mL (2.22 g, 11.8 mmol) NBu3, 829 mg (0.72 mmol)
Pd(PPh3)4 and 279 mg (6.58 mmol) LiCl (previously dried in vacuo at 200
°C overnight). 1.00 mL (1.84 g, 96% w/w, 18.0 mmol) H2SO4 was placed in a
50 mL Schlenk tube. Both Schlenk tubes were connected with each other by
a plastic tube (1.5 cm outer diameter, 0.2 cm thickness). The septa on
both Schlenk tubes were sealed with Teflon® tape, Parafilm® and secured
with springs (see Figure 1). A blast shield was placed in front of the
reaction setup as a precautionary measure. Both Schlenk tubes were then
heated to 75 °C, at which point 0.71 mL (0.87 g, 95% w/w, 17.9 mmol)
HCO2H was added to the stirred H2SO4 via syringe. After 23 hours, both
Schlenk tubes were cooled to room temperature and the reaction mixture
was filtered through a silica pad, which was washed with EtOAc. The
solvents were removed in vacuo and the crude product was purified by
flash column chromatography (9 to 13 to 17% EtOAc/n-pentane), yielding
13.
(4S,7R)-7-((R)-1-((tert-butyldimethylsilyl)oxy)propan-2-yl)-4-methyl-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one
(13) 1.90 g (98%), colorless oil. Rf: 0.55, 25% EtOAc/hexanes. 1H NMR
(400 MHz): δ 4.73 (ddd, 1H, J = 17.1, 3.3, 1.0 Hz) 4.66 (ddd, 1H, J =
17.1, 2.6, 1.5 Hz), 3.52 (dd, 1H, J = 10.0, 6.5 Hz), 3.48 (dd, 1H, J =
10.0, 8.3 Hz), 2.79 (br m, 2H), 2.51 (m, 1H), 1.98 (m, 1H), 1.78 (m, 1H),
1.43 (m, 1H), 1.28 (m, 1H), 1.11 (d, 3H, J = 7.1 Hz), 0.88 (s, 9H), 0.65
(d, 3H, J = 6.9 Hz), 0.05 (s, 3H), 0.04 (s, 3H). 13C NMR (100 MHz): δ
173.72, 166.28, 127.73, 70.02, 65.98, 34.13, 33.43, 30.88, 30.47, 26.07,
21.37, 18.77, 18.40, 11.51, -5.17, -5.32. IR: 2929, 1750, 1661, 1462,
1254, 1086, 1020 cm -1. HRMS (ESI) calcd for C18H33O3Si ([M + H]+)
325.2199, found 325.2194. [α]25D +43 (c = 0.33, CHCl3).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Sandresolide B and Amphilectolide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Ingrid T.; Baitinger, Irina; Schreyer, Lucas; Trauner, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(1), 166-169

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-5-methoxybenzenamine
C7H8INO
153898-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 I 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodo-5-methoxyphenyl)formamide
C8H8INO2
1261060-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 I 4.6200 0.0000 0.0 0
M  V30 5 O 1.5400 5.3349 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 153898-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1261060-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17010133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-5-methoxybenzenamine
C7H8INO
153898-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 I 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodo-5-methoxyphenyl)formamide
C8H8INO2
1261060-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 I 4.6200 0.0000 0.0 0
M  V30 5 O 1.5400 5.3349 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 153898-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1261060-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5248794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of tryprostatin A and B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamakawa, Takayuki; Ideue, Eiji; Iwaki, Yuzo; Sato, Ayumu; Tokuyama,
Hidetoshi; Shimokawa, Jun; Fukuyama, Tohru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(35), 6547-6560

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-5-methoxybenzenamine
C7H8INO
153898-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 I 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodo-5-methoxyphenyl)formamide
C8H8INO2
1261060-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 I 4.6200 0.0000 0.0 0
M  V30 5 O 1.5400 5.3349 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 153898-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1261060-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14027681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Tryprostatins A and B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamakawa, Takayuki; Ideue, Eiji; Shimokawa, Jun; Fukuyama, Tohru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2010), 49(48), 9262-9265,
S9262/1-S9262/86

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Chlorophenoxy)ethanol
C8H9ClO2
15480-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 Cl 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(2-chlorophenoxy)-, 1-formate
C9H9ClO3
67856-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 Cl 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15480-00-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67856-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24456223
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
N-(3-Bromophenyl)-4-(1,1-dimethylethyl)-2-nitrobenzenamine
C16H17BrN2O2
159724-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 4.0011 0.0 0
M  V30 2 N 6.1600 1.3336 0.0 0 VAL=5
M  V30 3 O 7.7000 1.3336 0.0 0
M  V30 4 O 5.3900 0.0000 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 Br 12.3200 6.6685 0.0 0
M  V30 10 C 6.1600 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 10.7800 6.6685 0.0 0
M  V30 20 C 8.4700 8.0021 0.0 0
M  V30 21 C 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 15
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)-5-(1,1-dimethylethyl)-1H-benzimidazole
C17H17BrN2
159725-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 3.2471 0.0 0
M  V30 2 C 0.7700 1.9133 0.0 0
M  V30 3 C 0.0000 3.2471 0.0 0
M  V30 4 C 0.7700 4.5807 0.0 0
M  V30 5 Br 12.8846 2.4580 0.0 0
M  V30 6 C 6.1600 3.2471 0.0 0
M  V30 7 N 7.6664 3.5673 0.0 0
M  V30 8 C 5.3900 4.5807 0.0 0
M  V30 9 C 5.3900 1.9133 0.0 0
M  V30 10 C 7.8274 5.0988 0.0 0
M  V30 11 C 3.8500 4.5807 0.0 0
M  V30 12 N 6.4206 5.7251 0.0 0
M  V30 13 C 3.8500 1.9133 0.0 0
M  V30 14 C 3.0800 3.2471 0.0 0
M  V30 15 C 8.8108 2.5367 0.0 0
M  V30 16 C 10.2755 3.0127 0.0 0
M  V30 17 C 8.4906 1.0304 0.0 0
M  V30 18 C 11.4199 1.9821 0.0 0
M  V30 19 C 9.6352 0.0000 0.0 0
M  V30 20 C 11.0997 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 14
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 15
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159724-47-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 159725-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1455680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A three-necked flask equipped with a mechanical stirrer, nitrogen inlet,
and thermowell was charged with iron powder (10.5 g, 186 mmol) and EtOH
(80 mL). HCl (12 N, 1.6 mL) was added and the mixture was stirred for 1
hour at 50° C. Aqueous ammonium chloride solution (25% w/v, 40 mL) was
added followed by the portion-wise addition of 40 (13 g, 37.2 mmol). The
mixture was heated at 60-70° C. for 5 hours. The dark mixture was
filtered through a pad of Celite washing with EtOAc (200 mL), and the
filtrate was concentrated to dryness.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole derivatives as modulators of GABAA receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Julie F.; Harbeson, Scott L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011047315 A1 2011-04-21

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-ethyl (2R,3R)-3-pentadecyl-1,2-aziridinedicarboxylate
C25H47NO4
1606993-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4374 3.8501 0.0 0
M  V30 2 O 2.1037 3.0801 0.0 0
M  V30 3 O 4.7712 3.0801 0.0 0
M  V30 4 C 2.1037 1.5400 0.0 0
M  V30 5 C 0.5637 1.5400 0.0 0
M  V30 6 C 2.1037 0.0000 0.0 0
M  V30 7 C 3.6437 1.5400 0.0 0
M  V30 8 C 1.3337 7.4938 0.0 0
M  V30 9 O 1.3337 9.0338 0.0 0
M  V30 10 O 0.0000 6.7238 0.0 0
M  V30 11 C 0.0000 9.8039 0.0 0
M  V30 12 C 0.0000 11.3439 0.0 0
M  V30 13 C 5.5412 7.4938 0.0 0
M  V30 14 C 6.8749 6.7238 0.0 0
M  V30 15 C 8.2085 7.4938 0.0 0
M  V30 16 C 9.5422 6.7238 0.0 0
M  V30 17 C 10.8760 7.4938 0.0 0
M  V30 18 C 12.2097 6.7238 0.0 0
M  V30 19 C 13.5434 7.4938 0.0 0
M  V30 20 C 14.8770 6.7238 0.0 0
M  V30 21 C 16.2109 7.4938 0.0 0
M  V30 22 C 17.5445 6.7238 0.0 0
M  V30 23 C 18.8782 7.4938 0.0 0
M  V30 24 C 20.2119 6.7238 0.0 0
M  V30 25 C 21.5457 7.4938 0.0 0
M  V30 26 C 22.8794 6.7238 0.0 0
M  V30 27 C 24.2130 7.4938 0.0 0
M  V30 28 N 3.4374 5.3901 0.0 0
M  V30 29 C 2.6673 6.7238 0.0 0 CFG=1
M  V30 30 C 4.2074 6.7238 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 28
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 29 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 30 13 CFG=1
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 28 29
M  V30 29 1 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 29 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl (2R,3S)-2-(formylamino)-3-hydroxyoctadecanoate
C21H41NO4
1606993-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0 CFG=1
M  V30 2 C 6.6687 4.6201 0.0 0 CFG=1
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 6.6687 6.1601 0.0 0
M  V30 7 O 2.6675 3.8501 0.0 0
M  V30 8 O 4.0012 6.1601 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 12 O 4.0012 0.0000 0.0 0
M  V30 13 C 10.6698 3.8501 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 12.0035 4.6201 0.0 0
M  V30 16 C 13.3372 3.8501 0.0 0
M  V30 17 C 14.6708 4.6201 0.0 0
M  V30 18 C 16.0046 3.8501 0.0 0
M  V30 19 C 17.3383 4.6201 0.0 0
M  V30 20 C 18.6720 3.8501 0.0 0
M  V30 21 C 20.0057 4.6201 0.0 0
M  V30 22 C 21.3395 3.8501 0.0 0
M  V30 23 C 22.6731 4.6201 0.0 0
M  V30 24 C 24.0068 3.8501 0.0 0
M  V30 25 C 25.3405 4.6201 0.0 0
M  V30 26 C 26.6743 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 24 1 24 25
M  V30 25 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1606993-83-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1606993-87-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-014-CAS-4000303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee:98%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A General Synthesis of Sphinganines through Multicomponent Catalytic
Asymmetric Aziridination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mukherjee, Munmun; Zhou, Yubai; Gupta, Anil K.; Guan, Yong; Wulff,
William D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2014), 2014(7), 1386-1390

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-(8α,9S)-cinchonan-9-ylbenzenepropanamide
C28H32N4O
1620137-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 2 N 6.9300 6.6684 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 C 4.6200 8.0020 0.0 0 CFG=1
M  V30 5 O 4.6200 5.3347 0.0 0
M  V30 6 C 3.0800 8.0020 0.0 0
M  V30 7 N 5.3900 9.3358 0.0 0
M  V30 8 C 13.5317 8.7289 0.0 0
M  V30 9 C 14.8305 7.9014 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0 CFG=2
M  V30 11 N 9.8522 6.8599 0.0 0 CFG=1
M  V30 12 C 10.1052 6.1623 0.0 0
M  V30 13 C 11.3361 6.8584 0.0 0
M  V30 14 C 8.7748 8.0530 0.0 0
M  V30 15 C 10.6542 8.0023 0.0 0 CFG=2
M  V30 16 C 12.1657 8.0179 0.0 0 CFG=2
M  V30 17 C 9.5228 9.2340 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 7.7000 2.6673 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 9.2400 2.6673 0.0 0
M  V30 23 C 4.6200 2.6673 0.0 0
M  V30 24 N 5.3900 1.3336 0.0 0
M  V30 25 C 7.7000 0.0000 0.0 0
M  V30 26 C 10.0100 1.3336 0.0 0
M  V30 27 C 9.2400 0.0000 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 3.0800 10.6694 0.0 0
M  V30 30 C 0.7700 9.3358 0.0 0
M  V30 31 C 2.3100 12.0031 0.0 0
M  V30 32 C 0.0000 10.6694 0.0 0
M  V30 33 C 0.7700 12.0031 0.0 0
M  V30 34 H 9.8137 3.9054 0.0 0
M  V30 35 H 11.2664 9.4154 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 10
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=3
M  V30 9 1 6 28
M  V30 10 2 8 9
M  V30 11 1 16 8 CFG=1
M  V30 12 1 10 11
M  V30 13 1 10 12 CFG=1
M  V30 14 1 10 34 CFG=3
M  V30 15 1 11 13 CFG=1
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 1 15 17
M  V30 22 1 15 35 CFG=1
M  V30 23 1 18 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 1 21 24
M  V30 29 1 21 25
M  V30 30 2 22 26
M  V30 31 2 23 24
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 34 2 28 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 2 30 32
M  V30 38 2 31 33
M  V30 39 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 4 10 11 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-N-(8α,9S)-Cinchonan-9-yl-α-(formylamino)benzenepropanamide
C29H32N4O2
1620137-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 5.3348 0.0 0 CFG=1
M  V30 2 N 6.9302 6.6685 0.0 0
M  V30 3 C 5.3901 6.6685 0.0 0
M  V30 4 C 4.6201 8.0022 0.0 0 CFG=1
M  V30 5 O 4.6201 5.3348 0.0 0
M  V30 6 C 3.0801 8.0022 0.0 0
M  V30 7 N 5.3901 9.3360 0.0 0
M  V30 8 C 4.6201 10.6697 0.0 0
M  V30 9 O 5.3901 12.0033 0.0 0
M  V30 10 C 13.5320 8.7291 0.0 0
M  V30 11 C 14.8308 7.9016 0.0 0
M  V30 12 C 9.2402 5.3348 0.0 0 CFG=2
M  V30 13 N 9.8524 6.8601 0.0 0 CFG=1
M  V30 14 C 10.1054 6.1624 0.0 0
M  V30 15 C 11.3363 6.8585 0.0 0
M  V30 16 C 8.7750 8.0531 0.0 0
M  V30 17 C 10.6544 8.0025 0.0 0 CFG=2
M  V30 18 C 12.1660 8.0180 0.0 0 CFG=2
M  V30 19 C 9.5230 9.2342 0.0 0
M  V30 20 C 6.9302 4.0012 0.0 0
M  V30 21 C 7.7002 2.6673 0.0 0
M  V30 22 C 5.3901 4.0012 0.0 0
M  V30 23 C 6.9302 1.3337 0.0 0
M  V30 24 C 9.2402 2.6673 0.0 0
M  V30 25 C 4.6201 2.6673 0.0 0
M  V30 26 N 5.3901 1.3337 0.0 0
M  V30 27 C 7.7002 0.0000 0.0 0
M  V30 28 C 10.0102 1.3337 0.0 0
M  V30 29 C 9.2402 0.0000 0.0 0
M  V30 30 C 2.3101 9.3360 0.0 0
M  V30 31 C 3.0801 10.6697 0.0 0
M  V30 32 C 0.7700 9.3360 0.0 0
M  V30 33 C 2.3101 12.0033 0.0 0
M  V30 34 C 0.0000 10.6697 0.0 0
M  V30 35 C 0.7700 12.0033 0.0 0
M  V30 36 H 9.8139 3.9055 0.0 0
M  V30 37 H 11.2666 9.4156 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 12
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=3
M  V30 9 1 6 30
M  V30 10 1 7 8
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 18 10 CFG=1
M  V30 14 1 12 13
M  V30 15 1 12 14 CFG=1
M  V30 16 1 12 36 CFG=3
M  V30 17 1 13 15 CFG=1
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 17 18
M  V30 23 1 17 19
M  V30 24 1 17 37 CFG=1
M  V30 25 1 20 21
M  V30 26 2 20 22
M  V30 27 2 21 23
M  V30 28 1 21 24
M  V30 29 1 22 25
M  V30 30 1 23 26
M  V30 31 1 23 27
M  V30 32 2 24 28
M  V30 33 2 25 26
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 4 12 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620137-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620137-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9788572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, literature preparation, 76% global yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel cinchona-amino acid hybrid organocatalysts for
asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrulas, Pedro; Benaglia, Maurizio; Burke, Anthony J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2014), 25(12), 923-935

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluorononyl 1,1,1-trifluoromethanesulfonate
C10H18F4O3S
1623804-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.6437 1.8973 0.0 0
M  V30 2 S 2.3101 2.6673 0.0 0 VAL=6
M  V30 3 C 4.9774 2.6673 0.0 0
M  V30 4 C 1.5400 1.3337 0.0 0
M  V30 5 O 0.9762 3.4374 0.0 0
M  V30 6 O 3.0801 4.0012 0.0 0
M  V30 7 C 6.3111 1.8973 0.0 0
M  V30 8 F 4.9774 4.2074 0.0 0
M  V30 9 F 2.3101 0.0000 0.0 0
M  V30 10 F 0.7700 0.0000 0.0 0
M  V30 11 F 0.0000 1.3337 0.0 0
M  V30 12 C 7.6449 2.6673 0.0 0
M  V30 13 C 8.9786 1.8973 0.0 0
M  V30 14 C 10.3122 2.6673 0.0 0
M  V30 15 C 11.6460 1.8973 0.0 0
M  V30 16 C 12.9797 2.6673 0.0 0
M  V30 17 C 14.3134 1.8973 0.0 0
M  V30 18 C 15.6471 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 4 11
M  V30 11 1 7 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Nonanol, 1-fluoro-, 1-formate
C10H19FO2
1665280-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 F 4.0010 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3358 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 2.3101 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1623804-85-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1665280-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-017-CAS-10826924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of 1-fluoroalkyl triflates with nucleophiles and bases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolbier, William R.; Okamoto, Masamune
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2015), 17933-41

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Diphenylacetylene
C14H10
501-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 C 8.4702 0.0000 0.0 0
M  V30 11 C 8.4702 2.6673 0.0 0
M  V30 12 C 10.0102 0.0000 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic-13C acid
CH2O2
1633-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0 MASS=13
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H12O2
2775383-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 C 4.0011 5.3900 0.0 0
M  V30 3 C 1.3336 5.3900 0.0 0 MASS=13
M  V30 4 O 1.3336 6.9300 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 C 2.6674 3.0800 0.0 0
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 0.7700 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 5.3900 0.0 0
M  V30 14 C 5.3347 3.0800 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6685 2.3100 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 501-65-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1633-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2775383-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32466808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, stereoselective, Schlenk tube used, in-situ generated
carbon monoxide
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient hydrocarboxylation of alkynes based on carbodiimide-regulated
in situ CO generation from HCOOH: An alternative indirect utilization of
CO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Shu-Mei; Yang, Zhi-Wen; Chen, Kai-Hong; Wang, Ning; He, Liang-Nian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Catalysis (2022), 43(7), 1642-1651

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-4-trifluoromethylaniline
C7H5F3IN
163444-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 I 6.1600 0.0000 0.0 0
M  V30 6 N 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Iodo-4-(trifluoromethyl)phenyl]formamide
C8H5F3INO
1632371-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 I 6.1600 0.0000 0.0 0
M  V30 6 N 7.7000 2.6673 0.0 0
M  V30 7 C 8.4700 4.0011 0.0 0
M  V30 8 O 10.0100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 163444-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1632371-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
2-[[(1,1-Dimethylethoxy)carbonyl]amino]propyl 2-chlorobenzoate
C15H20ClNO4
1660991-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 N 9.3358 1.5400 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 12.0033 1.5400 0.0 0
M  V30 10 O 10.6697 3.8501 0.0 0
M  V30 11 C 13.3370 2.3101 0.0 0
M  V30 12 C 12.5670 3.6437 0.0 0
M  V30 13 C 14.6707 3.0801 0.0 0
M  V30 14 C 14.1070 0.9764 0.0 0
M  V30 15 Cl 1.3337 0.0000 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 17
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-chloro-, formate (1:1)
C10H12ClNO2.CH2O2
1660991-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 5.3900 0.0 0
M  V30 2 O 5.3347 4.6200 0.0 0
M  V30 3 O 4.0011 6.9300 0.0 0
M  V30 4 C 6.6684 5.3900 0.0 0
M  V30 5 C 8.0021 4.6200 0.0 0
M  V30 6 C 9.3358 5.3900 0.0 0
M  V30 7 N 8.0021 3.0800 0.0 0
M  V30 8 Cl 1.3336 6.9300 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 1.3336 5.3900 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 0.0000 4.6200 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 4.6679 0.0000 0.0 0
M  V30 16 O 3.3342 0.7700 0.0 0
M  V30 17 O 6.0016 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1660991-40-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1660991-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-13619161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM stage 2 is preparative HPLC purification
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multidimensional De Novo Design Reveals 5-HT2B Receptor-Selective Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodrigues, Tiago; Hauser, Nadine; Reker, Daniel; Reutlinger, Michael;
Wunderlin, Tiffany; Hamon, Jacques; Koch, Guido; Schneider, Gisbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(5), 1551-1555

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[5-(3-Amino-4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulf...
C17H15F3N4O2S
170570-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 8.7795 0.0 0
M  V30 2 F 2.1511 10.0254 0.0 0
M  V30 3 F 0.0000 9.6848 0.0 0
M  V30 4 F 0.3406 7.5337 0.0 0
M  V30 5 N 2.8472 0.6403 0.0 0
M  V30 6 C 5.8599 0.0000 0.0 0
M  V30 7 S 11.0215 7.1043 0.0 0 VAL=6
M  V30 8 N 12.5615 7.1043 0.0 0
M  V30 9 O 11.0215 5.5643 0.0 0
M  V30 10 O 11.0215 8.6443 0.0 0
M  V30 11 C 3.9564 5.8585 0.0 0
M  V30 12 N 4.8615 7.1043 0.0 0
M  V30 13 C 2.4917 6.3343 0.0 0
M  V30 14 N 3.9564 8.3502 0.0 0
M  V30 15 C 2.4917 7.8743 0.0 0
M  V30 16 C 4.4323 4.3938 0.0 0
M  V30 17 C 3.4017 3.2494 0.0 0
M  V30 18 C 5.9385 4.0736 0.0 0
M  V30 19 C 3.8777 1.7847 0.0 0
M  V30 20 C 6.4144 2.6091 0.0 0
M  V30 21 C 5.3840 1.4645 0.0 0
M  V30 22 C 6.4015 7.1043 0.0 0
M  V30 23 C 7.1715 8.4380 0.0 0
M  V30 24 C 7.1715 5.7707 0.0 0
M  V30 25 C 8.7115 8.4380 0.0 0
M  V30 26 C 8.7115 5.7707 0.0 0
M  V30 27 C 9.4815 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 19
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 27
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 12 22
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[5-[3-(Formylamino)-4-methylphenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]ben...
C18H15F3N4O3S
911196-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6595 1.2459 0.0 0
M  V30 2 F 2.4137 2.1511 0.0 0
M  V30 3 F 2.7543 0.0000 0.0 0
M  V30 4 F 4.9054 0.3406 0.0 0
M  V30 5 N 2.6673 9.4815 0.0 0
M  V30 6 C 1.3336 8.7115 0.0 0
M  V30 7 O 0.0000 9.4815 0.0 0
M  V30 8 C 5.3347 11.0215 0.0 0
M  V30 9 S 12.4391 5.8599 0.0 0 VAL=6
M  V30 10 N 13.9038 6.3357 0.0 0
M  V30 11 O 12.9151 4.3953 0.0 0
M  V30 12 O 11.9632 7.3246 0.0 0
M  V30 13 C 5.3347 4.8615 0.0 0
M  V30 14 N 6.5806 3.9564 0.0 0
M  V30 15 C 4.0889 3.9564 0.0 0
M  V30 16 N 6.1047 2.4917 0.0 0
M  V30 17 C 4.5647 2.4917 0.0 0
M  V30 18 C 5.3347 6.4015 0.0 0
M  V30 19 C 4.0011 7.1715 0.0 0
M  V30 20 C 6.6684 7.1715 0.0 0
M  V30 21 C 4.0011 8.7115 0.0 0
M  V30 22 C 6.6684 8.7115 0.0 0
M  V30 23 C 5.3347 9.4815 0.0 0
M  V30 24 C 8.0453 4.4323 0.0 0
M  V30 25 C 8.3655 5.9386 0.0 0
M  V30 26 C 9.1897 3.4017 0.0 0
M  V30 27 C 9.8300 6.4144 0.0 0
M  V30 28 C 10.6544 3.8777 0.0 0
M  V30 29 C 10.9746 5.3840 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 2 6 7
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 9 12
M  V30 12 1 9 29
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 14 24
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 170570-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911196-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6225542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and anti-inflammatory evaluation of a series of novel
amino acid-binding 1,5-diarylpyrazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Ming-hui; Yin, Lin-lin; Cai, Mao-jun; Zhang, Wei-yu; Huang, Yue;
Wang, Xin; Zhu, Xing-zu; Shen, Jing-kang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Acta Pharmacologica Sinica (2005), 26(7), 865-872

$RFMT $RIREG SCHEME165 STEP1
$RXN



  3  1
$MOL
2-Oxa-6-azaspiro[3.3]heptane
C5H9NO
174-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1779 1.0889 0.0 0
M  V30 2 C 1.0889 0.0000 0.0 0
M  V30 3 C 3.2668 2.1779 0.0 0
M  V30 4 C 3.2668 0.0000 0.0 0
M  V30 5 C 1.0889 2.1779 0.0 0
M  V30 6 N 0.0000 1.0889 0.0 0
M  V30 7 O 4.3558 1.0889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[3-[3-Chloro-2-(4-formyl-3-methoxyphenyl)-4-pyridinyl]-2-(trifluoromethyl)p...
C27H18ClF3N2O4
2845305-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 6.6684 0.0 0
M  V30 2 F 8.2637 7.4384 0.0 0
M  V30 3 F 6.1601 8.0021 0.0 0
M  V30 4 F 5.5964 5.8984 0.0 0
M  V30 5 Cl 12.3201 5.3348 0.0 0
M  V30 6 O 2.3100 1.3337 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 O 0.0000 5.3348 0.0 0
M  V30 10 O 16.9402 10.6695 0.0 0
M  V30 11 C 16.1702 12.0032 0.0 0
M  V30 12 C 18.4802 8.0021 0.0 0
M  V30 13 O 19.2502 6.6684 0.0 0
M  V30 14 C 7.7001 5.3348 0.0 0
M  V30 15 C 9.2401 5.3348 0.0 0
M  V30 16 C 6.9301 4.0011 0.0 0
M  V30 17 C 10.0101 4.0011 0.0 0
M  V30 18 C 7.7001 2.6673 0.0 0
M  V30 19 C 9.2401 2.6673 0.0 0
M  V30 20 C 10.0101 6.6684 0.0 0
M  V30 21 C 11.5501 6.6684 0.0 0
M  V30 22 C 9.2401 8.0021 0.0 0
M  V30 23 C 12.3201 8.0021 0.0 0
M  V30 24 C 10.0101 9.3359 0.0 0
M  V30 25 N 11.5501 9.3359 0.0 0
M  V30 26 C 5.3901 4.0011 0.0 0
M  V30 27 N 4.6201 2.6673 0.0 0
M  V30 28 C 4.6201 5.3348 0.0 0
M  V30 29 C 3.0800 2.6673 0.0 0
M  V30 30 C 3.0800 5.3348 0.0 0
M  V30 31 C 2.3100 4.0011 0.0 0
M  V30 32 C 13.8602 8.0021 0.0 0
M  V30 33 C 14.6302 9.3359 0.0 0
M  V30 34 C 14.6302 6.6684 0.0 0
M  V30 35 C 16.1702 9.3359 0.0 0
M  V30 36 C 16.1702 6.6684 0.0 0
M  V30 37 C 16.9402 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 14
M  V30 5 1 5 21
M  V30 6 1 6 7
M  V30 7 1 6 29
M  V30 8 2 8 9
M  V30 9 1 8 31
M  V30 10 1 10 11
M  V30 11 1 10 35
M  V30 12 2 12 13
M  V30 13 1 12 37
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 1 16 26
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 32
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 6-[[4-[3-chloro-4-[3-[6-methoxy-5-(2-oxa-6-azaspiro[...
C37H36ClF3N4O4.CH2O2
2845296-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 58 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3465 6.3112 0.0 0
M  V30 2 O 4.8865 3.6437 0.0 0
M  V30 3 C 5.6565 2.3100 0.0 0
M  V30 4 C 9.5066 8.9785 0.0 0
M  V30 5 F 8.1730 8.2085 0.0 0
M  V30 6 F 8.7366 10.3122 0.0 0
M  V30 7 F 10.8403 9.7485 0.0 0
M  V30 8 Cl 14.8967 7.6448 0.0 0
M  V30 9 O 19.5168 12.9797 0.0 0
M  V30 10 C 18.7468 14.3133 0.0 0
M  V30 11 C 21.0569 10.3122 0.0 0
M  V30 12 C 1.4875 9.5309 0.0 0
M  V30 13 C 1.0890 8.0434 0.0 0
M  V30 14 C 2.9750 9.1324 0.0 0
M  V30 15 C 1.8861 11.0186 0.0 0
M  V30 16 C 0.0000 9.9296 0.0 0
M  V30 17 N 2.5765 7.6448 0.0 0
M  V30 18 O 0.3986 11.4172 0.0 0
M  V30 19 C 4.8865 6.3112 0.0 0
M  V30 20 C 5.6565 4.9774 0.0 0
M  V30 21 C 5.6565 7.6448 0.0 0
M  V30 22 N 7.1966 4.9774 0.0 0
M  V30 23 C 7.1966 7.6448 0.0 0
M  V30 24 C 7.9666 6.3112 0.0 0
M  V30 25 C 9.5066 6.3112 0.0 0
M  V30 26 C 10.2766 7.6448 0.0 0
M  V30 27 C 10.2766 4.9774 0.0 0
M  V30 28 C 11.8167 7.6448 0.0 0
M  V30 29 C 11.8167 4.9774 0.0 0
M  V30 30 C 12.5867 6.3112 0.0 0
M  V30 31 C 12.5867 8.9785 0.0 0
M  V30 32 C 14.1267 8.9785 0.0 0
M  V30 33 C 11.8167 10.3122 0.0 0
M  V30 34 C 14.8967 10.3122 0.0 0
M  V30 35 C 12.5867 11.6460 0.0 0
M  V30 36 N 14.1267 11.6460 0.0 0
M  V30 37 C 16.4368 10.3122 0.0 0
M  V30 38 C 17.2068 11.6460 0.0 0
M  V30 39 C 17.2068 8.9785 0.0 0
M  V30 40 C 18.7468 11.6460 0.0 0
M  V30 41 C 18.7468 8.9785 0.0 0
M  V30 42 C 19.5168 10.3122 0.0 0
M  V30 43 N 21.8269 8.9785 0.0 0
M  V30 44 C 21.4283 7.4910 0.0 0
M  V30 45 C 23.3144 8.5800 0.0 0
M  V30 46 C 22.9159 7.0924 0.0 0
M  V30 47 C 22.5173 5.6048 0.0 0
M  V30 48 C 24.4034 6.6937 0.0 0
M  V30 49 O 24.0048 5.2062 0.0 0
M  V30 50 C 12.2017 0.0000 0.0 0
M  V30 51 O 10.8680 0.7700 0.0 0
M  V30 52 O 13.5354 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 26
M  V30 9 1 8 32
M  V30 10 1 9 10
M  V30 11 1 9 40
M  V30 12 1 11 42
M  V30 13 1 11 43
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 28 31
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 34 37
M  V30 42 2 35 36
M  V30 43 2 37 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 2 39 41
M  V30 47 2 40 42
M  V30 48 1 41 42
M  V30 49 1 43 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 1 45 46
M  V30 53 1 46 47
M  V30 54 1 46 48
M  V30 55 1 47 49
M  V30 56 1 48 49
M  V30 57 1 50 51
M  V30 58 2 50 52
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 174-78-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2845305-29-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845296-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Diaminobenzonitrile
C7H7N3
17626-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 N 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole-6-carbonitrile
C8H5N3
6287-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2872 2.4782 0.0 0
M  V30 2 N 7.8272 2.4782 0.0 0
M  V30 3 C 2.4372 1.1444 0.0 0
M  V30 4 C 1.6672 2.4782 0.0 0
M  V30 5 C 3.9772 1.1444 0.0 0
M  V30 6 N 1.4068 0.0000 0.0 0
M  V30 7 C 2.4372 3.8118 0.0 0
M  V30 8 N 0.1609 2.1580 0.0 0
M  V30 9 C 4.7472 2.4782 0.0 0
M  V30 10 C 0.0000 0.6263 0.0 0
M  V30 11 C 3.9772 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17626-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6287-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-8518215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 1H-benzimidazole-5-carbonitrile A solution of
3,4-diaminobenzonitrile (1 g; 7.51 mmol) in formic acid (40 mL) was
heated at reflux for 3 hours then concentrated in vacuo to give a brown
oily residue. It was extracted with EtOAc from a saturated aqueous
solution of NaHCO3, dried over MgSO4 and evaporated under vacuum to give
the title compound as a light pink solid (1.05 g, 98%). 1H NMR (DMSO-d6):
δ 12.97 (br s, 1H), 8.48 (s, 1H), 8.16 (d, J = 0.8 Hz, 1H), 7.76 (d, J =
8.3 Hz, 1H), 7.59 (dd, J = 8.3, 1.5 Hz, 1H). LC/MS (Method B): 144.1
(M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazole fused heterocyclic derivatives as S1P1 receptor
agonists useful for the treatment of multiple sclerosis and other
immunoregulatory abnormality-related diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muzerelle, Mathilde; Quattropani, Anna; Montagne, Cyril; Dorbais, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010069949 A1 2010-06-24

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1H-Pyrazol-1-yl)aniline
C9H9N3
17635-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5298 1.3336 0.0 0
M  V30 2 C 3.9098 1.3336 0.0 0
M  V30 3 C 4.6798 2.6673 0.0 0
M  V30 4 C 4.6798 0.0000 0.0 0
M  V30 5 C 6.2198 2.6673 0.0 0
M  V30 6 C 6.2198 0.0000 0.0 0
M  V30 7 C 6.9898 1.3336 0.0 0
M  V30 8 N 2.3698 1.3336 0.0 0
M  V30 9 C 1.4645 2.5795 0.0 0
M  V30 10 N 1.4645 0.0878 0.0 0
M  V30 11 C 0.0000 2.1037 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(1H-pyrazol-1-yl)benzenamine
C10H11N3
1343377-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5299 1.3337 0.0 0
M  V30 2 C 9.2999 2.6673 0.0 0
M  V30 3 C 3.9098 1.3337 0.0 0
M  V30 4 C 4.6798 2.6673 0.0 0
M  V30 5 C 4.6798 0.0000 0.0 0
M  V30 6 C 6.2198 2.6673 0.0 0
M  V30 7 C 6.2198 0.0000 0.0 0
M  V30 8 C 6.9898 1.3337 0.0 0
M  V30 9 N 2.3698 1.3337 0.0 0
M  V30 10 C 1.4646 0.0878 0.0 0
M  V30 11 N 1.4646 2.5795 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 13 C 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17635-45-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1343377-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27917893
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyridine derivatives as histone demethylase
inhibitors for treating cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boloor, Amogh; Chen, Young K.; Wallace, Michael Brennan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015200709 A1 2015-12-30

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-nitrobenzenamine
C6H5FN2O2
17809-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Fluoro-6-nitrophenyl)formamide
C7H5FN2O3
1518128-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 4.0011 0.0 0
M  V30 2 C 0.7700 4.0011 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 N 5.3900 4.0011 0.0 0 VAL=5
M  V30 5 O 4.6200 5.3349 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 F 0.7700 1.3338 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 3.0800 0.0000 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17809-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1518128-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17145220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoreactivity of monofluorinated 2-azidobenzimidazoles towards
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kanitz, Nils Eckhard; Lindel, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2016), 71(12), 1287-1300

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-4-[[[3-(trifluoromethyl)phenyl]methyl]amino]benzoate
C16H15F3N2O2
1783872-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.8501 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 C 1.3338 3.8501 0.0 0
M  V30 4 F 2.1038 2.5164 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 F 0.5638 5.1838 0.0 0
M  V30 7 N 10.6698 6.1601 0.0 0
M  V30 8 C 13.3372 1.5400 0.0 0
M  V30 9 O 14.6708 2.3101 0.0 0
M  V30 10 O 13.3372 0.0000 0.0 0
M  V30 11 C 16.0046 1.5400 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 6.1601 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 10.6698 4.6201 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 12.0035 3.8501 0.0 0
M  V30 22 C 10.6698 1.5400 0.0 0
M  V30 23 C 12.0035 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 15
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 23
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[[3-(trifluoromethyl)phenyl]methyl]-1H-benzimidazole-5-carboxylate
C17H13F3N2O2
1783874-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.6017 0.0 0
M  V30 2 C 13.9284 1.7847 0.0 0
M  V30 3 O 14.4042 0.3202 0.0 0
M  V30 4 O 14.9588 2.9293 0.0 0
M  V30 5 C 15.9107 0.0000 0.0 0
M  V30 6 C 1.3338 2.6017 0.0 0
M  V30 7 F 0.5638 3.9354 0.0 0
M  V30 8 F 0.0000 1.8317 0.0 0
M  V30 9 F 2.1038 1.2681 0.0 0
M  V30 10 C 9.4091 2.7454 0.0 0
M  V30 11 N 8.0023 3.3717 0.0 0
M  V30 12 C 10.4397 3.8898 0.0 0
M  V30 13 C 9.8852 1.2807 0.0 0
M  V30 14 C 8.1633 4.9033 0.0 0
M  V30 15 C 11.9460 3.5696 0.0 0
M  V30 16 N 9.6697 5.2236 0.0 0
M  V30 17 C 11.3915 0.9605 0.0 0
M  V30 18 C 12.4219 2.1051 0.0 0
M  V30 19 C 5.3348 3.3717 0.0 0
M  V30 20 C 4.0012 2.6017 0.0 0
M  V30 21 C 5.3348 4.9118 0.0 0
M  V30 22 C 2.6675 3.3717 0.0 0
M  V30 23 C 4.0012 5.6818 0.0 0
M  V30 24 C 2.6675 4.9118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 22
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1783872-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1783874-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-14928876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Selective Inhibitor of Heme Biosynthesis in Endosymbiotic Bacteria
Elicits Antifilarial Activity In Vitro
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lentz, Christian S.; Halls, Victoria; Hannam, Jeffrey S.; Niebel, Bjoern;
Struebing, Uta; Mayer, Guenter; Hoerauf, Achim; Famulok, Michael; Pfarr,
Kenneth M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biology (Oxford, United Kingdom) (2013), 20(2), 177-187

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-α-(1-methylethyl)-3-(phenylmethoxy)benzeneethanamine
C19H25NO2
1802413-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 4.0012 0.0 0
M  V30 2 C 9.2402 5.3348 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 6.1601 0.0000 0.0 0
M  V30 5 C 3.8501 6.6685 0.0 0
M  V30 6 C 2.3101 6.6685 0.0 0
M  V30 7 C 1.5400 8.0023 0.0 0
M  V30 8 N 1.5400 5.3348 0.0 0
M  V30 9 C 0.0000 8.0023 0.0 0
M  V30 10 C 2.3101 9.3360 0.0 0
M  V30 11 C 6.9302 4.0012 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 C 6.1601 5.3348 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.8501 4.0012 0.0 0
M  V30 17 C 10.7802 5.3348 0.0 0
M  V30 18 C 11.5503 4.0012 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 13.0903 4.0012 0.0 0
M  V30 21 C 13.0903 6.6685 0.0 0
M  V30 22 C 13.8603 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-Methoxy-3-(phenylmethoxy)phenyl]methyl]-2-methylpropyl]formamide
C20H25NO3
1802413-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2402 4.0012 0.0 0
M  V30 2 C 10.0102 5.3348 0.0 0
M  V30 3 O 7.7002 1.3337 0.0 0
M  V30 4 C 6.9302 0.0000 0.0 0
M  V30 5 C 4.6201 6.6685 0.0 0
M  V30 6 C 3.0801 6.6685 0.0 0
M  V30 7 N 2.3101 5.3348 0.0 0
M  V30 8 C 2.3101 8.0023 0.0 0
M  V30 9 C 0.7700 5.3348 0.0 0
M  V30 10 C 0.7700 8.0023 0.0 0
M  V30 11 C 3.0801 9.3360 0.0 0
M  V30 12 O 0.0000 4.0012 0.0 0
M  V30 13 C 7.7002 4.0012 0.0 0
M  V30 14 C 6.9302 2.6675 0.0 0
M  V30 15 C 6.9302 5.3348 0.0 0
M  V30 16 C 5.3901 2.6675 0.0 0
M  V30 17 C 5.3901 5.3348 0.0 0
M  V30 18 C 4.6201 4.0012 0.0 0
M  V30 19 C 11.5503 5.3348 0.0 0
M  V30 20 C 12.3203 4.0012 0.0 0
M  V30 21 C 12.3203 6.6685 0.0 0
M  V30 22 C 13.8603 4.0012 0.0 0
M  V30 23 C 13.8603 6.6685 0.0 0
M  V30 24 C 14.6303 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1802413-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802413-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20786334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-α-(1-methylethyl)-3-(phenylmethoxy)benzeneethanamine
C19H25NO2
1802413-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 4.0012 0.0 0
M  V30 2 C 9.2402 5.3348 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 6.1601 0.0000 0.0 0
M  V30 5 C 3.8501 6.6685 0.0 0
M  V30 6 C 2.3101 6.6685 0.0 0
M  V30 7 C 1.5400 8.0023 0.0 0
M  V30 8 N 1.5400 5.3348 0.0 0
M  V30 9 C 0.0000 8.0023 0.0 0
M  V30 10 C 2.3101 9.3360 0.0 0
M  V30 11 C 6.9302 4.0012 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 C 6.1601 5.3348 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.8501 4.0012 0.0 0
M  V30 17 C 10.7802 5.3348 0.0 0
M  V30 18 C 11.5503 4.0012 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 13.0903 4.0012 0.0 0
M  V30 21 C 13.0903 6.6685 0.0 0
M  V30 22 C 13.8603 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[4-Methoxy-3-(phenylmethoxy)phenyl]methyl]-2-methylpropyl]formamide
C20H25NO3
1802413-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2402 4.0012 0.0 0
M  V30 2 C 10.0102 5.3348 0.0 0
M  V30 3 O 7.7002 1.3337 0.0 0
M  V30 4 C 6.9302 0.0000 0.0 0
M  V30 5 C 4.6201 6.6685 0.0 0
M  V30 6 C 3.0801 6.6685 0.0 0
M  V30 7 N 2.3101 5.3348 0.0 0
M  V30 8 C 2.3101 8.0023 0.0 0
M  V30 9 C 0.7700 5.3348 0.0 0
M  V30 10 C 0.7700 8.0023 0.0 0
M  V30 11 C 3.0801 9.3360 0.0 0
M  V30 12 O 0.0000 4.0012 0.0 0
M  V30 13 C 7.7002 4.0012 0.0 0
M  V30 14 C 6.9302 2.6675 0.0 0
M  V30 15 C 6.9302 5.3348 0.0 0
M  V30 16 C 5.3901 2.6675 0.0 0
M  V30 17 C 5.3901 5.3348 0.0 0
M  V30 18 C 4.6201 4.0012 0.0 0
M  V30 19 C 11.5503 5.3348 0.0 0
M  V30 20 C 12.3203 4.0012 0.0 0
M  V30 21 C 12.3203 6.6685 0.0 0
M  V30 22 C 13.8603 4.0012 0.0 0
M  V30 23 C 13.8603 6.6685 0.0 0
M  V30 24 C 14.6303 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1802413-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802413-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19625342
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-(4-methyl-1-piperaziny...
C26H32N6O4
1807698-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 4.0011 0.7700 0.0 0
M  V30 3 O 2.6673 3.0800 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 N 6.6684 0.7700 0.0 0
M  V30 6 N 9.3359 2.3100 0.0 0 VAL=5
M  V30 7 O 10.6695 3.0800 0.0 0
M  V30 8 O 9.3359 0.7700 0.0 0
M  V30 9 C 0.0000 7.7001 0.0 0
M  V30 10 C 5.3348 4.6200 0.0 0
M  V30 11 C 5.3348 3.0800 0.0 0
M  V30 12 C 6.6684 5.3900 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 N 4.0011 5.3900 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 4.0011 6.9301 0.0 0
M  V30 19 C 1.3337 5.3900 0.0 0
M  V30 20 C 2.6673 7.7001 0.0 0
M  V30 21 N 1.3337 6.9301 0.0 0
M  V30 22 C 9.3359 5.3900 0.0 0
M  V30 23 C 9.3359 6.9301 0.0 0
M  V30 24 C 10.6695 4.6200 0.0 0
M  V30 25 C 10.6695 7.7001 0.0 0
M  V30 26 C 12.0032 5.3900 0.0 0
M  V30 27 C 12.0032 6.9301 0.0 0
M  V30 28 N 10.9897 9.2063 0.0 0
M  V30 29 N 13.1477 7.9605 0.0 0
M  V30 30 C 12.5212 9.3673 0.0 0
M  V30 31 C 14.6540 7.6403 0.0 0
M  V30 32 C 15.1298 6.1756 0.0 0
M  V30 33 C 15.6844 8.7847 0.0 0
M  V30 34 C 16.6363 5.8554 0.0 0
M  V30 35 C 17.1908 8.4645 0.0 0
M  V30 36 C 17.6667 7.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 9 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 14 22
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1′-cyclohexyl-6-(4-methyl-1-piperazinyl)[4,5′-bi-1H-benzimidazole]-7-c...
C27H32N6O2
1807698-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 4.0011 0.7700 0.0 0
M  V30 3 O 2.6673 3.0800 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 0.0000 7.7001 0.0 0
M  V30 6 C 5.3348 4.6200 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 C 6.6684 5.3900 0.0 0
M  V30 9 C 6.6684 2.3100 0.0 0
M  V30 10 C 8.0021 4.6200 0.0 0
M  V30 11 C 8.0021 3.0800 0.0 0
M  V30 12 N 6.9886 0.8036 0.0 0
M  V30 13 N 9.1466 2.0494 0.0 0
M  V30 14 C 8.5203 0.6426 0.0 0
M  V30 15 N 4.0011 5.3900 0.0 0
M  V30 16 C 4.0011 6.9301 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 2.6673 7.7001 0.0 0
M  V30 19 C 1.3337 5.3900 0.0 0
M  V30 20 N 1.3337 6.9301 0.0 0
M  V30 21 C 9.3359 5.3900 0.0 0
M  V30 22 C 9.3359 6.9301 0.0 0
M  V30 23 C 10.6695 4.6200 0.0 0
M  V30 24 C 10.6695 7.7001 0.0 0
M  V30 25 C 12.0032 5.3900 0.0 0
M  V30 26 C 12.0032 6.9301 0.0 0
M  V30 27 N 10.9897 9.2063 0.0 0
M  V30 28 N 13.1477 7.9605 0.0 0
M  V30 29 C 12.5212 9.3673 0.0 0
M  V30 30 C 14.6540 7.6403 0.0 0
M  V30 31 C 15.1298 6.1756 0.0 0
M  V30 32 C 15.6844 8.7847 0.0 0
M  V30 33 C 16.6363 5.8554 0.0 0
M  V30 34 C 17.1908 8.4645 0.0 0
M  V30 35 C 17.6667 7.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 11
M  V30 14 1 10 21
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 2 25 26
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807698-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807698-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13823350
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128333 A1 2015-09-03

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4-(1-cyclohexyl-1H-benzimidazol-5-yl)-6-(4-methyl-1-piperaziny...
C26H32N6O4
1807698-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 4.0011 0.7700 0.0 0
M  V30 3 O 2.6673 3.0800 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 N 6.6684 0.7700 0.0 0
M  V30 6 N 9.3359 2.3100 0.0 0 VAL=5
M  V30 7 O 10.6695 3.0800 0.0 0
M  V30 8 O 9.3359 0.7700 0.0 0
M  V30 9 C 0.0000 7.7001 0.0 0
M  V30 10 C 5.3348 4.6200 0.0 0
M  V30 11 C 5.3348 3.0800 0.0 0
M  V30 12 C 6.6684 5.3900 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 8.0021 4.6200 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 N 4.0011 5.3900 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 4.0011 6.9301 0.0 0
M  V30 19 C 1.3337 5.3900 0.0 0
M  V30 20 C 2.6673 7.7001 0.0 0
M  V30 21 N 1.3337 6.9301 0.0 0
M  V30 22 C 9.3359 5.3900 0.0 0
M  V30 23 C 9.3359 6.9301 0.0 0
M  V30 24 C 10.6695 4.6200 0.0 0
M  V30 25 C 10.6695 7.7001 0.0 0
M  V30 26 C 12.0032 5.3900 0.0 0
M  V30 27 C 12.0032 6.9301 0.0 0
M  V30 28 N 10.9897 9.2063 0.0 0
M  V30 29 N 13.1477 7.9605 0.0 0
M  V30 30 C 12.5212 9.3673 0.0 0
M  V30 31 C 14.6540 7.6403 0.0 0
M  V30 32 C 15.1298 6.1756 0.0 0
M  V30 33 C 15.6844 8.7847 0.0 0
M  V30 34 C 16.6363 5.8554 0.0 0
M  V30 35 C 17.1908 8.4645 0.0 0
M  V30 36 C 17.6667 7.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 9 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 14 22
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1′-cyclohexyl-6-(4-methyl-1-piperazinyl)[4,5′-bi-1H-benzimidazole]-7-c...
C27H32N6O2
1807698-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 4.0011 0.7700 0.0 0
M  V30 3 O 2.6673 3.0800 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 0.0000 7.7001 0.0 0
M  V30 6 C 5.3348 4.6200 0.0 0
M  V30 7 C 5.3348 3.0800 0.0 0
M  V30 8 C 6.6684 5.3900 0.0 0
M  V30 9 C 6.6684 2.3100 0.0 0
M  V30 10 C 8.0021 4.6200 0.0 0
M  V30 11 C 8.0021 3.0800 0.0 0
M  V30 12 N 6.9886 0.8036 0.0 0
M  V30 13 N 9.1466 2.0494 0.0 0
M  V30 14 C 8.5203 0.6426 0.0 0
M  V30 15 N 4.0011 5.3900 0.0 0
M  V30 16 C 4.0011 6.9301 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 2.6673 7.7001 0.0 0
M  V30 19 C 1.3337 5.3900 0.0 0
M  V30 20 N 1.3337 6.9301 0.0 0
M  V30 21 C 9.3359 5.3900 0.0 0
M  V30 22 C 9.3359 6.9301 0.0 0
M  V30 23 C 10.6695 4.6200 0.0 0
M  V30 24 C 10.6695 7.7001 0.0 0
M  V30 25 C 12.0032 5.3900 0.0 0
M  V30 26 C 12.0032 6.9301 0.0 0
M  V30 27 N 10.9897 9.2063 0.0 0
M  V30 28 N 13.1477 7.9605 0.0 0
M  V30 29 C 12.5212 9.3673 0.0 0
M  V30 30 C 14.6540 7.6403 0.0 0
M  V30 31 C 15.1298 6.1756 0.0 0
M  V30 32 C 15.6844 8.7847 0.0 0
M  V30 33 C 16.6363 5.8554 0.0 0
M  V30 34 C 17.1908 8.4645 0.0 0
M  V30 35 C 17.6667 7.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 11
M  V30 14 1 10 21
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 2 25 26
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1807698-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807698-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-19302067
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed derivatives of imidazole useful as
pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Chevreuil, Francis; Faivre, Fabien; Lecointe, Nicolas;
Ledoussal, Benoit; Oliveira, Chrystelle; Simon, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2913330 A1 2015-09-02

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-6-(phenylmethoxy)-2-[(phenylthio)methyl]-3-quinolinecarboxylic acid...
C25H23N3O3S
1818354-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6673 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 O 5.3900 2.6673 0.0 0
M  V30 4 N 6.9300 0.0000 0.0 0
M  V30 5 O 13.8600 6.6684 0.0 0
M  V30 6 C 14.6300 5.3347 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 S 4.6200 6.6684 0.0 0
M  V30 9 O 12.3200 9.3358 0.0 0
M  V30 10 C 11.5500 10.6694 0.0 0
M  V30 11 C 10.0100 5.3347 0.0 0
M  V30 12 C 9.2400 6.6684 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 11.5500 5.3347 0.0 0
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 10.0100 8.0021 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 12.3200 6.6684 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 11.5500 8.0021 0.0 0
M  V30 21 C 16.1700 5.3347 0.0 0
M  V30 22 C 16.9400 4.0011 0.0 0
M  V30 23 C 16.9400 6.6684 0.0 0
M  V30 24 C 18.4800 4.0011 0.0 0
M  V30 25 C 18.4800 6.6684 0.0 0
M  V30 26 C 19.2500 5.3347 0.0 0
M  V30 27 C 3.0800 6.6684 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 2.3100 8.0021 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 0.7700 8.0021 0.0 0
M  V30 32 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 1 9 20
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-6-(phenylmethoxy)-2-[(phenylthio)methyl]-3-quinolinecarboxylic acid...
C26H23N3O4S
1818354-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 8.0020 0.0 0
M  V30 2 S 4.6200 9.3358 0.0 0
M  V30 3 O 12.3200 12.0031 0.0 0
M  V30 4 C 11.5500 13.3367 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 N 7.7000 4.0009 0.0 0
M  V30 7 O 5.3900 5.3347 0.0 0
M  V30 8 N 6.9300 2.6673 0.0 0
M  V30 9 C 7.7000 1.3336 0.0 0
M  V30 10 O 6.9300 0.0000 0.0 0
M  V30 11 O 13.8600 9.3358 0.0 0
M  V30 12 C 14.6300 8.0020 0.0 0
M  V30 13 C 9.2400 9.3358 0.0 0
M  V30 14 C 10.0100 8.0020 0.0 0
M  V30 15 N 7.7000 9.3358 0.0 0
M  V30 16 C 10.0100 10.6694 0.0 0
M  V30 17 C 9.2400 6.6684 0.0 0
M  V30 18 C 11.5500 8.0020 0.0 0
M  V30 19 C 6.9300 8.0020 0.0 0
M  V30 20 C 11.5500 10.6694 0.0 0
M  V30 21 C 7.7000 6.6684 0.0 0
M  V30 22 C 12.3200 9.3358 0.0 0
M  V30 23 C 3.0800 9.3358 0.0 0
M  V30 24 C 2.3100 8.0020 0.0 0
M  V30 25 C 2.3100 10.6694 0.0 0
M  V30 26 C 0.7700 8.0020 0.0 0
M  V30 27 C 0.7700 10.6694 0.0 0
M  V30 28 C 0.0000 9.3358 0.0 0
M  V30 29 C 16.1700 8.0020 0.0 0
M  V30 30 C 16.9400 9.3358 0.0 0
M  V30 31 C 16.9400 6.6684 0.0 0
M  V30 32 C 18.4800 9.3358 0.0 0
M  V30 33 C 18.4800 6.6684 0.0 0
M  V30 34 C 19.2500 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 22
M  V30 14 1 12 29
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1818354-34-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1818354-35-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3674079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-Hepatitis B Virus Evaluation of
7-Methoxy-3-heterocyclic quinolin-6-ols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yajing; Feng, Guobing; Ma, Zonghui; Xu, Chen; Guo, Zhuang; Gong,
Ping; Xu, Liying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2015), 348(11), 776-785

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-(2-aminopropoxy)benzonitrile
C10H13N3O
1820815-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 3.0800 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 C 8.0021 3.0800 0.0 0
M  V30 4 C 9.3358 3.8500 0.0 0
M  V30 5 N 8.0021 1.5400 0.0 0
M  V30 6 C 2.6674 1.5400 0.0 0
M  V30 7 N 2.6674 0.0000 0.0 0
M  V30 8 N 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 5.3900 0.0 0
M  V30 12 C 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 6.1600 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 3 6 7
M  V30 7 1 6 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Aminopropoxy)-4(3H)-quinazolinone
C11H13N3O2
1820815-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0021 3.0800 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 9.3358 2.3100 0.0 0
M  V30 6 O 4.0011 5.3900 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 12 N 0.0000 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 N 1.3336 5.3900 0.0 0
M  V30 15 C 2.6674 0.0000 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1820815-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1820815-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-10254929
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An expedient synthesis of oxazepino and oxazocino quinazolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hensbergen, Albertus Wijnand; Mills, Vanessa R.; Collins, Ian; Jones,
Alan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(46), 6478-6483

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 5-amino-2-methyl-, methyl ester
C9H11NO2
18595-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 N 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(formylamino)-2-methylbenzoate
C10H11NO3
2279975-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 O 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 N 6.6685 2.3101 0.0 0
M  V30 7 C 8.0023 3.0801 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18595-12-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2279975-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947922
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4R)-2-Methyl-4-thiazolidinecarboxylic acid
C5H9NO2S
190062-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.6218 0.0 0
M  V30 2 O 0.0000 1.8517 0.0 0
M  V30 3 O 1.3337 4.1618 0.0 0
M  V30 4 C 6.6363 1.4946 0.0 0
M  V30 5 C 2.6673 1.8517 0.0 0 CFG=2
M  V30 6 N 4.0743 2.4782 0.0 0
M  V30 7 C 2.8284 0.3202 0.0 0
M  V30 8 C 5.1048 1.3337 0.0 0 CFG=3
M  V30 9 S 4.3347 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=1
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R)-3-Formyl-2-methyl-4-thiazolidinecarboxylic acid
C6H9NO3S
864236-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.2418 3.9847 0.0 0
M  V30 2 O 0.7773 4.4606 0.0 0
M  V30 3 C 5.3026 2.6219 0.0 0
M  V30 4 O 5.3026 4.1619 0.0 0
M  V30 5 O 6.6363 1.8519 0.0 0
M  V30 6 C 0.0000 1.4948 0.0 0
M  V30 7 N 2.5620 2.4782 0.0 0
M  V30 8 C 3.9690 1.8519 0.0 0 CFG=2
M  V30 9 C 1.5316 1.3338 0.0 0 CFG=3
M  V30 10 C 3.8079 0.3202 0.0 0
M  V30 11 S 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 8 3 CFG=3
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 190062-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 864236-33-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-859486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of N-Formyl-1,3-thiazolidines.5 The
appropriate 2-substituted-1,3-thiazolidine-4-carboxylic acid (28.0 mmol)
was added to formic acid (28.0 mL), the temperature of the reaction
medium being kept below 25 °C. Acetic anhydride (19.2 mL) was added
dropwise to the solution while maintaining the temperature between 10 and
18 °C. After stirring for 20 h at a temperature of the order of 20 °C,
the solvent was evaporated off.
N-Formyl-2-methyl-1,3-thiazolidine-4-carboxylic acid 10a. The crude
product was purified by flash chromatography [hexane-ethyl acetate (1:1),
then hexane-ethyl acetate (1:3)] giving 10a as an oil (98%). IR (film)
1178, 1379, 1630, 1730 and 2933 cm-1; The 1H NMR spectrum showed the
presence of two diastereoisomers: 1H NMR 1.60 and 1.69 (3H, 2xd, J = 6.1
and 6.4), 3.27-3.51 (2H, m), 4.80-5.14 (1H, m), 5.20 and 5.35 (1H, 2xq, J
= 6.1 and 6.4, CHMe), 8.32 and 8.38 (1H, 2xs, CHO).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Vinyl- and C-Vinylpyrroles from Azafulvenium Methides. Flash Vacuum
Pyrolysis Route to 5-Oxo-5H-pyrrolizines and 1-Azabenzo[f]azulenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pinho e Melo, Teresa M. V. D.; Soares, Maria I. L.; Rocha Gonsalves,
Antonio M. d'A.; Paixao, Jose A.; Beja, Ana Matos; Silva, Manuela Ramos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(17), 6629-6638

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-4-methoxybenzenamine
C7H8INO
191348-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 I 1.5400 0.0000 0.0 0
M  V30 4 N 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodo-4-methoxyphenyl)formamide
C8H8INO2
1304143-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 7.7002 4.0010 0.0 0
M  V30 3 O 9.2402 4.0010 0.0 0
M  V30 4 I 5.3901 0.0000 0.0 0
M  V30 5 O 0.7700 2.6673 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 3.0801 4.0010 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 191348-14-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1304143-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
4-Chloro-α-(methoxymethyl)-α-phenylbenzenemethanol
C15H15ClO2
1977883-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.6200 0.0 0
M  V30 2 C 2.3100 4.6200 0.0 0
M  V30 3 O 3.8500 6.1600 0.0 0
M  V30 4 O 1.5400 5.9536 0.0 0
M  V30 5 C 0.0000 5.9536 0.0 0
M  V30 6 Cl 10.0100 4.6200 0.0 0
M  V30 7 C 5.3900 4.6200 0.0 0
M  V30 8 C 6.1600 5.9536 0.0 0
M  V30 9 C 6.1600 3.2864 0.0 0
M  V30 10 C 7.7000 5.9536 0.0 0
M  V30 11 C 7.7000 3.2864 0.0 0
M  V30 12 C 8.4700 4.6200 0.0 0
M  V30 13 C 3.8500 3.0800 0.0 0
M  V30 14 C 5.1836 2.3100 0.0 0
M  V30 15 C 2.5164 2.3100 0.0 0
M  V30 16 C 5.1836 0.7700 0.0 0
M  V30 17 C 2.5164 0.7700 0.0 0
M  V30 18 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneethanol, 4-chloro-β-phenyl-, 1-formate
C15H13ClO2
2413653-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.8500 5.3347 0.0 0
M  V30 3 O 2.3100 5.3347 0.0 0
M  V30 4 C 1.5400 6.6685 0.0 0
M  V30 5 O 0.0000 6.6685 0.0 0
M  V30 6 Cl 10.7800 4.0011 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 6.9300 5.3347 0.0 0
M  V30 9 C 6.9300 2.6674 0.0 0
M  V30 10 C 8.4700 5.3347 0.0 0
M  V30 11 C 8.4700 2.6674 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 4.6200 1.3338 0.0 0
M  V30 16 C 1.5400 1.3338 0.0 0
M  V30 17 C 3.8500 0.0000 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1977883-99-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413653-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-531-CAS-21848569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75-75-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 14024-61-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM glass pressure tube reactor, glove box is used, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Acid/Pd-Catalyzed Reductive Rearrangement of Glycol Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schmidt, Tanno A.; Ciszek, Benjamin; Kathe, Prasad; Fleischer, Ivana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(16), 3641-3646

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 2-(cyanoamino)-1,4-dihydro-6-methyl-4-(2-nitroph...
C14H13N5O4
2087929-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 1.3337 0.0 0
M  V30 3 O 3.0800 2.6675 0.0 0
M  V30 4 C 4.6201 0.0000 0.0 0
M  V30 5 N 3.0800 8.0022 0.0 0 VAL=5
M  V30 6 O 4.6201 8.0022 0.0 0
M  V30 7 O 2.3100 9.3359 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 N 7.7001 8.0022 0.0 0
M  V30 10 C 9.2401 8.0022 0.0 0
M  V30 11 N 10.7801 8.0022 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 N 5.3901 6.6684 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 6.9301 6.6684 0.0 0
M  V30 17 N 7.7001 5.3348 0.0 0
M  V30 18 C 3.0800 5.3348 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 0.7700 6.6684 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 3 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(2-nitrophenyl)-,...
C13H14N4O4.CH2O2
2087929-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9301 0.0 0
M  V30 2 O 8.0023 7.7001 0.0 0
M  V30 3 O 6.6685 5.3901 0.0 0
M  V30 4 C 9.3360 6.9301 0.0 0
M  V30 5 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 6 O 1.3337 6.9301 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 C 6.6685 10.0102 0.0 0
M  V30 9 N 1.3337 10.0102 0.0 0
M  V30 10 C 4.0012 6.9301 0.0 0
M  V30 11 C 5.3348 7.7001 0.0 0
M  V30 12 N 2.6675 7.7001 0.0 0
M  V30 13 C 5.3348 9.2402 0.0 0
M  V30 14 C 2.6675 9.2402 0.0 0
M  V30 15 N 4.0012 10.0102 0.0 0
M  V30 16 C 4.0012 5.3901 0.0 0
M  V30 17 C 2.6675 4.6201 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 2.6675 3.0800 0.0 0
M  V30 20 C 5.3348 3.0800 0.0 0
M  V30 21 C 4.0012 2.3100 0.0 0
M  V30 22 C 4.6680 0.0000 0.0 0
M  V30 23 O 3.3343 0.7700 0.0 0
M  V30 24 O 6.0017 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2087929-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2087929-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27294856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Biginelli reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the synthesis of deceptively simple Biginelli products through
N-CN bond cleavage
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fidencio, Juan Jesus Nolasco; Rios-Guerra, Hulme; Gonzalez-Villanueva,
Gilberto; Penieres-Carrillo, Jose Guillermo; Balcazar, Gustavo Guevara;
Nicolas-Vazquez, Ma. Ines; Delgado, Francisco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2016), 92(10), 1803-1809

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Formic acid-d
CHDO2
925-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 2.6673 0.7700 0.0 0
M  V30 3 O 0.0000 0.7700 0.0 0
M  V30 4 H 4.0010 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(1,2-Ethynediyl)bis[4-methoxybenzene]
C16H14O2
2132-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 1.3337 0.0 0
M  V30 2 C 8.4702 1.3337 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 O 14.6303 1.3337 0.0 0
M  V30 6 C 15.4003 0.0000 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 3.0801 0.0000 0.0 0
M  V30 11 C 3.0801 2.6673 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 10.0102 1.3337 0.0 0
M  V30 14 C 10.7802 0.0000 0.0 0
M  V30 15 C 10.7802 2.6673 0.0 0
M  V30 16 C 12.3203 0.0000 0.0 0
M  V30 17 C 12.3203 2.6673 0.0 0
M  V30 18 C 13.0903 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H16O4
2775383-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.9300 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 C 1.3336 7.7000 0.0 0
M  V30 4 O 0.0000 6.9300 0.0 0
M  V30 5 O 1.3336 9.2400 0.0 0
M  V30 6 O 2.6673 0.7700 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 O 9.3358 4.6200 0.0 0
M  V30 9 C 10.6694 5.3900 0.0 0
M  V30 10 C 2.6673 5.3900 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 1.3336 3.0800 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.3347 6.9300 0.0 0
M  V30 17 C 6.6684 7.7000 0.0 0
M  V30 18 C 5.3347 5.3900 0.0 0
M  V30 19 C 8.0021 6.9300 0.0 0
M  V30 20 C 6.6684 4.6200 0.0 0
M  V30 21 C 8.0021 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 925-94-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2132-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2775383-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32466805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, stereoselective, Schlenk tube used, in-situ generated
carbon monoxide
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient hydrocarboxylation of alkynes based on carbodiimide-regulated
in situ CO generation from HCOOH: An alternative indirect utilization of
CO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Shu-Mei; Yang, Zhi-Wen; Chen, Kai-Hong; Wang, Ning; He, Liang-Nian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Catalysis (2022), 43(7), 1642-1651

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrido[1,2-a]benzimidazole-7,8-diamine
C11H10N4
2202757-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.4000 0.0000 0.0 0
M  V30 2 N 8.9401 2.6673 0.0 0
M  V30 3 C 4.3200 2.6673 0.0 0
M  V30 4 N 2.8137 2.9876 0.0 0
M  V30 5 C 5.0900 4.0011 0.0 0
M  V30 6 C 5.0900 1.3336 0.0 0
M  V30 7 C 2.6527 4.5192 0.0 0
M  V30 8 C 1.5679 2.0824 0.0 0
M  V30 9 N 4.0596 5.1455 0.0 0
M  V30 10 C 6.6300 4.0011 0.0 0
M  V30 11 C 6.6300 1.3336 0.0 0
M  V30 12 C 1.2459 5.1455 0.0 0
M  V30 13 C 0.1609 2.7087 0.0 0
M  V30 14 C 7.4000 2.6673 0.0 0
M  V30 15 C 0.0000 4.2403 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 7 9
M  V30 12 1 7 12
M  V30 13 2 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazo[4,5-f]pyrido[1,2-a]benzimidazole
C12H8N4
73157-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5865 1.6538 0.0 0
M  V30 2 N 3.0800 1.3336 0.0 0
M  V30 3 C 4.7474 3.1855 0.0 0
M  V30 4 C 5.8323 0.7488 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 N 3.3404 3.8118 0.0 0
M  V30 8 C 6.1542 3.8118 0.0 0
M  V30 9 C 7.2391 1.3751 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 7.4000 2.9066 0.0 0
M  V30 13 N 8.6461 0.7488 0.0 0
M  V30 14 C 0.0000 1.3336 0.0 0
M  V30 15 N 8.9065 3.2268 0.0 0
M  V30 16 C 9.6765 1.8931 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 2 5 7
M  V30 10 1 5 10
M  V30 11 2 6 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2202757-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73157-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22753108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Quinone Derivatives of Benzannelated Heterocycles with
Bridgehead Nitrogen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Begunov, R. S.; Sokolov, A. A.; Filimonov, S. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2020), 56(8), 1383-1391

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrido[1,2-a]benzimidazole-7,8-diamine
C11H10N4
2202757-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.4000 0.0000 0.0 0
M  V30 2 N 8.9401 2.6673 0.0 0
M  V30 3 C 4.3200 2.6673 0.0 0
M  V30 4 N 2.8137 2.9876 0.0 0
M  V30 5 C 5.0900 4.0011 0.0 0
M  V30 6 C 5.0900 1.3336 0.0 0
M  V30 7 C 2.6527 4.5192 0.0 0
M  V30 8 C 1.5679 2.0824 0.0 0
M  V30 9 N 4.0596 5.1455 0.0 0
M  V30 10 C 6.6300 4.0011 0.0 0
M  V30 11 C 6.6300 1.3336 0.0 0
M  V30 12 C 1.2459 5.1455 0.0 0
M  V30 13 C 0.1609 2.7087 0.0 0
M  V30 14 C 7.4000 2.6673 0.0 0
M  V30 15 C 0.0000 4.2403 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 7 9
M  V30 12 1 7 12
M  V30 13 2 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazo[4,5-f]pyrido[1,2-a]benzimidazole
C12H8N4
73157-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5865 1.6538 0.0 0
M  V30 2 N 3.0800 1.3336 0.0 0
M  V30 3 C 4.7474 3.1855 0.0 0
M  V30 4 C 5.8323 0.7488 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 N 3.3404 3.8118 0.0 0
M  V30 8 C 6.1542 3.8118 0.0 0
M  V30 9 C 7.2391 1.3751 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 7.4000 2.9066 0.0 0
M  V30 13 N 8.6461 0.7488 0.0 0
M  V30 14 C 0.0000 1.3336 0.0 0
M  V30 15 N 8.9065 3.2268 0.0 0
M  V30 16 C 9.6765 1.8931 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 2 5 7
M  V30 10 1 5 10
M  V30 11 2 6 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2202757-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73157-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-18957935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient Way to the Synthesis of Polycyclic Fused Benzimidazole
Derivatives with a Bridgehead Nitrogen Atom
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Begunov, R. S.; Sokolov, A. A.; Gromova, D. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2018), 54(5), 747-750

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-(2-methylpropyl)-3-[(phenylmethyl)amino]butanamide
C15H24N2O2
2211037-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 9.3358 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 N 10.6697 2.3101 0.0 0
M  V30 9 O 9.3358 4.6201 0.0 0
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 C 13.3370 2.3101 0.0 0
M  V30 12 C 14.6707 3.0801 0.0 0
M  V30 13 C 13.3370 0.7700 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Formyl(phenylmethyl)amino]-2-hydroxy-N-(2-methylpropyl)butanamide
C16H24N2O3
2211039-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 2.6675 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 C 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 N 10.0102 5.3348 0.0 0
M  V30 11 O 10.0102 2.6675 0.0 0
M  V30 12 C 11.5503 5.3348 0.0 0
M  V30 13 C 12.3203 6.6687 0.0 0
M  V30 14 C 13.8603 6.6687 0.0 0
M  V30 15 C 11.5503 8.0023 0.0 0
M  V30 16 C 3.0801 4.0012 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.7700 5.3348 0.0 0
M  V30 21 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 16
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211037-93-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclohexylmethyl)-3-[(cyclopropylmethyl)amino]-2-hydroxybutanamide
C15H28N2O2
2211038-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 N 5.3348 2.3101 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 13.3370 2.3101 0.0 0
M  V30 12 C 14.1070 0.9764 0.0 0
M  V30 13 C 14.8770 2.3101 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 1.3337 0.0000 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclohexylmethyl)-3-[(cyclopropylmethyl)formylamino]-2-hydroxybutanamide
C16H28N2O3
2211039-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 1.5400 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3360 0.0000 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 O 8.0022 3.8501 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 O 6.6685 0.0000 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 13.3370 2.3101 0.0 0
M  V30 14 C 14.1070 3.6437 0.0 0
M  V30 15 C 14.8770 2.3101 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 16
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211038-00-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H34N2O2
2211038-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 N 4.6201 4.0012 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 7.7002 1.3338 0.0 0
M  V30 7 C 5.3901 0.0000 0.0 0
M  V30 8 N 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 3.0801 4.0012 0.0 0
M  V30 12 C 2.3101 5.3348 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 0.7700 5.3348 0.0 0
M  V30 15 C 0.7700 2.6675 0.0 0
M  V30 16 C 0.0000 4.0012 0.0 0
M  V30 17 C 11.5503 5.3348 0.0 0
M  V30 18 C 12.3203 4.0012 0.0 0
M  V30 19 C 12.3203 6.6687 0.0 0
M  V30 20 C 13.8603 4.0012 0.0 0
M  V30 21 C 13.8603 6.6687 0.0 0
M  V30 22 C 14.6303 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 11
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 17
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H34N2O3
2211039-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 O 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 O 6.6685 0.7700 0.0 0
M  V30 9 C 6.6685 5.3901 0.0 0
M  V30 10 N 9.3358 2.3101 0.0 0
M  V30 11 O 8.0022 4.6201 0.0 0
M  V30 12 C 10.6697 3.0801 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 12.0033 2.3101 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 21 C 13.3370 3.0801 0.0 0
M  V30 22 C 13.3370 0.0000 0.0 0
M  V30 23 C 14.6707 2.3101 0.0 0
M  V30 24 C 14.6707 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 10 12
M  V30 13 1 12 19
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211038-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112836
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[(Phenylmethyl)amino]cyclobutanepropanoic acid
C14H19NO2
2211040-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 N 4.6200 4.0011 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 O 3.0800 1.3336 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.1877 4.3996 0.0 0
M  V30 10 C 7.3015 5.4886 0.0 0
M  V30 11 C 8.7890 5.8871 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 0.7700 5.3347 0.0 0
M  V30 14 C 3.0800 6.6685 0.0 0
M  V30 15 C 0.0000 6.6685 0.0 0
M  V30 16 C 2.3100 8.0022 0.0 0
M  V30 17 C 0.7700 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 12
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[Formyl(phenylmethyl)amino]cyclobutanepropanoic acid
C15H19NO3
2211040-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.0279 2.6674 0.0 0
M  V30 2 C 4.4879 2.6674 0.0 0
M  V30 3 C 6.7979 4.0011 0.0 0
M  V30 4 C 6.7979 1.3338 0.0 0
M  V30 5 C 3.7179 1.3338 0.0 0
M  V30 6 C 3.7179 4.0011 0.0 0
M  V30 7 O 6.0279 0.0000 0.0 0
M  V30 8 O 2.1779 4.0011 0.0 0
M  V30 9 O 4.4879 5.3349 0.0 0
M  V30 10 C 8.3379 4.0011 0.0 0
M  V30 11 C 9.1079 5.3349 0.0 0
M  V30 12 C 9.1079 2.6674 0.0 0
M  V30 13 C 10.6479 5.3349 0.0 0
M  V30 14 C 10.6479 2.6674 0.0 0
M  V30 15 C 11.4179 4.0011 0.0 0
M  V30 16 C 2.1779 1.3338 0.0 0
M  V30 17 C 1.0889 2.4227 0.0 0
M  V30 18 C 1.0889 0.2449 0.0 0
M  V30 19 C 0.0000 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 10
M  V30 7 2 4 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211040-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211040-93-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19113114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(4-Chlorophenoxy)methyl]oxirane
C9H9ClO2
2212-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.6673 0.0 0
M  V30 2 O 3.6437 1.3337 0.0 0
M  V30 3 Cl 9.8039 1.3337 0.0 0
M  V30 4 C 1.3337 2.6673 0.0 0
M  V30 5 C 0.0000 3.4374 0.0 0
M  V30 6 O 0.0000 1.8973 0.0 0
M  V30 7 C 5.1838 1.3337 0.0 0
M  V30 8 C 5.9538 0.0000 0.0 0
M  V30 9 C 5.9538 2.6673 0.0 0
M  V30 10 C 7.4938 0.0000 0.0 0
M  V30 11 C 7.4938 2.6673 0.0 0
M  V30 12 C 8.2638 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 7
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 1-(4-chlorophenoxy)-3-iodo-, 2-formate
C10H10ClIO3
2389060-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 I 3.0800 0.0000 0.0 0
M  V30 8 O 0.0000 5.3349 0.0 0
M  V30 9 Cl 11.5500 4.0011 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3349 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2212-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2389060-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26792058
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile and efficient method for synthesis of β-iodocarboxylates from
terminal epoxides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Ye-Fu; Wei, Bo-Le; Wang, Wen-Qiong; Xuan, Li-Jiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2019), 60(50), 151353pp.

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenamine
C8H8F3N
22864-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-[4-(trifluoromethyl)phenyl]formamide
C9H8F3NO
1667785-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 8.4700 0.2064 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22864-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1667785-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20964073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly selective hydrogenation of amides catalysed by a molybdenum pincer
complex: scope and mechanism
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leischner, Thomas; Artus Suarez, Lluis; Spannenberg, Anke; Junge,
Kathrin; Nova, Ainara; Beller, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2019), 10(45), 10566-10576

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Amino-2,6-dimethyl-4-(methylamino)phenyl]acetamide
C11H17N3O
2407072-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 9.2400 4.0011 0.0 0
M  V30 5 C 5.3900 0.0000 0.0 0
M  V30 6 C 5.3900 5.3349 0.0 0
M  V30 7 N 2.3100 0.0000 0.0 0
M  V30 8 N 0.7700 2.6674 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 3.0800 1.3338 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,4,6-Trimethyl-1H-benzimidazol-5-yl)acetamide
C12H15N3O
2407072-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7307 0.0000 0.0 0
M  V30 2 C 0.0000 3.3777 0.0 0
M  V30 3 N 7.2708 2.6675 0.0 0
M  V30 4 C 8.0408 4.0011 0.0 0
M  V30 5 C 9.5808 4.0011 0.0 0
M  V30 6 O 7.2708 5.3350 0.0 0
M  V30 7 C 5.7307 5.3350 0.0 0
M  V30 8 C 3.4207 1.3338 0.0 0
M  V30 9 C 2.6507 2.6675 0.0 0
M  V30 10 C 4.9607 1.3338 0.0 0
M  V30 11 N 2.3903 0.1893 0.0 0
M  V30 12 C 3.4207 4.0011 0.0 0
M  V30 13 N 1.1444 2.3473 0.0 0
M  V30 14 C 5.7307 2.6675 0.0 0
M  V30 15 C 0.9835 0.8158 0.0 0
M  V30 16 C 4.9607 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2407072-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2407072-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22902088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted azaindoles as OGA inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartolome-Nebreda, Jose Manuel; Trabanco-Suarez, Andres Avelino;
Tresadern, Gary John; Martinez Lamenca, Carolina; Leenaerts, Joseph
Elisabeth; Oehlrich, Daniel; Buijnsters, Peter Jacobus Johannes Antonius;
Velter, Adriana Ingrid; Van Roosbroeck, Yves Emiel Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019243535 A1 2019-12-26

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyano-N-phenyl-5-(4-phenyl-1-piperazinyl)-2-thiophenecarboxamide
C22H21N5OS
2411701-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0187 1.0304 0.0 0
M  V30 2 N 5.8743 0.0000 0.0 0
M  V30 3 N 10.2959 0.3339 0.0 0
M  V30 4 C 11.9711 3.2355 0.0 0
M  V30 5 N 12.5976 4.6424 0.0 0
M  V30 6 O 12.8764 1.9896 0.0 0
M  V30 7 C 8.0022 3.5926 0.0 0
M  V30 8 C 8.1633 2.0610 0.0 0
M  V30 9 S 9.4091 4.2189 0.0 0
M  V30 10 C 9.6696 1.7409 0.0 0
M  V30 11 C 10.4396 3.0745 0.0 0
M  V30 12 N 6.6685 4.3626 0.0 0
M  V30 13 C 6.6685 5.9026 0.0 0
M  V30 14 C 5.3348 3.5926 0.0 0
M  V30 15 C 5.3348 6.6727 0.0 0
M  V30 16 C 4.0012 4.3626 0.0 0
M  V30 17 N 4.0012 5.9026 0.0 0
M  V30 18 C 2.6673 6.6727 0.0 0
M  V30 19 C 2.6673 8.2127 0.0 0
M  V30 20 C 1.3337 5.9026 0.0 0
M  V30 21 C 1.3337 8.9827 0.0 0
M  V30 22 C 0.0000 6.6727 0.0 0
M  V30 23 C 0.0000 8.2127 0.0 0
M  V30 24 C 14.1292 4.8034 0.0 0
M  V30 25 C 14.7555 6.2102 0.0 0
M  V30 26 C 15.0344 3.5575 0.0 0
M  V30 27 C 16.2871 6.3713 0.0 0
M  V30 28 C 16.5660 3.7184 0.0 0
M  V30 29 C 17.1923 5.1252 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 5 24
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-4-oxo-3-phenyl-6-(4-phenyl-1-piperazinyl)thieno[3,2-d]pyrimidine-...
C23H19N5OS
2412164-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6089 1.4647 0.0 0
M  V30 2 N 9.0848 0.0000 0.0 0
M  V30 3 O 5.3347 7.2552 0.0 0
M  V30 4 C 6.6684 3.4052 0.0 0
M  V30 5 C 6.6684 4.9452 0.0 0
M  V30 6 C 8.1330 2.9292 0.0 0
M  V30 7 N 5.3347 2.6352 0.0 0
M  V30 8 S 8.1330 5.4211 0.0 0
M  V30 9 C 5.3347 5.7152 0.0 0
M  V30 10 C 9.0383 4.1752 0.0 0
M  V30 11 C 4.0011 3.4052 0.0 0
M  V30 12 N 4.0011 4.9452 0.0 0
M  V30 13 N 10.5783 4.1752 0.0 0
M  V30 14 C 11.3483 2.8415 0.0 0
M  V30 15 C 11.3483 5.5089 0.0 0
M  V30 16 C 12.8883 2.8415 0.0 0
M  V30 17 C 12.8883 5.5089 0.0 0
M  V30 18 N 13.6583 4.1752 0.0 0
M  V30 19 C 2.6674 5.7152 0.0 0
M  V30 20 C 2.6674 7.2552 0.0 0
M  V30 21 C 1.3336 4.9452 0.0 0
M  V30 22 C 1.3336 8.0252 0.0 0
M  V30 23 C 0.0000 5.7152 0.0 0
M  V30 24 C 0.0000 7.2552 0.0 0
M  V30 25 C 15.1983 4.1752 0.0 0
M  V30 26 C 15.9683 2.8415 0.0 0
M  V30 27 C 15.9683 5.5089 0.0 0
M  V30 28 C 17.5083 2.8415 0.0 0
M  V30 29 C 17.5083 5.5089 0.0 0
M  V30 30 C 18.2783 4.1752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 2 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 12 19
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 18 25
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2411701-14-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412164-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22429689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New synthetic approaches to thieno[3,2-d]pyrimidine and
thieno[3,4-b]pyridine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Meligie, Salwa E. M.; Khalil, Nadia A.; El-Nassan, Hala B.; Ibraheem,
Ahmed A. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Papers (2020), 74(8), 2501-2514

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Phenylglycine methyl ester
C9H11NO2
24461-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 4.0011 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (αR)-α-(formylamino)benzeneacetate
C10H11NO3
78247-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 2 C 5.3347 4.6200 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 O 6.6685 3.8500 0.0 0
M  V30 5 O 5.3347 6.1600 0.0 0
M  V30 6 C 5.3347 1.5400 0.0 0
M  V30 7 C 8.0021 4.6200 0.0 0
M  V30 8 O 5.3347 0.0000 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24461-61-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 78247-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1389721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME190 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanol
CH4O
67-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lutetium texaphyrin
C52H72LuN5O14
246252-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  72 80 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5806 12.5958 0.0 0 CHG=-1 VAL=2
M  V30 2 C 11.9127 11.8279 0.0 0
M  V30 3 C 13.2321 12.6212 0.0 0
M  V30 4 O 11.9127 10.2879 0.0 0
M  V30 5 O 3.8309 12.0145 0.0 0 CHG=-1 VAL=2
M  V30 6 C 2.4988 11.2424 0.0 0
M  V30 7 C 1.1667 12.0145 0.0 0
M  V30 8 O 2.4988 9.7067 0.0 0
M  V30 9 C 1.4552 5.0061 0.0 0
M  V30 10 C 0.1230 5.7739 0.0 0
M  V30 11 C 1.3321 8.6036 0.0 0
M  V30 12 C 0.0000 7.8358 0.0 0
M  V30 13 C 10.6442 14.3479 0.0 0
M  V30 14 C 7.6406 15.3576 0.0 0
M  V30 15 C 6.3085 16.1255 0.0 0
M  V30 16 C 4.9764 15.3576 0.0 0
M  V30 17 O 3.6442 16.1255 0.0 0
M  V30 18 C 9.9188 0.0000 0.0 0
M  V30 19 C 5.7570 0.0764 0.0 0
M  V30 20 C 4.4248 0.8485 0.0 0
M  V30 21 C 3.0927 0.0764 0.0 0
M  V30 22 O 1.7606 0.8485 0.0 0
M  V30 23 O 16.7194 5.7315 0.0 0
M  V30 24 C 18.0558 6.4994 0.0 0
M  V30 25 C 19.3879 5.7315 0.0 0
M  V30 26 O 20.7200 6.4994 0.0 0
M  V30 27 C 22.0521 5.7315 0.0 0
M  V30 28 C 23.3842 6.4994 0.0 0
M  V30 29 O 24.7164 5.7315 0.0 0
M  V30 30 C 26.0485 6.4994 0.0 0
M  V30 31 C 27.3806 5.7315 0.0 0
M  V30 32 O 28.7127 6.4994 0.0 0
M  V30 33 C 30.0448 5.7315 0.0 0
M  V30 34 O 16.7194 9.0661 0.0 0
M  V30 35 C 18.0558 8.2982 0.0 0
M  V30 36 C 19.3879 9.0661 0.0 0
M  V30 37 O 20.7200 8.2982 0.0 0
M  V30 38 C 22.0521 9.0661 0.0 0
M  V30 39 C 23.3842 8.2982 0.0 0
M  V30 40 O 24.7164 9.0661 0.0 0
M  V30 41 C 26.0485 8.2982 0.0 0
M  V30 42 C 27.3806 9.0661 0.0 0
M  V30 43 O 28.7127 8.2982 0.0 0
M  V30 44 C 30.0448 9.0661 0.0 0
M  V30 45 Lu 7.6321 7.4836 0.0 0 CHG=3 VAL=7
M  V30 46 N 5.1588 7.5218 0.0 0 CHG=-1 VAL=3
M  V30 47 N 7.6321 11.0812 0.0 0 VAL=4
M  V30 48 N 7.6576 3.8564 0.0 0 VAL=4
M  V30 49 N 10.7079 5.6000 0.0 0 VAL=4
M  V30 50 N 10.8352 9.2570 0.0 0 VAL=4
M  V30 51 C 4.6582 5.4006 0.0 0
M  V30 52 C 4.1618 9.3333 0.0 0
M  V30 53 C 9.2824 11.9594 0.0 0
M  V30 54 C 6.6861 12.2945 0.0 0
M  V30 55 C 9.2188 2.8933 0.0 0
M  V30 56 C 6.6733 2.6770 0.0 0
M  V30 57 C 12.2733 6.4994 0.0 0
M  V30 58 C 10.7800 3.7927 0.0 0
M  V30 59 C 12.2733 8.2982 0.0 0
M  V30 60 C 10.8436 11.0558 0.0 0
M  V30 61 C 4.9085 3.4024 0.0 0
M  V30 62 C 2.7873 5.7739 0.0 0
M  V30 63 C 4.9721 12.0188 0.0 0
M  V30 64 C 2.6642 7.8358 0.0 0
M  V30 65 C 9.3970 13.4442 0.0 0
M  V30 66 C 7.6406 13.8176 0.0 0
M  V30 67 C 8.8667 1.1285 0.0 0
M  V30 68 C 7.0891 0.8485 0.0 0
M  V30 69 C 13.8345 5.6000 0.0 0
M  V30 70 C 13.8345 9.1976 0.0 0
M  V30 71 C 15.3873 6.4994 0.0 0
M  V30 72 C 15.3873 8.2982 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 45
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 45
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 62
M  V30 11 1 11 12
M  V30 12 1 11 64
M  V30 13 1 13 65
M  V30 14 1 14 15
M  V30 15 1 14 66
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 67
M  V30 19 1 19 20
M  V30 20 1 19 68
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 23 24
M  V30 24 1 23 71
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 34 35
M  V30 35 1 34 72
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 1 42 43
M  V30 44 1 43 44
M  V30 45 1 45 46
M  V30 46 1 45 47
M  V30 47 1 45 48
M  V30 48 1 45 49
M  V30 49 1 45 50
M  V30 50 1 46 51
M  V30 51 1 46 52
M  V30 52 2 47 53
M  V30 53 1 47 54
M  V30 54 2 48 55
M  V30 55 1 48 56
M  V30 56 1 49 57
M  V30 57 2 49 58
M  V30 58 1 50 59
M  V30 59 2 50 60
M  V30 60 1 51 61
M  V30 61 2 51 62
M  V30 62 1 52 63
M  V30 63 2 52 64
M  V30 64 1 53 60
M  V30 65 1 53 65
M  V30 66 2 54 63
M  V30 67 1 54 66
M  V30 68 1 55 58
M  V30 69 1 55 67
M  V30 70 2 56 61
M  V30 71 1 56 68
M  V30 72 1 57 59
M  V30 73 2 57 69
M  V30 74 2 59 70
M  V30 75 1 62 64
M  V30 76 2 65 66
M  V30 77 2 67 68
M  V30 78 1 69 71
M  V30 79 1 70 72
M  V30 80 2 71 72
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lutetium, [9,10-diethyl-20,21-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-4,15-d...
C50H68LuN5O14
402731-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  70 78 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5799 12.5949 0.0 0 CHG=-1 VAL=2
M  V30 2 C 11.9119 11.8271 0.0 0
M  V30 3 O 13.2312 12.6204 0.0 0
M  V30 4 O 3.8349 3.6864 0.0 0 CHG=-1 VAL=2
M  V30 5 C 2.5156 4.4797 0.0 0
M  V30 6 O 1.1836 3.7119 0.0 0
M  V30 7 C 1.4551 5.0057 0.0 0
M  V30 8 C 0.1230 5.7735 0.0 0
M  V30 9 C 1.3320 8.6030 0.0 0
M  V30 10 C 0.0000 7.8352 0.0 0
M  V30 11 C 10.6435 14.3469 0.0 0
M  V30 12 C 7.6401 15.3565 0.0 0
M  V30 13 C 6.3081 16.1244 0.0 0
M  V30 14 C 4.9760 15.3565 0.0 0
M  V30 15 O 3.6440 16.1244 0.0 0
M  V30 16 C 9.9181 0.0000 0.0 0
M  V30 17 C 5.7566 0.0764 0.0 0
M  V30 18 C 4.4245 0.8484 0.0 0
M  V30 19 C 3.0925 0.0764 0.0 0
M  V30 20 O 1.7605 0.8484 0.0 0
M  V30 21 O 16.7183 5.7311 0.0 0
M  V30 22 C 18.0545 6.4990 0.0 0
M  V30 23 C 19.3866 5.7311 0.0 0
M  V30 24 O 20.7186 6.4990 0.0 0
M  V30 25 C 22.0506 5.7311 0.0 0
M  V30 26 C 23.3826 6.4990 0.0 0
M  V30 27 O 24.7147 5.7311 0.0 0
M  V30 28 C 26.0467 6.4990 0.0 0
M  V30 29 C 27.3787 5.7311 0.0 0
M  V30 30 O 28.7108 6.4990 0.0 0
M  V30 31 C 30.0428 5.7311 0.0 0
M  V30 32 O 16.7183 9.0654 0.0 0
M  V30 33 C 18.0545 8.2976 0.0 0
M  V30 34 C 19.3866 9.0654 0.0 0
M  V30 35 O 20.7186 8.2976 0.0 0
M  V30 36 C 22.0506 9.0654 0.0 0
M  V30 37 C 23.3826 8.2976 0.0 0
M  V30 38 O 24.7147 9.0654 0.0 0
M  V30 39 C 26.0467 8.2976 0.0 0
M  V30 40 C 27.3787 9.0654 0.0 0
M  V30 41 O 28.7108 8.2976 0.0 0
M  V30 42 C 30.0428 9.0654 0.0 0
M  V30 43 Lu 7.6316 7.4831 0.0 0 CHG=3 VAL=7
M  V30 44 N 5.1584 7.5213 0.0 0 CHG=-1 VAL=3
M  V30 45 N 7.6316 11.0805 0.0 0 VAL=4
M  V30 46 N 7.6571 3.8561 0.0 0 VAL=4
M  V30 47 N 10.7071 5.5996 0.0 0 VAL=4
M  V30 48 N 10.8344 9.2563 0.0 0 VAL=4
M  V30 49 C 4.6579 5.4002 0.0 0
M  V30 50 C 4.1615 9.3327 0.0 0
M  V30 51 C 9.2818 11.9586 0.0 0
M  V30 52 C 6.6856 12.2937 0.0 0
M  V30 53 C 9.2182 2.8931 0.0 0
M  V30 54 C 6.6729 2.6768 0.0 0
M  V30 55 C 12.2725 6.4990 0.0 0
M  V30 56 C 10.7793 3.7925 0.0 0
M  V30 57 C 12.2725 8.2976 0.0 0
M  V30 58 C 10.8429 11.0550 0.0 0
M  V30 59 C 4.9081 3.4022 0.0 0
M  V30 60 C 2.7871 5.7735 0.0 0
M  V30 61 C 4.9718 12.0180 0.0 0
M  V30 62 C 2.6641 7.8352 0.0 0
M  V30 63 C 9.3963 13.4433 0.0 0
M  V30 64 C 7.6401 13.8166 0.0 0
M  V30 65 C 8.8661 1.1284 0.0 0
M  V30 66 C 7.0886 0.8484 0.0 0
M  V30 67 C 13.8336 5.5996 0.0 0
M  V30 68 C 13.8336 9.1969 0.0 0
M  V30 69 C 15.3862 6.4990 0.0 0
M  V30 70 C 15.3862 8.2976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 43
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 43
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 60
M  V30 9 1 9 10
M  V30 10 1 9 62
M  V30 11 1 11 63
M  V30 12 1 12 13
M  V30 13 1 12 64
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 65
M  V30 17 1 17 18
M  V30 18 1 17 66
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 69
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 32 33
M  V30 33 1 32 70
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 1 43 44
M  V30 44 1 43 45
M  V30 45 1 43 46
M  V30 46 1 43 47
M  V30 47 1 43 48
M  V30 48 1 44 49
M  V30 49 1 44 50
M  V30 50 2 45 51
M  V30 51 1 45 52
M  V30 52 2 46 53
M  V30 53 1 46 54
M  V30 54 1 47 55
M  V30 55 2 47 56
M  V30 56 1 48 57
M  V30 57 2 48 58
M  V30 58 1 49 59
M  V30 59 2 49 60
M  V30 60 1 50 61
M  V30 61 2 50 62
M  V30 62 1 51 58
M  V30 63 1 51 63
M  V30 64 2 52 61
M  V30 65 1 52 64
M  V30 66 1 53 56
M  V30 67 1 53 65
M  V30 68 2 54 59
M  V30 69 1 54 66
M  V30 70 1 55 57
M  V30 71 2 55 67
M  V30 72 2 57 68
M  V30 73 1 60 62
M  V30 74 2 63 64
M  V30 75 2 65 66
M  V30 76 1 67 69
M  V30 77 1 68 70
M  V30 78 2 69 70
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 246252-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402731-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-7639347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A. Preparation of a Compound of Formula I
where M is Lutetium, AL is Gluconate, and n is 2 Ambersep® 900 (OH) anion
exchange resin (100 mL, 90 meq) was slurried in 200 mL of deionized
water, poured into a Biorad® column and washed with 500 mL of deionized
water until the pH of the eluant was approximately 7. The resin was
poured out of the column into an Erlenmeyer flask and the excess solvent
decanted. 80 g of gluconic acid were dissolved in 200 mL of deionized
water. 100 mL of the aqueous solution were added to the flask and stirred
for one hour. The resultant mixture was poured onto the Biorad column and
the excess solution drained. The remaining 150 mL of gluconic acid
solution was then passed through the column followed by 500 mL of water
(until the pH μ4) and methanol (500 mL). LuTex diacetate (1.1687 g, 1.002
mmol) was dissolved in 50 mL of methanol and passed through the Biorad
column. The column was washed with 25 mL of methanol. The collected
eluant was passed through the column a second time and the column was
washed with an additional 100 mL of methanol. The combined solutions from
the column were collected and the methanol was evaporated under reduced
pressure. The green solid was dried overnight under vacuum to afford the
lutetium complex of
4,5-diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]pentaaza
pentacyclo- [20.2.1.13-6.18-11.014-19]heptacosa-1,3,5,7,9,11(27),12,14,
16,18,20,22(25),23-tridecaene bis gluconate. (Alternatively, LuTex bis
gluconate). 2) Substituting formic acid for gluconic acid gave the
lutetium complex of:
4,5-diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-pentaazapentacyclo
[20.2.1.13-6.18-11.014-19]heptacosa-1,3,5,7,9,11(27),12,14,16-18,20,22(25),
23-tridecaene bis formate. (LuTex bis formate) (0.885 mmol, 98.2% yield).
Characterizing analytical data are m.w.= 1138.07; ε(methanol)=41700 (at
733 nm), 126400 (at 475 nm); K(octanol/water)=0.02 (0.5 mg/ml), 0.02
(0.05 mg/ml); pH=5.5 (H2O); pH(octanol/water)= 5.1 (0.5 mg/ml), 5.6 (0.05
mg/ml).
$DTYPE RXN:VAR(1):NOTES
$DATUM Ambersep 900(OH) anion exchange resin was used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel metallotexaphyrin derivatives and their use in
pharmaceutical compositions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mody, Tarak D.; Galanter, Joshua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040171602 A1 2004-09-02

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lutetium texaphyrin
C52H72LuN5O14
246252-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  72 80 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5806 12.5958 0.0 0 CHG=-1 VAL=2
M  V30 2 C 11.9127 11.8279 0.0 0
M  V30 3 C 13.2321 12.6212 0.0 0
M  V30 4 O 11.9127 10.2879 0.0 0
M  V30 5 O 3.8309 12.0145 0.0 0 CHG=-1 VAL=2
M  V30 6 C 2.4988 11.2424 0.0 0
M  V30 7 C 1.1667 12.0145 0.0 0
M  V30 8 O 2.4988 9.7067 0.0 0
M  V30 9 C 1.4552 5.0061 0.0 0
M  V30 10 C 0.1230 5.7739 0.0 0
M  V30 11 C 1.3321 8.6036 0.0 0
M  V30 12 C 0.0000 7.8358 0.0 0
M  V30 13 C 10.6442 14.3479 0.0 0
M  V30 14 C 7.6406 15.3576 0.0 0
M  V30 15 C 6.3085 16.1255 0.0 0
M  V30 16 C 4.9764 15.3576 0.0 0
M  V30 17 O 3.6442 16.1255 0.0 0
M  V30 18 C 9.9188 0.0000 0.0 0
M  V30 19 C 5.7570 0.0764 0.0 0
M  V30 20 C 4.4248 0.8485 0.0 0
M  V30 21 C 3.0927 0.0764 0.0 0
M  V30 22 O 1.7606 0.8485 0.0 0
M  V30 23 O 16.7194 5.7315 0.0 0
M  V30 24 C 18.0558 6.4994 0.0 0
M  V30 25 C 19.3879 5.7315 0.0 0
M  V30 26 O 20.7200 6.4994 0.0 0
M  V30 27 C 22.0521 5.7315 0.0 0
M  V30 28 C 23.3842 6.4994 0.0 0
M  V30 29 O 24.7164 5.7315 0.0 0
M  V30 30 C 26.0485 6.4994 0.0 0
M  V30 31 C 27.3806 5.7315 0.0 0
M  V30 32 O 28.7127 6.4994 0.0 0
M  V30 33 C 30.0448 5.7315 0.0 0
M  V30 34 O 16.7194 9.0661 0.0 0
M  V30 35 C 18.0558 8.2982 0.0 0
M  V30 36 C 19.3879 9.0661 0.0 0
M  V30 37 O 20.7200 8.2982 0.0 0
M  V30 38 C 22.0521 9.0661 0.0 0
M  V30 39 C 23.3842 8.2982 0.0 0
M  V30 40 O 24.7164 9.0661 0.0 0
M  V30 41 C 26.0485 8.2982 0.0 0
M  V30 42 C 27.3806 9.0661 0.0 0
M  V30 43 O 28.7127 8.2982 0.0 0
M  V30 44 C 30.0448 9.0661 0.0 0
M  V30 45 Lu 7.6321 7.4836 0.0 0 CHG=3 VAL=7
M  V30 46 N 5.1588 7.5218 0.0 0 CHG=-1 VAL=3
M  V30 47 N 7.6321 11.0812 0.0 0 VAL=4
M  V30 48 N 7.6576 3.8564 0.0 0 VAL=4
M  V30 49 N 10.7079 5.6000 0.0 0 VAL=4
M  V30 50 N 10.8352 9.2570 0.0 0 VAL=4
M  V30 51 C 4.6582 5.4006 0.0 0
M  V30 52 C 4.1618 9.3333 0.0 0
M  V30 53 C 9.2824 11.9594 0.0 0
M  V30 54 C 6.6861 12.2945 0.0 0
M  V30 55 C 9.2188 2.8933 0.0 0
M  V30 56 C 6.6733 2.6770 0.0 0
M  V30 57 C 12.2733 6.4994 0.0 0
M  V30 58 C 10.7800 3.7927 0.0 0
M  V30 59 C 12.2733 8.2982 0.0 0
M  V30 60 C 10.8436 11.0558 0.0 0
M  V30 61 C 4.9085 3.4024 0.0 0
M  V30 62 C 2.7873 5.7739 0.0 0
M  V30 63 C 4.9721 12.0188 0.0 0
M  V30 64 C 2.6642 7.8358 0.0 0
M  V30 65 C 9.3970 13.4442 0.0 0
M  V30 66 C 7.6406 13.8176 0.0 0
M  V30 67 C 8.8667 1.1285 0.0 0
M  V30 68 C 7.0891 0.8485 0.0 0
M  V30 69 C 13.8345 5.6000 0.0 0
M  V30 70 C 13.8345 9.1976 0.0 0
M  V30 71 C 15.3873 6.4994 0.0 0
M  V30 72 C 15.3873 8.2982 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 45
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 45
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 62
M  V30 11 1 11 12
M  V30 12 1 11 64
M  V30 13 1 13 65
M  V30 14 1 14 15
M  V30 15 1 14 66
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 18 67
M  V30 19 1 19 20
M  V30 20 1 19 68
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 23 24
M  V30 24 1 23 71
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 34 35
M  V30 35 1 34 72
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 1 42 43
M  V30 44 1 43 44
M  V30 45 1 45 46
M  V30 46 1 45 47
M  V30 47 1 45 48
M  V30 48 1 45 49
M  V30 49 1 45 50
M  V30 50 1 46 51
M  V30 51 1 46 52
M  V30 52 2 47 53
M  V30 53 1 47 54
M  V30 54 2 48 55
M  V30 55 1 48 56
M  V30 56 1 49 57
M  V30 57 2 49 58
M  V30 58 1 50 59
M  V30 59 2 50 60
M  V30 60 1 51 61
M  V30 61 2 51 62
M  V30 62 1 52 63
M  V30 63 2 52 64
M  V30 64 1 53 60
M  V30 65 1 53 65
M  V30 66 2 54 63
M  V30 67 1 54 66
M  V30 68 1 55 58
M  V30 69 1 55 67
M  V30 70 2 56 61
M  V30 71 1 56 68
M  V30 72 1 57 59
M  V30 73 2 57 69
M  V30 74 2 59 70
M  V30 75 1 62 64
M  V30 76 2 65 66
M  V30 77 2 67 68
M  V30 78 1 69 71
M  V30 79 1 70 72
M  V30 80 2 71 72
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lutetium, [9,10-diethyl-20,21-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-4,15-d...
C50H68LuN5O14
402731-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  70 78 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.5799 12.5949 0.0 0 CHG=-1 VAL=2
M  V30 2 C 11.9119 11.8271 0.0 0
M  V30 3 O 13.2312 12.6204 0.0 0
M  V30 4 O 3.8349 3.6864 0.0 0 CHG=-1 VAL=2
M  V30 5 C 2.5156 4.4797 0.0 0
M  V30 6 O 1.1836 3.7119 0.0 0
M  V30 7 C 1.4551 5.0057 0.0 0
M  V30 8 C 0.1230 5.7735 0.0 0
M  V30 9 C 1.3320 8.6030 0.0 0
M  V30 10 C 0.0000 7.8352 0.0 0
M  V30 11 C 10.6435 14.3469 0.0 0
M  V30 12 C 7.6401 15.3565 0.0 0
M  V30 13 C 6.3081 16.1244 0.0 0
M  V30 14 C 4.9760 15.3565 0.0 0
M  V30 15 O 3.6440 16.1244 0.0 0
M  V30 16 C 9.9181 0.0000 0.0 0
M  V30 17 C 5.7566 0.0764 0.0 0
M  V30 18 C 4.4245 0.8484 0.0 0
M  V30 19 C 3.0925 0.0764 0.0 0
M  V30 20 O 1.7605 0.8484 0.0 0
M  V30 21 O 16.7183 5.7311 0.0 0
M  V30 22 C 18.0545 6.4990 0.0 0
M  V30 23 C 19.3866 5.7311 0.0 0
M  V30 24 O 20.7186 6.4990 0.0 0
M  V30 25 C 22.0506 5.7311 0.0 0
M  V30 26 C 23.3826 6.4990 0.0 0
M  V30 27 O 24.7147 5.7311 0.0 0
M  V30 28 C 26.0467 6.4990 0.0 0
M  V30 29 C 27.3787 5.7311 0.0 0
M  V30 30 O 28.7108 6.4990 0.0 0
M  V30 31 C 30.0428 5.7311 0.0 0
M  V30 32 O 16.7183 9.0654 0.0 0
M  V30 33 C 18.0545 8.2976 0.0 0
M  V30 34 C 19.3866 9.0654 0.0 0
M  V30 35 O 20.7186 8.2976 0.0 0
M  V30 36 C 22.0506 9.0654 0.0 0
M  V30 37 C 23.3826 8.2976 0.0 0
M  V30 38 O 24.7147 9.0654 0.0 0
M  V30 39 C 26.0467 8.2976 0.0 0
M  V30 40 C 27.3787 9.0654 0.0 0
M  V30 41 O 28.7108 8.2976 0.0 0
M  V30 42 C 30.0428 9.0654 0.0 0
M  V30 43 Lu 7.6316 7.4831 0.0 0 CHG=3 VAL=7
M  V30 44 N 5.1584 7.5213 0.0 0 CHG=-1 VAL=3
M  V30 45 N 7.6316 11.0805 0.0 0 VAL=4
M  V30 46 N 7.6571 3.8561 0.0 0 VAL=4
M  V30 47 N 10.7071 5.5996 0.0 0 VAL=4
M  V30 48 N 10.8344 9.2563 0.0 0 VAL=4
M  V30 49 C 4.6579 5.4002 0.0 0
M  V30 50 C 4.1615 9.3327 0.0 0
M  V30 51 C 9.2818 11.9586 0.0 0
M  V30 52 C 6.6856 12.2937 0.0 0
M  V30 53 C 9.2182 2.8931 0.0 0
M  V30 54 C 6.6729 2.6768 0.0 0
M  V30 55 C 12.2725 6.4990 0.0 0
M  V30 56 C 10.7793 3.7925 0.0 0
M  V30 57 C 12.2725 8.2976 0.0 0
M  V30 58 C 10.8429 11.0550 0.0 0
M  V30 59 C 4.9081 3.4022 0.0 0
M  V30 60 C 2.7871 5.7735 0.0 0
M  V30 61 C 4.9718 12.0180 0.0 0
M  V30 62 C 2.6641 7.8352 0.0 0
M  V30 63 C 9.3963 13.4433 0.0 0
M  V30 64 C 7.6401 13.8166 0.0 0
M  V30 65 C 8.8661 1.1284 0.0 0
M  V30 66 C 7.0886 0.8484 0.0 0
M  V30 67 C 13.8336 5.5996 0.0 0
M  V30 68 C 13.8336 9.1969 0.0 0
M  V30 69 C 15.3862 6.4990 0.0 0
M  V30 70 C 15.3862 8.2976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 43
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 43
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 60
M  V30 9 1 9 10
M  V30 10 1 9 62
M  V30 11 1 11 63
M  V30 12 1 12 13
M  V30 13 1 12 64
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 65
M  V30 17 1 17 18
M  V30 18 1 17 66
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 69
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 32 33
M  V30 33 1 32 70
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 1 43 44
M  V30 44 1 43 45
M  V30 45 1 43 46
M  V30 46 1 43 47
M  V30 47 1 43 48
M  V30 48 1 44 49
M  V30 49 1 44 50
M  V30 50 2 45 51
M  V30 51 1 45 52
M  V30 52 2 46 53
M  V30 53 1 46 54
M  V30 54 1 47 55
M  V30 55 2 47 56
M  V30 56 1 48 57
M  V30 57 2 48 58
M  V30 58 1 49 59
M  V30 59 2 49 60
M  V30 60 1 50 61
M  V30 61 2 50 62
M  V30 62 1 51 58
M  V30 63 1 51 63
M  V30 64 2 52 61
M  V30 65 1 52 64
M  V30 66 1 53 56
M  V30 67 1 53 65
M  V30 68 2 54 59
M  V30 69 1 54 66
M  V30 70 1 55 57
M  V30 71 2 55 67
M  V30 72 2 57 68
M  V30 73 1 60 62
M  V30 74 2 63 64
M  V30 75 2 65 66
M  V30 76 1 67 69
M  V30 77 1 68 70
M  V30 78 2 69 70
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(1):AMD
$DATUM metallotexaphyrin complex
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 246252-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402731-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-14739661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 197809-12-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A. Preparation of a Compound of Formula I
where M is Lutetium. AL is gluconate, and n is2 Ambersep® 900 (OH) anion
exchange resin (~100 mL, ~90 meq) was slurried in 200 mL of deionized
water, poured into a Biorad® column and washed with 500 mL of deionized
water until the pH of the eluant was approximately 7. The resin was
poured out of the column into an Erlenmeyer flask and the excess solvent
decanted. 80 g of gluconic acid were dissolved in 200 mL of deionized
water. 100 mL of the aqueous solution were added to the flask and stirred
for one hour. The resultant mixture was poured onto the Biorad column and
the excess solution drained. The remaining 150 mL of gluconic acid
solution was then passed through the column followed by 500 mL of water
(until the pH μ 4) and methanol (500mL). LuTex diacetate (1.1687g,
1.002mmol) was dissolved in 50 mL of methanol and passed through the
Biorad column. The column was washed with 25 mL of methanol.The collected
eluant was passed through the column a second time and the column was
washed with an additional 100 mL of methanol. The combined solutions from
the column were collected and the methanol was evaporated under reduced
pressure. The green solid was dried overnight under vacuum to afford the
lutetium complex of
4,5-diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]pentaazapentacyclo-[20.2.1.1
3,6]8,11'.014,19]heptacosa-1,3,5,7,9,11(27),12,14,16,18,20,22(25),23-tridecaene
bis gluconate. (Alternatively, LuTex bis gluconate). 2) Substituting
formic acid for gluconic acid gave the lutetium complex
of:4,5-diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,17-bis[2-[2-(2-metlioxyethoxy)ethoxy]ethoxy]-pentaazapentacyclo[20.2.1.13,6.
18,11.014,19]heptacosa-1,3,5,7,9,11(27),12,14,16-18,20,22(25),23-tridecaene
bis formate. (LuTexbis formate) (0.885 mmol, 98.2% yield). Characterizing
analytical data are m.w. = 1138.07; ε (methanol) = 41700 (at 733 nm),
126400 (at 475 nm); K(octanol/water) = 0.02 (0.5 mg/ml), 0.02 (0.05
mg/ml); pH = 5.5 (H2O); pH(octanol/water) = 5.1 (0.5mg/ml), 5.6 (0.05
mg/ml).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel metallotexaphyrin derivatives, their uses and
pharmaceutical compositions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mody, Tarak D.; Galanter, Joshua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002017908 A1 2002-03-07

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitro-4-(10-undecen-1-yloxy)benzenamine
C17H26N2O3
2570848-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 C 13.3372 2.3101 0.0 0
M  V30 7 C 14.6708 3.0801 0.0 0
M  V30 8 C 16.0045 2.3101 0.0 0
M  V30 9 C 17.3382 3.0801 0.0 0
M  V30 10 C 18.6720 2.3101 0.0 0
M  V30 11 C 20.0057 3.0801 0.0 0
M  V30 12 C 21.3393 2.3101 0.0 0
M  V30 13 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 14 O 1.3337 4.6201 0.0 0
M  V30 15 O 0.0000 2.3101 0.0 0
M  V30 16 N 1.3337 0.0000 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 20 C 2.6673 2.3101 0.0 0
M  V30 21 C 4.0012 0.0000 0.0 0
M  V30 22 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 20
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(10-Undecen-1-yloxy)-1H-benzimidazole
C18H26N2O
2570848-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3710 3.0801 0.0 0
M  V30 2 C 7.7046 2.3101 0.0 0
M  V30 3 C 9.0385 3.0801 0.0 0
M  V30 4 C 10.3721 2.3101 0.0 0
M  V30 5 C 11.7058 3.0801 0.0 0
M  V30 6 C 13.0395 2.3101 0.0 0
M  V30 7 C 14.3733 3.0801 0.0 0
M  V30 8 C 15.7070 2.3101 0.0 0
M  V30 9 C 17.0406 3.0801 0.0 0
M  V30 10 C 18.3743 2.3101 0.0 0
M  V30 11 C 19.7081 3.0801 0.0 0
M  V30 12 C 21.0418 2.3101 0.0 0
M  V30 13 C 2.3698 2.3101 0.0 0
M  V30 14 C 2.3698 0.7700 0.0 0
M  V30 15 C 3.7036 3.0801 0.0 0
M  V30 16 N 0.9052 2.7859 0.0 0
M  V30 17 C 3.7036 0.0000 0.0 0
M  V30 18 N 0.9052 0.2941 0.0 0
M  V30 19 C 5.0373 2.3101 0.0 0
M  V30 20 C 0.0000 1.5400 0.0 0
M  V30 21 C 5.0373 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2570848-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2570848-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22972715
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple direct formation of self-assembled N-heterocyclic carbene
monolayers on gold and their application in biosensing
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crudden, Cathleen M.; Horton, J. Hugh; Narouz, Mina R.; Li, Zhijun;
Smith, Christene A.; Munro, Kim; Baddeley, Christopher J.; Larrea,
Christian R.; Drevniok, Benedict; Thanabalasingam, Bheeshmon; McLean,
Alastair B.; Zenkina, Olena V.; Ebralidze, Iraklii I.; She, Zhe; Kraatz,
Heinz-Bernhard; Mosey, Nicholas J.; Saunders, Lisa N.; Yagi, Akiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2016), 712654

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5,6-Tribromo-2,3-pyridinediamine
C5H4Br3N3
2587505-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6674 0.0 0
M  V30 2 Br 1.5400 5.3349 0.0 0
M  V30 3 Br 1.5400 0.0000 0.0 0
M  V30 4 N 4.6200 5.3349 0.0 0
M  V30 5 N 6.1600 2.6674 0.0 0
M  V30 6 C 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7-Tribromo-3H-imidazo[4,5-b]pyridine
C6H2Br3N3
2587505-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.6674 0.0000 0.0 0
M  V30 2 Br 0.0000 4.6200 0.0 0
M  V30 3 Br 0.0000 1.5400 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 N 5.4658 4.3259 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 N 5.4658 1.8341 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 11 C 6.3710 3.0800 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2587505-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2587505-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-23203614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, biological properties and structural study of new halogenated
azolo[4,5-b]pyridines as inhibitors of CK2 kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chojnacki, K.; Lindenblatt, D.; Winska, P.; Wielechowska, M.; Toelzer,
C.; Niefind, K.; Bretner, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2021), 106104502

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-[1-(2-cyanoethyl)-1H-tetrazol-5-yl]-2-(3-dibenzofurany...
C23H24N6O3
261619-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1293 0.0 0
M  V30 2 C 4.0010 6.8994 0.0 0 CFG=1
M  V30 3 N 4.0010 8.4394 0.0 0
M  V30 4 C 2.6673 9.2094 0.0 0
M  V30 5 O 2.6673 10.7494 0.0 0
M  V30 6 O 1.3337 8.4394 0.0 0
M  V30 7 C 1.3337 11.5195 0.0 0
M  V30 8 C 0.5637 10.1858 0.0 0
M  V30 9 C 0.0000 12.2895 0.0 0
M  V30 10 C 2.1037 12.8531 0.0 0
M  V30 11 C 3.6508 3.5673 0.0 0
M  V30 12 C 3.3306 2.0609 0.0 0
M  V30 13 C 4.4752 1.0304 0.0 0
M  V30 14 N 5.6196 0.0000 0.0 0
M  V30 15 C 9.3358 8.4394 0.0 0
M  V30 16 C 9.3358 6.8994 0.0 0
M  V30 17 C 10.8006 8.9153 0.0 0
M  V30 18 C 8.0022 9.2094 0.0 0
M  V30 19 O 10.8006 6.4235 0.0 0
M  V30 20 C 8.0022 6.1293 0.0 0
M  V30 21 C 11.7058 7.6694 0.0 0
M  V30 22 C 11.4269 10.3222 0.0 0
M  V30 23 C 6.6685 8.4394 0.0 0
M  V30 24 C 6.6685 6.8994 0.0 0
M  V30 25 C 13.2374 7.8303 0.0 0
M  V30 26 C 12.9586 10.4832 0.0 0
M  V30 27 C 13.8637 9.2373 0.0 0
M  V30 28 C 2.6673 6.1293 0.0 0
M  V30 29 N 2.5064 4.5978 0.0 0
M  V30 30 N 1.2605 6.7558 0.0 0
M  V30 31 N 0.9999 4.2776 0.0 0
M  V30 32 N 0.2299 5.6113 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 28
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 29
M  V30 14 1 12 13
M  V30 15 3 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 21
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 23 24
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-[(1S)-1-amino-2-(3-dibenzofuranyl)ethyl]-1H-tetraz...
C18H16N6O.CH2O2
261619-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4995 7.9314 0.0 0
M  V30 2 C 5.1658 7.1614 0.0 0 CFG=1
M  V30 3 N 5.1658 5.6214 0.0 0
M  V30 4 C 2.1050 5.7986 0.0 0
M  V30 5 C 0.6403 5.3227 0.0 0
M  V30 6 C 0.3202 3.8163 0.0 0
M  V30 7 N 0.0000 2.3100 0.0 0
M  V30 8 C 10.5006 5.6214 0.0 0
M  V30 9 C 11.9651 5.1455 0.0 0
M  V30 10 C 10.5006 7.1614 0.0 0
M  V30 11 C 9.1669 4.8513 0.0 0
M  V30 12 C 12.8704 6.3914 0.0 0
M  V30 13 C 12.5916 3.7385 0.0 0
M  V30 14 O 11.9651 7.6372 0.0 0
M  V30 15 C 9.1669 7.9314 0.0 0
M  V30 16 C 7.8331 5.6214 0.0 0
M  V30 17 C 14.4019 6.2304 0.0 0
M  V30 18 C 14.1232 3.5776 0.0 0
M  V30 19 C 7.8331 7.1614 0.0 0
M  V30 20 C 15.0284 4.8235 0.0 0
M  V30 21 C 3.8322 7.9314 0.0 0
M  V30 22 N 2.4252 7.3049 0.0 0
M  V30 23 N 3.6711 9.4629 0.0 0
M  V30 24 N 1.3948 8.4494 0.0 0
M  V30 25 N 2.1648 9.7831 0.0 0
M  V30 26 C 7.5142 0.0000 0.0 0
M  V30 27 O 6.1805 0.7700 0.0 0
M  V30 28 O 8.8479 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 21
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 3 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 2 18 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 261619-41-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 261619-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-3904446
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-3-[5-(1-Amino-2-dibenzofuran-3-ylethyl)tetrazol-1-yl]propionitrile
Formate Salt (24). A solution of 23 (15.6 g, 36.1 mmol) in formic acid
(200 mL) was stirred at 48 °C for 50 min. The reaction mixture was
concentrated in vacuo to remove most of the formic acid. The oil
crystallized upon addition of Et2O. More Et2O was added and the mixture
was cooled in an ice bath. The solid was filtered and dried under high
vacuum at 50 °C to give 24. Yield 13.46 g, 98%. mp 173-174 °C; IR (KBr)
2203, 1632, 1557, 1190 cm -1; 1H NMR (DMSO-d6, 300 MHz) δ 3.0-3.21 (2H,
m), 4.58-4.73 (3H, m), 7.24 (1H, DD, J = 0.99, 7.9 Hz), 7.37 (1H, m),
7.48 (1H, m), 7.58 (1H, s), 7.66 (1H, d, J = 8.1 Hz), 8.02 (1H, d, J =
7.9 Hz), 8.09 (1H, d, J = 7.0 Hz), 8.15 (1H, s); [α]25 D = +11.850 (c =
1, DMSO). Anal. (C19H18N6O3) H, N; C: calcd, 60.31; found, 59.55.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting
Enzyme-1 with Sustained Duration of Action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Lombaert, Stephane; Blanchard, Louis; Stamford, Lisa B.; Tan, Jenny;
Wallace, Eli M.; Satoh, Yoshitaka; Fitt, John; Hoyer, Denton;
Simonsbergen, David; Moliterni, John; Marcopoulos, Nicholas; Savage,
Paula; Chou, Mary; Trapani, Angelo J.; Jeng, Arco Y.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(3), 488-504

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,6S,11S)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-met...
C18H26N2
262273-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5170 6.5734 0.0 0
M  V30 2 C 5.1504 2.9938 0.0 0
M  V30 3 N 0.0000 4.8348 0.0 0
M  V30 4 C 9.1348 1.9061 0.0 0
M  V30 5 C 5.0994 5.1478 0.0 0 CFG=2
M  V30 6 C 4.0011 4.0648 0.0 0
M  V30 7 C 6.5754 3.5780 0.0 0 CFG=2
M  V30 8 C 6.6323 5.1439 0.0 0
M  V30 9 C 4.0011 2.5248 0.0 0
M  V30 10 C 2.6673 4.8348 0.0 0
M  V30 11 C 6.6263 1.4240 0.0 0 CFG=1
M  V30 12 C 7.7248 4.0494 0.0 0
M  V30 13 C 5.0839 1.4240 0.0 0
M  V30 14 C 2.6673 1.7548 0.0 0
M  V30 15 C 1.3336 4.0648 0.0 0
M  V30 16 N 7.7153 2.5030 0.0 0
M  V30 17 C 1.3336 2.5248 0.0 0
M  V30 18 C 10.3616 2.8370 0.0 0
M  V30 19 C 10.9585 4.2566 0.0 0
M  V30 20 C 11.8894 3.0298 0.0 0
M  V30 21 H 7.2125 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 2 7
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=1
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 1 11 16
M  V30 18 1 11 21 CFG=3
M  V30 19 1 12 16
M  V30 20 1 14 17
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2S,6S,11S)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-...
C19H26N2O
422551-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3725 6.5734 0.0 0
M  V30 2 C 6.7390 2.9938 0.0 0
M  V30 3 N 11.8896 4.8349 0.0 0
M  V30 4 C 13.2232 4.0649 0.0 0
M  V30 5 O 14.5569 4.8349 0.0 0
M  V30 6 C 2.7546 1.9061 0.0 0
M  V30 7 C 7.8884 4.0649 0.0 0
M  V30 8 C 6.7901 5.1478 0.0 0 CFG=2
M  V30 9 C 7.8884 2.5249 0.0 0
M  V30 10 C 9.2221 4.8349 0.0 0
M  V30 11 C 5.3141 3.5781 0.0 0 CFG=2
M  V30 12 C 5.2572 5.1440 0.0 0
M  V30 13 C 6.8055 1.4241 0.0 0
M  V30 14 C 9.2221 1.7549 0.0 0
M  V30 15 C 10.5559 4.0649 0.0 0
M  V30 16 C 5.2632 1.4241 0.0 0 CFG=1
M  V30 17 C 4.1647 4.0495 0.0 0
M  V30 18 C 10.5559 2.5249 0.0 0
M  V30 19 N 4.1742 2.5030 0.0 0
M  V30 20 C 1.5279 2.8370 0.0 0
M  V30 21 C 0.0000 3.0298 0.0 0
M  V30 22 C 0.9309 4.2566 0.0 0
M  V30 23 H 4.6770 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 2 4 5
M  V30 6 1 6 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=3
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16 CFG=3
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 16 23 CFG=1
M  V30 23 1 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 11 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 262273-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 422551-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14085876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Redefining the structure-activity relationships of
2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wentland, Mark P.; Sun, Xufeng; Ye, Yingchun; Lou, Rongliang; Bidlack,
Jean M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(11), 1911-1914

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benza...
C18H26N2
262273-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0426 0.0000 0.0 0
M  V30 2 C 5.3809 2.7832 0.0 0
M  V30 3 N 0.0000 3.7641 0.0 0
M  V30 4 C 9.3754 1.7331 0.0 0
M  V30 5 C 4.2598 0.9434 0.0 0
M  V30 6 C 3.8500 2.4304 0.0 0
M  V30 7 C 6.3228 1.5648 0.0 0
M  V30 8 C 5.5893 0.1803 0.0 0
M  V30 9 C 4.6200 3.7641 0.0 0
M  V30 10 C 2.3100 2.4304 0.0 0
M  V30 11 C 7.4441 3.4048 0.0 0
M  V30 12 C 7.0826 0.5820 0.0 0
M  V30 13 C 6.1083 4.1760 0.0 0
M  V30 14 C 3.8500 5.0977 0.0 0
M  V30 15 C 1.5400 3.7641 0.0 0
M  V30 16 N 7.8475 1.9259 0.0 0
M  V30 17 C 2.3100 5.0977 0.0 0
M  V30 18 C 10.3063 2.9599 0.0 0
M  V30 19 C 10.4991 4.4877 0.0 0
M  V30 20 C 11.7259 3.5568 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 7
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 1 11 16
M  V30 18 1 12 16
M  V30 19 1 14 17
M  V30 20 2 15 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-N-[(2R,6R,11R)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-...
C19H26N2O
75331-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3725 6.5734 0.0 0
M  V30 2 C 6.7390 2.9938 0.0 0
M  V30 3 N 11.8896 4.8349 0.0 0
M  V30 4 C 13.2232 4.0649 0.0 0
M  V30 5 O 14.5569 4.8349 0.0 0
M  V30 6 C 2.7546 1.9061 0.0 0
M  V30 7 C 7.8884 4.0649 0.0 0
M  V30 8 C 6.7901 5.1478 0.0 0 CFG=1
M  V30 9 C 7.8884 2.5249 0.0 0
M  V30 10 C 9.2221 4.8349 0.0 0
M  V30 11 C 5.3141 3.5781 0.0 0 CFG=1
M  V30 12 C 5.2572 5.1440 0.0 0
M  V30 13 C 6.8055 1.4241 0.0 0
M  V30 14 C 9.2221 1.7549 0.0 0
M  V30 15 C 10.5559 4.0649 0.0 0
M  V30 16 C 5.2632 1.4241 0.0 0 CFG=2
M  V30 17 C 4.1647 4.0495 0.0 0
M  V30 18 C 10.5559 2.5249 0.0 0
M  V30 19 N 4.1742 2.5030 0.0 0
M  V30 20 C 1.5279 2.8370 0.0 0
M  V30 21 C 0.0000 3.0298 0.0 0
M  V30 22 C 0.9309 4.2566 0.0 0
M  V30 23 H 4.6770 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 2 4 5
M  V30 6 1 6 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16 CFG=1
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 16 23 CFG=3
M  V30 23 1 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 8 11 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 262273-25-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 75331-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13798169
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Redefining the structure-activity relationships of
2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wentland, Mark P.; Sun, Xufeng; Ye, Yingchun; Lou, Rongliang; Bidlack,
Jean M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(11), 1911-1914

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 7-(2,3-diaminophenyl)-4,7-diazaspiro[2.5]octane-4-carboxylate
C17H26N4O2
2631586-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 2.8736 0.0 0
M  V30 2 O 10.0100 4.2073 0.0 0
M  V30 3 O 10.0100 1.5400 0.0 0
M  V30 4 C 11.5500 4.2073 0.0 0
M  V30 5 C 11.5500 5.7473 0.0 0
M  V30 6 C 13.0900 4.2073 0.0 0
M  V30 7 C 11.5500 2.6673 0.0 0
M  V30 8 N 3.0800 5.5411 0.0 0
M  V30 9 N 0.0000 5.5411 0.0 0
M  V30 10 C 6.9300 1.5400 0.0 0
M  V30 11 N 7.7000 2.8736 0.0 0
M  V30 12 C 5.3900 1.5400 0.0 0
M  V30 13 C 8.2636 0.7700 0.0 0
M  V30 14 C 6.9300 0.0000 0.0 0
M  V30 15 C 6.9300 4.2073 0.0 0
M  V30 16 N 4.6200 2.8736 0.0 0
M  V30 17 C 5.3900 4.2073 0.0 0
M  V30 18 C 3.0800 2.8736 0.0 0
M  V30 19 C 2.3100 4.2073 0.0 0
M  V30 20 C 2.3100 1.5400 0.0 0
M  V30 21 C 0.7700 4.2073 0.0 0
M  V30 22 C 0.7700 1.5400 0.0 0
M  V30 23 C 0.0000 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 19
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(1H-Benzimidazol-7-yl)-4,7-diazaspiro[2.5]octane
C13H16N4
2631586-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8129 3.0801 0.0 0
M  V30 2 C 6.4792 2.3101 0.0 0
M  V30 3 C 8.5829 1.7464 0.0 0
M  V30 4 C 9.3529 3.0801 0.0 0
M  V30 5 N 7.8129 4.6201 0.0 0
M  V30 6 N 5.1456 3.0801 0.0 0
M  V30 7 C 6.4792 5.3901 0.0 0
M  V30 8 C 5.1456 4.6201 0.0 0
M  V30 9 C 3.8119 2.3101 0.0 0
M  V30 10 C 2.4781 3.0801 0.0 0
M  V30 11 C 3.8119 0.7700 0.0 0
M  V30 12 C 1.1444 2.3101 0.0 0
M  V30 13 N 2.1579 4.5864 0.0 0
M  V30 14 C 2.4781 0.0000 0.0 0
M  V30 15 N 0.0000 3.3405 0.0 0
M  V30 16 C 1.1444 0.7700 0.0 0
M  V30 17 C 0.6263 4.7475 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 4
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2631586-15-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2631586-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-23641785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzimidazole carboxamides and their use in the treatment of
medical disorders and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Ray, Soumya; Lansbury,
Peter T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021055591 A1 2021-03-25

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(8-Methyl-3,8-diazabicyclo[3.2.1]oct-3-yl)-1,2-benzenediamine
C13H20N4
2631586-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6201 0.0 0
M  V30 2 N 0.0000 3.0801 0.0 0
M  V30 3 C 10.5234 4.3209 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.3360 4.2881 0.0 0
M  V30 6 C 6.5869 3.2931 0.0 0
M  V30 7 C 7.8428 3.3822 0.0 0
M  V30 8 C 8.1785 2.3720 0.0 0
M  V30 9 N 9.1781 3.5713 0.0 0
M  V30 10 C 7.6960 1.9177 0.0 0
M  V30 11 C 8.3548 0.7123 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 4.0010 0.7700 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 15
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 12
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 1 8 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1H-Benzimidazol-7-yl)-8-methyl-3,8-diazabicyclo[3.2.1]octane
C14H18N4
2631586-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3342 4.3209 0.0 0
M  V30 2 C 3.8119 2.3101 0.0 0
M  V30 3 C 2.4782 3.0801 0.0 0
M  V30 4 C 3.8119 0.7700 0.0 0
M  V30 5 C 1.1446 2.3101 0.0 0
M  V30 6 N 2.1580 4.5864 0.0 0
M  V30 7 C 2.4782 0.0000 0.0 0
M  V30 8 C 1.1446 0.7700 0.0 0
M  V30 9 N 0.0000 3.3405 0.0 0
M  V30 10 C 0.6263 4.7473 0.0 0
M  V30 11 N 5.1456 3.0801 0.0 0
M  V30 12 C 6.3976 3.2929 0.0 0
M  V30 13 C 6.1467 4.2879 0.0 0
M  V30 14 C 7.9892 2.3718 0.0 0
M  V30 15 C 7.6535 3.3822 0.0 0
M  V30 16 N 8.9889 3.5713 0.0 0
M  V30 17 C 8.1656 0.7123 0.0 0
M  V30 18 C 7.5069 1.9177 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 8
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 1 15 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2631586-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2631586-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-23643699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzimidazole carboxamides and their use in the treatment of
medical disorders and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Ray, Soumya; Lansbury,
Peter T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021055591 A1 2021-03-25

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-[2-[1-[2-chloro-4-[[[5-(2,3-difluoro-4-methoxyphenyl)-1-m...
C31H36ClF2N5O5
2673221-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4632 2.4873 0.0 0
M  V30 2 F 4.9424 7.6299 0.0 0
M  V30 3 C 10.5240 3.8501 0.0 0
M  V30 4 N 11.8576 4.6201 0.0 0
M  V30 5 O 10.5240 2.3101 0.0 0
M  V30 6 F 1.8793 7.3081 0.0 0
M  V30 7 O 0.6265 4.4943 0.0 0
M  V30 8 C 0.0000 3.0873 0.0 0
M  V30 9 Cl 14.5250 0.0000 0.0 0
M  V30 10 C 17.1925 1.5400 0.0 0
M  V30 11 O 17.1925 0.0000 0.0 0
M  V30 12 C 22.5273 4.6201 0.0 0
M  V30 13 C 23.8610 3.8501 0.0 0
M  V30 14 N 25.1946 4.6201 0.0 0
M  V30 15 C 26.5285 3.8501 0.0 0
M  V30 16 O 27.8621 4.6201 0.0 0
M  V30 17 O 26.5285 2.3101 0.0 0
M  V30 18 C 29.1958 3.8501 0.0 0
M  V30 19 C 28.4258 2.5164 0.0 0
M  V30 20 C 30.5296 3.0801 0.0 0
M  V30 21 C 29.9658 5.1838 0.0 0
M  V30 22 C 6.7529 5.1382 0.0 0
M  V30 23 N 7.7833 3.9936 0.0 0
M  V30 24 C 7.5229 6.4718 0.0 0
M  V30 25 C 9.1902 4.6201 0.0 0
M  V30 26 N 9.0292 6.1517 0.0 0
M  V30 27 C 5.2212 4.9772 0.0 0
M  V30 28 C 4.3161 6.2231 0.0 0
M  V30 29 C 4.5948 3.5703 0.0 0
M  V30 30 C 2.7844 6.0620 0.0 0
M  V30 31 C 3.0633 3.4093 0.0 0
M  V30 32 C 2.1580 4.6552 0.0 0
M  V30 33 C 13.1913 3.8501 0.0 0
M  V30 34 C 13.1913 2.3101 0.0 0
M  V30 35 C 14.5250 4.6201 0.0 0
M  V30 36 C 14.5250 1.5400 0.0 0
M  V30 37 C 15.8588 3.8501 0.0 0
M  V30 38 C 15.8588 2.3101 0.0 0
M  V30 39 N 18.5261 2.3101 0.0 0
M  V30 40 C 18.5261 3.8501 0.0 0
M  V30 41 C 19.8598 1.5400 0.0 0
M  V30 42 C 19.8598 4.6201 0.0 0
M  V30 43 C 21.1936 2.3101 0.0 0
M  V30 44 C 21.1936 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 2 28
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 25
M  V30 6 1 4 33
M  V30 7 1 6 30
M  V30 8 1 7 8
M  V30 9 1 7 32
M  V30 10 1 9 36
M  V30 11 2 10 11
M  V30 12 1 10 38
M  V30 13 1 10 39
M  V30 14 1 12 13
M  V30 15 1 12 44
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 22 27
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 1 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with N-[4-[[4-(2-aminoethyl)-1-piperidinyl]carbonyl]-3-ch...
C26H28ClF2N5O3.CH2O2
2673209-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4630 4.7973 0.0 0
M  V30 2 F 4.9424 9.9399 0.0 0
M  V30 3 C 10.5238 6.1601 0.0 0
M  V30 4 N 11.8574 6.9301 0.0 0
M  V30 5 O 10.5238 4.6201 0.0 0
M  V30 6 F 1.8791 9.6180 0.0 0
M  V30 7 O 0.6263 6.8043 0.0 0
M  V30 8 C 0.0000 5.3973 0.0 0
M  V30 9 Cl 14.5249 2.3100 0.0 0
M  V30 10 C 17.1924 3.8500 0.0 0
M  V30 11 O 17.1924 2.3100 0.0 0
M  V30 12 C 22.5272 6.9301 0.0 0
M  V30 13 C 23.8608 6.1601 0.0 0
M  V30 14 N 25.1945 6.9301 0.0 0
M  V30 15 C 6.7527 7.4482 0.0 0
M  V30 16 N 7.7833 6.3036 0.0 0
M  V30 17 C 7.5227 8.7818 0.0 0
M  V30 18 C 9.1901 6.9301 0.0 0
M  V30 19 N 9.0292 8.4616 0.0 0
M  V30 20 C 5.2211 7.2872 0.0 0
M  V30 21 C 4.3159 8.5331 0.0 0
M  V30 22 C 4.5948 5.8803 0.0 0
M  V30 23 C 2.7844 8.3720 0.0 0
M  V30 24 C 3.0631 5.7193 0.0 0
M  V30 25 C 2.1580 6.9652 0.0 0
M  V30 26 C 13.1912 6.1601 0.0 0
M  V30 27 C 13.1912 4.6201 0.0 0
M  V30 28 C 14.5249 6.9301 0.0 0
M  V30 29 C 14.5249 3.8500 0.0 0
M  V30 30 C 15.8586 6.1601 0.0 0
M  V30 31 C 15.8586 4.6201 0.0 0
M  V30 32 N 18.5260 4.6201 0.0 0
M  V30 33 C 19.8597 3.8500 0.0 0
M  V30 34 C 18.5260 6.1601 0.0 0
M  V30 35 C 21.1934 4.6201 0.0 0
M  V30 36 C 19.8597 6.9301 0.0 0
M  V30 37 C 21.1934 6.1601 0.0 0
M  V30 38 C 12.5972 0.0000 0.0 0
M  V30 39 O 11.2636 0.7700 0.0 0
M  V30 40 O 13.9309 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 21
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 4 26
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 25
M  V30 10 1 9 29
M  V30 11 2 10 11
M  V30 12 1 10 31
M  V30 13 1 10 32
M  V30 14 1 12 13
M  V30 15 1 12 37
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 20
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 2 38 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2673221-43-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2673209-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31646919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel heterocyclic compounds as antibiotics and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Zhanling; Han, Xingchun; Kramer, Christian; Lerner, Christian;
Liu, Yongqiang; Nettekoven, Matthias; Pflieger, Philippe; Puellmann,
Bernd; Wang, Jianhua; Wang, Lisha; Wang, Min; Wang, Yongguang; Yang,
Song; Zhou, Chengang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021148420 A1 2021-07-29

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-[[(4-Bromophenyl)methyl]amino]-α-methylbenzeneacetonitrile
C16H15BrN2
268556-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.0800 0.0 0 CFG=1
M  V30 2 N 6.1600 3.0800 0.0 0
M  V30 3 C 4.6200 1.5400 0.0 0
M  V30 4 C 4.6200 4.6200 0.0 0
M  V30 5 C 6.9300 4.4136 0.0 0
M  V30 6 N 4.6200 0.0000 0.0 0
M  V30 7 Br 13.0900 4.4136 0.0 0
M  V30 8 C 3.0800 3.0800 0.0 0
M  V30 9 C 2.3100 1.7462 0.0 0
M  V30 10 C 2.3100 4.4136 0.0 0
M  V30 11 C 0.7700 1.7462 0.0 0
M  V30 12 C 0.7700 4.4136 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 8.4700 4.4136 0.0 0
M  V30 15 C 9.2400 3.0800 0.0 0
M  V30 16 C 9.2400 5.7473 0.0 0
M  V30 17 C 10.7800 3.0800 0.0 0
M  V30 18 C 10.7800 5.7473 0.0 0
M  V30 19 C 11.5500 4.4136 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 3 6
M  V30 7 1 5 14
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(4-Bromophenyl)methyl]-N-[(1R)-1-cyano-1-phenylethyl]formamide
C17H15BrN2O
268556-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0 CFG=1
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 C 4.6200 4.2073 0.0 0
M  V30 4 C 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 6.9300 1.3336 0.0 0
M  V30 7 N 4.6200 5.7473 0.0 0
M  V30 8 O 6.1600 0.0000 0.0 0
M  V30 9 Br 13.0900 4.0011 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 1.3336 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 C 10.7800 2.6673 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 10 CFG=3
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 3 3 7
M  V30 8 1 5 16
M  V30 9 2 6 8
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 268556-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 268556-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1042156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (4q): Mixed acetic formic anhydride, prepared14 from 12.5 mL (13.5 g,
0.132 mol) of acetic anhydride and 5.0 mL (6.10 g, 0.133 mol) formic acid
by heating at 60 °C, was cooled to 0 °C and added to 1.60 g (5.07 mmol,
>99.9% ee) of 3q. The reaction mixture was allowed to stir for 10 min and
poured into cold water (150 mL) and extracted with dichloromethane (300
mL). The organic layer was washed with 10% aqueous solution of sodium
bicarbonate (300 mL) and dried over Na2SO4. The solvents were removed
in-vacuo yielding 1.71 g (98% yield) of 4q as a clear oil; 4q, yield 1.71
g, 98% IR (thin film) 2240, 1676 cm-1; 1H NMR (400 MHz, CDCl3) δ 2.02 (s,
3H), 4.57 (dd, J1 = 28 Hz, J2 = 16 Hz, 2H), 7.07 (d, J = 8 Hz, 2H), 7.19
(m, 2H), 7.27 (m, 1H), 7.40 (m, 4H), 8.65 (s, 1H); 13C NMR {1H} (400 MHz,
CDCl3) δ 162.5, 138.0, 137.2, 136.0, 131.8, 130.0, 129.8, 129.8, 129.2,
128.4, 126.0, 125.5, 121.7, 119.3, 61.0, 46.3, 28.9, HRMS (ES) m/z (MH)+
calcd 343.0446, found 343.0462.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective catalytic addition of HCN to ketoimines. Catalytic
synthesis of quaternary amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vachal, Petr; Jacobsen, Eric N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2000), 2(6), 867-870

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H24N2O6
2713999-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.5244 0.0000 0.0 0
M  V30 2 C 8.0023 1.6203 0.0 0 CFG=2
M  V30 3 C 6.6686 2.3903 0.0 0
M  V30 4 O 8.0023 0.0802 0.0 0
M  V30 5 N 5.3348 1.6203 0.0 0
M  V30 6 C 4.0011 2.3903 0.0 0
M  V30 7 O 2.6675 1.6203 0.0 0
M  V30 8 O 4.0011 3.9303 0.0 0
M  V30 9 C 1.3338 2.3903 0.0 0
M  V30 10 C 0.5638 1.0566 0.0 0
M  V30 11 C 0.0000 3.1603 0.0 0
M  V30 12 C 2.1038 3.7239 0.0 0
M  V30 13 O 17.4417 5.1563 0.0 0
M  V30 14 C 18.6876 4.2511 0.0 0
M  V30 15 N 11.8141 2.6507 0.0 0
M  V30 16 C 10.4805 3.4207 0.0 0
M  V30 17 C 11.4940 1.1444 0.0 0
M  V30 18 C 9.3359 2.3903 0.0 0 CFG=2
M  V30 19 O 9.9623 0.9835 0.0 0
M  V30 20 C 13.2210 3.2772 0.0 0
M  V30 21 C 13.3819 4.8087 0.0 0
M  V30 22 C 14.4668 2.3719 0.0 0
M  V30 23 C 14.7889 5.4351 0.0 0
M  V30 24 C 15.8738 2.9983 0.0 0
M  V30 25 C 16.0347 4.5300 0.0 0
M  V30 26 H 8.4307 3.6362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 25
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 18 26 CFG=3
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5R)-5-[(1R)-2-amino-1-hydroxyethyl]-3-(4-methoxyphe...
C12H16N2O4.CH2O2
2713999-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9088 2.3100 0.0 0
M  V30 2 C 2.4367 5.6295 0.0 0 CFG=2
M  V30 3 C 1.5315 6.8755 0.0 0
M  V30 4 O 1.8103 4.2227 0.0 0
M  V30 5 N 0.0000 6.7144 0.0 0
M  V30 6 O 12.4980 5.0206 0.0 0
M  V30 7 C 13.2680 6.3542 0.0 0
M  V30 8 N 6.3380 5.0206 0.0 0
M  V30 9 C 5.4330 6.2664 0.0 0
M  V30 10 C 5.4330 3.7746 0.0 0
M  V30 11 C 3.9683 5.7906 0.0 0 CFG=2
M  V30 12 O 3.9683 4.2506 0.0 0
M  V30 13 C 7.8780 5.0206 0.0 0
M  V30 14 C 8.6480 6.3542 0.0 0
M  V30 15 C 8.6480 3.6868 0.0 0
M  V30 16 C 10.1880 6.3542 0.0 0
M  V30 17 C 10.1880 3.6868 0.0 0
M  V30 18 C 10.9580 5.0206 0.0 0
M  V30 19 H 3.6481 7.2968 0.0 0
M  V30 20 C 6.6340 0.0000 0.0 0
M  V30 21 O 5.3003 0.7700 0.0 0
M  V30 22 O 7.9677 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 11 19 CFG=3
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2713999-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2713999-81-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24584149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and their use in the treatment of
bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cumming, John G.; Kramer, Christian; Kreis, Lukas; Kuehne, Holger;
Schnider, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021190727 A1 2021-09-30

$RFMT $RIREG SCHEME202 STEP1
$RXN



  3  1
$MOL
5-Ethyl-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-naphthalenol
C18H22BFO3
2763159-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3496 5.6264 0.0 0
M  V30 2 C 1.0158 6.3964 0.0 0
M  V30 3 F 2.3496 8.7064 0.0 0
M  V30 4 O 9.0181 3.3163 0.0 0
M  V30 5 C 0.6091 0.8382 0.0 0
M  V30 6 C 2.4918 0.0000 0.0 0
M  V30 7 C 0.2155 3.9428 0.0 0
M  V30 8 C 0.0000 1.8932 0.0 0
M  V30 9 C 5.0170 5.6264 0.0 0
M  V30 10 C 5.0170 4.0863 0.0 0
M  V30 11 C 6.3506 6.3964 0.0 0
M  V30 12 C 3.6833 6.3964 0.0 0
M  V30 13 C 6.3506 3.3163 0.0 0
M  V30 14 C 7.6845 5.6264 0.0 0
M  V30 15 C 6.3506 7.9364 0.0 0
M  V30 16 C 3.6833 7.9364 0.0 0
M  V30 17 C 7.6845 4.0863 0.0 0
M  V30 18 C 5.0170 8.7064 0.0 0
M  V30 19 B 3.6833 3.3163 0.0 0
M  V30 20 O 3.5224 1.7847 0.0 0
M  V30 21 O 2.2765 3.9428 0.0 0
M  V30 22 C 2.0159 1.4646 0.0 0
M  V30 23 C 1.2459 2.7982 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 16
M  V30 4 1 4 17
M  V30 5 1 5 22
M  V30 6 1 6 22
M  V30 7 1 7 23
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 19
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Pyrazolo[1,5-a][1,4]diazepine-2-carboxamide, 5-[7-bromo-8-fluoro-2-[[(2R,7...
C27H32BrF2N7O2
2966011-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5410 8.0022 0.0 0
M  V30 2 O 6.0810 8.0022 0.0 0
M  V30 3 F 0.0000 8.0478 0.0 0
M  V30 4 F 4.5410 2.6674 0.0 0
M  V30 5 Br 6.0810 0.0000 0.0 0
M  V30 6 C 12.5632 9.7920 0.0 0
M  V30 7 C 15.9103 9.6417 0.0 0
M  V30 8 N 17.4332 9.4122 0.0 0
M  V30 9 O 15.3477 11.0753 0.0 0
M  V30 10 C 17.9957 7.9786 0.0 0
M  V30 11 C 18.3932 10.6162 0.0 0
M  V30 12 C 3.7710 9.3358 0.0 0 CFG=2
M  V30 13 N 3.0010 10.6695 0.0 0
M  V30 14 C 2.7404 8.1914 0.0 0
M  V30 15 C 5.2773 9.6560 0.0 0
M  V30 16 C 1.4946 10.3493 0.0 0
M  V30 17 C 4.0314 11.8140 0.0 0
M  V30 18 C 1.3336 8.8178 0.0 0 CFG=1
M  V30 19 C 5.4382 11.1875 0.0 0
M  V30 20 C 6.8510 6.6685 0.0 0
M  V30 21 N 8.3910 6.6685 0.0 0
M  V30 22 N 6.0810 5.3347 0.0 0
M  V30 23 C 9.1610 5.3347 0.0 0
M  V30 24 C 6.8510 4.0011 0.0 0
M  V30 25 C 8.3910 4.0011 0.0 0
M  V30 26 C 6.0810 2.6674 0.0 0
M  V30 27 C 9.1610 2.6674 0.0 0
M  V30 28 C 6.8510 1.3338 0.0 0
M  V30 29 C 8.3910 1.3338 0.0 0
M  V30 30 N 10.7010 5.3347 0.0 0
M  V30 31 C 11.3691 6.7223 0.0 0
M  V30 32 C 11.3691 3.9473 0.0 0
M  V30 33 C 12.8706 7.0649 0.0 0
M  V30 34 C 12.8706 3.6045 0.0 0
M  V30 35 N 14.0746 6.1047 0.0 0
M  V30 36 C 13.4116 8.5068 0.0 0
M  V30 37 C 14.0746 4.5647 0.0 0
M  V30 38 N 15.3599 6.9531 0.0 0
M  V30 39 C 14.9501 8.4377 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 20
M  V30 4 1 18 3 CFG=1
M  V30 5 1 4 26
M  V30 6 1 5 28
M  V30 7 1 6 36
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 39
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 30
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 33 36
M  V30 40 1 34 37
M  V30 41 1 35 37
M  V30 42 1 35 38
M  V30 43 1 36 39
M  V30 44 2 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-[7-(8-ethyl-7-fluoro-3-hydroxy-1-naphthalenyl)-8-f...
C39H42F3N7O3.CH2O2
2966010-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.8659 0.0 0
M  V30 2 O 8.0022 6.6359 0.0 0
M  V30 3 F 2.7586 3.5559 0.0 0
M  V30 4 F 4.0011 10.4859 0.0 0
M  V30 5 C 14.5110 8.3270 0.0 0
M  V30 6 C 17.3345 10.1306 0.0 0
M  V30 7 N 18.5385 11.0908 0.0 0
M  V30 8 O 17.5639 8.6079 0.0 0
M  V30 9 C 19.9721 10.5283 0.0 0
M  V30 10 C 18.3088 12.6137 0.0 0
M  V30 11 C 6.6685 15.1059 0.0 0
M  V30 12 C 8.0022 15.8759 0.0 0
M  V30 13 O 0.0000 12.7959 0.0 0
M  V30 14 F 6.6685 18.1860 0.0 0
M  V30 15 C 6.6685 4.3259 0.0 0 CFG=2
M  V30 16 N 6.6685 2.7859 0.0 0
M  V30 17 C 5.2038 4.8017 0.0 0
M  V30 18 C 8.1331 4.8017 0.0 0
M  V30 19 C 5.2038 2.3100 0.0 0
M  V30 20 C 8.1331 2.3100 0.0 0
M  V30 21 C 4.2986 3.5559 0.0 0 CFG=1
M  V30 22 C 9.0383 3.5559 0.0 0
M  V30 23 C 8.0022 8.1759 0.0 0
M  V30 24 N 9.3358 8.9459 0.0 0
M  V30 25 N 6.6685 8.9459 0.0 0
M  V30 26 C 9.3358 10.4859 0.0 0
M  V30 27 C 6.6685 10.4859 0.0 0
M  V30 28 C 8.0022 11.2559 0.0 0
M  V30 29 C 5.3347 11.2559 0.0 0
M  V30 30 C 8.0022 12.7959 0.0 0
M  V30 31 C 5.3347 12.7959 0.0 0
M  V30 32 C 6.6685 13.5659 0.0 0
M  V30 33 N 10.6695 11.2559 0.0 0
M  V30 34 C 11.9420 10.3884 0.0 0
M  V30 35 C 10.5544 12.7916 0.0 0
M  V30 36 C 13.4135 10.8423 0.0 0
M  V30 37 C 11.6834 13.8391 0.0 0
M  V30 38 N 13.9762 12.2759 0.0 0
M  V30 39 C 14.6031 9.8642 0.0 0
M  V30 40 C 13.2062 13.6095 0.0 0
M  V30 41 N 15.5134 12.1838 0.0 0
M  V30 42 C 15.9009 10.6934 0.0 0
M  V30 43 C 4.0011 13.5659 0.0 0
M  V30 44 C 4.0011 15.1059 0.0 0
M  V30 45 C 2.6674 12.7959 0.0 0
M  V30 46 C 2.6674 15.8759 0.0 0
M  V30 47 C 5.3347 15.8759 0.0 0
M  V30 48 C 1.3338 13.5659 0.0 0
M  V30 49 C 1.3338 15.1059 0.0 0
M  V30 50 C 2.6674 17.4160 0.0 0
M  V30 51 C 5.3347 17.4160 0.0 0
M  V30 52 C 4.0011 18.1860 0.0 0
M  V30 53 C 9.9860 0.0000 0.0 0
M  V30 54 O 8.6524 0.7700 0.0 0
M  V30 55 O 11.3197 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 23
M  V30 4 1 21 3 CFG=3
M  V30 5 1 4 29
M  V30 6 1 5 39
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 42
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 47
M  V30 14 1 13 48
M  V30 15 1 14 51
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 26 33
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 31 43
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 36 39
M  V30 44 1 37 40
M  V30 45 1 38 40
M  V30 46 1 38 41
M  V30 47 1 39 42
M  V30 48 2 41 42
M  V30 49 1 43 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 44 47
M  V30 53 1 45 48
M  V30 54 1 46 49
M  V30 55 1 46 50
M  V30 56 2 47 51
M  V30 57 2 48 49
M  V30 58 2 50 52
M  V30 59 1 51 52
M  V30 60 1 53 54
M  V30 61 2 53 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2763159-04-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2966011-51-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2966010-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39996561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1651823-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 5614-37-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carried out by preparative HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolines as pan-KRAS inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiaolun; Ivetac, Anthony; Kulyk, Svitlana; Lawson, John David;
Marx, Matthew Arnold; Smith, Christopher Ronald
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20240025907 A1 2024-01-25

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Diamino-4,5-dimethoxybenzene
C8H12N2O2
27841-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 N 5.3901 6.6686 0.0 0
M  V30 6 N 6.9301 4.0011 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.0800 2.6675 0.0 0
M  V30 9 C 3.0800 5.3348 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 5.3901 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dimethoxybenzimidazole
C9H10N2O2
72721-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2873 4.0012 0.0 0
M  V30 2 C 7.0574 5.3348 0.0 0
M  V30 3 O 4.7473 1.3337 0.0 0
M  V30 4 C 3.9773 0.0000 0.0 0
M  V30 5 C 2.4373 5.3348 0.0 0
M  V30 6 C 1.6672 4.0012 0.0 0
M  V30 7 C 3.9773 5.3348 0.0 0
M  V30 8 N 1.4068 6.4792 0.0 0
M  V30 9 C 2.4373 2.6673 0.0 0
M  V30 10 N 0.1609 4.3213 0.0 0
M  V30 11 C 4.7473 4.0012 0.0 0
M  V30 12 C 0.0000 5.8529 0.0 0
M  V30 13 C 3.9773 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27841-33-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72721-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1986518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of benzo[d]imidazole derivatives as
potential anti-cancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alkahtani, Hamad M.; Abbas, Abdullahi Y.; Wang, Shudong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(3), 1317-1321

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C35H47F3N2O3S
2786737-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0032 5.7473 0.0 0
M  V30 2 O 8.0021 3.4373 0.0 0
M  V30 3 S 6.6685 2.6673 0.0 0 VAL=6
M  V30 4 C 7.4385 1.3336 0.0 0
M  V30 5 O 5.3347 1.8973 0.0 0
M  V30 6 O 5.8985 4.0011 0.0 0
M  V30 7 F 8.9785 1.3336 0.0 0
M  V30 8 F 8.2085 0.0000 0.0 0
M  V30 9 F 6.6685 0.0000 0.0 0
M  V30 10 C 14.6705 7.2873 0.0 0
M  V30 11 C 13.9005 5.9536 0.0 0
M  V30 12 C 16.0043 6.5173 0.0 0
M  V30 13 C 15.4405 8.6211 0.0 0
M  V30 14 C 12.0032 11.9073 0.0 0
M  V30 15 C 13.5432 11.9073 0.0 0
M  V30 16 C 12.0032 13.4473 0.0 0
M  V30 17 C 10.4632 11.9073 0.0 0
M  V30 18 N 6.6685 10.3673 0.0 0
M  V30 19 C 4.0011 11.9073 0.0 0
M  V30 20 C 5.3347 12.6773 0.0 0
M  V30 21 C 4.0011 13.4473 0.0 0
M  V30 22 C 2.6674 12.6773 0.0 0
M  V30 23 C 1.3338 7.2873 0.0 0
M  V30 24 C 2.1038 5.9536 0.0 0
M  V30 25 C 0.0000 6.5173 0.0 0
M  V30 26 C 0.5638 8.6211 0.0 0
M  V30 27 C 9.3358 7.2873 0.0 0
M  V30 28 C 8.0021 8.0573 0.0 0
M  V30 29 C 9.3358 5.7473 0.0 0
M  V30 30 C 6.6685 7.2873 0.0 0
M  V30 31 C 8.0021 4.9773 0.0 0
M  V30 32 C 6.6685 5.7473 0.0 0
M  V30 33 C 10.6696 8.0573 0.0 0
M  V30 34 C 12.0032 7.2873 0.0 0
M  V30 35 C 10.6696 9.5973 0.0 0
M  V30 36 C 13.3369 8.0573 0.0 0
M  V30 37 C 12.0032 10.3673 0.0 0
M  V30 38 C 13.3369 9.5973 0.0 0
M  V30 39 C 5.3347 8.0573 0.0 0
M  V30 40 C 5.3347 9.5973 0.0 0
M  V30 41 C 4.0011 7.2873 0.0 0
M  V30 42 C 4.0011 10.3673 0.0 0
M  V30 43 C 2.6674 8.0573 0.0 0
M  V30 44 C 2.6674 9.5973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 34
M  V30 2 1 2 3
M  V30 3 1 2 31
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 36
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 37
M  V30 18 1 18 40
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 42
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 43
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 27 33
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 30 39
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 41 2 39 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 2 41 43
M  V30 45 2 42 44
M  V30 46 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C37H47F3N2O5S
2702980-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 5.7473 0.0 0
M  V30 2 C 2.6674 4.9773 0.0 0
M  V30 3 O 2.6674 3.4373 0.0 0
M  V30 4 C 1.3338 7.2873 0.0 0
M  V30 5 C 1.3338 8.8273 0.0 0
M  V30 6 C 0.0000 8.0573 0.0 0
M  V30 7 C 1.3338 5.7473 0.0 0
M  V30 8 C 4.0011 11.9073 0.0 0
M  V30 9 C 5.5411 11.9073 0.0 0
M  V30 10 C 4.0011 13.4473 0.0 0
M  V30 11 C 2.4611 11.9073 0.0 0
M  V30 12 O 8.0021 3.4373 0.0 0
M  V30 13 S 6.6685 2.6673 0.0 0 VAL=6
M  V30 14 C 7.4385 1.3336 0.0 0
M  V30 15 O 5.3347 1.8973 0.0 0
M  V30 16 O 5.8985 4.0011 0.0 0
M  V30 17 F 8.9785 1.3336 0.0 0
M  V30 18 F 8.2085 0.0000 0.0 0
M  V30 19 F 6.6685 0.0000 0.0 0
M  V30 20 N 12.0032 5.7473 0.0 0
M  V30 21 C 13.3369 4.9773 0.0 0
M  V30 22 O 13.3369 3.4373 0.0 0
M  V30 23 C 14.6705 7.2873 0.0 0
M  V30 24 C 14.6705 5.7473 0.0 0
M  V30 25 C 16.0043 6.5173 0.0 0
M  V30 26 C 16.0043 8.0573 0.0 0
M  V30 27 C 12.0032 11.9073 0.0 0
M  V30 28 C 10.4632 11.9073 0.0 0
M  V30 29 C 12.0032 13.4473 0.0 0
M  V30 30 C 13.5432 11.9073 0.0 0
M  V30 31 C 5.3347 8.0573 0.0 0
M  V30 32 C 4.0011 7.2873 0.0 0
M  V30 33 C 5.3347 9.5973 0.0 0
M  V30 34 C 2.6674 8.0573 0.0 0
M  V30 35 C 4.0011 10.3673 0.0 0
M  V30 36 C 2.6674 9.5973 0.0 0
M  V30 37 C 6.6685 7.2873 0.0 0
M  V30 38 C 8.0021 8.0573 0.0 0
M  V30 39 C 6.6685 5.7473 0.0 0
M  V30 40 C 9.3358 7.2873 0.0 0
M  V30 41 C 8.0021 4.9773 0.0 0
M  V30 42 C 9.3358 5.7473 0.0 0
M  V30 43 C 10.6696 8.0573 0.0 0
M  V30 44 C 12.0032 7.2873 0.0 0
M  V30 45 C 10.6696 9.5973 0.0 0
M  V30 46 C 13.3369 8.0573 0.0 0
M  V30 47 C 12.0032 10.3673 0.0 0
M  V30 48 C 13.3369 9.5973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 32
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 34
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 35
M  V30 12 1 12 13
M  V30 13 1 12 41
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 20 21
M  V30 21 1 20 44
M  V30 22 2 21 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 46
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 27 47
M  V30 31 2 31 32
M  V30 32 1 31 33
M  V30 33 1 31 37
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 38 2 37 38
M  V30 39 1 37 39
M  V30 40 1 38 40
M  V30 41 2 39 41
M  V30 42 2 40 42
M  V30 43 1 40 43
M  V30 44 1 41 42
M  V30 45 2 43 44
M  V30 46 1 43 45
M  V30 47 1 44 46
M  V30 48 2 45 47
M  V30 49 2 46 48
M  V30 50 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2786737-06-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2702980-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32518593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM acetic anhydride also act as solvent in stage 1,product obtained as
mixture of rotamers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrene-Decoration of a Chromium(0) Tris(diisocyanide) Enhances Excited
State Delocalization: A Strategy to Improve the Photoluminescence of 3d6
Metal Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wegeberg, Christina; Haussinger, Daniel; Wenger, Oliver S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2021), 143(38), 15800-15811

$RFMT $RIREG SCHEME205 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl carbonate
C3H6O3
616-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 O 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Butyl-2-iodo-N-(2-methyl-1-oxo-2-propen-1-yl)benzamide
C15H18INO2
2832046-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 N 4.0011 3.8500 0.0 0
M  V30 3 O 1.3336 3.8500 0.0 0
M  V30 4 C 5.3347 4.6200 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 6.6684 3.8500 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 O 5.3347 1.5400 0.0 0
M  V30 9 C 8.0021 4.6200 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 9.3358 3.8500 0.0 0
M  V30 13 I 0.0000 6.1600 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 1.3336 6.9300 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 17 C 1.3336 8.4700 0.0 0
M  V30 18 C 4.0011 8.4700 0.0 0
M  V30 19 C 2.6674 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 9 12
M  V30 13 1 13 15
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-butyl-1,2,3,4-tetrahydro-4-methyl-1,3-dioxo-4-isoquinolineacetate
C17H21NO4
2868335-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1096 4.9910 0.0 0
M  V30 2 C 9.5568 4.4643 0.0 0
M  V30 3 O 10.7364 5.4542 0.0 0
M  V30 4 O 9.8241 2.9477 0.0 0
M  V30 5 C 12.1836 4.9274 0.0 0
M  V30 6 C 8.1096 3.0112 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 3.8500 6.6685 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 C 1.5400 8.0021 0.0 0
M  V30 12 C 0.0000 8.0021 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 3.8500 4.0011 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 C 6.1600 0.0000 0.0 0
M  V30 21 N 4.6200 5.3347 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 14
M  V30 7 2 7 17
M  V30 8 2 8 18
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2832046-10-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868335-63-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34876194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 6163-58-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, optimization study, optimized on catalyst, optimized on
ligand, optimized on temperature, alternative preparation shown, stages 1
and 2 in separate pots (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cascade Carbonylative Synthesis of Functionalized
Isoquinoline-1,3-diones and Oxindoles Using Dimethyl Carbonate as both
Solvent and Reactant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wen, D.; Shen, Z.; Qi, X.; Wu, X.-F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2022), 2022(42), e202200971

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[6-[2-chloro-3-[3-chloro-2-[3-[[(2-methoxyethyl)amino]methy...
C41H46Cl2N6O5
2845302-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9813 11.2609 0.0 0
M  V30 2 N 26.4461 11.7367 0.0 0
M  V30 3 C 27.5905 10.7063 0.0 0
M  V30 4 C 29.0552 11.1822 0.0 0
M  V30 5 O 30.1996 10.1517 0.0 0
M  V30 6 C 31.6643 10.6276 0.0 0
M  V30 7 C 22.2707 15.9557 0.0 0
M  V30 8 Cl 17.7104 9.3038 0.0 0
M  V30 9 Cl 12.3203 10.6375 0.0 0
M  V30 10 O 7.7002 10.6375 0.0 0
M  V30 11 C 8.4702 11.9711 0.0 0
M  V30 12 C 6.1601 7.9700 0.0 0
M  V30 13 N 5.3901 6.6363 0.0 0
M  V30 14 C 6.1601 5.3026 0.0 0
M  V30 15 C 3.8501 6.6363 0.0 0
M  V30 16 O 3.0801 7.9700 0.0 0
M  V30 17 O 3.0801 5.3026 0.0 0
M  V30 18 C 1.5400 7.9700 0.0 0
M  V30 19 C 1.5400 9.5100 0.0 0
M  V30 20 C 0.0000 7.9700 0.0 0
M  V30 21 C 1.5400 6.4299 0.0 0
M  V30 22 O 5.0330 0.0000 0.0 0
M  V30 23 C 22.3305 11.9711 0.0 0
M  V30 24 C 21.5605 13.3048 0.0 0
M  V30 25 C 23.8369 12.2913 0.0 0
M  V30 26 C 21.5605 10.6375 0.0 0
M  V30 27 C 20.0204 13.3048 0.0 0
M  V30 28 N 22.5911 14.4494 0.0 0
M  V30 29 C 23.9979 13.8229 0.0 0
M  V30 30 C 20.0204 10.6375 0.0 0
M  V30 31 C 19.2504 11.9711 0.0 0
M  V30 32 C 17.7104 11.9711 0.0 0
M  V30 33 C 16.9404 10.6375 0.0 0
M  V30 34 N 16.9404 13.3048 0.0 0
M  V30 35 C 15.4003 10.6375 0.0 0
M  V30 36 C 15.4003 13.3048 0.0 0
M  V30 37 C 14.6303 11.9711 0.0 0
M  V30 38 C 14.6303 9.3038 0.0 0
M  V30 39 C 13.0903 9.3038 0.0 0
M  V30 40 C 15.4003 7.9700 0.0 0
M  V30 41 C 12.3203 7.9700 0.0 0
M  V30 42 C 14.6303 6.6363 0.0 0
M  V30 43 C 13.0903 6.6363 0.0 0
M  V30 44 C 10.7802 7.9700 0.0 0
M  V30 45 N 10.0102 9.3038 0.0 0
M  V30 46 C 10.0102 6.6363 0.0 0
M  V30 47 C 8.4702 9.3038 0.0 0
M  V30 48 C 8.4702 6.6363 0.0 0
M  V30 49 C 7.7002 7.9700 0.0 0
M  V30 50 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 51 N 6.0166 2.5620 0.0 0
M  V30 52 C 3.8586 3.8079 0.0 0
M  V30 53 C 4.8721 1.5316 0.0 0
M  V30 54 C 3.5384 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 28
M  V30 8 1 8 33
M  V30 9 1 9 39
M  V30 10 1 10 11
M  V30 11 1 10 47
M  V30 12 1 12 13
M  V30 13 1 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 50 14 CFG=1
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 53
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 2 24 27
M  V30 28 1 24 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 31 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 41 44
M  V30 48 1 42 43
M  V30 49 1 44 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 2 48 49
M  V30 55 1 50 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[2-chloro-3-[3-chloro-2-[3-[[(2-methoxy...
C36H38Cl2N6O3.CH2O2
2845290-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1594 9.6018 0.0 0
M  V30 2 N 26.6241 10.0776 0.0 0
M  V30 3 C 27.7685 9.0472 0.0 0
M  V30 4 C 29.2332 9.5231 0.0 0
M  V30 5 O 30.3776 8.4927 0.0 0
M  V30 6 C 31.8423 8.9685 0.0 0
M  V30 7 C 22.4489 14.2965 0.0 0
M  V30 8 Cl 17.8886 7.6447 0.0 0
M  V30 9 Cl 12.4986 8.9784 0.0 0
M  V30 10 O 7.8786 3.6437 0.0 0
M  V30 11 C 8.6486 2.3100 0.0 0
M  V30 12 C 6.3386 6.3109 0.0 0
M  V30 13 N 5.5686 7.6447 0.0 0
M  V30 14 C 4.0286 7.6447 0.0 0
M  V30 15 O 0.0000 11.2720 0.0 0
M  V30 16 C 22.5086 10.3120 0.0 0
M  V30 17 C 21.7386 11.6457 0.0 0
M  V30 18 C 24.0151 10.6322 0.0 0
M  V30 19 C 21.7386 8.9784 0.0 0
M  V30 20 C 20.1986 11.6457 0.0 0
M  V30 21 N 22.7691 12.7902 0.0 0
M  V30 22 C 24.1760 12.1639 0.0 0
M  V30 23 C 20.1986 8.9784 0.0 0
M  V30 24 C 19.4286 10.3120 0.0 0
M  V30 25 C 17.8886 10.3120 0.0 0
M  V30 26 C 17.1186 8.9784 0.0 0
M  V30 27 N 17.1186 11.6457 0.0 0
M  V30 28 C 15.5786 8.9784 0.0 0
M  V30 29 C 15.5786 11.6457 0.0 0
M  V30 30 C 14.8086 10.3120 0.0 0
M  V30 31 C 14.8086 7.6447 0.0 0
M  V30 32 C 13.2686 7.6447 0.0 0
M  V30 33 C 15.5786 6.3109 0.0 0
M  V30 34 C 12.4986 6.3109 0.0 0
M  V30 35 C 14.8086 4.9773 0.0 0
M  V30 36 C 13.2686 4.9773 0.0 0
M  V30 37 C 10.9586 6.3109 0.0 0
M  V30 38 N 10.1886 4.9773 0.0 0
M  V30 39 C 10.1886 7.6447 0.0 0
M  V30 40 C 8.6486 4.9773 0.0 0
M  V30 41 C 8.6486 7.6447 0.0 0
M  V30 42 C 7.8786 6.3109 0.0 0
M  V30 43 C 3.2586 8.9784 0.0 0 CFG=1
M  V30 44 C 3.8850 10.3852 0.0 0
M  V30 45 N 1.7271 9.1393 0.0 0
M  V30 46 C 2.7406 11.4157 0.0 0
M  V30 47 C 1.4069 10.6457 0.0 0
M  V30 48 C 15.9211 0.0000 0.0 0
M  V30 49 O 14.5875 0.7700 0.0 0
M  V30 50 O 17.2548 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 21
M  V30 8 1 8 26
M  V30 9 1 9 32
M  V30 10 1 10 11
M  V30 11 1 10 40
M  V30 12 1 12 13
M  V30 13 1 12 42
M  V30 14 1 13 14
M  V30 15 1 43 14 CFG=1
M  V30 16 2 15 47
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 34 37
M  V30 41 1 35 36
M  V30 42 1 37 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 42
M  V30 48 1 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 46 47
M  V30 53 1 48 49
M  V30 54 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845302-95-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741389
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[6-[2-chloro-3-[3-chloro-2-[1-methyl-3-[[(tetrahydro-1,1-di...
C43H48Cl2N6O6S
2845303-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 64 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9813 11.2609 0.0 0
M  V30 2 N 26.4461 11.7368 0.0 0
M  V30 3 C 22.2707 15.9557 0.0 0
M  V30 4 Cl 17.7104 9.3038 0.0 0
M  V30 5 O 30.0938 7.1203 0.0 0
M  V30 6 O 31.4185 8.5915 0.0 0
M  V30 7 Cl 12.3203 10.6375 0.0 0
M  V30 8 O 7.7002 10.6375 0.0 0
M  V30 9 C 8.4702 11.9711 0.0 0
M  V30 10 C 6.1601 7.9700 0.0 0
M  V30 11 N 5.3901 6.6363 0.0 0
M  V30 12 C 6.1601 5.3026 0.0 0
M  V30 13 C 3.8501 6.6363 0.0 0
M  V30 14 O 3.0801 7.9700 0.0 0
M  V30 15 O 3.0801 5.3026 0.0 0
M  V30 16 C 1.5400 7.9700 0.0 0
M  V30 17 C 1.5400 6.4299 0.0 0
M  V30 18 C 0.0000 7.9700 0.0 0
M  V30 19 C 1.5400 9.5100 0.0 0
M  V30 20 O 5.0330 0.0000 0.0 0
M  V30 21 C 22.3305 11.9711 0.0 0
M  V30 22 C 21.5605 13.3048 0.0 0
M  V30 23 C 23.8369 12.2913 0.0 0
M  V30 24 C 21.5605 10.6375 0.0 0
M  V30 25 C 20.0204 13.3048 0.0 0
M  V30 26 N 22.5909 14.4494 0.0 0
M  V30 27 C 23.9979 13.8229 0.0 0
M  V30 28 C 20.0204 10.6375 0.0 0
M  V30 29 C 19.2504 11.9711 0.0 0
M  V30 30 C 17.7104 11.9711 0.0 0
M  V30 31 C 16.9404 10.6375 0.0 0
M  V30 32 N 16.9404 13.3048 0.0 0
M  V30 33 C 15.4003 10.6375 0.0 0
M  V30 34 C 15.4003 13.3048 0.0 0
M  V30 35 C 14.6303 11.9711 0.0 0
M  V30 36 C 27.5905 10.7063 0.0 0
M  V30 37 C 29.0552 11.1822 0.0 0
M  V30 38 C 27.2703 9.1999 0.0 0
M  V30 39 C 30.1996 10.1517 0.0 0
M  V30 40 C 28.4147 8.1694 0.0 0
M  V30 41 S 29.8794 8.6453 0.0 0 VAL=6
M  V30 42 C 14.6303 9.3038 0.0 0
M  V30 43 C 13.0903 9.3038 0.0 0
M  V30 44 C 15.4003 7.9700 0.0 0
M  V30 45 C 12.3203 7.9700 0.0 0
M  V30 46 C 14.6303 6.6363 0.0 0
M  V30 47 C 13.0903 6.6363 0.0 0
M  V30 48 C 10.7802 7.9700 0.0 0
M  V30 49 N 10.0102 9.3038 0.0 0
M  V30 50 C 10.0102 6.6363 0.0 0
M  V30 51 C 8.4702 9.3038 0.0 0
M  V30 52 C 8.4702 6.6363 0.0 0
M  V30 53 C 7.7002 7.9700 0.0 0
M  V30 54 C 5.3901 3.9690 0.0 0 CFG=1
M  V30 55 C 3.8586 3.8079 0.0 0
M  V30 56 N 6.0164 2.5620 0.0 0
M  V30 57 C 3.5384 2.3016 0.0 0
M  V30 58 C 4.8720 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 36
M  V30 4 1 3 26
M  V30 5 1 4 31
M  V30 6 2 5 41
M  V30 7 2 6 41
M  V30 8 1 7 43
M  V30 9 1 8 9
M  V30 10 1 8 51
M  V30 11 1 10 11
M  V30 12 1 10 53
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 54 12 CFG=1
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 2 20 58
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 2 22 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 29 30
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 33 42
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 45 48
M  V30 53 1 46 47
M  V30 54 1 48 49
M  V30 55 2 48 50
M  V30 56 2 49 51
M  V30 57 1 50 52
M  V30 58 1 51 53
M  V30 59 2 52 53
M  V30 60 1 54 55
M  V30 61 1 54 56
M  V30 62 1 55 57
M  V30 63 1 56 58
M  V30 64 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[2-chloro-3-[3-chloro-2-[1-methyl-3-[[(...
C38H40Cl2N6O4S.CH2O2
2845290-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4370 9.6018 0.0 0
M  V30 2 N 4.9724 10.0776 0.0 0
M  V30 3 C 9.1476 14.2965 0.0 0
M  V30 4 Cl 13.7078 7.6447 0.0 0
M  V30 5 O 0.0000 6.9325 0.0 0
M  V30 6 O 1.3247 5.4613 0.0 0
M  V30 7 Cl 19.0978 8.9784 0.0 0
M  V30 8 O 23.7178 3.6437 0.0 0
M  V30 9 C 22.9478 2.3100 0.0 0
M  V30 10 C 25.2578 6.3109 0.0 0
M  V30 11 N 26.0278 7.6447 0.0 0
M  V30 12 C 27.5678 7.6447 0.0 0
M  V30 13 O 31.5965 11.2720 0.0 0
M  V30 14 C 9.0878 10.3120 0.0 0
M  V30 15 C 9.8578 11.6457 0.0 0
M  V30 16 C 7.5816 10.6322 0.0 0
M  V30 17 C 9.8578 8.9784 0.0 0
M  V30 18 C 11.3978 11.6457 0.0 0
M  V30 19 N 8.8274 12.7902 0.0 0
M  V30 20 C 7.4205 12.1637 0.0 0
M  V30 21 C 11.3978 8.9784 0.0 0
M  V30 22 C 12.1678 10.3120 0.0 0
M  V30 23 C 13.7078 10.3120 0.0 0
M  V30 24 C 14.4778 8.9784 0.0 0
M  V30 25 N 14.4778 11.6457 0.0 0
M  V30 26 C 16.0178 8.9784 0.0 0
M  V30 27 C 16.0178 11.6457 0.0 0
M  V30 28 C 16.7878 10.3120 0.0 0
M  V30 29 C 3.8280 9.0472 0.0 0
M  V30 30 C 4.1481 7.5408 0.0 0
M  V30 31 C 2.3633 9.5231 0.0 0
M  V30 32 C 3.0038 6.5104 0.0 0
M  V30 33 C 1.2189 8.4927 0.0 0
M  V30 34 S 1.5391 6.9862 0.0 0 VAL=6
M  V30 35 C 16.7878 7.6447 0.0 0
M  V30 36 C 18.3278 7.6447 0.0 0
M  V30 37 C 16.0178 6.3109 0.0 0
M  V30 38 C 19.0978 6.3109 0.0 0
M  V30 39 C 16.7878 4.9773 0.0 0
M  V30 40 C 18.3278 4.9773 0.0 0
M  V30 41 C 20.6378 6.3109 0.0 0
M  V30 42 N 21.4078 4.9773 0.0 0
M  V30 43 C 21.4078 7.6447 0.0 0
M  V30 44 C 22.9478 4.9773 0.0 0
M  V30 45 C 22.9478 7.6447 0.0 0
M  V30 46 C 23.7178 6.3109 0.0 0
M  V30 47 C 28.3378 8.9784 0.0 0 CFG=2
M  V30 48 N 29.8694 9.1393 0.0 0
M  V30 49 C 27.7115 10.3852 0.0 0
M  V30 50 C 30.1895 10.6457 0.0 0
M  V30 51 C 28.8559 11.4157 0.0 0
M  V30 52 C 15.7982 0.0000 0.0 0
M  V30 53 O 14.4646 0.7700 0.0 0
M  V30 54 O 17.1319 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 29
M  V30 4 1 3 19
M  V30 5 1 4 24
M  V30 6 2 5 34
M  V30 7 2 6 34
M  V30 8 1 7 36
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 10 11
M  V30 12 1 10 46
M  V30 13 1 11 12
M  V30 14 1 47 12 CFG=3
M  V30 15 2 13 50
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 22 23
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 26 35
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 38 41
M  V30 46 1 39 40
M  V30 47 1 41 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 2 45 46
M  V30 53 1 47 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 1 50 51
M  V30 58 1 52 53
M  V30 59 2 52 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 47)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-07-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-60-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 5-[3-chloro-4-[2-chloro-3-[5-[[[(1,1-dimethylethoxy)carbony...
C41H45Cl2N5O6
2845303-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 25.3316 14.5931 0.0 0
M  V30 2 O 26.6652 13.8230 0.0 0
M  V30 3 O 25.3316 16.1331 0.0 0
M  V30 4 C 27.9990 14.5931 0.0 0
M  V30 5 C 27.2290 15.9267 0.0 0
M  V30 6 C 29.3327 15.3631 0.0 0
M  V30 7 C 28.7691 13.2594 0.0 0
M  V30 8 Cl 17.7104 9.3038 0.0 0
M  V30 9 Cl 12.3203 10.6375 0.0 0
M  V30 10 O 7.7002 10.6375 0.0 0
M  V30 11 C 8.4702 11.9713 0.0 0
M  V30 12 C 6.1601 7.9701 0.0 0
M  V30 13 N 5.3901 6.6365 0.0 0
M  V30 14 C 6.1601 5.3026 0.0 0
M  V30 15 C 3.8501 6.6365 0.0 0
M  V30 16 O 3.0801 7.9701 0.0 0
M  V30 17 O 3.0801 5.3026 0.0 0
M  V30 18 C 1.5400 7.9701 0.0 0
M  V30 19 C 1.5400 9.5102 0.0 0
M  V30 20 C 0.0000 7.9701 0.0 0
M  V30 21 C 1.5400 6.4301 0.0 0
M  V30 22 O 5.0330 0.0000 0.0 0
M  V30 23 C 21.5605 13.3050 0.0 0
M  V30 24 C 22.3305 11.9713 0.0 0
M  V30 25 C 20.0204 13.3050 0.0 0
M  V30 26 C 22.5909 14.4494 0.0 0
M  V30 27 C 23.8369 12.2915 0.0 0
M  V30 28 C 21.5605 10.6375 0.0 0
M  V30 29 C 19.2504 11.9713 0.0 0
M  V30 30 N 23.9979 13.8230 0.0 0
M  V30 31 C 20.0204 10.6375 0.0 0
M  V30 32 C 17.7104 11.9713 0.0 0
M  V30 33 C 16.9404 10.6375 0.0 0
M  V30 34 N 16.9404 13.3050 0.0 0
M  V30 35 C 15.4003 10.6375 0.0 0
M  V30 36 C 15.4003 13.3050 0.0 0
M  V30 37 C 14.6303 11.9713 0.0 0
M  V30 38 C 14.6303 9.3038 0.0 0
M  V30 39 C 13.0903 9.3038 0.0 0
M  V30 40 C 15.4003 7.9701 0.0 0
M  V30 41 C 12.3203 7.9701 0.0 0
M  V30 42 C 14.6303 6.6365 0.0 0
M  V30 43 C 13.0903 6.6365 0.0 0
M  V30 44 C 10.7802 7.9701 0.0 0
M  V30 45 N 10.0102 9.3038 0.0 0
M  V30 46 C 10.0102 6.6365 0.0 0
M  V30 47 C 8.4702 9.3038 0.0 0
M  V30 48 C 8.4702 6.6365 0.0 0
M  V30 49 C 7.7002 7.9701 0.0 0
M  V30 50 C 5.3901 3.9690 0.0 0 CFG=1
M  V30 51 C 3.8586 3.8080 0.0 0
M  V30 52 N 6.0164 2.5622 0.0 0
M  V30 53 C 3.5384 2.3016 0.0 0
M  V30 54 C 4.8721 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 30
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 33
M  V30 9 1 9 39
M  V30 10 1 10 11
M  V30 11 1 10 47
M  V30 12 1 12 13
M  V30 13 1 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 50 14 CFG=1
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 54
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 34 1 29 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 41 44
M  V30 48 1 42 43
M  V30 49 1 44 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 2 48 49
M  V30 55 1 50 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[2-chloro-3-[3-chloro-2-(2,3-dihydro-1H...
C31H29Cl2N5O2.CH2O2
2845290-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.2873 7.6448 0.0 0
M  V30 2 Cl 11.6775 8.9787 0.0 0
M  V30 3 O 16.2976 3.6438 0.0 0
M  V30 4 C 15.5275 2.3100 0.0 0
M  V30 5 C 17.8376 6.3112 0.0 0
M  V30 6 N 18.6076 7.6448 0.0 0
M  V30 7 C 20.1476 7.6448 0.0 0
M  V30 8 O 24.1764 11.2724 0.0 0
M  V30 9 C 8.5974 8.9787 0.0 0
M  V30 10 C 7.0574 8.9787 0.0 0
M  V30 11 C 9.3674 10.3123 0.0 0
M  V30 12 C 6.2873 10.3123 0.0 0
M  V30 13 C 8.5974 11.6460 0.0 0
M  V30 14 N 7.0574 11.6460 0.0 0
M  V30 15 C 9.3674 7.6448 0.0 0
M  V30 16 C 10.9074 7.6448 0.0 0
M  V30 17 C 8.5974 6.3112 0.0 0
M  V30 18 C 11.6775 6.3112 0.0 0
M  V30 19 C 9.3674 4.9775 0.0 0
M  V30 20 C 10.9074 4.9775 0.0 0
M  V30 21 C 4.7473 10.3123 0.0 0
M  V30 22 C 3.9773 11.6460 0.0 0
M  V30 23 C 3.9773 8.9787 0.0 0
M  V30 24 C 2.4373 11.6460 0.0 0
M  V30 25 C 2.4373 8.9787 0.0 0
M  V30 26 C 1.6672 10.3123 0.0 0
M  V30 27 C 1.4068 12.7906 0.0 0
M  V30 28 C 0.1609 10.6325 0.0 0
M  V30 29 N 0.0000 12.1641 0.0 0
M  V30 30 C 13.2175 6.3112 0.0 0
M  V30 31 N 13.9875 4.9775 0.0 0
M  V30 32 C 13.9875 7.6448 0.0 0
M  V30 33 C 15.5275 4.9775 0.0 0
M  V30 34 C 15.5275 7.6448 0.0 0
M  V30 35 C 16.2976 6.3112 0.0 0
M  V30 36 C 20.9177 8.9787 0.0 0 CFG=2
M  V30 37 N 22.4494 9.1396 0.0 0
M  V30 38 C 20.2913 10.3855 0.0 0
M  V30 39 C 22.7696 10.6459 0.0 0
M  V30 40 C 21.4359 11.4159 0.0 0
M  V30 41 C 12.0882 0.0000 0.0 0
M  V30 42 O 10.7545 0.7700 0.0 0
M  V30 43 O 13.4219 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 33
M  V30 5 1 5 6
M  V30 6 1 5 35
M  V30 7 1 6 7
M  V30 8 1 36 7 CFG=3
M  V30 9 2 8 39
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 15
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 12 21
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 18 30
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 24 27
M  V30 31 2 25 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 40
M  V30 46 1 41 42
M  V30 47 2 41 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-11-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741406
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 3-[4-[3-chloro-4-[2-chloro-3-[5-[[[(1,1-dimethylethoxy)carb...
C39H45Cl2N7O6
2845303-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 26.3386 6.6924 0.0 0
M  V30 2 O 27.2437 7.9383 0.0 0
M  V30 3 O 26.9649 5.2854 0.0 0
M  V30 4 C 28.7754 7.7772 0.0 0
M  V30 5 C 28.6143 6.2456 0.0 0
M  V30 6 C 30.3069 7.6162 0.0 0
M  V30 7 C 28.9363 9.3089 0.0 0
M  V30 8 Cl 16.0045 8.2638 0.0 0
M  V30 9 Cl 12.0033 4.4137 0.0 0
M  V30 10 O 8.0023 2.1037 0.0 0
M  V30 11 C 9.3360 1.3337 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 13 N 4.0012 4.4137 0.0 0
M  V30 14 C 4.0012 5.9538 0.0 0
M  V30 15 C 2.6675 3.6437 0.0 0
M  V30 16 O 2.6675 2.1037 0.0 0
M  V30 17 O 1.3337 4.4137 0.0 0
M  V30 18 C 1.3337 1.3337 0.0 0
M  V30 19 C 0.5637 2.6673 0.0 0
M  V30 20 C 0.0000 0.5637 0.0 0
M  V30 21 C 2.1037 0.0000 0.0 0
M  V30 22 O 0.3738 9.9825 0.0 0
M  V30 23 C 22.6410 7.0809 0.0 0
M  V30 24 C 23.6101 5.8842 0.0 0
M  V30 25 C 23.8377 8.0501 0.0 0
M  V30 26 N 24.8069 6.8533 0.0 0
M  V30 27 N 21.1092 7.2419 0.0 0
M  V30 28 C 20.0788 6.0975 0.0 0
M  V30 29 N 20.3392 8.5757 0.0 0
M  V30 30 C 18.6720 6.7238 0.0 0
M  V30 31 C 18.8329 8.2554 0.0 0
M  V30 32 C 17.3382 5.9538 0.0 0
M  V30 33 C 16.0045 6.7238 0.0 0
M  V30 34 N 17.3382 4.4137 0.0 0
M  V30 35 C 14.6708 5.9538 0.0 0
M  V30 36 C 16.0045 3.6437 0.0 0
M  V30 37 C 14.6708 4.4137 0.0 0
M  V30 38 C 13.3372 6.7238 0.0 0
M  V30 39 C 12.0033 5.9538 0.0 0
M  V30 40 C 13.3372 8.2638 0.0 0
M  V30 41 C 10.6697 6.7238 0.0 0
M  V30 42 C 12.0033 9.0338 0.0 0
M  V30 43 C 10.6697 8.2638 0.0 0
M  V30 44 C 9.3360 5.9538 0.0 0
M  V30 45 N 9.3360 4.4137 0.0 0
M  V30 46 C 8.0023 6.7238 0.0 0
M  V30 47 C 8.0023 3.6437 0.0 0
M  V30 48 C 6.6685 5.9538 0.0 0
M  V30 49 C 6.6685 4.4137 0.0 0
M  V30 50 C 2.6675 6.7238 0.0 0 CFG=1
M  V30 51 C 1.2605 6.0975 0.0 0
M  V30 52 N 2.5064 8.2554 0.0 0
M  V30 53 C 0.2301 7.2419 0.0 0
M  V30 54 C 1.0001 8.5757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 33
M  V30 9 1 9 39
M  V30 10 1 10 11
M  V30 11 1 10 47
M  V30 12 1 12 13
M  V30 13 1 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 50 14 CFG=3
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 54
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 23 27
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 41 44
M  V30 48 1 42 43
M  V30 49 1 44 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 2 48 49
M  V30 55 1 50 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[3-[2-[1-(3-azetidinyl)-1H-pyrazol-4-yl...
C29H29Cl2N7O2.CH2O2
2845290-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9177 7.6447 0.0 0
M  V30 2 Cl 12.3077 8.9784 0.0 0
M  V30 3 O 16.9277 3.6437 0.0 0
M  V30 4 C 16.1577 2.3100 0.0 0
M  V30 5 C 18.4677 6.3111 0.0 0
M  V30 6 N 19.2377 7.6447 0.0 0
M  V30 7 C 20.7777 7.6447 0.0 0
M  V30 8 O 24.8063 11.2720 0.0 0
M  V30 9 C 5.3777 10.3120 0.0 0
M  V30 10 C 4.4725 11.5580 0.0 0
M  V30 11 C 4.4725 9.0662 0.0 0
M  V30 12 N 3.0079 11.0820 0.0 0
M  V30 13 N 3.0079 9.5420 0.0 0
M  V30 14 C 6.9177 10.3120 0.0 0
M  V30 15 C 7.6877 8.9784 0.0 0
M  V30 16 N 7.6877 11.6458 0.0 0
M  V30 17 C 9.2277 8.9784 0.0 0
M  V30 18 C 9.2277 11.6458 0.0 0
M  V30 19 C 9.9977 10.3120 0.0 0
M  V30 20 C 1.7619 11.9872 0.0 0
M  V30 21 C 0.2410 11.7464 0.0 0
M  V30 22 C 1.5211 13.5083 0.0 0
M  V30 23 N 0.0000 13.2674 0.0 0
M  V30 24 C 9.9977 7.6447 0.0 0
M  V30 25 C 11.5377 7.6447 0.0 0
M  V30 26 C 9.2277 6.3111 0.0 0
M  V30 27 C 12.3077 6.3111 0.0 0
M  V30 28 C 9.9977 4.9773 0.0 0
M  V30 29 C 11.5377 4.9773 0.0 0
M  V30 30 C 13.8477 6.3111 0.0 0
M  V30 31 N 14.6177 4.9773 0.0 0
M  V30 32 C 14.6177 7.6447 0.0 0
M  V30 33 C 16.1577 4.9773 0.0 0
M  V30 34 C 16.1577 7.6447 0.0 0
M  V30 35 C 16.9277 6.3111 0.0 0
M  V30 36 C 21.5477 8.9784 0.0 0 CFG=1
M  V30 37 C 20.9214 10.3853 0.0 0
M  V30 38 N 23.0792 9.1393 0.0 0
M  V30 39 C 22.0657 11.4157 0.0 0
M  V30 40 C 23.3994 10.6457 0.0 0
M  V30 41 C 12.4032 0.0000 0.0 0
M  V30 42 O 11.0695 0.7700 0.0 0
M  V30 43 O 13.7368 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 25
M  V30 3 1 3 4
M  V30 4 1 3 33
M  V30 5 1 5 6
M  V30 6 1 5 35
M  V30 7 1 6 7
M  V30 8 1 36 7 CFG=3
M  V30 9 2 8 40
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 12 20
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 17 24
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 27 30
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 40
M  V30 46 1 41 42
M  V30 47 2 41 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-12-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[4-[3-[3-[[(1-acetyl-4-piperidinyl)amino]methyl]-1-methy...
C45H51Cl2N7O5
2845303-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9813 11.2609 0.0 0
M  V30 2 N 26.4461 11.7368 0.0 0
M  V30 3 C 22.2707 15.9557 0.0 0
M  V30 4 Cl 17.7104 9.3038 0.0 0
M  V30 5 C 31.0238 7.6149 0.0 0
M  V30 6 C 30.7037 6.1084 0.0 0
M  V30 7 O 32.4886 8.0907 0.0 0
M  V30 8 Cl 12.3203 10.6375 0.0 0
M  V30 9 O 7.7002 10.6375 0.0 0
M  V30 10 C 8.4702 11.9711 0.0 0
M  V30 11 C 6.1601 7.9700 0.0 0
M  V30 12 N 5.3901 6.6363 0.0 0
M  V30 13 C 6.1601 5.3026 0.0 0
M  V30 14 C 3.8501 6.6363 0.0 0
M  V30 15 O 3.0801 7.9700 0.0 0
M  V30 16 O 3.0801 5.3026 0.0 0
M  V30 17 C 1.5400 7.9700 0.0 0
M  V30 18 C 1.5400 6.4299 0.0 0
M  V30 19 C 0.0000 7.9700 0.0 0
M  V30 20 C 1.5400 9.5100 0.0 0
M  V30 21 O 5.0330 0.0000 0.0 0
M  V30 22 C 22.3305 11.9711 0.0 0
M  V30 23 C 21.5605 13.3048 0.0 0
M  V30 24 C 23.8369 12.2913 0.0 0
M  V30 25 C 21.5605 10.6375 0.0 0
M  V30 26 N 20.0204 13.3048 0.0 0
M  V30 27 N 22.5909 14.4494 0.0 0
M  V30 28 C 23.9979 13.8229 0.0 0
M  V30 29 C 20.0204 10.6375 0.0 0
M  V30 30 C 19.2504 11.9711 0.0 0
M  V30 31 C 17.7104 11.9711 0.0 0
M  V30 32 C 16.9404 10.6375 0.0 0
M  V30 33 C 16.9404 13.3048 0.0 0
M  V30 34 C 15.4003 10.6375 0.0 0
M  V30 35 C 15.4003 13.3048 0.0 0
M  V30 36 C 14.6303 11.9711 0.0 0
M  V30 37 C 27.5905 10.7063 0.0 0
M  V30 38 C 29.0552 11.1822 0.0 0
M  V30 39 C 27.2703 9.1999 0.0 0
M  V30 40 C 30.1996 10.1517 0.0 0
M  V30 41 C 28.4147 8.1694 0.0 0
M  V30 42 N 29.8794 8.6453 0.0 0
M  V30 43 C 14.6303 9.3038 0.0 0
M  V30 44 C 13.0903 9.3038 0.0 0
M  V30 45 C 15.4003 7.9700 0.0 0
M  V30 46 C 12.3203 7.9700 0.0 0
M  V30 47 C 14.6303 6.6363 0.0 0
M  V30 48 N 13.0903 6.6363 0.0 0
M  V30 49 C 10.7802 7.9700 0.0 0
M  V30 50 C 10.0102 9.3038 0.0 0
M  V30 51 C 10.0102 6.6363 0.0 0
M  V30 52 C 8.4702 9.3038 0.0 0
M  V30 53 C 8.4702 6.6363 0.0 0
M  V30 54 C 7.7002 7.9700 0.0 0
M  V30 55 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 56 N 6.0164 2.5620 0.0 0
M  V30 57 C 3.8586 3.8079 0.0 0
M  V30 58 C 4.8721 1.5316 0.0 0
M  V30 59 C 3.5384 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 37
M  V30 4 1 3 27
M  V30 5 1 4 32
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 42
M  V30 9 1 8 44
M  V30 10 1 9 10
M  V30 11 1 9 52
M  V30 12 1 11 12
M  V30 13 1 11 54
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 55 13 CFG=1
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 21 58
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 2 23 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 30 31
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 34 43
M  V30 41 1 35 36
M  V30 42 1 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 42
M  V30 48 1 43 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 1 46 49
M  V30 54 2 47 48
M  V30 55 2 49 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 2 51 53
M  V30 59 2 52 54
M  V30 60 1 53 54
M  V30 61 1 55 56
M  V30 62 1 55 57
M  V30 63 1 56 58
M  V30 64 1 57 59
M  V30 65 1 58 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 55)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[4-[3-[3-[[(1-acetyl-4-piperidinyl)amin...
C40H43Cl2N7O3.CH2O2
2845291-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5070 9.6018 0.0 0
M  V30 2 N 6.0425 10.0776 0.0 0
M  V30 3 C 10.2176 14.2965 0.0 0
M  V30 4 Cl 14.7778 7.6447 0.0 0
M  V30 5 C 1.4647 5.9558 0.0 0
M  V30 6 C 1.7849 4.4494 0.0 0
M  V30 7 O 0.0000 6.4317 0.0 0
M  V30 8 Cl 20.1678 8.9784 0.0 0
M  V30 9 O 24.7878 3.6437 0.0 0
M  V30 10 C 24.0178 2.3100 0.0 0
M  V30 11 C 26.3278 6.3109 0.0 0
M  V30 12 N 27.0978 7.6447 0.0 0
M  V30 13 C 28.6378 7.6447 0.0 0
M  V30 14 O 32.6665 11.2720 0.0 0
M  V30 15 C 10.1578 10.3120 0.0 0
M  V30 16 C 10.9278 11.6457 0.0 0
M  V30 17 C 8.6516 10.6322 0.0 0
M  V30 18 C 10.9278 8.9784 0.0 0
M  V30 19 N 12.4678 11.6457 0.0 0
M  V30 20 N 9.8974 12.7902 0.0 0
M  V30 21 C 8.4905 12.1637 0.0 0
M  V30 22 C 12.4678 8.9784 0.0 0
M  V30 23 C 13.2378 10.3120 0.0 0
M  V30 24 C 14.7778 10.3120 0.0 0
M  V30 25 C 15.5478 8.9784 0.0 0
M  V30 26 C 15.5478 11.6457 0.0 0
M  V30 27 C 17.0878 8.9784 0.0 0
M  V30 28 C 17.0878 11.6457 0.0 0
M  V30 29 C 17.8578 10.3120 0.0 0
M  V30 30 C 4.8980 9.0472 0.0 0
M  V30 31 C 3.4334 9.5231 0.0 0
M  V30 32 C 5.2181 7.5408 0.0 0
M  V30 33 C 2.2889 8.4927 0.0 0
M  V30 34 C 4.0738 6.5104 0.0 0
M  V30 35 N 2.6091 6.9862 0.0 0
M  V30 36 C 17.8578 7.6447 0.0 0
M  V30 37 C 19.3978 7.6447 0.0 0
M  V30 38 C 17.0878 6.3109 0.0 0
M  V30 39 C 20.1678 6.3109 0.0 0
M  V30 40 C 17.8578 4.9773 0.0 0
M  V30 41 N 19.3978 4.9773 0.0 0
M  V30 42 C 21.7078 6.3109 0.0 0
M  V30 43 C 22.4778 4.9773 0.0 0
M  V30 44 C 22.4778 7.6447 0.0 0
M  V30 45 C 24.0178 4.9773 0.0 0
M  V30 46 C 24.0178 7.6447 0.0 0
M  V30 47 C 24.7878 6.3109 0.0 0
M  V30 48 C 29.4078 8.9784 0.0 0 CFG=2
M  V30 49 N 30.9394 9.1393 0.0 0
M  V30 50 C 28.7815 10.3852 0.0 0
M  V30 51 C 31.2595 10.6457 0.0 0
M  V30 52 C 29.9259 11.4157 0.0 0
M  V30 53 C 16.3332 0.0000 0.0 0
M  V30 54 O 14.9996 0.7700 0.0 0
M  V30 55 O 17.6669 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 30
M  V30 4 1 3 20
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 35
M  V30 9 1 8 37
M  V30 10 1 9 10
M  V30 11 1 9 45
M  V30 12 1 11 12
M  V30 13 1 11 47
M  V30 14 1 12 13
M  V30 15 1 48 13 CFG=3
M  V30 16 2 14 51
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 2 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 23 24
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 27 36
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 39 42
M  V30 47 2 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 54 1 48 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 1 51 52
M  V30 59 1 53 54
M  V30 60 2 53 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 48)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-39-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[(tetrahydro-1,1-di...
C43H48Cl2N6O6S
2845303-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 64 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9813 11.2609 0.0 0
M  V30 2 N 26.4461 11.7368 0.0 0
M  V30 3 C 22.2707 15.9557 0.0 0
M  V30 4 Cl 17.7104 9.3038 0.0 0
M  V30 5 O 30.0938 7.1203 0.0 0
M  V30 6 O 31.4185 8.5915 0.0 0
M  V30 7 Cl 12.3203 10.6375 0.0 0
M  V30 8 O 7.7002 10.6375 0.0 0
M  V30 9 C 8.4702 11.9711 0.0 0
M  V30 10 C 6.1601 7.9700 0.0 0
M  V30 11 N 5.3901 6.6363 0.0 0
M  V30 12 C 6.1601 5.3026 0.0 0
M  V30 13 C 3.8501 6.6363 0.0 0
M  V30 14 O 3.0801 7.9700 0.0 0
M  V30 15 O 3.0801 5.3026 0.0 0
M  V30 16 C 1.5400 7.9700 0.0 0
M  V30 17 C 1.5400 9.5100 0.0 0
M  V30 18 C 0.0000 7.9700 0.0 0
M  V30 19 C 1.5400 6.4299 0.0 0
M  V30 20 O 5.0330 0.0000 0.0 0
M  V30 21 C 22.3305 11.9711 0.0 0
M  V30 22 C 21.5605 13.3048 0.0 0
M  V30 23 C 23.8369 12.2913 0.0 0
M  V30 24 C 21.5605 10.6375 0.0 0
M  V30 25 N 20.0204 13.3048 0.0 0
M  V30 26 N 22.5909 14.4494 0.0 0
M  V30 27 C 23.9979 13.8229 0.0 0
M  V30 28 C 20.0204 10.6375 0.0 0
M  V30 29 C 19.2504 11.9711 0.0 0
M  V30 30 C 17.7104 11.9711 0.0 0
M  V30 31 C 16.9404 10.6375 0.0 0
M  V30 32 C 16.9404 13.3048 0.0 0
M  V30 33 C 15.4003 10.6375 0.0 0
M  V30 34 C 15.4003 13.3048 0.0 0
M  V30 35 C 14.6303 11.9711 0.0 0
M  V30 36 C 27.5905 10.7063 0.0 0
M  V30 37 C 29.0552 11.1822 0.0 0
M  V30 38 C 27.2703 9.1999 0.0 0
M  V30 39 C 30.1996 10.1517 0.0 0
M  V30 40 C 28.4147 8.1694 0.0 0
M  V30 41 S 29.8794 8.6453 0.0 0 VAL=6
M  V30 42 C 14.6303 9.3038 0.0 0
M  V30 43 C 13.0903 9.3038 0.0 0
M  V30 44 C 15.4003 7.9700 0.0 0
M  V30 45 C 12.3203 7.9700 0.0 0
M  V30 46 C 14.6303 6.6363 0.0 0
M  V30 47 N 13.0903 6.6363 0.0 0
M  V30 48 C 10.7802 7.9700 0.0 0
M  V30 49 C 10.0102 9.3038 0.0 0
M  V30 50 C 10.0102 6.6363 0.0 0
M  V30 51 C 8.4702 9.3038 0.0 0
M  V30 52 C 8.4702 6.6363 0.0 0
M  V30 53 C 7.7002 7.9700 0.0 0
M  V30 54 C 5.3901 3.9690 0.0 0 CFG=1
M  V30 55 C 3.8586 3.8079 0.0 0
M  V30 56 N 6.0164 2.5620 0.0 0
M  V30 57 C 3.5384 2.3016 0.0 0
M  V30 58 C 4.8720 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 36
M  V30 4 1 3 26
M  V30 5 1 4 31
M  V30 6 2 5 41
M  V30 7 2 6 41
M  V30 8 1 7 43
M  V30 9 1 8 9
M  V30 10 1 8 51
M  V30 11 1 10 11
M  V30 12 1 10 53
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 54 12 CFG=1
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 2 20 58
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 2 22 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 29 30
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 33 42
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 47 1 42 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 45 48
M  V30 53 2 46 47
M  V30 54 2 48 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 2 50 52
M  V30 58 2 51 53
M  V30 59 1 52 53
M  V30 60 1 54 55
M  V30 61 1 54 56
M  V30 62 1 55 57
M  V30 63 1 56 58
M  V30 64 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[(...
C38H40Cl2N6O4S.CH2O2
2845291-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4370 9.6018 0.0 0
M  V30 2 N 4.9724 10.0776 0.0 0
M  V30 3 C 9.1476 14.2965 0.0 0
M  V30 4 Cl 13.7078 7.6447 0.0 0
M  V30 5 O 0.0000 6.9325 0.0 0
M  V30 6 O 1.3247 5.4613 0.0 0
M  V30 7 Cl 19.0978 8.9784 0.0 0
M  V30 8 O 23.7178 3.6437 0.0 0
M  V30 9 C 22.9478 2.3100 0.0 0
M  V30 10 C 25.2578 6.3109 0.0 0
M  V30 11 N 26.0278 7.6447 0.0 0
M  V30 12 C 27.5678 7.6447 0.0 0
M  V30 13 O 31.5965 11.2720 0.0 0
M  V30 14 C 9.0878 10.3120 0.0 0
M  V30 15 C 9.8578 11.6457 0.0 0
M  V30 16 C 7.5816 10.6322 0.0 0
M  V30 17 C 9.8578 8.9784 0.0 0
M  V30 18 N 11.3978 11.6457 0.0 0
M  V30 19 N 8.8274 12.7902 0.0 0
M  V30 20 C 7.4205 12.1637 0.0 0
M  V30 21 C 11.3978 8.9784 0.0 0
M  V30 22 C 12.1678 10.3120 0.0 0
M  V30 23 C 13.7078 10.3120 0.0 0
M  V30 24 C 14.4778 8.9784 0.0 0
M  V30 25 C 14.4778 11.6457 0.0 0
M  V30 26 C 16.0178 8.9784 0.0 0
M  V30 27 C 16.0178 11.6457 0.0 0
M  V30 28 C 16.7878 10.3120 0.0 0
M  V30 29 C 3.8280 9.0472 0.0 0
M  V30 30 C 4.1481 7.5408 0.0 0
M  V30 31 C 2.3633 9.5231 0.0 0
M  V30 32 C 3.0038 6.5104 0.0 0
M  V30 33 C 1.2189 8.4927 0.0 0
M  V30 34 S 1.5391 6.9862 0.0 0 VAL=6
M  V30 35 C 16.7878 7.6447 0.0 0
M  V30 36 C 18.3278 7.6447 0.0 0
M  V30 37 C 16.0178 6.3109 0.0 0
M  V30 38 C 19.0978 6.3109 0.0 0
M  V30 39 C 16.7878 4.9773 0.0 0
M  V30 40 N 18.3278 4.9773 0.0 0
M  V30 41 C 20.6378 6.3109 0.0 0
M  V30 42 C 21.4078 4.9773 0.0 0
M  V30 43 C 21.4078 7.6447 0.0 0
M  V30 44 C 22.9478 4.9773 0.0 0
M  V30 45 C 22.9478 7.6447 0.0 0
M  V30 46 C 23.7178 6.3109 0.0 0
M  V30 47 C 28.3378 8.9784 0.0 0 CFG=2
M  V30 48 N 29.8694 9.1393 0.0 0
M  V30 49 C 27.7115 10.3852 0.0 0
M  V30 50 C 30.1895 10.6457 0.0 0
M  V30 51 C 28.8559 11.4157 0.0 0
M  V30 52 C 15.7982 0.0000 0.0 0
M  V30 53 O 14.4646 0.7700 0.0 0
M  V30 54 O 17.1319 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 29
M  V30 4 1 3 19
M  V30 5 1 4 24
M  V30 6 2 5 34
M  V30 7 2 6 34
M  V30 8 1 7 36
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 10 11
M  V30 12 1 10 46
M  V30 13 1 11 12
M  V30 14 1 47 12 CFG=3
M  V30 15 2 13 50
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 22 23
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 26 35
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 40 1 35 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 38 41
M  V30 46 2 39 40
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 46
M  V30 53 1 47 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 1 50 51
M  V30 58 1 52 53
M  V30 59 2 52 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 47)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-42-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741459
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[3-[[[(2S)-2-hydroxypropyl]amino...
C41H46Cl2N6O5
2845303-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9812 11.2609 0.0 0
M  V30 2 N 26.4459 11.7368 0.0 0
M  V30 3 C 27.5903 10.7063 0.0 0
M  V30 4 C 29.0550 11.1822 0.0 0 CFG=1
M  V30 5 C 30.1994 10.1517 0.0 0
M  V30 6 O 29.3752 12.6885 0.0 0
M  V30 7 C 22.2707 15.9557 0.0 0
M  V30 8 Cl 17.7104 9.3038 0.0 0
M  V30 9 Cl 12.3203 10.6375 0.0 0
M  V30 10 O 7.7002 10.6375 0.0 0
M  V30 11 C 8.4702 11.9711 0.0 0
M  V30 12 C 6.1601 7.9700 0.0 0
M  V30 13 N 5.3901 6.6363 0.0 0
M  V30 14 C 6.1601 5.3026 0.0 0
M  V30 15 C 3.8501 6.6363 0.0 0
M  V30 16 O 3.0801 7.9700 0.0 0
M  V30 17 O 3.0801 5.3026 0.0 0
M  V30 18 C 1.5400 7.9700 0.0 0
M  V30 19 C 1.5400 6.4299 0.0 0
M  V30 20 C 0.0000 7.9700 0.0 0
M  V30 21 C 1.5400 9.5100 0.0 0
M  V30 22 O 5.0330 0.0000 0.0 0
M  V30 23 C 22.3305 11.9711 0.0 0
M  V30 24 C 21.5605 13.3048 0.0 0
M  V30 25 C 23.8368 12.2913 0.0 0
M  V30 26 C 21.5605 10.6375 0.0 0
M  V30 27 N 20.0204 13.3048 0.0 0
M  V30 28 N 22.5909 14.4494 0.0 0
M  V30 29 C 23.9977 13.8229 0.0 0
M  V30 30 C 20.0204 10.6375 0.0 0
M  V30 31 C 19.2504 11.9711 0.0 0
M  V30 32 C 17.7104 11.9711 0.0 0
M  V30 33 C 16.9404 10.6375 0.0 0
M  V30 34 C 16.9404 13.3048 0.0 0
M  V30 35 C 15.4003 10.6375 0.0 0
M  V30 36 C 15.4003 13.3048 0.0 0
M  V30 37 C 14.6303 11.9711 0.0 0
M  V30 38 C 14.6303 9.3038 0.0 0
M  V30 39 C 13.0903 9.3038 0.0 0
M  V30 40 C 15.4003 7.9700 0.0 0
M  V30 41 C 12.3203 7.9700 0.0 0
M  V30 42 C 14.6303 6.6363 0.0 0
M  V30 43 N 13.0903 6.6363 0.0 0
M  V30 44 C 10.7802 7.9700 0.0 0
M  V30 45 C 10.0102 9.3038 0.0 0
M  V30 46 C 10.0102 6.6363 0.0 0
M  V30 47 C 8.4702 9.3038 0.0 0
M  V30 48 C 8.4702 6.6363 0.0 0
M  V30 49 C 7.7002 7.9700 0.0 0
M  V30 50 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 51 N 6.0164 2.5620 0.0 0
M  V30 52 C 3.8584 3.8079 0.0 0
M  V30 53 C 4.8719 1.5316 0.0 0
M  V30 54 C 3.5382 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 7 28
M  V30 8 1 8 33
M  V30 9 1 9 39
M  V30 10 1 10 11
M  V30 11 1 10 47
M  V30 12 1 12 13
M  V30 13 1 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 50 14 CFG=1
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 53
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 2 24 27
M  V30 28 1 24 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 31 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 41 44
M  V30 48 2 42 43
M  V30 49 2 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 2 46 48
M  V30 53 2 47 49
M  V30 54 1 48 49
M  V30 55 1 50 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[3-[[[(2S)-2-hy...
C36H38Cl2N6O3.CH2O2
2845291-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1598 9.6019 0.0 0
M  V30 2 N 26.6246 10.0778 0.0 0
M  V30 3 C 27.7690 9.0474 0.0 0
M  V30 4 C 29.2337 9.5232 0.0 0 CFG=1
M  V30 5 C 30.3781 8.4928 0.0 0
M  V30 6 O 29.5539 11.0295 0.0 0
M  V30 7 C 22.4494 14.2967 0.0 0
M  V30 8 Cl 17.8889 7.6448 0.0 0
M  V30 9 Cl 12.4988 8.9785 0.0 0
M  V30 10 O 7.8787 3.6437 0.0 0
M  V30 11 C 8.6487 2.3100 0.0 0
M  V30 12 C 6.3386 6.3110 0.0 0
M  V30 13 N 5.5686 7.6448 0.0 0
M  V30 14 C 4.0286 7.6448 0.0 0
M  V30 15 O 0.0000 11.2722 0.0 0
M  V30 16 C 22.5090 10.3122 0.0 0
M  V30 17 C 21.7390 11.6459 0.0 0
M  V30 18 C 24.0154 10.6324 0.0 0
M  V30 19 C 21.7390 8.9785 0.0 0
M  V30 20 N 20.1989 11.6459 0.0 0
M  V30 21 N 22.7696 12.7904 0.0 0
M  V30 22 C 24.1764 12.1639 0.0 0
M  V30 23 C 20.1989 8.9785 0.0 0
M  V30 24 C 19.4289 10.3122 0.0 0
M  V30 25 C 17.8889 10.3122 0.0 0
M  V30 26 C 17.1189 8.9785 0.0 0
M  V30 27 C 17.1189 11.6459 0.0 0
M  V30 28 C 15.5788 8.9785 0.0 0
M  V30 29 C 15.5788 11.6459 0.0 0
M  V30 30 C 14.8088 10.3122 0.0 0
M  V30 31 C 14.8088 7.6448 0.0 0
M  V30 32 C 13.2688 7.6448 0.0 0
M  V30 33 C 15.5788 6.3110 0.0 0
M  V30 34 C 12.4988 6.3110 0.0 0
M  V30 35 C 14.8088 4.9774 0.0 0
M  V30 36 N 13.2688 4.9774 0.0 0
M  V30 37 C 10.9587 6.3110 0.0 0
M  V30 38 C 10.1887 4.9774 0.0 0
M  V30 39 C 10.1887 7.6448 0.0 0
M  V30 40 C 8.6487 4.9774 0.0 0
M  V30 41 C 8.6487 7.6448 0.0 0
M  V30 42 C 7.8787 6.3110 0.0 0
M  V30 43 C 3.2586 8.9785 0.0 0 CFG=2
M  V30 44 N 1.7270 9.1395 0.0 0
M  V30 45 C 3.8850 10.3853 0.0 0
M  V30 46 C 1.4068 10.6459 0.0 0
M  V30 47 C 2.7405 11.4159 0.0 0
M  V30 48 C 15.1890 0.0000 0.0 0
M  V30 49 O 13.8554 0.7700 0.0 0
M  V30 50 O 16.5227 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 7 21
M  V30 8 1 8 26
M  V30 9 1 9 32
M  V30 10 1 10 11
M  V30 11 1 10 40
M  V30 12 1 12 13
M  V30 13 1 12 42
M  V30 14 1 13 14
M  V30 15 1 43 14 CFG=1
M  V30 16 2 15 46
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 34 37
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 1 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 46 47
M  V30 53 1 48 49
M  V30 54 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-49-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Azido-6-methoxy-3-nitroquinoline
C10H7N5O3
2857979-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 0.7700 0.0 0 CHG=1 VAL=4
M  V30 3 N 6.6685 0.0000 0.0 0 CHG=-1
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 1.3337 1.5400 0.0 0
M  V30 6 O 0.0000 3.8501 0.0 0
M  V30 7 O 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 3.8501 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 N 4.0012 6.1601 0.0 0
M  V30 15 C 6.6685 6.1601 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 8.0023 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Methoxy-3H-imidazo[4,5-c]quinoline
C11H9N3O
2857979-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.8129 1.6672 0.0 0
M  V30 2 C 9.1466 2.4373 0.0 0
M  V30 3 C 3.8117 2.4373 0.0 0
M  V30 4 C 2.4781 1.6672 0.0 0
M  V30 5 C 3.8117 3.9773 0.0 0
M  V30 6 C 5.1456 1.6672 0.0 0
M  V30 7 C 1.1444 2.4373 0.0 0
M  V30 8 N 2.1579 0.1609 0.0 0
M  V30 9 N 2.4781 4.7473 0.0 0
M  V30 10 C 5.1456 4.7473 0.0 0
M  V30 11 C 6.4792 2.4373 0.0 0
M  V30 12 C 1.1444 3.9773 0.0 0
M  V30 13 N 0.0000 1.4068 0.0 0
M  V30 14 C 0.6263 0.0000 0.0 0
M  V30 15 C 6.4792 3.9773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 2 9 12
M  V30 15 1 10 15
M  V30 16 2 11 15
M  V30 17 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2857979-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2857979-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34634392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 149-73-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel synthetic procedures for C2 substituted imidazoquinolines as
ligands for the α/β-interface of the GABAA-receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Draskovits, Markus; Catorci, Daniele; Wimmer, Laurin; Rehman, Sabah;
Siebert, David Chan Bodin; Ernst, Margot; Schnuerch, Michael;
Mihovilovic, Marko D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2023), 154(12), 1391-1404

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazole
C3H4N2
288-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 N 0.4759 2.3698 0.0 0
M  V30 4 N 2.4917 0.9052 0.0 0
M  V30 5 C 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazole-1-carboxaldehyde
C4H4N2O
3197-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 N 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 C 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 288-32-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3197-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-092-CAS-12055712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7R)-7-(4-Fluorophenyl)-3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-7-amine
C17H24FNO2
2886760-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.2596 4.1840 0.0 0
M  V30 2 C 1.7145 6.8515 0.0 0
M  V30 3 C 0.0000 5.8615 0.0 0
M  V30 4 F 10.3155 4.7743 0.0 0
M  V30 5 C 2.9871 2.6674 0.0 0
M  V30 6 C 4.5271 2.6674 0.0 0 CFG=1
M  V30 7 O 1.4471 2.6674 0.0 0
M  V30 8 O 3.7571 4.0011 0.0 0
M  V30 9 C 2.2171 1.3338 0.0 0
M  V30 10 C 5.2971 1.3338 0.0 0
M  V30 11 C 0.6771 4.0011 0.0 0
M  V30 12 C 2.9871 5.3347 0.0 0
M  V30 13 C 2.9871 0.0000 0.0 0
M  V30 14 C 4.5271 0.0000 0.0 0
M  V30 15 C 1.4471 5.3347 0.0 0
M  V30 16 C 5.9743 3.1941 0.0 0
M  V30 17 C 7.1539 2.2042 0.0 0
M  V30 18 C 6.2416 4.7107 0.0 0
M  V30 19 C 8.6011 2.7309 0.0 0
M  V30 20 C 7.6888 5.2374 0.0 0
M  V30 21 C 8.8684 4.2476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 16 CFG=3
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 1 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formamide, N-[(7R)-7-(4-fluorophenyl)-3,3-dimethyl-1,5-dioxaspiro[5.5]undec-7...
C18H24FNO3
3048183-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.2596 4.1840 0.0 0
M  V30 2 C 5.4394 5.1739 0.0 0
M  V30 3 O 5.1719 6.6905 0.0 0
M  V30 4 C 1.7145 6.8515 0.0 0
M  V30 5 C 0.0000 5.8615 0.0 0
M  V30 6 F 10.3155 4.7743 0.0 0
M  V30 7 C 4.5271 2.6674 0.0 0 CFG=1
M  V30 8 C 2.9871 2.6674 0.0 0
M  V30 9 C 5.2971 1.3338 0.0 0
M  V30 10 O 1.4471 2.6674 0.0 0
M  V30 11 O 3.7571 4.0011 0.0 0
M  V30 12 C 2.2171 1.3338 0.0 0
M  V30 13 C 4.5271 0.0000 0.0 0
M  V30 14 C 0.6771 4.0011 0.0 0
M  V30 15 C 2.9871 5.3347 0.0 0
M  V30 16 C 2.9871 0.0000 0.0 0
M  V30 17 C 1.4471 5.3347 0.0 0
M  V30 18 C 5.9743 3.1941 0.0 0
M  V30 19 C 7.1539 2.2042 0.0 0
M  V30 20 C 6.2416 4.7107 0.0 0
M  V30 21 C 8.6011 2.7309 0.0 0
M  V30 22 C 7.6888 5.2374 0.0 0
M  V30 23 C 8.8684 4.2476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 17
M  V30 5 1 5 17
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 18 CFG=3
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2886760-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3048183-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41953005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-phenyl-2-amino-cyclohexan-1-one derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senanayake, Chris Hugh; Sirasani, Gopal; Qu, Bo; Samankumara, Lalith
Palitha; Naini, Santosh Reddy; Gajula, Praveen Kumar; Gangu, Satya
Aravind; Leong, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024145422 A1 2024-07-04

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
1-Piperazinecarboxylic acid, 4-[[1-[trans-4-[(6aS)-5,6,6a,7,9,10-hexahydro-2-...
C36H54N8O3
2890777-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.7700 0.0 0
M  V30 2 C 20.0057 10.0102 0.0 0
M  V30 3 C 25.3405 6.9302 0.0 0
M  V30 4 O 26.6742 7.7002 0.0 0
M  V30 5 O 25.3405 5.3901 0.0 0
M  V30 6 C 28.0080 6.9302 0.0 0
M  V30 7 C 28.7780 8.2638 0.0 0
M  V30 8 C 29.3416 6.1601 0.0 0
M  V30 9 C 27.2380 5.5965 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 N 8.0023 3.0801 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0 CFG=1
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 N 8.0023 0.0000 0.0 0
M  V30 17 N 5.3348 0.0000 0.0 0
M  V30 18 C 4.0012 2.3101 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3360 0.7700 0.0 0
M  V30 21 C 9.3360 5.3901 0.0 0
M  V30 22 N 4.0012 0.7700 0.0 0
M  V30 23 N 10.6697 4.6201 0.0 0
M  V30 24 C 2.6675 3.0801 0.0 0
M  V30 25 C 1.3337 2.3101 0.0 0
M  V30 26 C 2.6675 4.6201 0.0 0
M  V30 27 C 0.0000 3.0801 0.0 0
M  V30 28 C 1.3337 5.3901 0.0 0
M  V30 29 C 0.0000 4.6201 0.0 0
M  V30 30 C 12.0033 5.3901 0.0 0 CFG=1
M  V30 31 C 13.3372 4.6201 0.0 0
M  V30 32 C 12.0033 6.9302 0.0 0
M  V30 33 C 14.6708 5.3901 0.0 0
M  V30 34 C 13.3372 7.7002 0.0 0
M  V30 35 C 14.6708 6.9302 0.0 0 CFG=1
M  V30 36 N 16.0045 7.7002 0.0 0
M  V30 37 C 16.0045 9.2402 0.0 0
M  V30 38 C 17.3383 6.9302 0.0 0
M  V30 39 C 17.3383 10.0102 0.0 0
M  V30 40 C 18.6720 7.7002 0.0 0
M  V30 41 C 18.6720 9.2402 0.0 0
M  V30 42 N 21.3393 9.2402 0.0 0
M  V30 43 C 21.3393 7.7002 0.0 0
M  V30 44 C 22.6731 10.0102 0.0 0
M  V30 45 C 22.6731 6.9302 0.0 0
M  V30 46 C 24.0068 9.2402 0.0 0
M  V30 47 N 24.0068 7.7002 0.0 0
M  V30 48 H 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 41
M  V30 3 1 2 42
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 47
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 14 48 CFG=1
M  V30 22 1 15 21
M  V30 23 1 16 20
M  V30 24 1 17 22
M  V30 25 2 18 22
M  V30 26 1 18 24
M  V30 27 1 19 23
M  V30 28 1 21 23
M  V30 29 1 30 23 CFG=1
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 1 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 35
M  V30 42 1 35 36 CFG=3
M  V30 43 1 36 37
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 41
M  V30 48 1 40 41
M  V30 49 1 42 43
M  V30 50 1 42 44
M  V30 51 1 43 45
M  V30 52 1 44 46
M  V30 53 1 45 47
M  V30 54 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-[(6aS)-6,6a,7,8,9,10-hexahydro-8-[trans-4-[4-(1-pi...
C31H46N8O.CH2O2
2890777-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 6.3111 0.0 0
M  V30 2 C 20.7900 7.6447 0.0 0
M  V30 3 C 5.3900 7.6447 0.0 0
M  V30 4 N 6.9300 7.6447 0.0 0
M  V30 5 C 4.6200 8.9785 0.0 0
M  V30 6 C 4.6200 6.3111 0.0 0
M  V30 7 C 7.7000 8.9785 0.0 0 CFG=1
M  V30 8 C 7.7000 6.3111 0.0 0
M  V30 9 N 5.3900 10.3122 0.0 0
M  V30 10 N 3.0800 8.9785 0.0 0
M  V30 11 C 3.0800 6.3111 0.0 0
M  V30 12 C 9.2400 8.9785 0.0 0
M  V30 13 C 6.9300 10.3122 0.0 0
M  V30 14 C 9.2400 6.3111 0.0 0
M  V30 15 N 2.3100 7.6447 0.0 0
M  V30 16 N 10.0100 7.6447 0.0 0
M  V30 17 C 2.3100 4.9775 0.0 0
M  V30 18 C 0.7700 4.9775 0.0 0
M  V30 19 C 3.0800 3.6437 0.0 0
M  V30 20 C 0.0000 3.6437 0.0 0
M  V30 21 C 2.3100 2.3100 0.0 0
M  V30 22 C 0.7700 2.3100 0.0 0
M  V30 23 C 11.5500 7.6447 0.0 0 CFG=1
M  V30 24 C 12.3200 6.3111 0.0 0
M  V30 25 C 12.3200 8.9785 0.0 0
M  V30 26 C 13.8600 6.3111 0.0 0
M  V30 27 C 13.8600 8.9785 0.0 0
M  V30 28 C 14.6300 7.6447 0.0 0 CFG=1
M  V30 29 N 16.1700 7.6447 0.0 0
M  V30 30 C 16.9400 6.3111 0.0 0
M  V30 31 C 16.9400 8.9785 0.0 0
M  V30 32 C 18.4800 6.3111 0.0 0
M  V30 33 C 18.4800 8.9785 0.0 0
M  V30 34 C 19.2500 7.6447 0.0 0
M  V30 35 N 21.5600 6.3111 0.0 0
M  V30 36 C 20.7900 4.9775 0.0 0
M  V30 37 C 23.1000 6.3111 0.0 0
M  V30 38 C 21.5600 3.6438 0.0 0
M  V30 39 C 23.8700 4.9775 0.0 0
M  V30 40 N 23.1000 3.6438 0.0 0
M  V30 41 H 8.4700 10.3122 0.0 0
M  V30 42 C 11.9350 0.0000 0.0 0
M  V30 43 O 10.6013 0.7700 0.0 0
M  V30 44 O 13.2687 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 34
M  V30 3 1 2 35
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 41 CFG=3
M  V30 15 1 8 14
M  V30 16 1 9 13
M  V30 17 1 10 15
M  V30 18 2 11 15
M  V30 19 1 11 17
M  V30 20 1 12 16
M  V30 21 1 14 16
M  V30 22 1 23 16 CFG=1
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 1 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 1 27 28
M  V30 35 1 28 29 CFG=3
M  V30 36 1 29 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 33 34
M  V30 42 1 35 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 40
M  V30 48 1 42 43
M  V30 49 2 42 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2890777-20-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2890777-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35822797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocycles as SMARCA degraders and preparation and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Fleming, Paul R.; Zhu, Xiao; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023278402 A1 2023-01-05

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
1-Piperazinecarboxylic acid, 4-[[1-[cis-4-[(6aS)-5,6,6a,7,9,10-hexahydro-2-(2...
C36H54N8O3
2890777-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.7700 0.0 0
M  V30 2 C 20.0057 10.0102 0.0 0
M  V30 3 C 25.3405 6.9302 0.0 0
M  V30 4 O 26.6742 7.7002 0.0 0
M  V30 5 O 25.3405 5.3901 0.0 0
M  V30 6 C 28.0080 6.9302 0.0 0
M  V30 7 C 27.2380 5.5965 0.0 0
M  V30 8 C 29.3416 6.1601 0.0 0
M  V30 9 C 28.7780 8.2638 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 N 8.0023 3.0801 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0 CFG=1
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 N 8.0023 0.0000 0.0 0
M  V30 17 N 5.3348 0.0000 0.0 0
M  V30 18 C 4.0012 2.3101 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 9.3360 0.7700 0.0 0
M  V30 21 C 9.3360 5.3901 0.0 0
M  V30 22 N 4.0012 0.7700 0.0 0
M  V30 23 N 10.6697 4.6201 0.0 0
M  V30 24 C 2.6675 3.0801 0.0 0
M  V30 25 C 1.3337 2.3101 0.0 0
M  V30 26 C 2.6675 4.6201 0.0 0
M  V30 27 C 0.0000 3.0801 0.0 0
M  V30 28 C 1.3337 5.3901 0.0 0
M  V30 29 C 0.0000 4.6201 0.0 0
M  V30 30 C 12.0033 5.3901 0.0 0 CFG=1
M  V30 31 C 12.0033 6.9302 0.0 0
M  V30 32 C 13.3372 4.6201 0.0 0
M  V30 33 C 13.3372 7.7002 0.0 0
M  V30 34 C 14.6708 5.3901 0.0 0
M  V30 35 C 14.6708 6.9302 0.0 0 CFG=2
M  V30 36 N 16.0045 7.7002 0.0 0
M  V30 37 C 17.3383 6.9302 0.0 0
M  V30 38 C 16.0045 9.2402 0.0 0
M  V30 39 C 18.6720 7.7002 0.0 0
M  V30 40 C 17.3383 10.0102 0.0 0
M  V30 41 C 18.6720 9.2402 0.0 0
M  V30 42 N 21.3393 9.2402 0.0 0
M  V30 43 C 21.3393 7.7002 0.0 0
M  V30 44 C 22.6731 10.0102 0.0 0
M  V30 45 C 22.6731 6.9302 0.0 0
M  V30 46 C 24.0068 9.2402 0.0 0
M  V30 47 N 24.0068 7.7002 0.0 0
M  V30 48 H 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 41
M  V30 3 1 2 42
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 47
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 14 48 CFG=1
M  V30 22 1 15 21
M  V30 23 1 16 20
M  V30 24 1 17 22
M  V30 25 2 18 22
M  V30 26 1 18 24
M  V30 27 1 19 23
M  V30 28 1 21 23
M  V30 29 1 30 23 CFG=3
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 1 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 35
M  V30 42 1 35 36 CFG=3
M  V30 43 1 36 37
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 41
M  V30 48 1 40 41
M  V30 49 1 42 43
M  V30 50 1 42 44
M  V30 51 1 43 45
M  V30 52 1 44 46
M  V30 53 1 45 47
M  V30 54 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-[(6aS)-6,6a,7,8,9,10-hexahydro-8-[cis-4-[4-(1-pipe...
C31H46N8O.CH2O2
2890777-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 6.3111 0.0 0
M  V30 2 C 20.7900 7.6447 0.0 0
M  V30 3 C 5.3900 7.6447 0.0 0
M  V30 4 N 6.9300 7.6447 0.0 0
M  V30 5 C 4.6200 8.9785 0.0 0
M  V30 6 C 4.6200 6.3111 0.0 0
M  V30 7 C 7.7000 8.9785 0.0 0 CFG=1
M  V30 8 C 7.7000 6.3111 0.0 0
M  V30 9 N 5.3900 10.3122 0.0 0
M  V30 10 N 3.0800 8.9785 0.0 0
M  V30 11 C 3.0800 6.3111 0.0 0
M  V30 12 C 9.2400 8.9785 0.0 0
M  V30 13 C 6.9300 10.3122 0.0 0
M  V30 14 C 9.2400 6.3111 0.0 0
M  V30 15 N 2.3100 7.6447 0.0 0
M  V30 16 N 10.0100 7.6447 0.0 0
M  V30 17 C 2.3100 4.9775 0.0 0
M  V30 18 C 0.7700 4.9775 0.0 0
M  V30 19 C 3.0800 3.6437 0.0 0
M  V30 20 C 0.0000 3.6437 0.0 0
M  V30 21 C 2.3100 2.3100 0.0 0
M  V30 22 C 0.7700 2.3100 0.0 0
M  V30 23 C 11.5500 7.6447 0.0 0 CFG=1
M  V30 24 C 12.3200 6.3111 0.0 0
M  V30 25 C 12.3200 8.9785 0.0 0
M  V30 26 C 13.8600 6.3111 0.0 0
M  V30 27 C 13.8600 8.9785 0.0 0
M  V30 28 C 14.6300 7.6447 0.0 0 CFG=2
M  V30 29 N 16.1700 7.6447 0.0 0
M  V30 30 C 16.9400 6.3111 0.0 0
M  V30 31 C 16.9400 8.9785 0.0 0
M  V30 32 C 18.4800 6.3111 0.0 0
M  V30 33 C 18.4800 8.9785 0.0 0
M  V30 34 C 19.2500 7.6447 0.0 0
M  V30 35 N 21.5600 6.3111 0.0 0
M  V30 36 C 20.7900 4.9775 0.0 0
M  V30 37 C 23.1000 6.3111 0.0 0
M  V30 38 C 21.5600 3.6438 0.0 0
M  V30 39 C 23.8700 4.9775 0.0 0
M  V30 40 N 23.1000 3.6438 0.0 0
M  V30 41 H 8.4700 10.3122 0.0 0
M  V30 42 C 11.9350 0.0000 0.0 0
M  V30 43 O 10.6013 0.7700 0.0 0
M  V30 44 O 13.2687 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 34
M  V30 3 1 2 35
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 41 CFG=3
M  V30 15 1 8 14
M  V30 16 1 9 13
M  V30 17 1 10 15
M  V30 18 2 11 15
M  V30 19 1 11 17
M  V30 20 1 12 16
M  V30 21 1 14 16
M  V30 22 1 23 16 CFG=1
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 1 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 1 27 28
M  V30 35 1 28 29 CFG=1
M  V30 36 1 29 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 1 31 33
M  V30 40 1 32 34
M  V30 41 1 33 34
M  V30 42 1 35 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 40
M  V30 48 1 42 43
M  V30 49 2 42 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2890777-21-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2890777-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35822791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocycles as SMARCA degraders and preparation and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Fleming, Paul R.; Zhu, Xiao; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023278402 A1 2023-01-05

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-[4-(Dimethoxymethyl)-1-piperidinyl]phenyl]-2,6-piperidinedione
C19H26N2O4
2891496-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.0903 0.0000 0.0 0
M  V30 2 O 17.7104 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 O 1.5400 1.3337 0.0 0
M  V30 5 O 1.5400 4.0010 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.0000 4.0010 0.0 0
M  V30 8 C 13.0903 2.6673 0.0 0
M  V30 9 C 13.8603 1.3337 0.0 0
M  V30 10 C 13.8603 4.0010 0.0 0
M  V30 11 N 15.4003 1.3337 0.0 0
M  V30 12 C 15.4003 4.0010 0.0 0
M  V30 13 C 16.1704 2.6673 0.0 0
M  V30 14 C 11.5503 2.6673 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 C 10.7802 1.3337 0.0 0
M  V30 17 C 9.2402 4.0010 0.0 0
M  V30 18 C 9.2402 1.3337 0.0 0
M  V30 19 C 8.4702 2.6673 0.0 0
M  V30 20 N 6.9302 2.6673 0.0 0
M  V30 21 C 6.1601 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 4.6201 1.3337 0.0 0
M  V30 24 C 4.6201 4.0010 0.0 0
M  V30 25 C 3.8501 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 25
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1-[4-(2,6-dioxo-3-piperidinyl)phenyl]-4-piperidineca...
C17H20N2O3.CH2O2
3030285-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.3100 0.0 0
M  V30 2 O 0.0000 4.9774 0.0 0
M  V30 3 C 15.4003 4.9774 0.0 0
M  V30 4 O 16.1704 6.3110 0.0 0
M  V30 5 C 4.6201 4.9774 0.0 0
M  V30 6 C 3.8501 3.6437 0.0 0
M  V30 7 C 3.8501 6.3110 0.0 0
M  V30 8 N 2.3101 3.6437 0.0 0
M  V30 9 C 2.3101 6.3110 0.0 0
M  V30 10 C 1.5400 4.9774 0.0 0
M  V30 11 C 6.1601 4.9774 0.0 0
M  V30 12 C 6.9302 6.3110 0.0 0
M  V30 13 C 6.9302 3.6437 0.0 0
M  V30 14 C 8.4702 6.3110 0.0 0
M  V30 15 C 8.4702 3.6437 0.0 0
M  V30 16 C 9.2402 4.9774 0.0 0
M  V30 17 N 10.7802 4.9774 0.0 0
M  V30 18 C 11.5503 6.3110 0.0 0
M  V30 19 C 11.5503 3.6437 0.0 0
M  V30 20 C 13.0903 6.3110 0.0 0
M  V30 21 C 13.0903 3.6437 0.0 0
M  V30 22 C 13.8603 4.9774 0.0 0
M  V30 23 C 8.0852 0.0000 0.0 0
M  V30 24 O 6.7515 0.7700 0.0 0
M  V30 25 O 9.4188 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 1 3 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2891496-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3030285-53-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40336686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and related heterocyclic compounds as CDK2
degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collier, Philip; Zheng, Xiaozhang; Zhu, Xiao; Ford, Melissa; Weiss,
Matthew M.; Aversa, Robert; Pennington, Lewis Dale; Comer, Eamon;
Mahasenan, Kiran Vijayakumari; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024039901 A2 2024-02-22

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
1-Piperidinepentanoic acid, 4-[2-[4-[(1R)-1-[[5-[[(3S,4S)-1-[(1,1-dimethyleth...
C43H55FN4O5
2922833-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 20.5294 5.3901 0.0 0
M  V30 2 C 21.8631 4.6201 0.0 0
M  V30 3 C 15.1946 8.4702 0.0 0 CFG=1
M  V30 4 N 13.8609 7.7002 0.0 0
M  V30 5 C 15.1946 10.0102 0.0 0
M  V30 6 C 12.5271 8.4702 0.0 0
M  V30 7 O 12.5271 10.0102 0.0 0
M  V30 8 C 12.5271 5.3901 0.0 0
M  V30 9 C 27.1979 1.5400 0.0 0
M  V30 10 C 28.5316 2.3100 0.0 0
M  V30 11 C 29.8654 1.5400 0.0 0
M  V30 12 C 31.1991 2.3100 0.0 0
M  V30 13 C 32.5327 1.5400 0.0 0
M  V30 14 O 33.8664 2.3100 0.0 0
M  V30 15 O 32.5327 0.0000 0.0 0
M  V30 16 C 35.2002 1.5400 0.0 0
M  V30 17 C 36.5339 2.3100 0.0 0
M  V30 18 N 7.1923 8.4702 0.0 0
M  V30 19 F 4.1316 9.8330 0.0 0
M  V30 20 C 3.5649 4.4415 0.0 0
M  V30 21 O 2.0333 4.2805 0.0 0
M  V30 22 O 4.4701 3.1956 0.0 0
M  V30 23 C 1.4068 2.8735 0.0 0
M  V30 24 C 2.8138 2.2472 0.0 0
M  V30 25 C 0.7805 1.4667 0.0 0
M  V30 26 C 0.0000 3.5000 0.0 0
M  V30 27 C 19.1957 7.7002 0.0 0
M  V30 28 C 17.8619 8.4702 0.0 0
M  V30 29 C 19.1957 6.1601 0.0 0
M  V30 30 C 20.5294 8.4702 0.0 0
M  V30 31 C 16.5282 7.7002 0.0 0
M  V30 32 C 17.8619 10.0102 0.0 0
M  V30 33 C 17.8619 5.3901 0.0 0
M  V30 34 C 20.5294 10.0102 0.0 0
M  V30 35 C 16.5282 6.1601 0.0 0
M  V30 36 C 19.1957 10.7802 0.0 0
M  V30 37 C 23.1967 3.8501 0.0 0
M  V30 38 C 23.1967 2.3100 0.0 0
M  V30 39 C 24.5306 4.6201 0.0 0
M  V30 40 C 24.5306 1.5400 0.0 0
M  V30 41 C 25.8642 3.8501 0.0 0
M  V30 42 N 25.8642 2.3100 0.0 0
M  V30 43 C 11.1934 7.7002 0.0 0
M  V30 44 C 9.8598 8.4702 0.0 0
M  V30 45 C 11.1934 6.1601 0.0 0
M  V30 46 C 8.5261 7.7002 0.0 0
M  V30 47 C 9.8598 5.3901 0.0 0
M  V30 48 C 8.5261 6.1601 0.0 0
M  V30 49 C 5.8586 7.7002 0.0 0 CFG=2
M  V30 50 C 5.6977 6.1686 0.0 0
M  V30 51 C 4.4518 8.3265 0.0 0 CFG=1
M  V30 52 N 4.1912 5.8484 0.0 0
M  V30 53 C 3.4212 7.1821 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 29
M  V30 3 1 2 37
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 3 31
M  V30 7 1 4 6
M  V30 8 2 6 7
M  V30 9 1 6 43
M  V30 10 1 8 45
M  V30 11 1 9 10
M  V30 12 1 9 42
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 18 46
M  V30 21 1 49 18 CFG=1
M  V30 22 1 51 19 CFG=3
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 20 52
M  V30 26 1 21 23
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 23 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 35 2 29 33
M  V30 36 2 30 34
M  V30 37 2 31 35
M  V30 38 2 32 36
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 47 2 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 2 45 47
M  V30 51 2 46 48
M  V30 52 1 47 48
M  V30 53 1 49 50
M  V30 54 1 49 51
M  V30 55 1 50 52
M  V30 56 1 51 53
M  V30 57 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 3 49 51)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 4-[2-[4-[(1R)-1-[[5-[[(3S,4S)-1-[(1,1-dimethylethoxy...
C41H51FN4O5.CH2O2
2922833-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.5294 7.7001 0.0 0
M  V30 2 C 21.8631 6.9301 0.0 0
M  V30 3 C 15.1946 10.7802 0.0 0 CFG=1
M  V30 4 N 13.8609 10.0102 0.0 0
M  V30 5 C 15.1946 12.3202 0.0 0
M  V30 6 C 12.5273 10.7802 0.0 0
M  V30 7 O 12.5273 12.3202 0.0 0
M  V30 8 C 12.5273 7.7001 0.0 0
M  V30 9 C 27.1979 3.8501 0.0 0
M  V30 10 C 28.5317 4.6201 0.0 0
M  V30 11 C 29.8654 3.8501 0.0 0
M  V30 12 C 31.1991 4.6201 0.0 0
M  V30 13 C 32.5327 3.8501 0.0 0
M  V30 14 O 32.5327 2.3100 0.0 0
M  V30 15 O 33.8666 4.6201 0.0 0
M  V30 16 N 7.1924 10.7802 0.0 0
M  V30 17 F 4.1316 12.1430 0.0 0
M  V30 18 C 3.5649 6.7515 0.0 0
M  V30 19 O 2.0333 6.5905 0.0 0
M  V30 20 O 4.4701 5.5056 0.0 0
M  V30 21 C 1.4070 5.1836 0.0 0
M  V30 22 C 0.0000 5.8101 0.0 0
M  V30 23 C 0.7805 3.7767 0.0 0
M  V30 24 C 2.8138 4.5572 0.0 0
M  V30 25 C 19.1958 10.0102 0.0 0
M  V30 26 C 17.8621 10.7802 0.0 0
M  V30 27 C 19.1958 8.4702 0.0 0
M  V30 28 C 20.5294 10.7802 0.0 0
M  V30 29 C 16.5283 10.0102 0.0 0
M  V30 30 C 17.8621 12.3202 0.0 0
M  V30 31 C 17.8621 7.7001 0.0 0
M  V30 32 C 20.5294 12.3202 0.0 0
M  V30 33 C 16.5283 8.4702 0.0 0
M  V30 34 C 19.1958 13.0903 0.0 0
M  V30 35 C 23.1969 6.1601 0.0 0
M  V30 36 C 24.5306 6.9301 0.0 0
M  V30 37 C 23.1969 4.6201 0.0 0
M  V30 38 C 25.8642 6.1601 0.0 0
M  V30 39 C 24.5306 3.8501 0.0 0
M  V30 40 N 25.8642 4.6201 0.0 0
M  V30 41 C 11.1934 10.0102 0.0 0
M  V30 42 C 9.8598 10.7802 0.0 0
M  V30 43 C 11.1934 8.4702 0.0 0
M  V30 44 C 8.5261 10.0102 0.0 0
M  V30 45 C 9.8598 7.7001 0.0 0
M  V30 46 C 8.5261 8.4702 0.0 0
M  V30 47 C 5.8586 10.0102 0.0 0 CFG=2
M  V30 48 C 5.6977 8.4786 0.0 0
M  V30 49 C 4.4518 10.6365 0.0 0 CFG=1
M  V30 50 N 4.1914 8.1584 0.0 0
M  V30 51 C 3.4213 9.4921 0.0 0
M  V30 52 C 16.9333 0.0000 0.0 0
M  V30 53 O 15.5996 0.7700 0.0 0
M  V30 54 O 18.2670 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 27
M  V30 3 1 2 35
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 3 29
M  V30 7 1 4 6
M  V30 8 2 6 7
M  V30 9 1 6 41
M  V30 10 1 8 43
M  V30 11 1 9 10
M  V30 12 1 9 40
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 16 44
M  V30 19 1 47 16 CFG=1
M  V30 20 1 49 17 CFG=3
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 50
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 2 27 31
M  V30 34 2 28 32
M  V30 35 2 29 33
M  V30 36 2 30 34
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 47 48
M  V30 52 1 47 49
M  V30 53 1 48 50
M  V30 54 1 49 51
M  V30 55 1 50 51
M  V30 56 1 52 53
M  V30 57 2 52 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 3 47 49)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2922833-18-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922833-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36504381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product purified by reverse phase column chromatography stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctionalized compounds as coronavirus non-structural
protein 3 degrading compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duplessis, Martin; Hanley, Ronan Patrick; Liang, Yanke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023059792 A1 2023-04-13

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-4-methylaniline
C7H8IN
29289-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 C 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodo-4-methylphenyl)formamide
C8H8INO
1304143-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 I 4.6201 0.0000 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29289-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1304143-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H39N5O4Si
2948323-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 5.6336 0.0 0
M  V30 2 O 4.0011 7.1736 0.0 0
M  V30 3 C 2.6674 7.9436 0.0 0
M  V30 4 C 2.6674 9.4836 0.0 0
M  V30 5 Si 1.3336 10.2536 0.0 0
M  V30 6 C 0.0000 11.0236 0.0 0
M  V30 7 C 2.1036 11.5873 0.0 0
M  V30 8 C 0.5636 8.9198 0.0 0
M  V30 9 C 5.8458 0.0000 0.0 0
M  V30 10 O 14.4490 8.8408 0.0 0
M  V30 11 C 15.9553 8.5207 0.0 0
M  V30 12 N 16.9859 9.6650 0.0 0
M  V30 13 O 16.4313 7.0560 0.0 0
M  V30 14 C 18.4922 9.3449 0.0 0 CFG=1
M  V30 15 C 19.5226 10.4894 0.0 0
M  V30 16 C 18.9680 7.8803 0.0 0
M  V30 17 O 21.0290 10.1692 0.0 0
M  V30 18 C 5.4956 3.3321 0.0 0
M  V30 19 N 5.3347 4.8636 0.0 0
M  V30 20 C 7.0021 3.0118 0.0 0
M  V30 21 C 6.7417 5.4899 0.0 0
M  V30 22 C 7.7721 4.3456 0.0 0
M  V30 23 N 7.2175 6.9546 0.0 0
M  V30 24 C 9.2783 4.6657 0.0 0
M  V30 25 C 8.7238 7.2748 0.0 0
M  V30 26 C 9.7542 6.1303 0.0 0
M  V30 27 C 4.3513 2.3015 0.0 0
M  V30 28 N 4.5122 0.7700 0.0 0
M  V30 29 C 2.8448 2.6217 0.0 0
M  V30 30 N 3.1054 0.1437 0.0 0
M  V30 31 C 2.0748 1.2881 0.0 0
M  V30 32 C 11.2606 6.4504 0.0 0 CFG=1
M  V30 33 C 11.8870 7.8574 0.0 0
M  V30 34 C 12.4050 5.4200 0.0 0
M  V30 35 C 13.4186 7.6965 0.0 0 CFG=2
M  V30 36 C 13.7388 6.1900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 28
M  V30 10 1 10 11
M  V30 11 1 35 10 CFG=3
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=3
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 27
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 32 26 CFG=3
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 32 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H39N5O5Si
2948323-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1747 6.3625 0.0 0
M  V30 2 O 3.6506 4.8980 0.0 0
M  V30 3 C 2.6202 3.7535 0.0 0
M  V30 4 C 3.0960 2.2889 0.0 0
M  V30 5 Si 2.0656 1.1444 0.0 0
M  V30 6 C 1.0350 0.0000 0.0 0
M  V30 7 C 0.9211 2.1748 0.0 0
M  V30 8 C 3.2100 0.1140 0.0 0
M  V30 9 C 3.1884 12.2905 0.0 0
M  V30 10 O 14.1025 6.5409 0.0 0
M  V30 11 C 15.4361 7.3109 0.0 0
M  V30 12 N 16.7699 6.5409 0.0 0
M  V30 13 O 15.4361 8.8509 0.0 0
M  V30 14 C 18.1036 7.3109 0.0 0 CFG=1
M  V30 15 C 19.4372 6.5409 0.0 0
M  V30 16 C 18.1036 8.8509 0.0 0
M  V30 17 O 20.7709 7.3109 0.0 0
M  V30 18 C 22.1047 6.5409 0.0 0
M  V30 19 O 23.4383 7.3109 0.0 0
M  V30 20 C 3.8850 9.0134 0.0 0
M  V30 21 N 4.2051 7.5071 0.0 0
M  V30 22 C 5.2186 9.7834 0.0 0
M  V30 23 C 5.7368 7.3460 0.0 0
M  V30 24 C 6.3632 8.7529 0.0 0
M  V30 25 N 6.6419 6.1001 0.0 0
M  V30 26 C 7.8947 8.9139 0.0 0
M  V30 27 C 8.1736 6.2611 0.0 0
M  V30 28 C 8.7999 7.6680 0.0 0
M  V30 29 C 2.4782 9.6397 0.0 0
M  V30 30 N 2.1580 11.1461 0.0 0
M  V30 31 C 1.1444 8.8697 0.0 0
M  V30 32 N 0.6263 11.3070 0.0 0
M  V30 33 C 0.0000 9.9002 0.0 0
M  V30 34 C 10.3314 7.8289 0.0 0 CFG=1
M  V30 35 C 11.3619 6.6846 0.0 0
M  V30 36 C 11.1015 9.1626 0.0 0
M  V30 37 C 12.7688 7.3109 0.0 0 CFG=2
M  V30 38 C 12.6079 8.8424 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 30
M  V30 10 1 10 11
M  V30 11 1 37 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=1
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 2 18 19
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 20 29
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 1 34 28 CFG=1
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 34 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2948323-58-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2948323-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36965191
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CDK2 inhibitors, pharmaceutically acceptable salt, or stereoisomer and
application thereof for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Feng; Li, Hailong; He, Hu; Zhong, Wenge; Wang, Yuanhao; Chen,
Xiumei; Huang, Wei; Sun, Xianqiang; Yu, Yang; Huang, Junhong; Liu, Wei;
Chen, Xinde
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023116884 A1 2023-06-29

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylthio)aniline
C7H9NS
2987-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 N 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(Methylthio)phenyl]formamide
C8H9NOS
18550-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 S 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2987-53-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18550-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37786976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd(II)-Catalyzed β-C(sp3)-H Functionalization of Ugi 4-CR Adducts Using
the 2-(Methylthio)-aniline (MTA) Directing Group
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becerra-Anaya, Silvia J.; Polindara-Garcia, Luis A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(34), e202303124

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H38O4
3027425-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 3.3501 4.4757 0.0 0
M  V30 3 C 6.6684 7.7000 0.0 0
M  V30 4 C 8.8404 7.2727 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5186 0.0 0
M  V30 6 C 7.3087 7.4336 0.0 0
M  V30 7 C 9.1192 9.9255 0.0 0
M  V30 8 C 10.0244 11.1714 0.0 0
M  V30 9 O 9.3981 12.5782 0.0 0
M  V30 10 O 11.5559 11.0104 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 13 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 14 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 15 C 6.6684 1.5400 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 19 C 9.4667 3.3740 0.0 0
M  V30 20 C 5.3347 0.7700 0.0 0
M  V30 21 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 22 C 2.6673 3.8500 0.0 0
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 9.4667 5.8659 0.0 0 CFG=2
M  V30 25 C 10.3720 4.6200 0.0 0
M  V30 26 C 2.6673 0.7700 0.0 0
M  V30 27 C 1.3336 3.0800 0.0 0
M  V30 28 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 29 H 7.7573 1.9909 0.0 0
M  V30 30 H 4.2458 4.9390 0.0 0
M  V30 31 H 8.7953 2.5299 0.0 0
M  V30 32 H 8.1631 6.9216 0.0 0
M  V30 33 H 4.0011 0.0000 0.0 0
M  V30 34 H 10.8004 6.6359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 16 2 CFG=1
M  V30 3 1 23 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 24
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 28 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=3
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 31 CFG=3
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 23
M  V30 27 1 18 24
M  V30 28 1 18 32 CFG=1
M  V30 29 1 19 25
M  V30 30 1 20 21
M  V30 31 1 21 26
M  V30 32 1 21 33 CFG=1
M  V30 33 1 22 27
M  V30 34 1 24 25
M  V30 35 1 24 34 CFG=1
M  V30 36 1 26 28
M  V30 37 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 4 12 13 14 16 18 21 23 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C25H38O5
3027426-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 0.7700 0.0 0
M  V30 2 C 6.0176 4.4757 0.0 0
M  V30 3 C 9.3357 7.7001 0.0 0
M  V30 4 C 11.5078 7.2727 0.0 0 CFG=2
M  V30 5 C 12.4130 8.5186 0.0 0
M  V30 6 C 9.9762 7.4337 0.0 0
M  V30 7 C 11.7865 9.9255 0.0 0
M  V30 8 C 12.6917 11.1714 0.0 0
M  V30 9 O 12.0654 12.5782 0.0 0
M  V30 10 O 14.2233 11.0105 0.0 0
M  V30 11 O 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 O 0.0000 0.7700 0.0 0
M  V30 14 C 9.3357 3.0800 0.0 0 CFG=1
M  V30 15 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 16 C 10.6695 3.8500 0.0 0 CFG=2
M  V30 17 C 9.3357 1.5400 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 19 C 8.0021 5.3901 0.0 0
M  V30 20 C 10.6695 5.3901 0.0 0 CFG=1
M  V30 21 C 12.1341 3.3740 0.0 0
M  V30 22 C 8.0021 0.7700 0.0 0
M  V30 23 C 6.6684 1.5400 0.0 0 CFG=1
M  V30 24 C 5.3348 3.8500 0.0 0
M  V30 25 C 9.3357 6.1601 0.0 0 CFG=1
M  V30 26 C 12.1341 5.8659 0.0 0 CFG=2
M  V30 27 C 13.0393 4.6200 0.0 0
M  V30 28 C 5.3348 0.7700 0.0 0
M  V30 29 C 4.0010 3.0800 0.0 0
M  V30 30 C 4.0010 1.5400 0.0 0 CFG=2
M  V30 31 H 10.4247 1.9909 0.0 0
M  V30 32 H 6.9131 4.9390 0.0 0
M  V30 33 H 11.4626 2.5299 0.0 0
M  V30 34 H 10.8305 6.9216 0.0 0
M  V30 35 H 6.6684 0.0000 0.0 0
M  V30 36 H 13.4677 6.6359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 18 2 CFG=1
M  V30 3 1 25 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 26
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 30 11 CFG=3
M  V30 13 2 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 31 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 32 CFG=3
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 16 33 CFG=3
M  V30 24 1 17 22
M  V30 25 1 18 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 20 25
M  V30 29 1 20 26
M  V30 30 1 20 34 CFG=1
M  V30 31 1 21 27
M  V30 32 1 22 23
M  V30 33 1 23 28
M  V30 34 1 23 35 CFG=1
M  V30 35 1 24 29
M  V30 36 1 26 27
M  V30 37 1 26 36 CFG=1
M  V30 38 1 28 30
M  V30 39 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 4 14 15 16 18 20 23 25 26 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3027425-72-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3027426-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36251402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of 12β-methyl-17-epi-18-nor-bile acids as potent and
selective TGR5 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luxenburger, Andreas; Harris, Lawrence D.; Ure, Elizabeth M.; Jiao,
Wanting; Woolhouse, Anthony D.; Cameron, Scott A.; Weymouth-Wilson, Alex;
Furneaux, Richard H.; Pitman, Janet L.; Hinkley, Simon F. R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 250115143

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1-methyl-1H-benzimidazole
C8H7BrN2
53484-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4294 0.0000 0.0 0
M  V30 2 Br 6.3710 1.1704 0.0 0
M  V30 3 C 2.3699 1.9404 0.0 0
M  V30 4 C 2.3699 3.4804 0.0 0
M  V30 5 N 0.9052 1.4645 0.0 0
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 3.7036 4.2504 0.0 0
M  V30 8 N 0.9052 3.9564 0.0 0
M  V30 9 C 0.0000 2.7104 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-2417689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as ACSS2 modulators and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Darryl David; Grina, Jonas; Josey, John A.; Rizzi, James P.;
Schlachter, Stephen T.; Wallace, Eli M.; Wang, Bin; Wehn, Paul; Yang,
Hanbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015175845 A1 2015-11-19

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H27N3O4
3052621-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 7.7001 0.0 0
M  V30 2 C 4.0011 6.9301 0.0 0
M  V30 3 O 2.6673 7.7001 0.0 0
M  V30 4 O 4.0011 5.3901 0.0 0
M  V30 5 C 1.3337 6.9301 0.0 0
M  V30 6 C 2.1037 5.5965 0.0 0
M  V30 7 C 0.0000 6.1601 0.0 0
M  V30 8 C 0.5637 8.2638 0.0 0
M  V30 9 O 15.5541 9.6092 0.0 0
M  V30 10 C 17.0604 9.2890 0.0 0
M  V30 11 O 10.6696 3.0801 0.0 0
M  V30 12 C 12.0033 2.3100 0.0 0
M  V30 13 N 9.3360 6.9301 0.0 0
M  V30 14 C 8.0021 7.7001 0.0 0
M  V30 15 C 10.4804 7.9606 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 6.6685 6.9301 0.0 0
M  V30 18 N 8.3225 9.2064 0.0 0
M  V30 19 C 9.8540 9.3675 0.0 0
M  V30 20 C 8.0021 4.6201 0.0 0
M  V30 21 C 6.6685 5.3901 0.0 0
M  V30 22 C 11.9868 7.6404 0.0 0
M  V30 23 C 13.0172 8.7849 0.0 0
M  V30 24 C 12.4627 6.1758 0.0 0
M  V30 25 C 14.5235 8.4648 0.0 0
M  V30 26 C 13.9690 5.8556 0.0 0
M  V30 27 C 14.9996 7.0000 0.0 0
M  V30 28 C 8.0021 3.0801 0.0 0
M  V30 29 C 9.3360 2.3100 0.0 0
M  V30 30 C 6.6685 2.3100 0.0 0
M  V30 31 C 9.3360 0.7700 0.0 0
M  V30 32 C 6.6685 0.7700 0.0 0
M  V30 33 C 8.0021 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 15 22
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 28
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-[6-(2-methoxyphenyl)-3-(3-methoxyphenyl)imidazo[1,2-a]pyridin-8-...
C22H19N3O3
3052621-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8501 1.3337 0.0 0
M  V30 2 C 2.3100 1.3337 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 13.6546 4.7901 0.0 0
M  V30 5 C 14.7990 5.8205 0.0 0
M  V30 6 O 1.5400 5.3348 0.0 0
M  V30 7 C 0.0000 5.3348 0.0 0
M  V30 8 N 6.9301 4.0011 0.0 0
M  V30 9 C 6.1601 2.6675 0.0 0
M  V30 10 C 8.4364 3.6810 0.0 0
M  V30 11 C 6.1601 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 N 7.1905 1.5229 0.0 0
M  V30 14 C 8.5973 2.1494 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.8501 4.0011 0.0 0
M  V30 17 C 9.5808 4.7114 0.0 0
M  V30 18 C 11.0455 4.2355 0.0 0
M  V30 19 C 9.2606 6.2178 0.0 0
M  V30 20 C 12.1899 5.2660 0.0 0
M  V30 21 C 10.4052 7.2483 0.0 0
M  V30 22 C 11.8697 6.7724 0.0 0
M  V30 23 C 3.8501 6.6685 0.0 0
M  V30 24 C 2.3100 6.6685 0.0 0
M  V30 25 C 4.6201 8.0023 0.0 0
M  V30 26 C 1.5400 8.0023 0.0 0
M  V30 27 C 3.8501 9.3359 0.0 0
M  V30 28 C 2.3100 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 10 17
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052621-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052621-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37103815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine
series that induces differentiation in multiple AML cell lines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Josa-Cullere, Laia; Galan, Sebastien R. G.; Cogswell, Thomas J.; Jackson,
Thomas R.; Jay-Smith, Morgan; Mola, Laura; Greaves, Christopher R.;
Carter, Tom S.; Madden, Katrina S.; Trott, Sophie; Zhang, Douzi;
Bataille, Carole J. R.; Davies, Stephen G.; Vyas, Paresh; Milne, Thomas
A.; Naylor, Alan; Wynne, Graham M.; Russell, Angela J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 258115509

$RFMT $RIREG SCHEME226 STEP1
$RXN



  3  1
$MOL
3-(Dimethylamino)-1-propanol
C5H13NO
3179-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-6-(2,4,6-trifluorophenyl)-N-[(1S)-1,2,2-trimethylpropyl][1,2,4]triaz...
C17H17ClF3N5
424824-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.7473 4.0012 0.0 0
M  V30 2 C 3.9773 2.6675 0.0 0 CFG=1
M  V30 3 C 4.7473 1.3337 0.0 0
M  V30 4 C 2.4373 2.6675 0.0 0
M  V30 5 C 3.4136 0.5637 0.0 0
M  V30 6 C 5.5173 0.0000 0.0 0
M  V30 7 C 6.0811 2.1037 0.0 0
M  V30 8 Cl 4.7473 9.3360 0.0 0
M  V30 9 F 6.2873 9.3360 0.0 0
M  V30 10 F 6.2873 4.0012 0.0 0
M  V30 11 F 10.9074 6.6685 0.0 0
M  V30 12 C 4.7473 6.6685 0.0 0
M  V30 13 C 3.9773 5.3348 0.0 0
M  V30 14 C 3.9773 8.0023 0.0 0
M  V30 15 N 2.4373 5.3348 0.0 0
M  V30 16 N 2.4373 8.0023 0.0 0
M  V30 17 C 1.6672 6.6685 0.0 0
M  V30 18 N 1.4068 4.1904 0.0 0
M  V30 19 N 0.1609 6.3483 0.0 0
M  V30 20 C 0.0000 4.8168 0.0 0
M  V30 21 C 6.2873 6.6685 0.0 0
M  V30 22 C 7.0574 8.0023 0.0 0
M  V30 23 C 7.0574 5.3348 0.0 0
M  V30 24 C 8.5974 8.0023 0.0 0
M  V30 25 C 8.5974 5.3348 0.0 0
M  V30 26 C 9.3674 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 14
M  V30 9 1 9 22
M  V30 10 1 10 23
M  V30 11 1 11 26
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 5-chloro-6-[4-[3-(dimethylamino)propoxy]-2,6-difluor...
C22H29ClF2N6O.CH2O2
2872565-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7035 6.1600 0.0 0
M  V30 2 C 2.3699 5.3900 0.0 0 CFG=1
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 1.0363 6.1600 0.0 0
M  V30 5 C 3.9099 3.8500 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 0.8299 3.8500 0.0 0
M  V30 8 Cl 6.3710 10.7800 0.0 0
M  V30 9 F 5.0372 5.3900 0.0 0
M  V30 10 F 7.7046 10.0100 0.0 0
M  V30 11 O 10.3719 5.3900 0.0 0
M  V30 12 C 11.7057 6.1600 0.0 0
M  V30 13 C 13.0393 5.3900 0.0 0
M  V30 14 C 14.3730 6.1600 0.0 0
M  V30 15 N 15.7066 5.3900 0.0 0
M  V30 16 C 15.7066 3.8500 0.0 0
M  V30 17 C 17.0404 6.1600 0.0 0
M  V30 18 C 5.0372 8.4700 0.0 0
M  V30 19 C 3.7035 7.7000 0.0 0
M  V30 20 C 5.0372 10.0100 0.0 0
M  V30 21 N 2.3699 8.4700 0.0 0
M  V30 22 N 3.7035 10.7800 0.0 0
M  V30 23 C 2.3699 10.0100 0.0 0
M  V30 24 N 0.9052 7.9942 0.0 0
M  V30 25 N 0.9052 10.4859 0.0 0
M  V30 26 C 0.0000 9.2400 0.0 0
M  V30 27 C 6.3710 7.7000 0.0 0
M  V30 28 C 6.3710 6.1600 0.0 0
M  V30 29 C 7.7046 8.4700 0.0 0
M  V30 30 C 7.7046 5.3900 0.0 0
M  V30 31 C 9.0383 7.7000 0.0 0
M  V30 32 C 9.0383 6.1600 0.0 0
M  V30 33 C 8.5202 0.0000 0.0 0
M  V30 34 O 7.1865 0.7700 0.0 0
M  V30 35 O 9.8539 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 20
M  V30 9 1 9 28
M  V30 10 1 10 29
M  V30 11 1 11 12
M  V30 12 1 11 32
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 27
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 22 23
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 1 33 34
M  V30 36 2 33 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3179-63-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 424824-49-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2872565-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35335047
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microtubule-Stabilizing 1,2,4-Triazolo[1,5-a]pyrimidines as Candidate
Therapeutics for Neurodegenerative Disease: Matched Molecular Pair
Analyses and Computational Studies Reveal New Structure-Activity Insights
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alle, Thibault; Varricchio, Carmine; Yao, Yuemang; Lucero, Bobby; Nzou,
Goodwell; Demuro, Stefania; Muench, Megan; Vuong, Khoa D.; Oukoloff,
Killian; Cornec, Anne-Sophie; Francisco, Karol R.; Caffrey, Conor R.;
Lee, Virginia M.-Y.; Smith, Amos B. III; Brancale, Andrea; Brunden, Kurt
R.; Ballatore, Carlo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(1), 435-459

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-Ephedrine
C10H15NO
321-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2S)-2-Hydroxy-1-methyl-2-phenylethyl]-N-methylformamide
C11H15NO2
894793-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 N 6.6684 3.0800 0.0 0
M  V30 5 C 5.3347 0.7700 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 O 9.3358 3.0800 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894793-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16482411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, solid-supported catalyst, no
solvent, sealed tube used, recyclable catalyst, silica supported catalyst
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metallophytes for organic synthesis: towards new bio-based selective
protection/deprotection procedures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grison, Claire M.; Velati, Alicia; Escande, Vincent; Grison, Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Environmental Science and Pollution Research (2015), 22(8), 5686-5698

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Etheno-1H-cyclopentacyclotetradecene-5-carboxylic acid, 1-[(1R,2E,4S)-1,4...
C31H46O3
330206-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7596 5.9113 0.0 0
M  V30 2 C 10.1413 5.6283 0.0 0 CFG=2
M  V30 3 C 11.6813 5.6283 0.0 0
M  V30 4 C 9.3713 6.9619 0.0 0
M  V30 5 C 12.4513 6.9619 0.0 0
M  V30 6 C 13.9913 6.9619 0.0 0 CFG=1
M  V30 7 C 14.7613 8.2956 0.0 0
M  V30 8 C 14.7613 5.6283 0.0 0
M  V30 9 C 16.3013 8.2956 0.0 0
M  V30 10 C 4.4391 2.4666 0.0 0
M  V30 11 O 3.2194 1.5263 0.0 0
M  V30 12 O 5.8633 1.8803 0.0 0
M  V30 13 C 3.4239 0.0000 0.0 0
M  V30 14 C 5.9914 6.0553 0.0 0
M  V30 15 O 0.0000 9.3078 0.0 0
M  V30 16 C 6.8795 4.2945 0.0 0 CFG=1
M  V30 17 C 8.1254 5.1997 0.0 0 CFG=1
M  V30 18 C 5.4772 4.9548 0.0 0
M  V30 19 C 7.3554 2.8299 0.0 0
M  V30 20 C 9.3713 4.2945 0.0 0 CFG=1
M  V30 21 C 8.1510 6.6131 0.0 0
M  V30 22 C 4.2347 3.9929 0.0 0
M  V30 23 C 5.2628 6.4691 0.0 0
M  V30 24 C 8.8954 2.8299 0.0 0
M  V30 25 C 7.6708 7.9551 0.0 0
M  V30 26 C 2.8060 4.5843 0.0 0
M  V30 27 C 3.8211 7.0617 0.0 0
M  V30 28 C 6.1748 8.4161 0.0 0
M  V30 29 C 2.6003 6.1047 0.0 0
M  V30 30 C 5.1037 7.3137 0.0 0
M  V30 31 C 1.1528 6.7211 0.0 0
M  V30 32 C 3.6504 7.4516 0.0 0
M  V30 33 C 1.2020 8.3451 0.0 0 CFG=1
M  V30 34 C 2.7863 8.7503 0.0 0
M  V30 35 H 5.7242 3.2762 0.0 0
M  V30 36 H 10.7781 3.6681 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 20
M  V30 5 2 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 1 14 30
M  V30 15 1 33 15 CFG=1
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 35 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 20 24
M  V30 26 1 20 36 CFG=3
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 1 23 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(6 2 6 16 17 20 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4,7-Etheno-1H-cyclopentacyclotetradecene-5-carboxylic acid, 1-[(1R,2E,4S)-1,4...
C32H46O4
330206-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3963 5.9113 0.0 0
M  V30 2 C 7.0758 2.4666 0.0 0
M  V30 3 O 5.8562 1.5263 0.0 0
M  V30 4 O 8.4999 1.8805 0.0 0
M  V30 5 C 6.0605 0.0000 0.0 0
M  V30 6 C 12.7780 5.6282 0.0 0 CFG=2
M  V30 7 C 14.3180 5.6282 0.0 0
M  V30 8 C 12.0080 6.9619 0.0 0
M  V30 9 C 15.0880 6.9619 0.0 0
M  V30 10 C 16.6280 6.9619 0.0 0 CFG=1
M  V30 11 C 17.3980 8.2955 0.0 0
M  V30 12 C 17.3980 5.6282 0.0 0
M  V30 13 C 18.9380 8.2955 0.0 0
M  V30 14 C 8.6282 6.0553 0.0 0
M  V30 15 O 2.6368 9.3078 0.0 0
M  V30 16 C 1.2020 8.7483 0.0 0
M  V30 17 O 0.0000 9.7109 0.0 0
M  V30 18 C 9.5161 4.2946 0.0 0 CFG=2
M  V30 19 C 8.1140 4.9548 0.0 0
M  V30 20 C 10.7621 5.1997 0.0 0 CFG=1
M  V30 21 C 9.9921 2.8299 0.0 0
M  V30 22 C 6.8715 3.9929 0.0 0
M  V30 23 C 7.8994 6.4691 0.0 0
M  V30 24 C 12.0080 4.2946 0.0 0 CFG=1
M  V30 25 C 10.7877 6.6131 0.0 0
M  V30 26 C 11.5321 2.8299 0.0 0
M  V30 27 C 5.4428 4.5844 0.0 0
M  V30 28 C 6.4578 7.0617 0.0 0
M  V30 29 C 10.3075 7.9550 0.0 0
M  V30 30 C 5.2371 6.1047 0.0 0
M  V30 31 C 8.8116 8.4161 0.0 0
M  V30 32 C 3.7896 6.7212 0.0 0
M  V30 33 C 7.7405 7.3136 0.0 0
M  V30 34 C 3.8388 8.3451 0.0 0 CFG=1
M  V30 35 C 6.2872 7.4516 0.0 0
M  V30 36 C 5.4231 8.7503 0.0 0
M  V30 37 H 8.3608 3.2762 0.0 0
M  V30 38 H 13.4148 3.6681 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 24
M  V30 9 2 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 14 33
M  V30 15 1 15 16
M  V30 16 1 34 15 CFG=1
M  V30 17 2 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 37 CFG=3
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 1 21 26
M  V30 27 2 22 27
M  V30 28 1 23 28
M  V30 29 1 24 26
M  V30 30 1 24 38 CFG=3
M  V30 31 1 25 29
M  V30 32 1 27 30
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(6 6 10 18 20 24 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 330206-05-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330206-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-1429254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10139-51-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ceric ammonium nitrate (CAN)-a useful catalyst for the rapid and
high-yield esterification of carboxylic acids and alcohols with special
reference to steroid and other multi-functional natural products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goswami, Papori; Chowdhury, Pritish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2000), 24(12), 955-957

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4aR,5R,6S,8S,8aR)-Octahydro-6-hydroxy-8-methyl-5-(1-methylethyl)-2(1H)-n...
C14H24O2
330206-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 C 2.3101 6.6687 0.0 0
M  V30 3 C 0.0000 5.3348 0.0 0
M  V30 4 C 4.6201 0.0000 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 O 8.4702 4.0012 0.0 0
M  V30 7 C 3.8501 4.0012 0.0 0 CFG=2
M  V30 8 C 4.6201 2.6675 0.0 0 CFG=1
M  V30 9 C 2.3101 4.0012 0.0 0 CFG=2
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 3.8501 1.3338 0.0 0 CFG=2
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 C 1.5400 2.6675 0.0 0 CFG=2
M  V30 14 C 6.1601 5.3348 0.0 0
M  V30 15 C 2.3101 1.3338 0.0 0
M  V30 16 C 6.9302 4.0012 0.0 0
M  V30 17 H 3.0801 5.3348 0.0 0
M  V30 18 H 5.3901 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 11 4 CFG=3
M  V30 5 1 13 5 CFG=1
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 17 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 18 CFG=3
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 7 8 9 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(4aR,5R,6S,8S,8aR)-6-(Formyloxy)octahydro-8-methyl-5-(1-methylethyl)-2(1H...
C15H24O3
330206-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 5.3348 0.0 0
M  V30 2 C 6.1601 6.6687 0.0 0
M  V30 3 C 8.4702 5.3348 0.0 0
M  V30 4 C 3.8501 0.0000 0.0 0
M  V30 5 O 8.4702 2.6675 0.0 0
M  V30 6 C 9.2402 1.3338 0.0 0
M  V30 7 O 10.7802 1.3338 0.0 0
M  V30 8 O 0.0000 4.0012 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 10 C 3.8501 2.6675 0.0 0 CFG=1
M  V30 11 C 6.1601 4.0012 0.0 0 CFG=2
M  V30 12 C 3.8501 5.3348 0.0 0
M  V30 13 C 4.6201 1.3338 0.0 0 CFG=2
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 6.9302 2.6675 0.0 0 CFG=2
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 6.1601 1.3338 0.0 0
M  V30 18 C 1.5400 4.0012 0.0 0
M  V30 19 H 5.3901 5.3348 0.0 0
M  V30 20 H 3.0801 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 13 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 15 5 CFG=3
M  V30 7 2 6 7
M  V30 8 2 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 19 CFG=1
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 20 CFG=1
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 9 10 11 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 330206-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330206-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-7777429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10139-51-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ceric ammonium nitrate (CAN)-a useful catalyst for the rapid and
high-yield esterification of carboxylic acids and alcohols with special
reference to steroid and other multi-functional natural products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goswami, Papori; Chowdhury, Pritish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2000), 24(12), 955-957

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-2,3-pyridinediamine
C5H6N4O2
3537-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Nitro-3H-imidazo[4,5-b]pyridine
C6H4N4O2
3537-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.3709 1.5400 0.0 0 VAL=5
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 N 0.9052 1.8341 0.0 0
M  V30 8 N 3.7036 4.6200 0.0 0
M  V30 9 N 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3537-14-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3537-09-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-15320027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step C: 5-Nitropyridine-2,3-diamine (0.050 g, 0.32 mmol) was dissolved in
formic acid (10 mL) and heated to 100°C for 6 hours. The reaction was
diluted with water (10 mL) and brought to a pH of 7 with 3N NaOH. The
aqueous portion was extracted with 25% isopropyl alcohol ("IPA")/DCM (6
x), dried over Na2SO4 and concentrated to give
6-nitro-3H-imidazo[4,5-b]pyridine (52 mg, 98%) as a solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[4,5-b]pyridine derivatives used as Raf inhibitors and their
preparation and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahrendt, Kateri A.; Buckmelter, Alexandre J.; Grina, Jonas; Hansen,
Joshua D.; Laird, Ellen R.; Newhouse, Brad; Ren, Li; Wenglowsky, Steven
M.; Feng, Bainian; Malesky, Kim; Mathieu, Simon; Rudolph, Joachim; Wen,
Zhaoyang; Young, Wendy B.; Moreno, David A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009111277 A1 2009-09-11

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-(4-methoxyphenyl)-2-thiophenecarboxamide
C12H12N2O2S
354812-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4068 1.5315 0.0 0
M  V30 2 N 1.5679 0.0000 0.0 0
M  V30 3 O 0.0000 2.1578 0.0 0
M  V30 4 N 1.4068 4.8818 0.0 0
M  V30 5 O 11.1826 3.2067 0.0 0
M  V30 6 C 11.9526 4.5404 0.0 0
M  V30 7 C 5.0226 3.2067 0.0 0
M  V30 8 S 4.1173 1.9607 0.0 0
M  V30 9 C 4.1173 4.4526 0.0 0
M  V30 10 C 2.6528 2.4367 0.0 0
M  V30 11 C 2.6528 3.9767 0.0 0
M  V30 12 C 6.5626 3.2067 0.0 0
M  V30 13 C 7.3326 1.8729 0.0 0
M  V30 14 C 7.3326 4.5404 0.0 0
M  V30 15 C 8.8726 1.8729 0.0 0
M  V30 16 C 8.8726 4.5404 0.0 0
M  V30 17 C 9.6426 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one
C13H10N2O2S
225385-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 O 11.1973 3.0801 0.0 0
M  V30 3 C 11.9673 4.4137 0.0 0
M  V30 4 C 5.0371 3.0801 0.0 0
M  V30 5 S 4.1321 1.8342 0.0 0
M  V30 6 C 4.1321 4.3260 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 N 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 6.5772 3.0801 0.0 0
M  V30 14 C 7.3472 1.7464 0.0 0
M  V30 15 C 7.3472 4.4137 0.0 0
M  V30 16 C 8.8872 1.7464 0.0 0
M  V30 17 C 8.8872 4.4137 0.0 0
M  V30 18 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 354812-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 225385-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-16482332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of thieno[3,2-d]pyrimidinones,
thieno[3,2-d]pyrimidines and quinazolinones: conformationally restricted
17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Perspicace, Enrico; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2013), 184487-4509

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-3,5-dimethylaniline
C9H13NO
35490-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6674 0.0 0
M  V30 2 C 0.0000 4.0011 0.0 0
M  V30 3 C 2.3100 5.3349 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methoxy-3,5-dimethylphenyl)formamide
C10H13NO2
1700619-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 O 8.0021 4.6200 0.0 0
M  V30 4 O 2.6674 6.1600 0.0 0
M  V30 5 C 1.3336 6.9300 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35490-72-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1700619-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13762428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-20-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and cation binding of acridono-18-crown-6 ether type ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nemeth, Tamas; Kormos, Attila; Toth, Tunde; Balogh, Gyorgy T.; Huszthy,
Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2015), 146(8), 1291-1297

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitro-1,2-phenylenediamine
C6H7N3O2
3694-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 N 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzimidazole
C7H5N3O2
10597-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0 VAL=5
M  V30 2 O 5.1456 4.6201 0.0 0
M  V30 3 O 6.4792 2.3101 0.0 0
M  V30 4 C 2.4781 3.0801 0.0 0
M  V30 5 C 1.1444 2.3101 0.0 0
M  V30 6 C 3.8119 2.3101 0.0 0
M  V30 7 N 2.1579 4.5864 0.0 0
M  V30 8 N 0.0000 3.3405 0.0 0
M  V30 9 C 1.1444 0.7700 0.0 0
M  V30 10 C 3.8119 0.7700 0.0 0
M  V30 11 C 0.6263 4.7473 0.0 0
M  V30 12 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3694-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10597-52-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13558912
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Nitro-1H-1,3-benzodiazole.23. 3-Nitrobenzene-1,2-diamine (500 mg; 3.26
mmol) was dissolved in formic acid (10 mL) and refluxed under argon for 7
h. After cooling to room temperature, the reaction mixture was
neutralized with satd NaHCO3 solution. The product precipitated as a
yellow solid and was recrystallized from methylenechloride/n-hexane. (522
mg; 98%). 1H NMR (250 MHz, DMSO-d6): δ = 13.37 (bs, 1H, NH), 8.46 (m, 1H,
aryl-H), 8.16 (d, J = 8 Hz, 2H, aryl-H), 7.42 (t, J = 8 Hz, 1H, aryl-H)
ppm. 13C NMR (63 MHz, DMSO-d6): δ = 165.6, 145.2, 133.6, 128.0, 126.3,
121.0, 118.7 ppm. Melting point: 247-249ºC (ref: 248-149ºC).24 IR: ν
(KBr) = 3448 (w), 3097 (m), 2974 (m), 2924 (m), 2775 (m), 1636 (m), 1583
(w), 1532 (s), 1490 (s), 1423 (m), 1366 (s), 1339 (s), 1293 (m), 1268
(s), 1184 (w), 1162 (w), 1127 (m), 1065 (w), 944 (m), 859 (w), 798 (w),
736 (m), 623 (w) cm-1. Elem. anal. C7H5N3O2 (163.13): C, 51.54; H, 3.09;
N, 25.76. Found: C, 51.26; H, 3.06; N, 25.64.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Aminobenzimidazole-1-Methylthymine: A Model for Investigating Hoogsteen
Base-Pairing between Adenine and Thymine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nosenko, Yevgeniy; Kunitski, Maksim; Stark, Tina; Gobel, Michael;
Tarakeshwar, Pilarisetty; Brutschy, Bernhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry A (2011), 115(41), 11403-11411

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N,N-dimethylbenzenamine
C8H10FN
403-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 403-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26287430
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-53-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6737-42-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 11057-89-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-96-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, conversion >99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM General catalytic methylation of amines with formic acid under mild
reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorribes, Ivan; Junge, Kathrin; Beller, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(26), 7878-7883

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethoxy-1,2-benzenediamine
C8H12N2O2
40328-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 N 2.3101 0.0000 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 7.7002 4.0010 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Dimethoxybenzimidazole
C9H10N2O2
7711-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 3.7035 0.0 0
M  V30 2 C 0.0000 5.0371 0.0 0
M  V30 3 O 6.9302 3.7035 0.0 0
M  V30 4 C 7.7002 5.0371 0.0 0
M  V30 5 C 3.0801 2.3698 0.0 0
M  V30 6 C 4.6201 2.3698 0.0 0
M  V30 7 C 2.3101 3.7035 0.0 0
M  V30 8 N 2.6042 0.9051 0.0 0
M  V30 9 C 5.3901 3.7035 0.0 0
M  V30 10 N 5.0960 0.9051 0.0 0
M  V30 11 C 3.0801 5.0371 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 13 C 4.6201 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40328-95-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7711-50-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-21871349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 17626-02-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antitumor activity of 1-monosubstituted
1H-naphth[2,3-d]imidazole-4,9-diones and
1H-anthra[2,3-d]imidazole-4,11-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Zhanxiong; Yuan, Jing; Zhang, Zhenfeng; Yan, Deyue; Zhang, Wanbin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Youji Huaxue (2018), 38(12), 3302-3317

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethoxy-1,2-benzenediamine
C8H12N2O2
40328-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 N 2.3101 0.0000 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 7.7002 4.0010 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Dimethoxybenzimidazole
C9H10N2O2
7711-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 3.7035 0.0 0
M  V30 2 C 0.0000 5.0371 0.0 0
M  V30 3 O 6.9302 3.7035 0.0 0
M  V30 4 C 7.7002 5.0371 0.0 0
M  V30 5 C 3.0801 2.3698 0.0 0
M  V30 6 C 4.6201 2.3698 0.0 0
M  V30 7 C 2.3101 3.7035 0.0 0
M  V30 8 N 2.6042 0.9051 0.0 0
M  V30 9 C 5.3901 3.7035 0.0 0
M  V30 10 N 5.0960 0.9051 0.0 0
M  V30 11 C 3.0801 5.0371 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 13 C 4.6201 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40328-95-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7711-50-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-21871348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antitumor activity of 1-monosubstituted
1H-naphth[2,3-d]imidazole-4,9-diones and
1H-anthra[2,3-d]imidazole-4,11-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Zhanxiong; Yuan, Jing; Zhang, Zhenfeng; Yan, Deyue; Zhang, Wanbin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Youji Huaxue (2018), 38(12), 3302-3317

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile
C9H10N2S
4651-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.3321 0.0 0
M  V30 2 N 6.8753 4.3626 0.0 0
M  V30 3 N 6.0811 0.0000 0.0 0
M  V30 4 C 3.0800 2.6217 0.0 0
M  V30 5 C 4.5863 2.3016 0.0 0
M  V30 6 C 2.3100 1.2881 0.0 0
M  V30 7 C 2.3100 3.9555 0.0 0
M  V30 8 C 4.7474 0.7700 0.0 0
M  V30 9 S 3.3405 0.1437 0.0 0
M  V30 10 C 0.7700 1.2881 0.0 0
M  V30 11 C 0.7700 3.9555 0.0 0
M  V30 12 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4651-91-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22379186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, biological evaluation and molecular modeling study of
new thieno[2,3-d]pyrimidines with anti-proliferative activity on
pancreatic cancer cell lines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salem, Mohamed S. H.; Abdel Aziz, Yasmine M.; Elgawish, Mohamed S.; Said,
Mohamed M.; Abouzid, Khaled A. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 94103472

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β)-3,21-Dihydroxypregna-5,16-dien-20-one
C21H30O3
48200-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1632 6.1516 0.0 0
M  V30 2 C 9.9426 6.5606 0.0 0
M  V30 3 C 11.4491 6.8808 0.0 0
M  V30 4 O 8.9122 7.7050 0.0 0
M  V30 5 O 11.9250 8.3453 0.0 0
M  V30 6 C 3.3503 3.7057 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 C 8.0022 3.0800 0.0 0 CFG=2
M  V30 9 C 6.6684 2.3100 0.0 0 CFG=2
M  V30 10 C 8.0022 4.6200 0.0 0 CFG=1
M  V30 11 C 9.4668 2.6042 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0 CFG=2
M  V30 13 C 6.6684 0.7700 0.0 0
M  V30 14 C 9.4668 5.0959 0.0 0
M  V30 15 C 6.6684 5.3901 0.0 0
M  V30 16 C 10.3720 3.8500 0.0 0
M  V30 17 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 18 C 5.3348 4.6200 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 4.0011 0.7700 0.0 0
M  V30 21 C 2.6675 3.0800 0.0 0
M  V30 22 C 2.6675 0.0000 0.0 0
M  V30 23 C 1.3337 2.3100 0.0 0
M  V30 24 C 1.3337 0.7700 0.0 0 CFG=1
M  V30 25 H 8.7953 1.7599 0.0 0
M  V30 26 H 7.5518 1.0484 0.0 0
M  V30 27 H 4.4514 4.3415 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 17 6 CFG=1
M  V30 7 1 24 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 25 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 26 CFG=1
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 12 18
M  V30 20 1 12 27 CFG=3
M  V30 21 1 13 19
M  V30 22 2 14 16
M  V30 23 1 15 18
M  V30 24 1 17 20
M  V30 25 1 17 21
M  V30 26 2 19 20
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 8 9 10 12 17 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pregna-5,16-dien-20-one, 3,21-bis(formyloxy)-, (3β)-
C23H30O5
548436-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.8304 6.1516 0.0 0
M  V30 2 C 12.6101 6.5606 0.0 0
M  V30 3 C 14.1164 6.8808 0.0 0
M  V30 4 O 11.5795 7.7050 0.0 0
M  V30 5 O 14.5922 8.3453 0.0 0
M  V30 6 C 16.0987 8.6655 0.0 0
M  V30 7 O 16.5745 10.1302 0.0 0
M  V30 8 C 6.0176 3.7057 0.0 0
M  V30 9 O 2.6673 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 O 0.0000 0.0000 0.0 0
M  V30 12 C 10.6695 3.0800 0.0 0 CFG=2
M  V30 13 C 9.3359 2.3100 0.0 0 CFG=2
M  V30 14 C 10.6695 4.6200 0.0 0 CFG=1
M  V30 15 C 12.1342 2.6042 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0 CFG=2
M  V30 17 C 9.3359 0.7700 0.0 0
M  V30 18 C 12.1342 5.0959 0.0 0
M  V30 19 C 9.3359 5.3900 0.0 0
M  V30 20 C 13.0393 3.8500 0.0 0
M  V30 21 C 6.6684 2.3100 0.0 0 CFG=2
M  V30 22 C 8.0021 4.6200 0.0 0
M  V30 23 C 8.0021 0.0000 0.0 0
M  V30 24 C 6.6684 0.7700 0.0 0
M  V30 25 C 5.3348 3.0800 0.0 0
M  V30 26 C 5.3348 0.0000 0.0 0
M  V30 27 C 4.0011 2.3100 0.0 0
M  V30 28 C 4.0011 0.7700 0.0 0 CFG=1
M  V30 29 H 11.4626 1.7599 0.0 0
M  V30 30 H 10.2192 1.0484 0.0 0
M  V30 31 H 7.1189 4.3414 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 21 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 28 9 CFG=1
M  V30 11 2 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 29 CFG=3
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 30 CFG=1
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 16 22
M  V30 24 1 16 31 CFG=3
M  V30 25 1 17 23
M  V30 26 2 18 20
M  V30 27 1 19 22
M  V30 28 1 21 24
M  V30 29 1 21 25
M  V30 30 2 23 24
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 12 13 14 16 21 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 48200-80-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 548436-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-9669461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2857-97-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solvent free, catalyst not specified
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chloro- or bromo-trimethylsilane induced rapid and quantitative
acid-ester conversion for steroid based alcohols with various carboxylic
acids under solvent free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goswami, Papori; Hazarika, Saroj; Borah, Parinita; Chowdhury, Pritish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2003), 42B(3), 678-682

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diphenylacetylene
C14H10
501-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 C 8.4702 0.0000 0.0 0
M  V30 11 C 8.4702 2.6673 0.0 0
M  V30 12 C 10.0102 0.0000 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-α-Phenylcinnamic acid
C15H12O2
91-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 C 4.0011 5.3900 0.0 0
M  V30 3 C 1.3336 5.3900 0.0 0
M  V30 4 O 1.3336 6.9300 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 C 2.6674 3.0800 0.0 0
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3336 0.7700 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 5.3900 0.0 0
M  V30 14 C 5.3347 3.0800 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 6.6685 2.3100 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 501-65-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32382416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, stereoselective, Schlenk tube used, in-situ generated
carbon monoxide, optimization study, optimized on catalyst, optimized on
ligand, optimized on dehydrant, optimized on stoichiometry of catalyst,
ligand, dehydrant and reactant, optimized on solvent, optimized on
temperature, scalable, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient hydrocarboxylation of alkynes based on carbodiimide-regulated
in situ CO generation from HCOOH: An alternative indirect utilization of
CO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Shu-Mei; Yang, Zhi-Wen; Chen, Kai-Hong; Wang, Ning; He, Liang-Nian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Catalysis (2022), 43(7), 1642-1651

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,6S,11S)-8-Amino-3-(cyclopropylmethyl)-6-ethyl-3,4,5,6-tetrahydro-11-m...
C19H26N2O
502962-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5170 1.2172 0.0 0
M  V30 2 C 5.4604 0.0000 0.0 0
M  V30 3 C 5.1504 4.7968 0.0 0
M  V30 4 O 4.4888 7.7869 0.0 0
M  V30 5 N 0.0000 2.9557 0.0 0
M  V30 6 C 9.1348 5.8845 0.0 0
M  V30 7 C 5.0994 2.6428 0.0 0 CFG=1
M  V30 8 C 4.0011 3.7257 0.0 0
M  V30 9 C 6.5754 4.2125 0.0 0 CFG=1
M  V30 10 C 6.6323 2.6466 0.0 0
M  V30 11 C 4.0011 5.2657 0.0 0
M  V30 12 C 2.6673 2.9557 0.0 0
M  V30 13 C 6.6263 6.3665 0.0 0 CFG=2
M  V30 14 C 7.7248 3.7411 0.0 0
M  V30 15 C 5.0839 6.3665 0.0 0
M  V30 16 C 2.6673 6.0357 0.0 0
M  V30 17 C 1.3336 3.7257 0.0 0
M  V30 18 N 7.7153 5.2876 0.0 0
M  V30 19 C 1.3336 5.2657 0.0 0
M  V30 20 C 10.3616 4.9536 0.0 0
M  V30 21 C 10.9585 3.5340 0.0 0
M  V30 22 C 11.8894 4.7608 0.0 0
M  V30 23 H 7.2125 7.7906 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 3 9
M  V30 4 2 4 15
M  V30 5 1 5 17
M  V30 6 1 6 18
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=1
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 1 13 18
M  V30 20 1 13 23 CFG=3
M  V30 21 1 14 18
M  V30 22 1 16 19
M  V30 23 2 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 7 9 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[3-(Cyclopropylmethyl)-6-ethyl-1,2,3,4,5,6-hexahydro-11-methyl-1-oxo-2,6-me...
C20H26N2O2
574731-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3725 1.2172 0.0 0
M  V30 2 C 6.4291 0.0000 0.0 0
M  V30 3 C 6.7389 4.7968 0.0 0
M  V30 4 O 7.4007 7.7869 0.0 0
M  V30 5 N 11.8895 2.9557 0.0 0
M  V30 6 C 13.2231 3.7257 0.0 0
M  V30 7 O 14.5568 2.9557 0.0 0
M  V30 8 C 2.7546 5.8845 0.0 0
M  V30 9 C 6.7900 2.6428 0.0 0
M  V30 10 C 7.8884 3.7257 0.0 0
M  V30 11 C 5.3141 4.2125 0.0 0
M  V30 12 C 5.2571 2.6468 0.0 0
M  V30 13 C 7.8884 5.2657 0.0 0
M  V30 14 C 9.2220 2.9557 0.0 0
M  V30 15 C 5.2631 6.3665 0.0 0
M  V30 16 C 4.1646 3.7413 0.0 0
M  V30 17 C 6.8054 6.3665 0.0 0
M  V30 18 C 9.2220 6.0357 0.0 0
M  V30 19 C 10.5558 3.7257 0.0 0
M  V30 20 N 4.1742 5.2876 0.0 0
M  V30 21 C 10.5558 5.2657 0.0 0
M  V30 22 C 1.5278 4.9536 0.0 0
M  V30 23 C 0.0000 4.7608 0.0 0
M  V30 24 C 0.9309 3.5340 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 2 4 17
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 1 8 20
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 1 15 20
M  V30 22 1 16 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 502962-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 574731-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13758142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Redefining the structure-activity relationships of
2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wentland, Mark P.; Sun, Xufeng; Ye, Yingchun; Lou, Rongliang; Bidlack,
Jean M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(11), 1911-1914

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminopyridine
C5H6N2
504-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-2-Pyridinylformamide
C6H6N2O
34813-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 N 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 504-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34813-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17598438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM catalyst with sulfamic acid on zeolite NaY
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 5329-14-6
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM catalyst with Cu(OAc)2 on zeolite NaY
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, green chemistry-catalyst,
solid-supported catalyst, no solvent, catalyst prepared and used,
recyclable catalyst, zeolite NaY support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NaY zeolite functionalized by sulfamic acid/Cu(OAc)2 as a new and
reusable heterogeneous hybrid catalyst for efficient solvent-free
formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazemi, Samira; Mobinikhaledi, Akbar; Zendehdel, Mojgan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(8), 1767-1772

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Indolecarboxylic hydrazide
C9H9N3O
5055-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 O 7.3472 0.2064 0.0 0
M  V30 4 N 8.8872 2.8737 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 0.7700 0.0 0
M  V30 7 C 4.1321 2.7859 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 N 4.1321 0.2941 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 5.0371 1.5400 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 2-formylhydrazide
C10H9N3O2
64932-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 N 7.4148 2.3101 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 N 8.7486 1.5400 0.0 0
M  V30 5 C 10.0823 2.3101 0.0 0
M  V30 6 O 11.4160 1.5400 0.0 0
M  V30 7 C 2.3101 2.8281 0.0 0
M  V30 8 C 3.0801 4.1618 0.0 0
M  V30 9 C 3.3405 1.6836 0.0 0
M  V30 10 C 0.7700 2.8281 0.0 0
M  V30 11 N 4.5864 3.8416 0.0 0
M  V30 12 C 2.3101 5.4955 0.0 0
M  V30 13 C 4.7475 2.3101 0.0 0
M  V30 14 C 0.0000 4.1618 0.0 0
M  V30 15 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5055-39-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64932-49-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19529491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxadiazole and phenol derivatives as antibacterial and/or herbicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hagen, Timothy J.; Thompson, Michael; Troxell, Jeremy R.; Hartnett, Brian
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180271098 A1 2018-09-27

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4,5,6,7,8-Octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline
C17H23NO
51072-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 O 11.5500 4.0011 0.0 0
M  V30 3 C 12.3200 5.3349 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 5.3900 1.3338 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5,6,7,8-Hexahydro-1-[(4-methoxyphenyl)methyl]-2(1H)-isoquinolinecarboxald...
C18H23NO2
63477-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 1.3338 0.0 0
M  V30 3 O 7.7000 0.0000 0.0 0
M  V30 4 O 11.5500 4.0011 0.0 0
M  V30 5 C 12.3200 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 5.3900 1.3338 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 0.0000 2.6674 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 7.7000 5.3349 0.0 0
M  V30 18 C 7.7000 2.6674 0.0 0
M  V30 19 C 9.2400 5.3349 0.0 0
M  V30 20 C 9.2400 2.6674 0.0 0
M  V30 21 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 2 10
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51072-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63477-91-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11329845
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave oven (1000 W)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of dextromethorphan under microwave irradiation in solventless
system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heravi, Majid M.; Motamedi, Radineh; Bahrami, Lila
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Heterocyclic Chemistry (2004), 14(2), 167-168

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Yamogenin
C27H42O3
512-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.4734 5.1960 0.0 0
M  V30 2 C 9.7919 4.8211 0.0 0
M  V30 3 C 17.7784 3.0281 0.0 0
M  V30 4 C 4.7543 4.9175 0.0 0
M  V30 5 O 0.0000 3.3834 0.0 0
M  V30 6 C 13.1836 2.5452 0.0 0 CFG=1
M  V30 7 C 12.1532 3.6895 0.0 0 CFG=1
M  V30 8 O 12.4136 1.2114 0.0 0
M  V30 9 C 13.8101 3.9519 0.0 0
M  V30 10 O 14.0888 1.2993 0.0 0
M  V30 11 C 10.7464 3.0632 0.0 0 CFG=2
M  V30 12 C 10.9074 1.5317 0.0 0 CFG=1
M  V30 13 C 15.3416 4.1129 0.0 0
M  V30 14 C 15.6204 1.4602 0.0 0
M  V30 15 C 9.2400 3.3834 0.0 0 CFG=2
M  V30 16 C 9.5004 0.9052 0.0 0
M  V30 17 C 16.2468 2.8670 0.0 0 CFG=2
M  V30 18 C 8.4700 2.0497 0.0 0 CFG=2
M  V30 19 C 8.4700 4.7170 0.0 0
M  V30 20 C 6.9300 2.0497 0.0 0 CFG=2
M  V30 21 C 6.9300 4.7170 0.0 0
M  V30 22 C 6.1600 3.3834 0.0 0 CFG=1
M  V30 23 C 6.1600 0.7159 0.0 0
M  V30 24 C 4.6200 3.3834 0.0 0 CFG=2
M  V30 25 C 4.6200 0.7159 0.0 0
M  V30 26 C 3.8500 2.0497 0.0 0
M  V30 27 C 3.8500 4.7170 0.0 0
M  V30 28 C 2.3100 2.0497 0.0 0
M  V30 29 C 2.3100 4.7170 0.0 0
M  V30 30 C 1.5400 3.3834 0.0 0 CFG=1
M  V30 31 H 10.9873 4.5843 0.0 0
M  V30 32 H 11.0683 0.0000 0.0 0
M  V30 33 H 8.4970 0.5099 0.0 0
M  V30 34 H 7.3286 0.5621 0.0 0
M  V30 35 H 6.0257 4.9175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=3
M  V30 2 1 15 2 CFG=1
M  V30 3 1 17 3 CFG=3
M  V30 4 1 24 4 CFG=1
M  V30 5 1 30 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 11 15
M  V30 16 1 11 31 CFG=3
M  V30 17 1 12 16
M  V30 18 1 12 32 CFG=3
M  V30 19 1 13 17
M  V30 20 1 14 17
M  V30 21 1 15 18
M  V30 22 1 15 19
M  V30 23 1 16 18
M  V30 24 1 18 20
M  V30 25 1 18 33 CFG=3
M  V30 26 1 19 21
M  V30 27 1 20 22
M  V30 28 1 20 23
M  V30 29 1 20 34 CFG=1
M  V30 30 1 21 22
M  V30 31 1 22 24
M  V30 32 1 22 35 CFG=3
M  V30 33 1 23 25
M  V30 34 1 24 26
M  V30 35 1 24 27
M  V30 36 2 25 26
M  V30 37 1 26 28
M  V30 38 1 27 29
M  V30 39 1 28 30
M  V30 40 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 6 7 11 12 15 17 18 20 22 24 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Spirost-5-en-3-ol, formate, (3β,25S)-
C28H42O4
548436-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9865 4.8211 0.0 0
M  V30 2 C 5.3050 5.1960 0.0 0
M  V30 3 C 12.7599 4.8709 0.0 0
M  V30 4 C 0.0000 3.0281 0.0 0
M  V30 5 O 17.7785 3.3834 0.0 0
M  V30 6 C 18.5485 4.7170 0.0 0
M  V30 7 O 20.0885 4.7170 0.0 0
M  V30 8 C 7.0320 3.0632 0.0 0 CFG=1
M  V30 9 C 8.5384 3.3834 0.0 0 CFG=2
M  V30 10 C 6.8711 1.5317 0.0 0 CFG=2
M  V30 11 C 5.6252 3.6896 0.0 0 CFG=2
M  V30 12 C 9.3084 2.0498 0.0 0 CFG=2
M  V30 13 C 9.3084 4.7170 0.0 0
M  V30 14 O 5.3648 1.2114 0.0 0
M  V30 15 C 8.2780 0.9052 0.0 0
M  V30 16 C 4.5948 2.5452 0.0 0 CFG=1
M  V30 17 C 10.8484 2.0498 0.0 0 CFG=2
M  V30 18 C 10.8484 4.7170 0.0 0
M  V30 19 C 3.9683 3.9520 0.0 0
M  V30 20 O 3.6896 1.2993 0.0 0
M  V30 21 C 11.6184 3.3834 0.0 0 CFG=1
M  V30 22 C 11.6184 0.7159 0.0 0
M  V30 23 C 2.4368 4.1129 0.0 0
M  V30 24 C 2.1580 1.4602 0.0 0
M  V30 25 C 13.1584 3.3834 0.0 0 CFG=2
M  V30 26 C 13.1584 0.7159 0.0 0
M  V30 27 C 1.5315 2.8670 0.0 0 CFG=2
M  V30 28 C 13.9284 2.0498 0.0 0
M  V30 29 C 13.9284 4.7170 0.0 0
M  V30 30 C 15.4685 2.0498 0.0 0
M  V30 31 C 15.4685 4.7170 0.0 0
M  V30 32 C 16.2385 3.3834 0.0 0 CFG=1
M  V30 33 H 6.5307 4.5193 0.0 0
M  V30 34 H 6.7101 0.0000 0.0 0
M  V30 35 H 9.2815 0.5099 0.0 0
M  V30 36 H 10.4499 0.5621 0.0 0
M  V30 37 H 11.7527 4.9176 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 11 2 CFG=1
M  V30 3 1 25 3 CFG=3
M  V30 4 1 27 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 32 5 CFG=3
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 33 CFG=1
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 10 34 CFG=1
M  V30 17 1 11 16
M  V30 18 1 12 15
M  V30 19 1 12 17
M  V30 20 1 12 35 CFG=1
M  V30 21 1 13 18
M  V30 22 1 16 14 CFG=3
M  V30 23 1 16 19
M  V30 24 1 16 20
M  V30 25 1 17 21
M  V30 26 1 17 22
M  V30 27 1 17 36 CFG=3
M  V30 28 1 18 21
M  V30 29 1 19 23
M  V30 30 1 20 24
M  V30 31 1 21 25
M  V30 32 1 21 37 CFG=1
M  V30 33 1 22 26
M  V30 34 1 23 27
M  V30 35 1 24 27
M  V30 36 1 25 28
M  V30 37 1 25 29
M  V30 38 2 26 28
M  V30 39 1 28 30
M  V30 40 1 29 31
M  V30 41 1 30 32
M  V30 42 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 8 9 10 11 12 16 17 21 25 27 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 512-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 548436-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-765128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2857-97-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solvent free, catalyst not specified
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chloro- or bromo-trimethylsilane induced rapid and quantitative
acid-ester conversion for steroid based alcohols with various carboxylic
acids under solvent free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goswami, Papori; Hazarika, Saroj; Borah, Parinita; Chowdhury, Pritish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2003), 42B(3), 678-682

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Androstenediol
C19H30O2
521-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6026 3.7975 0.0 0
M  V30 2 C 8.1632 6.1516 0.0 0
M  V30 3 O 9.9426 6.5605 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 6 C 5.3348 3.0800 0.0 0 CFG=2
M  V30 7 C 8.0022 3.0800 0.0 0 CFG=2
M  V30 8 C 6.6684 0.7700 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 10 C 5.3348 4.6200 0.0 0
M  V30 11 C 8.0022 4.6200 0.0 0 CFG=2
M  V30 12 C 9.4668 2.6040 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 6.6684 5.3901 0.0 0
M  V30 17 C 9.4668 5.0959 0.0 0 CFG=1
M  V30 18 C 10.3720 3.8500 0.0 0
M  V30 19 C 2.6675 0.0000 0.0 0
M  V30 20 C 1.3337 2.3100 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0 CFG=1
M  V30 22 H 7.5518 1.0484 0.0 0
M  V30 23 H 4.2458 4.1690 0.0 0
M  V30 24 H 8.5540 1.6423 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 11 2 CFG=1
M  V30 3 1 17 3 CFG=1
M  V30 4 1 21 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 23 CFG=3
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 24 CFG=3
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 10 16
M  V30 19 1 11 16
M  V30 20 1 11 17
M  V30 21 1 12 18
M  V30 22 2 13 14
M  V30 23 1 14 19
M  V30 24 1 15 20
M  V30 25 1 17 18
M  V30 26 1 19 21
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 5 6 7 9 11 17 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Androst-5-ene-3,17-diol, diformate, (3β,17β)-
C21H30O4
32696-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2699 3.7976 0.0 0
M  V30 2 C 10.8306 6.1517 0.0 0
M  V30 3 O 12.6103 6.5607 0.0 0
M  V30 4 C 14.1166 6.8809 0.0 0
M  V30 5 O 14.5924 8.3454 0.0 0
M  V30 6 O 2.6673 0.0000 0.0 0
M  V30 7 C 1.3337 0.7700 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0 CFG=2
M  V30 10 C 9.3360 2.3101 0.0 0 CFG=1
M  V30 11 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0 CFG=2
M  V30 14 C 9.3360 0.7700 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 5.3348 3.0801 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0 CFG=2
M  V30 19 C 12.1342 2.6042 0.0 0
M  V30 20 C 8.0022 0.0000 0.0 0
M  V30 21 C 5.3348 0.0000 0.0 0
M  V30 22 C 4.0012 2.3101 0.0 0
M  V30 23 C 12.1342 5.0960 0.0 0 CFG=1
M  V30 24 C 13.0395 3.8501 0.0 0
M  V30 25 C 4.0012 0.7700 0.0 0 CFG=1
M  V30 26 H 6.9132 4.1690 0.0 0
M  V30 27 H 10.2192 1.0485 0.0 0
M  V30 28 H 11.2216 1.6423 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 23 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 25 6 CFG=1
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 26 CFG=3
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 27 CFG=1
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 13 19
M  V30 21 1 13 28 CFG=3
M  V30 22 1 14 20
M  V30 23 2 15 20
M  V30 24 1 15 21
M  V30 25 1 16 22
M  V30 26 1 17 18
M  V30 27 1 18 23
M  V30 28 1 19 24
M  V30 29 1 21 25
M  V30 30 1 22 25
M  V30 31 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 9 10 11 13 18 23 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 521-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32696-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-7185680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2857-97-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solvent free, catalyst not specified
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chloro- or bromo-trimethylsilane induced rapid and quantitative
acid-ester conversion for steroid based alcohols with various carboxylic
acids under solvent free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goswami, Papori; Hazarika, Saroj; Borah, Parinita; Chowdhury, Pritish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2003), 42B(3), 678-682

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Aminophenyl)carbazole
C18H14N2
52708-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7544 7.5408 0.0 0
M  V30 2 N 4.4196 4.4608 0.0 0
M  V30 3 C 3.0127 5.0872 0.0 0
M  V30 4 C 4.2586 2.9292 0.0 0
M  V30 5 C 1.9823 3.9427 0.0 0
M  V30 6 C 2.5368 6.5518 0.0 0
M  V30 7 C 2.7523 2.6091 0.0 0
M  V30 8 C 5.2891 1.7849 0.0 0
M  V30 9 C 0.4759 4.2629 0.0 0
M  V30 10 C 1.0306 6.8719 0.0 0
M  V30 11 C 2.2764 1.1444 0.0 0
M  V30 12 C 4.8133 0.3202 0.0 0
M  V30 13 C 0.0000 5.7276 0.0 0
M  V30 14 C 3.3068 0.0000 0.0 0
M  V30 15 C 5.7533 5.2308 0.0 0
M  V30 16 C 5.7533 6.7708 0.0 0
M  V30 17 C 7.0869 4.4608 0.0 0
M  V30 18 C 7.0869 7.5408 0.0 0
M  V30 19 C 8.4206 5.2308 0.0 0
M  V30 20 C 8.4206 6.7708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 7
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 2 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(9H-Carbazol-9-yl)phenyl]formamide
C19H14N2O
1228784-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7544 7.5409 0.0 0
M  V30 2 C 11.0882 6.7709 0.0 0
M  V30 3 O 12.4219 7.5409 0.0 0
M  V30 4 N 4.4196 4.4609 0.0 0
M  V30 5 C 3.0128 5.0873 0.0 0
M  V30 6 C 4.2587 2.9293 0.0 0
M  V30 7 C 1.9823 3.9428 0.0 0
M  V30 8 C 2.5369 6.5519 0.0 0
M  V30 9 C 2.7523 2.6091 0.0 0
M  V30 10 C 5.2891 1.7849 0.0 0
M  V30 11 C 0.4759 4.2630 0.0 0
M  V30 12 C 1.0304 6.8721 0.0 0
M  V30 13 C 2.2765 1.1444 0.0 0
M  V30 14 C 4.8132 0.3202 0.0 0
M  V30 15 C 0.0000 5.7277 0.0 0
M  V30 16 C 3.3069 0.0000 0.0 0
M  V30 17 C 5.7534 5.2309 0.0 0
M  V30 18 C 7.0871 4.4609 0.0 0
M  V30 19 C 5.7534 6.7709 0.0 0
M  V30 20 C 8.4208 5.2309 0.0 0
M  V30 21 C 7.0871 7.5409 0.0 0
M  V30 22 C 8.4208 6.7709 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 9
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52708-37-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1228784-74-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14701116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of gold(I) complexes with
9-(4-isocyanophenyl)carbazole or 9-ethyl-3-isocyanocarbazole ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benavente, Rut; Espinet, Pablo; Lentijo, Sergio; Martin-Alvarez, Jose M.;
Miguel, Jesus A.; Paz Rodriguez-Medina, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2009), (35), 5399-5406

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxyaniline
C7H9NO
536-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 N 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxyphenyl)formamide
C8H9NO2
27153-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 536-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27153-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35104985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, catalyst prepared and used, recyclable
catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid-based periodic mesoporous organosilicas: Metal/solvent-free
synthesis of formamides and formamidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Seyed Mehran Hoseini; Haghighat, Mahdieh; Shirini, Farhad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1274(Part_1), 134473

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoaniline
C6H6IN
540-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-(4-iodophenyl)-
C7H6INO
6393-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 I 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 540-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6393-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13527197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of biphenyl anilines using iodophenylformamides via a one-pot
Suzuki coupling reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Lei; Patel, Manoj; Zhang, Mingbao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2008), 49(17), 2734-2737

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoaniline
C6H6IN
540-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-(4-iodophenyl)-
C7H6INO
6393-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 I 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 540-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6393-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4551102
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Iodoformanilide Step 1. To a solution of 4-iodoaniline (30.0 g, 137
mmol) in 100 mL THF and 100 mL toluene, a solution of acetic anhydride
(16.0 g, 157 mmol) and formic acid (10.8 g, 235 mmol) was slowly added
from an addition funnel under argon atmosphere. The reaction mixture
temperature was maintained below 15°C. during the addition. After the
addition was finished, the reaction mixture was stirred at rt overnight.
The reaction mixture was diluted with water (300 mL) and ethyl acetate
(200 mL). The organic layer was separated, washed with water (2x200 mL),
and 200 mL saturated aqueous sodium bicarbonate solution. After drying
over sodium sulfate, the mixture was concentrated under reduced pressure
to afford 4-Iodoformanilide. Yield 33.5 g (>98%), off-white solid. 1H NMR
(DMSO-d6) δ 10.27 (s, 1H), 8.26 (d, J=2 Hz, 1H), 7.64 (d, J=12 Hz, 2H),
7.40 (d, J=11.7 Hz, 2H) and 30% tautomer; ESI-MS m/z 248.0 (MH+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzazolylaminobiphenyloxoalkanoates for the treatment of
obesity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Roger; Campbell, Ann-Marie; Coish, Philip; Dai, Miao; Jenkins,
Susan; Lowe, Derek; O'Connor, Stephen; Su, Ning; Wang, Gan; Zhang,
Mingbao; Zhu, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040224997 A1 2004-11-11

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1H-Pyrrol-1-ylsulfonyl)benzenamine
C10H10N2O2S
54254-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 O 4.6200 1.1273 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 N 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6673 0.0 0
M  V30 6 C 2.3100 1.3336 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3336 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 N 6.1600 2.6673 0.0 0
M  V30 12 C 7.0652 3.9131 0.0 0
M  V30 13 C 7.0652 1.4214 0.0 0
M  V30 14 C 8.5298 3.4373 0.0 0
M  V30 15 C 8.5298 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 1 11
M  V30 5 1 4 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(1H-Pyrrol-1-ylsulfonyl)phenyl]formamide
C11H10N2O3S
159417-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.3349 0.0 0 VAL=6
M  V30 2 O 4.6200 3.7949 0.0 0
M  V30 3 O 4.6200 6.8749 0.0 0
M  V30 4 N 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 O 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.7700 6.6685 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 N 6.1600 5.3349 0.0 0
M  V30 14 C 7.0652 6.5807 0.0 0
M  V30 15 C 7.0652 4.0889 0.0 0
M  V30 16 C 8.5298 6.1049 0.0 0
M  V30 17 C 8.5298 4.5649 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 1 4 5
M  V30 6 1 4 8
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54254-41-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 159417-51-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10813212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The synthesis of pyrrolo[1,2-b][1,2,5]benzothiadiazepines from
1,2-thiazine 1-oxides-sulfonamide analogues of the pyrrolobenzodiazepine
antitumor natural products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hemming, Karl; Patel, Nilesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(41), 7553-7556

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Etheno-1H-cyclopentacyclotetradecene-5-carboxylic acid, 1-[(1R,2E,4S)-1,4...
C31H46O3
548436-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7596 5.9113 0.0 0
M  V30 2 C 10.1413 5.6283 0.0 0 CFG=2
M  V30 3 C 11.6813 5.6283 0.0 0
M  V30 4 C 9.3713 6.9619 0.0 0
M  V30 5 C 12.4513 6.9619 0.0 0
M  V30 6 C 13.9913 6.9619 0.0 0 CFG=1
M  V30 7 C 14.7613 8.2956 0.0 0
M  V30 8 C 14.7613 5.6283 0.0 0
M  V30 9 C 16.3013 8.2956 0.0 0
M  V30 10 C 4.4391 2.4666 0.0 0
M  V30 11 O 3.2194 1.5263 0.0 0
M  V30 12 O 5.8633 1.8803 0.0 0
M  V30 13 C 3.4239 0.0000 0.0 0
M  V30 14 C 5.9914 6.0553 0.0 0
M  V30 15 O 0.0000 9.3078 0.0 0
M  V30 16 C 6.8795 4.2945 0.0 0 CFG=1
M  V30 17 C 8.1254 5.1997 0.0 0 CFG=1
M  V30 18 C 5.4772 4.9548 0.0 0
M  V30 19 C 7.3554 2.8299 0.0 0
M  V30 20 C 9.3713 4.2945 0.0 0 CFG=1
M  V30 21 C 8.1510 6.6131 0.0 0
M  V30 22 C 4.2347 3.9929 0.0 0
M  V30 23 C 5.2628 6.4691 0.0 0
M  V30 24 C 8.8954 2.8299 0.0 0
M  V30 25 C 7.6708 7.9551 0.0 0
M  V30 26 C 2.8060 4.5843 0.0 0
M  V30 27 C 3.8211 7.0617 0.0 0
M  V30 28 C 6.1748 8.4161 0.0 0
M  V30 29 C 2.6003 6.1047 0.0 0
M  V30 30 C 5.1037 7.3137 0.0 0
M  V30 31 C 1.1528 6.7211 0.0 0
M  V30 32 C 3.6504 7.4516 0.0 0
M  V30 33 C 1.2020 8.3451 0.0 0 CFG=1
M  V30 34 C 2.7863 8.7503 0.0 0
M  V30 35 H 5.7242 3.2762 0.0 0
M  V30 36 H 10.7781 3.6681 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 20
M  V30 5 2 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 1 14 30
M  V30 15 1 33 15 CFG=1
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 35 CFG=3
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 1 20 24
M  V30 26 1 20 36 CFG=3
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 1 23 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 6 16 17 20 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4,7-Etheno-1H-cyclopentacyclotetradecene-5-carboxylic acid, 1-[(1R,2E,4S)-1,4...
C32H46O4
548436-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3963 5.9113 0.0 0
M  V30 2 C 7.0758 2.4666 0.0 0
M  V30 3 O 5.8562 1.5263 0.0 0
M  V30 4 O 8.4999 1.8805 0.0 0
M  V30 5 C 6.0605 0.0000 0.0 0
M  V30 6 C 12.7780 5.6282 0.0 0 CFG=2
M  V30 7 C 14.3180 5.6282 0.0 0
M  V30 8 C 12.0080 6.9619 0.0 0
M  V30 9 C 15.0880 6.9619 0.0 0
M  V30 10 C 16.6280 6.9619 0.0 0 CFG=1
M  V30 11 C 17.3980 8.2955 0.0 0
M  V30 12 C 17.3980 5.6282 0.0 0
M  V30 13 C 18.9380 8.2955 0.0 0
M  V30 14 C 8.6282 6.0553 0.0 0
M  V30 15 O 2.6368 9.3078 0.0 0
M  V30 16 C 1.2020 8.7483 0.0 0
M  V30 17 O 0.0000 9.7109 0.0 0
M  V30 18 C 9.5161 4.2946 0.0 0 CFG=2
M  V30 19 C 8.1140 4.9548 0.0 0
M  V30 20 C 10.7621 5.1997 0.0 0 CFG=1
M  V30 21 C 9.9921 2.8299 0.0 0
M  V30 22 C 6.8715 3.9929 0.0 0
M  V30 23 C 7.8994 6.4691 0.0 0
M  V30 24 C 12.0080 4.2946 0.0 0 CFG=1
M  V30 25 C 10.7877 6.6131 0.0 0
M  V30 26 C 11.5321 2.8299 0.0 0
M  V30 27 C 5.4428 4.5844 0.0 0
M  V30 28 C 6.4578 7.0617 0.0 0
M  V30 29 C 10.3075 7.9550 0.0 0
M  V30 30 C 5.2371 6.1047 0.0 0
M  V30 31 C 8.8116 8.4161 0.0 0
M  V30 32 C 3.7896 6.7212 0.0 0
M  V30 33 C 7.7405 7.3136 0.0 0
M  V30 34 C 3.8388 8.3451 0.0 0 CFG=1
M  V30 35 C 6.2872 7.4516 0.0 0
M  V30 36 C 5.4231 8.7503 0.0 0
M  V30 37 H 8.3608 3.2762 0.0 0
M  V30 38 H 13.4148 3.6681 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 22
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 24
M  V30 9 2 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 1 14 33
M  V30 15 1 15 16
M  V30 16 1 34 15 CFG=1
M  V30 17 2 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 37 CFG=3
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 1 21 26
M  V30 27 2 22 27
M  V30 28 1 23 28
M  V30 29 1 24 26
M  V30 30 1 24 38 CFG=3
M  V30 31 1 25 29
M  V30 32 1 27 30
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 6 10 18 20 24 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 548436-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 548436-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-8148380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2857-97-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solvent free, catalyst not specified
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chloro- or bromo-trimethylsilane induced rapid and quantitative
acid-ester conversion for steroid based alcohols with various carboxylic
acids under solvent free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goswami, Papori; Hazarika, Saroj; Borah, Parinita; Chowdhury, Pritish
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2003), 42B(3), 678-682

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroaniline
C6H5Cl2N
554-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dichlorophenyl)formamide
C7H5Cl2NO
22923-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 Cl 4.6201 0.0000 0.0 0
M  V30 5 Cl 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 554-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22923-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17598434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM catalyst with sulfamic acid on zeolite NaY
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 5329-14-6
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM catalyst with Cu(OAc)2 on zeolite NaY
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, green chemistry-catalyst,
solid-supported catalyst, no solvent, catalyst prepared and used,
recyclable catalyst, zeolite NaY support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NaY zeolite functionalized by sulfamic acid/Cu(OAc)2 as a new and
reusable heterogeneous hybrid catalyst for efficient solvent-free
formylation of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazemi, Samira; Mobinikhaledi, Akbar; Zendehdel, Mojgan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(8), 1767-1772

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Benzenetricarboxylic acid
C9H6O6
554-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9302 0.0 0
M  V30 4 C 4.0012 0.7700 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 C 6.6687 5.3901 0.0 0
M  V30 8 O 6.6687 6.9302 0.0 0
M  V30 9 O 8.0023 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis[μ-[1,3,5-benzenetricarboxylato(3-)-κO1:κO′1]]hexakis[μ-(formato-κO:κO′)]t...
C24H16O32Zr6
1579984-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  62 82 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5755 12.8475 0.0 0
M  V30 2 O 4.9625 12.6232 0.0 0 CHG=-1
M  V30 3 O 4.5755 13.2937 0.0 0
M  V30 4 C 2.9607 12.8475 0.0 0
M  V30 5 O 2.5737 12.6232 0.0 0 CHG=-1
M  V30 6 O 2.9607 13.2937 0.0 0
M  V30 7 C 3.3835 0.4474 0.0 0
M  V30 8 O 2.9965 0.6705 0.0 0 CHG=-1
M  V30 9 O 3.3835 0.0000 0.0 0
M  V30 10 C 4.9982 0.4474 0.0 0
M  V30 11 O 5.3853 0.6705 0.0 0 CHG=-1
M  V30 12 O 4.9982 0.0000 0.0 0
M  V30 13 O 2.5540 9.0461 0.0 0 CHG=-2 VAL=3
M  V30 14 Zr 1.7294 7.7803 0.0 0 CHG=4 VAL=7
M  V30 15 Zr 1.7294 6.2136 0.0 0 CHG=4 VAL=7
M  V30 16 Zr 4.1071 9.3136 0.0 0 CHG=4 VAL=6
M  V30 17 O 3.5968 6.5353 0.0 0 CHG=-2 VAL=3
M  V30 18 O 3.7915 8.1180 0.0 0 CHG=-1 VAL=4
M  V30 19 O 2.6896 4.7653 0.0 0 CHG=-1 VAL=4
M  V30 20 O 1.4816 9.5244 0.0 0 CHG=-1 VAL=2
M  V30 21 O 0.7346 7.7913 0.0 0 VAL=3
M  V30 22 O 0.4573 5.0747 0.0 0 CHG=-1 VAL=2
M  V30 23 O 4.2809 5.5739 0.0 0 CHG=-2 VAL=3
M  V30 24 O 4.3622 7.2847 0.0 0 CHG=-1 VAL=4
M  V30 25 O 1.9253 2.7758 0.0 0 VAL=3
M  V30 26 O 0.7346 6.2259 0.0 0 CHG=-1 VAL=2
M  V30 27 O 0.0000 7.8949 0.0 0 VAL=3
M  V30 28 O 5.6182 9.1768 0.0 0 CHG=-2 VAL=3
M  V30 29 O 5.4272 10.8125 0.0 0 VAL=3
M  V30 30 O 2.0375 10.8938 0.0 0 CHG=-1 VAL=2
M  V30 31 Zr 6.4318 7.7803 0.0 0 CHG=4 VAL=7
M  V30 32 Zr 4.1071 4.6285 0.0 0 CHG=4 VAL=6
M  V30 33 C 3.7669 11.4485 0.0 0
M  V30 34 C 0.2773 6.9100 0.0 0
M  V30 35 C 0.4253 3.5253 0.0 0
M  V30 36 Zr 6.4318 6.2136 0.0 0 CHG=4 VAL=7
M  V30 37 C 4.1909 1.8452 0.0 0
M  V30 38 C 0.2280 10.0458 0.0 0
M  V30 39 C 7.8246 10.6831 0.0 0
M  V30 40 O 5.6330 4.7431 0.0 0 CHG=-1 VAL=4
M  V30 41 O 6.4071 9.6218 0.0 0 VAL=3
M  V30 42 O 7.5128 7.7950 0.0 0 CHG=-1 VAL=2
M  V30 43 O 8.6406 5.8241 0.0 0 VAL=3
M  V30 44 O 4.8750 3.4920 0.0 0 CHG=-1 VAL=2
M  V30 45 O 3.1160 3.4279 0.0 0 VAL=3
M  V30 46 O 6.3738 2.5306 0.0 0 CHG=-1 VAL=2
M  V30 47 O 7.4980 6.2161 0.0 0 VAL=3
M  V30 48 O 8.4126 8.2523 0.0 0 CHG=-1 VAL=2
M  V30 49 C 8.0194 6.9975 0.0 0
M  V30 50 C 8.2486 3.5746 0.0 0
M  V30 51 C 3.7669 11.8959 0.0 0
M  V30 52 C 4.1884 12.1388 0.0 0
M  V30 53 C 3.3478 12.1388 0.0 0
M  V30 54 C 4.1884 12.6232 0.0 0
M  V30 55 C 3.3478 12.6232 0.0 0
M  V30 56 C 3.7669 12.8660 0.0 0
M  V30 57 C 4.1909 1.3990 0.0 0
M  V30 58 C 3.7706 1.1562 0.0 0
M  V30 59 C 4.6112 1.1562 0.0 0
M  V30 60 C 3.7706 0.6705 0.0 0
M  V30 61 C 4.6112 0.6705 0.0 0
M  V30 62 C 4.1909 0.4277 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 54
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 55
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 60
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 61
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 14 22
M  V30 22 1 15 19
M  V30 23 1 15 23
M  V30 24 1 15 24
M  V30 25 1 15 25
M  V30 26 1 15 26
M  V30 27 1 15 27
M  V30 28 1 16 18
M  V30 29 1 16 24
M  V30 30 1 16 28
M  V30 31 1 16 29
M  V30 32 1 16 30
M  V30 33 1 17 31
M  V30 34 1 17 32
M  V30 35 1 18 31
M  V30 36 1 19 32
M  V30 37 1 20 33
M  V30 38 2 21 34
M  V30 39 1 22 35
M  V30 40 1 23 32
M  V30 41 1 23 36
M  V30 42 1 24 36
M  V30 43 2 25 37
M  V30 44 1 26 34
M  V30 45 2 27 38
M  V30 46 1 28 31
M  V30 47 1 28 36
M  V30 48 2 29 39
M  V30 49 1 30 38
M  V30 50 1 31 40
M  V30 51 1 31 41
M  V30 52 1 31 42
M  V30 53 1 31 43
M  V30 54 1 32 40
M  V30 55 1 32 44
M  V30 56 1 32 45
M  V30 57 2 33 41
M  V30 58 1 33 51
M  V30 59 2 35 45
M  V30 60 1 36 40
M  V30 61 1 36 46
M  V30 62 1 36 47
M  V30 63 1 36 48
M  V30 64 1 37 46
M  V30 65 1 37 57
M  V30 66 1 39 48
M  V30 67 1 42 49
M  V30 68 2 43 50
M  V30 69 1 44 50
M  V30 70 2 47 49
M  V30 71 2 51 52
M  V30 72 1 51 53
M  V30 73 1 52 54
M  V30 74 2 53 55
M  V30 75 2 54 56
M  V30 76 1 55 56
M  V30 77 2 57 58
M  V30 78 1 57 59
M  V30 79 1 58 60
M  V30 80 2 59 61
M  V30 81 2 60 62
M  V30 82 1 61 62
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 554-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1579984-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34704764
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7699-43-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Defect-engineered MOF-808 with highly exposed Zr sites as highly
efficient catalysts for catalytic transfer hydrogenation of furfural
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fu, Qiuju; Liu, Dandan; Niu, Weijing; Zhang, Shuo; Chen, Ruihua; Wang,
Yujia; Zhao, Pengze; Jiang, Huimin; Zhao, Yanchao; Yang, Lingzhi; Yan,
Liting; Wang, Haiyan; Zhao, Xuebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Fuel (2022), 327125085

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-ethyl-2-nitrobenzenamine
C8H9BrN2O2
56136-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 N 6.1600 4.0011 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 Br 0.0000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-ethyl-1H-benzimidazole
C9H9BrN2
23073-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.1884 0.0 0
M  V30 2 C 8.7355 2.7126 0.0 0
M  V30 3 Br 0.0000 2.4782 0.0 0
M  V30 4 C 4.6200 2.4782 0.0 0
M  V30 5 C 3.8500 1.1444 0.0 0
M  V30 6 N 6.1264 2.1580 0.0 0
M  V30 7 C 3.8500 3.8118 0.0 0
M  V30 8 N 4.8806 0.0000 0.0 0
M  V30 9 C 2.3100 1.1444 0.0 0
M  V30 10 C 6.2874 0.6263 0.0 0
M  V30 11 C 2.3100 3.8118 0.0 0
M  V30 12 C 1.5400 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56136-82-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23073-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33547354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lactam (hetero)aryl fused pyrimidine derivatives as inhibitors of ERBB2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lyssikatos, Joseph P.; Kintz, Samuel; Ren, Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022140769 A1 2022-06-30

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1H-Benzimidazol-1-ylmethyl)benzenemethanamine
C15H15N3
562803-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 1.6414 0.0 0
M  V30 2 C 11.0882 1.6414 0.0 0
M  V30 3 N 12.4219 2.4114 0.0 0
M  V30 4 C 3.0128 1.7849 0.0 0
M  V30 5 N 4.4196 2.4114 0.0 0
M  V30 6 C 1.9823 2.9295 0.0 0
M  V30 7 C 2.5369 0.3203 0.0 0
M  V30 8 C 4.2587 3.9429 0.0 0
M  V30 9 N 2.7523 4.2631 0.0 0
M  V30 10 C 0.4759 2.6091 0.0 0
M  V30 11 C 1.0304 0.0000 0.0 0
M  V30 12 C 0.0000 1.1446 0.0 0
M  V30 13 C 7.0871 2.4114 0.0 0
M  V30 14 C 8.4208 1.6414 0.0 0
M  V30 15 C 7.0871 3.9514 0.0 0
M  V30 16 C 9.7544 2.4114 0.0 0
M  V30 17 C 8.4208 4.7214 0.0 0
M  V30 18 C 9.7544 3.9514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 9
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[3-(1H-Benzimidazol-1-ylmethyl)phenyl]methyl]formamide
C16H15N3O
2586195-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 1.6414 0.0 0
M  V30 2 C 11.0881 1.6414 0.0 0
M  V30 3 N 12.4219 2.4114 0.0 0
M  V30 4 C 13.7556 1.6414 0.0 0
M  V30 5 O 15.0893 2.4114 0.0 0
M  V30 6 C 3.0128 1.7849 0.0 0
M  V30 7 N 4.4196 2.4114 0.0 0
M  V30 8 C 1.9822 2.9295 0.0 0
M  V30 9 C 2.5369 0.3203 0.0 0
M  V30 10 C 4.2587 3.9429 0.0 0
M  V30 11 N 2.7522 4.2631 0.0 0
M  V30 12 C 0.4759 2.6091 0.0 0
M  V30 13 C 1.0304 0.0000 0.0 0
M  V30 14 C 0.0000 1.1446 0.0 0
M  V30 15 C 7.0871 2.4114 0.0 0
M  V30 16 C 8.4208 1.6414 0.0 0
M  V30 17 C 7.0871 3.9514 0.0 0
M  V30 18 C 9.7544 2.4114 0.0 0
M  V30 19 C 8.4208 4.7214 0.0 0
M  V30 20 C 9.7544 3.9514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 562803-75-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2586195-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24297204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine
2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual
Screening to in Vivo Pharmacodynamic Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serafini, Marta; Torre, Enza; Aprile, Silvio; Grosso, Erika Del; Gesu,
Alessandro; Griglio, Alessia; Colombo, Giorgia; Travelli, Cristina;
Paiella, Salvatore; Adamo, Annalisa; Orecchini, Elena; Coletti, Alice;
Pallotta, Maria Teresa; Ugel, Stefano; Massarotti, Alberto; Pirali,
Tracey; Fallarini, Silvia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(6), 3047-3065

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
L-Alanine
C3H7NO2
56-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0 CFG=1
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 2.6673 0.0000 0.0 0
M  V30 4 N 4.0010 2.3101 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formylalanine
C4H7NO3
10512-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0 CFG=1
M  V30 2 N 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 O 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-41-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10512-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17912620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An aryne-based three-component access to α-aroylamino amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Serafini, Marta; Griglio, Alessia; Viarengo, Sara; Aprile, Silvio;
Pirali, Tracey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(31), 6604-6612

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,2,2-Trifluoroethoxy)benzenamine
C8H8F3NO
57946-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 2.8736 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 F 1.5400 3.0800 0.0 0
M  V30 7 N 10.0100 2.8736 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 C 6.1600 4.2073 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 7.7000 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(2,2,2-trifluoroethoxy)benzenamine
C9H10F3NO
1175700-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 2.8736 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 F 1.5400 0.0000 0.0 0
M  V30 7 N 10.0100 2.8736 0.0 0
M  V30 8 C 10.7800 4.2073 0.0 0
M  V30 9 C 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57946-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1175700-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29765368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyridine derivatives as histone demethylase
inhibitors for treating cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boloor, Amogh; Chen, Young K.; Wallace, Michael Brennan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015200709 A1 2015-12-30

$RFMT $RIREG SCHEME256 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodobenzene
C6H5I
591-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylphenylacetylene
C9H8
766-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 3.8501 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Methylphenyl)-1-phenyl-2-propyn-1-one
C16H12O
14674-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0022 5.3901 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 9.3360 6.1601 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 2 4
M  V30 5 1 4 12
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-50-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 766-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14674-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36318082
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM UiO-66-NH2 supported cyanuric chloride and guanidine functionalized
nanoparticles
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1260119-00-3
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM cyanuric chloride and guanidine functionalized
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM UiO-66-NH2 supported cyanuric chloride and guanidine functionalized
palladium nanaoparticles prepared and used, carbonylative Sonogashira
coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium Nanoparticle-Decorated Porous Metal-Organic-Framework
(Zr)@Guanidine: Novel Efficient Catalyst in Cross-Coupling (Suzuki, Heck,
and Sonogashira) Reactions and Carbonylative Sonogashira under Mild
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohammadi, Leila; Vaezi, Mohammad Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2023), 8(18), 16395-16410

$RFMT $RIREG SCHEME256 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodobenzene
C6H5I
591-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylphenylacetylene
C9H8
766-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 3.8501 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Methylphenyl)-1-phenyl-2-propyn-1-one
C16H12O
14674-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0022 5.3901 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 9.3360 6.1601 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 2 4
M  V30 5 1 4 12
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-50-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 766-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14674-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23976794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 143334-20-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Sonogashira coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterogeneous Carbonylative Sonogashira Reaction Based on Pd/g-C3N4
Catalyst by Using Formic Acid as the CO Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huo, Yong-Wang; Qi, Xinxin; Xu, Tiefeng; Lu, Wangyang; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2021), 6(28), 7037-7039

$RFMT $RIREG SCHEME257 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodobenzene
C6H5I
591-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylphenylacetylene
C9H8
766-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 C 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Methylphenyl)-1-phenyl-2-propyn-1-one
C16H12O
14939-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 C 12.3200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 0.7700 2.6674 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 0.0000 1.3338 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 8.4700 5.3349 0.0 0
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 10.0100 5.3349 0.0 0
M  V30 16 C 10.0100 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 2 4
M  V30 5 1 4 12
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-50-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 766-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14939-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23976775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 143334-20-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Sonogashira coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterogeneous Carbonylative Sonogashira Reaction Based on Pd/g-C3N4
Catalyst by Using Formic Acid as the CO Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huo, Yong-Wang; Qi, Xinxin; Xu, Tiefeng; Lu, Wangyang; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2021), 6(28), 7037-7039

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenamine
C8H11NO
5961-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,N-dimethylbenzenamine
C9H13NO
701-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5961-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-56-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28791225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 9004-73-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1109-15-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-96-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-reagent, Schlenk tube was used, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Boron-catalyzed N-alkylation of amines using carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fu, Ming-Chen; Shang, Rui; Cheng, Wan-Min; Fu, Yao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(31), 9042-9046

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylindole
C9H9N
603-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 C 3.0801 2.4782 0.0 0
M  V30 3 C 2.3101 1.1444 0.0 0
M  V30 4 N 4.5864 2.1580 0.0 0
M  V30 5 C 2.3101 3.8119 0.0 0
M  V30 6 C 0.7700 1.1444 0.0 0
M  V30 7 C 3.3405 0.0000 0.0 0
M  V30 8 C 4.7473 0.6263 0.0 0
M  V30 9 C 0.7700 3.8119 0.0 0
M  V30 10 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 8
M  V30 11 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-Methylenebis[1-methyl-1H-indole]
C19H18N2
31896-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5242 4.6949 0.0 0
M  V30 2 C 8.2348 0.0000 0.0 0
M  V30 3 C 1.1385 1.5085 0.0 0
M  V30 4 C 6.6688 3.6643 0.0 0
M  V30 5 C 8.1751 3.9845 0.0 0
M  V30 6 C 6.5078 2.1328 0.0 0
M  V30 7 C 8.9451 2.6508 0.0 0
M  V30 8 C 8.9451 5.3183 0.0 0
M  V30 9 N 7.9146 1.5065 0.0 0
M  V30 10 C 10.4851 2.6508 0.0 0
M  V30 11 C 10.4851 5.3183 0.0 0
M  V30 12 C 11.2551 3.9845 0.0 0
M  V30 13 C 4.0597 4.2189 0.0 0
M  V30 14 C 2.8138 5.1241 0.0 0
M  V30 15 C 3.5838 2.7543 0.0 0
M  V30 16 C 1.5677 4.2189 0.0 0
M  V30 17 C 2.6527 6.6557 0.0 0
M  V30 18 N 2.0438 2.7543 0.0 0
M  V30 19 C 0.1609 4.8454 0.0 0
M  V30 20 C 1.2459 7.2822 0.0 0
M  V30 21 C 0.0000 6.3769 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 13
M  V30 3 1 2 9
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 603-76-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31896-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-086-CAS-19296196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 617-86-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1109-15-5
$DTYPE RXN:VAR(1):NOTES
$DATUM isolated yield 92%, no solvent, Friedel-Crafts reaction, optimization
study, optimized on catalyst, agent and solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Directly Bridging Indoles to 3,3'-Bisindolylmethanes by Using Carboxylic
Acids and Hydrosilanes under Mild Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiao, Chang; Liu, Xiao-Fang; Fu, Hong-Chen; Yang, Hao-Peng; Zhang,
Zhi-Bo; He, Liang-Nian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - An Asian Journal (2018), 13(18), 2664-2670

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Aminobenzo-15-crown-5
C14H21NO5
60835-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7406 5.8615 0.0 0
M  V30 2 C 6.8906 4.5278 0.0 0
M  V30 3 C 6.1206 5.8615 0.0 0
M  V30 4 C 8.4306 4.5278 0.0 0
M  V30 5 O 6.1206 3.1941 0.0 0
M  V30 6 C 6.8906 7.1952 0.0 0
M  V30 7 O 4.5806 5.8615 0.0 0
M  V30 8 C 9.2006 5.8615 0.0 0
M  V30 9 C 6.5964 1.7294 0.0 0
M  V30 10 C 8.4306 7.1952 0.0 0
M  V30 11 C 3.5502 7.0059 0.0 0
M  V30 12 C 5.5660 0.5850 0.0 0
M  V30 13 C 2.0437 6.6858 0.0 0
M  V30 14 O 4.0596 0.9052 0.0 0
M  V30 15 O 1.5679 5.2211 0.0 0
M  V30 16 C 2.8137 0.0000 0.0 0
M  V30 17 C 0.1609 4.5947 0.0 0
M  V30 18 C 1.4069 0.6265 0.0 0
M  V30 19 C 0.0000 3.0632 0.0 0
M  V30 20 O 1.2459 2.1580 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,3,5,6,8,9,11,12-Octahydro-1,4,7,10,13-benzopentaoxacyclopentadecin-15-yl...
C15H21NO6
1020075-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7009 5.0624 0.0 0
M  V30 2 C 12.0347 4.2924 0.0 0
M  V30 3 O 13.3683 5.0624 0.0 0
M  V30 4 C 6.6999 4.2924 0.0 0
M  V30 5 C 6.6999 2.7523 0.0 0
M  V30 6 C 8.0335 5.0624 0.0 0
M  V30 7 O 5.3661 5.0624 0.0 0
M  V30 8 C 8.0335 1.9823 0.0 0
M  V30 9 O 5.3661 1.9823 0.0 0
M  V30 10 C 9.3672 4.2924 0.0 0
M  V30 11 C 5.0459 6.5687 0.0 0
M  V30 12 C 9.3672 2.7523 0.0 0
M  V30 13 C 5.0459 0.4760 0.0 0
M  V30 14 C 3.5813 7.0447 0.0 0
M  V30 15 C 3.5813 0.0000 0.0 0
M  V30 16 O 2.4368 6.0141 0.0 0
M  V30 17 O 2.4368 1.0306 0.0 0
M  V30 18 C 0.9052 6.1752 0.0 0
M  V30 19 C 0.9052 0.8695 0.0 0
M  V30 20 C 0.0000 4.9292 0.0 0
M  V30 21 C 0.0000 2.1155 0.0 0
M  V30 22 O 0.6265 3.5223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60835-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1020075-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11608296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, no experimental detail, cis:trans 59:41
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Luminescence and Mesogenic Properties in Crown-Ether-Isocyanide or
Carbene Gold(I) Complexes: Luminescence in Solution, in the Solid, in the
Mesophase, and in the Isotropic Liquid State
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arias, Javier; Bardaji, Manuel; Espinet, Pablo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2008), 47(9), 3559-3567

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-2-iodoaniline
C6H5FIN
61272-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 F 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluoro-2-iodophenyl)formamide
C7H5FINO
1027821-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 I 4.6201 0.0000 0.0 0
M  V30 5 F 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61272-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1027821-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodotoluene
C7H7I
624-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 I 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluic acid
C8H8O2
99-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 624-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27638958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM selective carboxylation, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Ligand-Controlled Selective Synthesis of Aldehydes
and Acids from Aryl Halides and Formic Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Fu-Peng; Peng, Jin-Bao; Meng, Ling-Shen; Qi, Xinxin; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2017), 9(16), 3121-3124

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3-iodobenzene
C6H4ClI
625-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 I 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 625-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-182-CAS-21410505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2622-14-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, sealed tube used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Convenient Palladium-Catalyzed Reductive Carbonylation of Aryl Iodides
with Dual Role of Formic Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qi, Xinxin; Li, Chong-Liang; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(17), 5835-5838

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-iodoaniline
C6H5ClIN
63069-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chloro-2-iodophenyl)formamide
C7H5ClINO
1232682-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 I 4.6201 0.0000 0.0 0
M  V30 5 Cl 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63069-48-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1232682-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
1-Chloro-4-iodobenzene
C6H4ClI
637-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 I 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 637-87-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-182-CAS-21241241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM polymer-supported Schiff base complexes
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used, recyclable catalyst, reusable catalyst,
sealed tube used, optimization study, optimized on solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-incarcerated palladium-catalyzed facile in situ carbonylation for
the synthesis of aryl aldehydes and diaryl ketones using CO surrogates
under ambient conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Tusar Kanto; Basu, Priyanka; Riyajuddin, Sk; Ghosh, Aniruddha;
Ghosh, Kaushik; Manirul Islam, Sk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2019), 43(25), 9802-9814

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl 3,6-dihydro-2H-thiopyran-2,2-dicarboxylate
C9H12O4S
658045-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4863 4.2598 0.0 0
M  V30 2 O 6.0029 3.9923 0.0 0
M  V30 3 O 3.9596 5.7069 0.0 0
M  V30 4 C 6.9928 5.1721 0.0 0
M  V30 5 C 2.5065 4.2598 0.0 0
M  V30 6 O 0.9899 3.9923 0.0 0
M  V30 7 O 3.0332 5.7069 0.0 0
M  V30 8 C 0.0000 5.1721 0.0 0
M  V30 9 C 3.4964 3.0800 0.0 0
M  V30 10 C 4.8301 2.3100 0.0 0
M  V30 11 S 2.1628 2.3100 0.0 0
M  V30 12 C 4.8301 0.7700 0.0 0
M  V30 13 C 2.1628 0.7700 0.0 0
M  V30 14 C 3.4964 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2(3H)-Thiophenedicarboxylic acid, 5-[(formyloxy)methyl]dihydro-4-iodo-, dim...
C10H13IO6S
658045-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6687 0.0 0
M  V30 2 O 1.3338 6.2087 0.0 0
M  V30 3 O 0.0000 3.8987 0.0 0
M  V30 4 C 0.0000 6.9787 0.0 0
M  V30 5 C 1.7622 2.6528 0.0 0
M  V30 6 O 2.3886 1.2459 0.0 0
M  V30 7 O 0.2307 2.8137 0.0 0
M  V30 8 C 1.4833 0.0000 0.0 0
M  V30 9 C 6.5524 3.0118 0.0 0
M  V30 10 O 7.7983 3.9170 0.0 0
M  V30 11 C 9.2052 3.2907 0.0 0
M  V30 12 O 10.4511 4.1959 0.0 0
M  V30 13 I 5.8559 6.2891 0.0 0
M  V30 14 C 2.6674 3.8987 0.0 0
M  V30 15 S 3.8118 2.8683 0.0 0
M  V30 16 C 3.2938 5.3055 0.0 0
M  V30 17 C 5.1455 3.6383 0.0 0 CFG=1
M  V30 18 C 4.8253 5.1446 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 17 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 18 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 658045-26-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 658045-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-271-CAS-10479066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 516-12-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ring contraction of 3,6-dihydro-2H-thiopyrans to thiolanes by an
iodo-oxyacylation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucassen, Andre C. B.; Zwanenburg, Binne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2004), (1), 74-83

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl 3,6-dihydro-2H-thiopyran-2,2-dicarboxylate
C9H12O4S
658045-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4863 4.2598 0.0 0
M  V30 2 O 6.0029 3.9923 0.0 0
M  V30 3 O 3.9596 5.7069 0.0 0
M  V30 4 C 6.9928 5.1721 0.0 0
M  V30 5 C 2.5065 4.2598 0.0 0
M  V30 6 O 0.9899 3.9923 0.0 0
M  V30 7 O 3.0332 5.7069 0.0 0
M  V30 8 C 0.0000 5.1721 0.0 0
M  V30 9 C 3.4964 3.0800 0.0 0
M  V30 10 C 4.8301 2.3100 0.0 0
M  V30 11 S 2.1628 2.3100 0.0 0
M  V30 12 C 4.8301 0.7700 0.0 0
M  V30 13 C 2.1628 0.7700 0.0 0
M  V30 14 C 3.4964 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2(3H)-Thiophenedicarboxylic acid, 5-[(formyloxy)methyl]dihydro-4-iodo-, dim...
C10H13IO6S
658045-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6687 0.0 0
M  V30 2 O 1.3338 6.2087 0.0 0
M  V30 3 O 0.0000 3.8987 0.0 0
M  V30 4 C 0.0000 6.9787 0.0 0
M  V30 5 C 1.7622 2.6528 0.0 0
M  V30 6 O 2.3886 1.2459 0.0 0
M  V30 7 O 0.2307 2.8137 0.0 0
M  V30 8 C 1.4833 0.0000 0.0 0
M  V30 9 C 6.5524 3.0118 0.0 0
M  V30 10 O 7.7983 3.9170 0.0 0
M  V30 11 C 9.2052 3.2907 0.0 0
M  V30 12 O 10.4511 4.1959 0.0 0
M  V30 13 I 5.8559 6.2891 0.0 0
M  V30 14 C 2.6674 3.8987 0.0 0
M  V30 15 S 3.8118 2.8683 0.0 0
M  V30 16 C 3.2938 5.3055 0.0 0
M  V30 17 C 5.1455 3.6383 0.0 0 CFG=1
M  V30 18 C 4.8253 5.1446 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 17 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 18 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 658045-26-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 658045-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-271-CAS-12436166
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 516-12-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Dimethyl
(4,5-cis)-5-(formyloxymethyl)-4-iodotetrahydrothiophene-2,2-dicarboxylate
(3e): Synthesis of 4-iodotetrahydrothiolanes, general procedure: To a
solution of the thiopyran (1.0 mmol) and 3.0 mmol of carboxylic acid in 6
mL of chloroform was added N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 eq.)
in three portions with appox. 10 min intervals. The reaction was
monitored by TLC, after completion of the reaction chloroform (15 mL) was
added and the solution was poured into a separating funnel containing 10
% sodium thiosulfate (25 mL). The layers were separated and the aqueous
layer was extracted with chloroform (2x 20 mL). The combined organic
fractions were washed with 3 % sodium bicarbonate solution and then with
water. Drying (MgSO4), filtration and removal of the solvent in vacuo
yielded the crude product. Column chromatography over silica gel gave the
pure products. According to this procedure, the following derivative was
prepared: Obtained as a colorless oil (380 mg, 98 %) after column
chromatography (ethyl acetate: heptane = 1:3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfine-Based Synthesis of Four-, Five- and Six Membered Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucassen, Andreas Christianus Bernadus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2003), (20121004), No pp.

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-iodoaniline
C6H5BrIN
66416-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 Br 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromo-2-iodophenyl)formamide
C7H5BrINO
1352951-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 I 4.6201 0.0000 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66416-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352951-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-iodobenzenamine
C6H5ClIN
6828-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0
M  V30 2 I 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Chloro-2-iodophenyl)formamide
C7H5ClINO
1432726-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 6.9300 4.0011 0.0 0
M  V30 4 I 3.0800 0.0000 0.0 0
M  V30 5 Cl 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6828-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1432726-53-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16381510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed synthesis of 2-aminobenzothiazoles from 2-iodophenyl
isocyanides, potassium sulfide and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Hao; Xiao, Genhua; Liu, Wenjuan; Liang, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(47), 11088-11091

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-4-[(phenylmethyl)amino]benzoate
C15H16N2O2
68502-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 2.6674 0.0 0
M  V30 2 O 12.3200 4.0011 0.0 0
M  V30 3 O 12.3200 1.3338 0.0 0
M  V30 4 C 13.8600 4.0011 0.0 0
M  V30 5 N 6.9300 0.0000 0.0 0
M  V30 6 N 5.3900 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 10.0100 2.6674 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 7.7000 1.3338 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(phenylmethyl)-1H-benzimidazole-5-carboxylate
C16H14N2O2
185428-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3938 3.1884 0.0 0
M  V30 2 C 11.6646 2.4782 0.0 0
M  V30 3 O 12.4346 3.8118 0.0 0
M  V30 4 O 12.4346 1.1444 0.0 0
M  V30 5 C 13.9746 3.8118 0.0 0
M  V30 6 C 7.0446 2.4782 0.0 0
M  V30 7 C 7.8146 1.1444 0.0 0
M  V30 8 N 5.5383 2.1580 0.0 0
M  V30 9 C 7.8146 3.8118 0.0 0
M  V30 10 C 9.3546 1.1444 0.0 0
M  V30 11 N 6.7842 0.0000 0.0 0
M  V30 12 C 5.3774 0.6263 0.0 0
M  V30 13 C 9.3546 3.8118 0.0 0
M  V30 14 C 10.1246 2.4782 0.0 0
M  V30 15 C 2.9292 2.7126 0.0 0
M  V30 16 C 2.6091 1.2061 0.0 0
M  V30 17 C 1.7847 3.7430 0.0 0
M  V30 18 C 1.1444 0.7303 0.0 0
M  V30 19 C 0.3202 3.2671 0.0 0
M  V30 20 C 0.0000 1.7607 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68502-22-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 185428-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-8758966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Selective Inhibitor of Heme Biosynthesis in Endosymbiotic Bacteria
Elicits Antifilarial Activity In Vitro
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lentz, Christian S.; Halls, Victoria; Hannam, Jeffrey S.; Niebel, Bjoern;
Struebing, Uta; Mayer, Guenter; Hoerauf, Achim; Famulok, Michael; Pfarr,
Kenneth M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biology (Oxford, United Kingdom) (2013), 20(2), 177-187

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzylamine
C8H11NO
6850-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Methoxyphenyl)methyl]formamide
C9H11NO2
72221-87-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 8.4700 5.3349 0.0 0
M  V30 5 O 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6850-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72221-87-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-50000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 9002-89-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM aminated with ethanolamine
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, no solvent (stage 1), catalyst
prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amino group immobilized on polyvinyl alcohol as a reusable catalyst for
highly accelerated N-formylation of amines using formic acid under
solvent-free condition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rezazadeh, Soodabeh; Akhlaghinia, Batool
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Indian Chemical Society (2015), 92(8), 1277-1285

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carbonitrile
C8H8N2S
70291-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1779 3.3320 0.0 0
M  V30 2 N 6.5116 4.1020 0.0 0
M  V30 3 N 4.8277 0.0000 0.0 0
M  V30 4 C 2.4373 3.1885 0.0 0
M  V30 5 C 1.4068 2.0439 0.0 0
M  V30 6 C 3.8442 2.5620 0.0 0
M  V30 7 C 1.6672 4.5222 0.0 0
M  V30 8 S 2.1768 0.7103 0.0 0
M  V30 9 C 0.0000 2.6704 0.0 0
M  V30 10 C 3.6833 1.0304 0.0 0
M  V30 11 C 0.1609 4.2020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7-Tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
C9H8N2OS
14346-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.9933 2.3612 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3405 5.1455 0.0 0
M  V30 9 C 6.2537 4.8394 0.0 0
M  V30 10 C 7.0237 3.5057 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70291-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-22379185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, biological evaluation and molecular modeling study of
new thieno[2,3-d]pyrimidines with anti-proliferative activity on
pancreatic cancer cell lines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salem, Mohamed S. H.; Abdel Aziz, Yasmine M.; Elgawish, Mohamed S.; Said,
Mohamed M.; Abouzid, Khaled A. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 94103472

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Valine
C5H11NO2
72-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0 CFG=2
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 N 4.0010 3.0801 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 4.0010 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-valine
C6H11NO3
4289-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 O 4.0012 4.6201 0.0 0
M  V30 9 O 1.3338 4.6201 0.0 0
M  V30 10 O 6.6687 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 2 5 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72-18-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4289-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8101901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 39377-45-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable catalyst, exothermic, nano rod-shaped basic
Al2O3 catalyst used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nano rod-shaped and reusable basic Al2O3 catalyst for N-formylation of
amines under solvent-free conditions: A novel, practical and convenient
NOSE' approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Vijay Kumar; Devi, Rashmi Rekha; Raul, Prasanta Kumar; Thakur, Ashim
Jyoti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2012), 14(3), 847-854

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,6R,11R)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-met...
C18H26N2
72598-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5170 6.5734 0.0 0
M  V30 2 C 5.1504 2.9938 0.0 0
M  V30 3 N 0.0000 4.8348 0.0 0
M  V30 4 C 9.1348 1.9061 0.0 0
M  V30 5 C 5.0994 5.1478 0.0 0 CFG=1
M  V30 6 C 4.0011 4.0648 0.0 0
M  V30 7 C 6.5754 3.5780 0.0 0 CFG=1
M  V30 8 C 6.6323 5.1439 0.0 0
M  V30 9 C 4.0011 2.5248 0.0 0
M  V30 10 C 2.6673 4.8348 0.0 0
M  V30 11 C 6.6263 1.4240 0.0 0 CFG=2
M  V30 12 C 7.7248 4.0494 0.0 0
M  V30 13 C 5.0839 1.4240 0.0 0
M  V30 14 C 2.6673 1.7548 0.0 0
M  V30 15 C 1.3336 4.0648 0.0 0
M  V30 16 N 7.7153 2.5030 0.0 0
M  V30 17 C 1.3336 2.5248 0.0 0
M  V30 18 C 10.3616 2.8370 0.0 0
M  V30 19 C 10.9585 4.2566 0.0 0
M  V30 20 C 11.8894 3.0298 0.0 0
M  V30 21 H 7.2125 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=1
M  V30 2 1 2 7
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11 CFG=3
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 1 11 16
M  V30 18 1 11 21 CFG=1
M  V30 19 1 12 16
M  V30 20 1 14 17
M  V30 21 2 15 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R,6R,11R)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-...
C19H26N2O
60332-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3725 6.5734 0.0 0
M  V30 2 C 6.7390 2.9938 0.0 0
M  V30 3 N 11.8896 4.8349 0.0 0
M  V30 4 C 13.2232 4.0649 0.0 0
M  V30 5 O 14.5569 4.8349 0.0 0
M  V30 6 C 2.7546 1.9061 0.0 0
M  V30 7 C 7.8884 4.0649 0.0 0
M  V30 8 C 6.7901 5.1478 0.0 0 CFG=1
M  V30 9 C 7.8884 2.5249 0.0 0
M  V30 10 C 9.2221 4.8349 0.0 0
M  V30 11 C 5.3141 3.5781 0.0 0 CFG=1
M  V30 12 C 5.2572 5.1440 0.0 0
M  V30 13 C 6.8055 1.4241 0.0 0
M  V30 14 C 9.2221 1.7549 0.0 0
M  V30 15 C 10.5559 4.0649 0.0 0
M  V30 16 C 5.2632 1.4241 0.0 0 CFG=2
M  V30 17 C 4.1647 4.0495 0.0 0
M  V30 18 C 10.5559 2.5249 0.0 0
M  V30 19 N 4.1742 2.5030 0.0 0
M  V30 20 C 1.5279 2.8370 0.0 0
M  V30 21 C 0.0000 3.0298 0.0 0
M  V30 22 C 0.9309 4.2566 0.0 0
M  V30 23 H 4.6770 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 2 4 5
M  V30 6 1 6 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16 CFG=1
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 16 23 CFG=3
M  V30 23 1 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 11 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72598-11-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60332-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9819688
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Redefining the structure-activity relationships of
2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wentland, Mark P.; Sun, Xufeng; Ye, Yingchun; Lou, Rongliang; Bidlack,
Jean M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(11), 1911-1914

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
C10H11NO2
74163-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 5.3900 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 O 1.3338 6.9300 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 5.3347 3.0800 0.0 0
M  V30 6 C 2.6674 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 5.3347 4.6200 0.0 0
M  V30 9 C 6.6685 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0 CFG=1
M  V30 11 C 5.3347 0.0000 0.0 0
M  V30 12 N 4.0011 5.3900 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-2-Formyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
C11H11NO3
412912-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0 CFG=2
M  V30 7 N 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74163-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 412912-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11962454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4.5 kg of HCOOH 95-97% is loaded into a suitable reactor; it is cooled to
approx. 5°C and 1.23 kg of the product obtained in Example 1 is added
slowly at < 10°C; it is stirred for 30 min and 0.86 kg of acetic
anhydride is added slowly at < 10°C; then the temperature is allowed to
rise to 20°C and it is stirred for 2h. It is disted under vacuum at 40°C
until there is a residue, it is absorbed in 0.3 kg of ethyl acetate and
then disted until there is a residue. 3.7 kg of H2O is added, and it is
kept stirred for 30 min, allowing the product to "gin"; it is cooled to
5°C, stirred for 2h and filtered on a diaphm. It is then dried in a stove
under vacuum at > 7°C. Yield 1.39 kg 97.6 % HPLC purity 97%; Mol.
Formula: C11H11NO3, MW: 205.21.
$DTYPE RXN:VAR(1):NOTES
$DATUM temperature lesser than 10 degrees Celsius used (stage 2), alternative
reaction condition shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method of preparation of
(s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bellani, Pietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002030905 A1 2002-04-18

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-4-methoxybenzenamine
C7H8INO
74587-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 I 2.3101 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Iodo-4-methoxyphenyl)formamide
C8H8INO2
2242626-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6673 0.0 0
M  V30 2 C 7.7002 4.0010 0.0 0
M  V30 3 O 9.2402 4.0010 0.0 0
M  V30 4 I 2.3101 0.0000 0.0 0
M  V30 5 O 0.7700 2.6673 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 3.0801 4.0010 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74587-12-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242626-26-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19189588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct Anodic Dehydrogenative Cross- and Homo-Coupling of Formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulz, Lara; Franke, Robert; Waldvogel, Siegfried R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemElectroChem (2018), 5(15), 2069-2072

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,6-dimethylpyrimidine
C6H9N3
767-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 4.6200 0.0 0
M  V30 2 C 5.3349 4.6200 0.0 0
M  V30 3 N 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4,6-Dimethyl-2-pyrimidinyl)formamide
C7H9N3O
38272-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 O 8.0021 4.6200 0.0 0
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 4.0011 2.3100 0.0 0
M  V30 8 N 2.6674 4.6200 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 767-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 38272-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20697973
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7429-90-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM mesoporous silica-supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst,
aluminum-MCM-41-catalyst prepared and used, optimized on catalyst,
optimization study, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Characterization and Properties of N- Heteroaryl Formamide
Derivatives in the Presence of the Al-MCM-41-Nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmadi Meleh Amiri, Kianoosh; Saadati, Zohreh; Vafayi Bagheri, Zahra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Silicon (2019), 11(4), 2117-2125

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[5-(Acetyloxy)-1-methylenepentyl]-1H-isoindole-1,3(2H)-dione
C16H17NO4
849097-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0203 5.3182 0.0 0
M  V30 2 O 5.7309 0.6234 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 C 7.4148 3.1854 0.0 0
M  V30 5 C 6.0811 5.4955 0.0 0
M  V30 6 C 8.7485 3.9554 0.0 0
M  V30 7 C 10.0821 3.1854 0.0 0
M  V30 8 C 11.4160 3.9554 0.0 0
M  V30 9 O 12.7496 3.1854 0.0 0
M  V30 10 C 14.0833 3.9554 0.0 0
M  V30 11 C 14.0833 5.4955 0.0 0
M  V30 12 O 15.4170 3.1854 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 14 C 3.0801 1.3337 0.0 0
M  V30 15 C 3.3405 3.8119 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 4.5864 1.6538 0.0 0
M  V30 18 C 2.3101 0.0000 0.0 0
M  V30 19 N 4.7473 3.1854 0.0 0
M  V30 20 C 0.0000 1.3337 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 1 18 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-[4-(Acetyloxy)butyl]-1,3-dihydro-1,3-dioxo-2H-isoindole-2-propanoic acid
C17H19NO6
1801658-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.8501 0.0 0
M  V30 2 C 7.4148 4.6201 0.0 0
M  V30 3 C 6.0811 2.3101 0.0 0
M  V30 4 C 8.7485 3.8501 0.0 0
M  V30 5 C 7.4148 1.5400 0.0 0
M  V30 6 C 10.0821 4.6201 0.0 0
M  V30 7 O 7.4148 0.0000 0.0 0
M  V30 8 O 8.7485 2.3101 0.0 0
M  V30 9 C 11.4160 3.8501 0.0 0
M  V30 10 O 12.7496 4.6201 0.0 0
M  V30 11 C 14.0833 3.8501 0.0 0
M  V30 12 C 14.0833 2.3101 0.0 0
M  V30 13 O 15.4170 4.6201 0.0 0
M  V30 14 O 3.0203 2.4873 0.0 0
M  V30 15 O 5.7309 7.1821 0.0 0
M  V30 16 N 4.7473 4.6201 0.0 0
M  V30 17 C 3.3405 3.9936 0.0 0
M  V30 18 C 4.5864 6.1517 0.0 0
M  V30 19 C 2.3101 5.1382 0.0 0
M  V30 20 C 3.0801 6.4718 0.0 0
M  V30 21 C 0.7700 5.1382 0.0 0
M  V30 22 C 2.3101 7.8055 0.0 0
M  V30 23 C 0.0000 6.4718 0.0 0
M  V30 24 C 0.7700 7.8055 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 14 17
M  V30 15 2 15 18
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849097-75-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1801658-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-4652365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 166330-10-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile approach to β-amino acid derivatives via palladium-catalyzed
hydrocarboxylation of enimides with formic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Wang, Haining; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(31), 8429-8432

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Cyclohexylethenyl)-1H-isoindole-1,3(2H)-dione
C16H17NO2
849097-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 C 6.0811 0.0000 0.0 0
M  V30 3 O 5.7309 4.8721 0.0 0
M  V30 4 O 3.0203 0.1773 0.0 0
M  V30 5 N 4.7475 2.3101 0.0 0
M  V30 6 C 4.5865 3.8416 0.0 0
M  V30 7 C 3.3405 1.6836 0.0 0
M  V30 8 C 3.0801 4.1618 0.0 0
M  V30 9 C 2.3101 2.8281 0.0 0
M  V30 10 C 2.3101 5.4955 0.0 0
M  V30 11 C 0.7700 2.8281 0.0 0
M  V30 12 C 0.7700 5.4955 0.0 0
M  V30 13 C 0.0000 4.1618 0.0 0
M  V30 14 C 7.4148 2.3101 0.0 0
M  V30 15 C 7.4148 3.8501 0.0 0
M  V30 16 C 8.7486 1.5400 0.0 0
M  V30 17 C 8.7486 4.6201 0.0 0
M  V30 18 C 10.0823 2.3101 0.0 0
M  V30 19 C 10.0823 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 14
M  V30 4 2 3 6
M  V30 5 2 4 7
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Cyclohexyl-1,3-dihydro-1,3-dioxo-2H-isoindole-2-propanoic acid
C17H19NO4
777904-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 4.6201 0.0 0
M  V30 2 C 7.4148 5.3901 0.0 0
M  V30 3 C 8.7486 4.6201 0.0 0
M  V30 4 O 8.7486 3.0801 0.0 0
M  V30 5 O 10.0823 5.3901 0.0 0
M  V30 6 O 3.0203 3.2573 0.0 0
M  V30 7 O 5.7309 7.9521 0.0 0
M  V30 8 N 4.7475 5.3901 0.0 0
M  V30 9 C 3.3405 4.7636 0.0 0
M  V30 10 C 4.5865 6.9217 0.0 0
M  V30 11 C 2.3101 5.9082 0.0 0
M  V30 12 C 3.0801 7.2419 0.0 0
M  V30 13 C 0.7700 5.9082 0.0 0
M  V30 14 C 2.3101 8.5755 0.0 0
M  V30 15 C 0.0000 7.2419 0.0 0
M  V30 16 C 0.7700 8.5755 0.0 0
M  V30 17 C 6.0811 3.0801 0.0 0
M  V30 18 C 4.7475 2.3101 0.0 0
M  V30 19 C 7.4148 2.3101 0.0 0
M  V30 20 C 4.7475 0.7700 0.0 0
M  V30 21 C 7.4148 0.7700 0.0 0
M  V30 22 C 6.0811 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849097-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 777904-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-13188964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 166330-10-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile approach to β-amino acid derivatives via palladium-catalyzed
hydrocarboxylation of enimides with formic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Jie; Ren, Wenlong; Wang, Haining; Shi, Yian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(31), 8429-8432

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-(2-amino-1,1-dimethylethyl)carbamate
C12H18N2O2
850203-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 10.1060 1.7464 0.0 0
M  V30 8 C 10.6697 3.8501 0.0 0
M  V30 9 C 8.5660 4.4137 0.0 0
M  V30 10 N 11.6460 1.7464 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[2-(formylamino)-1,1-dimethylethyl]carbamate
C13H18N2O3
1037832-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 10.1059 2.8737 0.0 0
M  V30 8 C 8.5659 0.2064 0.0 0
M  V30 9 C 10.6695 0.7700 0.0 0
M  V30 10 N 11.6459 2.8737 0.0 0
M  V30 11 C 12.4159 4.2075 0.0 0
M  V30 12 O 13.9559 4.2075 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6675 3.8500 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 850203-57-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037832-90-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-156402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM This amine (5 g, 22.5 mmol) was added to a pre-stirred mixture of formic
acid (0.84 mL, 22.5 mmol) and 1,1'-carbonyl-diimidazole (3.64 g, 22.5
mmol) in THF, stirred for 2 h and concentrated. The residue was suspended
in EtOAc and washed with sat. NaHCO3, dried over sodium sulfate and
concentrated to yield the N-formyl derivative (5.5 g, 98%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-halogenated amino compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Najafi, Ramin; Jain, Rakesh K.; Shiau, Timothy P.; Low, Eddy; Nair,
Satheesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008083347 A1 2008-07-10

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4-(trifluoromethyl)-2-pyridinemethanamine
C7H6ClF3N2
862120-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 2.1037 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5637 3.2864 0.0 0
M  V30 5 C 6.6687 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 Cl 4.0012 0.0000 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 N 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[6-Chloro-4-(trifluoromethyl)-2-pyridinyl]methyl]formamide
C8H6ClF3N2O
2064217-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 0.5637 3.2864 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 2.1037 5.9538 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 10.6697 3.8501 0.0 0
M  V30 9 Cl 4.0012 0.0000 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 862120-77-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2064217-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17031402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridine derivatives for use as TDO and/or IDO
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cowley, Phillip M.; Wise, Alan; Brown, Thomas J.; McGowan, Meredeth A.;
Zhou, Hua; Han, Yongxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017007700 A1 2017-01-12

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Diamino[1,1′-biphenyl]-2-carbonitrile
C13H11N3
870486-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 N 3.8500 0.0000 0.0 0
M  V30 3 N 7.7000 1.3338 0.0 0
M  V30 4 N 9.2400 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 5.3900 5.3349 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3349 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Phenyl-1H-benzimidazole-7-carbonitrile
C14H9N3
870485-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7472 1.3338 0.0 0
M  V30 2 N 5.5172 0.0000 0.0 0
M  V30 3 C 4.7472 4.0011 0.0 0
M  V30 4 C 3.9772 2.6674 0.0 0
M  V30 5 C 3.9772 5.3349 0.0 0
M  V30 6 C 2.4372 2.6674 0.0 0
M  V30 7 C 2.4372 5.3349 0.0 0
M  V30 8 C 1.6672 4.0011 0.0 0
M  V30 9 N 1.4068 1.5231 0.0 0
M  V30 10 N 0.1609 3.6809 0.0 0
M  V30 11 C 0.0000 2.1494 0.0 0
M  V30 12 C 6.2872 4.0011 0.0 0
M  V30 13 C 7.0572 5.3349 0.0 0
M  V30 14 C 7.0572 2.6674 0.0 0
M  V30 15 C 8.5972 5.3349 0.0 0
M  V30 16 C 8.5972 2.6674 0.0 0
M  V30 17 C 9.3672 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 8
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 870486-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870485-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-7268386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Phenyl-3H-benoimidazole-4-carbonitrile :Example 1A (400 mg, 1.9 mmol)
was stirred in 85% formic acid (12 mL) with a catalytic amount of PPA at
reflux for 2 h. After cooling, the solution was concentrated in vacuo.
The residue was quenched with sat. NaHCO3 and extracted with EtOAc.
Organics were dried (MgSO4) and concentrated in vacuo.
5-Phenyl-3H-benoimidazole-4-carbonitrile as an off-white solid , yield
412 mg, 98% . 1H NMR (400 MHz, MeOD-d4): δ 8.39 (s, 1H), 7.93 (d, 1H, J =
8.0 Hz), 7.60-7.63 (m, 2H), 7.4-7.53 (m, 4H). MS (ES) [m+H] calc'd for
C14H9N3, 220; found 220.
$DTYPE RXN:VAR(1):NOTES
$DATUM polyphosphoric acid (PPA) used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl-substituted benzimidazoles as dipeptidyl peptidase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feng, Jun; Gwaltney, Stephen L.; Wallace, Michael B.; Zhang, Zhiyuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050272765 A1 2005-12-08

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6aR,8S,9R,10R,10aR)-8-Chloro-9-ethenyl-5,6,6a,7,8,9,10,10a-octahydro-6,6,9-t...
C20H25ClN2
870987-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 6.4791 0.0 0
M  V30 2 C 5.6504 0.0000 0.0 0
M  V30 3 C 3.6346 0.4284 0.0 0
M  V30 4 C 0.8629 5.6721 0.0 0
M  V30 5 C 0.5955 7.1887 0.0 0
M  V30 6 C 2.5775 6.6620 0.0 0
M  V30 7 Cl 0.0000 3.8118 0.0 0
M  V30 8 C 6.1264 3.4916 0.0 0
M  V30 9 C 4.6200 3.8118 0.0 0 CFG=2
M  V30 10 C 6.2874 1.9600 0.0 0
M  V30 11 C 7.5332 4.1180 0.0 0
M  V30 12 C 3.8500 2.4780 0.0 0 CFG=1
M  V30 13 C 3.8500 5.1454 0.0 0 CFG=1
M  V30 14 C 4.8804 1.3336 0.0 0
M  V30 15 N 7.7936 1.6398 0.0 0
M  V30 16 C 8.5636 2.9736 0.0 0
M  V30 17 C 8.0091 5.5827 0.0 0
M  V30 18 C 2.3100 2.4780 0.0 0
M  V30 19 C 2.3100 5.1454 0.0 0 CFG=1
M  V30 20 C 10.0701 3.2938 0.0 0
M  V30 21 C 9.5155 5.9028 0.0 0
M  V30 22 C 1.5400 3.8118 0.0 0 CFG=2
M  V30 23 C 10.5459 4.7583 0.0 0
M  V30 24 H 5.5252 5.0577 0.0 0
M  V30 25 H 3.2237 1.0712 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=3
M  V30 2 1 2 14
M  V30 3 1 3 14
M  V30 4 2 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 19 6 CFG=1
M  V30 7 1 22 7 CFG=3
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 24 CFG=3
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 12 14
M  V30 19 1 12 18
M  V30 20 1 12 25 CFG=1
M  V30 21 1 13 19
M  V30 22 1 15 16
M  V30 23 2 16 20
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 12 13 19 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(6aR,8S,9R,10R,10aR)-8-Chloro-9-ethenyl-5,6,6a,7,8,9,10,10a-octahydro-6,6,...
C21H25ClN2O
871254-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6673 0.0 0
M  V30 2 C 3.8500 1.3337 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 5.6505 9.1465 0.0 0
M  V30 5 C 3.6346 8.7180 0.0 0
M  V30 6 C 0.8629 3.4743 0.0 0
M  V30 7 C 0.5955 1.9577 0.0 0
M  V30 8 C 2.5775 2.4844 0.0 0
M  V30 9 Cl 0.0000 5.3348 0.0 0
M  V30 10 C 6.1265 5.6549 0.0 0
M  V30 11 C 4.6200 5.3348 0.0 0 CFG=2
M  V30 12 C 6.2874 7.1865 0.0 0
M  V30 13 C 7.5333 5.0285 0.0 0
M  V30 14 C 3.8500 6.6684 0.0 0 CFG=1
M  V30 15 C 3.8500 4.0010 0.0 0 CFG=1
M  V30 16 C 4.8805 7.8128 0.0 0
M  V30 17 N 7.7937 7.5067 0.0 0
M  V30 18 C 8.5637 6.1730 0.0 0
M  V30 19 C 8.0092 3.5639 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 2.3100 4.0010 0.0 0 CFG=1
M  V30 22 C 10.0702 5.8528 0.0 0
M  V30 23 C 9.5156 3.2437 0.0 0
M  V30 24 C 1.5400 5.3348 0.0 0 CFG=2
M  V30 25 C 10.5460 4.3881 0.0 0
M  V30 26 H 5.5253 4.0887 0.0 0
M  V30 27 H 3.2237 8.0752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 16
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 21 6 CFG=1
M  V30 8 1 21 8 CFG=3
M  V30 9 1 24 9 CFG=1
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 11 26 CFG=1
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 2 13 19
M  V30 20 1 14 16
M  V30 21 1 14 20
M  V30 22 1 14 27 CFG=3
M  V30 23 1 15 21
M  V30 24 1 17 18
M  V30 25 2 18 22
M  V30 26 1 19 23
M  V30 27 1 20 24
M  V30 28 1 21 24
M  V30 29 1 22 25
M  V30 30 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 14 15 21 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 870987-53-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871254-05-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4896194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 3140-73-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The following compounds were added sequentially to a flask, maintained at
room temperature, in the following order: compound 9 (132.3 mg, 0.40
mmol), formic acid (15.1 μL, 0.40 mmol), 2-chloro-4,6-dimethoxy-1,3,5-
triazine (77.7 mg, 0.44 mmol), DMAP (1.5 mg, 0.012 mmol),
N-methylmorpholine (49.8 μL, 0.44 mmol), and CH2Cl2 (1.1 mL). The
reaction was stirred for 45 minutes at room temperature, after which time
the reaction was diluted with CH2Cl2 (75 mL) and washed twice with 1 N
HCl (50 mL), once with saturated NaHCO3 (50 mL), once with water (50 mL),
and brine (50 mL). The organic layer was dried (MgSO4) and evaporated
under reduced pressure to give 11 (139.9 mg, 98%), which was sufficiently
pure for further reaction; light yellow oil; 11 (139.9 mg, 98%), Rf =
0.46 (silica gel, 1:1 hexane:EtOAc); [α]D nat. = + 20.0 (CH2Cl2, c 0.20),
ent. = - 11.8 (CH2Cl2, c 0.72); IR (film) νmax 3394, 3290, 2960, 1678,
1570, 1498, 1476, 1449, 1365, 1304, 1273, 1241, 1205, 1141, 1104, 1072,
998, 909, 735 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.50 (s, 1 H,), 7.95 (bs, 1
H, D2O exchangeable), 7.34 (d, J = 7.2 Hz, 1 H), 7.22 (d, J = 7.6 Hz, 1
H), 7.08 - 7.14 (m, 2 H), 6.18 (d, J = 8.8 Hz, 1 H) 5.84 (dd, J = 17.2,
10.8 Hz, 1 H), 5.20 (d, J = 17.2 Hz, 1 H), 5.12 (d, J = 12.0 Hz, 1 H),
4.35 (dd, J = 9.2, 5.6 Hz, 1 H), 3.99 (dd, J = 12.4, 5.2 Hz, 2 H), 3.86
(t, J = 5.6 Hz), 2.51 - 2.57 (m, 1 H), 2.05 - 2.18 (m, 2 H), 1.36 (s, 3
H), 1.31 (s, 3 H), 1.20 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 203.2,
169.9, 160.6, 150.3, 140.4, 135.5, 124.1, 120.8, 120.0, 119.5, 115.8,
111.9, 67.5, 54.4, 53.6, 46.7, 42.1, 32.3, 25.7, 22.0, 20.9; HRMS (ESI)
calcd. For C21H25ClNaN2O [M + Na+] 356.1548, found 379.1543
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Syntheses of Welwitindolinone A and Fischerindoles
I and G
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baran, Phil S.; Richter, Jeremy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2005), 127(44), 15394-15396

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cefpodoxime proxetil
C21H27N5O9S2
87239-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4701 5.3347 0.0 0
M  V30 2 O 6.9300 5.3347 0.0 0
M  V30 3 O 9.2401 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0 CFG=3
M  V30 5 O 4.6200 4.0011 0.0 0
M  V30 6 C 6.9300 2.6673 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 O 2.3100 2.6673 0.0 0
M  V30 9 O 4.6200 1.3336 0.0 0
M  V30 10 C 1.5400 1.3336 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 0.0000 1.3336 0.0 0
M  V30 13 O 12.5123 4.4109 0.0 0
M  V30 14 N 14.3712 7.6308 0.0 0
M  V30 15 C 15.4602 6.5417 0.0 0
M  V30 16 C 16.9478 6.9404 0.0 0
M  V30 17 O 15.0616 5.0542 0.0 0
M  V30 18 N 17.3464 8.4279 0.0 0
M  V30 19 O 16.2574 9.5168 0.0 0
M  V30 20 C 16.6560 11.0043 0.0 0
M  V30 21 C 6.9300 8.0020 0.0 0
M  V30 22 O 6.1600 9.3358 0.0 0
M  V30 23 C 4.6200 9.3358 0.0 0
M  V30 24 N 21.7779 4.4791 0.0 0
M  V30 25 N 10.7801 6.6684 0.0 0
M  V30 26 C 11.5501 8.0020 0.0 0 CFG=2
M  V30 27 C 9.2401 6.6684 0.0 0
M  V30 28 C 12.1137 5.8984 0.0 0
M  V30 29 C 12.8837 7.2320 0.0 0 CFG=2
M  V30 30 S 10.7801 9.3358 0.0 0
M  V30 31 C 8.4701 8.0020 0.0 0
M  V30 32 C 9.2401 9.3358 0.0 0
M  V30 33 C 18.0368 5.8514 0.0 0
M  V30 34 N 19.5578 6.0923 0.0 0
M  V30 35 C 17.7957 4.3304 0.0 0
M  V30 36 C 20.2568 4.7201 0.0 0
M  V30 37 S 19.1679 3.6312 0.0 0
M  V30 38 H 12.6390 9.0910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 13 28
M  V30 14 1 14 15
M  V30 15 1 29 14 CFG=3
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 16 33
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 31
M  V30 24 1 22 23
M  V30 25 1 24 36
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 25 28
M  V30 29 1 26 29
M  V30 30 1 26 30
M  V30 31 1 26 38 CFG=1
M  V30 32 2 27 31
M  V30 33 1 28 29
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-[2-(formylamino)-4-...
C22H27N5O10S2
96680-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 5.3347 0.0 0
M  V30 2 O 6.9300 5.3347 0.0 0
M  V30 3 O 9.2400 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0 CFG=3
M  V30 5 O 4.6200 4.0011 0.0 0
M  V30 6 C 6.9300 2.6673 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 O 2.3100 2.6673 0.0 0
M  V30 9 O 4.6200 1.3336 0.0 0
M  V30 10 C 1.5400 1.3336 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 0.0000 1.3336 0.0 0
M  V30 13 O 12.5124 4.4109 0.0 0
M  V30 14 N 14.3713 7.6307 0.0 0
M  V30 15 C 15.4602 6.5416 0.0 0
M  V30 16 C 16.9477 6.9403 0.0 0
M  V30 17 O 15.0617 5.0541 0.0 0
M  V30 18 N 17.3463 8.4278 0.0 0
M  V30 19 O 16.2573 9.5168 0.0 0
M  V30 20 C 16.6560 11.0042 0.0 0
M  V30 21 C 6.9300 8.0020 0.0 0
M  V30 22 O 6.1600 9.3358 0.0 0
M  V30 23 C 4.6200 9.3358 0.0 0
M  V30 24 N 21.7779 4.4791 0.0 0
M  V30 25 C 22.3299 3.0415 0.0 0
M  V30 26 O 23.8509 2.8005 0.0 0
M  V30 27 N 10.7800 6.6684 0.0 0
M  V30 28 C 11.5500 8.0020 0.0 0 CFG=2
M  V30 29 C 9.2400 6.6684 0.0 0
M  V30 30 C 12.1138 5.8984 0.0 0
M  V30 31 C 12.8838 7.2320 0.0 0 CFG=2
M  V30 32 S 10.7800 9.3358 0.0 0
M  V30 33 C 8.4700 8.0020 0.0 0
M  V30 34 C 9.2400 9.3358 0.0 0
M  V30 35 C 18.0367 5.8514 0.0 0
M  V30 36 N 19.5577 6.0922 0.0 0
M  V30 37 C 17.7958 4.3303 0.0 0
M  V30 38 C 20.2569 4.7201 0.0 0
M  V30 39 S 19.1679 3.6312 0.0 0
M  V30 40 H 12.6390 9.0909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 13 30
M  V30 14 1 14 15
M  V30 15 1 31 14 CFG=3
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 16 35
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 33
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 38
M  V30 27 2 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 27 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 28 40 CFG=1
M  V30 34 2 29 33
M  V30 35 1 30 31
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87239-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96680-30-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15197483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A PROCESS FOR THE PREPARATION OF PURE CEFPODOXIME PROXETIL
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anonymous
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM IP.com Journal (2008), 8(8B), 3

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichlorophenol
C6H3Cl3O
88-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 Cl 1.5400 5.3349 0.0 0
M  V30 4 Cl 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2,4,6-trichloro-, 1-formate
C7H3Cl3O2
4525-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 Cl 4.6200 5.3349 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 Cl 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-06-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4525-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-11149284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 2. Representative procedure of the synthesis
of phenyl formates (Table 1, entry 1) Formic acid (19 mL, 500 mmol, 5.0
equiv) was added to acetic anhydride (38 mL, 400 mmol, 4.0 equiv) at rt.
The mixture was stirred at 60 °C for 1 h and cooled to rt. The resulting
solution was poured to the flask containing phenol (9.4 g, 100 mmol) and
AcONa (4.1 g, 50 mmol, 0.5 equiv). The mixture was stirred for 4 h in
water bath and then diluted with toluene (150 mL), washed with H2O (100
mL) three times, dried over MgSO4, filtered, and concentrated to afford
the desired product. This product was used for carbonylation reaction
without further purification. 2,4,6-Trichlorophenyl formate (1f)11 1f was
obtained from 2,4,6-trichlorophenol as a pale yellow crystal. 8 equiv of
Ac2O, 10 equiv of HCOOH, and 1 equiv of AcONa were used. Yield: 98%. M.p.
68 °C, 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H), 7.40 (s, 2H); 13C NMR (100
MHz, CDCl3) δ 156.2, 141.9, 132.5, 129.2, and 128.7; IR (ATR) 3078, 1732,
1562, 1447, 1418, 1385, 1368, 1227, 1084, 1055, 849, 818, 804, 687, and
561 cm-1; HRMS (CI) [M+H]+ calcd for C7H3Cl3O2: 224.9271; found 224.9279.
$DTYPE RXN:VAR(1):NOTES
$DATUM components prepared in stage 1 were added to components in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Trichlorophenyl Formate: Highly Reactive and Easily Accessible
Crystalline CO Surrogate for Palladium-Catalyzed Carbonylation of
Aryl/Alkenyl Halides and Triflates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ueda, Tsuyoshi; Konishi, Hideyuki; Manabe, Kei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(20), 5370-5373

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (3aR,4S,7R,7aS)-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indazole-3-...
C10H14N2O2
881689-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2989 2.4575 0.0 0
M  V30 2 O 7.6325 3.2275 0.0 0
M  V30 3 O 6.2989 0.9175 0.0 0
M  V30 4 C 8.9663 2.4575 0.0 0
M  V30 5 C 3.5584 2.6010 0.0 0 CFG=2
M  V30 6 C 2.5280 3.7455 0.0 0 CFG=1
M  V30 7 C 3.0895 1.1427 0.0 0 CFG=1
M  V30 8 C 4.9653 3.2275 0.0 0
M  V30 9 C 1.0285 3.4315 0.0 0 CFG=2
M  V30 10 N 3.2980 5.0791 0.0 0
M  V30 11 C 1.7081 1.9712 0.0 0
M  V30 12 C 1.5825 0.8219 0.0 0
M  V30 13 N 4.8044 4.7590 0.0 0
M  V30 14 C 0.5521 1.9664 0.0 0
M  V30 15 H 4.7044 1.5723 0.0 0
M  V30 16 H 1.6247 4.9927 0.0 0
M  V30 17 H 4.1219 0.0000 0.0 0
M  V30 18 H 0.0000 4.5777 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 15 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 16 CFG=1
M  V30 12 1 7 11 CFG=3
M  V30 13 1 7 12
M  V30 14 1 7 17
M  V30 15 2 8 13
M  V30 16 1 9 11 CFG=3
M  V30 17 1 9 14
M  V30 18 1 9 18
M  V30 19 1 10 13
M  V30 20 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 5 6 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Methyl (3aR,4S,7R,7aS)-1-formyl-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-in...
C11H14N2O3
1240504-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2989 5.2744 0.0 0
M  V30 2 O 7.6326 4.5044 0.0 0
M  V30 3 O 6.2989 6.8144 0.0 0
M  V30 4 C 8.9663 5.2744 0.0 0
M  V30 5 C 2.6717 1.2458 0.0 0
M  V30 6 O 3.5769 0.0000 0.0 0
M  V30 7 C 3.5584 5.1307 0.0 0 CFG=1
M  V30 8 C 2.5280 3.9864 0.0 0 CFG=1
M  V30 9 C 4.9653 4.5044 0.0 0
M  V30 10 C 3.0895 6.5892 0.0 0 CFG=1
M  V30 11 C 1.0285 4.3004 0.0 0 CFG=2
M  V30 12 N 3.2980 2.6528 0.0 0
M  V30 13 N 4.8044 2.9729 0.0 0
M  V30 14 C 1.7081 5.7607 0.0 0
M  V30 15 C 1.5825 6.9100 0.0 0
M  V30 16 C 0.5521 5.7655 0.0 0
M  V30 17 H 4.7045 6.1594 0.0 0
M  V30 18 H 1.6247 2.7391 0.0 0
M  V30 19 H 4.1219 7.7319 0.0 0
M  V30 20 H 0.0000 3.1542 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 17 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 18 CFG=3
M  V30 14 2 9 13
M  V30 15 1 10 14 CFG=1
M  V30 16 1 10 15
M  V30 17 1 10 19
M  V30 18 1 11 14 CFG=1
M  V30 19 1 11 16
M  V30 20 1 11 20
M  V30 21 1 12 13
M  V30 22 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 7 8 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 881689-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240504-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9895471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 3-Formyl-exo-3,4-diazatricyclo[5.2.1.02,6]dec-4-ene-5-carboxylate
(8). A solution of the pyrazoline 1 (0.8 g, 4.12 mmol) in HCOOH (15 ml)
was boiled for 2 h in the presence of 0.08 g of 5% Pd/C with vigorous
stirring. The cooled reaction mixture was filtered, and the filtrate was
evaporated at reduced pressure. We obtained 0.98 g (98%) of compound 8 in
the form of colorless crystals; mp 86-87°C (HCO2H). IR spectrum, ν, cm-1
: 724, 952, 1114, 1318, 1372, 1456, 1690, 2848-2926. 1H NMR spectrum, δ,
ppm (J, Hz): 1.22 (2H, s, H-10); 1.27-1.37 (2H, m, H endo -8 and H endo
-9); 1.56-1.60 (2H, m, H exo -9 and H exo -8); 2.63 (1H, br. s, H-7);
2.84 (1H, br. s, H-1); 3.31 (1H, d, 3 J 6,2= 8.8, H-6); 3.87 (3H, s,
CH3); 4.25 (1H, d, 3 J 6,2= 8.8, H-2); 8.84 (1H, s, CHO). 13C NMR
spectrum, δ, ppm: 24.32 (C-9); 27.35 (C-8); 32.55 (C-10); 40.12 (C-7);
40.95 (C-1); 52.73 (CH3); 54.55 (C-6); 64.84 (C-2); 151.12 (C-5); 161.23
(CHO); 161.69 (CO2). Found, %: C 59.31; H 6.40; N 12.60. C11H14N2O3.
Calculated, %: C 59.45; H 6.35; N 12.61.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic hydrogenation of methyl
3,4-diazatricyclo-[5.2.1.02,6]dec-4-ene-5-carboxylate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorpinchenko, V. A.; Petrov, D. V.; Khursan, S. L.; Dokichev, V. A.;
Tomilov, Yu. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2009),
45(9), 1039-1046

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-5-fluoro-, methyl ester
C8H8FNO2
884497-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 F 0.0000 4.6200 0.0 0
M  V30 6 N 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-fluoro-5-(formylamino)benzoate
C9H8FNO3
2279975-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 3.8501 0.0 0
M  V30 3 O 2.6673 6.1601 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 O 10.6697 4.6201 0.0 0
M  V30 8 F 5.3348 0.0000 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 884497-46-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2279975-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Thia-2,5,9-triazaundecanedioic acid, 10-[2-(methylthio)ethyl]-4-oxo-3-(phen...
C22H35N3O7S2
885695-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 8.0020 0.0 0 CFG=2
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 7.7000 8.0020 0.0 0
M  V30 4 N 5.3900 6.6684 0.0 0
M  V30 5 N 8.4700 6.6684 0.0 0
M  V30 6 O 8.4700 9.3358 0.0 0
M  V30 7 C 3.8500 6.6684 0.0 0
M  V30 8 C 10.0100 6.6684 0.0 0
M  V30 9 O 3.0800 5.3347 0.0 0
M  V30 10 O 3.0800 8.0020 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 S 12.3200 5.3347 0.0 0 VAL=6
M  V30 14 C 1.5400 3.7947 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 1.5400 6.8747 0.0 0
M  V30 17 N 13.8600 5.3347 0.0 0
M  V30 18 O 12.3200 3.7947 0.0 0
M  V30 19 O 12.3200 6.8747 0.0 0
M  V30 20 C 14.6300 4.0009 0.0 0 CFG=2
M  V30 21 C 16.1700 4.0009 0.0 0
M  V30 22 C 13.8600 2.6673 0.0 0
M  V30 23 C 16.9400 5.3347 0.0 0
M  V30 24 O 14.6300 1.3336 0.0 0
M  V30 25 O 12.3200 2.6673 0.0 0
M  V30 26 S 18.4800 5.3347 0.0 0
M  V30 27 C 13.8600 0.0000 0.0 0
M  V30 28 C 19.2500 6.6684 0.0 0
M  V30 29 C 6.1600 10.6694 0.0 0
M  V30 30 C 7.7000 10.6694 0.0 0
M  V30 31 C 5.3900 12.0031 0.0 0
M  V30 32 C 8.4700 12.0031 0.0 0
M  V30 33 C 6.1600 13.3367 0.0 0
M  V30 34 C 7.7000 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 29
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 2 13 19
M  V30 20 1 17 20
M  V30 21 1 20 21 CFG=1
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 26 28
M  V30 29 2 29 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 2 31 33
M  V30 33 2 32 34
M  V30 34 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
8-Thia-2,5,9-triazaundecan-11-oic acid, 10-[2-(methylthio)ethyl]-1,4-dioxo-3-...
C18H27N3O6S2
885695-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.8600 4.0011 0.0 0 CFG=1
M  V30 2 N 13.0900 5.3347 0.0 0
M  V30 3 C 13.0900 2.6673 0.0 0
M  V30 4 C 15.4000 4.0011 0.0 0
M  V30 5 S 11.5500 5.3347 0.0 0 VAL=6
M  V30 6 O 13.8600 1.3336 0.0 0
M  V30 7 O 11.5500 2.6673 0.0 0
M  V30 8 C 16.1700 5.3347 0.0 0
M  V30 9 C 10.0100 5.3347 0.0 0
M  V30 10 O 11.5500 6.8747 0.0 0
M  V30 11 O 11.5500 3.7947 0.0 0
M  V30 12 C 13.0900 0.0000 0.0 0
M  V30 13 S 17.7100 5.3347 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 18.4800 6.6684 0.0 0
M  V30 16 N 7.7000 6.6684 0.0 0
M  V30 17 C 6.9300 8.0020 0.0 0
M  V30 18 C 5.3900 8.0020 0.0 0 CFG=1
M  V30 19 O 7.7000 9.3358 0.0 0
M  V30 20 C 4.6200 6.6684 0.0 0
M  V30 21 N 4.6200 9.3358 0.0 0
M  V30 22 C 5.3900 10.6694 0.0 0
M  V30 23 O 4.6200 12.0031 0.0 0
M  V30 24 C 3.0800 6.6684 0.0 0
M  V30 25 C 2.3100 8.0020 0.0 0
M  V30 26 C 2.3100 5.3347 0.0 0
M  V30 27 C 0.7700 8.0020 0.0 0
M  V30 28 C 0.7700 5.3347 0.0 0
M  V30 29 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 18 20
M  V30 20 1 18 21 CFG=3
M  V30 21 1 20 24
M  V30 22 1 21 22
M  V30 23 2 22 23
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 885695-40-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 885695-46-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5269497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16357-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Peptide/β-sulfonamidopeptide hybrids: Analogs of the chemotactic agent
for-Met-Leu-Phe-OMe
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giordano, Cesare; Lucente, Gino; Masi, Annalisa; Paradisi, Mario
Paglialunga; Sansone, Anna; Spisani, Susanna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(8), 2642-2652

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzylamine
C7H8ClN
89-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methyl]formamide
C8H8ClNO
86386-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 N 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 Cl 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-97-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86386-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12384437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxyaniline
C7H9NO
90-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 N 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methoxyphenyl)formamide
C8H9NO2
23896-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23896-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4876356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nanoceria-catalyzed highly efficient procedure for N-formylation of
amines at room temperature under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patil, Umakant B.; Singh, Abhilash S.; Nagarkar, Jayashree M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2013), 42(5), 524-526

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [1,1-dimethyl-3-[(phenylmethoxy)amino]propyl]-, diethyl ester
C16H28NO4P
902526-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 2 C 4.7710 5.3350 0.0 0
M  V30 3 O 3.2310 2.6675 0.0 0
M  V30 4 O 2.6673 4.7712 0.0 0
M  V30 5 O 5.3348 3.2311 0.0 0
M  V30 6 C 6.1048 4.5650 0.0 0
M  V30 7 C 3.4374 6.1050 0.0 0
M  V30 8 C 5.5410 6.6687 0.0 0
M  V30 9 C 4.0010 1.3338 0.0 0
M  V30 10 C 1.3337 4.0012 0.0 0
M  V30 11 C 7.4385 5.3350 0.0 0
M  V30 12 C 3.2310 0.0000 0.0 0
M  V30 13 C 0.0000 4.7712 0.0 0
M  V30 14 N 8.7722 4.5650 0.0 0
M  V30 15 O 10.1059 5.3350 0.0 0
M  V30 16 C 11.4397 4.5650 0.0 0
M  V30 17 C 12.7733 5.3350 0.0 0
M  V30 18 C 14.1070 4.5650 0.0 0
M  V30 19 C 12.7733 6.8750 0.0 0
M  V30 20 C 15.4407 5.3350 0.0 0
M  V30 21 C 14.1070 7.6450 0.0 0
M  V30 22 C 15.4407 6.8750 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [3-[formyl(phenylmethoxy)amino]-1,1-dimethylpropyl]-, diethy...
C17H28NO5P
902526-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 4.5648 0.0 0 VAL=5
M  V30 2 C 4.4137 5.3348 0.0 0
M  V30 3 O 1.7464 3.7948 0.0 0
M  V30 4 O 2.3101 5.8986 0.0 0
M  V30 5 O 3.8501 3.2311 0.0 0
M  V30 6 C 5.1838 4.0012 0.0 0
M  V30 7 C 3.6437 6.6687 0.0 0
M  V30 8 C 5.7474 6.1048 0.0 0
M  V30 9 C 1.7464 2.2548 0.0 0
M  V30 10 C 0.7700 5.8986 0.0 0
M  V30 11 C 6.7238 4.0012 0.0 0
M  V30 12 C 0.4126 1.4847 0.0 0
M  V30 13 C 0.0000 7.2323 0.0 0
M  V30 14 N 7.4938 2.6675 0.0 0
M  V30 15 O 9.0338 2.6675 0.0 0
M  V30 16 C 6.7238 1.3337 0.0 0
M  V30 17 C 9.8039 4.0012 0.0 0
M  V30 18 O 7.4938 0.0000 0.0 0
M  V30 19 C 11.3439 4.0012 0.0 0
M  V30 20 C 12.1139 5.3348 0.0 0
M  V30 21 C 12.1139 2.6675 0.0 0
M  V30 22 C 13.6539 5.3348 0.0 0
M  V30 23 C 13.6539 2.6675 0.0 0
M  V30 24 C 14.4240 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 902526-34-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 902526-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8932538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimalarial activity of chain substituted
pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurz, Thomas; Schlueter, Katrin; Kaula, Uwe; Bergmann, Baerbel; Walter,
Rolf D.; Geffken, Detlef
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(15), 5121-5135

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [1-(2-fluorophenyl)-3-[(phenylmethoxy)amino]propyl]-, diethy...
C20H27FNO4P
902526-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0012 4.0010 0.0 0 VAL=5
M  V30 2 C 5.3348 4.7710 0.0 0
M  V30 3 O 2.6675 3.2310 0.0 0
M  V30 4 O 4.7712 2.6673 0.0 0
M  V30 5 O 3.2311 5.3348 0.0 0
M  V30 6 C 6.6687 4.0010 0.0 0
M  V30 7 C 1.3338 4.0010 0.0 0
M  V30 8 C 4.0012 1.3337 0.0 0
M  V30 9 C 8.0023 4.7710 0.0 0
M  V30 10 C 0.0000 3.2310 0.0 0
M  V30 11 C 4.7712 0.0000 0.0 0
M  V30 12 N 9.3360 4.0010 0.0 0
M  V30 13 O 10.6698 4.7710 0.0 0
M  V30 14 C 12.0035 4.0010 0.0 0
M  V30 15 F 8.0023 6.3111 0.0 0
M  V30 16 C 5.3348 6.3111 0.0 0
M  V30 17 C 6.6687 7.0811 0.0 0
M  V30 18 C 4.0012 7.0811 0.0 0
M  V30 19 C 6.6687 8.6211 0.0 0
M  V30 20 C 4.0012 8.6211 0.0 0
M  V30 21 C 5.3348 9.3911 0.0 0
M  V30 22 C 13.3372 4.7710 0.0 0
M  V30 23 C 13.3372 6.3111 0.0 0
M  V30 24 C 14.6708 4.0010 0.0 0
M  V30 25 C 14.6708 7.0811 0.0 0
M  V30 26 C 16.0046 4.7710 0.0 0
M  V30 27 C 16.0046 6.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 16
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 22
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [1-(2-fluorophenyl)-3-[formyl(phenylmethoxy)amino]propyl]-, ...
C21H27FNO5P
902526-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 5.3901 0.0 0
M  V30 2 P 4.0010 3.8501 0.0 0 VAL=5
M  V30 3 C 5.3348 6.1601 0.0 0
M  V30 4 O 4.0010 2.3101 0.0 0
M  V30 5 O 2.4610 3.8501 0.0 0
M  V30 6 O 5.5410 3.8501 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 1.6910 2.5164 0.0 0
M  V30 10 N 8.0022 6.1601 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 0.1509 2.5164 0.0 0
M  V30 13 O 9.3358 5.3901 0.0 0
M  V30 14 C 8.0022 7.7002 0.0 0
M  V30 15 C 10.6697 6.1601 0.0 0
M  V30 16 O 9.3358 8.4702 0.0 0
M  V30 17 F 4.0010 8.4702 0.0 0
M  V30 18 C 2.6673 6.1601 0.0 0
M  V30 19 C 2.6673 7.7002 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 21 C 1.3337 8.4702 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 23 C 0.0000 7.7002 0.0 0
M  V30 24 C 12.0033 5.3901 0.0 0
M  V30 25 C 12.0033 3.8501 0.0 0
M  V30 26 C 13.3370 6.1601 0.0 0
M  V30 27 C 13.3370 3.0801 0.0 0
M  V30 28 C 14.6707 5.3901 0.0 0
M  V30 29 C 14.6707 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 24
M  V30 18 1 17 19
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 902526-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 902526-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5261496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimalarial activity of chain substituted
pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurz, Thomas; Schlueter, Katrin; Kaula, Uwe; Bergmann, Baerbel; Walter,
Rolf D.; Geffken, Detlef
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(15), 5121-5135

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N2-methyl-5-nitro-1,2-benzenediamine
C8H11N3O3
928406-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 2.3100 0.0 0
M  V30 2 C 8.0022 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 6.6686 5.3901 0.0 0
M  V30 6 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 7 O 1.3337 6.9301 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 5.3348 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-1-methyl-5-nitro-1H-benzimidazole
C9H9N3O3
928406-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6507 1.3337 0.0 0
M  V30 2 C 3.4207 0.0000 0.0 0
M  V30 3 C 0.0000 3.2907 0.0 0
M  V30 4 N 7.2708 4.0012 0.0 0 VAL=5
M  V30 5 O 8.0408 2.6673 0.0 0
M  V30 6 O 8.0408 5.3348 0.0 0
M  V30 7 C 3.4207 5.3348 0.0 0
M  V30 8 C 2.6507 4.0012 0.0 0
M  V30 9 C 4.9608 5.3348 0.0 0
M  V30 10 N 2.3903 6.4792 0.0 0
M  V30 11 C 3.4207 2.6673 0.0 0
M  V30 12 N 1.1444 4.3213 0.0 0
M  V30 13 C 5.7308 4.0012 0.0 0
M  V30 14 C 0.9835 5.8529 0.0 0
M  V30 15 C 4.9608 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928406-26-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928406-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-14782642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibition of cobalamin-dependent methionine synthase by substituted
benzo-fused heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banks, Elizabeth C.; Doughty, Stephen W.; Toms, Steven M.; Wheelhouse,
Richard T.; Nicolaou, Anna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM FEBS Journal (2007), 274(1), 287-299

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl 4-aminobenzoate
C11H15NO2
94-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 N 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl 4-(formylamino)benzoate
C12H15NO3
205810-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 9.3358 2.3101 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 10.6697 1.5400 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 C 13.3370 1.5400 0.0 0
M  V30 7 C 14.6707 2.3101 0.0 0
M  V30 8 N 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 O 0.0000 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205810-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7629840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [83] <Example 4> [84] Preparation of
N-4-butoxycarbonylphenyl-N'-4-ethoxycarbonylphenyl-N-3,5-di-tert-butyl-4-hydroxybenzylformamidine
[85] 17.4g of benzocaine was dissolved in 20 ml of toluene at 43°C + 3°C
with stirring, and then 5.4 ml of formic acid was added dropwise thereto.
The mixture was reacted at 100°C + 5°C for 2 hours, and water was removed
from the reaction mixture. Thereafter, the reaction mixture was allowed
to cool to room temperature, filtered, and washed with water to obtain
19.6g (yield: 98%) of a solid product (a).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylformamidine derivatives as ultraviolet light
absorbers for plastic products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Byung-Il
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005115973 A1 2005-12-08

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-amine
C6H5BrN4
947248-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.9110 1.5400 0.0 0
M  V30 2 Br 0.0000 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 N 4.0011 2.3100 0.0 0
M  V30 5 N 5.4658 0.2941 0.0 0
M  V30 6 C 2.6674 0.0000 0.0 0
M  V30 7 N 5.4658 2.7859 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 6.3710 1.5400 0.0 0
M  V30 10 C 1.3338 0.7700 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 9
M  V30 11 2 8 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-yl)formamide
C7H5BrN4O
1456778-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.6211 3.9554 0.0 0
M  V30 2 C 8.9550 3.1854 0.0 0
M  V30 3 O 10.2886 3.9554 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 N 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 N 4.8807 3.8119 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 N 6.1265 1.6538 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 6.2875 3.1854 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 2 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 947248-68-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456778-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1227808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anticancer activity evaluation of a series of
[1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiao-Meng; Xu, Jing; Li, Yi-Ping; Li, Huan; Jiang, Cong-Shan; Yang,
Guang-De; Lu, She-Min; Zhang, San-Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 67243-251

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-methyl-1,2-benzenediamine
C7H9BrN2
952511-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 N 4.6201 0.0000 0.0 0
M  V30 3 Br 0.0000 2.6673 0.0 0
M  V30 4 N 6.1601 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 1.5400 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-7-methyl-1H-benzimidazole
C8H7BrN2
952511-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7036 0.0000 0.0 0
M  V30 2 Br 6.3710 1.5400 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 3.8500 0.0 0
M  V30 5 C 3.7036 1.5400 0.0 0
M  V30 6 N 0.9052 1.8341 0.0 0
M  V30 7 C 3.7036 4.6200 0.0 0
M  V30 8 N 0.9052 4.3259 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 952511-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 952511-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-5013392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM step 3: A mixture of 156 (28 g,140 mmol), formic acid (240 mL) and 37%
concentrated HCl (400 mL) was heated to 60 °C for 12 h, cooled in an
ice-water bath, and the pH slowly adjusted to 8-9 with 28% concentrated
NH4OH. The solid was collected by filtration, washed with water and dried
in air to afford 5-bromo-4-methyl-1H-benzo[d]imidazole (158). Yellow
solid, yield 25 g (98%). MS (ESI) m/z = 213 [M+1]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoimidazolylmethylpyrimidinediamine derivatives and
analogs for use as serine/threonine PAK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aliagas-Martin, Ignacio; Crawford, James; Lee, Wendy; Mathieu, Simon;
Rudolph, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013026914 A1 2013-02-28

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminophenol
C6H7NO
95-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyphenyl)formamide
C7H7NO2
2843-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2843-27-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1118742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75383-74-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Guanidine derived ionic liquids: catalyst free medium for N-formylation
of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akbari, Jafar; Hekmati, Malak; Sheykhan, Mehdi; Heydari, Akbar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2009), (11), 123-129

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Aminophenol
C6H7NO
95-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyphenyl)formamide
C7H7NO2
2843-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2843-27-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8920725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1317-38-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, optimization study, optimized on catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macroporous metal oxides as an efficient heterogeneous catalyst for
various organic transformations-A comparative study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thakuria, Harjyoti; Borah, Ballav Moni; Das, Gopal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2007), 274(1-2), 1-10

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromophenol
C6H5BrO
95-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol, 2-bromo-, 1-formate
C7H5BrO2
4619-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-56-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4619-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35315849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium(II)-catalyzed Regioselective Hydroesterification of
1,3-Conjugated Enynes with Aryl Formates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Xia-Bin; Wang, Sheng; Xu, Teng; Chen, Shanshan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(4), 587-591

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dichloroaniline
C6H5Cl2N
95-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 N 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dichlorophenyl)formamide
C7H5Cl2NO
5470-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 Cl 1.5400 0.0000 0.0 0
M  V30 5 Cl 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95-76-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17922217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1715923-43-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM SBA-15 supported
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, no solvent, recyclable
catalyst used, SBA-15 support used, ionic liquid used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mesoporous silica SBA-15 functionalized with acidic deep eutectic
solvent: A highly active heterogeneous N-formylation catalyst under
solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Azizi, Najmedin; Edrisi, Mahtab; Abbasi, Faezeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2018), 32(1), n/a

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-2-nitroaniline
C7H8N2O3
96-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxybenzimidazole
C8H8N2O
4887-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-96-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4887-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-13765371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Experimental Procedure
1H-Benzo[d]imidazole15 (1): A 40 mL glass vial was charged with
o-nitroaniline (0.138 g, 1.00 mmol), iron powder 325 mesh (0.558 g, 10.0
mmol), NH4Cl (0.535 g, 10.0 mmol), and a magnetic stir bar. 2-PrOH (5.0
mL) and formic acid (5.0 mL) were added, and the reaction vial was sealed
with a Teflon-lined cap. The reaction mixture was stirred at 80 °C for 1
h at which time LC-MS analysis indicated that conversion into the product
was complete. The reaction mixture was diluted with 2-PrOH (10 mL) and
filtered to remove insoluble materials. The filtrate was concentrated to
dryness, and the resulting residue partitioned between CH2Cl2 (20 mL) and
(5 mL) sat. aq NaHCO3. The aqueous layer was extracted with additional
CH2Cl2 (5 x 20 mL). The combined organic extracts were dried over MgSO4,
filtered, and concentrated. 5-Ethoxy-1H-benzo[d]imidazole (5). ESI-MS:
m/z = 163.0 [M + H]+. 1H NMR (400 MHz, DMSO, reported as a mixture of
tautomers): δ = 12.25 (br s, 0.4 H), 12.20 (br s, 0.6 H), 8.10 (br s, 0.4
H), 8.04 (br s, 0.6 H), 7.49 (br d, J = 8.8 Hz, 0.6 H), 7.38 (br d, J =
8.2 Hz, 0.4 H), 7.14 (br s, 0.4 H), 6.98 (br s, 0.6 H), 6.83-6.77 (m, 1
H), 4.03 (q, J = 6.9 Hz, 2 H), 1.34 (t, J = 6.9 Hz, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild and general one-pot reduction and cyclization of aromatic and
heteroaromatic 2-nitroamines to bicyclic 2H-imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanan, Emily J.; Chan, Bryan K.; Estrada, Anthony A.; Shore, Daniel G.;
Lyssikatos, Joseph P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2010), (18), 2759-2764

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N′-(2-Methylpropyl)quinoline-3,4-diamine
C13H17N3
99010-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 8.0021 2.3100 0.0 0
M  V30 4 C 8.0021 0.7700 0.0 0
M  V30 5 C 9.3358 3.0800 0.0 0
M  V30 6 N 5.3347 5.3900 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 N 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3336 0.0000 0.0 0
M  V30 15 C 2.6674 5.3900 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinoline
C14H15N3
99010-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9415 1.7847 0.0 0
M  V30 2 C 7.4479 1.4645 0.0 0
M  V30 3 C 8.4784 2.6091 0.0 0
M  V30 4 C 7.9238 0.0000 0.0 0
M  V30 5 C 4.0011 3.7253 0.0 0
M  V30 6 C 2.6673 2.9553 0.0 0
M  V30 7 C 4.0011 5.2653 0.0 0
M  V30 8 N 5.4656 3.2494 0.0 0
M  V30 9 C 1.3336 3.7253 0.0 0
M  V30 10 C 2.6673 1.4153 0.0 0
M  V30 11 N 5.4656 5.7411 0.0 0
M  V30 12 C 2.6673 6.0353 0.0 0
M  V30 13 C 6.3709 4.4953 0.0 0
M  V30 14 N 1.3336 5.2653 0.0 0
M  V30 15 C 0.0000 2.9553 0.0 0
M  V30 16 C 1.3336 0.6453 0.0 0
M  V30 17 C 0.0000 1.4153 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 2 11 13
M  V30 17 2 12 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99010-09-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99010-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-4922228
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 1-Isobutyl-1H- imidazo-[4,5-c]-quinoline (II) Dissolve
3-Amino-4-isobutyl amino quinoline (215 gm, 1.0 mole) in formic acid (1.0
L) and reflux the reaction mass to 110-115 °C. Maintain refluxing for
8-10 h. On completion of reaction remove excess formic acid under reduced
pressure and add 3.5 L of water to the concentrated mass. Basify this
diluted mass with 30 % NaOH to pH 10-11 at 20 °C. Cool the reaction mass
to 10 °C and stir for further 3 h to obtain solid product. Filter the
solid, wash with water and dry to get the title compound as a white
solid. Yield: 221 gm, 98 % M.P. 91 to 94°C MS - (m/z) M+ 226 1HNMR(200
MHz, DMSO D6) δ values: 0,95 (6H, d, CH3 x 2), 2.1-2.2 (1H, m, -CH2), 4.5
(2H. d, CH2), 7,7 (2H, m, Ar), 8.2-8,3 (2H, m, Ar), 8.4 (1H, s,
>N-CH=N-), 9.25 (1H, s, -N-CH=N-)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of substantially pure
4-amino-1-isobutyl-1H-imidazo[4,5-c]-quinoline (imiquimod)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tarur, Venkatasubramanian Radhakrishnan; Kadam, Suresh Mahadev; Joshi,
Anil Purushottam; Gavhane, Sachin Baban
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006070408 A2 2006-07-06

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N′-(2-Methylpropyl)quinoline-3,4-diamine
C13H17N3
99010-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 8.0021 2.3100 0.0 0
M  V30 4 C 8.0021 0.7700 0.0 0
M  V30 5 C 9.3358 3.0800 0.0 0
M  V30 6 N 5.3347 5.3900 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 N 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3336 0.0000 0.0 0
M  V30 15 C 2.6674 5.3900 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinoline
C14H15N3
99010-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9415 1.7847 0.0 0
M  V30 2 C 7.4479 1.4645 0.0 0
M  V30 3 C 8.4784 2.6091 0.0 0
M  V30 4 C 7.9238 0.0000 0.0 0
M  V30 5 C 4.0011 3.7253 0.0 0
M  V30 6 C 2.6673 2.9553 0.0 0
M  V30 7 C 4.0011 5.2653 0.0 0
M  V30 8 N 5.4656 3.2494 0.0 0
M  V30 9 C 1.3336 3.7253 0.0 0
M  V30 10 C 2.6673 1.4153 0.0 0
M  V30 11 N 5.4656 5.7411 0.0 0
M  V30 12 C 2.6673 6.0353 0.0 0
M  V30 13 C 6.3709 4.4953 0.0 0
M  V30 14 N 1.3336 5.2653 0.0 0
M  V30 15 C 0.0000 2.9553 0.0 0
M  V30 16 C 1.3336 0.6453 0.0 0
M  V30 17 C 0.0000 1.4153 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 2 11 13
M  V30 17 2 12 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99010-09-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99010-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-754878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 1-Isobutyl-1H-imidazo-[4,5-c]-quinoline (II)
3-Amino-4-isobutyl amino quinoline (215 gm, 1.0 mole) was dissolved in
formic acid (1000 ml) and further refluxed the reaction mass to 110
-115°C. Reflux was maintained for 8 -10 hrs. After completion of reaction
excess formic acid was removed under reduced pressure and 3.5 L of water
was added to the concentrated mass. This diluted mass was then basified
with 30% NaOH to pH (10 to 11) at 20°C. The reaction mass was further
cooled to 10°C and stirred for further 3 hrs to obtain solid. The solid
was filtered, washed with water and dried to get the title compound (221
gm, 98 %) as a white solid. M.P. 91 to 94°C MS -(m/z) M+ 226
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of
4-amino-1-isobutyl-1H-imidazo[4,5-c]-quinoline (imiquimod)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tarur, Venkatasubramanian Radhakrishnan; Kadam, Suresh Mahadev; Joshi,
Anil Purushottam; Gavhane, Sachin Baban
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006070379 A1 2006-07-06

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Aminoacetophenone
C8H9NO
99-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Acetylphenyl)formamide
C9H9NO2
41656-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-92-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41656-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9402179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nanoceria-catalyzed highly efficient procedure for N-formylation of
amines at room temperature under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patil, Umakant B.; Singh, Abhilash S.; Nagarkar, Jayashree M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2013), 42(5), 524-526

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4-Dimethyl-2-pentyne
C7H12
999-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 C 4.6200 1.5400 0.0 0
M  V30 4 C 1.5400 3.0800 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-2,4,4-Trimethyl-2-pentenoic acid
C8H14O2
60065-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 O 5.3348 0.0000 0.0 0
M  V30 7 O 6.6687 2.3101 0.0 0
M  V30 8 C 0.5638 0.9764 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 2.1038 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 999-78-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60065-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-263-CAS-21081364
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1538-75-6
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 13991-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-Catalyzed Regio- and Stereoselective Hydrocarboxylation of Alkynes
with Formic Acid through Catalytic CO Recycling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fu, Ming-Chen; Shang, Rui; Cheng, Wan-Min; Fu, Yao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2016), 6(4), 2501-2505

$RFMT $RIREG SCHEME303 STEP1
$RXN



  3  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Hydroxyethyl)aniline
C8H11NO
122-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenoxyethanol
C8H10O2
122-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(phenylamino)-, 1-formate
C9H11NO2
52487-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-phenoxy-, 1-formate
C9H10O3
58214-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-98-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 122-99-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52487-25-9
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 58214-97-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24457292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  2
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxy-2-oxo-2H-1-benzopyran-3-yl)acetamide
C11H9NO4
13948-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0
M  V30 3 C 8.0023 2.3101 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 O 4.0012 4.6201 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-hydroxycoumarin
C9H7NO3
5725-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 O 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 O 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 10
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Hydroxy-2-oxo-2H-1-benzopyran-3-yl)formamide
C10H7NO4
900330-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 O 6.6685 4.6201 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 9.3360 1.5400 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 O 4.0012 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13948-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5725-79-1
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 900330-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-23488090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 2
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation (44W), optimization study, optimized on reaction
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot Synthesis of 2-Substituted 4H-Chromeno[3,4-d]oxazol-4-ones from
4-Hydroxy-3-nitrocoumarin and Acids in the Presence of Triphenylphosphine
and Phosphorus Pentoxide under Microwave Irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balalas, T. D.; Stratidis, G.; Papatheodorou, D.; Vlachou, E.-E.;
Gabriel, C.; Hadjipavlou-Litina, D. J.; Litinas, K. E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM SynOpen (2018), 2(2), 0105-0113

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-[2-oxo-2-[(triphenylmethoxy)amino]ethyl]-N-(phenylmethyl)glycy...
C37H37N5O5.CH2O2
1333227-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 10.3122 0.0 0
M  V30 2 O 6.1600 10.3122 0.0 0
M  V30 3 N 6.9300 8.9785 0.0 0
M  V30 4 C 8.4700 8.9785 0.0 0
M  V30 5 C 9.2400 7.6447 0.0 0
M  V30 6 O 9.2400 10.3122 0.0 0
M  V30 7 N 10.7800 7.6447 0.0 0
M  V30 8 C 11.5500 6.3111 0.0 0
M  V30 9 C 11.5500 8.9785 0.0 0
M  V30 10 C 13.0900 8.9785 0.0 0
M  V30 11 N 13.8600 10.3122 0.0 0
M  V30 12 O 13.8600 7.6447 0.0 0
M  V30 13 C 15.4000 10.3122 0.0 0 CFG=2
M  V30 14 C 16.1700 8.9785 0.0 0
M  V30 15 C 16.1700 11.6458 0.0 0
M  V30 16 O 15.4000 12.9794 0.0 0
M  V30 17 O 17.7100 11.6458 0.0 0
M  V30 18 C 16.1700 14.3132 0.0 0
M  V30 19 C 4.6200 8.7722 0.0 0
M  V30 20 C 3.2864 8.0022 0.0 0
M  V30 21 C 5.9536 8.0022 0.0 0
M  V30 22 C 3.2864 6.4622 0.0 0
M  V30 23 C 5.9536 6.4622 0.0 0
M  V30 24 C 4.6200 5.6922 0.0 0
M  V30 25 C 3.0800 10.3122 0.0 0
M  V30 26 C 2.3100 11.6458 0.0 0
M  V30 27 C 2.3100 8.9785 0.0 0
M  V30 28 C 0.7700 11.6458 0.0 0
M  V30 29 C 0.7700 8.9785 0.0 0
M  V30 30 C 0.0000 10.3122 0.0 0
M  V30 31 C 4.6200 11.8522 0.0 0
M  V30 32 C 5.9536 12.6222 0.0 0
M  V30 33 C 3.2864 12.6222 0.0 0
M  V30 34 C 5.9536 14.1622 0.0 0
M  V30 35 C 3.2864 14.1622 0.0 0
M  V30 36 C 4.6200 14.9322 0.0 0
M  V30 37 C 10.7800 4.9775 0.0 0
M  V30 38 C 9.2400 4.9775 0.0 0
M  V30 39 C 11.5500 3.6437 0.0 0
M  V30 40 C 8.4700 3.6437 0.0 0
M  V30 41 C 10.7800 2.3100 0.0 0
M  V30 42 C 9.2400 2.3100 0.0 0
M  V30 43 C 17.7100 8.9785 0.0 0
M  V30 44 C 18.6152 7.7325 0.0 0
M  V30 45 N 18.6152 10.2244 0.0 0
M  V30 46 N 20.0798 8.2085 0.0 0
M  V30 47 C 20.0798 9.7485 0.0 0
M  V30 48 C 10.0399 0.0000 0.0 0
M  V30 49 O 8.7062 0.7700 0.0 0
M  V30 50 O 11.3735 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 1 31
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 2 4 6
M  V30 9 1 5 7
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 8 37
M  V30 13 1 9 10
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 11 13
M  V30 17 1 13 14 CFG=3
M  V30 18 1 13 15
M  V30 19 1 14 43
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 16 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 2 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 2 46 47
M  V30 52 1 48 49
M  V30 53 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-[2-(hydroxyamino)-2-oxoethyl]-N-(phenylmethyl)glycyl-, methyl ...
C18H23N5O5.2C2HF3O2
1333227-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 10.5185 0.0 0
M  V30 2 C 3.0800 10.5185 0.0 0
M  V30 3 C 5.3900 11.8521 0.0 0
M  V30 4 C 5.3900 9.1848 0.0 0
M  V30 5 C 6.9300 11.8521 0.0 0
M  V30 6 C 4.6200 7.8510 0.0 0
M  V30 7 N 7.7000 13.1858 0.0 0
M  V30 8 O 7.7000 10.5185 0.0 0
M  V30 9 N 5.3900 6.5174 0.0 0
M  V30 10 O 3.0800 7.8510 0.0 0
M  V30 11 C 9.2400 13.1858 0.0 0 CFG=2
M  V30 12 O 4.6200 5.1837 0.0 0
M  V30 13 C 10.0101 11.8521 0.0 0
M  V30 14 C 10.0101 14.5196 0.0 0
M  V30 15 O 9.2400 15.8532 0.0 0
M  V30 16 O 11.5501 14.5196 0.0 0
M  V30 17 C 10.0101 17.1869 0.0 0
M  V30 18 C 2.3100 11.8521 0.0 0
M  V30 19 C 0.7700 11.8521 0.0 0
M  V30 20 C 3.0800 13.1858 0.0 0
M  V30 21 C 0.0000 13.1858 0.0 0
M  V30 22 C 2.3100 14.5196 0.0 0
M  V30 23 C 0.7700 14.5196 0.0 0
M  V30 24 C 11.5501 11.8521 0.0 0
M  V30 25 C 12.4553 13.0980 0.0 0
M  V30 26 N 12.4553 10.6062 0.0 0
M  V30 27 N 13.9198 12.6221 0.0 0
M  V30 28 C 13.9198 11.0821 0.0 0
M  V30 29 C 6.2931 2.3101 0.0 0
M  V30 30 C 7.6267 1.5400 0.0 0
M  V30 31 F 7.0631 3.6437 0.0 0
M  V30 32 F 4.9594 3.0801 0.0 0
M  V30 33 F 5.5231 0.9764 0.0 0
M  V30 34 O 8.9604 2.3101 0.0 0
M  V30 35 O 7.6267 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13 CFG=3
M  V30 14 1 11 14
M  V30 15 1 13 24
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 2 30 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333227-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-2966077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Exemple 7: synthesis of final products
according to the invention (67-82). General procedure for deprotection
(67-82): The tritylated compound or t-Bu-squaric derivative was
deprotected in DCM with TFA (5-50% volume). Triisopropylsilane was added
until the yellow solution became colorless. The mixture was stirred at
room temperature for 1H. The solvent was evaporated and the crude product
was triturated in diethyl ether and purified by preparative HPLC if
necessary. Reactant:
(S)-2-[2-(Carboxymethyl-pyridin-4-ylmethyl-amino)-acetylamino]-3-(1-trityl-1H-imidazol-4-yl)-propionic
acid methyl ester (59). Reactant:
(S)-2-[2-(Benzyl-hydroxycarbamoylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (61).
(S)-2-[2-(Benzyl-hydroxycarbamoylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (78).2CF3COOH was obtained as a white powder (98%).
Purity 100%. 1H NMR (DMSO) δ ppm: 10.66 (s, 1H), 8.97 (d, J=1.2Hz, 1H),
8.68 (d, J= 8.1Hz, 1H), 7.38-7.30 (m, 5H), 4.71 (m, 1H), 3.72 (s, 2H),
3.64 (s, 3H), 3.22-3.15 (m, 5H), 3.08 (dd, J= 9.2 and 15.3 Hz, 1H). LC
tR=2.6 min, MS (ESI+): m/z=390 (M+H)+. IC50: 3.4 μM. pIC50: 5.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2371421 A1 2011-10-05

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-[2-oxo-2-[(triphenylmethoxy)amino]ethyl]-N-(phenylmethyl)glycy...
C37H37N5O5.CH2O2
1333227-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 10.3122 0.0 0
M  V30 2 O 6.1600 10.3122 0.0 0
M  V30 3 N 6.9300 8.9785 0.0 0
M  V30 4 C 8.4700 8.9785 0.0 0
M  V30 5 C 9.2400 7.6447 0.0 0
M  V30 6 O 9.2400 10.3122 0.0 0
M  V30 7 N 10.7800 7.6447 0.0 0
M  V30 8 C 11.5500 6.3111 0.0 0
M  V30 9 C 11.5500 8.9785 0.0 0
M  V30 10 C 13.0900 8.9785 0.0 0
M  V30 11 N 13.8600 10.3122 0.0 0
M  V30 12 O 13.8600 7.6447 0.0 0
M  V30 13 C 15.4000 10.3122 0.0 0 CFG=2
M  V30 14 C 16.1700 8.9785 0.0 0
M  V30 15 C 16.1700 11.6458 0.0 0
M  V30 16 O 15.4000 12.9794 0.0 0
M  V30 17 O 17.7100 11.6458 0.0 0
M  V30 18 C 16.1700 14.3132 0.0 0
M  V30 19 C 4.6200 8.7722 0.0 0
M  V30 20 C 3.2864 8.0022 0.0 0
M  V30 21 C 5.9536 8.0022 0.0 0
M  V30 22 C 3.2864 6.4622 0.0 0
M  V30 23 C 5.9536 6.4622 0.0 0
M  V30 24 C 4.6200 5.6922 0.0 0
M  V30 25 C 3.0800 10.3122 0.0 0
M  V30 26 C 2.3100 11.6458 0.0 0
M  V30 27 C 2.3100 8.9785 0.0 0
M  V30 28 C 0.7700 11.6458 0.0 0
M  V30 29 C 0.7700 8.9785 0.0 0
M  V30 30 C 0.0000 10.3122 0.0 0
M  V30 31 C 4.6200 11.8522 0.0 0
M  V30 32 C 5.9536 12.6222 0.0 0
M  V30 33 C 3.2864 12.6222 0.0 0
M  V30 34 C 5.9536 14.1622 0.0 0
M  V30 35 C 3.2864 14.1622 0.0 0
M  V30 36 C 4.6200 14.9322 0.0 0
M  V30 37 C 10.7800 4.9775 0.0 0
M  V30 38 C 9.2400 4.9775 0.0 0
M  V30 39 C 11.5500 3.6437 0.0 0
M  V30 40 C 8.4700 3.6437 0.0 0
M  V30 41 C 10.7800 2.3100 0.0 0
M  V30 42 C 9.2400 2.3100 0.0 0
M  V30 43 C 17.7100 8.9785 0.0 0
M  V30 44 C 18.6152 7.7325 0.0 0
M  V30 45 N 18.6152 10.2244 0.0 0
M  V30 46 N 20.0798 8.2085 0.0 0
M  V30 47 C 20.0798 9.7485 0.0 0
M  V30 48 C 10.0399 0.0000 0.0 0
M  V30 49 O 8.7062 0.7700 0.0 0
M  V30 50 O 11.3735 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 1 31
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 2 4 6
M  V30 9 1 5 7
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 8 37
M  V30 13 1 9 10
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 11 13
M  V30 17 1 13 14 CFG=3
M  V30 18 1 13 15
M  V30 19 1 14 43
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 16 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 47 2 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 2 46 47
M  V30 52 1 48 49
M  V30 53 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Histidine, N-[2-(hydroxyamino)-2-oxoethyl]-N-(phenylmethyl)glycyl-, methyl ...
C18H23N5O5.2C2HF3O2
1333227-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 10.5185 0.0 0
M  V30 2 C 3.0800 10.5185 0.0 0
M  V30 3 C 5.3900 11.8521 0.0 0
M  V30 4 C 5.3900 9.1848 0.0 0
M  V30 5 C 6.9300 11.8521 0.0 0
M  V30 6 C 4.6200 7.8510 0.0 0
M  V30 7 N 7.7000 13.1858 0.0 0
M  V30 8 O 7.7000 10.5185 0.0 0
M  V30 9 N 5.3900 6.5174 0.0 0
M  V30 10 O 3.0800 7.8510 0.0 0
M  V30 11 C 9.2400 13.1858 0.0 0 CFG=2
M  V30 12 O 4.6200 5.1837 0.0 0
M  V30 13 C 10.0101 11.8521 0.0 0
M  V30 14 C 10.0101 14.5196 0.0 0
M  V30 15 O 9.2400 15.8532 0.0 0
M  V30 16 O 11.5501 14.5196 0.0 0
M  V30 17 C 10.0101 17.1869 0.0 0
M  V30 18 C 2.3100 11.8521 0.0 0
M  V30 19 C 0.7700 11.8521 0.0 0
M  V30 20 C 3.0800 13.1858 0.0 0
M  V30 21 C 0.0000 13.1858 0.0 0
M  V30 22 C 2.3100 14.5196 0.0 0
M  V30 23 C 0.7700 14.5196 0.0 0
M  V30 24 C 11.5501 11.8521 0.0 0
M  V30 25 C 12.4553 13.0980 0.0 0
M  V30 26 N 12.4553 10.6062 0.0 0
M  V30 27 N 13.9198 12.6221 0.0 0
M  V30 28 C 13.9198 11.0821 0.0 0
M  V30 29 C 6.2931 2.3101 0.0 0
M  V30 30 C 7.6267 1.5400 0.0 0
M  V30 31 F 7.0631 3.6437 0.0 0
M  V30 32 F 4.9594 3.0801 0.0 0
M  V30 33 F 5.5231 0.9764 0.0 0
M  V30 34 O 8.9604 2.3101 0.0 0
M  V30 35 O 7.6267 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13 CFG=3
M  V30 14 1 11 14
M  V30 15 1 13 24
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 2 30 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333227-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333227-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-8462469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for deprotection (67-82):
The tritylated compound or t-Bu-squaric derivative was deprotected in DCM
with TFA (5-50% volume). Triisopropylsilane was added until the yellow
solution became colorless. The mixture was stirred at room temperature
for 1h. The solvent was evaporated and the crude product was triturated
in diethyl ether and purified by preparative HPLC if necessary.
(S)-2-[2-(Benzyl-hydroxycarbamoylmethyl-amino)-acetylamino]-3-(1H-imidazol-4-yl)-propionic
acid methyl ester (78)•2CF3COOH was obtained from (61) as a white powder
(98%). Purity 100%; 1H NMR (DMSO) δ ppm: 10.66 (s, 1H), 8.97 (d, J =
1.2Hz, 1H), 8.68 (d, J = 8.1Hz, 1H), 7.38-7.30 (m, 5H), 4.71 (m, 1H),
3.72 (s, 2H), 3.64 (s, 3H), 3.22-3.15 (m, 5H), 3.08 (dd, J = 9.2 and 15.3
Hz, 1H). LC tR=2.6 min, MS (ESI+): m/z=390 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylcarboxymethylaminoacetylaminoimidazolylpropionic
acid derivatives and analogs for use as insulin degrading enzyme
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deprez-Poulain, Rebecca Franziska; Charton, Julie Jeanne Marine; Deprez,
Benoit Gaston Pierre; Leroux, Florence Catherine Gilberte; Gauriot,
Marion; Tang, Wei-Jen; Totobenazara, Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011107948 A2 2011-09-09

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,1-dimethylethyl N-[2-[1-[1-(2,6-dioxo-3-piperidiny...
C26H36N4O4.CH2O2
2912305-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1440 2.3100 0.0 0
M  V30 2 O 1.6486 5.0226 0.0 0
M  V30 3 O 0.0000 10.0963 0.0 0
M  V30 4 C 15.3246 6.2945 0.0 0
M  V30 5 C 16.0946 7.6282 0.0 0
M  V30 6 N 17.6346 7.6282 0.0 0
M  V30 7 C 18.4046 8.9620 0.0 0
M  V30 8 O 19.9447 8.9620 0.0 0
M  V30 9 O 17.6346 10.2957 0.0 0
M  V30 10 C 20.7147 10.2957 0.0 0
M  V30 11 C 22.0484 9.5257 0.0 0
M  V30 12 C 21.4847 11.6294 0.0 0
M  V30 13 C 19.3809 11.0657 0.0 0
M  V30 14 C 6.0844 6.2945 0.0 0
M  V30 15 N 4.5779 5.9744 0.0 0
M  V30 16 C 6.8544 4.9609 0.0 0
M  V30 17 C 6.8544 7.6282 0.0 0
M  V30 18 C 4.4170 4.4428 0.0 0
M  V30 19 C 8.3944 4.9609 0.0 0
M  V30 20 C 5.8238 3.8163 0.0 0
M  V30 21 C 8.3944 7.6282 0.0 0
M  V30 22 C 9.1644 6.2945 0.0 0
M  V30 23 C 3.4335 7.0048 0.0 0
M  V30 24 C 1.9688 6.5289 0.0 0
M  V30 25 C 3.7537 8.5113 0.0 0
M  V30 26 N 0.8244 7.5594 0.0 0
M  V30 27 C 2.6091 9.5417 0.0 0
M  V30 28 C 1.1446 9.0658 0.0 0
M  V30 29 N 10.7045 6.2945 0.0 0
M  V30 30 C 11.4745 4.9609 0.0 0
M  V30 31 C 11.4745 7.6282 0.0 0
M  V30 32 C 13.0145 4.9609 0.0 0
M  V30 33 C 13.0145 7.6282 0.0 0
M  V30 34 C 13.7845 6.2945 0.0 0
M  V30 35 C 11.0242 0.0000 0.0 0
M  V30 36 O 9.6905 0.7700 0.0 0
M  V30 37 O 12.3578 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 2 2 24
M  V30 3 2 3 28
M  V30 4 1 4 5
M  V30 5 1 4 34
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 15 23
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 20
M  V30 23 1 19 22
M  V30 24 2 21 22
M  V30 25 1 22 29
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 2 35 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Piperidinedione, 3-[5-[4-(2-aminoethyl)-1-piperidinyl]-3-methyl-1H-indol-...
C21H28N4O2.C2HF3O2
2912305-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1438 5.1837 0.0 0
M  V30 2 O 1.6486 7.8963 0.0 0
M  V30 3 O 0.0000 12.9700 0.0 0
M  V30 4 C 15.3242 9.1683 0.0 0
M  V30 5 C 16.0942 10.5020 0.0 0
M  V30 6 N 17.6342 10.5020 0.0 0
M  V30 7 C 6.0842 9.1683 0.0 0
M  V30 8 N 4.5778 8.8480 0.0 0
M  V30 9 C 6.8542 7.8345 0.0 0
M  V30 10 C 6.8542 10.5020 0.0 0
M  V30 11 C 4.4169 7.3165 0.0 0
M  V30 12 C 8.3942 7.8345 0.0 0
M  V30 13 C 5.8237 6.6901 0.0 0
M  V30 14 C 8.3942 10.5020 0.0 0
M  V30 15 C 9.1642 9.1683 0.0 0
M  V30 16 C 3.4334 9.8786 0.0 0
M  V30 17 C 1.9687 9.4027 0.0 0
M  V30 18 C 3.7536 11.3848 0.0 0
M  V30 19 N 0.8244 10.4331 0.0 0
M  V30 20 C 2.6091 12.4154 0.0 0
M  V30 21 C 1.1445 11.9394 0.0 0
M  V30 22 N 10.7042 9.1683 0.0 0
M  V30 23 C 11.4742 7.8345 0.0 0
M  V30 24 C 11.4742 10.5020 0.0 0
M  V30 25 C 13.0142 7.8345 0.0 0
M  V30 26 C 13.0142 10.5020 0.0 0
M  V30 27 C 13.7842 9.1683 0.0 0
M  V30 28 C 8.1503 2.3101 0.0 0
M  V30 29 C 9.4840 1.5400 0.0 0
M  V30 30 F 8.9203 3.6437 0.0 0
M  V30 31 F 6.8166 3.0801 0.0 0
M  V30 32 F 7.3803 0.9764 0.0 0
M  V30 33 O 10.8176 2.3101 0.0 0
M  V30 34 O 9.4840 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 2 2 17
M  V30 3 2 3 21
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 15 22
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 35 1 29 33
M  V30 36 2 29 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2912305-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2912305-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36098189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of protein tyrosine phosphatase targeting ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veits, Gesine Kerstin; Fitzgerald, Mark E.; Hird, Alexander W.;
Henderson, James A.; Vora, Harit U.; Sweis, Ramzi F.; Kort, Michael E.;
Matulenko, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023019166 A1 2023-02-16

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,1-dimethylethyl N-[(1R)-2-[[trans-4-[[4-[4-[(2,6-d...
C31H47FN4O5.CH2O2
3030283-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 8.0022 2.3100 0.0 0
M  V30 2 C 14.6707 9.2401 0.0 0
M  V30 3 N 5.3348 3.8500 0.0 0
M  V30 4 O 2.6675 2.3100 0.0 0
M  V30 5 O 20.0054 6.1601 0.0 0
M  V30 6 C 21.3391 6.9301 0.0 0
M  V30 7 C 22.6729 6.1601 0.0 0 CFG=1
M  V30 8 N 24.0066 6.9301 0.0 0
M  V30 9 C 22.6729 4.6200 0.0 0
M  V30 10 C 25.3402 6.1601 0.0 0
M  V30 11 O 26.6739 6.9301 0.0 0
M  V30 12 O 25.3402 4.6200 0.0 0
M  V30 13 C 28.0077 6.1601 0.0 0
M  V30 14 C 28.7777 7.4937 0.0 0
M  V30 15 C 29.3413 5.3901 0.0 0
M  V30 16 C 27.2377 4.8264 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 18 C 10.6695 6.9301 0.0 0
M  V30 19 C 12.0032 6.1601 0.0 0
M  V30 20 C 10.6695 8.4701 0.0 0
M  V30 21 C 13.3370 6.9301 0.0 0
M  V30 22 C 12.0032 9.2401 0.0 0
M  V30 23 N 13.3370 8.4701 0.0 0
M  V30 24 C 9.3359 6.1601 0.0 0
M  V30 25 C 9.3359 4.6200 0.0 0
M  V30 26 C 8.0022 6.9301 0.0 0
M  V30 27 C 8.0022 3.8500 0.0 0
M  V30 28 C 6.6684 6.1601 0.0 0
M  V30 29 C 6.6684 4.6200 0.0 0
M  V30 30 C 16.0043 8.4701 0.0 0 CFG=2
M  V30 31 C 16.0043 6.9301 0.0 0
M  V30 32 C 17.3381 9.2401 0.0 0
M  V30 33 C 17.3381 6.1601 0.0 0
M  V30 34 C 18.6718 8.4701 0.0 0
M  V30 35 C 18.6718 6.9301 0.0 0 CFG=2
M  V30 36 C 4.0011 4.6200 0.0 0 CFG=3
M  V30 37 C 2.6675 3.8500 0.0 0
M  V30 38 C 4.0011 6.1601 0.0 0
M  V30 39 N 1.3337 4.6200 0.0 0
M  V30 40 C 2.6675 6.9301 0.0 0
M  V30 41 C 1.3337 6.1601 0.0 0
M  V30 42 C 14.6707 0.0000 0.0 0
M  V30 43 O 13.3370 0.7700 0.0 0
M  V30 44 O 16.0043 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 2 23
M  V30 3 1 30 2 CFG=3
M  V30 4 1 3 29
M  V30 5 1 3 36
M  V30 6 2 4 37
M  V30 7 1 5 6
M  V30 8 1 35 5 CFG=1
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 7 9 CFG=3
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 2 17 41
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 24
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 45 1 42 43
M  V30 46 2 42 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,6-Piperidinedione, 3-[[4-[1-[[trans-4-[(2R)-2-aminopropoxy]cyclohexyl]methy...
C26H39FN4O3.C2HF3O2
3030283-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 8.0022 5.1837 0.0 0
M  V30 2 N 5.3348 6.7238 0.0 0
M  V30 3 C 14.6708 12.1139 0.0 0
M  V30 4 O 2.6673 5.1837 0.0 0
M  V30 5 O 0.0000 9.8038 0.0 0
M  V30 6 O 20.0057 9.0338 0.0 0
M  V30 7 C 21.3393 9.8038 0.0 0
M  V30 8 C 22.6730 9.0338 0.0 0 CFG=2
M  V30 9 C 22.6730 7.4938 0.0 0
M  V30 10 N 24.0067 9.8038 0.0 0
M  V30 11 C 9.3358 9.0338 0.0 0
M  V30 12 C 9.3358 7.4938 0.0 0
M  V30 13 C 8.0022 9.8038 0.0 0
M  V30 14 C 8.0022 6.7238 0.0 0
M  V30 15 C 6.6685 9.0338 0.0 0
M  V30 16 C 6.6685 7.4938 0.0 0
M  V30 17 C 10.6697 9.8038 0.0 0
M  V30 18 C 10.6697 11.3439 0.0 0
M  V30 19 C 12.0033 9.0338 0.0 0
M  V30 20 C 12.0033 12.1139 0.0 0
M  V30 21 C 13.3370 9.8038 0.0 0
M  V30 22 N 13.3370 11.3439 0.0 0
M  V30 23 C 4.0010 7.4938 0.0 0 CFG=3
M  V30 24 C 2.6673 6.7238 0.0 0
M  V30 25 C 4.0010 9.0338 0.0 0
M  V30 26 N 1.3337 7.4938 0.0 0
M  V30 27 C 2.6673 9.8038 0.0 0
M  V30 28 C 1.3337 9.0338 0.0 0
M  V30 29 C 16.0045 11.3439 0.0 0 CFG=2
M  V30 30 C 16.0045 9.8038 0.0 0
M  V30 31 C 17.3382 12.1139 0.0 0
M  V30 32 C 17.3382 9.0338 0.0 0
M  V30 33 C 18.6718 11.3439 0.0 0
M  V30 34 C 18.6718 9.8038 0.0 0 CFG=2
M  V30 35 C 11.3365 2.3101 0.0 0
M  V30 36 C 12.6702 1.5400 0.0 0
M  V30 37 F 12.1065 3.6437 0.0 0
M  V30 38 F 10.0028 3.0801 0.0 0
M  V30 39 F 10.5665 0.9764 0.0 0
M  V30 40 O 14.0038 2.3101 0.0 0
M  V30 41 O 12.6702 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 16
M  V30 3 1 2 23
M  V30 4 1 3 22
M  V30 5 1 29 3 CFG=3
M  V30 6 2 4 24
M  V30 7 2 5 28
M  V30 8 1 6 7
M  V30 9 1 34 6 CFG=1
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 8 10 CFG=3
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 11 17
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 35 38
M  V30 41 1 35 39
M  V30 42 1 36 40
M  V30 43 2 36 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 29 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3030283-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3030283-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40336429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and related heterocyclic compounds as CDK2
degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collier, Philip; Zheng, Xiaozhang; Zhu, Xiao; Ford, Melissa; Weiss,
Matthew M.; Aversa, Robert; Pennington, Lewis Dale; Comer, Eamon;
Mahasenan, Kiran Vijayakumari; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024039901 A2 2024-02-22

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Acetic anhydride
C4H6O3
108-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1,3,8,10-tetraacetyloctahydro-5,2,6-(iminomethenimin...
C14H20N6O4.2CH2O2
245730-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5938 8.2864 0.0 0
M  V30 2 C 1.5535 6.4229 0.0 0
M  V30 3 O 0.0000 9.2533 0.0 0
M  V30 4 C 5.5117 12.6385 0.0 0
M  V30 5 C 7.3609 12.8738 0.0 0
M  V30 6 O 4.3834 14.1223 0.0 0
M  V30 7 C 10.4690 8.2305 0.0 0
M  V30 8 C 10.4690 10.0946 0.0 0
M  V30 9 O 12.0833 7.2985 0.0 0
M  V30 10 C 6.4963 3.8181 0.0 0
M  V30 11 C 7.5920 2.3100 0.0 0
M  V30 12 O 4.6425 3.6231 0.0 0
M  V30 13 C 3.3932 10.6063 0.0 0
M  V30 14 C 8.7002 5.8283 0.0 0
M  V30 15 N 3.2278 9.1834 0.0 0
M  V30 16 N 4.7909 10.9195 0.0 0
M  V30 17 N 8.8546 7.2985 0.0 0
M  V30 18 N 7.2544 5.5209 0.0 0
M  V30 19 C 4.5169 8.5586 0.0 0
M  V30 20 C 5.5473 9.7030 0.0 0
M  V30 21 C 7.5042 7.8998 0.0 0
M  V30 22 C 6.5151 6.8010 0.0 0
M  V30 23 N 5.0041 7.0977 0.0 0
M  V30 24 N 7.0509 9.3713 0.0 0
M  V30 25 C 6.0417 0.0000 0.0 0
M  V30 26 O 4.7080 0.7700 0.0 0
M  V30 27 O 7.3753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 1 21 24
M  V30 27 1 22 23
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,8,10-Tetraacetylhexahydro-5,2,6-(iminomethenimino)-1H-imidazo[4,5-b]pyraz...
C16H20N6O6
192382-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3813 5.4090 0.0 0
M  V30 2 C 1.4823 6.9458 0.0 0
M  V30 3 O 0.0000 4.7281 0.0 0
M  V30 4 C 2.2411 1.3629 0.0 0
M  V30 5 C 0.7021 1.4233 0.0 0
M  V30 6 O 2.9581 0.0000 0.0 0
M  V30 7 C 8.2362 2.2439 0.0 0
M  V30 8 C 9.7762 2.2439 0.0 0
M  V30 9 O 7.4662 0.9100 0.0 0
M  V30 10 C 7.2165 7.0419 0.0 0
M  V30 11 C 5.9706 7.9473 0.0 0
M  V30 12 O 8.6235 7.6682 0.0 0
M  V30 13 C 4.4914 6.8216 0.0 0
M  V30 14 O 3.0324 7.3146 0.0 0
M  V30 15 C 5.6568 1.3368 0.0 0
M  V30 16 O 4.5240 0.2934 0.0 0
M  V30 17 C 2.1921 3.4670 0.0 0
M  V30 18 C 7.9630 4.6931 0.0 0
M  V30 19 N 2.6617 4.5532 0.0 0
M  V30 20 N 3.0628 2.6654 0.0 0
M  V30 21 N 7.4662 3.5775 0.0 0
M  V30 22 N 7.0554 5.5103 0.0 0
M  V30 23 C 3.8420 4.4677 0.0 0
M  V30 24 C 4.1065 3.2235 0.0 0
M  V30 25 C 6.2515 3.7050 0.0 0
M  V30 26 C 5.9979 4.8998 0.0 0
M  V30 27 N 4.7940 5.3116 0.0 0
M  V30 28 N 5.3193 2.8394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 21
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 2 13 14
M  V30 14 1 13 27
M  V30 15 2 15 16
M  V30 16 1 15 28
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 26
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 245730-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192382-51-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17633292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and reactions of hexaazaisowurtzitane-type compounds in
synthesis of hexanitrohexaazaisowurtzitane (HNIW) explosive
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wardle, Robert B.; Hinshaw, Jerald C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6147209 A 2000-11-14

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
tert-Butyl 3-bromopropionate
C7H13BrO2
55666-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 6.6687 1.5400 0.0 0
M  V30 7 C 2.1037 0.2064 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 0.5637 2.8737 0.0 0
M  V30 10 Br 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 1-[2,6-bis(phenylmethoxy)-3-pyridinyl]-1,3-dihydro-3...
C31H31N5O3.CH2O2
2888605-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.3523 6.6780 0.0 0
M  V30 2 O 6.6685 7.7001 0.0 0
M  V30 3 C 5.3348 6.9301 0.0 0
M  V30 4 C 11.6297 5.9814 0.0 0
M  V30 5 O 4.0010 12.3202 0.0 0
M  V30 6 C 4.0010 13.8602 0.0 0
M  V30 7 N 9.3358 9.2401 0.0 0
M  V30 8 C 10.7428 9.8665 0.0 0
M  V30 9 C 9.4969 7.7086 0.0 0
M  V30 10 C 11.7732 8.7221 0.0 0
M  V30 11 C 11.2186 11.3312 0.0 0
M  V30 12 N 11.0032 7.3884 0.0 0
M  V30 13 C 13.2797 9.0422 0.0 0
M  V30 14 C 12.7251 11.6514 0.0 0
M  V30 15 C 13.7555 10.5070 0.0 0
M  V30 16 C 8.0021 10.0102 0.0 0
M  V30 17 C 6.6685 9.2401 0.0 0
M  V30 18 C 8.0021 11.5502 0.0 0
M  V30 19 N 5.3348 10.0102 0.0 0
M  V30 20 C 6.6685 12.3202 0.0 0
M  V30 21 C 5.3348 11.5502 0.0 0
M  V30 22 N 15.2618 10.8271 0.0 0
M  V30 23 C 15.7379 12.2917 0.0 0
M  V30 24 C 16.2924 9.6826 0.0 0
M  V30 25 C 17.2442 12.6119 0.0 0
M  V30 26 C 17.7987 10.0028 0.0 0
M  V30 27 N 18.2746 11.4675 0.0 0
M  V30 28 C 5.3348 5.3901 0.0 0
M  V30 29 C 6.6685 4.6201 0.0 0
M  V30 30 C 4.0010 4.6201 0.0 0
M  V30 31 C 6.6685 3.0800 0.0 0
M  V30 32 C 4.0010 3.0800 0.0 0
M  V30 33 C 5.3348 2.3100 0.0 0
M  V30 34 C 2.6673 14.6302 0.0 0
M  V30 35 C 1.3337 13.8602 0.0 0
M  V30 36 C 2.6673 16.1703 0.0 0
M  V30 37 C 0.0000 14.6302 0.0 0
M  V30 38 C 1.3337 16.9403 0.0 0
M  V30 39 C 0.0000 16.1703 0.0 0
M  V30 40 C 9.1373 0.0000 0.0 0
M  V30 41 O 7.8036 0.7700 0.0 0
M  V30 42 O 10.4710 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 28
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 34
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 16
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 10 12
M  V30 16 2 10 13
M  V30 17 1 11 14
M  V30 18 1 13 15
M  V30 19 2 14 15
M  V30 20 1 15 22
M  V30 21 2 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 2 40 42
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[1-[2,6-bis(phenylmethoxy)-3-pyridinyl]-2,3-dihydro-3-met...
C38H43N5O5
2888605-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.3522 4.3679 0.0 0
M  V30 2 O 6.6684 5.3900 0.0 0
M  V30 3 C 5.3347 4.6200 0.0 0
M  V30 4 C 11.6293 3.6714 0.0 0
M  V30 5 O 4.0009 10.0100 0.0 0
M  V30 6 C 4.0009 11.5500 0.0 0
M  V30 7 C 19.7807 9.4775 0.0 0
M  V30 8 C 20.2565 10.9422 0.0 0
M  V30 9 C 21.7628 11.2623 0.0 0
M  V30 10 O 22.2387 12.7269 0.0 0
M  V30 11 O 22.7934 10.1178 0.0 0
M  V30 12 C 23.7451 13.0470 0.0 0
M  V30 13 C 23.4249 14.5535 0.0 0
M  V30 14 C 25.2514 13.3674 0.0 0
M  V30 15 C 24.0653 11.5408 0.0 0
M  V30 16 N 9.3356 6.9300 0.0 0
M  V30 17 C 10.7426 7.5563 0.0 0
M  V30 18 C 9.4967 5.3985 0.0 0
M  V30 19 C 11.7730 6.4119 0.0 0
M  V30 20 C 11.2184 9.0210 0.0 0
M  V30 21 N 11.0030 5.0783 0.0 0
M  V30 22 C 13.2794 6.7321 0.0 0
M  V30 23 C 12.7247 9.3412 0.0 0
M  V30 24 C 13.7553 8.1968 0.0 0
M  V30 25 C 8.0020 7.7000 0.0 0
M  V30 26 C 6.6684 6.9300 0.0 0
M  V30 27 C 8.0020 9.2400 0.0 0
M  V30 28 N 5.3347 7.7000 0.0 0
M  V30 29 C 6.6684 10.0100 0.0 0
M  V30 30 C 5.3347 9.2400 0.0 0
M  V30 31 N 15.2616 8.5170 0.0 0
M  V30 32 C 16.2921 7.3724 0.0 0
M  V30 33 C 15.7374 9.9815 0.0 0
M  V30 34 C 17.7984 7.6926 0.0 0
M  V30 35 C 17.2438 10.3017 0.0 0
M  V30 36 N 18.2743 9.1573 0.0 0
M  V30 37 C 5.3347 3.0800 0.0 0
M  V30 38 C 4.0009 2.3100 0.0 0
M  V30 39 C 6.6684 2.3100 0.0 0
M  V30 40 C 4.0009 0.7700 0.0 0
M  V30 41 C 6.6684 0.7700 0.0 0
M  V30 42 C 5.3347 0.0000 0.0 0
M  V30 43 C 2.6673 12.3200 0.0 0
M  V30 44 C 2.6673 13.8600 0.0 0
M  V30 45 C 1.3336 11.5500 0.0 0
M  V30 46 C 1.3336 14.6300 0.0 0
M  V30 47 C 0.0000 12.3200 0.0 0
M  V30 48 C 0.0000 13.8600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 26
M  V30 4 1 3 37
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 5 30
M  V30 8 1 6 43
M  V30 9 1 7 8
M  V30 10 1 7 36
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 25
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 1 24 31
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55666-43-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2888605-78-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2888605-79-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35576334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Degrader compounds and application
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veits, Gesine Kerstin; Fitzgerald, Mark E.; Hird, Alexander W.; Sweis,
Ramzi F.; Kort, Michael E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022271727 A1 2022-12-29

$RFMT $RIREG SCHEME310 STEP1
$RXN



  1  1
$MOL
Formic acid, compd. with 1,3,8,10-tetraacetyloctahydro-5,2,6-(iminomethenimin...
C14H20N6O4.2CH2O2
245730-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5938 8.2864 0.0 0
M  V30 2 C 1.5535 6.4229 0.0 0
M  V30 3 O 0.0000 9.2533 0.0 0
M  V30 4 C 5.5117 12.6385 0.0 0
M  V30 5 C 7.3609 12.8738 0.0 0
M  V30 6 O 4.3834 14.1223 0.0 0
M  V30 7 C 10.4690 8.2305 0.0 0
M  V30 8 C 10.4690 10.0946 0.0 0
M  V30 9 O 12.0833 7.2985 0.0 0
M  V30 10 C 6.4963 3.8181 0.0 0
M  V30 11 C 7.5920 2.3100 0.0 0
M  V30 12 O 4.6425 3.6231 0.0 0
M  V30 13 C 3.3932 10.6063 0.0 0
M  V30 14 C 8.7002 5.8283 0.0 0
M  V30 15 N 3.2278 9.1834 0.0 0
M  V30 16 N 4.7909 10.9195 0.0 0
M  V30 17 N 8.8546 7.2985 0.0 0
M  V30 18 N 7.2544 5.5209 0.0 0
M  V30 19 C 4.5169 8.5586 0.0 0
M  V30 20 C 5.5473 9.7030 0.0 0
M  V30 21 C 7.5042 7.8998 0.0 0
M  V30 22 C 6.5151 6.8010 0.0 0
M  V30 23 N 5.0041 7.0977 0.0 0
M  V30 24 N 7.0509 9.3713 0.0 0
M  V30 25 C 6.0417 0.0000 0.0 0
M  V30 26 O 4.7080 0.7700 0.0 0
M  V30 27 O 7.3753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 1 21 24
M  V30 27 1 22 23
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,8,10-Tetraacetylhexahydro-5,2,6-(iminomethenimino)-1H-imidazo[4,5-b]pyraz...
C16H20N6O6
192382-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3813 5.4090 0.0 0
M  V30 2 C 1.4823 6.9458 0.0 0
M  V30 3 O 0.0000 4.7281 0.0 0
M  V30 4 C 2.2411 1.3629 0.0 0
M  V30 5 C 0.7021 1.4233 0.0 0
M  V30 6 O 2.9581 0.0000 0.0 0
M  V30 7 C 8.2362 2.2439 0.0 0
M  V30 8 C 9.7762 2.2439 0.0 0
M  V30 9 O 7.4662 0.9100 0.0 0
M  V30 10 C 7.2165 7.0419 0.0 0
M  V30 11 C 5.9706 7.9473 0.0 0
M  V30 12 O 8.6235 7.6682 0.0 0
M  V30 13 C 4.4914 6.8216 0.0 0
M  V30 14 O 3.0324 7.3146 0.0 0
M  V30 15 C 5.6568 1.3368 0.0 0
M  V30 16 O 4.5240 0.2934 0.0 0
M  V30 17 C 2.1921 3.4670 0.0 0
M  V30 18 C 7.9630 4.6931 0.0 0
M  V30 19 N 2.6617 4.5532 0.0 0
M  V30 20 N 3.0628 2.6654 0.0 0
M  V30 21 N 7.4662 3.5775 0.0 0
M  V30 22 N 7.0554 5.5103 0.0 0
M  V30 23 C 3.8420 4.4677 0.0 0
M  V30 24 C 4.1065 3.2235 0.0 0
M  V30 25 C 6.2515 3.7050 0.0 0
M  V30 26 C 5.9979 4.8998 0.0 0
M  V30 27 N 4.7940 5.3116 0.0 0
M  V30 28 N 5.3193 2.8394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 21
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 2 13 14
M  V30 14 1 13 27
M  V30 15 2 15 16
M  V30 16 1 15 28
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 26
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 245730-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192382-51-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-363720
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 6 To a stirred slurry of 5.0 g (11.67 mmol) of bis formate salt
(IV A bis) in 200 ml of acetic anhydride were added 50 ml of pyridine.
After 20 hours, all volatiles were removed under reduced pressure. Then
the residue was treated with 100 ml of EtOAc. A precipitate formed which
was removed by filtration. The solvent was removed and the residue passed
through a plug of silica gel using acetone as eluent. Obtained was 4.5 g
(98.3%) yield of bis formyl compound. Rf=0.35 (acetone). 1H NMR (CHCl3):
(δ )2.0-2.3 (multiplet, 12H, CH3CO), 6.06 (doublet, 0.2H, CH, J=4.8 Hz),
6.15 (broad singlet, 0.45H, CH), 6.26 (doublet, 1.5H, CH, J=7.8, 1.8 Hz),
6.46 (singlet, 1.7H, CH), 6.67 (doublet, 1.5H, CH, J=7.8, 1.81 Hz),
6.75-6.81 (multiplet, 0.65H, CH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polycyclic, polyamides as precursors for energetic polycyclic
polynitramine oxidizers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wardle, Robert B.; Hinshaw, Jerald C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7129348 B1 2006-10-31

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
1-(1-Oxo-4-pentyn-1-yl)-2,5-pyrrolidinedione
C9H9NO3
852511-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.3320 0.0 0
M  V30 2 C 5.1048 2.5620 0.0 0
M  V30 3 O 3.7711 4.8721 0.0 0
M  V30 4 C 6.4386 3.3320 0.0 0
M  V30 5 C 7.7722 2.5620 0.0 0
M  V30 6 C 9.1059 1.7920 0.0 0
M  V30 7 O 0.7103 4.6948 0.0 0
M  V30 8 O 3.4209 0.0000 0.0 0
M  V30 9 N 2.4374 2.5620 0.0 0
M  V30 10 C 1.0304 3.1885 0.0 0
M  V30 11 C 2.2763 1.0304 0.0 0
M  V30 12 C 0.0000 2.0439 0.0 0
M  V30 13 C 0.7700 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 3 5 6
M  V30 7 2 7 10
M  V30 8 2 8 11
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Glutamic acid, N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]ami...
C24H45N3O7.CH2O2
1980012-04-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 11.6459 0.0 0 CFG=2
M  V30 2 N 8.2638 11.6459 0.0 0
M  V30 3 C 5.9538 10.3122 0.0 0
M  V30 4 C 5.9538 12.9797 0.0 0
M  V30 5 C 9.0338 10.3122 0.0 0
M  V30 6 C 4.4137 10.3122 0.0 0
M  V30 7 O 6.7238 14.3133 0.0 0
M  V30 8 O 4.4137 12.9797 0.0 0
M  V30 9 N 10.5739 10.3122 0.0 0
M  V30 10 O 8.2638 8.9785 0.0 0
M  V30 11 C 3.6437 8.9785 0.0 0
M  V30 12 C 5.9538 15.6470 0.0 0
M  V30 13 C 11.3439 8.9785 0.0 0 CFG=1
M  V30 14 O 2.1037 8.9785 0.0 0
M  V30 15 O 4.4137 7.6448 0.0 0
M  V30 16 C 4.6201 14.8770 0.0 0
M  V30 17 C 5.1838 16.9807 0.0 0
M  V30 18 C 7.2874 16.4170 0.0 0
M  V30 19 C 12.8839 8.9785 0.0 0
M  V30 20 C 10.5739 7.6448 0.0 0
M  V30 21 C 1.3337 7.6448 0.0 0
M  V30 22 O 13.6539 10.3122 0.0 0
M  V30 23 O 13.6539 7.6448 0.0 0
M  V30 24 C 11.3439 6.3110 0.0 0
M  V30 25 C 2.6673 6.8748 0.0 0
M  V30 26 C 0.5637 6.3110 0.0 0
M  V30 27 C 0.0000 8.4149 0.0 0
M  V30 28 C 15.1940 10.3122 0.0 0
M  V30 29 C 10.5739 4.9774 0.0 0
M  V30 30 C 15.1940 11.8522 0.0 0
M  V30 31 C 16.7340 10.3122 0.0 0
M  V30 32 C 15.1940 8.7722 0.0 0
M  V30 33 C 11.3439 3.6437 0.0 0
M  V30 34 N 10.5739 2.3100 0.0 0
M  V30 35 C 8.3670 0.0000 0.0 0
M  V30 36 O 7.0333 0.7700 0.0 0
M  V30 37 O 9.7007 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 13 20 CFG=3
M  V30 20 1 14 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 21 27
M  V30 27 1 22 28
M  V30 28 1 24 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 32 1 29 33
M  V30 33 1 33 34
M  V30 34 1 35 36
M  V30 35 2 35 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H49N3O8
2081951-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.7238 0.0 0 CFG=2
M  V30 2 N 5.3348 8.2638 0.0 0
M  V30 3 C 6.6685 5.9538 0.0 0
M  V30 4 C 4.0012 5.9538 0.0 0
M  V30 5 C 6.6685 9.0338 0.0 0
M  V30 6 C 6.6685 4.4137 0.0 0
M  V30 7 O 2.6673 6.7238 0.0 0
M  V30 8 O 4.0012 4.4137 0.0 0
M  V30 9 N 6.6685 10.5739 0.0 0
M  V30 10 O 8.0023 8.2638 0.0 0
M  V30 11 C 8.0023 3.6437 0.0 0
M  V30 12 C 1.3337 5.9538 0.0 0
M  V30 13 C 8.0023 11.3439 0.0 0 CFG=1
M  V30 14 O 8.0023 2.1037 0.0 0
M  V30 15 O 9.3360 4.4137 0.0 0
M  V30 16 C 0.5637 7.2874 0.0 0
M  V30 17 C 0.0000 5.1838 0.0 0
M  V30 18 C 2.1037 4.6201 0.0 0
M  V30 19 C 8.0023 12.8839 0.0 0
M  V30 20 C 9.3360 10.5739 0.0 0
M  V30 21 C 9.3360 1.3337 0.0 0
M  V30 22 O 6.6685 13.6539 0.0 0
M  V30 23 O 9.3360 13.6539 0.0 0
M  V30 24 C 10.6697 11.3439 0.0 0
M  V30 25 C 10.1060 2.6673 0.0 0
M  V30 26 C 10.6697 0.5637 0.0 0
M  V30 27 C 8.5660 0.0000 0.0 0
M  V30 28 C 6.6685 15.1940 0.0 0
M  V30 29 C 12.0033 10.5739 0.0 0
M  V30 30 C 5.1285 15.1940 0.0 0
M  V30 31 C 6.6685 16.7340 0.0 0
M  V30 32 C 8.2085 15.1940 0.0 0
M  V30 33 C 13.3372 11.3439 0.0 0
M  V30 34 N 14.6708 10.5739 0.0 0
M  V30 35 C 16.0045 11.3439 0.0 0
M  V30 36 C 17.3382 10.5739 0.0 0
M  V30 37 O 16.0045 12.8839 0.0 0
M  V30 38 C 18.6720 11.3439 0.0 0
M  V30 39 C 20.0057 10.5739 0.0 0
M  V30 40 C 21.3393 9.8039 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 13 20 CFG=3
M  V30 20 1 14 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 21 27
M  V30 27 1 22 28
M  V30 28 1 24 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 32 1 29 33
M  V30 33 1 33 34
M  V30 34 1 34 35
M  V30 35 1 35 36
M  V30 36 2 35 37
M  V30 37 1 36 38
M  V30 38 1 38 39
M  V30 39 3 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 852511-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1980012-04-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2081951-99-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-16982701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazole conjugated ureas, thioureas, carbamates, and
"reversed" carbamates prostate-specific membrane antigen-targeted imaging
agents and their uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pomper, Martin G.; Chen, Ying; Yang, Xing; Mease, Ronnie C.; Ray,
Sangeeta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017027870 A1 2017-02-16

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-nitrobenzene
C6H4ClNO2
100-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-3899544
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 154769-61-6
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM graphitic
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, solid-supported catalyst, graphitic carbon nitride used as
support, catalyst prepared and used, 40 W domestic bulb used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A photoactive bimetallic framework for direct aminoformylation of
nitroarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasir Baig, R. B.; Verma, Sanny; Nadagouda, Mallikarjuna N.; Varma,
Rajender S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(4), 1019-1022

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-2-[[(phenylmethyl)amino]methyl]-2-hexenoate
C15H21NO2
1000393-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 O 7.7000 1.3336 0.0 0
M  V30 9 O 5.3900 2.6674 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 12.3200 6.6685 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-2-[[formyl(phenylmethyl)amino]methyl]-2-hexenoate
C16H21NO3
1000393-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 4.0011 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 C 6.9301 2.6675 0.0 0
M  V30 4 C 9.2401 4.0011 0.0 0
M  V30 5 N 5.3901 5.3348 0.0 0
M  V30 6 O 7.7001 1.3337 0.0 0
M  V30 7 O 5.3901 2.6675 0.0 0
M  V30 8 C 10.0101 5.3348 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 4.6201 6.6686 0.0 0
M  V30 11 C 6.9301 0.0000 0.0 0
M  V30 12 C 11.5501 5.3348 0.0 0
M  V30 13 O 5.3901 8.0022 0.0 0
M  V30 14 C 12.3201 6.6686 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 5.3348 0.0 0
M  V30 17 C 2.3100 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 8 12
M  V30 12 1 9 15
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000393-25-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000393-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5421696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM E:Z = 65:35
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective hydrogenation of α-aminomethylacrylates containing a
free N-H group for the synthesis of β-amino acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiu, Liqin; Prashad, Mahavir; Hu, Bin; Prasad, Kapa; Repic, Oljan;
Blacklock, Thomas J.; Kwong, Fuk Yee; Kok, Stanton H. L.; Lee, Hang Wai;
Chan, Albert S. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2007), 104(43), 16787-16792

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Diamino-6-hydroxy-2-mercaptopyrimidine
C4H6N4OS
1004-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 2.6674 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thioxanthine
C5H4N4OS
2487-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 S 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1004-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2487-40-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11991307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Mercaptoxanthine 4,5-Diamino-6-hydroxy-2-mercaptopyrimidine (MW 158,
Aldrich 95%, used as supplied, 100 g) was refluxed with 90% formic acid
(500 mL) for 2 h in a 3 1, 3-neck flask with mechanical stirring. The
mixture initially solidified and a further 100 mL of formic acid is
added. The mixture was cooled on ice and crude
4-amino-5-formamido-6-hydroxy-2-mercaptopyrirnidine was filtered on a
large sinter. It was covered with a rubber dam and dried under vacuum for
30 min giving a light-yellow product. The filtration cake was suspended
in formamide (225 mL) in a large beaker and heated at 175-185 °C (bath
temperature) in a liquid paraffin bath with occasional hand stirring for
2 h. Considerable frothing occurs in the early stages. The mixture was
cooled to room temperature and filtered with dam on large sinter, then
dissolved in approximatelly 2 L of 1M NaOH and precipitated with glacial
AcOH at 10 °C. Then it was filtered, pressed dry and vacuum dried at 95
°C for 2 h. Yield 103 g (97%, cf 85% theory, product incompletely dry).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of formic acid (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 6-(benzylamino)-purine riboside derivatives as
anti-apoptotic and anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Szucova, Lucie; Krystof, Vladimir; Zatloukal, Marek; Dolezal, Karel;
Strnad, Miroslav; Spichal, Lukas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010130233 A1 2010-11-18

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Diamino-6-hydroxy-2-mercaptopyrimidine
C4H6N4OS
1004-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 2.6674 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 S 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thioxanthine
C5H4N4OS
2487-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 S 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1004-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2487-40-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-426006
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Thioxanthine 4,5-Diamino-6-hydroxy-2-thiopyrimidine (MW 158, Aldrich
95%, 100 g) was refluxed with 90% formic acid (500 ml) for 2 h with
mechanical stirring. The mix initially solidifies and a further 100 ml of
formic acid is added. The mixture was cooled to 1°C on ice and then
filtered to get crude 4-amino-5-formamido-6-hydroxy-2-thiopyrimidine
which is dried under vacuum for 30 min. The filter cake was resuspended
in formamide (225 ml) and heated to 175-185 °C in a liquid paraffin bath
with occasional hand stirring for 2 h. Subsequently, the reaction mixture
was cooled to the room temperature and filtered. It was dissolved in
approx. 2 L 1 M NaOH, filtered, and vacuum dried at 95°C for 2 h. Yield
103 g (97 %). 2-Thioxanthine, Yield (103 g, 97%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted 6-anilinopurine derivatives as inhibitors of cytokinin
oxidase/dehydrogenase and preparations containing these derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spichal, Lukas; Gemrotova, Marketa; Zatloukal, Marek; Frebortova, Jitka;
Galuszka, Petr; Werner, Tomas; Schmulling, Thomas; Dolezal, Karel;
Strnad, Miroslav
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009003428 A2 2009-01-08

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Hydroxy-1-[[3-(4-morpholinyl)propyl]amino]-4-nitro-9(10H)-acridinone
C20H22N4O5
1005416-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 9.2402 0.0 0 VAL=5
M  V30 2 O 0.0000 8.4702 0.0 0
M  V30 3 O 1.3337 10.7802 0.0 0
M  V30 4 N 6.6685 6.1601 0.0 0
M  V30 5 C 8.0022 6.9302 0.0 0
M  V30 6 C 9.3358 6.1601 0.0 0
M  V30 7 C 10.6697 6.9302 0.0 0
M  V30 8 O 5.3348 3.8501 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 2.6673 6.9302 0.0 0
M  V30 11 C 4.0010 6.1601 0.0 0
M  V30 12 C 2.6673 8.4702 0.0 0
M  V30 13 N 1.3337 6.1601 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 4.0010 9.2402 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 5.3348 8.4702 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 0.0000 3.8501 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 1.3337 1.5400 0.0 0
M  V30 24 N 12.0033 6.1601 0.0 0
M  V30 25 C 13.3370 6.9302 0.0 0
M  V30 26 C 12.0033 4.6201 0.0 0
M  V30 27 C 14.6707 6.1601 0.0 0
M  V30 28 C 13.3370 3.8501 0.0 0
M  V30 29 O 14.6707 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 24
M  V30 9 2 8 15
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Hydroxy-5-[[3-(4-morpholinyl)propyl]amino]-6H-imidazo[4,5,1-de]acridin-6-one
C21H22N4O3
1005416-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9072 6.0140 0.0 0
M  V30 2 C 8.2409 6.7840 0.0 0
M  V30 3 C 9.5745 6.0140 0.0 0
M  V30 4 C 10.9083 6.7840 0.0 0
M  V30 5 O 5.4238 3.6067 0.0 0
M  V30 6 O 1.1737 0.0000 0.0 0
M  V30 7 C 2.9415 6.7969 0.0 0
M  V30 8 C 4.2349 6.0000 0.0 0
M  V30 9 N 1.5765 6.1609 0.0 0
M  V30 10 C 2.8959 8.3021 0.0 0
M  V30 11 C 5.5735 6.7840 0.0 0
M  V30 12 C 4.1364 4.4518 0.0 0
M  V30 13 C 1.4875 4.6095 0.0 0
M  V30 14 C 0.5704 7.3549 0.0 0
M  V30 15 N 1.3771 8.6641 0.0 0
M  V30 16 C 4.2419 9.0791 0.0 0
M  V30 17 C 5.5831 8.3237 0.0 0
M  V30 18 C 2.7659 3.7506 0.0 0
M  V30 19 C 0.1046 3.9318 0.0 0
M  V30 20 C 2.6612 2.2141 0.0 0
M  V30 21 C 0.0000 2.3954 0.0 0
M  V30 22 C 1.2782 1.5365 0.0 0
M  V30 23 N 12.2420 6.0140 0.0 0
M  V30 24 C 13.5757 6.7840 0.0 0
M  V30 25 C 12.2420 4.4739 0.0 0
M  V30 26 C 14.9093 6.0140 0.0 0
M  V30 27 C 13.5757 3.7039 0.0 0
M  V30 28 O 14.9093 4.4739 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 23
M  V30 6 2 5 12
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 1 13 18
M  V30 20 2 13 19
M  V30 21 2 14 15
M  V30 22 2 16 17
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1005416-48-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1005416-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28256524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7772-99-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of
7-hydroxy-1-(3-morpholinopropylamino)-4-nitroacridin-9(10H)-one (5.56 g,
13.9 mmol) in formic acid (99%, 100 niL) was added a solution of tin (II)
chloride dehydrate (13.99 g, 62 mmol) in 37% hydrochloric acid (18 mL) at
RT. The mixture was heated at 103° C for 22 hours, and concentrated to
dryness. The resulting solid was dissolved in water, basified with
saturated aqueous sodium bicarbonate solution (500 mL). The resulting
precipitate was collected by filtration, washed with water, and
air-dried. Recrystallization from pyridine gave the title compound (5.1
Ig, 97% yield) as a yellow solid. 1H NMR (400 MHz, DMSO-d6):δ 10.08 (IH,
s), 9.06 (IH, s), 8.89 (IH5 s), 8.22 (IH, d, J = 8.6 Hz), 7.91 (IH, d, J
= 8.6 Hz), 7.70 (IH, s), 7.31 (IH, d, J = 8.6 Hz), 6.77 (IH, d, J = 8.6
Hz)5 3.58 (4H5 m), 3.41-3.33 (6H, m), 2.40-2.34 (2H5 m), 1.79 (2H, m).
13CNMR (100 MHz, DMSO-d6): δ 178.13, 155.84, 150.11, 135.71, 132.56,
131.09, 129.6O5 128.53, 126.80, 122.74, 118.2I5 111.90, 106.86, 102.53,
66.83, 56.51, 54.13, 41.35, 26.15.HPLC: tR= 3.63 minute (95.47%); LRMS:
m/z = 379.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Morpholino imidazoacridinone compounds for treating inflammatory and
demyelinating diseases and cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ajami, Alfred M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008016661 A2 2008-02-07

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Triethanolamine
C6H15NO3
102-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 O 0.0000 6.6685 0.0 0
M  V30 9 O 6.9300 5.3347 0.0 0
M  V30 10 O 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2,2′,2′′-nitrilotris[ethanol] (1:1)
C6H15NO3.CH2O2
24794-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 6.3111 0.0 0
M  V30 2 C 2.3100 7.6447 0.0 0
M  V30 3 C 4.6200 6.3111 0.0 0
M  V30 4 C 2.3100 4.9775 0.0 0
M  V30 5 C 0.7700 7.6447 0.0 0
M  V30 6 C 5.3900 7.6447 0.0 0
M  V30 7 C 3.0800 3.6438 0.0 0
M  V30 8 O 0.0000 8.9785 0.0 0
M  V30 9 O 6.9300 7.6447 0.0 0
M  V30 10 O 2.3100 2.3100 0.0 0
M  V30 11 C 3.4650 0.0000 0.0 0
M  V30 12 O 2.1313 0.7700 0.0 0
M  V30 13 O 4.7987 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 11 12
M  V30 11 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 102-71-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24794-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27451545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid prepd.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Hydroxyethylammonium carboxylates - highly biodegradable and slightly
toxic ionic liquids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zicmanis, A.; Pavlovica, S.; Gzibovska, E.; Mekss, P.; Klavins, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Latvijas Kimijas Zurnals (2010), (3/4), 269-276

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,5S,7aS)-1-(1,1-Dimethylethoxy)-7a-ethyl-2,3,5,6,7,7a-hexahydro-1H-inden-5-ol
C15H26O2
1032401-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6748 1.4069 0.0 0
M  V30 2 C 5.3013 0.0000 0.0 0
M  V30 3 O 2.9292 1.9426 0.0 0
M  V30 4 C 1.4647 2.4184 0.0 0
M  V30 5 C 0.9887 0.9537 0.0 0
M  V30 6 C 0.0000 2.8943 0.0 0
M  V30 7 C 1.9406 3.8831 0.0 0
M  V30 8 O 10.2000 2.6528 0.0 0
M  V30 9 C 5.5800 2.6528 0.0 0 CFG=2
M  V30 10 C 4.0738 2.9730 0.0 0 CFG=1
M  V30 11 C 6.3500 3.9864 0.0 0
M  V30 12 C 6.3500 1.3192 0.0 0
M  V30 13 C 3.9127 4.5045 0.0 0
M  V30 14 C 5.3196 5.1310 0.0 0
M  V30 15 C 7.8900 3.9864 0.0 0
M  V30 16 C 7.8900 1.3192 0.0 0
M  V30 17 C 8.6600 2.6528 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 10 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 17 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-Inden-5-ol, 1-(1,1-dimethylethoxy)-7a-ethyl-2,3,5,6,7,7a-hexahydro-, 5-for...
C16H26O3
1032401-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6748 1.4069 0.0 0
M  V30 2 C 5.3013 0.0000 0.0 0
M  V30 3 O 2.9292 1.9426 0.0 0
M  V30 4 C 1.4647 2.4184 0.0 0
M  V30 5 C 0.9887 0.9537 0.0 0
M  V30 6 C 0.0000 2.8943 0.0 0
M  V30 7 C 1.9406 3.8831 0.0 0
M  V30 8 O 10.2000 2.6528 0.0 0
M  V30 9 C 10.9700 3.9864 0.0 0
M  V30 10 O 12.5100 3.9864 0.0 0
M  V30 11 C 5.5800 2.6528 0.0 0 CFG=1
M  V30 12 C 6.3500 3.9864 0.0 0
M  V30 13 C 4.0738 2.9730 0.0 0 CFG=1
M  V30 14 C 6.3500 1.3192 0.0 0
M  V30 15 C 7.8900 3.9864 0.0 0
M  V30 16 C 5.3196 5.1310 0.0 0
M  V30 17 C 3.9127 4.5045 0.0 0
M  V30 18 C 7.8900 1.3192 0.0 0
M  V30 19 C 8.6600 2.6528 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 13 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 19 8 CFG=1
M  V30 10 2 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 13 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032401-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032401-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-5397684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (-)-(1S,5S,7aS)-1-tert-Butoxy-7a-ethyl-7,7a-dihydroindan-5-yl-formate
(XIV, R2 = hydrogen, R3 = tert-butyl)): Formic acid (2.45 mL, 65.0 mmol)
was slowly added at room temperature to a solution of
N,N'-carbonyldiimidazole (10.5 g, 64.5 mmol) in THF 35 (200 mL). The
resulting mixture was stirred for 24 h at room temperature. The solvent
was removed and the residue was dried for 30 min in vacuo and then
resolved in THF (40 mL). A solution of the alcohol XIII (7.46 g, 31.3
mmol) in THF (10 mL) was added at room temperature and the mixture was
stirred for further 3 h. The solvent was removed in vacuo, the residue
then resolved in n-pentane (200 mL) and decanted from insoluble
components. The organic layer was washed with brine and dried over
Na2SO4. Removal of the solvent afforded compound XIV (8.13 g, 97 %) as
colourless oil.
(-)-(1S,5S,7aS)-1-tert-Butoxy-7a-ethyl-7,7a-dihydroindan-5-yl-formate,
yield (8.13 g, 97 %) Rf = 0.66 (n-pentane/EtOAc 4:1); [α] D 20 = -60.0 (c
= 1.0 in CHCl3); 1H NMR (500 MHz, CDCl3): δ = 0.94 (t, J=7.6 Hz, 3 H,
7a-CH2CH3), 1.13 (s, 9H, 1-OC(CH3)3), 1.32 (dt, J= 13.2 Hz, 3.5 Hz, 1H,
7-Ha), 1.48 (dq, J=14.8 Hz, 7.6 Hz, 1H, 7a-CHaHbCH3), 1.63 (dq, J= 14.8
Hz, 7.6 Hz, 1 H, 7a- CHaHbCH3), 1.66-1.75 (m, 2H, 2-Ha, 6-Ha), 1.85-1.98
(m, 2H, 2-Hb, 6-Hb), 2.01 (ddd, J= 13.2 Hz, 5.8 Hz, 3.5 Hz, 1H, 7-Hb),
2.08 (mc, 1H, 3-Ha), 2.43 (mc, 1H, 3-Hb), 3.46 10 (t, J= 8.7 Hz, 1H,
1-H), 5.38-5.45 (m, 2H, 4-H, 5-H), 8.07 (d, J= 0.9 Hz, 1H, 5-OCHO); 13C
NMR (75.5 MHz, CDCl3): δ = 10.12 (7a-CH2CH3), 24.63 (7a CH2CH3), 25.15
(C- 6), 26.74 (C-3), 28.59 (1-OC(CH3)3), 29.52 (C-7), 30.03 (C-2), 45.54
(C-7a), 70.48 (C-5), 72.57 (1-OC(CH3)3), 80.44 (C-1), 117.6 (C-4), 152.3
(C-3a), 161.2 (5-OCHO); IR(Film): ν ~ = 2971, 1724, 1462, 1363, 1181,
1083, 919, 871 cm-1; UV (CH3CN): λmax (Ig ε) = 197.5 nm (4.0231); MS
(DCI, NH3): m/z (%) = 284.3 (2) [M++NH4], 238.3 (100) [M+-CO2-H2 + NH4];
elemental analysis calcd (%) for C16H26O3 (266.4): C 72.14, H 9.84;
found: C 72.06, H 9.66.
$DTYPE RXN:VAR(1):NOTES
$DATUM third stage dried in vacuo
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of enantiopure desogestrel
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tietze, Lutz Friedjahn; Krimmelbein, Ilga Kristine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009033499 A1 2009-03-19

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,5S,7aS)-1-(1,1-Dimethylethoxy)-7a-ethyl-2,3,5,6,7,7a-hexahydro-1H-inden-5-ol
C15H26O2
1032401-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6748 1.4069 0.0 0
M  V30 2 C 5.3013 0.0000 0.0 0
M  V30 3 O 2.9292 1.9426 0.0 0
M  V30 4 C 1.4647 2.4184 0.0 0
M  V30 5 C 0.9887 0.9537 0.0 0
M  V30 6 C 0.0000 2.8943 0.0 0
M  V30 7 C 1.9406 3.8831 0.0 0
M  V30 8 O 10.2000 2.6528 0.0 0
M  V30 9 C 5.5800 2.6528 0.0 0 CFG=2
M  V30 10 C 4.0738 2.9730 0.0 0 CFG=1
M  V30 11 C 6.3500 3.9864 0.0 0
M  V30 12 C 6.3500 1.3192 0.0 0
M  V30 13 C 3.9127 4.5045 0.0 0
M  V30 14 C 5.3196 5.1310 0.0 0
M  V30 15 C 7.8900 3.9864 0.0 0
M  V30 16 C 7.8900 1.3192 0.0 0
M  V30 17 C 8.6600 2.6528 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 10 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 17 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-Inden-5-ol, 1-(1,1-dimethylethoxy)-7a-ethyl-2,3,5,6,7,7a-hexahydro-, 5-for...
C16H26O3
1032401-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6748 1.4069 0.0 0
M  V30 2 C 5.3013 0.0000 0.0 0
M  V30 3 O 2.9292 1.9426 0.0 0
M  V30 4 C 1.4647 2.4184 0.0 0
M  V30 5 C 0.9887 0.9537 0.0 0
M  V30 6 C 0.0000 2.8943 0.0 0
M  V30 7 C 1.9406 3.8831 0.0 0
M  V30 8 O 10.2000 2.6528 0.0 0
M  V30 9 C 10.9700 3.9864 0.0 0
M  V30 10 O 12.5100 3.9864 0.0 0
M  V30 11 C 5.5800 2.6528 0.0 0 CFG=1
M  V30 12 C 6.3500 3.9864 0.0 0
M  V30 13 C 4.0738 2.9730 0.0 0 CFG=1
M  V30 14 C 6.3500 1.3192 0.0 0
M  V30 15 C 7.8900 3.9864 0.0 0
M  V30 16 C 5.3196 5.1310 0.0 0
M  V30 17 C 3.9127 4.5045 0.0 0
M  V30 18 C 7.8900 1.3192 0.0 0
M  V30 19 C 8.6600 2.6528 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 13 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 19 8 CFG=1
M  V30 10 2 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 13 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032401-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032401-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-6658589
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant (1st stage)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective total synthesis of the oral contraceptive desogestrel by
a double Heck reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tietze, Lutz F.; Krimmelbein, Ilga K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2008), 14(5), 1541-1551

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[4-(3-Aminophenoxy)phenyl]ethyl]formamide
C15H16N2O2
1035450-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 C 10.6698 3.0801 0.0 0
M  V30 3 C 12.0035 2.3101 0.0 0
M  V30 4 N 13.3372 3.0801 0.0 0
M  V30 5 C 14.6708 2.3101 0.0 0
M  V30 6 O 16.0046 3.0801 0.0 0
M  V30 7 N 0.0000 0.0000 0.0 0
M  V30 8 C 6.6687 0.7700 0.0 0
M  V30 9 C 6.6687 2.3101 0.0 0
M  V30 10 C 8.0023 0.0000 0.0 0
M  V30 11 C 8.0023 3.0801 0.0 0
M  V30 12 C 9.3360 0.7700 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 2.6675 0.0000 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 1.3338 0.7700 0.0 0
M  V30 18 C 2.6675 3.0801 0.0 0
M  V30 19 C 1.3338 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-[2-(Formylamino)ethyl]phenoxy]phenyl]formamide
C16H16N2O3
1009807-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 0.0000 0.0 0
M  V30 2 N 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 0.7700 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 13.3372 3.0801 0.0 0
M  V30 6 C 14.6708 2.3101 0.0 0
M  V30 7 N 16.0045 3.0801 0.0 0
M  V30 8 C 17.3383 2.3101 0.0 0
M  V30 9 O 18.6720 3.0801 0.0 0
M  V30 10 C 6.6685 0.7700 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 12.0035 0.7700 0.0 0
M  V30 21 C 12.0035 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 2 3 4
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1035450-75-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009807-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15061913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM mixed anhydride added to amine in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Natural product inspired meta/para'-biaryl ether lactam macrocycles by
double Ugi multicomponent reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Westermann, Bernhard; Michalik, Dirk; Schaks, Angela; Kreye, Oliver;
Wagner, Christoph; Merzweiler, Kurt; Wessjohann, Ludger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2007), 73863-872

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitroaniline
C6H5BrN2O2
10403-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Chloro-5-nitrophenyl)formamide
C7H5ClN2O3
53666-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 Cl 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10403-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53666-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-174-CAS-16654023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of
Potential Drugs for Human African Trypanosomiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patrick, Donald A.; Gillespie, J. Robert; McQueen, Joshua; Hulverson,
Matthew A.; Ranade, Ranae M.; Creason, Sharon A.; Herbst, Zackary M.;
Gelb, Michael H.; Buckner, Frederick S.; Tidwell, Richard R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(3), 957-971

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
2-Bromo-4-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-6-nitrobenzenamine
C19H23BrN4O3
1048379-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.0903 8.0023 0.0 0
M  V30 2 C 13.8603 9.3360 0.0 0
M  V30 3 C 6.9302 5.3348 0.0 0
M  V30 4 C 6.1601 4.0012 0.0 0
M  V30 5 N 1.5400 1.3337 0.0 0 VAL=5
M  V30 6 O 2.3101 0.0000 0.0 0
M  V30 7 O 0.0000 1.3337 0.0 0
M  V30 8 Br 1.5400 6.6685 0.0 0
M  V30 9 N 0.0000 4.0012 0.0 0
M  V30 10 C 13.0903 5.3348 0.0 0
M  V30 11 C 13.8603 6.6685 0.0 0
M  V30 12 C 13.8603 4.0012 0.0 0
M  V30 13 C 15.4003 6.6685 0.0 0
M  V30 14 C 15.4003 4.0012 0.0 0
M  V30 15 C 16.1704 5.3348 0.0 0
M  V30 16 N 11.5503 5.3348 0.0 0
M  V30 17 C 10.7802 6.6685 0.0 0
M  V30 18 C 10.7802 4.0012 0.0 0
M  V30 19 C 9.2402 6.6685 0.0 0
M  V30 20 C 9.2402 4.0012 0.0 0
M  V30 21 N 8.4702 5.3348 0.0 0
M  V30 22 C 4.6201 4.0012 0.0 0
M  V30 23 C 3.8501 2.6675 0.0 0
M  V30 24 C 3.8501 5.3348 0.0 0
M  V30 25 C 2.3101 2.6675 0.0 0
M  V30 26 C 2.3101 5.3348 0.0 0
M  V30 27 C 1.5400 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 4 22
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 25
M  V30 9 1 8 26
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-5-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-1H-benzimidazole
C20H23BrN4O
1061567-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 14.6300 2.6673 0.0 0
M  V30 2 C 10.0100 5.3347 0.0 0
M  V30 3 C 9.2400 4.0009 0.0 0
M  V30 4 O 3.0800 1.3336 0.0 0
M  V30 5 C 2.3100 0.0000 0.0 0
M  V30 6 C 13.8600 6.6684 0.0 0
M  V30 7 C 14.6300 5.3347 0.0 0
M  V30 8 C 12.3200 6.6684 0.0 0
M  V30 9 N 14.8904 7.8127 0.0 0
M  V30 10 C 13.8600 4.0009 0.0 0
M  V30 11 N 16.1363 5.6549 0.0 0
M  V30 12 C 11.5500 5.3347 0.0 0
M  V30 13 C 16.2972 7.1864 0.0 0
M  V30 14 C 12.3200 4.0009 0.0 0
M  V30 15 N 7.7000 4.0009 0.0 0
M  V30 16 C 6.9300 2.6673 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 5.3900 2.6673 0.0 0
M  V30 19 C 5.3900 5.3347 0.0 0
M  V30 20 N 4.6200 4.0009 0.0 0
M  V30 21 C 3.0800 4.0009 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 0.7700 2.6673 0.0 0
M  V30 25 C 0.7700 5.3347 0.0 0
M  V30 26 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 20 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1048379-90-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1061567-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-7329268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7803-57-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney-Ni used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, binding properties and receptor docking of
4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands
of D2 and 5-HT1A receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andric, Deana; Roglic, Goran; Sukalovic, Vladimir; Soskic, Vukic;
Kostic-Rajacic, Sladjana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2008), 43(8), 1696-1705

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Isocyano-4-methoxybenzene
C8H7NO
10349-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 1.3337 0.0 0 CHG=1 VAL=4
M  V30 2 C 8.4701 1.3337 0.0 0 CHG=-1
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10349-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27967593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-Light-Induced Radical Cascade Cyclization: Synthesis of the ABCD
Ring Cores of Camptothecins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Yao; Dong, Wuheng; Gao, Xiaoshuang; Gao, Huang; Xie, Xiaomin;
Zhang, Zhaoguo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(5), 2840-2846

$RFMT $RIREG SCHEME322 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-chlorobenzene
C6H4BrCl
106-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Cl 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Morpholineethanamine
C6H14N2O
2038-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 N 6.9302 2.6673 0.0 0
M  V30 4 N 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Moclobemide
C13H17ClN2O2
71320-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 N 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 Cl 13.8600 4.0011 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 C 10.0100 2.6674 0.0 0
M  V30 9 C 10.0100 5.3349 0.0 0
M  V30 10 C 11.5500 2.6674 0.0 0
M  V30 11 C 11.5500 5.3349 0.0 0
M  V30 12 C 12.3200 4.0011 0.0 0
M  V30 13 N 3.0800 1.3338 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 O 0.0000 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-39-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2038-03-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 71320-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26696887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction mixture from stage 1 added in stage 3, reaction mixture from
stage 2 and 3 added in stage 4, in-situ generated reactant (carbon
monoxide) (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Low-cost instant CO generation at room temperature using formic acid,
mesyl chloride and triethylamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veryser, Cedrick; Van Mileghem, Seger; Egle, Brecht; Gilles, Philippe; De
Borggraeve, Wim M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Reaction Chemistry & Engineering (2016), 1(2), 142-146

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloroaniline
C6H6ClN
108-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chlorophenyl)formamide
C7H6ClNO
139-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 139-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35914081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, zinc oxide nanoparticles catalyst prepared and used,
reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO nanoparticles catalyzed C-N bond-forming reactions: a highly
efficient protocol to convert electron-deficient anilines to formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saikia, Tulan Chandra; Iraqui, Saddam; Rashid, Harunar Md.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry (2022-) (2022), 61(6), 573-581

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloroaniline
C6H6ClN
108-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chlorophenyl)formamide
C7H6ClNO
139-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 139-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22250353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1632541-44-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, ionic liquid used (catalyst), recyclable
catalyst used, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Introduction of Two New Bronsted Acidic Ionic Liquids for the Formamide
and Formamidine Derivatization of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hosseini Lakeh, Elham; Yeganeh Shariyati, Armaghan; Safarpoor Nikoo
Langarudi, Mohaddeseh; Tajik, Hassan; Shirini, Farhad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2020), 5(25), 7488-7491

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloroaniline
C6H6ClN
108-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N,N-dimethylbenzenamine
C8H10ClN
6848-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6848-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25418723
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-53-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6737-42-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 11057-89-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-96-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, conversion >99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM General catalytic methylation of amines with formic acid under mild
reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorribes, Ivan; Junge, Kathrin; Beller, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(26), 7878-7883

$RFMT $RIREG SCHEME325 STEP1
$RXN



  3  1
$MOL
m-Toluidine
C7H9N
108-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methyl]-4-fluoro-3-nitrobenzamide
C14H10ClFN2O3
1096799-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 N 12.0033 1.5400 0.0 0 VAL=5
M  V30 6 O 13.3370 2.3101 0.0 0
M  V30 7 O 12.0033 0.0000 0.0 0
M  V30 8 F 12.0033 4.6201 0.0 0
M  V30 9 Cl 1.3337 0.0000 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 10.6697 2.3101 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methyl]-1-(3-methylphenyl)-1H-benzimidazole-5-carboxamide
C22H18ClN3O
422554-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 N 4.6200 4.0009 0.0 0
M  V30 3 O 4.6200 6.6684 0.0 0
M  V30 4 C 3.0800 4.0009 0.0 0
M  V30 5 C 16.7346 4.5456 0.0 0
M  V30 6 Cl 0.0000 4.0009 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 N 11.5164 5.6549 0.0 0
M  V30 9 C 9.2400 6.6684 0.0 0
M  V30 10 C 9.2400 4.0009 0.0 0
M  V30 11 C 11.6774 7.1864 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 N 10.2706 7.8127 0.0 0
M  V30 14 C 7.7000 4.0009 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 12.6608 4.6243 0.0 0
M  V30 17 C 14.1255 5.1003 0.0 0
M  V30 18 C 12.3406 3.1180 0.0 0
M  V30 19 C 15.2699 4.0698 0.0 0
M  V30 20 C 13.4852 2.0876 0.0 0
M  V30 21 C 14.9497 2.5635 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 0.7700 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.0000 1.3336 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 22
M  V30 6 1 5 19
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 16
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 13
M  V30 17 1 12 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-44-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1096799-01-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 422554-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11119537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives for treatment of diseases associated with
protein aggregation and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Linquist, Susan L.; Buchwald, Stephen L.; Tardiff, Daniel; Jui, Nathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014145887 A1 2014-09-18

$RFMT $RIREG SCHEME325 STEP1
$RXN



  3  1
$MOL
m-Toluidine
C7H9N
108-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.0800 0.0 0
M  V30 2 N 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methyl]-4-fluoro-3-nitrobenzamide
C14H10ClFN2O3
1096799-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 N 12.0033 1.5400 0.0 0 VAL=5
M  V30 6 O 13.3370 2.3101 0.0 0
M  V30 7 O 12.0033 0.0000 0.0 0
M  V30 8 F 12.0033 4.6201 0.0 0
M  V30 9 Cl 1.3337 0.0000 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 10.6697 2.3101 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methyl]-1-(3-methylphenyl)-1H-benzimidazole-5-carboxamide
C22H18ClN3O
422554-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 N 4.6200 4.0009 0.0 0
M  V30 3 O 4.6200 6.6684 0.0 0
M  V30 4 C 3.0800 4.0009 0.0 0
M  V30 5 C 16.7346 4.5456 0.0 0
M  V30 6 Cl 0.0000 4.0009 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 N 11.5164 5.6549 0.0 0
M  V30 9 C 9.2400 6.6684 0.0 0
M  V30 10 C 9.2400 4.0009 0.0 0
M  V30 11 C 11.6774 7.1864 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 N 10.2706 7.8127 0.0 0
M  V30 14 C 7.7000 4.0009 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 12.6608 4.6243 0.0 0
M  V30 17 C 14.1255 5.1003 0.0 0
M  V30 18 C 12.3406 3.1180 0.0 0
M  V30 19 C 15.2699 4.0698 0.0 0
M  V30 20 C 13.4852 2.0876 0.0 0
M  V30 21 C 14.9497 2.5635 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 0.7700 2.6673 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.0000 1.3336 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 22
M  V30 6 1 5 19
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 16
M  V30 13 2 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 13
M  V30 17 1 12 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-44-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1096799-01-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 422554-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13416521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7439-89-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM safety (in stage 3), sealed tube used in stages 1 and 2, pressure buildup
due to release of CO2 in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates
α-Synuclein Toxicity in Neurons
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tardiff, Daniel F.; Jui, Nathan T.; Khurana, Vikram; Tambe, Mitali A.;
Thompson, Michelle L.; Chung, Chee Yeun; Kamadurai, Hari B.; Kim, Hyoung
Tae; Lancaster, Alex K.; Caldwell, Kim A.; Caldwell, Guy A.; Rochet,
Jean-Christophe; Buchwald, Stephen L.; Lindquist, Susan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Science (Washington, DC, United States) (2013), 342(6161), 979-983

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)ethanol
C3H9NO
109-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 N 4.0010 0.0000 0.0 0
M  V30 4 O 0.0000 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 2-(methylamino)ethanol (1:1)
C3H9NO.CH2O2
866569-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 N 4.0010 2.3100 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 5.3348 3.0800 0.0 0
M  V30 6 C 2.6674 0.0000 0.0 0
M  V30 7 O 1.3337 0.7700 0.0 0
M  V30 8 O 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 6 7
M  V30 6 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-83-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866569-50-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26001852
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, product is an ionic liquid, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyl ammonium ionic liquids as media for biocatalytic oxidations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Papadopoulou, Athena A.; Tzani, Andromachi; Alivertis, Dimitrios;
Katsoura, Maria H.; Polydera, Angeliki C.; Detsi, Anastasia; Stamatis,
Haralambos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(4), 1147-1158

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2S)-2-Methylbutoxy]benzenamine
C11H17NO
112418-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0 CFG=1
M  V30 4 C 9.2402 0.0000 0.0 0
M  V30 5 C 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 N 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[4-[(2S)-2-Methylbutoxy]phenyl]formamide
C12H17NO2
1111097-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 1.5400 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 1.5400 0.0 0 CFG=1
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 C 10.6697 0.0000 0.0 0
M  V30 6 C 13.3370 1.5400 0.0 0
M  V30 7 N 2.6673 4.6201 0.0 0
M  V30 8 C 1.3337 3.8501 0.0 0
M  V30 9 O 0.0000 4.6201 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112418-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1111097-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5356210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Syntheses of 7-9. After
a mixture of formic acid (1.02 mL, 27.1 mmol) and acetic anhydride (0.511
mL, 5.41 mmol) was stirred at room temperature for 1 h under Ar,
4-((S)-3,7-dimethyloctyloxy)aniline (4a) (1.35 g, 5.41 mmol) in dry ethyl
acetate (10 mL) was added to the mixture at 0°C. The dispersion solution
was stirred at 0°C for 30 min and then at room temperature for 30 min. To
the solution was added ethyl acetate (50 mL), and the mixture was
filtered. The filtrate was washed with H2O (100 mL) and then dried over
anhydrous MgSO4 After the solvent was removed under reduced pressure, the
crude product was purified by SEC with CHCl3 as the eluent. Product 7b:
97% yield. mp 40.9-41.7°C. IR (KBr, cm-1): 3270 (ν N-H), 1683 (amide I),
1512 (amide Π), 1247 (ν C-O ether). 1H NMR (CDCl3, rt, 300 MHz, δ):
0.91-0.97 (m, CH3, 3H), 0.99-1.02 (m, CH3, 3H), 1.17-1.34 (m, CH2, 1H),
1.48-1.63 (m, CH2, 1H), 1.77-1.91 (m, CH, 1H), 3.66-3.82 (m, CH2, 2H),
6.81-6.90 (m, Hm to NH, 2H), 6.99-7.05 (m, Ho to NH in trans, 1H),
7.40-7.45 (m, Ho to NH in cis, 1H), 7.73 (s, HCO in cis, 0.5H), 8.29 (d,
J = 1.8 Hz, NH in cis, 0.5H), 8.44-8.54 (m, HCO and NH in trans, 1H). 13C
NMR (CDCl3, rt, 75 MHz, δ): 11.49, 16.70, 26.30, 34.89, 73.38, 73.46,
115.04, 115.69, 121.72, 122.00, 129.60, 130.00, 156.67, 157.56, 159.31,
163.51.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Helical Polyisocyanides with Fan-Shaped Pendants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kajitani, Takashi; Lin, Hongzhen; Nagai, Kanji; Okoshi, Kento; Onouchi,
Hisanari; Yashima, Eiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Macromolecules (Washington, DC, United States) (2009), 42(2), 560-567

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzophenone
C13H11NO
1137-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 6.6684 1.5400 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 C 8.0021 2.3100 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Benzoylphenyl)formamide
C14H11NO2
86490-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 N 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 2 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1137-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86490-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15178053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(4-Benzoyl)phenyl Isocyanide (14). N-(4-Benzoylphenyl)formamide: A
mixture of Ac2O (21.0 mL, 222 mmol) and formic acid (12.0 mL, 318 mmol)
was heated at 65 °C for 3 h. The mixed anhydride was added under reflux
to a solution of 4-aminobenzophenone (13; 4.00 g, 20.3 mmol) and Et3N
(9.00 mL, 64.6 mmol) in THF (150 mL). The resulting mixture was refluxed
for further 3 h. After cooling to r.t., the solvent was evaporated and
the residue was taken up in EtOAc (200 mL) and H2O (50 mL). The solution
was neutralized with solid Na2CO3. The organic phase was separated and
washed with sat. aq NaHCO3 (2 × 50 mL) and brine (2 × 50 mL). After
drying (Na2SO4), the organic solvent was evaporated.
N-(4-Benzoylphenyl)formamide. Yield: (4.43 g, 97%) as a white solid. mp
85.9-87.5 °C; Rf = 0.41 (hexanes-EtOAc, 1:1). 1H NMR (300 MHz, CDCl3): δ
= 7.23 (m, 2 H, CH), 7.40-7.50 (m, 4 H, CH), 7.52-7.62 (m, 2 H, CH),
7.69-7.87 (m, 10 H), 8.28 (s, 1 H), 8.43 (s, 1 H), 8.89 (m, 2 H). 13C NMR
(75 MHz, CDCl3): δ = 117.1, 119.1, 128.3, 128.4, 129.7, 129.8, 131.6,
132.2, 132.4, 132.5, 133.3, 133.8, 137.4, 137.6, 140.8, 140.9, 159.4,
162.0, 195.5, 195.9. ESI-MS: m/z = 226.4 [M + H]+, 224.4 [M - H]-. HRMS
(ESI): m/z calcd for C14H10NO2 [M - H]-: 224.07115; found: 224.07126.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoaffinity-labeled peptoids and depsipeptides by multicomponent
reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Henze, Michael; Kreye, Oliver; Brauch, Sebastian; Nitsche, Christoph;
Naumann, Kai; Wessjohann, Ludger A.; Westermann, Bernhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (17), 2997-3003

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-methionyl-L-leucylglycyl-L-phenylalanine m...
C28H44N4O7S
1197155-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 10.0101 0.0 0 CFG=1
M  V30 2 C 4.0011 8.4701 0.0 0
M  V30 3 N 5.3348 10.7801 0.0 0
M  V30 4 C 2.6675 10.7801 0.0 0
M  V30 5 C 6.6686 10.0101 0.0 0
M  V30 6 O 2.6675 12.3201 0.0 0
M  V30 7 O 1.3338 10.0101 0.0 0
M  V30 8 C 8.0022 10.7801 0.0 0
M  V30 9 O 6.6686 8.4701 0.0 0
M  V30 10 C 1.3338 13.0901 0.0 0
M  V30 11 N 9.3359 10.0101 0.0 0
M  V30 12 C 10.6695 10.7801 0.0 0
M  V30 13 C 12.0034 10.0101 0.0 0 CFG=2
M  V30 14 O 10.6695 12.3201 0.0 0
M  V30 15 N 12.0034 8.4701 0.0 0
M  V30 16 C 13.3370 10.7801 0.0 0
M  V30 17 C 13.3370 7.7001 0.0 0
M  V30 18 C 13.3370 12.3201 0.0 0
M  V30 19 C 13.3370 6.1601 0.0 0 CFG=2
M  V30 20 O 14.6707 8.4701 0.0 0
M  V30 21 C 14.6707 13.0901 0.0 0
M  V30 22 C 12.0034 13.0901 0.0 0
M  V30 23 N 12.0034 5.3901 0.0 0
M  V30 24 C 14.6707 5.3901 0.0 0
M  V30 25 C 12.0034 3.8500 0.0 0
M  V30 26 C 16.0043 6.1601 0.0 0
M  V30 27 O 10.6695 3.0800 0.0 0
M  V30 28 O 13.3370 3.0800 0.0 0
M  V30 29 S 17.3381 5.3901 0.0 0
M  V30 30 C 10.6695 1.5400 0.0 0
M  V30 31 C 18.6718 6.1601 0.0 0
M  V30 32 C 9.1295 1.5400 0.0 0
M  V30 33 C 10.6695 0.0000 0.0 0
M  V30 34 C 12.2096 1.5400 0.0 0
M  V30 35 C 2.6675 7.7001 0.0 0
M  V30 36 C 1.3337 8.4701 0.0 0
M  V30 37 C 2.6675 6.1601 0.0 0
M  V30 38 C 0.0000 7.7001 0.0 0
M  V30 39 C 1.3337 5.3901 0.0 0
M  V30 40 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 35
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24 CFG=3
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 25 28
M  V30 29 1 26 29
M  V30 30 1 27 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 30 33
M  V30 34 1 30 34
M  V30 35 2 35 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 2 37 39
M  V30 39 2 38 40
M  V30 40 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 13 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-L-methionyl-L-leucylglycyl-L-phenylalanine methyl ester
C24H36N4O6S
1197155-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 8.0022 0.0 0 CFG=1
M  V30 2 C 4.6201 9.3360 0.0 0
M  V30 3 N 4.6201 6.6685 0.0 0
M  V30 4 C 2.3101 8.0022 0.0 0
M  V30 5 C 6.1601 6.6685 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 O 1.5400 9.3360 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 O 6.9302 8.0022 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 N 8.4702 5.3348 0.0 0
M  V30 12 C 9.2402 4.0010 0.0 0
M  V30 13 C 10.7802 4.0010 0.0 0 CFG=2
M  V30 14 O 8.4702 2.6673 0.0 0
M  V30 15 N 11.5503 5.3348 0.0 0
M  V30 16 C 11.5503 2.6673 0.0 0
M  V30 17 C 13.0903 5.3348 0.0 0
M  V30 18 C 10.7802 1.3337 0.0 0
M  V30 19 C 13.8603 6.6685 0.0 0 CFG=1
M  V30 20 O 13.8603 4.0010 0.0 0
M  V30 21 C 11.5503 0.0000 0.0 0
M  V30 22 C 9.2402 1.3337 0.0 0
M  V30 23 C 15.4003 6.6685 0.0 0
M  V30 24 N 13.0903 8.0022 0.0 0
M  V30 25 C 16.1704 8.0022 0.0 0
M  V30 26 C 13.8603 9.3358 0.0 0
M  V30 27 S 17.7104 8.0022 0.0 0
M  V30 28 O 13.0903 10.6697 0.0 0
M  V30 29 C 18.4804 9.3358 0.0 0
M  V30 30 C 3.8501 10.6697 0.0 0
M  V30 31 C 4.6201 12.0033 0.0 0
M  V30 32 C 2.3101 10.6697 0.0 0
M  V30 33 C 3.8501 13.3370 0.0 0
M  V30 34 C 1.5400 12.0033 0.0 0
M  V30 35 C 2.3101 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 30
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24 CFG=1
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 2 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 2 32 34
M  V30 34 2 33 35
M  V30 35 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 13 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1197155-91-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1197155-92-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5141317
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16357-59-8
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solution phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe
analogues incorporating spacer amino acids at the lateral positions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucente, Gino; Giordano, Cesare; Sansone, Anna; Torino, Domenica;
Spisani, Susanna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2009), 37(2), 285-295

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z,8Z)-5,8-Tetradecadien-1-ol
C14H26O
121695-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1600 0.0 0
M  V30 2 C 4.0011 6.9300 0.0 0
M  V30 3 C 6.6684 6.9300 0.0 0
M  V30 4 C 2.6673 6.1600 0.0 0
M  V30 5 C 8.0021 6.1600 0.0 0
M  V30 6 C 2.6673 4.6200 0.0 0
M  V30 7 C 8.0021 4.6200 0.0 0
M  V30 8 C 1.3336 3.8500 0.0 0
M  V30 9 C 9.3358 3.8500 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 9.3358 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 10.6694 1.5400 0.0 0
M  V30 14 C 0.0000 0.0000 0.0 0
M  V30 15 O 10.6694 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Tetradecadien-1-ol, formate, (Z,Z)-
C15H26O2
169054-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 9.3359 0.0 0
M  V30 2 C 2.3100 8.0022 0.0 0
M  V30 3 C 4.6201 9.3359 0.0 0
M  V30 4 C 0.7700 8.0022 0.0 0
M  V30 5 C 5.3901 8.0022 0.0 0
M  V30 6 C 0.0000 6.6684 0.0 0
M  V30 7 C 6.9301 8.0022 0.0 0
M  V30 8 C 0.7700 5.3348 0.0 0
M  V30 9 C 7.7001 6.6684 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 9.2401 6.6684 0.0 0
M  V30 12 C 0.7700 2.6675 0.0 0
M  V30 13 O 10.0101 5.3348 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 15 C 11.5501 5.3348 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 O 12.3201 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121695-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 169054-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-21160456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Steglich esterification
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and field test of a pheromone analog of Chilecomadia valdiviana
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Herrera, Heidy; Barros-Parada, Wilson; Flores, M. Fernanda;
Fuentes-Contreras, Eduardo; Bergmann, Jan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chilean Chemical Society (2018), 63(2), 4019-4022

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3-nitrobenzene
C6H4ClNO2
121-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chlorophenyl)formamide
C7H6ClNO
139-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 139-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-522-CAS-22062813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM decorated on covalent organic framework
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1491156-89-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, solid-supported catalyst, silver
nanoparticles-decorated covalent organic framework catalyst prepared and
used, reusable catalyst, sunlight irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of Ag/TFPG-DMB COF in carbamates synthesis via CO2 fixation
reaction and one-pot reductive N-formylation of nitroarenes under
sunlight
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hazra Chowdhury, Arpita; Hazra Chowdhury, Ipsita; Biswas, Surajit; Islam,
Sk. Manirul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Catalysis (2020), 493111050

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1H-Imidazol-1-yl)-1H-benzimidazole
C10H8N4
123396-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0372 1.5400 0.0 0
M  V30 2 N 4.1320 0.2941 0.0 0
M  V30 3 N 4.1320 2.7859 0.0 0
M  V30 4 C 2.6674 0.7700 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 1.3338 3.0800 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 N 6.5772 1.5400 0.0 0
M  V30 11 C 7.4824 0.2941 0.0 0
M  V30 12 C 7.4824 2.7859 0.0 0
M  V30 13 C 8.9471 0.7700 0.0 0
M  V30 14 N 8.9471 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1H-Imidazol-1-yl)-1-methyl-1H-benzimidazole
C11H10N4
22509-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6080 0.0000 0.0 0
M  V30 2 C 5.0372 2.7104 0.0 0
M  V30 3 N 4.1320 1.4645 0.0 0
M  V30 4 N 4.1320 3.9564 0.0 0
M  V30 5 C 2.6674 1.9404 0.0 0
M  V30 6 C 2.6674 3.4804 0.0 0
M  V30 7 C 1.3338 1.1704 0.0 0
M  V30 8 C 1.3338 4.2504 0.0 0
M  V30 9 C 0.0000 1.9404 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 N 6.5772 2.7104 0.0 0
M  V30 12 C 7.4824 3.9564 0.0 0
M  V30 13 C 7.4824 1.4645 0.0 0
M  V30 14 C 8.9471 3.4804 0.0 0
M  V30 15 N 8.9471 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123396-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22509-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21029288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of tertiary amine by direct N-alkylation of secondary
amine with carboxylic acid using Ni (0) encat catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quadri, Syed Aziz Imam; Das, Tonmoy C.; Jadhav, Shivaji; Farooqui,
Mazahar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2018), 48(3), 267-277

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Bromophenyl)-4-hydrazinyl-7-phenyl-7H-pyrrolo[2,3-d]pyrimidine
C18H14BrN5
1257391-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0821 5.9145 0.0 0
M  V30 2 N 11.6221 5.9145 0.0 0
M  V30 3 Br 0.0000 8.1789 0.0 0
M  V30 4 N 5.4956 3.5673 0.0 0
M  V30 5 C 5.3347 5.0989 0.0 0
M  V30 6 C 7.0021 3.2471 0.0 0
M  V30 7 C 6.7417 5.7253 0.0 0
M  V30 8 C 7.7721 4.5809 0.0 0
M  V30 9 N 7.7721 1.9135 0.0 0
M  V30 10 C 9.3121 4.5809 0.0 0
M  V30 11 C 9.3121 1.9135 0.0 0
M  V30 12 N 10.0821 3.2471 0.0 0
M  V30 13 C 4.3513 2.5368 0.0 0
M  V30 14 C 4.6714 1.0306 0.0 0
M  V30 15 C 2.8866 3.0127 0.0 0
M  V30 16 C 3.5271 0.0000 0.0 0
M  V30 17 C 1.7422 1.9823 0.0 0
M  V30 18 C 2.0624 0.4760 0.0 0
M  V30 19 C 4.0011 5.8689 0.0 0
M  V30 20 C 2.6674 5.0989 0.0 0
M  V30 21 C 4.0011 7.4089 0.0 0
M  V30 22 C 1.3336 5.8689 0.0 0
M  V30 23 C 2.6674 8.1789 0.0 0
M  V30 24 C 1.3336 7.4089 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 24
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 2 6 8
M  V30 10 1 6 9
M  V30 11 1 7 8
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(4-Bromophenyl)-7-phenyl-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine
C19H12BrN5
1257391-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 12.3416 5.6398 0.0 0
M  V30 2 N 5.2764 4.3938 0.0 0
M  V30 3 C 3.8118 4.8698 0.0 0
M  V30 4 C 6.1816 5.6398 0.0 0
M  V30 5 C 3.8118 6.4098 0.0 0
M  V30 6 N 2.4782 4.0998 0.0 0
M  V30 7 C 5.2764 6.8857 0.0 0
M  V30 8 C 2.4782 7.1798 0.0 0
M  V30 9 C 1.1444 4.8698 0.0 0
M  V30 10 N 1.1444 6.4098 0.0 0
M  V30 11 N 2.1579 8.6861 0.0 0
M  V30 12 N 0.0000 7.4402 0.0 0
M  V30 13 C 0.6263 8.8470 0.0 0
M  V30 14 C 5.7524 2.9292 0.0 0
M  V30 15 C 4.7218 1.7847 0.0 0
M  V30 16 C 7.2587 2.6091 0.0 0
M  V30 17 C 5.1977 0.3202 0.0 0
M  V30 18 C 7.7345 1.1444 0.0 0
M  V30 19 C 6.7041 0.0000 0.0 0
M  V30 20 C 7.7216 5.6398 0.0 0
M  V30 21 C 8.4916 6.9735 0.0 0
M  V30 22 C 8.4916 4.3060 0.0 0
M  V30 23 C 10.0316 6.9735 0.0 0
M  V30 24 C 10.0316 4.3060 0.0 0
M  V30 25 C 10.8016 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 14
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 4 20
M  V30 9 1 5 7
M  V30 10 1 5 8
M  V30 11 2 6 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 10
M  V30 15 1 10 12
M  V30 16 1 11 13
M  V30 17 2 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1257391-92-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257391-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30337566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial
and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hassan Hilmy, Khalid Mohammed; Khalifa, Maha M. A.; Allah Hawata,
Mohammed Abd; AboAlzeen Keshk, Reda Mohammed; El-Torgman, Abd Almeneam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2010), 45(11), 5243-5250

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3,4-Diaminophenyl)-4-(3-fluorophenyl)-2-oxazolidinone
C15H14FN3O2
1276024-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4873 0.7102 0.0 0
M  V30 2 N 0.0000 5.1046 0.0 0
M  V30 3 F 11.2251 3.9248 0.0 0
M  V30 4 N 1.5400 7.7721 0.0 0
M  V30 5 N 4.6200 2.4374 0.0 0
M  V30 6 C 6.1515 2.2764 0.0 0
M  V30 7 C 3.9935 1.0304 0.0 0
M  V30 8 C 6.4717 0.7700 0.0 0
M  V30 9 O 5.1381 0.0000 0.0 0
M  V30 10 C 3.8500 3.7710 0.0 0
M  V30 11 C 2.3100 3.7710 0.0 0
M  V30 12 C 4.6200 5.1046 0.0 0
M  V30 13 C 1.5400 5.1046 0.0 0
M  V30 14 C 3.8500 6.4384 0.0 0
M  V30 15 C 2.3100 6.4384 0.0 0
M  V30 16 C 7.1819 3.4208 0.0 0
M  V30 17 C 8.6884 3.1006 0.0 0
M  V30 18 C 6.7061 4.8855 0.0 0
M  V30 19 C 9.7188 4.2450 0.0 0
M  V30 20 C 7.7365 6.0299 0.0 0
M  V30 21 C 9.2429 5.7097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 1 3 19
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-3-(1H-Benzimidazol-6-yl)-4-(3-fluorophenyl)-2-oxazolidinone
C16H12FN3O2
1276023-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.8562 0.1437 0.0 0
M  V30 2 F 11.7348 5.1046 0.0 0
M  V30 3 N 5.5833 2.2764 0.0 0
M  V30 4 C 7.1148 2.4374 0.0 0 CFG=1
M  V30 5 C 5.2629 0.7700 0.0 0
M  V30 6 C 7.7411 1.0304 0.0 0
M  V30 7 O 6.5967 0.0000 0.0 0
M  V30 8 C 4.5527 3.4208 0.0 0
M  V30 9 C 3.0464 3.1006 0.0 0
M  V30 10 C 5.0286 4.8855 0.0 0
M  V30 11 C 2.0159 4.2450 0.0 0
M  V30 12 C 3.9981 6.0299 0.0 0
M  V30 13 C 2.4919 5.7097 0.0 0
M  V30 14 N 0.4759 4.2450 0.0 0
M  V30 15 N 1.2459 6.6149 0.0 0
M  V30 16 C 0.0000 5.7097 0.0 0
M  V30 17 C 7.8848 3.7710 0.0 0
M  V30 18 C 9.4248 3.7710 0.0 0
M  V30 19 C 7.1148 5.1046 0.0 0
M  V30 20 C 10.1948 5.1046 0.0 0
M  V30 21 C 7.8848 6.4384 0.0 0
M  V30 22 C 9.4248 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 4 17 CFG=1
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 12 13
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1276024-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1276023-27-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1937970
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Then the above product (450mg, 1.56mmol) was dissolved in formic acid,
yield: 450mg (96.77%). Conversion into HCl-salt: Free base (440mg,
1.48mmol) in acetone and 1M HCl in ether (1.8mL, 1.8mmol) yield: 60mg
(74%). MS m/z 298.2 (M+H)+; 1H-NMR (400MHz, DMSO-d6): δ 9.35 (bs, 1H);
7.91(s, 1H); 7.75(d, 1H); 7.56 (d, 1H); 7.25-7.41(m, 3H); 7.13-7.09(m,
1H); 5.88(t, 1H); 4.88(t, 1H); 4.21(q,1H); HPLC (λ = 214 nm, [A]: rt 8.93
min (100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, product isolated as HCl salt in 74% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic imidazole derivatives as therapeutic
inhibitors of glutaminyl cyclase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heiser, Ulrich; Sommer, Robert; Ramsbeck, Daniel; Meyer, Antje; Hoffmann,
Torsten; Boehme, Livia; Demuth, Hans-Ulrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011029920 A1 2011-03-17

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-3-Amino-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl][(1R)-1-phenylethyl]...
C33H38N2O3
1315510-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 12.0031 4.6200 0.0 0
M  V30 2 C 12.0031 3.0800 0.0 0 CFG=1
M  V30 3 C 10.6694 5.3900 0.0 0
M  V30 4 C 13.3369 5.3900 0.0 0 CFG=2
M  V30 5 C 13.3369 2.3100 0.0 0
M  V30 6 C 10.6694 6.9300 0.0 0 CFG=1
M  V30 7 C 14.6705 4.6200 0.0 0
M  V30 8 C 13.3369 6.9300 0.0 0
M  V30 9 O 12.0031 7.7000 0.0 0
M  V30 10 N 8.0020 11.5500 0.0 0
M  V30 11 O 5.3347 10.0100 0.0 0
M  V30 12 C 4.0011 9.2400 0.0 0
M  V30 13 O 20.0052 7.7000 0.0 0
M  V30 14 C 21.3389 6.9300 0.0 0
M  V30 15 C 10.6694 2.3100 0.0 0
M  V30 16 C 10.6694 0.7700 0.0 0
M  V30 17 C 9.3358 3.0800 0.0 0
M  V30 18 C 9.3358 0.0000 0.0 0
M  V30 19 C 8.0020 2.3100 0.0 0
M  V30 20 C 8.0020 0.7700 0.0 0
M  V30 21 C 9.3358 7.7000 0.0 0
M  V30 22 C 9.3358 9.2400 0.0 0
M  V30 23 C 8.0020 6.9300 0.0 0
M  V30 24 C 8.0020 10.0100 0.0 0
M  V30 25 C 6.6684 7.7000 0.0 0
M  V30 26 C 6.6684 9.2400 0.0 0
M  V30 27 C 16.0041 5.3900 0.0 0
M  V30 28 C 17.3378 4.6200 0.0 0
M  V30 29 C 16.0041 6.9300 0.0 0
M  V30 30 C 18.6716 5.3900 0.0 0
M  V30 31 C 17.3378 7.7000 0.0 0
M  V30 32 C 18.6716 6.9300 0.0 0
M  V30 33 C 2.6673 10.0100 0.0 0
M  V30 34 C 1.3336 9.2400 0.0 0
M  V30 35 C 2.6673 11.5500 0.0 0
M  V30 36 C 0.0000 10.0100 0.0 0
M  V30 37 C 1.3336 12.3200 0.0 0
M  V30 38 C 0.0000 11.5500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 15
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8 CFG=3
M  V30 9 1 6 9 CFG=1
M  V30 10 1 6 21
M  V30 11 1 7 27
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 1 11 26
M  V30 15 1 12 33
M  V30 16 1 13 14
M  V30 17 1 13 32
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[5-[(1R)-1-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl][(1R)-1-pheny...
C34H38N2O4
1316100-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 10.0100 0.0 0
M  V30 2 C 4.0011 9.2400 0.0 0
M  V30 3 N 8.0020 11.5500 0.0 0
M  V30 4 C 9.3358 12.3200 0.0 0
M  V30 5 O 9.3358 13.8600 0.0 0
M  V30 6 C 10.6694 6.9300 0.0 0 CFG=1
M  V30 7 C 10.6694 5.3900 0.0 0
M  V30 8 O 12.0031 7.7000 0.0 0
M  V30 9 N 12.0031 4.6200 0.0 0
M  V30 10 C 12.0031 3.0800 0.0 0 CFG=1
M  V30 11 C 13.3369 5.3900 0.0 0 CFG=2
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 4.6200 0.0 0
M  V30 14 C 13.3369 6.9300 0.0 0
M  V30 15 O 20.0052 7.7000 0.0 0
M  V30 16 C 21.3389 6.9300 0.0 0
M  V30 17 C 6.6684 9.2400 0.0 0
M  V30 18 C 8.0020 10.0100 0.0 0
M  V30 19 C 6.6684 7.7000 0.0 0
M  V30 20 C 9.3358 9.2400 0.0 0
M  V30 21 C 8.0020 6.9300 0.0 0
M  V30 22 C 9.3358 7.7000 0.0 0
M  V30 23 C 2.6673 10.0100 0.0 0
M  V30 24 C 2.6673 11.5500 0.0 0
M  V30 25 C 1.3336 9.2400 0.0 0
M  V30 26 C 1.3336 12.3200 0.0 0
M  V30 27 C 0.0000 10.0100 0.0 0
M  V30 28 C 0.0000 11.5500 0.0 0
M  V30 29 C 10.6694 2.3100 0.0 0
M  V30 30 C 9.3358 3.0800 0.0 0
M  V30 31 C 10.6694 0.7700 0.0 0
M  V30 32 C 8.0020 2.3100 0.0 0
M  V30 33 C 9.3358 0.0000 0.0 0
M  V30 34 C 8.0020 0.7700 0.0 0
M  V30 35 C 16.0041 5.3900 0.0 0
M  V30 36 C 16.0041 6.9300 0.0 0
M  V30 37 C 17.3378 4.6200 0.0 0
M  V30 38 C 17.3378 7.7000 0.0 0
M  V30 39 C 18.6716 5.3900 0.0 0
M  V30 40 C 18.6716 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 2 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12 CFG=3
M  V30 14 1 10 29
M  V30 15 1 11 13
M  V30 16 1 11 14 CFG=3
M  V30 17 1 13 35
M  V30 18 1 15 16
M  V30 19 1 15 40
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315510-05-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1316100-17-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3005518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of
(R,R)-N-(2-Benzyloxy-5-{1-hydroxy-2-[[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-amino]-ethyl)-phenyl)-formamide
(VI) 24 mL (0.63 mol) of formic acid was added to 27 mL (0.28 mol) of
acetic anhydride and stirred at 50 °C for 2 h under nitrogen atmosphere.
The resulting mixture was diluted with 100 mL of CH2Cl2 and cooled to 0
°C. A solution of 78 g (0.15 mol) of V in 300 mL de CH2Cl2 was slowly
added and stirred for 1h at 0 °C. Then, 150 mL of 10% K2CO3 aqueous
solution were added and stirred at 0 °C for 15 min. The organic phase was
washed twice with 400 mL of 10% K2CO3 aqueous solution and concentrated
under reduced pressure to give 80 g (97% yield, 100% e.e.) (75% chemical
purity) of compound VIas an oil.
(R,R)-N-(2-Benzyloxy-5-{1-hydroxy-2-[[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-amino]-ethyl)-phenyl)-formamide
(VI), yield 80 g, 97%. 1H-NMR (200 MHz, CDCl3) δ: 0.98 (d, 3H); 1.42 (d,
3H), 2.60-2.90 (m, 4H); 3.20-3.30 (m, 1H); 3.75 (s, 3H); 4.10-4.20 (m,
1H); 4.30-4.40 (m, 1H), 5.09 (s, 2H); 6.67-7.41 (m, 17H); 8.4 (d, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of intermediates of arformoterol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Navarro Munoz, Isabel; Huguet Clotet, Juan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2348013 A1 2011-07-27

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-(6-quinolinylmethyl)-2,3-pyridinediamine
C15H13ClN4
1350425-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0011 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0
M  V30 4 Cl 0.0000 5.3348 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 C 10.0101 4.0011 0.0 0
M  V30 7 C 7.7001 5.3348 0.0 0
M  V30 8 C 10.0101 6.6686 0.0 0
M  V30 9 C 9.2401 2.6675 0.0 0
M  V30 10 N 11.5501 4.0011 0.0 0
M  V30 11 C 6.9301 4.0011 0.0 0
M  V30 12 C 11.5501 6.6686 0.0 0
M  V30 13 C 7.7001 2.6675 0.0 0
M  V30 14 C 12.3201 5.3348 0.0 0
M  V30 15 C 3.0800 2.6675 0.0 0
M  V30 16 C 2.3100 1.3338 0.0 0
M  V30 17 N 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 1.3338 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 15
M  V30 4 1 3 16
M  V30 5 1 4 19
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(5-Chloro-3H-imidazo[4,5-b]pyridin-3-yl)methyl]quinoline
C16H11ClN4
1350426-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 Cl 12.9850 2.5770 0.0 0
M  V30 3 C 9.2315 4.1620 0.0 0
M  V30 4 N 7.7000 4.0011 0.0 0
M  V30 5 C 9.5517 5.6684 0.0 0
M  V30 6 N 10.3759 3.1316 0.0 0
M  V30 7 C 7.0735 5.4079 0.0 0
M  V30 8 N 8.2181 6.4384 0.0 0
M  V30 9 C 11.0164 6.1443 0.0 0
M  V30 10 C 11.8406 3.6074 0.0 0
M  V30 11 C 12.1608 5.1139 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.0800 1.3336 0.0 0
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 19 N 0.7700 2.6674 0.0 0
M  V30 20 C 0.7700 0.0000 0.0 0
M  V30 21 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350425-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350426-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-5400176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 34:
6-((5-chloro-3H-imidazo[4,5-b]pyridin-3-yl)methyl)quinoline::
Intermediate 5 (0.200 g, 0.702 mmol) was dissolved in formic acid (1.0
ml), heated to 100 °C and stirred for 12h. The reaction mixture was
poured into ice water and pH adjusted to 7-8 with sodium bicarbonate
solution, extracted with ethyl acetate, washed with brine, dried over
sodium sulphate and concentrated to afford the title compound. Yield:
(0.200 g, 97%), yellowish brown solid. 1H-NMR (δ ppm, DMSO-d6, 400 MHz):
δ 8.88 (dd, J = 4.0,1.3Hz, 1H), 8.70 (s, 1H), 8.33 (d, J = 8.2Hz, 1H),
8.19 (d, J = 8.3Hz, 1H), 8.01 (d, J = 8.8Hz, 1H), 7.81 (s, 1H), 7.73 (dd,
J = 8.7,1.7Hz, 1H), 7.52 (dd, J = 8.3,2.2Hz, 1H), 7.37 (d, J = 8.4Hz,
1H), 5.69 (s, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of disubstituted imidazo[4,5-b]pyridine and disubstituted
[1,2,3]triazolo[4,5-b]pyridine compounds as c-Met protein kinases
inhibitors for treatment of kinase-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vakkalanka, Swaroop Kumar Venkata Satya; Nagarathnam, Dhanapalan;
Viswanadha, Srikant; Muthuppalaniappan, Meyyappan; Babu, Govindarajulu;
Bhavar, Prashant K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013144737 A2 2013-10-03

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-(6-quinolinylmethyl)-2,3-pyridinediamine
C15H13ClN4
1350425-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0011 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0
M  V30 4 Cl 0.0000 5.3348 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 C 10.0101 4.0011 0.0 0
M  V30 7 C 7.7001 5.3348 0.0 0
M  V30 8 C 10.0101 6.6686 0.0 0
M  V30 9 C 9.2401 2.6675 0.0 0
M  V30 10 N 11.5501 4.0011 0.0 0
M  V30 11 C 6.9301 4.0011 0.0 0
M  V30 12 C 11.5501 6.6686 0.0 0
M  V30 13 C 7.7001 2.6675 0.0 0
M  V30 14 C 12.3201 5.3348 0.0 0
M  V30 15 C 3.0800 2.6675 0.0 0
M  V30 16 C 2.3100 1.3338 0.0 0
M  V30 17 N 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 1.3338 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 15
M  V30 4 1 3 16
M  V30 5 1 4 19
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(5-Chloro-3H-imidazo[4,5-b]pyridin-3-yl)methyl]quinoline
C16H11ClN4
1350426-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 Cl 12.9850 2.5770 0.0 0
M  V30 3 C 9.2315 4.1620 0.0 0
M  V30 4 N 7.7000 4.0011 0.0 0
M  V30 5 C 9.5517 5.6684 0.0 0
M  V30 6 N 10.3759 3.1316 0.0 0
M  V30 7 C 7.0735 5.4079 0.0 0
M  V30 8 N 8.2181 6.4384 0.0 0
M  V30 9 C 11.0164 6.1443 0.0 0
M  V30 10 C 11.8406 3.6074 0.0 0
M  V30 11 C 12.1608 5.1139 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.0800 1.3336 0.0 0
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 19 N 0.7700 2.6674 0.0 0
M  V30 20 C 0.7700 0.0000 0.0 0
M  V30 21 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350425-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350426-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-3525114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 29:
6-((5-chloro-3H-imidazo[4,5-b]pyridin-3-yl)methyl)quinoline [0603]
Intermediate 9 (0.200 g, 0.702 mmol) was dissolved in formic acid (1.0
ml) and heated to 100° C. and stirred for 12 h. The reaction mixture was
poured into ice water and pH adjusted to 7-8 with sodium bicarbonate
solution, extracted with ethyl acetate, washed with brine, dried over
sodium sulphate and concentrated to afford the title compound. As
yellowish brown solid (0.200 g, 97% yield). 1H-NMR (δ ppm, DMSO-d6, 400
MHz): δ 8.88 (dd, J=4.0, 1.3 Hz, 1H), 8.70 (s, 1H), 8.33 (d, J=8.2 Hz,
1H), 8.19 (d, J=8.3 Hz, 1H), 8.01 (d, J=8.8 Hz, 1H), 7.81 (s, 1H), 7.73
(dd, J=8.7, 1.7 Hz, 1H), 7.52 (dd, J=8.3, 2.2 Hz, 1H), 7.37 (d, J=8.4 Hz,
1H), 5.69 (s, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and
3,5-disubstituted-3H-[1,2,3]triazolo[4,5-b]pyridine compounds as
modulators of protein kinases, especially inhibitors of c-Met and AKt
kinases, for treating cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muthuppalaniappan, Meyyappan; Viswanadha, Srikant; Babu, Govindarajulu;
Vakkalanka, Swaroop Kumar V. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110281865 A1 2011-11-17

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-3-(3-Bromophenoxy)-2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-p...
C16H28BrNO2Si
1357622-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 C 6.6685 0.7700 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 N 8.0022 0.0000 0.0 0
M  V30 8 Si 2.6673 3.0801 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 C 1.8973 1.7464 0.0 0
M  V30 11 C 3.4374 4.4137 0.0 0
M  V30 12 C 2.1037 5.1838 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 0.5637 2.5164 0.0 0
M  V30 15 Br 14.6707 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 13.3370 3.0801 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 15 19
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2R)-3-(3-Bromophenoxy)-2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]p...
C17H28BrNO3Si
1357622-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0 CFG=1
M  V30 2 C 7.7000 6.6684 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 O 9.2400 6.6684 0.0 0
M  V30 6 O 4.6200 6.6684 0.0 0
M  V30 7 N 6.9300 2.6673 0.0 0
M  V30 8 Si 3.0800 6.6684 0.0 0
M  V30 9 C 7.7000 1.3336 0.0 0
M  V30 10 C 1.5400 6.6684 0.0 0
M  V30 11 C 3.0800 5.1284 0.0 0
M  V30 12 C 3.0800 8.2084 0.0 0
M  V30 13 O 6.9300 0.0000 0.0 0
M  V30 14 C 1.5400 5.1284 0.0 0
M  V30 15 C 0.0000 6.6684 0.0 0
M  V30 16 C 1.5400 8.2084 0.0 0
M  V30 17 Br 13.8600 9.3358 0.0 0
M  V30 18 C 10.0100 8.0021 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 9.2400 9.3358 0.0 0
M  V30 21 C 12.3200 9.3358 0.0 0
M  V30 22 C 10.0100 10.6694 0.0 0
M  V30 23 C 11.5500 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 17 21
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357622-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357622-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7103077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity oriented and chemoenzymatic synthesis of densely functionalized
pyrrolidines through a highly diastereoselective Ugi multicomponent
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cerulli, Valentina; Banfi, Luca; Basso, Andrea; Rocca, Valeria; Riva,
Renata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2012), 10(6), 1255-1274

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-3-(3-Bromophenoxy)-2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-p...
C16H28BrNO2Si
1357622-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 C 6.6685 0.7700 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 N 8.0022 0.0000 0.0 0
M  V30 8 Si 2.6673 3.0801 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 C 1.8973 1.7464 0.0 0
M  V30 11 C 3.4374 4.4137 0.0 0
M  V30 12 C 2.1037 5.1838 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 0.5637 2.5164 0.0 0
M  V30 15 Br 14.6707 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 13.3370 3.0801 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 15 19
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2S)-3-(3-Bromophenoxy)-2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]p...
C17H28BrNO3Si
1357622-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 2 C 7.7000 6.6684 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 O 9.2400 6.6684 0.0 0
M  V30 6 O 4.6200 6.6684 0.0 0
M  V30 7 N 6.9300 2.6673 0.0 0
M  V30 8 Si 3.0800 6.6684 0.0 0
M  V30 9 C 7.7000 1.3336 0.0 0
M  V30 10 C 1.5400 6.6684 0.0 0
M  V30 11 C 3.0800 5.1284 0.0 0
M  V30 12 C 3.0800 8.2084 0.0 0
M  V30 13 O 6.9300 0.0000 0.0 0
M  V30 14 C 1.5400 5.1284 0.0 0
M  V30 15 C 0.0000 6.6684 0.0 0
M  V30 16 C 1.5400 8.2084 0.0 0
M  V30 17 Br 13.8600 9.3358 0.0 0
M  V30 18 C 10.0100 8.0021 0.0 0
M  V30 19 C 11.5500 8.0021 0.0 0
M  V30 20 C 9.2400 9.3358 0.0 0
M  V30 21 C 12.3200 9.3358 0.0 0
M  V30 22 C 10.0100 10.6694 0.0 0
M  V30 23 C 11.5500 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 17 21
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357622-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357622-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9321345
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity oriented and chemoenzymatic synthesis of densely functionalized
pyrrolidines through a highly diastereoselective Ugi multicomponent
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cerulli, Valentina; Banfi, Luca; Basso, Andrea; Rocca, Valeria; Riva,
Renata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2012), 10(6), 1255-1274

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Diethyl N-[4-[2-(2,4-diamino-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-y...
C25H34N6O5
1359861-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 17.7100 14.6703 0.0 0
M  V30 2 N 22.3300 12.0031 0.0 0
M  V30 3 C 13.8600 10.6694 0.0 0
M  V30 4 C 13.0900 9.3356 0.0 0
M  V30 5 C 6.9300 9.3356 0.0 0
M  V30 6 N 6.1600 8.0020 0.0 0
M  V30 7 O 6.1600 10.6694 0.0 0
M  V30 8 C 4.6200 8.0020 0.0 0 CFG=2
M  V30 9 C 3.8500 6.6684 0.0 0
M  V30 10 C 3.8500 9.3356 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 O 2.3100 9.3356 0.0 0
M  V30 13 O 4.6200 10.6694 0.0 0
M  V30 14 C 3.8500 4.0009 0.0 0
M  V30 15 C 1.5400 10.6694 0.0 0
M  V30 16 O 4.6200 2.6673 0.0 0
M  V30 17 O 2.3100 4.0009 0.0 0
M  V30 18 C 0.0000 10.6694 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 C 4.6200 0.0000 0.0 0
M  V30 21 C 18.4800 10.6694 0.0 0
M  V30 22 C 17.7100 12.0031 0.0 0
M  V30 23 C 17.7100 9.3356 0.0 0
M  V30 24 N 20.0200 10.6694 0.0 0
M  V30 25 N 16.1700 12.0031 0.0 0
M  V30 26 C 18.4800 13.3367 0.0 0
M  V30 27 C 16.1700 9.3356 0.0 0
M  V30 28 C 20.7900 12.0031 0.0 0
M  V30 29 C 15.4000 10.6694 0.0 0 CFG=3
M  V30 30 N 20.0200 13.3367 0.0 0
M  V30 31 C 11.5500 9.3356 0.0 0
M  V30 32 C 10.7800 8.0020 0.0 0
M  V30 33 C 10.7800 10.6694 0.0 0
M  V30 34 C 9.2400 8.0020 0.0 0
M  V30 35 C 9.2400 10.6694 0.0 0
M  V30 36 C 8.4700 9.3356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 26
M  V30 2 1 2 28
M  V30 3 1 3 4
M  V30 4 1 3 29
M  V30 5 1 4 31
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 36
M  V30 9 1 6 8
M  V30 10 1 8 9 CFG=1
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,5-Diethyl N-[4-[2-(2,4-diamino-5-formyl-5,6,7,8-tetrahydropyrido[3,2-d]pyri...
C26H34N6O6
1359861-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 10.6694 0.0 0
M  V30 2 O 8.4700 10.6694 0.0 0
M  V30 3 N 4.6200 12.0031 0.0 0
M  V30 4 C 8.4700 8.0020 0.0 0
M  V30 5 C 9.2400 6.6684 0.0 0
M  V30 6 N 0.0000 9.3358 0.0 0
M  V30 7 C 15.4000 6.6684 0.0 0
M  V30 8 N 16.1700 5.3347 0.0 0
M  V30 9 O 16.1700 8.0020 0.0 0
M  V30 10 C 17.7100 5.3347 0.0 0 CFG=2
M  V30 11 C 18.4800 6.6684 0.0 0
M  V30 12 C 18.4800 4.0011 0.0 0
M  V30 13 C 20.0200 6.6684 0.0 0
M  V30 14 O 17.7100 2.6673 0.0 0
M  V30 15 O 20.0200 4.0011 0.0 0
M  V30 16 C 20.7900 8.0020 0.0 0
M  V30 17 C 18.4800 1.3336 0.0 0
M  V30 18 O 22.3300 8.0020 0.0 0
M  V30 19 O 20.0200 9.3358 0.0 0
M  V30 20 C 17.7100 0.0000 0.0 0
M  V30 21 C 23.1000 9.3358 0.0 0
M  V30 22 C 24.6400 9.3358 0.0 0
M  V30 23 C 4.6200 9.3358 0.0 0
M  V30 24 N 6.1600 9.3358 0.0 0
M  V30 25 C 3.8500 8.0020 0.0 0
M  V30 26 C 3.8500 10.6694 0.0 0
M  V30 27 C 6.9300 8.0020 0.0 0 CFG=3
M  V30 28 C 4.6200 6.6684 0.0 0
M  V30 29 N 2.3100 8.0020 0.0 0
M  V30 30 N 2.3100 10.6694 0.0 0
M  V30 31 C 6.1600 6.6684 0.0 0
M  V30 32 C 1.5400 9.3358 0.0 0
M  V30 33 C 10.7800 6.6684 0.0 0
M  V30 34 C 11.5500 8.0020 0.0 0
M  V30 35 C 11.5500 5.3347 0.0 0
M  V30 36 C 13.0900 8.0020 0.0 0
M  V30 37 C 13.0900 5.3347 0.0 0
M  V30 38 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 24
M  V30 3 1 3 26
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 5 33
M  V30 7 1 6 32
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 38
M  V30 11 1 8 10
M  V30 12 1 10 11 CFG=1
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 31
M  V30 33 1 29 32
M  V30 34 2 30 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1359861-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1359861-16-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5689301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Antifolate and Anticancer Activities of N5-Substituted
8,10-Dideazatetrahydrofolate Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tian, Chao; Zhang, Zhili; Zhou, Shouxin; Yuan, Mengmeng; Wang, Xiaowei;
Liu, Junyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2016), 87(3), 444-454

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3-Amino-6-bromo-4-cinnolinyl)amino]-α,α-dimethylbenzeneacetonitrile
C18H16BrN5
1366050-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.8501 0.0 0
M  V30 2 N 5.3348 6.9302 0.0 0
M  V30 3 Br 1.3337 0.0000 0.0 0
M  V30 4 C 10.6697 6.9302 0.0 0
M  V30 5 C 12.0033 6.1601 0.0 0
M  V30 6 C 12.0033 7.7002 0.0 0
M  V30 7 C 10.6697 8.4702 0.0 0
M  V30 8 N 13.3370 5.3901 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0010 6.1601 0.0 0
M  V30 14 N 1.3337 6.1601 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 N 2.6673 6.9302 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 6.6685 4.6201 0.0 0
M  V30 20 C 8.0022 3.8501 0.0 0
M  V30 21 C 6.6685 6.1601 0.0 0
M  V30 22 C 9.3360 4.6201 0.0 0
M  V30 23 C 8.0022 6.9302 0.0 0
M  V30 24 C 9.3360 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 1 2 13
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 24
M  V30 9 3 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(8-Bromo-1H-imidazo[4,5-c]cinnolin-1-yl)-α,α-dimethylbenzeneacetonitrile
C19H14BrN5
1366050-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.1218 0.0000 0.0 0
M  V30 2 C 9.7543 2.7646 0.0 0
M  V30 3 C 11.0881 3.5346 0.0 0
M  V30 4 C 11.0881 1.9946 0.0 0
M  V30 5 C 9.7543 1.2246 0.0 0
M  V30 6 N 12.4217 4.3046 0.0 0
M  V30 7 C 3.0127 5.2182 0.0 0
M  V30 8 N 4.4195 5.8447 0.0 0
M  V30 9 C 2.5369 3.7536 0.0 0
M  V30 10 C 1.9823 6.3627 0.0 0
M  V30 11 C 4.2586 7.3762 0.0 0
M  V30 12 C 1.0304 3.4333 0.0 0
M  V30 13 C 3.5673 2.6091 0.0 0
M  V30 14 N 2.7523 7.6964 0.0 0
M  V30 15 N 0.4759 6.0424 0.0 0
M  V30 16 N 0.0000 4.5778 0.0 0
M  V30 17 C 0.5546 1.9688 0.0 0
M  V30 18 C 3.0914 1.1445 0.0 0
M  V30 19 C 1.5850 0.8242 0.0 0
M  V30 20 C 5.7533 5.0746 0.0 0
M  V30 21 C 7.0870 5.8447 0.0 0
M  V30 22 C 5.7533 3.5346 0.0 0
M  V30 23 C 8.4206 5.0746 0.0 0
M  V30 24 C 7.0870 2.7646 0.0 0
M  V30 25 C 8.4206 3.5346 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 25
M  V30 6 3 3 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 20
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 2 11 14
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 2 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1366050-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1366050-71-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-12729248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Under N2, a brown solution of
2-(4-(3-amino-6-bromocinnolin-4-ylamino)phenyl)-2-methyl-propanenitrile
(250 mg, 0.654 mmol) in HCO2H (3 mL) was heated to reflux for 4 h. The
reaction mixture was quenched with H2O, and was then concentrated to
remove the solvent. The crude product was used in thenext step directly
without further purification.
2-(4-(8-bromo-1H-imidazo[4,5-c]cinnolin-1-yl)phenyl)-2-methylpropanenitrile,
(250 mg, yield 97%). MS (m/z): 394 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinyltriazoloquinoxaline derivatives and analogs for
use as PI3K inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Su, Weiguo; Zhang, Weihan; Yang, Haibin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012034526 A1 2012-03-22

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Diamino-1,4-naphthoquinone
C10H8N2O2
13755-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 N 6.9300 2.6674 0.0 0
M  V30 4 N 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Naphth[2,3-d]imidazole-4,9-dione
C11H6N2O2
4496-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 N 6.7994 1.8341 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 N 6.7994 4.3259 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 7.7046 3.0800 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 1.3338 1.5400 0.0 0
M  V30 13 C 1.3338 4.6200 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13755-95-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4496-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-21871330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antitumor activity of 1-monosubstituted
1H-naphth[2,3-d]imidazole-4,9-diones and
1H-anthra[2,3-d]imidazole-4,11-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Zhanxiong; Yuan, Jing; Zhang, Zhenfeng; Yan, Deyue; Zhang, Wanbin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Youji Huaxue (2018), 38(12), 3302-3317

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-pyridinecarboximidic acid hydrazide
C6H7BrN4
1394848-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 N 5.3347 0.0000 0.0 0
M  V30 4 N 8.0021 1.5400 0.0 0
M  V30 5 Br 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-6-(1H-1,2,4-triazol-5-yl)pyridine
C7H5BrN4
2377744-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 N 5.1046 3.0800 0.0 0
M  V30 4 C 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 C 2.4374 3.0800 0.0 0
M  V30 9 N 2.2764 4.6115 0.0 0
M  V30 10 N 1.0304 2.4535 0.0 0
M  V30 11 C 0.7700 4.9317 0.0 0
M  V30 12 N 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1394848-87-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377744-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-20848843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient room-temperature phosphorescence achieved by gadolinium
complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Boxun; Wei, Chen; Wei, Huibo; Cai, Zelun; Liu, Huanyu; Zang, Zhiyu;
Yan, Wenchao; Liu, Zhiwei; Bian, Zuqiang; Huang, Chunhui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2019), 48(40), 14958-14961

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanolamine
C2H7NO
141-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 N 0.0000 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [[(2-hydroxyethyl)amino]methylene]bis-
C3H11NO7P2
29712-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 P 1.3337 3.8500 0.0 0 VAL=5
M  V30 3 P 2.6675 1.5400 0.0 0 VAL=5
M  V30 4 N 4.0011 3.8500 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 O 2.1037 5.1837 0.0 0
M  V30 7 O 0.5636 2.5164 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 9 O 1.1274 1.5400 0.0 0
M  V30 10 O 4.2075 1.5400 0.0 0
M  V30 11 C 5.3348 3.0800 0.0 0
M  V30 12 C 6.6686 3.8500 0.0 0
M  V30 13 O 8.0022 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 2 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 4 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29712-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30642135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1795-31-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 27607-77-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic N-diphosphonomethylation of amino alkanols and bisamino alkanes
using tris(trimethylsilyl) phosphite as a convenient synthon
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prishchenko, Andrey A.; Alekseyev, Roman S.; Novikova, Olga P.;
Livantsov, Mikhail V.; Livantsova, Ludmila I.; Petrosyan, Valery S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2022), 957122143

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(2-Amino-4-bromophenyl)amino]-3′,4′-difluoro[1,1′-biphenyl]-3-yl]acetamide
C20H16BrF2N3O
1430728-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 8.0021 0.0 0
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 C 6.9300 1.3336 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 O 6.1600 0.0000 0.0 0
M  V30 6 F 13.8600 8.0021 0.0 0
M  V30 7 F 15.4000 5.3347 0.0 0
M  V30 8 N 4.6200 10.6694 0.0 0
M  V30 9 Br 0.0000 8.0021 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 8.4700 6.6684 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.1600 5.3347 0.0 0
M  V30 16 C 10.7800 5.3347 0.0 0
M  V30 17 C 11.5500 6.6684 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 13.0900 6.6684 0.0 0
M  V30 20 C 13.0900 4.0011 0.0 0
M  V30 21 C 13.8600 5.3347 0.0 0
M  V30 22 C 4.6200 8.0021 0.0 0
M  V30 23 C 3.8500 9.3358 0.0 0
M  V30 24 C 3.8500 6.6684 0.0 0
M  V30 25 C 2.3100 9.3358 0.0 0
M  V30 26 C 2.3100 6.6684 0.0 0
M  V30 27 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 19
M  V30 8 1 7 21
M  V30 9 1 8 23
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-(5-Bromo-1H-benzimidazol-1-yl)-3′,4′-difluoro[1,1′-biphenyl]-3-yl]acetamide
C21H14BrF2N3O
1430728-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 2.3100 0.0 0
M  V30 2 C 5.3347 1.5400 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 Br 15.2617 5.3430 0.0 0
M  V30 6 F 2.6674 10.7800 0.0 0
M  V30 7 F 0.0000 9.2400 0.0 0
M  V30 8 N 9.3358 6.9300 0.0 0
M  V30 9 C 10.7426 6.3037 0.0 0
M  V30 10 C 9.4967 8.4615 0.0 0
M  V30 11 C 11.7731 7.4481 0.0 0
M  V30 12 C 11.2186 4.8390 0.0 0
M  V30 13 N 11.0031 8.7817 0.0 0
M  V30 14 C 13.2794 7.1279 0.0 0
M  V30 15 C 12.7249 4.5188 0.0 0
M  V30 16 C 13.7553 5.6632 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 5.3347 6.1600 0.0 0
M  V30 21 C 6.6684 3.8500 0.0 0
M  V30 22 C 5.3347 4.6200 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 24 C 4.0011 8.4700 0.0 0
M  V30 25 C 2.6674 6.1600 0.0 0
M  V30 26 C 2.6674 9.2400 0.0 0
M  V30 27 C 1.3336 6.9300 0.0 0
M  V30 28 C 1.3336 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 16
M  V30 6 1 6 26
M  V30 7 1 7 28
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1430728-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430728-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-11558497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: e)
N-(5-(5-bromo-1H-benzo[d]imidazol-1-yl)biphenyl-3-yl)acetamide. A mixture
of the compound of Example 148(d) (0.4 g, 1.01 mmol) and formic acid (10
ml) was heated at 100 °C for 2 h. The formic acid was distilled off and
the crude was dissolved in ethyl acetate. The ethyl acetate layer was
washed with water, brine and dried over sodium sulphate. The solvent was
distilled off and the residue was purified by column chromatography
(60-120 silica gel, 50 % ethyl acetate in hexane) to give the product.
N-(5-(5-bromo-1H-benzo[d]imidazol-1-yl)-3',4'-difluorobiphenyl-3-yl)acet-amide.
The compound was prepared from the compound of Example 150(d) (0.4 g,
0.93 mmol) using the procedure of Example 148(e) to give the product in
97 % yield (0.4 g).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazoles and related compounds as protein kinase inhibitors and
their preparation and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Linnanen, Tero; Wohlfahrt, Gerd; Nanduri, Srinivas; Ujjinamatada, Ravi;
Rajagopalan, Srinivasan; Mukherjee, Subhendu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013053983 A1 2013-04-18

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(2-Amino-4-bromophenyl)amino]-3′,4′-difluoro[1,1′-biphenyl]-3-yl]acetamide
C20H16BrF2N3O
1430728-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 8.0021 0.0 0
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 C 6.9300 1.3336 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 O 6.1600 0.0000 0.0 0
M  V30 6 F 13.8600 8.0021 0.0 0
M  V30 7 F 15.4000 5.3347 0.0 0
M  V30 8 N 4.6200 10.6694 0.0 0
M  V30 9 Br 0.0000 8.0021 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 8.4700 6.6684 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.1600 5.3347 0.0 0
M  V30 16 C 10.7800 5.3347 0.0 0
M  V30 17 C 11.5500 6.6684 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 13.0900 6.6684 0.0 0
M  V30 20 C 13.0900 4.0011 0.0 0
M  V30 21 C 13.8600 5.3347 0.0 0
M  V30 22 C 4.6200 8.0021 0.0 0
M  V30 23 C 3.8500 9.3358 0.0 0
M  V30 24 C 3.8500 6.6684 0.0 0
M  V30 25 C 2.3100 9.3358 0.0 0
M  V30 26 C 2.3100 6.6684 0.0 0
M  V30 27 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 19
M  V30 8 1 7 21
M  V30 9 1 8 23
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-(5-Bromo-1H-benzimidazol-1-yl)-3′,4′-difluoro[1,1′-biphenyl]-3-yl]acetamide
C21H14BrF2N3O
1430728-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 2.3100 0.0 0
M  V30 2 C 5.3347 1.5400 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 Br 15.2617 5.3430 0.0 0
M  V30 6 F 2.6674 10.7800 0.0 0
M  V30 7 F 0.0000 9.2400 0.0 0
M  V30 8 N 9.3358 6.9300 0.0 0
M  V30 9 C 10.7426 6.3037 0.0 0
M  V30 10 C 9.4967 8.4615 0.0 0
M  V30 11 C 11.7731 7.4481 0.0 0
M  V30 12 C 11.2186 4.8390 0.0 0
M  V30 13 N 11.0031 8.7817 0.0 0
M  V30 14 C 13.2794 7.1279 0.0 0
M  V30 15 C 12.7249 4.5188 0.0 0
M  V30 16 C 13.7553 5.6632 0.0 0
M  V30 17 C 8.0021 6.1600 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 5.3347 6.1600 0.0 0
M  V30 21 C 6.6684 3.8500 0.0 0
M  V30 22 C 5.3347 4.6200 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 24 C 4.0011 8.4700 0.0 0
M  V30 25 C 2.6674 6.1600 0.0 0
M  V30 26 C 2.6674 9.2400 0.0 0
M  V30 27 C 1.3336 6.9300 0.0 0
M  V30 28 C 1.3336 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 16
M  V30 6 1 6 26
M  V30 7 1 7 28
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1430728-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430728-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-18607586
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazoles and related compounds as protein kinase inhibitors and
their preparation and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nanduri, Srinivas; Ujjinamatada, Ravi Kotrabasaiah; Rajagopalan,
Srinivasan; Mukherjee, Subhendu; Linnanen, Tero; Wohlfahrt, Gerd
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2011KO01306 A 2013-04-12

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(2-Amino-4-cyanophenyl)amino]-2′,4′-difluoro[1,1′-biphenyl]-3-yl]acetamide
C21H16F2N4O
1430729-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6200 8.0021 0.0 0
M  V30 2 N 9.2400 8.0021 0.0 0
M  V30 3 N 9.2400 2.6673 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 C 6.9300 1.3336 0.0 0
M  V30 6 O 9.2400 0.0000 0.0 0
M  V30 7 F 0.0000 5.3347 0.0 0
M  V30 8 N 10.7800 10.6694 0.0 0
M  V30 9 C 15.4000 8.0021 0.0 0
M  V30 10 N 16.9400 8.0021 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 3.8500 6.6684 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 2.3100 6.6684 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 1.5400 5.3347 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 6.9300 6.6684 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 8.4700 6.6684 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 10.7800 8.0021 0.0 0
M  V30 24 C 11.5500 9.3358 0.0 0
M  V30 25 C 11.5500 6.6684 0.0 0
M  V30 26 C 13.0900 9.3358 0.0 0
M  V30 27 C 13.0900 6.6684 0.0 0
M  V30 28 C 13.8600 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 20
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 21
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 7 16
M  V30 9 1 8 24
M  V30 10 3 9 10
M  V30 11 1 9 28
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-(5-Cyano-1H-benzimidazol-1-yl)-2′,4′-difluoro[1,1′-biphenyl]-3-yl]acetamide
C22H14F2N4O
1430729-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 15.2619 5.3431 0.0 0
M  V30 6 N 16.7683 5.0229 0.0 0
M  V30 7 F 5.3348 9.2401 0.0 0
M  V30 8 F 0.0000 9.2401 0.0 0
M  V30 9 N 9.3359 6.9301 0.0 0
M  V30 10 C 10.7428 6.3038 0.0 0
M  V30 11 C 9.4968 8.4616 0.0 0
M  V30 12 C 11.7733 7.4481 0.0 0
M  V30 13 C 11.2187 4.8390 0.0 0
M  V30 14 N 11.0033 8.7818 0.0 0
M  V30 15 C 13.2796 7.1280 0.0 0
M  V30 16 C 12.7250 4.5189 0.0 0
M  V30 17 C 13.7556 5.6633 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 6.6686 6.9301 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0
M  V30 21 C 5.3348 6.1601 0.0 0
M  V30 22 C 6.6686 3.8500 0.0 0
M  V30 23 C 5.3348 4.6201 0.0 0
M  V30 24 C 4.0011 6.9301 0.0 0
M  V30 25 C 4.0011 8.4701 0.0 0
M  V30 26 C 2.6675 6.1601 0.0 0
M  V30 27 C 2.6675 9.2401 0.0 0
M  V30 28 C 1.3338 6.9301 0.0 0
M  V30 29 C 1.3338 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 3 5 6
M  V30 6 1 5 17
M  V30 7 1 7 25
M  V30 8 1 8 29
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1430729-35-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430729-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1433501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) N-(5-(5-cyano-1H-benzo[d]
imidazol-1-yl)-2',4'-difluoro-[1,1'-biphenyl]-3-yl)-acetamide. A mixture
of the compound of Example 313(b) (0.8 g, 2.11 mmol) and formic acid (10
ml) was heated at 100 °C for 4 h. The formic acid was distilled off and
the crude was dissolved in ethyl acetate. The ethyl acetate layer was
washed with water, brine and dried over sodium sulphate. The solvent was
distilled off to afford the crude residue. 97 % yield (0.8 g).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazoles and related compounds as protein kinase inhibitors and
their preparation and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Linnanen, Tero; Wohlfahrt, Gerd; Nanduri, Srinivas; Ujjinamatada, Ravi;
Rajagopalan, Srinivasan; Mukherjee, Subhendu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013053983 A1 2013-04-18

$RFMT $RIREG SCHEME346 STEP1
$RXN



  4  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propargylamine
C3H5N
2450-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodonium, diphenyl-, 2,2,2-trifluoroacetate (1:1)
C12H10I.C2F3O2
16668-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9533 6.5174 0.0 0
M  V30 2 C 5.2869 5.7474 0.0 0
M  V30 3 F 4.7233 7.8511 0.0 0
M  V30 4 F 2.6196 7.2874 0.0 0
M  V30 5 F 3.1833 5.1837 0.0 0
M  V30 6 O 6.6206 6.5174 0.0 0 CHG=-1
M  V30 7 O 5.2869 4.2073 0.0 0
M  V30 8 I 4.6201 1.3337 0.0 0 CHG=1 VAL=2
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 15 C 6.1601 1.3337 0.0 0
M  V30 16 C 6.9302 0.0000 0.0 0
M  V30 17 C 6.9302 2.6673 0.0 0
M  V30 18 C 8.4702 0.0000 0.0 0
M  V30 19 C 8.4702 2.6673 0.0 0
M  V30 20 C 9.2402 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 8 9
M  V30 8 1 8 15
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trifluoro-N-(4-fluorophenyl)ethanimidoyl chloride
C8H4ClF4N
145372-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 2.8736 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 Cl 3.8500 0.2062 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 F 0.0000 1.5400 0.0 0
M  V30 7 F 1.5400 3.0800 0.0 0
M  V30 8 F 10.0100 2.8736 0.0 0
M  V30 9 C 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 4.2073 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 12 C 7.7000 4.2073 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-(4-Fluorophenyl)-2-(trifluoromethyl)-1H-imidazol-5-yl]-1-phenylethanone
C18H12F4N2O
2412501-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8342 5.8820 0.0 0
M  V30 2 C 8.1679 6.6520 0.0 0
M  V30 3 O 8.1679 8.1921 0.0 0
M  V30 4 C 1.5316 7.0090 0.0 0
M  V30 5 F 1.3706 8.5407 0.0 0
M  V30 6 F 0.0000 6.8481 0.0 0
M  V30 7 F 1.6925 5.4774 0.0 0
M  V30 8 F 2.8129 0.0000 0.0 0
M  V30 9 N 4.0937 6.0255 0.0 0
M  V30 10 C 5.5005 6.6520 0.0 0
M  V30 11 C 3.0631 7.1701 0.0 0
M  V30 12 C 5.3396 8.1836 0.0 0
M  V30 13 N 3.8331 8.5038 0.0 0
M  V30 14 C 3.7734 4.5192 0.0 0
M  V30 15 C 4.9179 3.4886 0.0 0
M  V30 16 C 2.3088 4.0434 0.0 0
M  V30 17 C 4.5978 1.9823 0.0 0
M  V30 18 C 1.9886 2.5369 0.0 0
M  V30 19 C 3.1330 1.5065 0.0 0
M  V30 20 C 9.5017 5.8820 0.0 0
M  V30 21 C 9.5017 4.3420 0.0 0
M  V30 22 C 10.8354 6.6520 0.0 0
M  V30 23 C 10.8354 3.5720 0.0 0
M  V30 24 C 12.1690 5.8820 0.0 0
M  V30 25 C 12.1690 4.3420 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 11
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2450-71-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16668-99-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 145372-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412501-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25904026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Four-Component Carbonylative Cyclization Reaction of
Trifluoroacetimidoyl Chlorides, Propargyl Amines, and Diaryliodonium
Salts: Access to Trifluoromethyl-Containing Trisubstituted Imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhengkai; Wang, Wei-Feng; Yang, Hefei; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2020), 22(5), 1980-1984

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 4-chloro-3-nitro-, methyl ester
C8H6ClNO4
14719-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 Cl 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzothiazolecarboxylic acid, methyl ester
C9H7NO2S
478169-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 3.8500 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 3.7036 4.6200 0.0 0
M  V30 10 S 0.9052 4.3259 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14719-83-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-65-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28932370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-31-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of dimethyl 4,4'-dithio-bis-(3-nitrobenzoate)
(900mg, 2.12 mmol) methanol is added tin powder (1.91 g, 17.0mmol). The
mixture is heated in a 70°C oil bath for 30 minutes before 2.8 mL of
concentrated hydrochloric acid is added drop-wise. After complete
addition, the mixture is stirred for an additional 10 min, followed by
cooling to RT. The reaction mixture is filtered and the filtrate is
concentrated in vacuo to a solid. The solid is washed with 1.0M aqueous
hydrochloric acid and dried in vacuo to afford a yellow solid. The solid
(750 mg, 3.42 mmol) is suspended in formic acid (4 mL) in a 100°C oil
bath. Zinc dust (15 mg) is added to the reaction. The mixture is stirred
for 10 min, followed by cooling to RT. The mixture is diluted with water
and extracted with EtOAc. The organic layer is dried (MgSO4), filtered
and concentrated in vacuo to afford methyl
1,3-benzothiazole-5-carboxylate. Yellow solid, yield 640 mg, 97% 1H NMR
(400 MHz, CDCl3) δ 9.1, 8.9, 8.2, 8.1, 4.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(quinuclidinyl)heteroarylamides as nicotinic
acetylcholine receptor agonists for use in combination therapy for the
treatment of ADHD
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Groppi, Vincent Edward, Jr.; Jacobsen, Eric Jon; Myers, Jason Kenneth;
Piotrowski, David Walter; Rogers, Bruce Nelsen; Walker, Daniel Patrick;
Wishka, Donn Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052461 A1 2004-06-24

$RFMT $RIREG SCHEME348 STEP1
$RXN



  3  1
$MOL
Phenyl N-[5-(1,1-difluoroethyl)-2-fluorophenyl]carbamate
C15H12F3NO2
1529770-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9537 2.6675 0.0 0
M  V30 2 C 6.7237 4.0011 0.0 0
M  V30 3 O 8.2637 4.0011 0.0 0
M  V30 4 O 5.9537 5.3348 0.0 0
M  V30 5 F 4.4137 0.0000 0.0 0
M  V30 6 C 1.3337 5.3348 0.0 0
M  V30 7 C 2.1037 6.6686 0.0 0
M  V30 8 F 0.0000 4.5648 0.0 0
M  V30 9 F 0.0000 6.1048 0.0 0
M  V30 10 C 4.4137 2.6675 0.0 0
M  V30 11 C 3.6437 4.0011 0.0 0
M  V30 12 C 3.6437 1.3337 0.0 0
M  V30 13 C 2.1037 4.0011 0.0 0
M  V30 14 C 2.1037 1.3337 0.0 0
M  V30 15 C 1.3337 2.6675 0.0 0
M  V30 16 C 9.0337 5.3348 0.0 0
M  V30 17 C 10.5738 5.3348 0.0 0
M  V30 18 C 8.2637 6.6686 0.0 0
M  V30 19 C 11.3438 6.6686 0.0 0
M  V30 20 C 9.0337 8.0022 0.0 0
M  V30 21 C 10.5738 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 16
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 13
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1,3-Dihydro-6-(hydroxymethyl)-1-oxo-2H-isoindol-2-yl]-2,6-piperidinedione
C14H14N2O4
2803882-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5894 5.3780 0.0 0
M  V30 2 O 4.6200 0.0000 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 C 12.5309 4.2074 0.0 0
M  V30 5 O 13.8647 3.4374 0.0 0
M  V30 6 N 6.1600 2.6674 0.0 0
M  V30 7 C 7.0652 3.9133 0.0 0
M  V30 8 C 7.0652 1.4216 0.0 0
M  V30 9 C 8.5299 3.4374 0.0 0
M  V30 10 C 8.5299 1.8974 0.0 0
M  V30 11 C 9.8636 4.2074 0.0 0
M  V30 12 C 9.8636 1.1274 0.0 0
M  V30 13 C 11.1972 3.4374 0.0 0
M  V30 14 C 11.1972 1.8974 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 3.8500 1.3338 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 N 2.3100 1.3338 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 16
M  V30 3 2 3 20
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-3-oxo-1H-isoindol-5-yl]methyl N-[5-(...
C23H20F3N3O5
2803882-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.1503 4.0132 0.0 0
M  V30 2 O 16.1195 9.3911 0.0 0
M  V30 3 O 20.7396 6.7238 0.0 0
M  V30 4 C 8.2085 5.1838 0.0 0
M  V30 5 O 6.8749 5.9538 0.0 0
M  V30 6 C 5.5412 5.1838 0.0 0
M  V30 7 N 4.2074 5.9538 0.0 0
M  V30 8 O 5.5412 3.6437 0.0 0
M  V30 9 F 1.5400 7.4938 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 2.8737 0.5637 0.0 0
M  V30 12 F 0.0000 1.3337 0.0 0
M  V30 13 F 0.7700 0.0000 0.0 0
M  V30 14 N 14.5795 6.7238 0.0 0
M  V30 15 C 13.6743 5.4779 0.0 0
M  V30 16 C 13.6743 7.9697 0.0 0
M  V30 17 C 12.2097 5.9538 0.0 0
M  V30 18 C 12.2097 7.4938 0.0 0
M  V30 19 C 10.8760 5.1838 0.0 0
M  V30 20 C 10.8760 8.2638 0.0 0
M  V30 21 C 9.5422 5.9538 0.0 0
M  V30 22 C 9.5422 7.4938 0.0 0
M  V30 23 C 16.1195 6.7238 0.0 0
M  V30 24 C 16.8895 8.0575 0.0 0
M  V30 25 C 16.8895 5.3901 0.0 0
M  V30 26 N 18.4296 8.0575 0.0 0
M  V30 27 C 18.4296 5.3901 0.0 0
M  V30 28 C 19.1996 6.7238 0.0 0
M  V30 29 C 2.8737 5.1838 0.0 0
M  V30 30 C 2.8737 3.6437 0.0 0
M  V30 31 C 1.5400 5.9538 0.0 0
M  V30 32 C 1.5400 2.8737 0.0 0
M  V30 33 C 0.2064 5.1838 0.0 0
M  V30 34 C 0.2064 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 24
M  V30 3 2 3 28
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 29
M  V30 10 1 9 31
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 32
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 23
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1529770-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2803882-16-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2803882-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34294856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM last stage is carried out by preparative HPLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoindolinone compounds as modulators of cereblon
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fasching, Bernhard; Ryckmans, Thomas; Flohr, Alexander; Ritzen, Andreas;
Harvey, Freya; McAllister, Laura
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022152821 A1 2022-07-21

$RFMT $RIREG SCHEME349 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl carbonate
C3H6O3
616-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 O 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Iodophenyl)-N,2-dimethyl-2-propenamide
C11H12INO
154386-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 4.6200 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 O 5.3347 0.7700 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 I 1.3336 4.6200 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetate
C13H15NO3
273730-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1266 3.6644 0.0 0
M  V30 2 C 6.8966 4.9980 0.0 0
M  V30 3 O 8.4366 4.9980 0.0 0
M  V30 4 O 6.1266 6.3317 0.0 0
M  V30 5 C 9.2066 6.3317 0.0 0
M  V30 6 C 4.7475 5.1959 0.0 0
M  V30 7 O 6.0811 1.3628 0.0 0
M  V30 8 C 3.0203 0.0000 0.0 0
M  V30 9 C 3.0801 3.9845 0.0 0
M  V30 10 C 4.5865 3.6644 0.0 0
M  V30 11 C 2.3101 2.6509 0.0 0
M  V30 12 C 2.3101 5.3182 0.0 0
M  V30 13 C 4.7475 2.1328 0.0 0
M  V30 14 N 3.3406 1.5063 0.0 0
M  V30 15 C 0.7700 2.6509 0.0 0
M  V30 16 C 0.7700 5.3182 0.0 0
M  V30 17 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 10
M  V30 7 2 7 13
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 154386-63-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 273730-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34876191
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 6163-58-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 616-38-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, stages 1 and 2 in separate pots (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cascade Carbonylative Synthesis of Functionalized
Isoquinoline-1,3-diones and Oxindoles Using Dimethyl Carbonate as both
Solvent and Reactant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wen, D.; Shen, Z.; Qi, X.; Wu, X.-F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2022), 2022(42), e202200971

$RFMT $RIREG SCHEME350 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8,9,10,16,17-Octahydrodibenzo[e,m][1,4,8,11]dithiadiazacyclotetradecine
C18H22N2S2
156391-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 2.6674 0.0 0
M  V30 3 S 4.6200 4.0011 0.0 0
M  V30 4 C 2.3100 5.3349 0.0 0
M  V30 5 C 0.7700 2.6674 0.0 0
M  V30 6 C 3.0800 1.3338 0.0 0
M  V30 7 C 5.3900 5.3349 0.0 0
M  V30 8 C 0.7700 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 6.9300 5.3349 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 S 7.7000 4.0011 0.0 0
M  V30 14 C 6.9300 0.0000 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 N 7.7000 1.3338 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 10.0100 5.3349 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 21 C 11.5500 5.3349 0.0 0
M  V30 22 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 9
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8,9,10,16,17-Octahydro-6,9-dimethyldibenzo[e,m][1,4,8,11]dithiadiazacyc...
C20H26N2S2
1006885-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 S 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 5.3349 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 N 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3349 0.0 0
M  V30 14 C 5.3900 0.0000 0.0 0
M  V30 15 S 7.7000 4.0011 0.0 0
M  V30 16 C 6.9300 0.0000 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 N 7.7000 1.3338 0.0 0
M  V30 19 C 10.0100 2.6674 0.0 0
M  V30 20 C 10.0100 5.3349 0.0 0
M  V30 21 C 9.2400 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 23 C 11.5500 5.3349 0.0 0
M  V30 24 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 156391-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1006885-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9719546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and characterization of mononuclear Ni complexes of
tetradentate amine-thioether and amine-thiolate ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fritz, Thorsten; Steinfeld, Gunther; Kersting, Berthold
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: Chemical Sciences (2007), 62(4),
508-518

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-1,2-benzenediamine
C6H7BrN2
1575-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.0000 0.0 0
M  V30 2 Br 0.0000 1.5400 0.0 0
M  V30 3 N 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3338 3.8500 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-1H-benzimidazole
C7H5BrN2
83741-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 N 2.1579 4.5864 0.0 0
M  V30 6 C 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 C 3.8119 0.7700 0.0 0
M  V30 9 C 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1575-36-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83741-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-16773460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyridinamines as Stk4 inhibitors for treatment
of hematologic malignancies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Buhrlage, Sara; Anderson, Kenneth; Cottini,
Francesca; Tonon, Giovanni
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016161145 A1 2016-10-06

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-(4-Amino-3-bromophenyl)pentafluorosulfur
C6H5BrF5NS
159727-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 F 0.0000 2.6673 0.0 0
M  V30 3 F 2.3101 1.3337 0.0 0
M  V30 4 F 0.7700 4.0010 0.0 0
M  V30 5 F 0.7700 1.3337 0.0 0
M  V30 6 F 2.3101 4.0010 0.0 0
M  V30 7 Br 6.1601 0.0000 0.0 0
M  V30 8 N 7.7002 2.6673 0.0 0
M  V30 9 C 3.0801 2.6673 0.0 0
M  V30 10 C 3.8501 1.3337 0.0 0
M  V30 11 C 3.8501 4.0010 0.0 0
M  V30 12 C 5.3901 1.3337 0.0 0
M  V30 13 C 5.3901 4.0010 0.0 0
M  V30 14 C 6.1601 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 9
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-[3-Bromo-4-(formylamino)phenyl]pentafluorosulfur
C7H5BrF5NOS
2245940-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 F 0.0000 2.6673 0.0 0
M  V30 3 F 2.3101 1.3337 0.0 0
M  V30 4 F 0.7700 4.0010 0.0 0
M  V30 5 F 0.7700 1.3337 0.0 0
M  V30 6 F 2.3101 4.0010 0.0 0
M  V30 7 Br 6.1601 0.0000 0.0 0
M  V30 8 N 7.7002 2.6673 0.0 0
M  V30 9 C 8.4702 4.0010 0.0 0
M  V30 10 O 10.0102 4.0010 0.0 0
M  V30 11 C 3.0801 2.6673 0.0 0
M  V30 12 C 3.8501 1.3337 0.0 0
M  V30 13 C 3.8501 4.0010 0.0 0
M  V30 14 C 5.3901 1.3337 0.0 0
M  V30 15 C 5.3901 4.0010 0.0 0
M  V30 16 C 6.1601 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 11
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159727-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2245940-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19378161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heteroaryl derivatives as voltage-gated sodium
channels modulators useful in treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Jia-Ning; Xu, Xuesong; Zhou, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018176343 A1 2018-10-04

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Technetium-99Tc, tricarbonylhydrobis(triphenylphosphine)-, (OC-6-13)-
C39H31O3P2Tc
160568-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Tc 8.5209 6.7847 0.0 0 CHG=1 MASS=99
M  V30 2 P 12.4548 4.5479 0.0 0 VAL=4
M  V30 3 P 4.6183 4.4970 0.0 0 VAL=4
M  V30 4 C 11.3599 6.7847 0.0 0
M  V30 5 C 5.5294 6.7847 0.0 0
M  V30 6 C 8.5209 9.6198 0.0 0
M  V30 7 H 8.5209 3.9496 0.0 0 CHG=-1 VAL=1
M  V30 8 O 12.7755 6.7847 0.0 0 VAL=3
M  V30 9 O 4.1099 6.7847 0.0 0 VAL=3
M  V30 10 O 9.9404 9.6198 0.0 0 VAL=3
M  V30 11 C 13.6827 5.2557 0.0 0
M  V30 12 C 13.6827 6.7964 0.0 0
M  V30 13 C 15.0201 4.4892 0.0 0
M  V30 14 C 15.0201 7.5668 0.0 0
M  V30 15 C 16.3497 5.2557 0.0 0
M  V30 16 C 16.3497 6.7964 0.0 0
M  V30 17 C 12.4548 3.1284 0.0 0
M  V30 18 C 11.1214 2.3580 0.0 0
M  V30 19 C 13.7883 2.3580 0.0 0
M  V30 20 C 11.1214 0.8212 0.0 0
M  V30 21 C 13.7883 0.8212 0.0 0
M  V30 22 C 12.4548 0.0508 0.0 0
M  V30 23 C 14.4218 3.4295 0.0 0
M  V30 24 C 14.4218 1.8888 0.0 0
M  V30 25 C 15.7592 4.1998 0.0 0
M  V30 26 C 15.7592 1.1223 0.0 0
M  V30 27 C 17.0887 3.4295 0.0 0
M  V30 28 C 17.0887 1.8888 0.0 0
M  V30 29 C 3.3904 5.2048 0.0 0
M  V30 30 C 3.3904 6.7456 0.0 0
M  V30 31 C 2.0608 4.4345 0.0 0
M  V30 32 C 2.0608 7.5159 0.0 0
M  V30 33 C 0.7234 5.2048 0.0 0
M  V30 34 C 0.7234 6.7456 0.0 0
M  V30 35 C 2.6669 3.3552 0.0 0
M  V30 36 C 1.3374 4.1255 0.0 0
M  V30 37 C 2.6669 1.8145 0.0 0
M  V30 38 C 0.0000 3.3552 0.0 0
M  V30 39 C 1.3374 1.0441 0.0 0
M  V30 40 C 0.0000 1.8145 0.0 0
M  V30 41 C 4.6183 3.0775 0.0 0
M  V30 42 C 3.2848 2.3072 0.0 0
M  V30 43 C 5.9517 2.3072 0.0 0
M  V30 44 C 3.2848 0.7704 0.0 0
M  V30 45 C 5.9517 0.7704 0.0 0
M  V30 46 C 4.6183 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 11
M  V30 8 1 2 17
M  V30 9 1 2 23
M  V30 10 1 3 29
M  V30 11 1 3 35
M  V30 12 1 3 41
M  V30 13 3 4 8
M  V30 14 3 5 9
M  V30 15 3 6 10
M  V30 16 2 11 12
M  V30 17 1 11 13
M  V30 18 1 12 14
M  V30 19 2 13 15
M  V30 20 2 14 16
M  V30 21 1 15 16
M  V30 22 2 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C39H31O4P2Tc
2668174-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.7294 5.2493 0.0 0 VAL=4
M  V30 2 P 9.0485 6.6955 0.0 0 VAL=4
M  V30 3 C 8.6459 9.2361 0.0 0
M  V30 4 O 8.6459 10.6510 0.0 0 VAL=3
M  V30 5 C 7.2740 4.8897 0.0 0
M  V30 6 O 8.5052 4.1822 0.0 0 VAL=3
M  V30 7 Tc 6.3554 7.5710 0.0 0 CHG=1 MASS=99
M  V30 8 O 3.7875 7.5710 0.0 0 CHG=-1 VAL=2
M  V30 9 O 6.3554 10.1390 0.0 0 VAL=3
M  V30 10 C 3.7875 10.1390 0.0 0
M  V30 11 C 2.6657 7.3873 0.0 0
M  V30 12 C 2.6657 8.9234 0.0 0
M  V30 13 C 1.3289 6.6173 0.0 0
M  V30 14 C 1.3289 9.6934 0.0 0
M  V30 15 C 0.0000 7.3873 0.0 0
M  V30 16 C 0.0000 8.9234 0.0 0
M  V30 17 C 4.1041 3.0761 0.0 0
M  V30 18 C 5.4408 2.3061 0.0 0
M  V30 19 C 2.7751 2.3061 0.0 0
M  V30 20 C 5.4408 0.7661 0.0 0
M  V30 21 C 2.7751 0.7661 0.0 0
M  V30 22 C 4.1041 0.0000 0.0 0
M  V30 23 C 3.3458 4.9288 0.0 0
M  V30 24 C 3.3458 3.3927 0.0 0
M  V30 25 C 2.0129 5.6988 0.0 0
M  V30 26 C 2.0129 2.6227 0.0 0
M  V30 27 C 0.6801 4.9288 0.0 0
M  V30 28 C 0.6801 3.3927 0.0 0
M  V30 29 C 11.0067 7.8251 0.0 0
M  V30 30 C 11.0067 9.3651 0.0 0
M  V30 31 C 12.3435 7.0551 0.0 0
M  V30 32 C 12.3435 10.1312 0.0 0
M  V30 33 C 13.6724 7.8251 0.0 0
M  V30 34 C 13.6724 9.3651 0.0 0
M  V30 35 C 10.6471 5.7809 0.0 0
M  V30 36 C 10.6432 4.2448 0.0 0
M  V30 37 C 11.9799 6.5509 0.0 0
M  V30 38 C 11.9799 3.4748 0.0 0
M  V30 39 C 13.3128 5.7848 0.0 0
M  V30 40 C 13.3089 4.2448 0.0 0
M  V30 41 C 9.0485 3.7249 0.0 0
M  V30 42 C 7.7156 2.9549 0.0 0
M  V30 43 C 10.3813 2.9549 0.0 0
M  V30 44 C 7.7156 1.4149 0.0 0
M  V30 45 C 10.3813 1.4149 0.0 0
M  V30 46 C 9.0485 0.6449 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 1 23
M  V30 5 1 2 7
M  V30 6 1 2 29
M  V30 7 1 2 35
M  V30 8 1 2 41
M  V30 9 3 3 4
M  V30 10 1 3 7
M  V30 11 3 5 6
M  V30 12 1 5 7
M  V30 13 1 7 8
M  V30 14 1 7 9
M  V30 15 1 8 10
M  V30 16 2 9 10
M  V30 17 2 11 12
M  V30 18 1 11 13
M  V30 19 1 12 14
M  V30 20 2 13 15
M  V30 21 2 14 16
M  V30 22 1 15 16
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 2 31 33
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 41 2 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 2 37 39
M  V30 45 2 38 40
M  V30 46 1 39 40
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160568-68-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2668174-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24201793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM crystal formed 2h in refrigerator
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Technetium Hydrides Revisited: Syntheses, Structures, and Reactions of
[TcH3(PPh3)4] and [TcH(CO)3(PPh3)2]
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jungfer, Maximilian Roca; Elsholz, Laura; Abram, Ulrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2021), 40(18), 3095-3112

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-9-(1,1-Dimethylethyl) 4-methyl (1R,4aR,9aS)-1,2-dihydro-1-[[(2Z)-2-iodo-2...
C25H31IN2O5
1620110-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0432 7.6403 0.0 0
M  V30 2 O 3.0127 8.7847 0.0 0
M  V30 3 O 3.5673 6.1756 0.0 0
M  V30 4 C 1.5063 8.4645 0.0 0
M  V30 5 C 1.8265 6.9582 0.0 0
M  V30 6 C 0.0000 8.1444 0.0 0
M  V30 7 C 1.1861 9.9710 0.0 0
M  V30 8 N 5.3603 4.6200 0.0 0
M  V30 9 C 5.3603 3.0800 0.0 0
M  V30 10 C 4.0265 2.3100 0.0 0
M  V30 11 C 4.0265 0.7700 0.0 0
M  V30 12 I 2.6929 3.0800 0.0 0
M  V30 13 C 2.6929 0.0000 0.0 0
M  V30 14 C 10.6951 7.7001 0.0 0
M  V30 15 O 12.0287 6.9301 0.0 0
M  V30 16 O 10.6951 9.2401 0.0 0
M  V30 17 C 13.3624 7.7001 0.0 0
M  V30 18 C 6.6940 6.9301 0.0 0 CFG=1
M  V30 19 C 8.0276 7.7001 0.0 0 CFG=2
M  V30 20 N 5.5496 7.9605 0.0 0
M  V30 21 C 5.9281 5.3095 0.0 0 CFG=1
M  V30 22 O 7.0142 5.4236 0.0 0
M  V30 23 C 7.7075 9.2064 0.0 0
M  V30 24 C 9.3613 6.9301 0.0 0
M  V30 25 C 9.1722 6.6695 0.0 0
M  V30 26 C 6.1759 9.3674 0.0 0
M  V30 27 C 8.0276 4.6200 0.0 0
M  V30 28 C 8.5457 5.2627 0.0 0
M  V30 29 C 8.6127 10.4522 0.0 0
M  V30 30 C 9.3613 5.3901 0.0 0
M  V30 31 C 5.5496 10.7743 0.0 0
M  V30 32 C 7.9864 11.8592 0.0 0
M  V30 33 C 6.4547 12.0201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 21 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 24
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 23
M  V30 23 1 19 24
M  V30 24 1 19 25 CFG=3
M  V30 25 1 20 26
M  V30 26 1 21 27
M  V30 27 1 22 28
M  V30 28 1 23 26
M  V30 29 2 23 29
M  V30 30 2 24 30
M  V30 31 1 25 28
M  V30 32 2 26 31
M  V30 33 1 27 30
M  V30 34 1 29 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 18 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-9-(1,1-Dimethylethyl) 4-methyl (1R,4aR,9aS)-1-[formyl[(2Z)-2-iodo-2-buten...
C26H31IN2O6
1620110-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0431 7.6403 0.0 0
M  V30 2 O 3.0127 8.7846 0.0 0
M  V30 3 O 3.5673 6.1756 0.0 0
M  V30 4 C 1.5063 8.4645 0.0 0
M  V30 5 C 1.8264 6.9582 0.0 0
M  V30 6 C 0.0000 8.1443 0.0 0
M  V30 7 C 1.1861 9.9709 0.0 0
M  V30 8 N 5.3603 4.6200 0.0 0
M  V30 9 C 5.3603 3.0800 0.0 0
M  V30 10 C 4.0265 5.3900 0.0 0
M  V30 11 C 4.0265 2.3100 0.0 0
M  V30 12 O 2.6929 4.6200 0.0 0
M  V30 13 C 4.0265 0.7700 0.0 0
M  V30 14 I 2.6929 3.0800 0.0 0
M  V30 15 C 2.6929 0.0000 0.0 0
M  V30 16 C 10.6950 7.7000 0.0 0
M  V30 17 O 12.0287 6.9300 0.0 0
M  V30 18 O 10.6950 9.2400 0.0 0
M  V30 19 C 13.3623 7.7000 0.0 0
M  V30 20 C 6.6939 6.9300 0.0 0 CFG=1
M  V30 21 C 8.0276 7.7000 0.0 0 CFG=2
M  V30 22 N 5.5496 7.9604 0.0 0
M  V30 23 C 5.9281 5.3095 0.0 0 CFG=1
M  V30 24 O 7.0141 5.4236 0.0 0
M  V30 25 C 7.7074 9.2063 0.0 0
M  V30 26 C 9.3612 6.9300 0.0 0
M  V30 27 C 9.1721 6.6696 0.0 0
M  V30 28 C 6.1759 9.3674 0.0 0
M  V30 29 C 8.0276 4.6200 0.0 0
M  V30 30 C 8.5456 5.2627 0.0 0
M  V30 31 C 8.6126 10.4522 0.0 0
M  V30 32 C 9.3612 5.3900 0.0 0
M  V30 33 C 5.5496 10.7742 0.0 0
M  V30 34 C 7.9863 11.8591 0.0 0
M  V30 35 C 6.4546 12.0200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 23 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 26
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 21 27 CFG=3
M  V30 27 1 22 28
M  V30 28 1 23 29
M  V30 29 1 24 30
M  V30 30 1 25 28
M  V30 31 2 25 31
M  V30 32 2 26 32
M  V30 33 1 27 30
M  V30 34 2 28 33
M  V30 35 1 29 32
M  V30 36 1 31 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 20 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620110-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620110-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6238488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM isolated yield 82%, reactant also recovered
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of the Monoterpenoid Indole Alkaloid (±)-Aspidophylline A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Teng, Mingxing; Zi, Weiwei; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2014), 53(7), 1814-1817

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-(8α,9S)-cinchonan-9-ylacetamide
C21H26N4O
1620137-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 3.8500 6.6685 0.0 0
M  V30 3 C 2.3100 6.6685 0.0 0
M  V30 4 C 1.5400 8.0021 0.0 0
M  V30 5 O 1.5400 5.3347 0.0 0
M  V30 6 N 0.0000 8.0021 0.0 0
M  V30 7 C 10.4517 8.7290 0.0 0
M  V30 8 C 11.7505 7.9016 0.0 0
M  V30 9 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 10 N 6.7721 6.8599 0.0 0 CFG=1
M  V30 11 C 7.0252 6.1625 0.0 0
M  V30 12 C 8.2561 6.8584 0.0 0
M  V30 13 C 5.6948 8.0531 0.0 0
M  V30 14 C 7.5743 8.0025 0.0 0 CFG=2
M  V30 15 C 9.0857 8.0179 0.0 0 CFG=2
M  V30 16 C 6.4427 9.2341 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 3.8500 1.3338 0.0 0
M  V30 21 C 6.1600 2.6674 0.0 0
M  V30 22 C 1.5400 2.6674 0.0 0
M  V30 23 N 2.3100 1.3338 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 6.9300 1.3338 0.0 0
M  V30 26 C 6.1600 0.0000 0.0 0
M  V30 27 H 6.7336 3.9056 0.0 0
M  V30 28 H 8.1863 9.4156 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 9
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 15 7 CFG=1
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 9 27 CFG=3
M  V30 13 1 10 12 CFG=1
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 14 28 CFG=1
M  V30 21 1 17 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 23
M  V30 27 1 20 24
M  V30 28 2 21 25
M  V30 29 2 22 23
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 9 10 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-(8α,9S)-Cinchonan-9-yl-2-(formylamino)acetamide
C22H26N4O2
1620137-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1305 5.3347 0.0 0 CFG=1
M  V30 2 N 7.9005 6.6685 0.0 0
M  V30 3 C 9.4405 6.6685 0.0 0
M  V30 4 C 10.2105 8.0021 0.0 0
M  V30 5 O 10.2105 5.3347 0.0 0
M  V30 6 N 11.7505 8.0021 0.0 0
M  V30 7 C 12.5205 9.3358 0.0 0
M  V30 8 O 14.0605 9.3358 0.0 0
M  V30 9 C 1.2988 8.7290 0.0 0
M  V30 10 C 0.0000 7.9016 0.0 0
M  V30 11 C 5.5905 5.3347 0.0 0 CFG=2
M  V30 12 N 4.9784 6.8599 0.0 0 CFG=1
M  V30 13 C 4.7253 6.1625 0.0 0
M  V30 14 C 3.4944 6.8584 0.0 0
M  V30 15 C 6.0557 8.0531 0.0 0
M  V30 16 C 4.1762 8.0025 0.0 0 CFG=2
M  V30 17 C 2.6648 8.0179 0.0 0 CFG=2
M  V30 18 C 5.3078 9.2341 0.0 0
M  V30 19 C 7.9005 4.0011 0.0 0
M  V30 20 C 7.1305 2.6674 0.0 0
M  V30 21 C 9.4405 4.0011 0.0 0
M  V30 22 C 7.9005 1.3338 0.0 0
M  V30 23 C 5.5905 2.6674 0.0 0
M  V30 24 C 10.2105 2.6674 0.0 0
M  V30 25 N 9.4405 1.3338 0.0 0
M  V30 26 C 7.1305 0.0000 0.0 0
M  V30 27 C 4.8205 1.3338 0.0 0
M  V30 28 C 5.5905 0.0000 0.0 0
M  V30 29 H 5.0169 3.9056 0.0 0
M  V30 30 H 3.5642 9.4156 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 11
M  V30 3 1 1 19
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 17 9 CFG=3
M  V30 12 1 11 12
M  V30 13 1 11 13 CFG=3
M  V30 14 1 11 29 CFG=1
M  V30 15 1 12 14 CFG=3
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 16 30 CFG=3
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 20 23
M  V30 27 1 21 24
M  V30 28 1 22 25
M  V30 29 1 22 26
M  V30 30 2 23 27
M  V30 31 2 24 25
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 11 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620137-41-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620137-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14039971
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, literature preparation, 59% global yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel cinchona-amino acid hybrid organocatalysts for
asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrulas, Pedro; Benaglia, Maurizio; Burke, Anthony J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2014), 25(12), 923-935

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethylhexyl 9-decenoate
C18H34O2
1627923-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 4.6201 0.0 0
M  V30 2 C 4.0012 3.8501 0.0 0
M  V30 3 C 1.3337 3.8501 0.0 0
M  V30 4 C 2.6675 6.1601 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 C 1.3337 6.9302 0.0 0
M  V30 8 C 6.6685 3.8501 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 8.0023 4.6201 0.0 0
M  V30 11 O 6.6685 2.3101 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 C 12.0035 3.8501 0.0 0
M  V30 16 C 13.3372 4.6201 0.0 0
M  V30 17 C 14.6708 3.8501 0.0 0
M  V30 18 C 16.0045 4.6201 0.0 0
M  V30 19 C 17.3383 3.8501 0.0 0
M  V30 20 C 18.6720 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethylhexyl 9-(formyloxy)decanoate
C19H36O4
1807489-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 C 4.0012 3.8501 0.0 0
M  V30 3 C 1.3337 3.8501 0.0 0
M  V30 4 C 2.6673 6.1601 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 C 1.3337 6.9302 0.0 0
M  V30 8 C 6.6685 3.8501 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 8.0023 4.6201 0.0 0
M  V30 11 O 6.6685 2.3101 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 C 12.0033 3.8501 0.0 0
M  V30 16 C 13.3372 4.6201 0.0 0
M  V30 17 C 14.6708 3.8501 0.0 0
M  V30 18 C 16.0045 4.6201 0.0 0
M  V30 19 C 17.3382 3.8501 0.0 0
M  V30 20 O 18.6720 4.6201 0.0 0
M  V30 21 C 17.3382 2.3101 0.0 0
M  V30 22 C 20.0057 3.8501 0.0 0
M  V30 23 O 21.3393 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1627923-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1807489-81-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-237-CAS-19495396
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of formic acid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Branched diesters for use to reduce the fuel consumption of an engine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanson, Julien; Champagne, Nicolas; Benard, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3124580 A1 2017-02-01

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[6-Chloro-4-(1H-pyrrol-1-yl)-2-pyridinyl]-4-(1-methyl-1H-pyrazol-4-yl)-1,2...
C19H17ClN6
1630834-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7721 1.8517 0.0 0
M  V30 2 Cl 5.1048 6.4718 0.0 0
M  V30 3 N 10.4396 0.3117 0.0 0
M  V30 4 C 17.0759 5.2889 0.0 0
M  V30 5 C 3.7711 2.6218 0.0 0
M  V30 6 C 5.1048 1.8517 0.0 0
M  V30 7 C 3.7711 4.1618 0.0 0
M  V30 8 C 6.4384 2.6218 0.0 0
M  V30 9 C 5.1048 4.9318 0.0 0
M  V30 10 N 6.4384 4.1618 0.0 0
M  V30 11 N 2.4373 1.8517 0.0 0
M  V30 12 C 2.2763 0.3202 0.0 0
M  V30 13 C 1.0304 2.4781 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 16 C 9.1059 2.6218 0.0 0
M  V30 17 C 10.4396 1.8517 0.0 0
M  V30 18 C 9.1059 4.1618 0.0 0
M  V30 19 C 11.7733 2.6218 0.0 0
M  V30 20 C 10.4396 4.9318 0.0 0
M  V30 21 C 11.7733 4.1618 0.0 0
M  V30 22 C 13.1069 4.9318 0.0 0
M  V30 23 C 13.2680 6.4634 0.0 0
M  V30 24 C 14.5139 4.3055 0.0 0
M  V30 25 N 14.7743 6.7835 0.0 0
M  V30 26 N 15.5443 5.4499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 16
M  V30 3 1 2 9
M  V30 4 1 3 17
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[6-Chloro-4-(1H-pyrrol-1-yl)-2-pyridinyl]-5-(1-methyl-1H-pyrazol-4-yl)-1H-b...
C20H15ClN6
1630834-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.1048 0.0000 0.0 0
M  V30 2 C 17.5832 3.9200 0.0 0
M  V30 3 N 7.7721 4.6201 0.0 0
M  V30 4 C 9.1791 3.9936 0.0 0
M  V30 5 C 7.9332 6.1517 0.0 0
M  V30 6 C 10.2095 5.1382 0.0 0
M  V30 7 C 9.6549 2.5290 0.0 0
M  V30 8 N 9.4395 6.4718 0.0 0
M  V30 9 C 11.7160 4.8180 0.0 0
M  V30 10 C 11.1612 2.2089 0.0 0
M  V30 11 C 12.1918 3.3533 0.0 0
M  V30 12 C 6.4384 3.8501 0.0 0
M  V30 13 C 5.1048 4.6201 0.0 0
M  V30 14 N 6.4384 2.3101 0.0 0
M  V30 15 C 3.7711 3.8501 0.0 0
M  V30 16 C 5.1048 1.5400 0.0 0
M  V30 17 C 3.7711 2.3101 0.0 0
M  V30 18 N 2.4373 4.6201 0.0 0
M  V30 19 C 1.0304 3.9936 0.0 0
M  V30 20 C 2.2763 6.1517 0.0 0
M  V30 21 C 0.0000 5.1382 0.0 0
M  V30 22 C 0.7700 6.4718 0.0 0
M  V30 23 C 13.6981 3.0331 0.0 0
M  V30 24 C 14.8427 4.0635 0.0 0
M  V30 25 C 14.3246 1.6263 0.0 0
M  V30 26 N 16.1764 3.2935 0.0 0
M  V30 27 N 15.8562 1.7872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 26
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 11 23
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630834-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630834-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-18615268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzo[d]imidazol-1-yl)pyridin-2-amine compounds as FGFR
protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajagopalan, Srinivasan; Appukuttan, Prasad; Narasingapuram Arumugam,
Karthikeyan; Ujjinamatada, Ravi Kotrabasaiah; George, Shyla
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2013KO00382 A 2014-10-10

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[6-Chloro-4-(1H-pyrrol-1-yl)-2-pyridinyl]-4-(1-methyl-1H-pyrazol-4-yl)-1,2...
C19H17ClN6
1630834-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7721 1.8517 0.0 0
M  V30 2 Cl 5.1048 6.4718 0.0 0
M  V30 3 N 10.4396 0.3117 0.0 0
M  V30 4 C 17.0759 5.2889 0.0 0
M  V30 5 C 3.7711 2.6218 0.0 0
M  V30 6 C 5.1048 1.8517 0.0 0
M  V30 7 C 3.7711 4.1618 0.0 0
M  V30 8 C 6.4384 2.6218 0.0 0
M  V30 9 C 5.1048 4.9318 0.0 0
M  V30 10 N 6.4384 4.1618 0.0 0
M  V30 11 N 2.4373 1.8517 0.0 0
M  V30 12 C 2.2763 0.3202 0.0 0
M  V30 13 C 1.0304 2.4781 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 16 C 9.1059 2.6218 0.0 0
M  V30 17 C 10.4396 1.8517 0.0 0
M  V30 18 C 9.1059 4.1618 0.0 0
M  V30 19 C 11.7733 2.6218 0.0 0
M  V30 20 C 10.4396 4.9318 0.0 0
M  V30 21 C 11.7733 4.1618 0.0 0
M  V30 22 C 13.1069 4.9318 0.0 0
M  V30 23 C 13.2680 6.4634 0.0 0
M  V30 24 C 14.5139 4.3055 0.0 0
M  V30 25 N 14.7743 6.7835 0.0 0
M  V30 26 N 15.5443 5.4499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 16
M  V30 3 1 2 9
M  V30 4 1 3 17
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[6-Chloro-4-(1H-pyrrol-1-yl)-2-pyridinyl]-5-(1-methyl-1H-pyrazol-4-yl)-1H-b...
C20H15ClN6
1630834-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.1048 0.0000 0.0 0
M  V30 2 C 17.5832 3.9200 0.0 0
M  V30 3 N 7.7721 4.6201 0.0 0
M  V30 4 C 9.1791 3.9936 0.0 0
M  V30 5 C 7.9332 6.1517 0.0 0
M  V30 6 C 10.2095 5.1382 0.0 0
M  V30 7 C 9.6549 2.5290 0.0 0
M  V30 8 N 9.4395 6.4718 0.0 0
M  V30 9 C 11.7160 4.8180 0.0 0
M  V30 10 C 11.1612 2.2089 0.0 0
M  V30 11 C 12.1918 3.3533 0.0 0
M  V30 12 C 6.4384 3.8501 0.0 0
M  V30 13 C 5.1048 4.6201 0.0 0
M  V30 14 N 6.4384 2.3101 0.0 0
M  V30 15 C 3.7711 3.8501 0.0 0
M  V30 16 C 5.1048 1.5400 0.0 0
M  V30 17 C 3.7711 2.3101 0.0 0
M  V30 18 N 2.4373 4.6201 0.0 0
M  V30 19 C 1.0304 3.9936 0.0 0
M  V30 20 C 2.2763 6.1517 0.0 0
M  V30 21 C 0.0000 5.1382 0.0 0
M  V30 22 C 0.7700 6.4718 0.0 0
M  V30 23 C 13.6981 3.0331 0.0 0
M  V30 24 C 14.8427 4.0635 0.0 0
M  V30 25 C 14.3246 1.6263 0.0 0
M  V30 26 N 16.1764 3.2935 0.0 0
M  V30 27 N 15.8562 1.7872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 26
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 11 23
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630834-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630834-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-15517520
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzo[d]imidazol-1-yl)pyridin-2-amine compounds as FGFR
protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajagopalan, Srinivasan; Appukuttan, Prasad; Narasingapuram Arumugam,
Karthikeyan; Ujjinamatada, Ravi Kotrabasaiah; George, Shyla; Linnanen,
Tero
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014162039 A1 2014-10-09

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[[2-Amino-4-(1-methyl-1H-pyrazol-4-yl)phenyl]amino]-6-chloro-2-pyrimidin...
C16H16ClN7O
1630834-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 0.0000 0.0 0
M  V30 2 C 17.3060 4.9772 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0
M  V30 4 N 2.6673 1.5400 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 Cl 5.3348 6.1601 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 13.4981 6.1517 0.0 0
M  V30 17 C 14.7440 3.9936 0.0 0
M  V30 18 N 15.0044 6.4718 0.0 0
M  V30 19 N 15.7744 5.1382 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 N 5.3348 1.5400 0.0 0
M  V30 22 C 6.6685 3.8501 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 N 4.0010 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 19
M  V30 3 1 3 14
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Chloro-6-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-pyrimidin...
C17H14ClN7O
1630834-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 Cl 5.3348 0.0000 0.0 0
M  V30 6 C 17.8133 3.9200 0.0 0
M  V30 7 C 9.4091 3.9936 0.0 0
M  V30 8 N 8.0022 4.6201 0.0 0
M  V30 9 C 10.4396 5.1382 0.0 0
M  V30 10 C 9.8850 2.5290 0.0 0
M  V30 11 C 8.1633 6.1517 0.0 0
M  V30 12 C 11.9459 4.8180 0.0 0
M  V30 13 N 9.6696 6.4718 0.0 0
M  V30 14 C 11.3913 2.2089 0.0 0
M  V30 15 C 12.4219 3.3533 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 17 N 5.3348 4.6201 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 4.0010 3.8501 0.0 0
M  V30 20 C 5.3348 1.5400 0.0 0
M  V30 21 N 4.0010 2.3101 0.0 0
M  V30 22 C 13.9282 3.0331 0.0 0
M  V30 23 C 14.5545 1.6263 0.0 0
M  V30 24 C 15.0728 4.0635 0.0 0
M  V30 25 N 16.0863 1.7872 0.0 0
M  V30 26 N 16.4064 3.2935 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 20
M  V30 6 1 6 26
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 15 22
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630834-69-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630834-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-18615300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzo[d]imidazol-1-yl)pyridin-2-amine compounds as FGFR
protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajagopalan, Srinivasan; Appukuttan, Prasad; Narasingapuram Arumugam,
Karthikeyan; Ujjinamatada, Ravi Kotrabasaiah; George, Shyla
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2013KO00382 A 2014-10-10

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[[2-Amino-4-(1-methyl-1H-pyrazol-4-yl)phenyl]amino]-6-chloro-2-pyrimidin...
C16H16ClN7O
1630834-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 0.0000 0.0 0
M  V30 2 C 17.3060 4.9772 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0
M  V30 4 N 2.6673 1.5400 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 O 0.0000 1.5400 0.0 0
M  V30 8 Cl 5.3348 6.1601 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 13.4981 6.1517 0.0 0
M  V30 17 C 14.7440 3.9936 0.0 0
M  V30 18 N 15.0044 6.4718 0.0 0
M  V30 19 N 15.7744 5.1382 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 N 5.3348 1.5400 0.0 0
M  V30 22 C 6.6685 3.8501 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 N 4.0010 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 19
M  V30 3 1 3 14
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Chloro-6-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-pyrimidin...
C17H14ClN7O
1630834-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 Cl 5.3348 0.0000 0.0 0
M  V30 6 C 17.8133 3.9200 0.0 0
M  V30 7 C 9.4091 3.9936 0.0 0
M  V30 8 N 8.0022 4.6201 0.0 0
M  V30 9 C 10.4396 5.1382 0.0 0
M  V30 10 C 9.8850 2.5290 0.0 0
M  V30 11 C 8.1633 6.1517 0.0 0
M  V30 12 C 11.9459 4.8180 0.0 0
M  V30 13 N 9.6696 6.4718 0.0 0
M  V30 14 C 11.3913 2.2089 0.0 0
M  V30 15 C 12.4219 3.3533 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 17 N 5.3348 4.6201 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 4.0010 3.8501 0.0 0
M  V30 20 C 5.3348 1.5400 0.0 0
M  V30 21 N 4.0010 2.3101 0.0 0
M  V30 22 C 13.9282 3.0331 0.0 0
M  V30 23 C 14.5545 1.6263 0.0 0
M  V30 24 C 15.0728 4.0635 0.0 0
M  V30 25 N 16.0863 1.7872 0.0 0
M  V30 26 N 16.4064 3.2935 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 20
M  V30 6 1 6 26
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 15 22
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1630834-69-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1630834-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-12368756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzo[d]imidazol-1-yl)pyridin-2-amine compounds as FGFR
protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajagopalan, Srinivasan; Appukuttan, Prasad; Narasingapuram Arumugam,
Karthikeyan; Ujjinamatada, Ravi Kotrabasaiah; George, Shyla; Linnanen,
Tero
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014162039 A1 2014-10-09

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(2-Amino-4-bromophenyl)amino]-4′-fluoro-2′-methoxy[1,1′-biphenyl]-3-yl]...
C21H19BrFN3O2
1632137-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.7800 8.0021 0.0 0
M  V30 2 C 11.5500 9.3358 0.0 0
M  V30 3 N 6.1600 8.0021 0.0 0
M  V30 4 N 6.1600 2.6673 0.0 0
M  V30 5 C 6.9300 1.3336 0.0 0
M  V30 6 C 6.1600 0.0000 0.0 0
M  V30 7 O 8.4700 1.3336 0.0 0
M  V30 8 F 15.4000 5.3347 0.0 0
M  V30 9 N 4.6200 10.6694 0.0 0
M  V30 10 Br 0.0000 8.0021 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 8.4700 6.6684 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 10.7800 5.3347 0.0 0
M  V30 18 C 11.5500 6.6684 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 13.0900 6.6684 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 C 13.8600 5.3347 0.0 0
M  V30 23 C 4.6200 8.0021 0.0 0
M  V30 24 C 3.8500 9.3358 0.0 0
M  V30 25 C 3.8500 6.6684 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 2.3100 6.6684 0.0 0
M  V30 28 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 14
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 8 22
M  V30 10 1 9 24
M  V30 11 1 10 28
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-(5-Bromo-1H-benzimidazol-1-yl)-4′-fluoro-2′-methoxy[1,1′-biphenyl]-3-yl]...
C22H17BrFN3O2
1632137-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 O 4.0011 2.3100 0.0 0
M  V30 5 Br 15.2619 5.3431 0.0 0
M  V30 6 O 5.3348 9.2401 0.0 0
M  V30 7 C 5.3348 10.7801 0.0 0
M  V30 8 F 0.0000 9.2401 0.0 0
M  V30 9 N 9.3359 6.9301 0.0 0
M  V30 10 C 10.7427 6.3038 0.0 0
M  V30 11 C 9.4968 8.4616 0.0 0
M  V30 12 C 11.7733 7.4481 0.0 0
M  V30 13 C 11.2187 4.8390 0.0 0
M  V30 14 N 11.0033 8.7818 0.0 0
M  V30 15 C 13.2796 7.1280 0.0 0
M  V30 16 C 12.7250 4.5189 0.0 0
M  V30 17 C 13.7554 5.6633 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 6.6684 6.9301 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0
M  V30 21 C 5.3348 6.1601 0.0 0
M  V30 22 C 6.6684 3.8500 0.0 0
M  V30 23 C 5.3348 4.6201 0.0 0
M  V30 24 C 4.0011 6.9301 0.0 0
M  V30 25 C 4.0011 8.4701 0.0 0
M  V30 26 C 2.6675 6.1601 0.0 0
M  V30 27 C 2.6675 9.2401 0.0 0
M  V30 28 C 1.3337 6.9301 0.0 0
M  V30 29 C 1.3337 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 1 8 29
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1632137-43-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1632137-44-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-18607681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazoles and related compounds as protein kinase inhibitors and
their preparation and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nanduri, Srinivas; Ujjinamatada, Ravi Kotrabasaiah; Rajagopalan,
Srinivasan; Mukherjee, Subhendu; Linnanen, Tero; Wohlfahrt, Gerd
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2011KO01306 A 2013-04-12

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Nitrophenoxy)ethanol
C8H9NO4
16365-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(3-nitrophenoxy)-, 1-formate
C9H9NO5
2417431-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 O 13.3370 2.3101 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16365-26-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24445913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Nitrophenoxy)ethanol
C8H9NO4
16365-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 O 10.6697 3.8501 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(4-nitrophenoxy)-, 1-formate
C9H9NO5
2417431-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 O 10.6697 3.8501 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 O 13.3370 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16365-27-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-41-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24486878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17595-33-4
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry, 0.2 g scale used, no solvent (stage 1),
excess of formic acid recovered as sodium formate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective O-formyl and O-acyl protection of alkanolamines,
phenoxyethanols and alcohols catalyzed by nickel(II) and
copper(II)-catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sonawane, Rahul B.; Sonawane, Swapnali R.; Rasal, Nishant K.; Jagtap,
Sangeeta V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2020), 22(10), 3186-3195

$RFMT $RIREG SCHEME362 STEP1
$RXN



  4  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propargylamine
C3H5N
2450-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodonium, diphenyl-, 2,2,2-trifluoroacetate (1:1)
C12H10I.C2F3O2
16668-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9533 6.5174 0.0 0
M  V30 2 C 5.2869 5.7474 0.0 0
M  V30 3 F 4.7233 7.8511 0.0 0
M  V30 4 F 2.6196 7.2874 0.0 0
M  V30 5 F 3.1833 5.1837 0.0 0
M  V30 6 O 6.6206 6.5174 0.0 0 CHG=-1
M  V30 7 O 5.2869 4.2073 0.0 0
M  V30 8 I 4.6201 1.3337 0.0 0 CHG=1 VAL=2
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 15 C 6.1601 1.3337 0.0 0
M  V30 16 C 6.9302 0.0000 0.0 0
M  V30 17 C 6.9302 2.6673 0.0 0
M  V30 18 C 8.4702 0.0000 0.0 0
M  V30 19 C 8.4702 2.6673 0.0 0
M  V30 20 C 9.2402 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 8 9
M  V30 8 1 8 15
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromo-1-naphthalenyl)-2,2,2-trifluoroethanimidoyl chloride
C12H6BrClF3N
2376974-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 Cl 6.1600 6.6685 0.0 0
M  V30 5 F 8.4700 6.8749 0.0 0
M  V30 6 F 10.0100 5.3349 0.0 0
M  V30 7 F 8.4700 3.7949 0.0 0
M  V30 8 Br 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 1.5400 1.3338 0.0 0
M  V30 15 C 3.8500 5.3349 0.0 0
M  V30 16 C 3.8500 0.0000 0.0 0
M  V30 17 C 2.3100 5.3349 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-(4-Bromo-1-naphthalenyl)-2-(trifluoromethyl)-1H-imidazol-5-yl]-1-phenyle...
C22H14BrF3N2O
2412501-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8857 6.5892 0.0 0
M  V30 2 C 8.0302 7.6198 0.0 0
M  V30 3 O 7.7100 9.1261 0.0 0
M  V30 4 C 1.4647 6.5892 0.0 0
M  V30 5 F 1.9406 5.1247 0.0 0
M  V30 6 F 0.0000 6.1134 0.0 0
M  V30 7 F 0.9888 8.0539 0.0 0
M  V30 8 Br 4.1753 0.0000 0.0 0
M  V30 9 N 4.1753 6.1600 0.0 0
M  V30 10 C 5.4211 7.0652 0.0 0
M  V30 11 C 2.9294 7.0652 0.0 0
M  V30 12 C 4.9453 8.5298 0.0 0
M  V30 13 N 3.4053 8.5298 0.0 0
M  V30 14 C 4.1753 4.6200 0.0 0
M  V30 15 C 5.5089 3.8500 0.0 0
M  V30 16 C 2.8415 3.8500 0.0 0
M  V30 17 C 5.5089 2.3100 0.0 0
M  V30 18 C 6.8425 4.6200 0.0 0
M  V30 19 C 2.8415 2.3100 0.0 0
M  V30 20 C 4.1753 1.5400 0.0 0
M  V30 21 C 6.8425 1.5400 0.0 0
M  V30 22 C 8.1762 3.8500 0.0 0
M  V30 23 C 8.1762 2.3100 0.0 0
M  V30 24 C 9.4947 7.1439 0.0 0
M  V30 25 C 9.8151 5.6375 0.0 0
M  V30 26 C 10.6393 8.1743 0.0 0
M  V30 27 C 11.2796 5.1616 0.0 0
M  V30 28 C 12.1038 7.6985 0.0 0
M  V30 29 C 12.4241 6.1920 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 11
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 20
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2450-71-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16668-99-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2376974-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412501-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27226689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Four-Component Carbonylative Cyclization Reaction of
Trifluoroacetimidoyl Chlorides, Propargyl Amines, and Diaryliodonium
Salts: Access to Trifluoromethyl-Containing Trisubstituted Imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhengkai; Wang, Wei-Feng; Yang, Hefei; Wu, Xiao-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2020), 22(5), 1980-1984

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5,6,7,8-tetrahydro-2-(phenylamino)[1]benzothieno[2,3-d]pyrimidin-4(3H...
C16H16N4OS
168280-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3200 0.0000 0.0 0
M  V30 2 N 7.4000 0.0000 0.0 0
M  V30 3 N 8.9401 2.6674 0.0 0
M  V30 4 C 4.3200 2.6674 0.0 0
M  V30 5 C 5.0900 4.0011 0.0 0
M  V30 6 C 2.8137 2.9876 0.0 0
M  V30 7 C 5.0900 1.3338 0.0 0
M  V30 8 S 4.0596 5.1456 0.0 0
M  V30 9 N 6.6300 4.0011 0.0 0
M  V30 10 C 2.6527 4.5192 0.0 0
M  V30 11 C 1.5679 2.0824 0.0 0
M  V30 12 N 6.6300 1.3338 0.0 0
M  V30 13 C 7.4000 2.6674 0.0 0
M  V30 14 C 1.2459 5.1456 0.0 0
M  V30 15 C 0.1609 2.7089 0.0 0
M  V30 16 C 0.0000 4.2404 0.0 0
M  V30 17 C 9.7101 4.0011 0.0 0
M  V30 18 C 11.2501 4.0011 0.0 0
M  V30 19 C 8.9401 5.3347 0.0 0
M  V30 20 C 12.0201 5.3347 0.0 0
M  V30 21 C 9.7101 6.6685 0.0 0
M  V30 22 C 11.2501 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 13
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 8 10
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 13
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,8,9-Tetrahydro-3-phenyl[1]benzothieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimid...
C17H14N4OS
168280-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5051 0.5094 0.0 0
M  V30 2 C 7.0725 2.4782 0.0 0
M  V30 3 N 6.0420 1.3337 0.0 0
M  V30 4 N 8.4793 1.8517 0.0 0
M  V30 5 N 6.5966 3.9428 0.0 0
M  V30 6 C 4.5356 1.6538 0.0 0
M  V30 7 N 6.8120 0.0000 0.0 0
M  V30 8 C 8.3183 0.3202 0.0 0
M  V30 9 C 5.0901 4.2630 0.0 0
M  V30 10 C 4.0597 3.1186 0.0 0
M  V30 11 S 4.3201 5.5966 0.0 0
M  V30 12 C 2.6527 3.7449 0.0 0
M  V30 13 C 2.8138 5.2765 0.0 0
M  V30 14 C 1.2459 3.1186 0.0 0
M  V30 15 C 1.5679 6.1817 0.0 0
M  V30 16 C 0.0000 4.0238 0.0 0
M  V30 17 C 0.1609 5.5554 0.0 0
M  V30 18 C 9.8131 2.6218 0.0 0
M  V30 19 C 11.1468 1.8517 0.0 0
M  V30 20 C 9.8131 4.1618 0.0 0
M  V30 21 C 12.4804 2.6218 0.0 0
M  V30 22 C 11.1468 4.9318 0.0 0
M  V30 23 C 12.4804 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 18
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 168280-54-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 168280-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-7325246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Title studies on the reaction of
N-(3-carbethoxy-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)-N'-phenylthiourea
with hydrazine hydrate (Part 1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Sherief, Hassan A. H.; El-Naggar, Galal M.; Hozien, Zeinab A.;
El-Sawaisi, Suliman M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2008), 45(2), 467-473

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenylmethyl)valine
C12H17NO2
16975-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 N 5.3347 3.0800 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 C 6.6684 0.7700 0.0 0
M  V30 5 C 8.0021 3.0800 0.0 0
M  V30 6 C 5.3347 0.0000 0.0 0
M  V30 7 C 8.0021 0.0000 0.0 0
M  V30 8 O 9.3358 2.3100 0.0 0
M  V30 9 O 8.0021 4.6200 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 1.3336 5.3900 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Formyl-N-(phenylmethyl)valine
C13H17NO3
2211040-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 4.6200 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3336 3.0800 0.0 0
M  V30 7 O 2.6674 5.3900 0.0 0
M  V30 8 C 4.0011 0.0000 0.0 0
M  V30 9 C 1.3336 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 O 1.3336 4.6200 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0
M  V30 15 C 9.3358 3.0800 0.0 0
M  V30 16 C 8.0021 5.3900 0.0 0
M  V30 17 C 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 12
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16975-39-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211040-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19113113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-4-[[(4-chlorophenyl)methyl]amino]benzoate
C15H15ClN2O2
174422-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 N 6.9300 0.0000 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 O 1.5400 4.0011 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 Cl 15.4000 4.0011 0.0 0
M  V30 9 C 6.9300 2.6674 0.0 0
M  V30 10 C 6.1600 1.3338 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 3.8500 2.6674 0.0 0
M  V30 15 C 10.7800 4.0011 0.0 0
M  V30 16 C 11.5500 2.6674 0.0 0
M  V30 17 C 11.5500 5.3349 0.0 0
M  V30 18 C 13.0900 2.6674 0.0 0
M  V30 19 C 13.0900 5.3349 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[(4-chlorophenyl)methyl]-1H-benzimidazole-5-carboxylate
C16H13ClN2O2
1168139-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.4287 0.0 0
M  V30 2 C 12.8553 1.5064 0.0 0
M  V30 3 O 13.9998 2.5368 0.0 0
M  V30 4 O 13.1756 0.0000 0.0 0
M  V30 5 C 15.4644 2.0610 0.0 0
M  V30 6 Cl 0.0000 4.4287 0.0 0
M  V30 7 C 8.4615 2.9340 0.0 0
M  V30 8 C 8.7817 1.4277 0.0 0
M  V30 9 N 6.9300 3.0949 0.0 0
M  V30 10 C 9.6059 3.9644 0.0 0
M  V30 11 C 10.2462 0.9517 0.0 0
M  V30 12 N 7.4481 0.6577 0.0 0
M  V30 13 C 6.3035 1.6881 0.0 0
M  V30 14 C 11.0706 3.4886 0.0 0
M  V30 15 C 11.3908 1.9823 0.0 0
M  V30 16 C 4.6200 4.4287 0.0 0
M  V30 17 C 3.8500 3.0949 0.0 0
M  V30 18 C 3.8500 5.7624 0.0 0
M  V30 19 C 2.3100 3.0949 0.0 0
M  V30 20 C 2.3100 5.7624 0.0 0
M  V30 21 C 1.5400 4.4287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 174422-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1168139-13-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-1323178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Description 85 (D85). Methyl
3-amino-4-{[(4-chlorophenyl)methyl]amino}benzoate (preparable, for
example, as in 039) (500mg, 1.72mmol) was dissolved in formic acid
(4.25ml) and heated to 110°C for 30 minutes. The mixture was cooled to
room temperature and then to 0°C. It was neutralised carefully with
saturated sodium bicarbonate solution (∼100ml). It was then extracted
with ethyl acetate (50ml) which was washed with brine (50ml), and water
(3×50ml) then dried over MgSO4. The mixture was evaporated. the title
compound. Methyl
1-[(4-chlorophenyl)methyl]-1H-benzimidazole-5-carboxylate. yellow solid
(500mg, 1.66mmol, 97% yield). LC/MS: Rt=2.66 min, [MH]+ 301.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazol-5-ylamides as agonists of PPARγ and preparation and
treatment of diseases thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blanc, Jean-Baptiste Emmanuel; Allan, Amanda Claire; Fieldhouse,
Charlotte; Giblin, Gerard Martin Paul; Gibson, Mairi; Healy, Mark
Patrick; Jandu, Karamjit Singh; Lambert, Millard Hurst, III; Price, Helen
Susanne; Shearer, Barry George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009083526 A1 2009-07-09

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenylmethyl)-1-(triphenylmethyl)-L-histidine methyl ester
C33H31N3O2
176752-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 8.2493 0.0 0
M  V30 2 C 7.6286 4.2206 0.0 0
M  V30 3 C 9.1601 4.0597 0.0 0 CFG=1
M  V30 4 N 10.0654 5.3056 0.0 0
M  V30 5 C 9.7866 2.6527 0.0 0
M  V30 6 C 11.5969 5.1446 0.0 0
M  V30 7 O 8.8814 1.4068 0.0 0
M  V30 8 O 11.3182 2.4918 0.0 0
M  V30 9 C 9.5077 0.0000 0.0 0
M  V30 10 N 5.3348 7.4793 0.0 0
M  V30 11 C 5.4958 5.9476 0.0 0
M  V30 12 C 6.7417 8.1057 0.0 0
M  V30 13 C 7.0022 5.6274 0.0 0
M  V30 14 N 7.7722 6.9613 0.0 0
M  V30 15 C 3.2311 6.9155 0.0 0
M  V30 16 C 4.0012 5.5819 0.0 0
M  V30 17 C 1.6911 6.9155 0.0 0
M  V30 18 C 3.2311 4.2482 0.0 0
M  V30 19 C 0.9211 5.5819 0.0 0
M  V30 20 C 1.6911 4.2482 0.0 0
M  V30 21 C 2.6673 9.0194 0.0 0
M  V30 22 C 1.3337 8.2493 0.0 0
M  V30 23 C 2.6673 10.5594 0.0 0
M  V30 24 C 0.0000 9.0194 0.0 0
M  V30 25 C 1.3337 11.3294 0.0 0
M  V30 26 C 0.0000 10.5594 0.0 0
M  V30 27 C 4.7712 9.5830 0.0 0
M  V30 28 C 6.3112 9.5830 0.0 0
M  V30 29 C 4.0012 10.9167 0.0 0
M  V30 30 C 7.0812 10.9167 0.0 0
M  V30 31 C 4.7712 12.2504 0.0 0
M  V30 32 C 6.3112 12.2504 0.0 0
M  V30 33 C 12.5021 6.3905 0.0 0
M  V30 34 C 14.0337 6.2294 0.0 0
M  V30 35 C 11.8758 7.7973 0.0 0
M  V30 36 C 14.9389 7.4755 0.0 0
M  V30 37 C 12.7810 9.0432 0.0 0
M  V30 38 C 14.3126 8.8823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 1 27
M  V30 5 1 2 3
M  V30 6 1 2 13
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 5 7
M  V30 11 2 5 8
M  V30 12 1 6 33
M  V30 13 1 7 9
M  V30 14 1 10 11
M  V30 15 1 10 12
M  V30 16 2 11 13
M  V30 17 2 12 14
M  V30 18 1 13 14
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Formyl-N-(phenylmethyl)-1-(triphenylmethyl)-L-histidine methyl ester
C34H31N3O3
2211039-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 C 9.7758 6.2952 0.0 0
M  V30 3 C 11.1826 5.6689 0.0 0 CFG=1
M  V30 4 N 12.4284 6.5740 0.0 0
M  V30 5 C 11.3436 4.1372 0.0 0
M  V30 6 C 13.8354 5.9476 0.0 0
M  V30 7 C 12.2675 8.1056 0.0 0
M  V30 8 O 12.7504 3.5109 0.0 0
M  V30 9 O 10.0976 3.2320 0.0 0
M  V30 10 O 10.8607 8.7320 0.0 0
M  V30 11 C 12.9114 1.9794 0.0 0
M  V30 12 N 6.1600 4.6200 0.0 0
M  V30 13 C 7.0652 5.8659 0.0 0
M  V30 14 C 7.0652 3.3741 0.0 0
M  V30 15 C 8.5299 5.3900 0.0 0
M  V30 16 N 8.5299 3.8500 0.0 0
M  V30 17 C 4.6200 3.0800 0.0 0
M  V30 18 C 5.9538 2.3100 0.0 0
M  V30 19 C 3.2864 2.3100 0.0 0
M  V30 20 C 5.9538 0.7700 0.0 0
M  V30 21 C 3.2864 0.7700 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 3.0800 4.6200 0.0 0
M  V30 24 C 2.3100 5.9536 0.0 0
M  V30 25 C 2.3100 3.2864 0.0 0
M  V30 26 C 0.7700 5.9536 0.0 0
M  V30 27 C 0.7700 3.2864 0.0 0
M  V30 28 C 0.0000 4.6200 0.0 0
M  V30 29 C 4.6200 6.1600 0.0 0
M  V30 30 C 3.2864 6.9300 0.0 0
M  V30 31 C 5.9538 6.9300 0.0 0
M  V30 32 C 3.2864 8.4700 0.0 0
M  V30 33 C 5.9538 8.4700 0.0 0
M  V30 34 C 4.6200 9.2400 0.0 0
M  V30 35 C 15.0812 6.8528 0.0 0
M  V30 36 C 16.4882 6.2265 0.0 0
M  V30 37 C 14.9203 8.3844 0.0 0
M  V30 38 C 17.7340 7.1316 0.0 0
M  V30 39 C 16.1662 9.2896 0.0 0
M  V30 40 C 17.5729 8.6633 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 1 29
M  V30 5 1 2 3
M  V30 6 1 2 15
M  V30 7 1 3 4 CFG=3
M  V30 8 1 3 5
M  V30 9 1 4 6
M  V30 10 1 4 7
M  V30 11 1 5 8
M  V30 12 2 5 9
M  V30 13 1 6 35
M  V30 14 2 7 10
M  V30 15 1 8 11
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176752-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211039-84-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19112943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Ac2O also used as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(4-Fluorophenyl)hydroxymethyl]-1-methyl-6-[2-(1-methylethyl)phenoxy]-3-[3-...
C32H36FN3O6
1878199-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2699 5.7884 0.0 0
M  V30 2 O 4.7824 5.3899 0.0 0
M  V30 3 O 9.3359 5.7359 0.0 0
M  V30 4 O 4.0011 7.2759 0.0 0
M  V30 5 C 9.3359 11.8960 0.0 0
M  V30 6 C 12.0032 7.2759 0.0 0
M  V30 7 C 13.3370 8.0459 0.0 0
M  V30 8 C 14.6706 7.2759 0.0 0
M  V30 9 O 16.0043 8.0459 0.0 0
M  V30 10 O 12.0032 10.3560 0.0 0
M  V30 11 C 1.3337 5.7359 0.0 0
M  V30 12 C 0.0000 4.9659 0.0 0
M  V30 13 C 2.6675 4.9659 0.0 0
M  V30 14 F 8.3767 0.0000 0.0 0
M  V30 15 C 8.0022 8.0459 0.0 0
M  V30 16 C 6.6684 7.2759 0.0 0
M  V30 17 C 8.0022 9.5860 0.0 0
M  V30 18 C 9.3359 7.2759 0.0 0
M  V30 19 C 5.3348 8.0459 0.0 0
M  V30 20 N 6.6684 10.3560 0.0 0
M  V30 21 N 9.3359 10.3560 0.0 0
M  V30 22 N 10.6695 8.0459 0.0 0
M  V30 23 C 5.3348 9.5860 0.0 0
M  V30 24 C 10.6695 9.5860 0.0 0
M  V30 25 C 6.7965 4.3413 0.0 0
M  V30 26 C 8.3131 4.0739 0.0 0
M  V30 27 C 5.8066 3.1616 0.0 0
M  V30 28 C 8.8400 2.6268 0.0 0
M  V30 29 C 6.3335 1.7145 0.0 0
M  V30 30 C 7.8501 1.4470 0.0 0
M  V30 31 C 2.6675 8.0459 0.0 0
M  V30 32 C 1.3337 7.2759 0.0 0
M  V30 33 C 2.6675 9.5860 0.0 0
M  V30 34 C 0.0000 8.0459 0.0 0
M  V30 35 C 1.3337 10.3560 0.0 0
M  V30 36 C 0.0000 9.5860 0.0 0
M  V30 37 C 17.3379 7.2759 0.0 0
M  V30 38 C 17.3379 5.7359 0.0 0
M  V30 39 O 18.6717 8.0459 0.0 0
M  V30 40 C 18.6717 4.9659 0.0 0
M  V30 41 C 20.0054 7.2759 0.0 0
M  V30 42 C 20.0054 5.7359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 2 3 18
M  V30 5 1 4 19
M  V30 6 1 4 31
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 1 6 22
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 37
M  V30 13 2 10 24
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 32
M  V30 17 1 14 30
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 2 19 23
M  V30 26 1 20 23
M  V30 27 1 21 24
M  V30 28 1 22 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(4-Fluorophenyl)methyl]-3-[3-(formyloxy)propyl]-1-methyl-6-[2-(1-methyleth...
C28H28FN3O5
1878199-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0176 6.0665 0.0 0
M  V30 2 O 9.3358 5.9222 0.0 0
M  V30 3 O 4.0011 7.4622 0.0 0
M  V30 4 C 9.3358 12.0822 0.0 0
M  V30 5 C 12.0032 7.4622 0.0 0
M  V30 6 C 13.3369 8.2322 0.0 0
M  V30 7 C 14.6705 7.4622 0.0 0
M  V30 8 O 16.0041 8.2322 0.0 0
M  V30 9 C 17.3379 7.4622 0.0 0
M  V30 10 O 18.6716 8.2322 0.0 0
M  V30 11 O 12.0032 10.5422 0.0 0
M  V30 12 C 1.3336 5.9222 0.0 0
M  V30 13 C 0.0000 5.1522 0.0 0
M  V30 14 C 2.6674 5.1522 0.0 0
M  V30 15 F 7.0872 0.0000 0.0 0
M  V30 16 C 8.0021 8.2322 0.0 0
M  V30 17 C 6.6684 7.4622 0.0 0
M  V30 18 C 8.0021 9.7722 0.0 0
M  V30 19 C 9.3358 7.4622 0.0 0
M  V30 20 C 5.3347 8.2322 0.0 0
M  V30 21 N 6.6684 10.5422 0.0 0
M  V30 22 N 9.3358 10.5422 0.0 0
M  V30 23 N 10.6694 8.2322 0.0 0
M  V30 24 C 5.3347 9.7722 0.0 0
M  V30 25 C 10.6694 9.7722 0.0 0
M  V30 26 C 6.2850 4.5499 0.0 0
M  V30 27 C 5.1053 3.5600 0.0 0
M  V30 28 C 7.7322 4.0231 0.0 0
M  V30 29 C 5.3728 2.0434 0.0 0
M  V30 30 C 7.9995 2.5065 0.0 0
M  V30 31 C 6.8199 1.5166 0.0 0
M  V30 32 C 2.6674 8.2322 0.0 0
M  V30 33 C 1.3336 7.4622 0.0 0
M  V30 34 C 2.6674 9.7722 0.0 0
M  V30 35 C 0.0000 8.2322 0.0 0
M  V30 36 C 1.3336 10.5422 0.0 0
M  V30 37 C 0.0000 9.7722 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 26
M  V30 3 2 2 19
M  V30 4 1 3 20
M  V30 5 1 3 32
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 5 23
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 2 11 25
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 33
M  V30 17 1 15 31
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 23 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1878199-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1878199-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-531-CAS-15675063
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives as TRPC5 modulators
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chenard, Bertrand L.; Gallaschun, Randall J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016023830 A1 2016-02-18

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-5-[hydroxy[6-(trifluoromethyl)-3-pyridinyl]methyl]-1-methyl-3-[3-[(te...
C23H24BrF3N4O5
1878199-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 6.6684 0.0 0
M  V30 2 O 11.5500 5.3347 0.0 0
M  V30 3 O 10.0100 5.3347 0.0 0
M  V30 4 Br 13.8600 9.3358 0.0 0
M  V30 5 C 6.9300 10.6694 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 O 5.3900 8.0021 0.0 0
M  V30 11 C 18.4800 6.6684 0.0 0
M  V30 12 F 18.4800 5.1284 0.0 0
M  V30 13 F 20.0200 6.6684 0.0 0
M  V30 14 F 18.4800 8.2084 0.0 0
M  V30 15 C 10.0100 8.0021 0.0 0
M  V30 16 C 11.5500 8.0021 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 C 9.2400 6.6684 0.0 0
M  V30 19 C 12.3200 9.3358 0.0 0
M  V30 20 N 7.7000 9.3358 0.0 0
M  V30 21 N 10.0100 10.6694 0.0 0
M  V30 22 N 7.7000 6.6684 0.0 0
M  V30 23 C 11.5500 10.6694 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 13.8600 6.6684 0.0 0
M  V30 26 C 14.6300 8.0021 0.0 0
M  V30 27 C 14.6300 5.3347 0.0 0
M  V30 28 C 16.1700 8.0021 0.0 0
M  V30 29 N 16.1700 5.3347 0.0 0
M  V30 30 C 16.9400 6.6684 0.0 0
M  V30 31 C 2.3100 2.6673 0.0 0
M  V30 32 C 0.7700 2.6673 0.0 0
M  V30 33 O 3.0800 1.3336 0.0 0
M  V30 34 C 0.0000 1.3336 0.0 0
M  V30 35 C 2.3100 0.0000 0.0 0
M  V30 36 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 1 25
M  V30 4 2 3 18
M  V30 5 1 4 19
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 31
M  V30 12 2 10 24
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 30
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-3-[3-(formyloxy)propyl]-1-methyl-5-[[6-(trifluoromethyl)-3-pyridinyl]...
C19H16BrF3N4O4
1950578-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 O 10.0100 2.6674 0.0 0
M  V30 3 C 13.0900 8.0021 0.0 0
M  V30 4 Br 6.1600 6.6685 0.0 0
M  V30 5 C 13.0900 2.6674 0.0 0
M  V30 6 C 14.6300 2.6674 0.0 0
M  V30 7 C 15.4000 1.3336 0.0 0
M  V30 8 O 16.9400 1.3336 0.0 0
M  V30 9 C 17.7100 0.0000 0.0 0
M  V30 10 O 19.2500 0.0000 0.0 0
M  V30 11 O 14.6300 5.3347 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 F 1.5400 5.5411 0.0 0
M  V30 14 F 0.0000 4.0011 0.0 0
M  V30 15 F 1.5400 2.4611 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 10.7800 6.6685 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 N 12.3200 6.6685 0.0 0
M  V30 21 N 10.0100 8.0021 0.0 0
M  V30 22 C 7.7000 6.6685 0.0 0
M  V30 23 N 12.3200 4.0011 0.0 0
M  V30 24 C 13.0900 5.3347 0.0 0
M  V30 25 C 8.4700 8.0021 0.0 0
M  V30 26 C 6.1600 4.0011 0.0 0
M  V30 27 C 5.3900 2.6674 0.0 0
M  V30 28 C 5.3900 5.3347 0.0 0
M  V30 29 C 3.8500 2.6674 0.0 0
M  V30 30 N 3.8500 5.3347 0.0 0
M  V30 31 C 3.0800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 26
M  V30 3 2 2 19
M  V30 4 1 3 20
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 1 5 23
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 2 11 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 31
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 24
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1878199-39-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1950578-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-531-CAS-15651747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives as TRPC5 modulators
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chenard, Bertrand L.; Gallaschun, Randall J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016023830 A1 2016-02-18

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-[2-(hydroxymethyl)-4-methoxyphenyl]benzamide
C15H16N2O3
1883679-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 O 5.3900 6.6685 0.0 0
M  V30 4 C 6.9300 1.3336 0.0 0
M  V30 5 O 7.7000 0.0000 0.0 0
M  V30 6 O 11.5500 4.0011 0.0 0
M  V30 7 C 12.3200 5.3347 0.0 0
M  V30 8 N 3.0800 8.0021 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 7.7000 2.6674 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 0.7700 6.6685 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 6 7
M  V30 8 1 6 14
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-(Hydroxymethyl)-4-methoxyphenyl]-4(3H)-quinazolinone
C16H14N2O3
1883679-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.3338 0.0 0
M  V30 2 O 7.7000 0.0000 0.0 0
M  V30 3 O 5.3900 6.6685 0.0 0
M  V30 4 O 11.5500 4.0011 0.0 0
M  V30 5 C 12.3200 5.3347 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 C 9.2400 2.6674 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 N 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 N 3.0800 2.6674 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 2.3100 6.6685 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 17
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1883679-83-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1883679-85-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-5723811
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and neuroprotective activity of dictyoquinazol A and analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lizarme, Yuvixza; Wangsahardja, Jonatan; Marcolin, Gabriella M.; Morris,
Jonathan C.; Jones, Nicole M.; Hunter, Luke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(7), 1480-1487

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-amino-3-iodo-, methyl ester
C8H8INO2
19718-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 I 1.5400 0.0000 0.0 0
M  V30 6 N 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(formylamino)-3-iodobenzoate
C9H8INO3
514805-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 O 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 I 6.9302 0.0000 0.0 0
M  V30 6 N 8.4702 2.6673 0.0 0
M  V30 7 C 9.2402 4.0010 0.0 0
M  V30 8 O 10.7802 4.0010 0.0 0
M  V30 9 C 3.8501 2.6673 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 6.1601 1.3337 0.0 0
M  V30 13 C 6.1601 4.0010 0.0 0
M  V30 14 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19718-49-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 514805-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3434936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Formylamino-3-iodobenzoic acid methyl ester (198): Methyl
3-iodo-4-aminobenzoate (45.5 g, 164 mmol) was dissolved in formic acid
(500 mL). The solution was refluxed for 4 hr and volatile material was
removed in vacuo to give 48.7 g (97 %) of 198, which was recrystallized
from ethanol to afford white needles, mp 159-162 degC, obtained as a
mixture of rotamers.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel route to 4-quinolones and an enantioselective total synthesis of
virantmycin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wulff, Jeremy Earle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2004), 65(12), 253 pages

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H38N2O4Si
2146093-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7715 4.1066 0.0 0
M  V30 2 Si 2.0716 5.4782 0.0 0
M  V30 3 C 1.3718 6.8501 0.0 0
M  V30 4 C 0.6998 4.7785 0.0 0
M  V30 5 C 3.4434 6.1782 0.0 0
M  V30 6 C 2.7435 7.5500 0.0 0
M  V30 7 C 0.6719 8.2219 0.0 0
M  V30 8 C 0.0000 6.1503 0.0 0
M  V30 9 C 4.0502 5.5448 0.0 0
M  V30 10 N 2.4258 2.4334 0.0 0
M  V30 11 C 8.3554 7.6133 0.0 0
M  V30 12 O 9.8954 7.6133 0.0 0
M  V30 13 O 7.5854 8.9471 0.0 0
M  V30 14 C 10.6654 8.9471 0.0 0
M  V30 15 C 5.7337 4.6123 0.0 0 CFG=2
M  V30 16 C 7.0674 3.8423 0.0 0 CFG=1
M  V30 17 C 4.3094 4.0266 0.0 0 CFG=1
M  V30 18 O 5.4548 2.8880 0.0 0
M  V30 19 C 6.0539 6.1187 0.0 0
M  V30 20 C 7.1371 2.4143 0.0 0
M  V30 21 C 8.2117 4.8729 0.0 0
M  V30 22 C 3.9409 2.7096 0.0 0 CFG=1
M  V30 23 C 6.2124 1.4234 0.0 0 CFG=1
M  V30 24 N 7.5854 6.2797 0.0 0
M  V30 25 C 4.8488 1.4733 0.0 0
M  V30 26 C 12.2054 8.9471 0.0 0
M  V30 27 C 12.9754 7.6133 0.0 0
M  V30 28 C 12.9754 10.2807 0.0 0
M  V30 29 C 14.5154 7.6133 0.0 0
M  V30 30 C 14.5154 10.2807 0.0 0
M  V30 31 C 15.2854 8.9471 0.0 0
M  V30 32 H 8.4891 3.2505 0.0 0
M  V30 33 H 6.8003 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 17 9 CFG=1
M  V30 10 1 22 10 CFG=3
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 24
M  V30 14 1 12 14
M  V30 15 1 14 26
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18 CFG=1
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 16 32 CFG=3
M  V30 23 1 17 22
M  V30 24 1 23 18 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 23
M  V30 27 1 21 24
M  V30 28 1 22 25
M  V30 29 1 23 25
M  V30 30 1 23 33
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 15 16 17 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C19H24N2O5
2146090-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7600 5.5708 0.0 0
M  V30 2 O 5.5866 6.1771 0.0 0
M  V30 3 N 2.6241 4.2947 0.0 0
M  V30 4 C 1.4501 3.2980 0.0 0
M  V30 5 O 0.0000 3.8162 0.0 0
M  V30 6 C 10.3495 5.8158 0.0 0
M  V30 7 O 11.6832 5.0458 0.0 0
M  V30 8 O 10.3495 7.3558 0.0 0
M  V30 9 C 13.0170 5.8158 0.0 0
M  V30 10 C 6.5784 4.5277 0.0 0 CFG=1
M  V30 11 C 7.3484 3.1940 0.0 0 CFG=2
M  V30 12 C 5.0521 4.7327 0.0 0 CFG=2
M  V30 13 C 7.6088 5.6723 0.0 0
M  V30 14 O 5.4747 3.1739 0.0 0
M  V30 15 C 8.8547 3.5142 0.0 0
M  V30 16 C 6.6947 1.9223 0.0 0
M  V30 17 C 4.0743 3.7763 0.0 0 CFG=1
M  V30 18 N 9.0158 5.0458 0.0 0
M  V30 19 C 5.3984 1.5266 0.0 0 CFG=1
M  V30 20 C 4.2425 2.2515 0.0 0
M  V30 21 C 14.3506 5.0458 0.0 0
M  V30 22 C 14.3506 3.5057 0.0 0
M  V30 23 C 15.6843 5.8158 0.0 0
M  V30 24 C 15.6843 2.7357 0.0 0
M  V30 25 C 17.0180 5.0458 0.0 0
M  V30 26 C 17.0180 3.5057 0.0 0
M  V30 27 H 8.2837 1.9706 0.0 0
M  V30 28 H 5.1959 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 12 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 17 3 CFG=3
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14 CFG=1
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 27 CFG=3
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 19 14 CFG=1
M  V30 21 1 15 18
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 19 20
M  V30 25 1 19 28
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 10 11 12 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2146093-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2146090-85-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-18694359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 429-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Demonstration of the Biological Relevance of sp3-rich
Scaffolds Distantly Related to Natural Product Frameworks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Foley, Daniel J.; Craven, Philip G. E.; Collins, Patrick M.; Doveston,
Richard G.; Aimon, Anthony; Talon, Romain; Churcher, Ian; von Delft,
Frank; Marsden, Stephen P.; Nelson, Adam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2017), 23(60), 15227-15232

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-amino-5-bromo-2-(methylthio)-4-pyrimidineacetate
C9H12BrN3O2S
2170605-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 6.9300 1.3338 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 O 6.1600 5.3349 0.0 0
M  V30 6 C 9.2400 5.3349 0.0 0
M  V30 7 C 10.7800 5.3349 0.0 0
M  V30 8 Br 4.6200 0.0000 0.0 0
M  V30 9 S 1.5400 5.3349 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 N 3.8500 4.0011 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 N 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-α-(formylamino)-2-(methylthio)-4-pyrimidineacetate
C10H12BrN3O3S
2170605-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 O 2.3100 4.0011 0.0 0
M  V30 5 O 4.6200 5.3349 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 1.5400 5.3349 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 C 0.0000 5.3349 0.0 0
M  V30 10 Br 6.1600 0.0000 0.0 0
M  V30 11 S 9.2400 5.3349 0.0 0
M  V30 12 C 10.7800 5.3349 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 N 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 1.3338 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 8.4700 1.3338 0.0 0
M  V30 18 N 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2170605-17-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2170605-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19856714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazopyrimidine compounds useful for the treatment of cancer and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chan, Ho Man; Fu, Xingnian; Gu, Xiang-Ju Justin; Huang, Ying; Li, Ling;
Mi, Yuan; Qi, Wei; Sendzik, Martin; Sun, Yongfeng; Wang, Long; Yu,
Zhengtian; Zhang, Hailong; Zhang, Ji Yue; Zhang, Man; Zhang, Qiong; Zhao,
Kehao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017221100 A1 2017-12-28

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo-1H-purine-1-acetate
C13H18N4O4
2223642-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 6.1601 0.0 0
M  V30 2 C 0.4294 5.7906 0.0 0
M  V30 3 C 3.7036 0.0000 0.0 0
M  V30 4 C 6.3709 4.6201 0.0 0
M  V30 5 C 7.7046 3.8501 0.0 0
M  V30 6 O 9.0384 4.6201 0.0 0
M  V30 7 O 7.7046 2.3100 0.0 0
M  V30 8 C 10.3720 3.8501 0.0 0
M  V30 9 C 11.1421 5.1837 0.0 0
M  V30 10 C 11.7057 3.0800 0.0 0
M  V30 11 C 9.6020 2.5164 0.0 0
M  V30 12 O 6.3709 1.5400 0.0 0
M  V30 13 C 2.3698 3.8501 0.0 0
M  V30 14 C 2.3698 2.3100 0.0 0
M  V30 15 C 3.7036 4.6201 0.0 0
M  V30 16 N 0.9052 4.3259 0.0 0
M  V30 17 N 3.7036 1.5400 0.0 0
M  V30 18 N 0.9052 1.8342 0.0 0
M  V30 19 N 5.0373 3.8501 0.0 0
M  V30 20 C 0.0000 3.0800 0.0 0
M  V30 21 C 5.0373 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 16
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 21
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,6,7-Tetrahydro-3,7-dimethyl-2,6-dioxo-1H-purine-1-acetic acid
C9H10N4O4
5614-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 6.1600 0.0 0
M  V30 2 C 0.4294 5.7906 0.0 0
M  V30 3 C 3.7036 0.0000 0.0 0
M  V30 4 C 6.3708 4.6200 0.0 0
M  V30 5 C 7.7046 3.8500 0.0 0
M  V30 6 O 7.7046 2.3100 0.0 0
M  V30 7 O 9.0383 4.6200 0.0 0
M  V30 8 O 6.3708 1.5400 0.0 0
M  V30 9 C 2.3699 3.8500 0.0 0
M  V30 10 C 2.3699 2.3100 0.0 0
M  V30 11 C 3.7036 4.6200 0.0 0
M  V30 12 N 0.9052 4.3259 0.0 0
M  V30 13 N 3.7036 1.5400 0.0 0
M  V30 14 N 0.9052 1.8341 0.0 0
M  V30 15 N 5.0372 3.8500 0.0 0
M  V30 16 C 0.0000 3.0800 0.0 0
M  V30 17 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 12
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 8 17
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2223642-06-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5614-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36963774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and methods for treating inflammation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McKearin, James M.; Livingston, David J.; Lavery, Karen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023122190 A1 2023-06-29

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-7-methoxy-1-oxo-...
C23H30N4O6
2242743-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6696 0.7700 0.0 0
M  V30 2 C 9.3358 0.0000 0.0 0
M  V30 3 O 13.9438 1.1395 0.0 0
M  V30 4 O 15.9130 6.5175 0.0 0
M  V30 5 O 20.5331 3.8501 0.0 0
M  V30 6 C 4.0010 7.7001 0.0 0
M  V30 7 O 2.6673 6.9301 0.0 0
M  V30 8 O 4.0010 9.2401 0.0 0
M  V30 9 C 1.3337 7.7001 0.0 0
M  V30 10 C 0.5636 6.3664 0.0 0
M  V30 11 C 0.0000 8.4701 0.0 0
M  V30 12 C 2.1037 9.0338 0.0 0
M  V30 13 C 12.0032 4.6201 0.0 0
M  V30 14 C 12.0032 3.0800 0.0 0
M  V30 15 C 13.4678 5.0959 0.0 0
M  V30 16 C 10.6696 5.3901 0.0 0
M  V30 17 C 10.6696 2.3100 0.0 0
M  V30 18 C 13.4678 2.6042 0.0 0
M  V30 19 N 14.3730 3.8501 0.0 0
M  V30 20 C 9.3358 4.6201 0.0 0
M  V30 21 C 9.3358 3.0800 0.0 0
M  V30 22 C 15.9130 3.8501 0.0 0
M  V30 23 C 16.6830 5.1837 0.0 0
M  V30 24 C 16.6830 2.5164 0.0 0
M  V30 25 N 18.2231 5.1837 0.0 0
M  V30 26 C 18.2231 2.5164 0.0 0
M  V30 27 C 18.9931 3.8501 0.0 0
M  V30 28 N 8.0021 5.3901 0.0 0
M  V30 29 C 6.6684 4.6201 0.0 0
M  V30 30 C 8.0021 6.9301 0.0 0
M  V30 31 C 5.3348 5.3901 0.0 0
M  V30 32 C 6.6684 7.7001 0.0 0
M  V30 33 N 5.3348 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 2 3 18
M  V30 4 2 4 23
M  V30 5 2 5 27
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 33
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 19 22
M  V30 23 2 20 21
M  V30 24 1 20 28
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 3-[1,3-dihydro-7-methoxy-1-oxo-5-(1-piperazinyl)-2H-...
C18H22N4O4.2CH2O2
2500656-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.6089 3.4495 0.0 0
M  V30 2 O 5.3347 3.0800 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 O 10.5783 8.8275 0.0 0
M  V30 5 O 15.1983 6.1600 0.0 0
M  V30 6 C 6.6684 5.3900 0.0 0
M  V30 7 C 6.6684 6.9300 0.0 0
M  V30 8 C 8.1330 4.9142 0.0 0
M  V30 9 C 5.3347 4.6200 0.0 0
M  V30 10 C 8.1330 7.4059 0.0 0
M  V30 11 C 5.3347 7.7000 0.0 0
M  V30 12 N 9.0383 6.1600 0.0 0
M  V30 13 C 4.0011 5.3900 0.0 0
M  V30 14 C 4.0011 6.9300 0.0 0
M  V30 15 C 10.5783 6.1600 0.0 0
M  V30 16 C 11.3483 7.4937 0.0 0
M  V30 17 C 11.3483 4.8264 0.0 0
M  V30 18 N 12.8883 7.4937 0.0 0
M  V30 19 C 12.8883 4.8264 0.0 0
M  V30 20 C 13.6583 6.1600 0.0 0
M  V30 21 N 2.6674 7.7000 0.0 0
M  V30 22 C 2.6674 9.2400 0.0 0
M  V30 23 C 1.3336 6.9300 0.0 0
M  V30 24 C 1.3336 10.0100 0.0 0
M  V30 25 C 0.0000 7.7000 0.0 0
M  V30 26 N 0.0000 9.2400 0.0 0
M  V30 27 C 7.5991 0.0000 0.0 0
M  V30 28 O 6.2655 0.7700 0.0 0
M  V30 29 O 8.9328 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 2 4 16
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 14
M  V30 17 1 14 21
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242743-85-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2500656-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-23290016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidinyltetrahydropyridoindoles as estrogen receptor degrading PROTACs
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Bin; Hayhow, Thomas George Christopher; Fallan, Charlene; Scott,
James Stewart; Diene, Coura; Barlaam, Bernard Christophe; Nissink,
Johannes Wilhelmus Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020201080 A1 2020-10-08

$RFMT $RIREG SCHEME375 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N2-Bis[[2-[(1,1-dimethylethyl)thio]phenyl]methyl]-1,2-ethanediamine
C24H36N2S2
226383-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 N 7.7000 6.6684 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 N 10.7800 4.0011 0.0 0
M  V30 6 C 12.3200 4.0011 0.0 0
M  V30 7 S 3.0800 6.6684 0.0 0
M  V30 8 C 1.5400 6.6684 0.0 0
M  V30 9 C 1.5400 8.2084 0.0 0
M  V30 10 C 0.0000 6.6684 0.0 0
M  V30 11 C 1.5400 5.1284 0.0 0
M  V30 12 S 15.4000 4.0011 0.0 0
M  V30 13 C 16.9400 4.0011 0.0 0
M  V30 14 C 16.9400 2.4611 0.0 0
M  V30 15 C 18.4800 4.0011 0.0 0
M  V30 16 C 16.9400 5.5411 0.0 0
M  V30 17 C 5.3900 8.0021 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 6.1600 9.3358 0.0 0
M  V30 20 C 3.0800 9.3358 0.0 0
M  V30 21 C 5.3900 10.6694 0.0 0
M  V30 22 C 3.8500 10.6694 0.0 0
M  V30 23 C 13.0900 2.6673 0.0 0
M  V30 24 C 14.6300 2.6673 0.0 0
M  V30 25 C 12.3200 1.3336 0.0 0
M  V30 26 C 15.4000 1.3336 0.0 0
M  V30 27 C 13.0900 0.0000 0.0 0
M  V30 28 C 14.6300 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N2-Bis[[2-[(1,1-dimethylethyl)thio]phenyl]methyl]-N1,N2-dimethyl-1,2-ethan...
C26H40N2S2
1006885-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0800 6.6684 0.0 0
M  V30 2 C 1.5400 6.6684 0.0 0
M  V30 3 C 1.5400 8.2084 0.0 0
M  V30 4 C 0.0000 6.6684 0.0 0
M  V30 5 C 1.5400 5.1284 0.0 0
M  V30 6 C 6.1600 6.6684 0.0 0
M  V30 7 N 7.7000 6.6684 0.0 0
M  V30 8 C 8.4700 5.3347 0.0 0
M  V30 9 C 8.4700 8.0021 0.0 0
M  V30 10 C 10.0100 5.3347 0.0 0
M  V30 11 N 10.7800 4.0011 0.0 0
M  V30 12 C 12.3200 4.0011 0.0 0
M  V30 13 C 10.0100 2.6673 0.0 0
M  V30 14 S 15.4000 4.0011 0.0 0
M  V30 15 C 16.9400 4.0011 0.0 0
M  V30 16 C 16.9400 5.5411 0.0 0
M  V30 17 C 18.4800 4.0011 0.0 0
M  V30 18 C 16.9400 2.4611 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 C 5.3900 8.0021 0.0 0
M  V30 21 C 3.0800 9.3358 0.0 0
M  V30 22 C 6.1600 9.3358 0.0 0
M  V30 23 C 3.8500 10.6694 0.0 0
M  V30 24 C 5.3900 10.6694 0.0 0
M  V30 25 C 13.0900 2.6673 0.0 0
M  V30 26 C 14.6300 2.6673 0.0 0
M  V30 27 C 12.3200 1.3336 0.0 0
M  V30 28 C 15.4000 1.3336 0.0 0
M  V30 29 C 13.0900 0.0000 0.0 0
M  V30 30 C 14.6300 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 25
M  V30 15 1 14 15
M  V30 16 1 14 26
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 226383-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1006885-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2214255
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and characterization of mononuclear Ni complexes of
tetradentate amine-thioether and amine-thiolate ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fritz, Thorsten; Steinfeld, Gunther; Kersting, Berthold
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: Chemical Sciences (2007), 62(4),
508-518

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Amino-3-cyano-4-phenyl-1H-pyrrol-1-yl)benzoic acid
C18H13N3O2
2279111-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7383 1.4070 0.0 0
M  V30 2 N 4.1120 0.0000 0.0 0
M  V30 3 N 8.0157 2.1035 0.0 0
M  V30 4 C 12.3670 7.7457 0.0 0
M  V30 5 O 12.3670 9.2857 0.0 0
M  V30 6 O 13.7007 6.9757 0.0 0
M  V30 7 C 4.5948 4.1476 0.0 0
M  V30 8 C 5.3648 2.8138 0.0 0
M  V30 9 C 5.6252 5.2920 0.0 0
M  V30 10 C 6.8711 3.1339 0.0 0
M  V30 11 N 7.0322 4.6657 0.0 0
M  V30 12 C 3.0633 4.3085 0.0 0
M  V30 13 C 2.4368 5.7153 0.0 0
M  V30 14 C 2.1580 3.0626 0.0 0
M  V30 15 C 0.9052 5.8764 0.0 0
M  V30 16 C 0.6265 3.2236 0.0 0
M  V30 17 C 0.0000 4.6304 0.0 0
M  V30 18 C 8.3659 5.4357 0.0 0
M  V30 19 C 9.6995 4.6657 0.0 0
M  V30 20 C 8.3659 6.9757 0.0 0
M  V30 21 C 11.0332 5.4357 0.0 0
M  V30 22 C 9.6995 7.7457 0.0 0
M  V30 23 C 11.0332 6.9757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 11 18
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dihydro-4-oxo-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)benzoic acid
C19H13N3O3
2279111-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.3825 8.2566 0.0 0
M  V30 2 C 12.3669 1.5400 0.0 0
M  V30 3 O 12.3669 0.0000 0.0 0
M  V30 4 O 13.7006 2.3100 0.0 0
M  V30 5 C 5.3648 6.4718 0.0 0
M  V30 6 C 4.5948 5.1381 0.0 0
M  V30 7 C 6.8711 6.1516 0.0 0
M  V30 8 C 4.8889 7.9365 0.0 0
M  V30 9 C 5.6252 3.9936 0.0 0
M  V30 10 N 7.0322 4.6200 0.0 0
M  V30 11 N 7.9017 7.2960 0.0 0
M  V30 12 N 5.9194 9.0809 0.0 0
M  V30 13 C 7.4256 8.7607 0.0 0
M  V30 14 C 3.0632 4.9772 0.0 0
M  V30 15 C 2.4368 3.5702 0.0 0
M  V30 16 C 2.1580 6.2230 0.0 0
M  V30 17 C 0.9052 3.4093 0.0 0
M  V30 18 C 0.6265 6.0621 0.0 0
M  V30 19 C 0.0000 4.6552 0.0 0
M  V30 20 C 8.3658 3.8500 0.0 0
M  V30 21 C 9.6995 4.6200 0.0 0
M  V30 22 C 8.3658 2.3100 0.0 0
M  V30 23 C 11.0331 3.8500 0.0 0
M  V30 24 C 9.6995 1.5400 0.0 0
M  V30 25 C 11.0331 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 14
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 10 20
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2279111-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2279111-97-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-19650634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of some heterocyclic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohamed, Menna-Allah; Mohamed, Yassin; Eid, Nahed M.; Barsoum, Flora F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Applied Pharmaceutical Research (2018), 6(2), 01-15

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N2-(2,2,6,6-tetramethyl-4-piperidinyl)-2,3-pyrazinediamine
C13H22BrN5
2407852-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5177 1.5400 0.0 0
M  V30 2 N 8.1850 0.0000 0.0 0
M  V30 3 Br 10.8525 4.6200 0.0 0
M  V30 4 C 0.0000 2.5774 0.0 0
M  V30 5 C 0.9899 0.8629 0.0 0
M  V30 6 C 3.8402 5.7997 0.0 0
M  V30 7 C 1.8605 5.7997 0.0 0
M  V30 8 C 6.8514 2.3100 0.0 0
M  V30 9 C 8.1850 1.5400 0.0 0
M  V30 10 N 6.8514 3.8500 0.0 0
M  V30 11 N 9.5188 2.3100 0.0 0
M  V30 12 C 8.1850 4.6200 0.0 0
M  V30 13 C 9.5188 3.8500 0.0 0
M  V30 14 C 4.1841 2.3100 0.0 0
M  V30 15 C 2.8503 1.5400 0.0 0
M  V30 16 C 4.1841 3.8500 0.0 0
M  V30 17 C 1.5166 2.3100 0.0 0
M  V30 18 C 2.8503 4.6200 0.0 0
M  V30 19 N 1.5166 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 9
M  V30 4 1 3 13
M  V30 5 1 4 17
M  V30 6 1 5 17
M  V30 7 1 6 18
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-(2,2,6,6-tetramethyl-4-piperidinyl)-1H-imidazo[4,5-b]pyrazine
C14H20BrN5
2407852-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.9899 4.9369 0.0 0
M  V30 2 C 0.0000 3.2224 0.0 0
M  V30 3 C 1.8604 0.0000 0.0 0
M  V30 4 C 3.8402 0.0000 0.0 0
M  V30 5 Br 11.4437 2.6727 0.0 0
M  V30 6 C 4.1840 3.4897 0.0 0
M  V30 7 C 2.8503 4.2597 0.0 0
M  V30 8 C 4.1840 1.9497 0.0 0
M  V30 9 C 1.5166 3.4897 0.0 0
M  V30 10 C 2.8503 1.1797 0.0 0
M  V30 11 N 1.5166 1.9497 0.0 0
M  V30 12 N 5.5176 4.2597 0.0 0
M  V30 13 C 6.9246 3.6334 0.0 0
M  V30 14 C 5.6787 5.7913 0.0 0
M  V30 15 C 7.9550 4.7778 0.0 0
M  V30 16 N 7.4005 2.1687 0.0 0
M  V30 17 N 7.1850 6.1115 0.0 0
M  V30 18 N 9.4615 4.4576 0.0 0
M  V30 19 C 8.9069 1.8485 0.0 0
M  V30 20 C 9.9374 2.9929 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 9
M  V30 3 1 3 10
M  V30 4 1 4 10
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2407852-34-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2407852-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-21812126
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic and heteroaryl compounds for treating
Huntington's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sydorenko, Nadiya; Alam, Md Rauful; Arnold, Michael A.; Babu, Suresh;
Bhattacharyya, Anuradha; Chen, Guangming; Gerasyuto, Aleksey I.; Karp,
Gary Mitchell; Kassick, Andrew J.; Mazzotti, Anthony R.; Moon,
Young-Choon; Narasimhan, Jana; Patel, Jigar; Turpoff, Anthony; Woll,
Matthew G.; Yan, Wuming; Zhang, Nanjing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020005873 A1 2020-01-02

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 2-[2-[1-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-3-methyl-2-ox...
C27H37N5O5
2434843-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.5049 2.3101 0.0 0
M  V30 2 C 11.1711 3.0801 0.0 0
M  V30 3 C 19.7258 6.4792 0.0 0
M  V30 4 O 21.0595 5.7092 0.0 0
M  V30 5 O 19.7258 8.0193 0.0 0
M  V30 6 C 22.3933 6.4792 0.0 0
M  V30 7 C 21.6233 7.8129 0.0 0
M  V30 8 C 23.7270 7.2492 0.0 0
M  V30 9 C 23.1633 5.1454 0.0 0
M  V30 10 C 9.2140 5.7309 0.0 0
M  V30 11 O 5.8819 6.0811 0.0 0
M  V30 12 O 3.9647 5.6296 0.0 0
M  V30 13 O 0.0000 2.0598 0.0 0
M  V30 14 C 15.7247 4.1692 0.0 0
M  V30 15 C 15.3261 2.6815 0.0 0
M  V30 16 C 14.2371 4.5677 0.0 0
M  V30 17 C 15.7247 5.7092 0.0 0
M  V30 18 C 17.0585 3.3992 0.0 0
M  V30 19 N 13.8386 3.0801 0.0 0
M  V30 20 C 17.0585 6.4792 0.0 0
M  V30 21 C 18.3922 4.1692 0.0 0
M  V30 22 N 18.3922 5.7092 0.0 0
M  V30 23 C 9.8374 2.3101 0.0 0
M  V30 24 C 8.5038 3.0801 0.0 0
M  V30 25 C 9.8374 0.7700 0.0 0
M  V30 26 C 7.1701 2.3101 0.0 0
M  V30 27 N 8.1836 4.5865 0.0 0
M  V30 28 C 8.5038 0.0000 0.0 0
M  V30 29 N 6.0255 3.3406 0.0 0
M  V30 30 C 7.1701 0.7700 0.0 0
M  V30 31 C 6.6519 4.7475 0.0 0
M  V30 32 C 4.5192 3.0205 0.0 0
M  V30 33 C 3.4886 4.1649 0.0 0
M  V30 34 C 4.0432 1.5557 0.0 0
M  V30 35 N 1.9823 3.8447 0.0 0
M  V30 36 C 2.5369 1.2356 0.0 0
M  V30 37 C 1.5065 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 27
M  V30 12 2 11 31
M  V30 13 2 12 33
M  V30 14 2 13 37
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 2 25 28
M  V30 30 1 26 29
M  V30 31 2 26 30
M  V30 32 1 27 31
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 29 32
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with 3-[4-[2-(2,7-diazaspiro[3.5]non-2-yl)ethyl]-2,3-dihy...
C22H29N5O3.CH2O2
2434843-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8871 4.6200 0.0 0
M  V30 2 C 7.2208 5.3900 0.0 0
M  V30 3 C 9.1778 8.0408 0.0 0
M  V30 4 O 12.5099 8.3910 0.0 0
M  V30 5 O 14.4272 7.9395 0.0 0
M  V30 6 O 18.3916 4.3698 0.0 0
M  V30 7 C 2.6673 6.4791 0.0 0
M  V30 8 C 3.0658 4.9915 0.0 0
M  V30 9 C 4.1548 6.8777 0.0 0
M  V30 10 C 1.3336 5.7091 0.0 0
M  V30 11 C 2.6673 8.0191 0.0 0
M  V30 12 N 4.5535 5.3900 0.0 0
M  V30 13 C 0.0000 6.4791 0.0 0
M  V30 14 C 1.3336 8.7891 0.0 0
M  V30 15 N 0.0000 8.0191 0.0 0
M  V30 16 C 8.5544 4.6200 0.0 0
M  V30 17 C 9.8882 5.3900 0.0 0
M  V30 18 C 8.5544 3.0800 0.0 0
M  V30 19 C 11.2218 4.6200 0.0 0
M  V30 20 N 10.2084 6.8964 0.0 0
M  V30 21 C 9.8882 2.3100 0.0 0
M  V30 22 N 12.3662 5.6506 0.0 0
M  V30 23 C 11.2218 3.0800 0.0 0
M  V30 24 C 11.7399 7.0574 0.0 0
M  V30 25 C 13.8726 5.3304 0.0 0
M  V30 26 C 14.9030 6.4748 0.0 0
M  V30 27 C 14.3485 3.8657 0.0 0
M  V30 28 N 16.4095 6.1546 0.0 0
M  V30 29 C 15.8549 3.5456 0.0 0
M  V30 30 C 16.8853 4.6899 0.0 0
M  V30 31 C 9.1958 0.0000 0.0 0
M  V30 32 O 7.8621 0.7700 0.0 0
M  V30 33 O 10.5295 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 16
M  V30 4 1 3 20
M  V30 5 2 4 24
M  V30 6 2 5 26
M  V30 7 2 6 30
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2434843-17-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2434843-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-22611278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 9-decenoate
C11H20O2
25601-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6673 1.5400 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 O 1.3337 2.3101 0.0 0
M  V30 6 O 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 9.3358 2.3101 0.0 0
M  V30 10 C 10.6697 1.5400 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 13.3370 1.5400 0.0 0
M  V30 13 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 9-(formyloxy)decanoate
C12H22O4
2139355-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0035 2.3101 0.0 0
M  V30 2 C 10.6697 1.5400 0.0 0
M  V30 3 C 13.3372 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 14.6708 2.3101 0.0 0
M  V30 6 C 13.3372 0.0000 0.0 0
M  V30 7 C 8.0023 1.5400 0.0 0
M  V30 8 C 16.0045 1.5400 0.0 0
M  V30 9 C 6.6687 2.3101 0.0 0
M  V30 10 O 17.3383 2.3101 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 O 1.3338 2.3101 0.0 0
M  V30 15 O 2.6675 0.0000 0.0 0
M  V30 16 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25601-41-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139355-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-237-CAS-19495395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Branched diesters for use to reduce the fuel consumption of an engine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanson, Julien; Champagne, Nicolas; Benard, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3124580 A1 2017-02-01

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3R,3aR,6aR)-hexahydro-3-hydroxy-3-(phenylmethyl)-5H-fu...
C18H25NO4
2586078-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.8895 0.0 0
M  V30 2 O 5.9610 5.5264 0.0 0
M  V30 3 C 10.7092 2.8736 0.0 0
M  V30 4 O 11.4792 1.5400 0.0 0
M  V30 5 O 11.4792 4.2074 0.0 0
M  V30 6 C 13.0192 1.5400 0.0 0
M  V30 7 C 13.0192 0.0000 0.0 0
M  V30 8 C 14.5592 1.5400 0.0 0
M  V30 9 C 13.0192 3.0800 0.0 0
M  V30 10 C 6.7994 3.6436 0.0 0 CFG=2
M  V30 11 C 5.3347 4.1195 0.0 0 CFG=2
M  V30 12 C 6.7994 2.1036 0.0 0 CFG=1
M  V30 13 C 8.2639 4.1195 0.0 0
M  V30 14 C 4.4295 2.8736 0.0 0
M  V30 15 C 8.2639 1.6278 0.0 0
M  V30 16 O 5.3347 1.6278 0.0 0
M  V30 17 N 9.1692 2.8736 0.0 0
M  V30 18 C 2.6674 4.1195 0.0 0
M  V30 19 C 2.6674 2.5795 0.0 0
M  V30 20 C 1.3336 4.8895 0.0 0
M  V30 21 C 1.3336 1.8095 0.0 0
M  V30 22 C 0.0000 4.1195 0.0 0
M  V30 23 C 0.0000 2.5795 0.0 0
M  V30 24 H 6.7994 5.1836 0.0 0
M  V30 25 H 6.7994 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 1 18
M  V30 3 1 11 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 24 CFG=1
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 12 25 CFG=1
M  V30 19 1 13 17
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 10 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (3R,3aR,6aR)-hexahydro-3-(phenylmethyl)-2H-furo[2,3-...
C13H17NO2.CH2O2
2586078-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1681 6.6359 0.0 0
M  V30 2 O 3.2081 7.2728 0.0 0
M  V30 3 C 2.3698 5.3900 0.0 0 CFG=2
M  V30 4 C 3.8345 5.8659 0.0 0 CFG=2
M  V30 5 C 2.3698 3.8500 0.0 0 CFG=2
M  V30 6 C 0.9052 5.8659 0.0 0
M  V30 7 C 4.7397 4.6200 0.0 0
M  V30 8 O 3.8345 3.3742 0.0 0
M  V30 9 C 0.9052 3.3742 0.0 0
M  V30 10 N 0.0000 4.6200 0.0 0
M  V30 11 C 6.5017 5.8659 0.0 0
M  V30 12 C 7.8355 6.6359 0.0 0
M  V30 13 C 6.5017 4.3259 0.0 0
M  V30 14 C 9.1692 5.8659 0.0 0
M  V30 15 C 7.8355 3.5559 0.0 0
M  V30 16 C 9.1692 4.3259 0.0 0
M  V30 17 H 2.3698 6.9300 0.0 0
M  V30 18 H 2.3698 2.3100 0.0 0
M  V30 19 C 4.5846 0.0000 0.0 0
M  V30 20 O 3.2509 0.7700 0.0 0
M  V30 21 O 5.9183 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=3
M  V30 2 1 1 11
M  V30 3 1 4 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 17 CFG=3
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 5 18 CFG=3
M  V30 12 1 6 10
M  V30 13 1 7 8
M  V30 14 1 9 10
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 3 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2586078-69-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2586078-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-23207200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective synthesis of oxabicyclic pyrrolidines of medicinal
relevance: merging chemoenzymatic and catalytic methods
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hocine, Sofiane; Montagnon, Claire; Reddy Vakiti, Jithender; Fourquez,
Jean-Marie; Hanessian, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(2), 274-283

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-methanamine
C8H9NO2
2620-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 O 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,3-Benzodioxol-5-ylmethyl)formamide
C9H9NO3
757248-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7046 2.3100 0.0 0
M  V30 3 C 9.0384 3.0800 0.0 0
M  V30 4 O 10.3720 2.3100 0.0 0
M  V30 5 C 2.3698 2.3100 0.0 0
M  V30 6 C 2.3698 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 O 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0373 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0373 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2620-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 757248-50-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23015580
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-83-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1610891-42-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-catalyst, catalyst prepared and used,
reusable catalyst, 92% isolated yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalysed efficient N-formylation of amines with a recyclable
polyoxometalate-supported green catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dan, Demin; Chen, Fubo; Zhao, Whenshu; Yu, Han; Han, Sheng; Wei, Yongge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2021), 50(1), 90-94

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Imidazo[1,5-a]pyridin-5-yl-1-piperazinyl)-1,2-benzenediamine
C17H20N6
2631586-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.4802 3.0800 0.0 0
M  V30 2 N 13.1477 4.6200 0.0 0
M  V30 3 C 3.8118 2.3100 0.0 0
M  V30 4 N 2.4782 3.0800 0.0 0
M  V30 5 C 3.8118 0.7700 0.0 0
M  V30 6 C 1.1445 2.3100 0.0 0
M  V30 7 C 2.1580 4.5863 0.0 0
M  V30 8 C 2.4782 0.0000 0.0 0
M  V30 9 C 1.1445 0.7700 0.0 0
M  V30 10 C 0.0000 3.3404 0.0 0
M  V30 11 N 0.6265 4.7474 0.0 0
M  V30 12 N 5.1455 3.0800 0.0 0
M  V30 13 C 5.1455 4.6200 0.0 0
M  V30 14 C 6.4793 2.3100 0.0 0
M  V30 15 C 6.4793 5.3900 0.0 0
M  V30 16 C 7.8129 3.0800 0.0 0
M  V30 17 N 7.8129 4.6200 0.0 0
M  V30 18 C 9.1466 5.3900 0.0 0
M  V30 19 C 10.4802 4.6200 0.0 0
M  V30 20 C 9.1466 6.9300 0.0 0
M  V30 21 C 11.8140 5.3900 0.0 0
M  V30 22 C 10.4802 7.7001 0.0 0
M  V30 23 C 11.8140 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 21
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 2 8 9
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(4-Imidazo[1,5-a]pyridin-5-yl-1-piperazinyl)-1H-benzimidazole
C18H18N6
2631586-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8117 5.3901 0.0 0
M  V30 2 C 2.4781 4.6201 0.0 0
M  V30 3 C 3.8117 6.9302 0.0 0
M  V30 4 C 1.1444 5.3901 0.0 0
M  V30 5 N 2.1579 3.1138 0.0 0
M  V30 6 C 2.4781 7.7002 0.0 0
M  V30 7 C 1.1444 6.9302 0.0 0
M  V30 8 N 0.0000 4.3597 0.0 0
M  V30 9 C 0.6263 2.9527 0.0 0
M  V30 10 N 5.1456 4.6201 0.0 0
M  V30 11 C 5.1456 3.0801 0.0 0
M  V30 12 C 6.4792 5.3901 0.0 0
M  V30 13 C 6.4792 2.3101 0.0 0
M  V30 14 C 7.8129 4.6201 0.0 0
M  V30 15 N 7.8129 3.0801 0.0 0
M  V30 16 C 9.1467 2.3101 0.0 0
M  V30 17 N 10.4804 3.0801 0.0 0
M  V30 18 C 9.1467 0.7700 0.0 0
M  V30 19 C 11.8141 2.3101 0.0 0
M  V30 20 C 10.8006 4.5864 0.0 0
M  V30 21 C 10.4804 0.0000 0.0 0
M  V30 22 C 11.8141 0.7700 0.0 0
M  V30 23 C 12.9585 3.3405 0.0 0
M  V30 24 N 12.3321 4.7475 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 7
M  V30 11 2 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 2 20 24
M  V30 27 2 21 22
M  V30 28 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2631586-12-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2631586-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-23645690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzimidazole carboxamides and their use in the treatment of
medical disorders and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Ray, Soumya; Lansbury,
Peter T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021055591 A1 2021-03-25

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Trifluoromethyl)-1,2,4-benzenetriamine
C7H8F3N3
2658557-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6201 0.0 0
M  V30 2 F 0.5638 3.2864 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 2.1038 5.9538 0.0 0
M  V30 5 N 4.0012 6.1601 0.0 0
M  V30 6 N 6.6687 4.6201 0.0 0
M  V30 7 N 4.0012 0.0000 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Trifluoromethyl)-1H-benzimidazol-5-amine
C8H6F3N3
1804174-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.7474 0.0 0
M  V30 2 F 2.1038 6.0812 0.0 0
M  V30 3 F 0.0000 5.5174 0.0 0
M  V30 4 F 0.5638 3.4138 0.0 0
M  V30 5 N 6.6686 4.7474 0.0 0
M  V30 6 C 2.6675 2.4374 0.0 0
M  V30 7 C 2.6675 3.9774 0.0 0
M  V30 8 C 4.0011 1.6674 0.0 0
M  V30 9 N 1.5229 1.4070 0.0 0
M  V30 10 C 4.0011 4.7474 0.0 0
M  V30 11 C 5.3348 2.4374 0.0 0
M  V30 12 N 3.6810 0.1611 0.0 0
M  V30 13 C 2.1494 0.0000 0.0 0
M  V30 14 C 5.3348 3.9774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2658557-21-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1804174-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31539680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole compounds as HDAC6 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piscopio, Anthony D.; Zhang, Gan; Hunt, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021133957 A1 2021-07-01

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[3-(3,4-dihydro-3-oxo-2H-pyrazino[2,3-b]-1,4-oxazin-6-...
C16H21N5O6
2713999-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3592 0.0000 0.0 0
M  V30 2 C 10.5457 4.3858 0.0 0
M  V30 3 C 11.9526 3.7593 0.0 0
M  V30 4 N 13.1985 4.6645 0.0 0
M  V30 5 C 14.6053 4.0382 0.0 0
M  V30 6 O 15.8511 4.9434 0.0 0
M  V30 7 O 14.7664 2.5067 0.0 0
M  V30 8 C 17.2581 4.3169 0.0 0
M  V30 9 C 16.6318 2.9102 0.0 0
M  V30 10 C 18.6649 3.6906 0.0 0
M  V30 11 C 17.8844 5.7239 0.0 0
M  V30 12 O 0.0000 6.7117 0.0 0
M  V30 13 C 5.3900 2.7106 0.0 0
M  V30 14 N 4.6200 4.0442 0.0 0
M  V30 15 C 4.6200 1.3769 0.0 0
M  V30 16 C 3.0800 4.0442 0.0 0
M  V30 17 N 3.0800 1.3769 0.0 0
M  V30 18 C 2.3100 2.7106 0.0 0
M  V30 19 N 2.3100 5.3780 0.0 0
M  V30 20 O 0.7700 2.7106 0.0 0
M  V30 21 C 0.7700 5.3780 0.0 0
M  V30 22 C 0.0000 4.0442 0.0 0
M  V30 23 N 6.9300 2.7106 0.0 0
M  V30 24 C 7.8351 3.9564 0.0 0
M  V30 25 C 7.8351 1.4647 0.0 0
M  V30 26 C 9.2998 3.4806 0.0 0
M  V30 27 O 9.2998 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 23
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C11H13N5O4.CH2O2
3055276-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3594 9.0217 0.0 0
M  V30 2 C 10.5457 4.6359 0.0 0
M  V30 3 C 11.9526 5.2624 0.0 0
M  V30 4 N 13.1985 4.3571 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 N 6.9300 6.3111 0.0 0
M  V30 7 C 7.8353 5.0652 0.0 0
M  V30 8 C 7.8353 7.5570 0.0 0
M  V30 9 C 9.2998 5.5411 0.0 0
M  V30 10 O 9.2998 7.0811 0.0 0
M  V30 11 C 5.3900 6.3111 0.0 0
M  V30 12 N 4.6200 4.9775 0.0 0
M  V30 13 C 4.6200 7.6448 0.0 0
M  V30 14 C 3.0800 4.9775 0.0 0
M  V30 15 N 3.0800 7.6448 0.0 0
M  V30 16 C 2.3100 6.3111 0.0 0
M  V30 17 N 2.3100 3.6438 0.0 0
M  V30 18 O 0.7700 6.3111 0.0 0
M  V30 19 C 0.7700 3.6437 0.0 0
M  V30 20 C 0.0000 4.9775 0.0 0
M  V30 21 C 6.5992 0.0000 0.0 0
M  V30 22 O 5.2656 0.7700 0.0 0
M  V30 23 O 7.9329 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 3 4
M  V30 5 2 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2713999-28-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3055276-36-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38374841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and
Minimal hERG Inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cumming, John G.; Kreis, Lukas; Kuhne, Holger; Wermuth, Roger;
Vercruysse, Maarten; Cantrill, Carina; Bissantz, Caterina; Qiu, Hongxia;
Kramer, Christian; Andreotti, Daniele; Fossati, Giacomo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(12), 1791-1799

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL

C25H41ClN2O8S
2744245-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.8256 7.0368 0.0 0
M  V30 2 N 8.3522 8.4839 0.0 0
M  V30 3 O 8.8155 5.8571 0.0 0
M  V30 4 C 9.8688 8.7514 0.0 0 CFG=1
M  V30 5 C 10.8588 7.5716 0.0 0 CFG=1
M  V30 6 C 12.3754 7.8391 0.0 0
M  V30 7 Cl 10.3321 6.1246 0.0 0
M  V30 8 C 6.3568 4.0256 0.0 0
M  V30 9 O 5.5408 2.7195 0.0 0
M  V30 10 O 7.8959 3.9718 0.0 0
M  V30 11 C 6.2637 1.3598 0.0 0
M  V30 12 C 7.6235 2.0827 0.0 0
M  V30 13 C 6.9867 0.0000 0.0 0
M  V30 14 C 4.9040 0.6368 0.0 0
M  V30 15 C 0.5122 9.4975 0.0 0
M  V30 16 C 0.0000 10.9499 0.0 0
M  V30 17 O 9.0619 12.5086 0.0 0
M  V30 18 S 14.3966 9.4285 0.0 0
M  V30 19 C 15.7303 10.1986 0.0 0
M  V30 20 O 11.7293 14.0486 0.0 0
M  V30 21 O 14.3966 12.5086 0.0 0
M  V30 22 C 6.3090 6.7694 0.0 0 CFG=1
M  V30 23 C 5.2011 7.8393 0.0 0 CFG=2
M  V30 24 N 5.6338 5.3853 0.0 0
M  V30 25 C 3.8414 7.1162 0.0 0 CFG=1
M  V30 26 O 5.4837 9.3531 0.0 0
M  V30 27 C 4.1087 5.5996 0.0 0
M  V30 28 C 2.4283 7.7285 0.0 0
M  V30 29 C 4.4762 10.5178 0.0 0
M  V30 30 C 2.0260 9.2151 0.0 0 CFG=2
M  V30 31 C 2.9374 10.4564 0.0 0
M  V30 32 C 10.3955 10.1986 0.0 0 CFG=2
M  V30 33 O 11.7293 9.4285 0.0 0
M  V30 34 C 10.3955 11.7386 0.0 0 CFG=2
M  V30 35 C 13.0630 10.1986 0.0 0 CFG=2
M  V30 36 C 11.7293 12.5086 0.0 0 CFG=2
M  V30 37 C 13.0630 11.7386 0.0 0 CFG=2
M  V30 38 H 6.6681 8.3077 0.0 0
M  V30 39 H 2.6326 6.1620 0.0 0
M  V30 40 H 8.8789 10.4659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 22 1 CFG=1
M  V30 4 1 4 2 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 32
M  V30 7 1 5 6
M  V30 8 1 5 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 24
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 16
M  V30 17 1 30 15 CFG=3
M  V30 18 1 34 17 CFG=3
M  V30 19 1 18 19
M  V30 20 1 35 18 CFG=1
M  V30 21 1 36 20 CFG=3
M  V30 22 1 37 21 CFG=1
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 1 23 38 CFG=3
M  V30 28 1 24 27
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 25 39 CFG=1
M  V30 32 1 26 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 32 40 CFG=1
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 5 22 23 25 30 32 34 35 36 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H33ClN2O6S.CH2O2
2744244-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4266 6.4304 0.0 0
M  V30 2 N 7.2469 5.4405 0.0 0
M  V30 3 O 8.1592 7.9470 0.0 0
M  V30 4 C 5.7998 5.9672 0.0 0 CFG=1
M  V30 5 C 5.5323 7.4840 0.0 0 CFG=1
M  V30 6 C 4.0852 8.0106 0.0 0
M  V30 7 Cl 6.7121 8.4737 0.0 0
M  V30 8 C 16.0560 7.5839 0.0 0
M  V30 9 C 16.8128 8.9251 0.0 0
M  V30 10 O 4.6200 2.3100 0.0 0
M  V30 11 S 1.5400 7.6447 0.0 0
M  V30 12 C 0.0000 7.6447 0.0 0
M  V30 13 O 1.5400 2.3100 0.0 0
M  V30 14 O 0.0000 4.9775 0.0 0
M  V30 15 C 11.1504 6.7649 0.0 0 CFG=2
M  V30 16 C 9.8737 5.9038 0.0 0 CFG=1
M  V30 17 C 12.3639 5.8168 0.0 0 CFG=1
M  V30 18 O 11.1351 8.3048 0.0 0
M  V30 19 N 10.2981 4.4234 0.0 0
M  V30 20 C 11.8372 4.3696 0.0 0
M  V30 21 C 13.8618 6.1745 0.0 0
M  V30 22 C 12.3294 9.2770 0.0 0
M  V30 23 C 14.5162 7.5685 0.0 0 CFG=2
M  V30 24 C 13.8341 8.9493 0.0 0
M  V30 25 C 4.6200 4.9775 0.0 0 CFG=2
M  V30 26 O 3.8500 6.3111 0.0 0
M  V30 27 C 3.8500 3.6437 0.0 0 CFG=2
M  V30 28 C 2.3100 6.3111 0.0 0 CFG=2
M  V30 29 C 2.3100 3.6437 0.0 0 CFG=2
M  V30 30 C 1.5400 4.9775 0.0 0 CFG=2
M  V30 31 H 9.7872 7.4810 0.0 0
M  V30 32 H 13.3888 4.6673 0.0 0
M  V30 33 H 5.7998 3.9875 0.0 0
M  V30 34 C 8.4064 0.0000 0.0 0
M  V30 35 O 7.0727 0.7700 0.0 0
M  V30 36 O 9.7401 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 4 2 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 5 6
M  V30 8 1 5 7 CFG=3
M  V30 9 2 8 9
M  V30 10 1 23 8 CFG=1
M  V30 11 1 27 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 28 11 CFG=1
M  V30 14 1 29 13 CFG=3
M  V30 15 1 30 14 CFG=1
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 31 CFG=1
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 17 32 CFG=3
M  V30 24 1 18 22
M  V30 25 1 19 20
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 25 33 CFG=1
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 36 1 34 35
M  V30 37 2 34 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 5 15 16 17 23 25 27 28 29 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2744245-93-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2744244-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25141222
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product purified by preparative high-performance liquid chromatography
and isolated as formic acid salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of lincosamide antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Myers, Andrew G.; Silvestre, Katherine J.; Mitcheltree, Matthew James;
Testolin, Giambattista; Mason, Jeremy D.; Pote, Aditya; Terwilliger,
Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021236911 A1 2021-11-25

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[6-[2-chloro-3-[3-chloro-2-[3-[[(2-hydroxyethyl)amino]methy...
C40H44Cl2N6O5
2845302-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9812 11.2609 0.0 0
M  V30 2 N 26.4459 11.7368 0.0 0
M  V30 3 C 27.5903 10.7063 0.0 0
M  V30 4 C 29.0550 11.1822 0.0 0
M  V30 5 O 30.1994 10.1517 0.0 0
M  V30 6 C 22.2707 15.9557 0.0 0
M  V30 7 Cl 17.7104 9.3038 0.0 0
M  V30 8 Cl 12.3203 10.6375 0.0 0
M  V30 9 O 7.7002 10.6375 0.0 0
M  V30 10 C 8.4702 11.9711 0.0 0
M  V30 11 C 6.1601 7.9700 0.0 0
M  V30 12 N 5.3901 6.6363 0.0 0
M  V30 13 C 6.1601 5.3026 0.0 0
M  V30 14 C 3.8501 6.6363 0.0 0
M  V30 15 O 3.0801 7.9700 0.0 0
M  V30 16 O 3.0801 5.3026 0.0 0
M  V30 17 C 1.5399 7.9700 0.0 0
M  V30 18 C 1.5400 9.5100 0.0 0
M  V30 19 C 0.0000 7.9700 0.0 0
M  V30 20 C 1.5400 6.4299 0.0 0
M  V30 21 O 5.0330 0.0000 0.0 0
M  V30 22 C 22.3305 11.9711 0.0 0
M  V30 23 C 21.5605 13.3048 0.0 0
M  V30 24 C 23.8368 12.2913 0.0 0
M  V30 25 C 21.5605 10.6375 0.0 0
M  V30 26 C 20.0204 13.3048 0.0 0
M  V30 27 N 22.5909 14.4494 0.0 0
M  V30 28 C 23.9977 13.8230 0.0 0
M  V30 29 C 20.0204 10.6375 0.0 0
M  V30 30 C 19.2504 11.9711 0.0 0
M  V30 31 C 17.7104 11.9711 0.0 0
M  V30 32 C 16.9404 10.6375 0.0 0
M  V30 33 N 16.9404 13.3048 0.0 0
M  V30 34 C 15.4003 10.6375 0.0 0
M  V30 35 C 15.4003 13.3048 0.0 0
M  V30 36 C 14.6303 11.9711 0.0 0
M  V30 37 C 14.6303 9.3038 0.0 0
M  V30 38 C 13.0903 9.3038 0.0 0
M  V30 39 C 15.4003 7.9700 0.0 0
M  V30 40 C 12.3203 7.9700 0.0 0
M  V30 41 C 14.6303 6.6363 0.0 0
M  V30 42 C 13.0903 6.6363 0.0 0
M  V30 43 C 10.7802 7.9700 0.0 0
M  V30 44 N 10.0102 9.3038 0.0 0
M  V30 45 C 10.0102 6.6363 0.0 0
M  V30 46 C 8.4702 9.3038 0.0 0
M  V30 47 C 8.4702 6.6363 0.0 0
M  V30 48 C 7.7002 7.9700 0.0 0
M  V30 49 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 50 N 6.0164 2.5620 0.0 0
M  V30 51 C 3.8584 3.8079 0.0 0
M  V30 52 C 4.8719 1.5316 0.0 0
M  V30 53 C 3.5382 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 27
M  V30 7 1 7 32
M  V30 8 1 8 38
M  V30 9 1 9 10
M  V30 10 1 9 46
M  V30 11 1 11 12
M  V30 12 1 11 48
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 49 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 21 52
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 2 23 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 30 31
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 34 37
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 40 43
M  V30 47 1 41 42
M  V30 48 1 43 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 48
M  V30 54 1 49 50
M  V30 55 1 49 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 49)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[2-chloro-3-[3-chloro-2-[3-[[(2-hydroxy...
C35H36Cl2N6O3.CH2O2
2845290-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1598 9.6019 0.0 0
M  V30 2 N 26.6246 10.0778 0.0 0
M  V30 3 C 27.7690 9.0474 0.0 0
M  V30 4 C 29.2337 9.5232 0.0 0
M  V30 5 O 30.3781 8.4928 0.0 0
M  V30 6 C 22.4494 14.2967 0.0 0
M  V30 7 Cl 17.8889 7.6448 0.0 0
M  V30 8 Cl 12.4988 8.9785 0.0 0
M  V30 9 O 7.8787 3.6437 0.0 0
M  V30 10 C 8.6487 2.3100 0.0 0
M  V30 11 C 6.3386 6.3110 0.0 0
M  V30 12 N 5.5686 7.6448 0.0 0
M  V30 13 C 4.0286 7.6448 0.0 0
M  V30 14 O 0.0000 11.2722 0.0 0
M  V30 15 C 22.5090 10.3122 0.0 0
M  V30 16 C 21.7390 11.6459 0.0 0
M  V30 17 C 24.0154 10.6324 0.0 0
M  V30 18 C 21.7390 8.9785 0.0 0
M  V30 19 C 20.1989 11.6459 0.0 0
M  V30 20 N 22.7696 12.7904 0.0 0
M  V30 21 C 24.1764 12.1639 0.0 0
M  V30 22 C 20.1989 8.9785 0.0 0
M  V30 23 C 19.4289 10.3122 0.0 0
M  V30 24 C 17.8889 10.3122 0.0 0
M  V30 25 C 17.1189 8.9785 0.0 0
M  V30 26 N 17.1189 11.6459 0.0 0
M  V30 27 C 15.5788 8.9785 0.0 0
M  V30 28 C 15.5788 11.6459 0.0 0
M  V30 29 C 14.8088 10.3122 0.0 0
M  V30 30 C 14.8088 7.6448 0.0 0
M  V30 31 C 13.2688 7.6448 0.0 0
M  V30 32 C 15.5788 6.3110 0.0 0
M  V30 33 C 12.4988 6.3110 0.0 0
M  V30 34 C 14.8088 4.9774 0.0 0
M  V30 35 C 13.2688 4.9774 0.0 0
M  V30 36 C 10.9587 6.3110 0.0 0
M  V30 37 N 10.1887 4.9774 0.0 0
M  V30 38 C 10.1887 7.6448 0.0 0
M  V30 39 C 8.6487 4.9774 0.0 0
M  V30 40 C 8.6487 7.6448 0.0 0
M  V30 41 C 7.8787 6.3110 0.0 0
M  V30 42 C 3.2586 8.9785 0.0 0 CFG=2
M  V30 43 N 1.7270 9.1395 0.0 0
M  V30 44 C 3.8850 10.3853 0.0 0
M  V30 45 C 1.4068 10.6459 0.0 0
M  V30 46 C 2.7405 11.4159 0.0 0
M  V30 47 C 15.1890 0.0000 0.0 0
M  V30 48 O 13.8554 0.7700 0.0 0
M  V30 49 O 16.5227 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 20
M  V30 7 1 7 25
M  V30 8 1 8 31
M  V30 9 1 9 10
M  V30 10 1 9 39
M  V30 11 1 11 12
M  V30 12 1 11 41
M  V30 13 1 12 13
M  V30 14 1 42 13 CFG=1
M  V30 15 2 14 45
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 23 24
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 27 30
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 33 36
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 41
M  V30 47 1 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 1 45 46
M  V30 52 1 47 48
M  V30 53 2 47 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845302-94-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741391
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[6-[2-chloro-3-[3-chloro-2-[3-[[(2-hydroxy-2-methylpropyl)a...
C42H48Cl2N6O5
2845303-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9813 11.2608 0.0 0
M  V30 2 N 26.4458 11.7367 0.0 0
M  V30 3 C 27.5904 10.7063 0.0 0
M  V30 4 C 29.0549 11.1821 0.0 0
M  V30 5 C 28.5791 12.6469 0.0 0
M  V30 6 C 30.5197 11.6580 0.0 0
M  V30 7 O 29.5310 9.7174 0.0 0
M  V30 8 C 22.2707 15.9556 0.0 0
M  V30 9 Cl 17.7103 9.3038 0.0 0
M  V30 10 Cl 12.3202 10.6374 0.0 0
M  V30 11 O 7.7001 10.6374 0.0 0
M  V30 12 C 8.4702 11.9711 0.0 0
M  V30 13 C 6.1601 7.9700 0.0 0
M  V30 14 N 5.3901 6.6363 0.0 0
M  V30 15 C 6.1601 5.3026 0.0 0
M  V30 16 C 3.8501 6.6363 0.0 0
M  V30 17 O 3.0801 7.9700 0.0 0
M  V30 18 O 3.0801 5.3026 0.0 0
M  V30 19 C 1.5400 7.9700 0.0 0
M  V30 20 C 1.5400 9.5100 0.0 0
M  V30 21 C 0.0000 7.9700 0.0 0
M  V30 22 C 1.5400 6.4299 0.0 0
M  V30 23 O 5.0330 0.0000 0.0 0
M  V30 24 C 22.3304 11.9711 0.0 0
M  V30 25 C 21.5604 13.3048 0.0 0
M  V30 26 C 23.8367 12.2913 0.0 0
M  V30 27 C 21.5604 10.6374 0.0 0
M  V30 28 C 20.0204 13.3048 0.0 0
M  V30 29 N 22.5908 14.4493 0.0 0
M  V30 30 C 23.9978 13.8230 0.0 0
M  V30 31 C 20.0204 10.6374 0.0 0
M  V30 32 C 19.2504 11.9711 0.0 0
M  V30 33 C 17.7103 11.9711 0.0 0
M  V30 34 C 16.9403 10.6374 0.0 0
M  V30 35 N 16.9403 13.3048 0.0 0
M  V30 36 C 15.4003 10.6374 0.0 0
M  V30 37 C 15.4003 13.3048 0.0 0
M  V30 38 C 14.6303 11.9711 0.0 0
M  V30 39 C 14.6303 9.3038 0.0 0
M  V30 40 C 13.0902 9.3038 0.0 0
M  V30 41 C 15.4003 7.9700 0.0 0
M  V30 42 C 12.3202 7.9700 0.0 0
M  V30 43 C 14.6303 6.6363 0.0 0
M  V30 44 C 13.0902 6.6363 0.0 0
M  V30 45 C 10.7802 7.9700 0.0 0
M  V30 46 N 10.0102 9.3038 0.0 0
M  V30 47 C 10.0102 6.6363 0.0 0
M  V30 48 C 8.4702 9.3038 0.0 0
M  V30 49 C 8.4702 6.6363 0.0 0
M  V30 50 C 7.7001 7.9700 0.0 0
M  V30 51 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 52 N 6.0164 2.5620 0.0 0
M  V30 53 C 3.8585 3.8079 0.0 0
M  V30 54 C 4.8720 1.5316 0.0 0
M  V30 55 C 3.5384 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 29
M  V30 9 1 9 34
M  V30 10 1 10 40
M  V30 11 1 11 12
M  V30 12 1 11 48
M  V30 13 1 13 14
M  V30 14 1 13 50
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 51 15 CFG=1
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 23 54
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 2 24 27
M  V30 28 2 25 28
M  V30 29 1 25 29
M  V30 30 2 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 32 33
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 36 39
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 42 45
M  V30 49 1 43 44
M  V30 50 1 45 46
M  V30 51 2 45 47
M  V30 52 2 46 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 2 49 50
M  V30 56 1 51 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 55
M  V30 60 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 51)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[2-chloro-3-[3-chloro-2-[3-[[(2-hydroxy...
C37H40Cl2N6O3.CH2O2
2845290-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1594 9.6018 0.0 0
M  V30 2 N 26.6240 10.0776 0.0 0
M  V30 3 C 27.7685 9.0472 0.0 0
M  V30 4 C 29.2331 9.5231 0.0 0
M  V30 5 C 28.7572 10.9878 0.0 0
M  V30 6 C 30.6977 9.9989 0.0 0
M  V30 7 O 29.7091 8.0584 0.0 0
M  V30 8 C 22.4489 14.2965 0.0 0
M  V30 9 Cl 17.8886 7.6447 0.0 0
M  V30 10 Cl 12.4986 8.9784 0.0 0
M  V30 11 O 7.8786 3.6437 0.0 0
M  V30 12 C 8.6486 2.3100 0.0 0
M  V30 13 C 6.3386 6.3109 0.0 0
M  V30 14 N 5.5686 7.6447 0.0 0
M  V30 15 C 4.0286 7.6447 0.0 0
M  V30 16 O 0.0000 11.2720 0.0 0
M  V30 17 C 22.5086 10.3120 0.0 0
M  V30 18 C 21.7386 11.6457 0.0 0
M  V30 19 C 24.0149 10.6322 0.0 0
M  V30 20 C 21.7386 8.9784 0.0 0
M  V30 21 C 20.1986 11.6457 0.0 0
M  V30 22 N 22.7691 12.7902 0.0 0
M  V30 23 C 24.1760 12.1639 0.0 0
M  V30 24 C 20.1986 8.9784 0.0 0
M  V30 25 C 19.4286 10.3120 0.0 0
M  V30 26 C 17.8886 10.3120 0.0 0
M  V30 27 C 17.1186 8.9784 0.0 0
M  V30 28 N 17.1186 11.6457 0.0 0
M  V30 29 C 15.5786 8.9784 0.0 0
M  V30 30 C 15.5786 11.6457 0.0 0
M  V30 31 C 14.8086 10.3120 0.0 0
M  V30 32 C 14.8086 7.6447 0.0 0
M  V30 33 C 13.2686 7.6447 0.0 0
M  V30 34 C 15.5786 6.3109 0.0 0
M  V30 35 C 12.4986 6.3109 0.0 0
M  V30 36 C 14.8086 4.9773 0.0 0
M  V30 37 C 13.2686 4.9773 0.0 0
M  V30 38 C 10.9586 6.3109 0.0 0
M  V30 39 N 10.1886 4.9773 0.0 0
M  V30 40 C 10.1886 7.6447 0.0 0
M  V30 41 C 8.6486 4.9773 0.0 0
M  V30 42 C 8.6486 7.6447 0.0 0
M  V30 43 C 7.8786 6.3109 0.0 0
M  V30 44 C 3.2586 8.9784 0.0 0 CFG=2
M  V30 45 N 1.7271 9.1393 0.0 0
M  V30 46 C 3.8850 10.3852 0.0 0
M  V30 47 C 1.4069 10.6457 0.0 0
M  V30 48 C 2.7406 11.4157 0.0 0
M  V30 49 C 15.3489 0.0000 0.0 0
M  V30 50 O 14.0152 0.7700 0.0 0
M  V30 51 O 16.6825 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 22
M  V30 9 1 9 27
M  V30 10 1 10 33
M  V30 11 1 11 12
M  V30 12 1 11 41
M  V30 13 1 13 14
M  V30 14 1 13 43
M  V30 15 1 14 15
M  V30 16 1 44 15 CFG=1
M  V30 17 2 16 47
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 2 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 25 26
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 29 32
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 35 38
M  V30 42 1 36 37
M  V30 43 1 38 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 43
M  V30 49 1 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 1 47 48
M  V30 54 1 49 50
M  V30 55 2 49 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-01-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[6-[2-chloro-3-[3-chloro-2-[1-methyl-3-[[(tetrahydro-2H-pyr...
C43H48Cl2N6O5
2845303-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 62 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9810 11.2608 0.0 0
M  V30 2 N 26.4457 11.7367 0.0 0
M  V30 3 C 22.2706 15.9556 0.0 0
M  V30 4 Cl 17.7103 9.3037 0.0 0
M  V30 5 Cl 12.3202 10.6374 0.0 0
M  V30 6 O 7.7001 10.6374 0.0 0
M  V30 7 C 8.4701 11.9711 0.0 0
M  V30 8 C 6.1601 7.9699 0.0 0
M  V30 9 N 5.3901 6.6363 0.0 0
M  V30 10 C 6.1599 5.3026 0.0 0
M  V30 11 C 3.8501 6.6363 0.0 0
M  V30 12 O 3.0800 7.9699 0.0 0
M  V30 13 O 3.0799 5.3026 0.0 0
M  V30 14 C 1.5400 7.9699 0.0 0
M  V30 15 C 1.5400 9.5100 0.0 0
M  V30 16 C 0.0000 7.9699 0.0 0
M  V30 17 C 1.5400 6.4299 0.0 0
M  V30 18 O 5.0330 0.0000 0.0 0
M  V30 19 C 22.3303 11.9711 0.0 0
M  V30 20 C 21.5603 13.3047 0.0 0
M  V30 21 C 23.8366 12.2912 0.0 0
M  V30 22 C 21.5603 10.6374 0.0 0
M  V30 23 C 20.0203 13.3047 0.0 0
M  V30 24 N 22.5908 14.4493 0.0 0
M  V30 25 C 23.9976 13.8228 0.0 0
M  V30 26 C 20.0203 10.6374 0.0 0
M  V30 27 C 19.2503 11.9711 0.0 0
M  V30 28 C 17.7103 11.9711 0.0 0
M  V30 29 C 16.9403 10.6374 0.0 0
M  V30 30 N 16.9403 13.3047 0.0 0
M  V30 31 C 15.4002 10.6374 0.0 0
M  V30 32 C 15.4002 13.3047 0.0 0
M  V30 33 C 14.6302 11.9711 0.0 0
M  V30 34 C 27.5901 10.7062 0.0 0
M  V30 35 C 29.0548 11.1821 0.0 0
M  V30 36 C 27.2700 9.1998 0.0 0
M  V30 37 C 30.1992 10.1517 0.0 0
M  V30 38 C 28.4145 8.1694 0.0 0
M  V30 39 O 29.8791 8.6452 0.0 0
M  V30 40 C 14.6302 9.3037 0.0 0
M  V30 41 C 13.0902 9.3037 0.0 0
M  V30 42 C 15.4002 7.9699 0.0 0
M  V30 43 C 12.3202 7.9699 0.0 0
M  V30 44 C 14.6302 6.6363 0.0 0
M  V30 45 C 13.0902 6.6363 0.0 0
M  V30 46 C 10.7802 7.9699 0.0 0
M  V30 47 N 10.0102 9.3037 0.0 0
M  V30 48 C 10.0102 6.6363 0.0 0
M  V30 49 C 8.4701 9.3037 0.0 0
M  V30 50 C 8.4701 6.6363 0.0 0
M  V30 51 C 7.7001 7.9699 0.0 0
M  V30 52 C 5.3899 3.9689 0.0 0 CFG=2
M  V30 53 N 6.0164 2.5620 0.0 0
M  V30 54 C 3.8584 3.8079 0.0 0
M  V30 55 C 4.8719 1.5316 0.0 0
M  V30 56 C 3.5382 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 34
M  V30 4 1 3 24
M  V30 5 1 4 29
M  V30 6 1 5 41
M  V30 7 1 6 7
M  V30 8 1 6 49
M  V30 9 1 8 9
M  V30 10 1 8 51
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 52 10 CFG=1
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 18 55
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 27 28
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 31 40
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 43 46
M  V30 51 1 44 45
M  V30 52 1 46 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 2 50 51
M  V30 58 1 52 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[2-chloro-3-[3-chloro-2-[1-methyl-3-[[(...
C38H40Cl2N6O3.CH2O2
2845290-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2182 9.6019 0.0 0
M  V30 2 N 3.7535 10.0777 0.0 0
M  V30 3 C 7.9287 14.2966 0.0 0
M  V30 4 Cl 12.4891 7.6448 0.0 0
M  V30 5 Cl 17.8792 8.9785 0.0 0
M  V30 6 O 22.4993 3.6437 0.0 0
M  V30 7 C 21.7293 2.3100 0.0 0
M  V30 8 C 24.0393 6.3110 0.0 0
M  V30 9 N 24.8093 7.6448 0.0 0
M  V30 10 C 26.3494 7.6448 0.0 0
M  V30 11 O 30.3779 11.2722 0.0 0
M  V30 12 C 7.8691 10.3121 0.0 0
M  V30 13 C 8.6391 11.6458 0.0 0
M  V30 14 C 6.3626 10.6323 0.0 0
M  V30 15 C 8.6391 8.9785 0.0 0
M  V30 16 C 10.1791 11.6458 0.0 0
M  V30 17 N 7.6085 12.7903 0.0 0
M  V30 18 C 6.2017 12.1639 0.0 0
M  V30 19 C 10.1791 8.9785 0.0 0
M  V30 20 C 10.9491 10.3121 0.0 0
M  V30 21 C 12.4891 10.3121 0.0 0
M  V30 22 C 13.2591 8.9785 0.0 0
M  V30 23 N 13.2591 11.6458 0.0 0
M  V30 24 C 14.7992 8.9785 0.0 0
M  V30 25 C 14.7992 11.6458 0.0 0
M  V30 26 C 15.5692 10.3121 0.0 0
M  V30 27 C 2.6091 9.0473 0.0 0
M  V30 28 C 2.9293 7.5409 0.0 0
M  V30 29 C 1.1444 9.5232 0.0 0
M  V30 30 C 1.7847 6.5104 0.0 0
M  V30 31 C 0.0000 8.4928 0.0 0
M  V30 32 O 0.3202 6.9863 0.0 0
M  V30 33 C 15.5692 7.6448 0.0 0
M  V30 34 C 17.1092 7.6448 0.0 0
M  V30 35 C 14.7992 6.3110 0.0 0
M  V30 36 C 17.8792 6.3110 0.0 0
M  V30 37 C 15.5692 4.9773 0.0 0
M  V30 38 C 17.1092 4.9773 0.0 0
M  V30 39 C 19.4192 6.3110 0.0 0
M  V30 40 N 20.1893 4.9773 0.0 0
M  V30 41 C 20.1893 7.6448 0.0 0
M  V30 42 C 21.7293 4.9773 0.0 0
M  V30 43 C 21.7293 7.6448 0.0 0
M  V30 44 C 22.4993 6.3110 0.0 0
M  V30 45 C 27.1194 8.9785 0.0 0 CFG=2
M  V30 46 N 28.6509 9.1394 0.0 0
M  V30 47 C 26.4929 10.3853 0.0 0
M  V30 48 C 28.9711 10.6459 0.0 0
M  V30 49 C 27.6374 11.4159 0.0 0
M  V30 50 C 15.1889 0.0000 0.0 0
M  V30 51 O 13.8553 0.7700 0.0 0
M  V30 52 O 16.5226 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 27
M  V30 4 1 3 17
M  V30 5 1 4 22
M  V30 6 1 5 34
M  V30 7 1 6 7
M  V30 8 1 6 42
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 9 10
M  V30 12 1 45 10 CFG=3
M  V30 13 2 11 48
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 20 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 24 33
M  V30 31 1 25 26
M  V30 32 1 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 36 39
M  V30 44 1 37 38
M  V30 45 1 39 40
M  V30 46 2 39 41
M  V30 47 2 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 44
M  V30 51 1 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 49
M  V30 56 1 50 51
M  V30 57 2 50 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-06-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 3-[[4-[3-chloro-4-[2-chloro-3-[5-[[[(1,1-dimethylethoxy)car...
C40H47Cl2N7O6
2845303-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 12.3201 10.6375 0.0 0
M  V30 2 Cl 17.7101 9.3037 0.0 0
M  V30 3 O 7.7000 10.6375 0.0 0
M  V30 4 C 8.4700 11.9711 0.0 0
M  V30 5 C 22.8659 13.6463 0.0 0
M  V30 6 C 6.1600 7.9700 0.0 0
M  V30 7 N 5.3900 6.6364 0.0 0
M  V30 8 C 6.1600 5.3027 0.0 0
M  V30 9 C 3.8500 6.6364 0.0 0
M  V30 10 O 3.0800 7.9700 0.0 0
M  V30 11 O 3.0800 5.3027 0.0 0
M  V30 12 C 1.5400 7.9700 0.0 0
M  V30 13 C 1.5400 9.5100 0.0 0
M  V30 14 C 0.0000 7.9700 0.0 0
M  V30 15 C 1.5400 6.4300 0.0 0
M  V30 16 C 27.6692 11.5077 0.0 0
M  V30 17 O 28.9150 12.4129 0.0 0
M  V30 18 O 27.8301 9.9762 0.0 0
M  V30 19 C 30.3220 11.7865 0.0 0
M  V30 20 C 29.6955 10.3797 0.0 0
M  V30 21 C 31.7288 11.1601 0.0 0
M  V30 22 C 30.9483 13.1934 0.0 0
M  V30 23 O 5.0329 0.0000 0.0 0
M  V30 24 C 14.6301 9.3037 0.0 0
M  V30 25 C 13.0901 9.3037 0.0 0
M  V30 26 C 15.4001 7.9700 0.0 0
M  V30 27 C 12.3201 7.9700 0.0 0
M  V30 28 C 14.6301 6.6364 0.0 0
M  V30 29 C 13.0901 6.6364 0.0 0
M  V30 30 C 15.4001 10.6375 0.0 0
M  V30 31 C 16.9401 10.6375 0.0 0
M  V30 32 C 14.6301 11.9711 0.0 0
M  V30 33 C 17.7101 11.9711 0.0 0
M  V30 34 C 15.4001 13.3047 0.0 0
M  V30 35 N 16.9401 13.3047 0.0 0
M  V30 36 C 10.7801 7.9700 0.0 0
M  V30 37 N 10.0101 9.3037 0.0 0
M  V30 38 C 10.0101 6.6364 0.0 0
M  V30 39 C 8.4700 9.3037 0.0 0
M  V30 40 C 8.4700 6.6364 0.0 0
M  V30 41 C 7.7000 7.9700 0.0 0
M  V30 42 C 19.2501 11.9711 0.0 0
M  V30 43 C 20.1553 13.2170 0.0 0
M  V30 44 C 20.1553 10.7252 0.0 0
M  V30 45 N 21.6199 12.7411 0.0 0
M  V30 46 N 21.6199 11.2011 0.0 0
M  V30 47 C 24.2727 13.0198 0.0 0
M  V30 48 C 24.8246 11.5821 0.0 0
M  V30 49 C 25.7104 13.5718 0.0 0
M  V30 50 N 26.2624 12.1340 0.0 0
M  V30 51 C 5.3900 3.9689 0.0 0 CFG=1
M  V30 52 C 3.8585 3.8080 0.0 0
M  V30 53 N 6.0163 2.5621 0.0 0
M  V30 54 C 3.5383 2.3017 0.0 0
M  V30 55 C 4.8720 1.5317 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 31
M  V30 3 1 3 4
M  V30 4 1 3 39
M  V30 5 1 5 45
M  V30 6 1 5 47
M  V30 7 1 6 7
M  V30 8 1 6 41
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 51 8 CFG=1
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 16 50
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 2 23 55
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 24 30
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 27 36
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 33 42
M  V30 40 2 34 35
M  V30 41 1 36 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 52 1 47 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 1 49 50
M  V30 56 1 51 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 55
M  V30 60 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 51)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[3-[2-[1-(3-azetidinylmethyl)-1H-pyrazo...
C30H31Cl2N7O2.CH2O2
2845290-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 13.9423 8.9786 0.0 0
M  V30 2 Cl 8.5523 7.6448 0.0 0
M  V30 3 O 18.5623 3.6438 0.0 0
M  V30 4 C 17.7923 2.3100 0.0 0
M  V30 5 C 3.3965 11.9874 0.0 0
M  V30 6 C 20.1023 6.3111 0.0 0
M  V30 7 N 20.8723 7.6448 0.0 0
M  V30 8 C 22.4123 7.6448 0.0 0
M  V30 9 O 26.4410 11.2722 0.0 0
M  V30 10 C 11.6323 7.6448 0.0 0
M  V30 11 C 13.1723 7.6448 0.0 0
M  V30 12 C 10.8623 6.3111 0.0 0
M  V30 13 C 13.9423 6.3111 0.0 0
M  V30 14 C 11.6323 4.9775 0.0 0
M  V30 15 C 13.1723 4.9775 0.0 0
M  V30 16 C 10.8623 8.9786 0.0 0
M  V30 17 C 9.3223 8.9786 0.0 0
M  V30 18 C 11.6323 10.3122 0.0 0
M  V30 19 C 8.5523 10.3122 0.0 0
M  V30 20 C 10.8623 11.6459 0.0 0
M  V30 21 N 9.3223 11.6459 0.0 0
M  V30 22 C 15.4823 6.3111 0.0 0
M  V30 23 N 16.2523 4.9775 0.0 0
M  V30 24 C 16.2523 7.6448 0.0 0
M  V30 25 C 17.7923 4.9775 0.0 0
M  V30 26 C 17.7923 7.6448 0.0 0
M  V30 27 C 18.5623 6.3111 0.0 0
M  V30 28 C 7.0123 10.3122 0.0 0
M  V30 29 C 6.1071 11.5581 0.0 0
M  V30 30 C 6.1071 9.0663 0.0 0
M  V30 31 N 4.6424 11.0822 0.0 0
M  V30 32 N 4.6424 9.5422 0.0 0
M  V30 33 C 1.9897 11.3610 0.0 0
M  V30 34 C 0.5519 11.9129 0.0 0
M  V30 35 C 1.4378 9.9234 0.0 0
M  V30 36 N 0.0000 10.4751 0.0 0
M  V30 37 C 23.1824 8.9786 0.0 0 CFG=1
M  V30 38 C 22.5560 10.3854 0.0 0
M  V30 39 N 24.7139 9.1395 0.0 0
M  V30 40 C 23.7004 11.4158 0.0 0
M  V30 41 C 25.0341 10.6458 0.0 0
M  V30 42 C 13.2205 0.0000 0.0 0
M  V30 43 O 11.8868 0.7700 0.0 0
M  V30 44 O 14.5542 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 1 5 31
M  V30 6 1 5 33
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 1 7 8
M  V30 10 1 37 8 CFG=3
M  V30 11 2 9 41
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 10 16
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 13 22
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 19 28
M  V30 26 2 20 21
M  V30 27 1 22 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 42 1 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 47 1 42 43
M  V30 48 2 42 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-13-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[[(2S)-2-oxetanylme...
C42H46Cl2N6O5
2845303-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 61 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9812 11.2608 0.0 0
M  V30 2 N 26.4459 11.7367 0.0 0
M  V30 3 C 27.5903 10.7062 0.0 0
M  V30 4 C 22.2706 15.9556 0.0 0
M  V30 5 Cl 17.7103 9.3037 0.0 0
M  V30 6 Cl 12.3202 10.6374 0.0 0
M  V30 7 O 7.7001 10.6374 0.0 0
M  V30 8 C 8.4701 11.9711 0.0 0
M  V30 9 C 6.1601 7.9699 0.0 0
M  V30 10 N 5.3901 6.6363 0.0 0
M  V30 11 C 6.1601 5.3026 0.0 0
M  V30 12 C 3.8501 6.6363 0.0 0
M  V30 13 O 3.0800 7.9699 0.0 0
M  V30 14 O 3.0800 5.3026 0.0 0
M  V30 15 C 1.5400 7.9699 0.0 0
M  V30 16 C 1.5400 9.5099 0.0 0
M  V30 17 C 0.0000 7.9699 0.0 0
M  V30 18 C 1.5400 6.4299 0.0 0
M  V30 19 O 5.0329 0.0000 0.0 0
M  V30 20 C 22.3303 11.9711 0.0 0
M  V30 21 C 21.5603 13.3047 0.0 0
M  V30 22 C 23.8368 12.2912 0.0 0
M  V30 23 C 21.5603 10.6374 0.0 0
M  V30 24 N 20.0203 13.3047 0.0 0
M  V30 25 N 22.5909 14.4493 0.0 0
M  V30 26 C 23.9977 13.8228 0.0 0
M  V30 27 C 20.0203 10.6374 0.0 0
M  V30 28 C 19.2503 11.9711 0.0 0
M  V30 29 C 17.7103 11.9711 0.0 0
M  V30 30 C 16.9402 10.6374 0.0 0
M  V30 31 C 16.9402 13.3047 0.0 0
M  V30 32 C 15.4002 10.6374 0.0 0
M  V30 33 C 15.4002 13.3047 0.0 0
M  V30 34 C 14.6302 11.9711 0.0 0
M  V30 35 C 29.0550 11.1821 0.0 0 CFG=1
M  V30 36 C 30.4271 10.4829 0.0 0
M  V30 37 O 29.7542 12.5543 0.0 0
M  V30 38 C 31.1263 11.8551 0.0 0
M  V30 39 C 14.6302 9.3037 0.0 0
M  V30 40 C 13.0902 9.3037 0.0 0
M  V30 41 C 15.4002 7.9699 0.0 0
M  V30 42 C 12.3202 7.9699 0.0 0
M  V30 43 C 14.6302 6.6363 0.0 0
M  V30 44 N 13.0902 6.6363 0.0 0
M  V30 45 C 10.7802 7.9699 0.0 0
M  V30 46 C 10.0101 9.3037 0.0 0
M  V30 47 C 10.0101 6.6363 0.0 0
M  V30 48 C 8.4701 9.3037 0.0 0
M  V30 49 C 8.4701 6.6363 0.0 0
M  V30 50 C 7.7001 7.9699 0.0 0
M  V30 51 C 5.3901 3.9689 0.0 0 CFG=2
M  V30 52 N 6.0166 2.5620 0.0 0
M  V30 53 C 3.8585 3.8079 0.0 0
M  V30 54 C 4.8720 1.5316 0.0 0
M  V30 55 C 3.5384 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 35 3 CFG=1
M  V30 5 1 4 25
M  V30 6 1 5 30
M  V30 7 1 6 40
M  V30 8 1 7 8
M  V30 9 1 7 48
M  V30 10 1 9 10
M  V30 11 1 9 50
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 51 11 CFG=1
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 2 19 54
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 28 29
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 32 39
M  V30 39 1 33 34
M  V30 40 1 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 44 1 39 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 42 45
M  V30 50 2 43 44
M  V30 51 2 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 2 48 50
M  V30 56 1 49 50
M  V30 57 1 51 52
M  V30 58 1 51 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 35 51)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[[...
C37H38Cl2N6O3.CH2O2
2845291-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 56 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1595 9.6018 0.0 0
M  V30 2 N 26.6242 10.0776 0.0 0
M  V30 3 C 27.7686 9.0472 0.0 0
M  V30 4 C 22.4489 14.2965 0.0 0
M  V30 5 Cl 17.8887 7.6447 0.0 0
M  V30 6 Cl 12.4987 8.9784 0.0 0
M  V30 7 O 7.8787 3.6437 0.0 0
M  V30 8 C 8.6487 2.3100 0.0 0
M  V30 9 C 6.3386 6.3109 0.0 0
M  V30 10 N 5.5686 7.6447 0.0 0
M  V30 11 C 4.0286 7.6447 0.0 0
M  V30 12 O 0.0000 11.2721 0.0 0
M  V30 13 C 22.5087 10.3120 0.0 0
M  V30 14 C 21.7387 11.6457 0.0 0
M  V30 15 C 24.0151 10.6322 0.0 0
M  V30 16 C 21.7387 8.9784 0.0 0
M  V30 17 N 20.1987 11.6457 0.0 0
M  V30 18 N 22.7691 12.7902 0.0 0
M  V30 19 C 24.1760 12.1637 0.0 0
M  V30 20 C 20.1987 8.9784 0.0 0
M  V30 21 C 19.4287 10.3120 0.0 0
M  V30 22 C 17.8887 10.3120 0.0 0
M  V30 23 C 17.1187 8.9784 0.0 0
M  V30 24 C 17.1187 11.6457 0.0 0
M  V30 25 C 15.5787 8.9784 0.0 0
M  V30 26 C 15.5787 11.6457 0.0 0
M  V30 27 C 14.8087 10.3120 0.0 0
M  V30 28 C 29.2332 9.5231 0.0 0 CFG=1
M  V30 29 C 30.6054 8.8239 0.0 0
M  V30 30 O 29.9324 10.8952 0.0 0
M  V30 31 C 31.3046 10.1961 0.0 0
M  V30 32 C 14.8087 7.6447 0.0 0
M  V30 33 C 13.2687 7.6447 0.0 0
M  V30 34 C 15.5787 6.3109 0.0 0
M  V30 35 C 12.4987 6.3109 0.0 0
M  V30 36 C 14.8087 4.9773 0.0 0
M  V30 37 N 13.2687 4.9773 0.0 0
M  V30 38 C 10.9587 6.3109 0.0 0
M  V30 39 C 10.1887 4.9773 0.0 0
M  V30 40 C 10.1887 7.6447 0.0 0
M  V30 41 C 8.6487 4.9773 0.0 0
M  V30 42 C 8.6487 7.6447 0.0 0
M  V30 43 C 7.8787 6.3109 0.0 0
M  V30 44 C 3.2586 8.9784 0.0 0 CFG=2
M  V30 45 N 1.7271 9.1393 0.0 0
M  V30 46 C 3.8851 10.3852 0.0 0
M  V30 47 C 1.4069 10.6457 0.0 0
M  V30 48 C 2.7406 11.4157 0.0 0
M  V30 49 C 15.6523 0.0000 0.0 0
M  V30 50 O 14.3186 0.7700 0.0 0
M  V30 51 O 16.9859 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 28 3 CFG=1
M  V30 5 1 4 18
M  V30 6 1 5 23
M  V30 7 1 6 33
M  V30 8 1 7 8
M  V30 9 1 7 41
M  V30 10 1 9 10
M  V30 11 1 9 43
M  V30 12 1 10 11
M  V30 13 1 44 11 CFG=1
M  V30 14 2 12 47
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 21 22
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 25 32
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 35 38
M  V30 43 2 36 37
M  V30 44 2 38 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 43
M  V30 50 1 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 48
M  V30 55 1 49 50
M  V30 56 2 49 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 28 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-40-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[(tetrahydro-2H-pyr...
C43H48Cl2N6O5
2845303-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 62 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9811 11.2608 0.0 0
M  V30 2 N 26.4458 11.7367 0.0 0
M  V30 3 C 22.2707 15.9556 0.0 0
M  V30 4 Cl 17.7103 9.3038 0.0 0
M  V30 5 Cl 12.3202 10.6374 0.0 0
M  V30 6 O 7.7001 10.6374 0.0 0
M  V30 7 C 8.4702 11.9711 0.0 0
M  V30 8 C 6.1601 7.9700 0.0 0
M  V30 9 N 5.3901 6.6363 0.0 0
M  V30 10 C 6.1601 5.3026 0.0 0
M  V30 11 C 3.8501 6.6363 0.0 0
M  V30 12 O 3.0801 7.9700 0.0 0
M  V30 13 O 3.0801 5.3026 0.0 0
M  V30 14 C 1.5400 7.9700 0.0 0
M  V30 15 C 1.5400 9.5100 0.0 0
M  V30 16 C 0.0000 7.9700 0.0 0
M  V30 17 C 1.5400 6.4299 0.0 0
M  V30 18 O 5.0330 0.0000 0.0 0
M  V30 19 C 22.3304 11.9711 0.0 0
M  V30 20 C 21.5604 13.3048 0.0 0
M  V30 21 C 23.8367 12.2913 0.0 0
M  V30 22 C 21.5604 10.6374 0.0 0
M  V30 23 N 20.0204 13.3048 0.0 0
M  V30 24 N 22.5908 14.4493 0.0 0
M  V30 25 C 23.9977 13.8228 0.0 0
M  V30 26 C 20.0204 10.6374 0.0 0
M  V30 27 C 19.2504 11.9711 0.0 0
M  V30 28 C 17.7103 11.9711 0.0 0
M  V30 29 C 16.9403 10.6374 0.0 0
M  V30 30 C 16.9403 13.3048 0.0 0
M  V30 31 C 15.4003 10.6374 0.0 0
M  V30 32 C 15.4003 13.3048 0.0 0
M  V30 33 C 14.6303 11.9711 0.0 0
M  V30 34 C 27.5902 10.7063 0.0 0
M  V30 35 C 29.0550 11.1821 0.0 0
M  V30 36 C 27.2701 9.1998 0.0 0
M  V30 37 C 30.1993 10.1517 0.0 0
M  V30 38 C 28.4146 8.1694 0.0 0
M  V30 39 O 29.8792 8.6453 0.0 0
M  V30 40 C 14.6303 9.3038 0.0 0
M  V30 41 C 13.0902 9.3038 0.0 0
M  V30 42 C 15.4003 7.9700 0.0 0
M  V30 43 C 12.3202 7.9700 0.0 0
M  V30 44 C 14.6303 6.6363 0.0 0
M  V30 45 N 13.0902 6.6363 0.0 0
M  V30 46 C 10.7802 7.9700 0.0 0
M  V30 47 C 10.0102 9.3038 0.0 0
M  V30 48 C 10.0102 6.6363 0.0 0
M  V30 49 C 8.4702 9.3038 0.0 0
M  V30 50 C 8.4702 6.6363 0.0 0
M  V30 51 C 7.7001 7.9700 0.0 0
M  V30 52 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 53 N 6.0164 2.5620 0.0 0
M  V30 54 C 3.8584 3.8079 0.0 0
M  V30 55 C 4.8719 1.5316 0.0 0
M  V30 56 C 3.5382 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 34
M  V30 4 1 3 24
M  V30 5 1 4 29
M  V30 6 1 5 41
M  V30 7 1 6 7
M  V30 8 1 6 49
M  V30 9 1 8 9
M  V30 10 1 8 51
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 52 10 CFG=1
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 18 55
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 27 28
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 31 40
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 43 46
M  V30 51 2 44 45
M  V30 52 2 46 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 2 48 50
M  V30 56 2 49 51
M  V30 57 1 50 51
M  V30 58 1 52 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[(...
C38H40Cl2N6O3.CH2O2
2845291-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2182 9.6019 0.0 0
M  V30 2 N 3.7535 10.0777 0.0 0
M  V30 3 C 7.9287 14.2966 0.0 0
M  V30 4 Cl 12.4891 7.6448 0.0 0
M  V30 5 Cl 17.8792 8.9785 0.0 0
M  V30 6 O 22.4993 3.6437 0.0 0
M  V30 7 C 21.7293 2.3100 0.0 0
M  V30 8 C 24.0393 6.3110 0.0 0
M  V30 9 N 24.8093 7.6448 0.0 0
M  V30 10 C 26.3494 7.6448 0.0 0
M  V30 11 O 30.3779 11.2722 0.0 0
M  V30 12 C 7.8691 10.3121 0.0 0
M  V30 13 C 8.6391 11.6458 0.0 0
M  V30 14 C 6.3626 10.6323 0.0 0
M  V30 15 C 8.6391 8.9785 0.0 0
M  V30 16 N 10.1791 11.6458 0.0 0
M  V30 17 N 7.6085 12.7903 0.0 0
M  V30 18 C 6.2017 12.1639 0.0 0
M  V30 19 C 10.1791 8.9785 0.0 0
M  V30 20 C 10.9491 10.3121 0.0 0
M  V30 21 C 12.4891 10.3121 0.0 0
M  V30 22 C 13.2591 8.9785 0.0 0
M  V30 23 C 13.2591 11.6458 0.0 0
M  V30 24 C 14.7992 8.9785 0.0 0
M  V30 25 C 14.7992 11.6458 0.0 0
M  V30 26 C 15.5692 10.3121 0.0 0
M  V30 27 C 2.6091 9.0473 0.0 0
M  V30 28 C 2.9293 7.5409 0.0 0
M  V30 29 C 1.1444 9.5232 0.0 0
M  V30 30 C 1.7847 6.5104 0.0 0
M  V30 31 C 0.0000 8.4928 0.0 0
M  V30 32 O 0.3202 6.9863 0.0 0
M  V30 33 C 15.5692 7.6448 0.0 0
M  V30 34 C 17.1092 7.6448 0.0 0
M  V30 35 C 14.7992 6.3110 0.0 0
M  V30 36 C 17.8792 6.3110 0.0 0
M  V30 37 C 15.5692 4.9773 0.0 0
M  V30 38 N 17.1092 4.9773 0.0 0
M  V30 39 C 19.4192 6.3110 0.0 0
M  V30 40 C 20.1893 4.9773 0.0 0
M  V30 41 C 20.1893 7.6448 0.0 0
M  V30 42 C 21.7293 4.9773 0.0 0
M  V30 43 C 21.7293 7.6448 0.0 0
M  V30 44 C 22.4993 6.3110 0.0 0
M  V30 45 C 27.1194 8.9785 0.0 0 CFG=2
M  V30 46 N 28.6509 9.1394 0.0 0
M  V30 47 C 26.4929 10.3853 0.0 0
M  V30 48 C 28.9711 10.6459 0.0 0
M  V30 49 C 27.6374 11.4159 0.0 0
M  V30 50 C 15.1889 0.0000 0.0 0
M  V30 51 O 13.8553 0.7700 0.0 0
M  V30 52 O 16.5226 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 27
M  V30 4 1 3 17
M  V30 5 1 4 22
M  V30 6 1 5 34
M  V30 7 1 6 7
M  V30 8 1 6 42
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 9 10
M  V30 12 1 45 10 CFG=3
M  V30 13 2 11 48
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 20 21
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 24 33
M  V30 31 1 25 26
M  V30 32 1 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 36 39
M  V30 44 2 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 1 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 49
M  V30 56 1 50 51
M  V30 57 2 50 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-41-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[[[(2S)-tetrahydro-...
C43H48Cl2N6O5
2845303-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 62 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9810 11.2607 0.0 0
M  V30 2 N 26.4458 11.7366 0.0 0
M  V30 3 C 27.5901 10.7062 0.0 0
M  V30 4 C 22.2705 15.9555 0.0 0
M  V30 5 Cl 17.7102 9.3037 0.0 0
M  V30 6 Cl 12.3201 10.6373 0.0 0
M  V30 7 O 7.7001 10.6373 0.0 0
M  V30 8 C 8.4701 11.9710 0.0 0
M  V30 9 C 6.1601 7.9699 0.0 0
M  V30 10 N 5.3901 6.6362 0.0 0
M  V30 11 C 6.1601 5.3026 0.0 0
M  V30 12 C 3.8500 6.6362 0.0 0
M  V30 13 O 3.0800 7.9699 0.0 0
M  V30 14 O 3.0800 5.3026 0.0 0
M  V30 15 C 1.5400 7.9699 0.0 0
M  V30 16 C 1.5400 6.4299 0.0 0
M  V30 17 C 0.0000 7.9699 0.0 0
M  V30 18 C 1.5400 9.5099 0.0 0
M  V30 19 O 5.0329 0.0000 0.0 0
M  V30 20 C 22.3302 11.9710 0.0 0
M  V30 21 C 21.5602 13.3047 0.0 0
M  V30 22 C 23.8367 12.2912 0.0 0
M  V30 23 C 21.5602 10.6373 0.0 0
M  V30 24 N 20.0202 13.3047 0.0 0
M  V30 25 N 22.5906 14.4492 0.0 0
M  V30 26 C 23.9976 13.8227 0.0 0
M  V30 27 C 20.0202 10.6373 0.0 0
M  V30 28 C 19.2502 11.9710 0.0 0
M  V30 29 C 17.7102 11.9710 0.0 0
M  V30 30 C 16.9402 10.6373 0.0 0
M  V30 31 C 16.9402 13.3047 0.0 0
M  V30 32 C 15.4001 10.6373 0.0 0
M  V30 33 C 15.4001 13.3047 0.0 0
M  V30 34 C 14.6301 11.9710 0.0 0
M  V30 35 C 29.0548 11.1820 0.0 0 CFG=1
M  V30 36 C 30.3007 10.2768 0.0 0
M  V30 37 O 29.5307 12.6468 0.0 0
M  V30 38 C 31.5466 11.1820 0.0 0
M  V30 39 C 31.0707 12.6468 0.0 0
M  V30 40 C 14.6301 9.3037 0.0 0
M  V30 41 C 13.0901 9.3037 0.0 0
M  V30 42 C 15.4001 7.9699 0.0 0
M  V30 43 C 12.3201 7.9699 0.0 0
M  V30 44 C 14.6301 6.6362 0.0 0
M  V30 45 N 13.0901 6.6362 0.0 0
M  V30 46 C 10.7801 7.9699 0.0 0
M  V30 47 C 10.0101 9.3037 0.0 0
M  V30 48 C 10.0101 6.6362 0.0 0
M  V30 49 C 8.4701 9.3037 0.0 0
M  V30 50 C 8.4701 6.6362 0.0 0
M  V30 51 C 7.7001 7.9699 0.0 0
M  V30 52 C 5.3901 3.9689 0.0 0 CFG=1
M  V30 53 C 3.8585 3.8078 0.0 0
M  V30 54 N 6.0164 2.5620 0.0 0
M  V30 55 C 3.5383 2.3016 0.0 0
M  V30 56 C 4.8720 1.5315 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 35 3 CFG=1
M  V30 5 1 4 25
M  V30 6 1 5 30
M  V30 7 1 6 41
M  V30 8 1 7 8
M  V30 9 1 7 49
M  V30 10 1 9 10
M  V30 11 1 9 51
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 52 11 CFG=1
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 2 19 56
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 28 29
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 32 40
M  V30 39 1 33 34
M  V30 40 1 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 43 46
M  V30 51 2 44 45
M  V30 52 2 46 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 2 48 50
M  V30 56 2 49 51
M  V30 57 1 50 51
M  V30 58 1 52 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 1 54 56
M  V30 62 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 35 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[[[...
C38H40Cl2N6O3.CH2O2
2845291-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 57 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1594 9.6018 0.0 0
M  V30 2 N 26.6240 10.0776 0.0 0
M  V30 3 C 27.7685 9.0472 0.0 0
M  V30 4 C 22.4489 14.2965 0.0 0
M  V30 5 Cl 17.8886 7.6447 0.0 0
M  V30 6 Cl 12.4986 8.9784 0.0 0
M  V30 7 O 7.8786 3.6437 0.0 0
M  V30 8 C 8.6486 2.3100 0.0 0
M  V30 9 C 6.3386 6.3109 0.0 0
M  V30 10 N 5.5686 7.6447 0.0 0
M  V30 11 C 4.0286 7.6447 0.0 0
M  V30 12 O 0.0000 11.2720 0.0 0
M  V30 13 C 22.5086 10.3120 0.0 0
M  V30 14 C 21.7386 11.6457 0.0 0
M  V30 15 C 24.0149 10.6322 0.0 0
M  V30 16 C 21.7386 8.9784 0.0 0
M  V30 17 N 20.1986 11.6457 0.0 0
M  V30 18 N 22.7691 12.7902 0.0 0
M  V30 19 C 24.1760 12.1639 0.0 0
M  V30 20 C 20.1986 8.9784 0.0 0
M  V30 21 C 19.4286 10.3120 0.0 0
M  V30 22 C 17.8886 10.3120 0.0 0
M  V30 23 C 17.1186 8.9784 0.0 0
M  V30 24 C 17.1186 11.6457 0.0 0
M  V30 25 C 15.5786 8.9784 0.0 0
M  V30 26 C 15.5786 11.6457 0.0 0
M  V30 27 C 14.8086 10.3120 0.0 0
M  V30 28 C 29.2331 9.5231 0.0 0 CFG=1
M  V30 29 C 29.7091 10.9878 0.0 0
M  V30 30 O 30.4791 8.6179 0.0 0
M  V30 31 C 31.2491 10.9878 0.0 0
M  V30 32 C 31.7249 9.5231 0.0 0
M  V30 33 C 14.8086 7.6447 0.0 0
M  V30 34 C 13.2686 7.6447 0.0 0
M  V30 35 C 15.5786 6.3109 0.0 0
M  V30 36 C 12.4986 6.3109 0.0 0
M  V30 37 C 14.8086 4.9773 0.0 0
M  V30 38 N 13.2686 4.9773 0.0 0
M  V30 39 C 10.9586 6.3109 0.0 0
M  V30 40 C 10.1886 4.9773 0.0 0
M  V30 41 C 10.1886 7.6447 0.0 0
M  V30 42 C 8.6486 4.9773 0.0 0
M  V30 43 C 8.6486 7.6447 0.0 0
M  V30 44 C 7.8786 6.3109 0.0 0
M  V30 45 C 3.2586 8.9784 0.0 0 CFG=2
M  V30 46 N 1.7271 9.1393 0.0 0
M  V30 47 C 3.8850 10.3852 0.0 0
M  V30 48 C 1.4069 10.6457 0.0 0
M  V30 49 C 2.7406 11.4157 0.0 0
M  V30 50 C 15.8625 0.0000 0.0 0
M  V30 51 O 14.5288 0.7700 0.0 0
M  V30 52 O 17.1961 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 28 3 CFG=3
M  V30 5 1 4 18
M  V30 6 1 5 23
M  V30 7 1 6 34
M  V30 8 1 7 8
M  V30 9 1 7 42
M  V30 10 1 9 10
M  V30 11 1 9 44
M  V30 12 1 10 11
M  V30 13 1 45 11 CFG=1
M  V30 14 2 12 48
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 21 22
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 25 33
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 36 39
M  V30 44 2 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 1 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 49
M  V30 56 1 50 51
M  V30 57 2 50 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 28 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-44-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[(methylamino)methyl...
C39H42Cl2N6O4
2845303-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9812 11.2609 0.0 0
M  V30 2 N 26.4459 11.7368 0.0 0
M  V30 3 C 27.5903 10.7063 0.0 0
M  V30 4 C 22.2707 15.9557 0.0 0
M  V30 5 Cl 17.7104 9.3038 0.0 0
M  V30 6 Cl 12.3203 10.6375 0.0 0
M  V30 7 O 7.7002 10.6375 0.0 0
M  V30 8 C 8.4702 11.9711 0.0 0
M  V30 9 C 6.1601 7.9700 0.0 0
M  V30 10 N 5.3901 6.6363 0.0 0
M  V30 11 C 6.1601 5.3026 0.0 0
M  V30 12 C 3.8501 6.6363 0.0 0
M  V30 13 O 3.0801 7.9700 0.0 0
M  V30 14 O 3.0801 5.3026 0.0 0
M  V30 15 C 1.5400 7.9700 0.0 0
M  V30 16 C 1.5400 6.4299 0.0 0
M  V30 17 C 0.0000 7.9700 0.0 0
M  V30 18 C 1.5400 9.5100 0.0 0
M  V30 19 O 5.0330 0.0000 0.0 0
M  V30 20 C 22.3305 11.9711 0.0 0
M  V30 21 C 21.5605 13.3048 0.0 0
M  V30 22 C 23.8368 12.2913 0.0 0
M  V30 23 C 21.5605 10.6375 0.0 0
M  V30 24 N 20.0204 13.3048 0.0 0
M  V30 25 N 22.5909 14.4494 0.0 0
M  V30 26 C 23.9977 13.8230 0.0 0
M  V30 27 C 20.0204 10.6375 0.0 0
M  V30 28 C 19.2504 11.9711 0.0 0
M  V30 29 C 17.7104 11.9711 0.0 0
M  V30 30 C 16.9404 10.6375 0.0 0
M  V30 31 C 16.9404 13.3048 0.0 0
M  V30 32 C 15.4003 10.6375 0.0 0
M  V30 33 C 15.4003 13.3048 0.0 0
M  V30 34 C 14.6303 11.9711 0.0 0
M  V30 35 C 14.6303 9.3038 0.0 0
M  V30 36 C 13.0903 9.3038 0.0 0
M  V30 37 C 15.4003 7.9700 0.0 0
M  V30 38 C 12.3203 7.9700 0.0 0
M  V30 39 C 14.6303 6.6363 0.0 0
M  V30 40 N 13.0903 6.6363 0.0 0
M  V30 41 C 10.7802 7.9700 0.0 0
M  V30 42 C 10.0102 9.3038 0.0 0
M  V30 43 C 10.0102 6.6363 0.0 0
M  V30 44 C 8.4702 9.3038 0.0 0
M  V30 45 C 8.4702 6.6363 0.0 0
M  V30 46 C 7.7002 7.9700 0.0 0
M  V30 47 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 48 N 6.0164 2.5620 0.0 0
M  V30 49 C 3.8584 3.8079 0.0 0
M  V30 50 C 4.8721 1.5316 0.0 0
M  V30 51 C 3.5382 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 4 25
M  V30 5 1 5 30
M  V30 6 1 6 36
M  V30 7 1 7 8
M  V30 8 1 7 44
M  V30 9 1 9 10
M  V30 10 1 9 46
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 47 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 19 50
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 28 29
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 32 35
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 38 41
M  V30 45 2 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 52 1 47 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 47)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[1-methyl-3-[(m...
C34H34Cl2N6O2.CH2O2
2845291-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 9.6019 0.0 0
M  V30 2 N 1.1444 10.0778 0.0 0
M  V30 3 C 0.0000 9.0474 0.0 0
M  V30 4 C 5.3196 14.2967 0.0 0
M  V30 5 Cl 9.8801 7.6448 0.0 0
M  V30 6 Cl 15.2702 8.9785 0.0 0
M  V30 7 O 19.8903 3.6437 0.0 0
M  V30 8 C 19.1203 2.3100 0.0 0
M  V30 9 C 21.4303 6.3110 0.0 0
M  V30 10 N 22.2004 7.6448 0.0 0
M  V30 11 C 23.7404 7.6448 0.0 0
M  V30 12 O 27.7690 11.2722 0.0 0
M  V30 13 C 5.2600 10.3122 0.0 0
M  V30 14 C 6.0300 11.6459 0.0 0
M  V30 15 C 3.7535 10.6324 0.0 0
M  V30 16 C 6.0300 8.9785 0.0 0
M  V30 17 N 7.5700 11.6459 0.0 0
M  V30 18 N 4.9994 12.7904 0.0 0
M  V30 19 C 3.5926 12.1639 0.0 0
M  V30 20 C 7.5700 8.9785 0.0 0
M  V30 21 C 8.3401 10.3122 0.0 0
M  V30 22 C 9.8801 10.3122 0.0 0
M  V30 23 C 10.6501 8.9785 0.0 0
M  V30 24 C 10.6501 11.6459 0.0 0
M  V30 25 C 12.1901 8.9785 0.0 0
M  V30 26 C 12.1901 11.6459 0.0 0
M  V30 27 C 12.9602 10.3122 0.0 0
M  V30 28 C 12.9602 7.6448 0.0 0
M  V30 29 C 14.5002 7.6448 0.0 0
M  V30 30 C 12.1901 6.3110 0.0 0
M  V30 31 C 15.2702 6.3110 0.0 0
M  V30 32 C 12.9602 4.9774 0.0 0
M  V30 33 N 14.5002 4.9774 0.0 0
M  V30 34 C 16.8102 6.3110 0.0 0
M  V30 35 C 17.5803 4.9774 0.0 0
M  V30 36 C 17.5803 7.6448 0.0 0
M  V30 37 C 19.1203 4.9774 0.0 0
M  V30 38 C 19.1203 7.6448 0.0 0
M  V30 39 C 19.8903 6.3110 0.0 0
M  V30 40 C 24.5104 8.9785 0.0 0 CFG=2
M  V30 41 N 26.0420 9.1395 0.0 0
M  V30 42 C 23.8839 10.3853 0.0 0
M  V30 43 C 26.3621 10.6459 0.0 0
M  V30 44 C 25.0285 11.4159 0.0 0
M  V30 45 C 13.8845 0.0000 0.0 0
M  V30 46 O 12.5508 0.7700 0.0 0
M  V30 47 O 15.2182 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 4 18
M  V30 5 1 5 23
M  V30 6 1 6 29
M  V30 7 1 7 8
M  V30 8 1 7 37
M  V30 9 1 9 10
M  V30 10 1 9 39
M  V30 11 1 10 11
M  V30 12 1 40 11 CFG=3
M  V30 13 2 12 43
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 21 22
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 31 34
M  V30 38 2 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 50 1 45 46
M  V30 51 2 45 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-45-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[3-[[(4,4-difluorocyclohexyl)ami...
C44H48Cl2F2N6O4
2845303-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 64 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9813 11.2609 0.0 0
M  V30 2 N 26.4461 11.7368 0.0 0
M  V30 3 C 22.2707 15.9557 0.0 0
M  V30 4 Cl 17.7104 9.3038 0.0 0
M  V30 5 F 30.0938 7.1203 0.0 0
M  V30 6 F 31.4185 8.5915 0.0 0
M  V30 7 Cl 12.3203 10.6375 0.0 0
M  V30 8 O 7.7002 10.6375 0.0 0
M  V30 9 C 8.4702 11.9711 0.0 0
M  V30 10 C 6.1601 7.9700 0.0 0
M  V30 11 N 5.3901 6.6363 0.0 0
M  V30 12 C 6.1601 5.3026 0.0 0
M  V30 13 C 3.8501 6.6363 0.0 0
M  V30 14 O 3.0801 7.9700 0.0 0
M  V30 15 O 3.0801 5.3026 0.0 0
M  V30 16 C 1.5400 7.9700 0.0 0
M  V30 17 C 1.5400 9.5100 0.0 0
M  V30 18 C 0.0000 7.9700 0.0 0
M  V30 19 C 1.5400 6.4299 0.0 0
M  V30 20 O 5.0330 0.0000 0.0 0
M  V30 21 C 22.3305 11.9711 0.0 0
M  V30 22 C 21.5605 13.3048 0.0 0
M  V30 23 C 23.8369 12.2913 0.0 0
M  V30 24 C 21.5605 10.6375 0.0 0
M  V30 25 N 20.0204 13.3048 0.0 0
M  V30 26 N 22.5909 14.4494 0.0 0
M  V30 27 C 23.9979 13.8229 0.0 0
M  V30 28 C 20.0204 10.6375 0.0 0
M  V30 29 C 19.2504 11.9711 0.0 0
M  V30 30 C 17.7104 11.9711 0.0 0
M  V30 31 C 16.9404 10.6375 0.0 0
M  V30 32 C 16.9404 13.3048 0.0 0
M  V30 33 C 15.4003 10.6375 0.0 0
M  V30 34 C 15.4003 13.3048 0.0 0
M  V30 35 C 14.6303 11.9711 0.0 0
M  V30 36 C 27.5905 10.7063 0.0 0
M  V30 37 C 29.0552 11.1822 0.0 0
M  V30 38 C 27.2703 9.1999 0.0 0
M  V30 39 C 30.1996 10.1517 0.0 0
M  V30 40 C 28.4147 8.1694 0.0 0
M  V30 41 C 29.8794 8.6453 0.0 0
M  V30 42 C 14.6303 9.3038 0.0 0
M  V30 43 C 13.0903 9.3038 0.0 0
M  V30 44 C 15.4003 7.9700 0.0 0
M  V30 45 C 12.3203 7.9700 0.0 0
M  V30 46 C 14.6303 6.6363 0.0 0
M  V30 47 N 13.0903 6.6363 0.0 0
M  V30 48 C 10.7802 7.9700 0.0 0
M  V30 49 C 10.0102 9.3038 0.0 0
M  V30 50 C 10.0102 6.6363 0.0 0
M  V30 51 C 8.4702 9.3038 0.0 0
M  V30 52 C 8.4702 6.6363 0.0 0
M  V30 53 C 7.7002 7.9700 0.0 0
M  V30 54 C 5.3901 3.9690 0.0 0 CFG=1
M  V30 55 C 3.8586 3.8079 0.0 0
M  V30 56 N 6.0164 2.5620 0.0 0
M  V30 57 C 3.5384 2.3016 0.0 0
M  V30 58 C 4.8720 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 36
M  V30 4 1 3 26
M  V30 5 1 4 31
M  V30 6 1 5 41
M  V30 7 1 6 41
M  V30 8 1 7 43
M  V30 9 1 8 9
M  V30 10 1 8 51
M  V30 11 1 10 11
M  V30 12 1 10 53
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 54 12 CFG=1
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 2 20 58
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 2 22 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 29 30
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 33 42
M  V30 40 1 34 35
M  V30 41 1 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 47 1 42 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 45 48
M  V30 53 2 46 47
M  V30 54 2 48 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 2 50 52
M  V30 58 2 51 53
M  V30 59 1 52 53
M  V30 60 1 54 55
M  V30 61 1 54 56
M  V30 62 1 55 57
M  V30 63 1 56 58
M  V30 64 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[3-[[(4,4-diflu...
C39H40Cl2F2N6O2.CH2O2
2845291-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4370 9.6018 0.0 0
M  V30 2 N 4.9724 10.0776 0.0 0
M  V30 3 C 9.1476 14.2965 0.0 0
M  V30 4 Cl 13.7078 7.6447 0.0 0
M  V30 5 F 0.0000 6.9325 0.0 0
M  V30 6 F 1.3247 5.4613 0.0 0
M  V30 7 Cl 19.0978 8.9784 0.0 0
M  V30 8 O 23.7178 3.6437 0.0 0
M  V30 9 C 22.9478 2.3100 0.0 0
M  V30 10 C 25.2578 6.3109 0.0 0
M  V30 11 N 26.0278 7.6447 0.0 0
M  V30 12 C 27.5678 7.6447 0.0 0
M  V30 13 O 31.5965 11.2720 0.0 0
M  V30 14 C 9.0878 10.3120 0.0 0
M  V30 15 C 9.8578 11.6457 0.0 0
M  V30 16 C 7.5816 10.6322 0.0 0
M  V30 17 C 9.8578 8.9784 0.0 0
M  V30 18 N 11.3978 11.6457 0.0 0
M  V30 19 N 8.8274 12.7902 0.0 0
M  V30 20 C 7.4205 12.1637 0.0 0
M  V30 21 C 11.3978 8.9784 0.0 0
M  V30 22 C 12.1678 10.3120 0.0 0
M  V30 23 C 13.7078 10.3120 0.0 0
M  V30 24 C 14.4778 8.9784 0.0 0
M  V30 25 C 14.4778 11.6457 0.0 0
M  V30 26 C 16.0178 8.9784 0.0 0
M  V30 27 C 16.0178 11.6457 0.0 0
M  V30 28 C 16.7878 10.3120 0.0 0
M  V30 29 C 3.8280 9.0472 0.0 0
M  V30 30 C 4.1481 7.5408 0.0 0
M  V30 31 C 2.3633 9.5231 0.0 0
M  V30 32 C 3.0038 6.5104 0.0 0
M  V30 33 C 1.2189 8.4927 0.0 0
M  V30 34 C 1.5391 6.9862 0.0 0
M  V30 35 C 16.7878 7.6447 0.0 0
M  V30 36 C 18.3278 7.6447 0.0 0
M  V30 37 C 16.0178 6.3109 0.0 0
M  V30 38 C 19.0978 6.3109 0.0 0
M  V30 39 C 16.7878 4.9773 0.0 0
M  V30 40 N 18.3278 4.9773 0.0 0
M  V30 41 C 20.6378 6.3109 0.0 0
M  V30 42 C 21.4078 4.9773 0.0 0
M  V30 43 C 21.4078 7.6447 0.0 0
M  V30 44 C 22.9478 4.9773 0.0 0
M  V30 45 C 22.9478 7.6447 0.0 0
M  V30 46 C 23.7178 6.3109 0.0 0
M  V30 47 C 28.3378 8.9784 0.0 0 CFG=2
M  V30 48 N 29.8694 9.1393 0.0 0
M  V30 49 C 27.7115 10.3852 0.0 0
M  V30 50 C 30.1895 10.6457 0.0 0
M  V30 51 C 28.8559 11.4157 0.0 0
M  V30 52 C 15.7982 0.0000 0.0 0
M  V30 53 O 14.4646 0.7700 0.0 0
M  V30 54 O 17.1319 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 29
M  V30 4 1 3 19
M  V30 5 1 4 24
M  V30 6 1 5 34
M  V30 7 1 6 34
M  V30 8 1 7 36
M  V30 9 1 8 9
M  V30 10 1 8 44
M  V30 11 1 10 11
M  V30 12 1 10 46
M  V30 13 1 11 12
M  V30 14 1 47 12 CFG=3
M  V30 15 2 13 50
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 22 23
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 26 35
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 40 1 35 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 38 41
M  V30 46 2 39 40
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 46
M  V30 53 1 47 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 51
M  V30 57 1 50 51
M  V30 58 1 52 53
M  V30 59 2 52 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 47)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-47-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-86-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[4-[3-chloro-4-[2-chloro-3-[3-[[(2-hydroxyethyl)methylamino...
C41H46Cl2N6O5
2845303-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9812 11.2609 0.0 0
M  V30 2 N 26.4459 11.7368 0.0 0
M  V30 3 C 27.5903 10.7063 0.0 0
M  V30 4 C 26.7661 13.2432 0.0 0
M  V30 5 C 29.0550 11.1822 0.0 0
M  V30 6 O 30.1994 10.1517 0.0 0
M  V30 7 C 22.2707 15.9557 0.0 0
M  V30 8 Cl 17.7104 9.3038 0.0 0
M  V30 9 Cl 12.3203 10.6375 0.0 0
M  V30 10 O 7.7002 10.6375 0.0 0
M  V30 11 C 8.4702 11.9711 0.0 0
M  V30 12 C 6.1601 7.9700 0.0 0
M  V30 13 N 5.3901 6.6363 0.0 0
M  V30 14 C 6.1601 5.3026 0.0 0
M  V30 15 C 3.8501 6.6363 0.0 0
M  V30 16 O 3.0801 7.9700 0.0 0
M  V30 17 O 3.0801 5.3026 0.0 0
M  V30 18 C 1.5399 7.9700 0.0 0
M  V30 19 C 1.5400 6.4299 0.0 0
M  V30 20 C 0.0000 7.9700 0.0 0
M  V30 21 C 1.5400 9.5100 0.0 0
M  V30 22 O 5.0330 0.0000 0.0 0
M  V30 23 C 22.3305 11.9711 0.0 0
M  V30 24 C 21.5605 13.3048 0.0 0
M  V30 25 C 23.8368 12.2913 0.0 0
M  V30 26 C 21.5605 10.6375 0.0 0
M  V30 27 N 20.0204 13.3048 0.0 0
M  V30 28 N 22.5909 14.4494 0.0 0
M  V30 29 C 23.9977 13.8230 0.0 0
M  V30 30 C 20.0204 10.6375 0.0 0
M  V30 31 C 19.2504 11.9711 0.0 0
M  V30 32 C 17.7104 11.9711 0.0 0
M  V30 33 C 16.9404 10.6375 0.0 0
M  V30 34 C 16.9404 13.3048 0.0 0
M  V30 35 C 15.4003 10.6375 0.0 0
M  V30 36 C 15.4003 13.3048 0.0 0
M  V30 37 C 14.6303 11.9711 0.0 0
M  V30 38 C 14.6303 9.3038 0.0 0
M  V30 39 C 13.0903 9.3038 0.0 0
M  V30 40 C 15.4003 7.9700 0.0 0
M  V30 41 C 12.3203 7.9700 0.0 0
M  V30 42 C 14.6303 6.6363 0.0 0
M  V30 43 N 13.0903 6.6363 0.0 0
M  V30 44 C 10.7802 7.9700 0.0 0
M  V30 45 C 10.0102 9.3038 0.0 0
M  V30 46 C 10.0102 6.6363 0.0 0
M  V30 47 C 8.4702 9.3038 0.0 0
M  V30 48 C 8.4702 6.6363 0.0 0
M  V30 49 C 7.7002 7.9700 0.0 0
M  V30 50 C 5.3901 3.9690 0.0 0 CFG=2
M  V30 51 N 6.0164 2.5620 0.0 0
M  V30 52 C 3.8584 3.8079 0.0 0
M  V30 53 C 4.8719 1.5316 0.0 0
M  V30 54 C 3.5382 2.3016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 28
M  V30 8 1 8 33
M  V30 9 1 9 39
M  V30 10 1 10 11
M  V30 11 1 10 47
M  V30 12 1 12 13
M  V30 13 1 12 49
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 50 14 CFG=1
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 53
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 2 24 27
M  V30 28 1 24 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 31 32
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 35 38
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 41 44
M  V30 48 2 42 43
M  V30 49 2 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 2 46 48
M  V30 53 2 47 49
M  V30 54 1 48 49
M  V30 55 1 50 51
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[4-[3-chloro-4-[2-chloro-3-[3-[[(2-hydroxy...
C36H38Cl2N6O3.CH2O2
2845291-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.1598 9.6019 0.0 0
M  V30 2 N 26.6245 10.0778 0.0 0
M  V30 3 C 27.7689 9.0473 0.0 0
M  V30 4 C 26.9447 11.5842 0.0 0
M  V30 5 C 29.2336 9.5232 0.0 0
M  V30 6 O 30.3780 8.4928 0.0 0
M  V30 7 C 22.4493 14.2967 0.0 0
M  V30 8 Cl 17.8888 7.6448 0.0 0
M  V30 9 Cl 12.4987 8.9785 0.0 0
M  V30 10 O 7.8786 3.6437 0.0 0
M  V30 11 C 8.6486 2.3100 0.0 0
M  V30 12 C 6.3386 6.3110 0.0 0
M  V30 13 N 5.5686 7.6448 0.0 0
M  V30 14 C 4.0286 7.6448 0.0 0
M  V30 15 O 0.0000 11.2722 0.0 0
M  V30 16 C 22.5089 10.3122 0.0 0
M  V30 17 C 21.7389 11.6458 0.0 0
M  V30 18 C 24.0154 10.6323 0.0 0
M  V30 19 C 21.7389 8.9785 0.0 0
M  V30 20 N 20.1989 11.6458 0.0 0
M  V30 21 N 22.7695 12.7904 0.0 0
M  V30 22 C 24.1763 12.1639 0.0 0
M  V30 23 C 20.1989 8.9785 0.0 0
M  V30 24 C 19.4288 10.3122 0.0 0
M  V30 25 C 17.8888 10.3122 0.0 0
M  V30 26 C 17.1188 8.9785 0.0 0
M  V30 27 C 17.1188 11.6458 0.0 0
M  V30 28 C 15.5788 8.9785 0.0 0
M  V30 29 C 15.5788 11.6458 0.0 0
M  V30 30 C 14.8088 10.3122 0.0 0
M  V30 31 C 14.8088 7.6448 0.0 0
M  V30 32 C 13.2687 7.6448 0.0 0
M  V30 33 C 15.5788 6.3110 0.0 0
M  V30 34 C 12.4987 6.3110 0.0 0
M  V30 35 C 14.8088 4.9773 0.0 0
M  V30 36 N 13.2687 4.9773 0.0 0
M  V30 37 C 10.9587 6.3110 0.0 0
M  V30 38 C 10.1887 4.9773 0.0 0
M  V30 39 C 10.1887 7.6448 0.0 0
M  V30 40 C 8.6486 4.9773 0.0 0
M  V30 41 C 8.6486 7.6448 0.0 0
M  V30 42 C 7.8786 6.3110 0.0 0
M  V30 43 C 3.2585 8.9785 0.0 0 CFG=2
M  V30 44 N 1.7270 9.1394 0.0 0
M  V30 45 C 3.8850 10.3853 0.0 0
M  V30 46 C 1.4068 10.6459 0.0 0
M  V30 47 C 2.7405 11.4159 0.0 0
M  V30 48 C 15.1890 0.0000 0.0 0
M  V30 49 O 13.8553 0.7700 0.0 0
M  V30 50 O 16.5227 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 21
M  V30 8 1 8 26
M  V30 9 1 9 32
M  V30 10 1 10 11
M  V30 11 1 10 40
M  V30 12 1 12 13
M  V30 13 1 12 42
M  V30 14 1 13 14
M  V30 15 1 43 14 CFG=1
M  V30 16 2 15 46
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 34 37
M  V30 41 2 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 1 43 44
M  V30 49 1 43 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 1 46 47
M  V30 53 1 48 49
M  V30 54 2 48 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2845303-52-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845291-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 6-[4-[(5S)-5,7,8,9-tetrahydro-3-(2-hydroxyphenyl)-5-methyl-...
C37H51N7O3
2890776-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 23.7951 1.5400 0.0 0
M  V30 2 O 25.1287 2.3100 0.0 0
M  V30 3 O 23.7951 0.0000 0.0 0
M  V30 4 C 26.4625 1.5400 0.0 0
M  V30 5 C 27.2325 2.8737 0.0 0
M  V30 6 C 27.7962 0.7700 0.0 0
M  V30 7 C 25.6925 0.2064 0.0 0
M  V30 8 C 8.0195 7.5680 0.0 0
M  V30 9 O 0.0000 7.5124 0.0 0
M  V30 10 C 20.5752 3.3990 0.0 0
M  V30 11 C 20.1766 4.8865 0.0 0
M  V30 12 C 19.0877 3.0004 0.0 0
M  V30 13 C 20.9739 1.9115 0.0 0
M  V30 14 C 22.0628 3.7975 0.0 0
M  V30 15 C 18.6891 4.4879 0.0 0
M  V30 16 N 22.4614 2.3100 0.0 0
M  V30 17 N 17.3554 5.2579 0.0 0
M  V30 18 C 16.0216 4.4879 0.0 0
M  V30 19 C 17.3554 6.7980 0.0 0
M  V30 20 C 14.6880 5.2579 0.0 0
M  V30 21 C 16.0216 7.5680 0.0 0
M  V30 22 C 14.6880 6.7980 0.0 0
M  V30 23 N 13.3543 7.5680 0.0 0
M  V30 24 C 13.3543 9.1080 0.0 0
M  V30 25 C 12.0207 6.7980 0.0 0
M  V30 26 C 12.0207 9.8780 0.0 0
M  V30 27 C 10.6868 7.5680 0.0 0
M  V30 28 C 10.6868 9.1080 0.0 0
M  V30 29 N 9.3532 9.8780 0.0 0
M  V30 30 C 8.0195 9.1080 0.0 0 CFG=1
M  V30 31 C 9.3532 11.4180 0.0 0
M  V30 32 C 6.6859 9.8780 0.0 0
M  V30 33 C 8.0195 12.1881 0.0 0
M  V30 34 C 5.2211 9.4021 0.0 0
M  V30 35 C 6.6859 11.4180 0.0 0
M  V30 36 C 4.3159 10.6480 0.0 0
M  V30 37 C 4.5948 7.9952 0.0 0
M  V30 38 N 5.2211 11.8939 0.0 0
M  V30 39 N 2.7844 10.4871 0.0 0
M  V30 40 C 3.0633 7.8343 0.0 0
M  V30 41 N 2.1580 9.0801 0.0 0
M  V30 42 C 2.4368 6.4274 0.0 0
M  V30 43 C 0.9052 6.2664 0.0 0
M  V30 44 C 3.3420 5.1816 0.0 0
M  V30 45 C 0.2789 4.8595 0.0 0
M  V30 46 C 2.7157 3.7746 0.0 0
M  V30 47 C 1.1840 3.6137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 30 8 CFG=1
M  V30 9 1 9 43
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 28 29
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 32 35
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 34 37
M  V30 42 1 35 38
M  V30 43 1 36 38
M  V30 44 2 36 39
M  V30 45 1 37 40
M  V30 46 1 39 41
M  V30 47 2 40 41
M  V30 48 1 40 42
M  V30 49 2 42 43
M  V30 50 1 42 44
M  V30 51 1 43 45
M  V30 52 2 44 46
M  V30 53 2 45 47
M  V30 54 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H43N7O.CH2O2
2890776-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0194 7.9666 0.0 0
M  V30 2 O 0.0000 7.9110 0.0 0
M  V30 3 C 6.6857 10.2766 0.0 0
M  V30 4 C 5.2212 9.8007 0.0 0
M  V30 5 C 6.6857 11.8166 0.0 0
M  V30 6 C 8.0194 9.5066 0.0 0 CFG=2
M  V30 7 C 4.3159 11.0466 0.0 0
M  V30 8 C 4.5947 8.3939 0.0 0
M  V30 9 N 5.2212 12.2925 0.0 0
M  V30 10 C 8.0194 12.5867 0.0 0
M  V30 11 N 9.3532 10.2766 0.0 0
M  V30 12 N 2.7844 10.8857 0.0 0
M  V30 13 C 3.0631 8.2328 0.0 0
M  V30 14 C 9.3532 11.8166 0.0 0
M  V30 15 N 2.1579 9.4787 0.0 0
M  V30 16 C 10.6869 9.5066 0.0 0
M  V30 17 C 10.6869 7.9666 0.0 0
M  V30 18 C 12.0206 10.2766 0.0 0
M  V30 19 C 12.0206 7.1965 0.0 0
M  V30 20 C 13.3542 9.5066 0.0 0
M  V30 21 N 13.3542 7.9666 0.0 0
M  V30 22 C 2.4368 6.8260 0.0 0
M  V30 23 C 0.9051 6.6651 0.0 0
M  V30 24 C 3.3420 5.5801 0.0 0
M  V30 25 C 0.2787 5.2581 0.0 0
M  V30 26 C 2.7155 4.1731 0.0 0
M  V30 27 C 1.1840 4.0122 0.0 0
M  V30 28 C 14.6881 7.1965 0.0 0
M  V30 29 C 16.0217 7.9666 0.0 0
M  V30 30 C 14.6881 5.6565 0.0 0
M  V30 31 C 17.3554 7.1965 0.0 0
M  V30 32 C 16.0217 4.8865 0.0 0
M  V30 33 N 17.3554 5.6565 0.0 0
M  V30 34 C 18.6891 4.8865 0.0 0
M  V30 35 C 19.0878 3.3990 0.0 0
M  V30 36 C 20.1768 5.2851 0.0 0
M  V30 37 C 20.5753 3.7975 0.0 0
M  V30 38 C 20.9739 2.3100 0.0 0
M  V30 39 C 22.0628 4.1961 0.0 0
M  V30 40 N 22.4614 2.7086 0.0 0
M  V30 41 C 11.2307 0.0000 0.0 0
M  V30 42 O 9.8970 0.7700 0.0 0
M  V30 43 O 12.5644 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 11 16
M  V30 17 1 12 15
M  V30 18 2 13 15
M  V30 19 1 13 22
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 21 28
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 33 34
M  V30 40 1 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 36 37
M  V30 44 1 37 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 40
M  V30 48 1 41 42
M  V30 49 2 41 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2890776-16-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2890776-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35822696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocycles as SMARCA degraders and preparation and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yi; Fleming, Paul R.; Zhu, Xiao; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023278402 A1 2023-01-05

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Carbamic acid, N-[[6-[3-[2-[3-[[(1-acetyl-4-piperidinyl)methylamino]methyl]-1...
C46H53Cl2N7O5
2924116-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 66 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 24.9810 11.2607 0.0 0
M  V30 2 N 26.4457 11.7366 0.0 0
M  V30 3 C 26.7659 13.2430 0.0 0
M  V30 4 C 22.2704 15.9554 0.0 0
M  V30 5 Cl 17.7101 9.3037 0.0 0
M  V30 6 C 31.0234 7.6147 0.0 0
M  V30 7 C 32.4881 8.0906 0.0 0
M  V30 8 O 30.7032 6.1083 0.0 0
M  V30 9 Cl 12.3201 10.6373 0.0 0
M  V30 10 O 7.7001 10.6373 0.0 0
M  V30 11 C 8.4701 11.9710 0.0 0
M  V30 12 C 6.1600 7.9699 0.0 0
M  V30 13 N 5.3900 6.6362 0.0 0
M  V30 14 C 6.1600 5.3026 0.0 0
M  V30 15 C 3.8500 6.6362 0.0 0
M  V30 16 O 3.0800 7.9699 0.0 0
M  V30 17 O 3.0800 5.3026 0.0 0
M  V30 18 C 1.5400 7.9699 0.0 0
M  V30 19 C 1.5400 9.5099 0.0 0
M  V30 20 C 0.0000 7.9699 0.0 0
M  V30 21 C 1.5400 6.4299 0.0 0
M  V30 22 O 5.0329 0.0000 0.0 0
M  V30 23 C 22.3302 11.9710 0.0 0
M  V30 24 C 21.5602 13.3046 0.0 0
M  V30 25 C 23.8366 12.2911 0.0 0
M  V30 26 C 21.5602 10.6373 0.0 0
M  V30 27 C 20.0201 13.3046 0.0 0
M  V30 28 N 22.5906 14.4492 0.0 0
M  V30 29 C 23.9975 13.8228 0.0 0
M  V30 30 C 20.0201 10.6373 0.0 0
M  V30 31 C 19.2501 11.9710 0.0 0
M  V30 32 C 17.7101 11.9710 0.0 0
M  V30 33 C 16.9401 10.6373 0.0 0
M  V30 34 N 16.9401 13.3046 0.0 0
M  V30 35 C 15.4001 10.6373 0.0 0
M  V30 36 C 15.4001 13.3046 0.0 0
M  V30 37 C 14.6301 11.9710 0.0 0
M  V30 38 C 27.5901 10.7062 0.0 0
M  V30 39 C 29.0548 11.1820 0.0 0
M  V30 40 C 27.2699 9.1997 0.0 0
M  V30 41 C 30.1992 10.1516 0.0 0
M  V30 42 C 28.4143 8.1693 0.0 0
M  V30 43 N 29.8790 8.6452 0.0 0
M  V30 44 C 14.6301 9.3037 0.0 0
M  V30 45 C 13.0901 9.3037 0.0 0
M  V30 46 C 15.4001 7.9699 0.0 0
M  V30 47 C 12.3201 7.9699 0.0 0
M  V30 48 C 14.6301 6.6362 0.0 0
M  V30 49 C 13.0901 6.6362 0.0 0
M  V30 50 C 10.7801 7.9699 0.0 0
M  V30 51 N 10.0101 9.3037 0.0 0
M  V30 52 C 10.0101 6.6362 0.0 0
M  V30 53 C 8.4701 9.3037 0.0 0
M  V30 54 C 8.4701 6.6362 0.0 0
M  V30 55 C 7.7001 7.9699 0.0 0
M  V30 56 C 5.3900 3.9689 0.0 0 CFG=2
M  V30 57 N 6.0164 2.5620 0.0 0
M  V30 58 C 3.8585 3.8078 0.0 0
M  V30 59 C 4.8720 1.5315 0.0 0
M  V30 60 C 3.5383 2.3015 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 2 38
M  V30 5 1 4 28
M  V30 6 1 5 33
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 43
M  V30 10 1 9 45
M  V30 11 1 10 11
M  V30 12 1 10 53
M  V30 13 1 12 13
M  V30 14 1 12 55
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 56 14 CFG=1
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 2 22 59
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 2 24 27
M  V30 29 1 24 28
M  V30 30 2 25 29
M  V30 31 1 26 30
M  V30 32 1 27 31
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 31 32
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 35 44
M  V30 42 1 36 37
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 43
M  V30 49 2 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 2 46 48
M  V30 53 2 47 49
M  V30 54 1 47 50
M  V30 55 1 48 49
M  V30 56 1 50 51
M  V30 57 2 50 52
M  V30 58 2 51 53
M  V30 59 1 52 54
M  V30 60 1 53 55
M  V30 61 2 54 55
M  V30 62 1 56 57
M  V30 63 1 56 58
M  V30 64 1 57 59
M  V30 65 1 58 60
M  V30 66 1 59 60
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 56)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S)-5-[[[[6-[3-[2-[3-[[(1-acetyl-4-piperidinyl)meth...
C41H45Cl2N7O3.CH2O2
2845290-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5070 9.6018 0.0 0
M  V30 2 N 6.0425 10.0776 0.0 0
M  V30 3 C 5.7222 11.5841 0.0 0
M  V30 4 C 10.2176 14.2965 0.0 0
M  V30 5 Cl 14.7778 7.6447 0.0 0
M  V30 6 C 1.4647 5.9558 0.0 0
M  V30 7 C 0.0000 6.4317 0.0 0
M  V30 8 O 1.7849 4.4494 0.0 0
M  V30 9 Cl 20.1678 8.9784 0.0 0
M  V30 10 O 24.7878 3.6437 0.0 0
M  V30 11 C 24.0178 2.3100 0.0 0
M  V30 12 C 26.3278 6.3109 0.0 0
M  V30 13 N 27.0978 7.6447 0.0 0
M  V30 14 C 28.6378 7.6447 0.0 0
M  V30 15 O 32.6665 11.2720 0.0 0
M  V30 16 C 10.1578 10.3120 0.0 0
M  V30 17 C 10.9278 11.6457 0.0 0
M  V30 18 C 8.6516 10.6322 0.0 0
M  V30 19 C 10.9278 8.9784 0.0 0
M  V30 20 C 12.4678 11.6457 0.0 0
M  V30 21 N 9.8974 12.7902 0.0 0
M  V30 22 C 8.4905 12.1639 0.0 0
M  V30 23 C 12.4678 8.9784 0.0 0
M  V30 24 C 13.2378 10.3120 0.0 0
M  V30 25 C 14.7778 10.3120 0.0 0
M  V30 26 C 15.5478 8.9784 0.0 0
M  V30 27 N 15.5478 11.6457 0.0 0
M  V30 28 C 17.0878 8.9784 0.0 0
M  V30 29 C 17.0878 11.6457 0.0 0
M  V30 30 C 17.8578 10.3120 0.0 0
M  V30 31 C 4.8980 9.0472 0.0 0
M  V30 32 C 3.4334 9.5231 0.0 0
M  V30 33 C 5.2181 7.5408 0.0 0
M  V30 34 C 2.2889 8.4927 0.0 0
M  V30 35 C 4.0738 6.5104 0.0 0
M  V30 36 N 2.6091 6.9862 0.0 0
M  V30 37 C 17.8578 7.6447 0.0 0
M  V30 38 C 19.3978 7.6447 0.0 0
M  V30 39 C 17.0878 6.3109 0.0 0
M  V30 40 C 20.1678 6.3109 0.0 0
M  V30 41 C 17.8578 4.9773 0.0 0
M  V30 42 C 19.3978 4.9773 0.0 0
M  V30 43 C 21.7078 6.3109 0.0 0
M  V30 44 N 22.4778 4.9773 0.0 0
M  V30 45 C 22.4778 7.6447 0.0 0
M  V30 46 C 24.0178 4.9773 0.0 0
M  V30 47 C 24.0178 7.6447 0.0 0
M  V30 48 C 24.7878 6.3109 0.0 0
M  V30 49 C 29.4078 8.9784 0.0 0 CFG=2
M  V30 50 N 30.9394 9.1393 0.0 0
M  V30 51 C 28.7815 10.3852 0.0 0
M  V30 52 C 31.2595 10.6457 0.0 0
M  V30 53 C 29.9259 11.4157 0.0 0
M  V30 54 C 16.3332 0.0000 0.0 0
M  V30 55 O 14.9996 0.7700 0.0 0
M  V30 56 O 17.6669 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 31
M  V30 5 1 4 21
M  V30 6 1 5 26
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 36
M  V30 10 1 9 38
M  V30 11 1 10 11
M  V30 12 1 10 46
M  V30 13 1 12 13
M  V30 14 1 12 48
M  V30 15 1 13 14
M  V30 16 1 49 14 CFG=3
M  V30 17 2 15 52
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 24 25
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 28 37
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 40 43
M  V30 48 1 41 42
M  V30 49 1 43 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 48
M  V30 55 1 49 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 1 51 53
M  V30 59 1 52 53
M  V30 60 1 54 55
M  V30 61 2 54 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 49)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2924116-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2845290-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34741427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated as formic acid salt by using reversed phase
chromatography
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-aryl-1'-heteroaryl compounds, substituted
1,1'-biheteroaryl compounds, and methods using same in the treatment of
cancer and hepatitis B and D
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahuja, Vijay; Cole, Andrew G.; Dorsey, Bruce D.; Fan, Yi; Heffernan,
Gavin D.; Kakarla, Ramesh; Kultgen, Steven G.; Nguyen, Duyan; Ozturk,
Seyma; Quintero, Jorge; Sofia, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022208269 A2 2022-10-06

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Spiro[3H-indole-3,4′-piperidin]-2(1H)-one, 1-[(4-methoxyphenyl)methyl]-2′-met...
C24H27N5O2
2935490-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.2620 6.3404 0.0 0
M  V30 2 C 6.9300 6.6906 0.0 0
M  V30 3 C 11.2806 0.0000 0.0 0
M  V30 4 C 17.3602 5.6437 0.0 0
M  V30 5 O 0.7700 6.6906 0.0 0
M  V30 6 C 0.0000 8.0244 0.0 0
M  V30 7 C 9.5517 3.6896 0.0 0 CFG=2
M  V30 8 C 8.2181 2.9195 0.0 0
M  V30 9 C 9.2316 5.1960 0.0 0
M  V30 10 C 10.7976 4.5948 0.0 0
M  V30 11 C 9.7127 2.1580 0.0 0
M  V30 12 C 7.0736 3.9501 0.0 0
M  V30 13 C 7.8979 1.4133 0.0 0
M  V30 14 N 7.7000 5.3569 0.0 0
M  V30 15 C 12.2046 3.9684 0.0 0 CFG=1
M  V30 16 C 11.1196 1.5317 0.0 0 CFG=2
M  V30 17 C 5.6090 3.4741 0.0 0
M  V30 18 C 6.4332 0.9374 0.0 0
M  V30 19 N 12.3655 2.4369 0.0 0
M  V30 20 C 5.2888 1.9678 0.0 0
M  V30 21 C 13.4504 4.8737 0.0 0
M  V30 22 C 14.9150 4.3976 0.0 0
M  V30 23 N 13.4504 6.4137 0.0 0
M  V30 24 N 15.8202 5.6437 0.0 0
M  V30 25 N 14.9150 6.8895 0.0 0
M  V30 26 C 5.3900 6.6906 0.0 0
M  V30 27 C 4.6200 8.0244 0.0 0
M  V30 28 C 4.6200 5.3569 0.0 0
M  V30 29 C 3.0800 8.0244 0.0 0
M  V30 30 C 3.0800 5.3569 0.0 0
M  V30 31 C 2.3100 6.6906 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 14
M  V30 3 1 2 26
M  V30 4 1 16 3 CFG=1
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 5 31
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 1 15 21 CFG=1
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 2 18 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (2′S,3S,6′S)-2′-methyl-6′-(1-methyl-1H-1,2,3-triazol...
C16H19N5O.CH2O2
2935489-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 8.7221 0.0 0
M  V30 2 C 5.7534 2.3100 0.0 0
M  V30 3 C 12.3899 7.2873 0.0 0
M  V30 4 C 4.4197 6.1601 0.0 0 CFG=1
M  V30 5 C 3.0128 5.5336 0.0 0
M  V30 6 C 5.7534 6.9301 0.0 0
M  V30 7 C 4.2588 7.6917 0.0 0
M  V30 8 C 4.4197 4.6201 0.0 0
M  V30 9 C 1.9823 6.6782 0.0 0
M  V30 10 C 2.5369 4.0690 0.0 0
M  V30 11 C 7.0871 6.1601 0.0 0 CFG=1
M  V30 12 N 2.7523 8.0118 0.0 0
M  V30 13 C 5.7534 3.8501 0.0 0 CFG=2
M  V30 14 C 0.4760 6.3580 0.0 0
M  V30 15 C 1.0306 3.7489 0.0 0
M  V30 16 N 7.0871 4.6201 0.0 0
M  V30 17 C 0.0000 4.8933 0.0 0
M  V30 18 C 8.4209 6.9301 0.0 0
M  V30 19 C 9.8277 6.3036 0.0 0
M  V30 20 N 8.5818 8.4617 0.0 0
M  V30 21 N 10.8582 7.4482 0.0 0
M  V30 22 N 10.0881 8.7819 0.0 0
M  V30 23 C 6.1949 0.0000 0.0 0
M  V30 24 O 4.8613 0.7700 0.0 0
M  V30 25 O 7.5286 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 13 2 CFG=1
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7 CFG=3
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 12
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 11 18 CFG=1
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 2 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2935490-31-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2935489-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37008162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1493-13-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spiroisochromanepiperidine derivatives as APOL1 inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Senter, Timothy J.; Dakin, Leslie A.; Chen, Ming; Stone, Steven D.;
Dolgikh, Elena; Olsen, Jessica H.; Wang, Haoxuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023101981 A1 2023-06-08

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-iodoaniline
C6H5FIN
29632-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 I 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Fluoro-4-iodophenyl)formamide
C7H5FINO
791112-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 F 4.6201 0.0000 0.0 0
M  V30 5 I 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29632-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 791112-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13182161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Fluoro-4-iodophenylformamide Step 1. To a cooled solution (0°C.) of
4-iodo-2 fluoroaniline (3.05 g, 12.9 mmol) in tetrahydrofuran (15 mL) and
toluene (15 mL), was slowly added a mixture of acetic anhydride (1.39 mL,
14.7 mmol) and formic acid (0.83 mL, 22.0 mmol). The reaction mixture was
stirred at rt overnight, then diluted with ethyl acetate (100 mL) and 1N
aqueous HCl (100 mL). The layers were separated, and the organic layer
was washed with water and saturated sodium carbonate solution, and dried
over sodium sulfate. The solvent was removed under reduced pressure to
afford 2-fluoro-4-iodophenylformamide. Yield 3.32 g (97%), off-white
solid. GC-MS ret. time 2.27 min, m/z 265 (M+); 1H NMR (300 MHz, CDCl3) δ
: 7.37-7.51 (m, 3H), 8.13 (t, 1H), 8.46 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzazolylaminobiphenyloxoalkanoates for the treatment of
obesity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Roger; Campbell, Ann-Marie; Coish, Philip; Dai, Miao; Jenkins,
Susan; Lowe, Derek; O'Connor, Stephen; Su, Ning; Wang, Gan; Zhang,
Mingbao; Zhu, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040224997 A1 2004-11-11

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,5-a]pyridine-1-carboxamide, 7-amino-N,3-dimethyl-
C10H12N4O
2973298-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7307 4.6949 0.0 0
M  V30 2 N 7.1954 4.2189 0.0 0
M  V30 3 O 5.4105 6.2012 0.0 0
M  V30 4 C 8.3398 5.2495 0.0 0
M  V30 5 C 3.0203 0.0000 0.0 0
M  V30 6 N 0.0000 6.6519 0.0 0
M  V30 7 C 3.0800 3.9845 0.0 0
M  V30 8 N 2.3100 2.6508 0.0 0
M  V30 9 C 4.5863 3.6643 0.0 0
M  V30 10 C 2.3100 5.3183 0.0 0
M  V30 11 C 3.3405 1.5064 0.0 0
M  V30 12 C 0.7700 2.6508 0.0 0
M  V30 13 N 4.7473 2.1328 0.0 0
M  V30 14 C 0.7700 5.3183 0.0 0
M  V30 15 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 2 12 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,5-a]pyridine-1-carboxamide, 7-(formylamino)-N,3-dimethyl-
C11H12N4O2
2973299-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0408 4.6948 0.0 0
M  V30 2 N 9.5056 4.2189 0.0 0
M  V30 3 O 7.7207 6.2013 0.0 0
M  V30 4 C 10.6500 5.2495 0.0 0
M  V30 5 C 5.3304 0.0000 0.0 0
M  V30 6 N 2.3101 6.6520 0.0 0
M  V30 7 C 0.7700 6.6520 0.0 0
M  V30 8 O 0.0000 7.9857 0.0 0
M  V30 9 C 5.3901 3.9845 0.0 0
M  V30 10 N 4.6201 2.6509 0.0 0
M  V30 11 C 6.8964 3.6644 0.0 0
M  V30 12 C 4.6201 5.3182 0.0 0
M  V30 13 C 5.6505 1.5065 0.0 0
M  V30 14 C 3.0801 2.6509 0.0 0
M  V30 15 N 7.0574 2.1328 0.0 0
M  V30 16 C 3.0801 5.3182 0.0 0
M  V30 17 C 2.3101 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 15
M  V30 17 2 14 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2973298-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2973299-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37737858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barlaam, Bernard; Boiko, Scott; Boyd, Scott; Dry, Hannah; Gingipalli,
Lakshmaiah; Ikeda, Timothy; Johnson, Tony; Kawatkar, Sameer; Lorthioir,
Olivier; Pike, Andy; Pollard, Hannah; Read, Jon; Su, Qibin; Wang, Haiyun;
Wang, Huimin; Wang, Lianghe; Wang, Peng; Edmondson, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127523

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzo[b]thiophene-6-carbonitrile, 5-amino-2-methyl-, 1,1-dioxide
C10H8N2O2S
3031970-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.1116 0.6369 0.0 0
M  V30 2 O 3.0717 0.0000 0.0 0
M  V30 3 C 0.0000 2.6528 0.0 0
M  V30 4 N 7.9109 4.1928 0.0 0
M  V30 5 C 7.9109 1.1128 0.0 0
M  V30 6 N 9.2447 0.3428 0.0 0
M  V30 7 C 3.9099 3.4228 0.0 0
M  V30 8 C 3.9099 1.8828 0.0 0
M  V30 9 C 2.4452 3.8987 0.0 0
M  V30 10 C 5.2436 4.1928 0.0 0
M  V30 11 C 5.2436 1.1128 0.0 0
M  V30 12 S 2.4452 1.4070 0.0 0 VAL=6
M  V30 13 C 1.5400 2.6528 0.0 0
M  V30 14 C 6.5772 3.4228 0.0 0
M  V30 15 C 6.5772 1.8828 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 13
M  V30 4 1 4 14
M  V30 5 3 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-g]quinazolin-4(3H)-one, 7-methyl-, 6,6-dioxide
C11H8N2O3S
3031970-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.1330 1.0641 0.0 0
M  V30 2 O 6.1731 0.4272 0.0 0
M  V30 3 C 9.2446 3.0800 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 S 6.7994 1.8341 0.0 0 VAL=6
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 6.7994 4.3259 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 7.7046 3.0800 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 1.3338 1.5400 0.0 0
M  V30 15 N 1.3338 4.6200 0.0 0
M  V30 16 N 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 8
M  V30 3 1 3 12
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3031970-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3031970-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34556582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and structure-activity relationship of novel RIPK2
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Shuwei; Xu, Liben; Wang, Xinhui; Yang, Qing; Wang, Jingrui; He,
Sudan; Zhang, Xiaohu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 75128968

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(5S,8S,10aR)-3-(cyanomethyl)-8-[[[(4R)-3,4-dihydro-2H-1-ben...
C26H35N5O5
3043957-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 8.8412 0.0 0
M  V30 2 N 5.3348 9.6112 0.0 0
M  V30 3 O 6.6684 7.3012 0.0 0
M  V30 4 O 8.0997 6.7839 0.0 0
M  V30 5 N 10.1201 4.9649 0.0 0
M  V30 6 C 11.1202 3.7938 0.0 0
M  V30 7 O 10.6061 2.3421 0.0 0
M  V30 8 O 12.6345 4.0744 0.0 0
M  V30 9 C 11.6063 1.1710 0.0 0
M  V30 10 C 12.7774 2.1713 0.0 0
M  V30 11 C 12.6064 0.0000 0.0 0
M  V30 12 C 10.4353 0.1709 0.0 0
M  V30 13 C 14.6542 7.1275 0.0 0
M  V30 14 C 15.8252 8.1276 0.0 0
M  V30 15 N 16.9962 9.1278 0.0 0
M  V30 16 N 9.4090 8.9849 0.0 0
M  V30 17 C 8.0022 9.6112 0.0 0 CFG=2
M  V30 18 C 10.4395 10.1293 0.0 0 CFG=1
M  V30 19 C 9.4896 7.4469 0.0 0
M  V30 20 C 8.1632 11.1428 0.0 0
M  V30 21 C 9.6695 11.4630 0.0 0
M  V30 22 C 11.9775 10.2099 0.0 0
M  V30 23 C 10.6341 6.4165 0.0 0 CFG=1
M  V30 24 C 13.1219 9.1794 0.0 0
M  V30 25 C 12.1720 6.4970 0.0 0
M  V30 26 N 13.2024 7.6416 0.0 0
M  V30 27 C 4.0011 8.8412 0.0 0 CFG=2
M  V30 28 C 2.6675 9.6112 0.0 0
M  V30 29 C 4.0011 7.3012 0.0 0
M  V30 30 C 1.3337 8.8412 0.0 0
M  V30 31 C 2.6675 11.1513 0.0 0
M  V30 32 C 2.6675 6.5312 0.0 0
M  V30 33 O 1.3337 7.3012 0.0 0
M  V30 34 C 0.0000 9.6112 0.0 0
M  V30 35 C 1.3337 11.9213 0.0 0
M  V30 36 C 0.0000 11.1513 0.0 0
M  V30 37 H 11.1744 11.4827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 27 2 CFG=3
M  V30 5 2 4 19
M  V30 6 1 5 6
M  V30 7 1 23 5 CFG=3
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 26
M  V30 16 3 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 18 37 CFG=1
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 1 30 33
M  V30 36 2 30 34
M  V30 37 1 31 35
M  V30 38 1 32 33
M  V30 39 1 34 36
M  V30 40 2 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 18 23 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S,8S,10aR)-5-amino-3-(cyanomethyl)-N-[(4R)-3,4-dih...
C21H27N5O3.CH2O2
3043957-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.1865 0.0 0
M  V30 2 N 5.3347 6.9565 0.0 0
M  V30 3 O 6.6684 4.6465 0.0 0
M  V30 4 O 8.0996 4.1292 0.0 0
M  V30 5 N 10.1200 2.3100 0.0 0
M  V30 6 C 14.6540 4.4726 0.0 0
M  V30 7 C 15.8250 5.4729 0.0 0
M  V30 8 N 16.9961 6.4729 0.0 0
M  V30 9 N 9.4089 6.3300 0.0 0
M  V30 10 C 8.0021 6.9565 0.0 0 CFG=2
M  V30 11 C 10.4394 7.4746 0.0 0 CFG=1
M  V30 12 C 9.4895 4.7922 0.0 0
M  V30 13 C 8.1631 8.4880 0.0 0
M  V30 14 C 9.6694 8.8082 0.0 0
M  V30 15 C 11.9773 7.5551 0.0 0
M  V30 16 C 10.6340 3.7618 0.0 0 CFG=1
M  V30 17 C 13.1217 6.5247 0.0 0
M  V30 18 C 12.1719 3.8423 0.0 0
M  V30 19 N 13.2023 4.9868 0.0 0
M  V30 20 C 4.0011 6.1865 0.0 0 CFG=2
M  V30 21 C 2.6674 6.9565 0.0 0
M  V30 22 C 4.0011 4.6465 0.0 0
M  V30 23 C 1.3336 6.1865 0.0 0
M  V30 24 C 2.6674 8.4965 0.0 0
M  V30 25 C 2.6674 3.8765 0.0 0
M  V30 26 O 1.3336 4.6465 0.0 0
M  V30 27 C 0.0000 6.9565 0.0 0
M  V30 28 C 1.3336 9.2665 0.0 0
M  V30 29 C 0.0000 8.4965 0.0 0
M  V30 30 H 11.1742 8.8279 0.0 0
M  V30 31 C 8.4980 0.0000 0.0 0
M  V30 32 O 7.1644 0.7700 0.0 0
M  V30 33 O 9.8317 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=3
M  V30 4 1 20 2 CFG=3
M  V30 5 2 4 12
M  V30 6 1 16 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 3 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 30 CFG=1
M  V30 17 1 12 16
M  V30 18 1 13 14
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 2 23 27
M  V30 30 1 24 28
M  V30 31 1 25 26
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 11 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3043957-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3043957-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41787976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diazabicyclic Smac mimetics as inhibitors of IAP proteins
and their use in the treatment HIV infections and cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marx, Leo; Adam, Aurelien; Wiedemann, Norbert; Bravo, Juan; Muzerelle,
Mathilde; Fuchss, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024121395 A1 2024-06-13

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(1S)-2-[[(5S,8S,10aR)-3-(cyanomethyl)-8-[[[(4R)-3,4-dihydro...
C30H42N6O6
3043957-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0873 8.0394 0.0 0
M  V30 2 N 4.6356 8.5535 0.0 0
M  V30 3 O 7.2583 9.0395 0.0 0
M  V30 4 O 8.5811 8.2872 0.0 0
M  V30 5 N 11.2765 7.9324 0.0 0
M  V30 6 C 12.8165 7.9324 0.0 0
M  V30 7 C 13.5865 9.2660 0.0 0 CFG=2
M  V30 8 O 13.5865 6.5986 0.0 0
M  V30 9 N 15.1265 9.2660 0.0 0
M  V30 10 C 12.8165 10.5997 0.0 0
M  V30 11 C 15.8965 10.5997 0.0 0
M  V30 12 C 15.8965 7.9324 0.0 0
M  V30 13 O 17.4365 10.5997 0.0 0
M  V30 14 O 15.1265 11.9333 0.0 0
M  V30 15 C 18.2065 11.9333 0.0 0
M  V30 16 C 19.5402 11.1633 0.0 0
M  V30 17 C 18.9765 13.2671 0.0 0
M  V30 18 C 16.8729 12.7033 0.0 0
M  V30 19 C 12.5767 3.0800 0.0 0
M  V30 20 C 12.5767 1.5400 0.0 0
M  V30 21 N 12.5767 0.0000 0.0 0
M  V30 22 N 7.7579 5.8622 0.0 0
M  V30 23 C 6.3679 6.5251 0.0 0 CFG=2
M  V30 24 C 7.5570 4.3354 0.0 0 CFG=1
M  V30 25 C 8.9798 6.7997 0.0 0
M  V30 26 C 5.3079 5.4080 0.0 0
M  V30 27 C 6.0427 4.0547 0.0 0
M  V30 28 C 8.4944 3.1136 0.0 0
M  V30 29 C 10.5065 6.5986 0.0 0 CFG=1
M  V30 30 C 10.0213 2.9126 0.0 0
M  V30 31 C 11.4441 5.3769 0.0 0
M  V30 32 N 11.2429 3.8500 0.0 0
M  V30 33 C 4.3550 10.0676 0.0 0 CFG=2
M  V30 34 C 2.9034 10.5817 0.0 0
M  V30 35 C 5.5260 11.0678 0.0 0
M  V30 36 C 2.6226 12.0960 0.0 0
M  V30 37 C 1.7324 9.5816 0.0 0
M  V30 38 C 5.2454 12.5820 0.0 0
M  V30 39 O 3.7936 13.0960 0.0 0
M  V30 40 C 1.1710 12.6100 0.0 0
M  V30 41 C 0.2806 10.0956 0.0 0
M  V30 42 C 0.0000 11.6098 0.0 0
M  V30 43 H 7.0050 2.8977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=1
M  V30 4 1 33 2 CFG=1
M  V30 5 2 4 25
M  V30 6 1 5 6
M  V30 7 1 29 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=3
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 32
M  V30 22 3 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 24 43 CFG=3
M  V30 30 1 25 29
M  V30 31 1 26 27
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 34 37
M  V30 40 1 35 38
M  V30 41 1 36 39
M  V30 42 2 36 40
M  V30 43 1 37 41
M  V30 44 1 38 39
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 23 24 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Formic acid, compd. with (5S,8S,10aR)-3-(cyanomethyl)-N-[(4R)-3,4-dihydro-2H-...
C25H34N6O4.CH2O2
3043957-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 11.4319 0.0 0
M  V30 2 N 5.3348 12.2020 0.0 0
M  V30 3 O 6.6685 9.8919 0.0 0
M  V30 4 O 8.0998 9.3746 0.0 0
M  V30 5 N 10.1202 7.5555 0.0 0
M  V30 6 C 11.1203 6.3845 0.0 0
M  V30 7 C 10.6062 4.9327 0.0 0 CFG=2
M  V30 8 O 12.6346 6.6651 0.0 0
M  V30 9 N 11.6065 3.7617 0.0 0
M  V30 10 C 9.0921 4.6521 0.0 0
M  V30 11 C 11.0924 2.3100 0.0 0
M  V30 12 C 14.6543 9.7182 0.0 0
M  V30 13 C 15.8254 10.7183 0.0 0
M  V30 14 N 16.9964 11.7185 0.0 0
M  V30 15 N 9.4091 11.5756 0.0 0
M  V30 16 C 8.0023 12.2020 0.0 0 CFG=2
M  V30 17 C 10.4396 12.7200 0.0 0 CFG=1
M  V30 18 C 9.4897 10.0378 0.0 0
M  V30 19 C 8.1633 13.7335 0.0 0
M  V30 20 C 9.6696 14.0539 0.0 0
M  V30 21 C 11.9776 12.8007 0.0 0
M  V30 22 C 10.6342 9.0072 0.0 0 CFG=1
M  V30 23 C 13.1220 11.7701 0.0 0
M  V30 24 C 12.1721 9.0879 0.0 0
M  V30 25 N 13.2026 10.2323 0.0 0
M  V30 26 C 4.0012 11.4319 0.0 0 CFG=2
M  V30 27 C 2.6675 12.2020 0.0 0
M  V30 28 C 4.0012 9.8919 0.0 0
M  V30 29 C 1.3337 11.4319 0.0 0
M  V30 30 C 2.6675 13.7420 0.0 0
M  V30 31 C 2.6675 9.1219 0.0 0
M  V30 32 O 1.3337 9.8919 0.0 0
M  V30 33 C 0.0000 12.2020 0.0 0
M  V30 34 C 1.3337 14.5120 0.0 0
M  V30 35 C 0.0000 13.7420 0.0 0
M  V30 36 H 11.1745 14.0734 0.0 0
M  V30 37 C 8.4982 0.0000 0.0 0
M  V30 38 O 7.1645 0.7700 0.0 0
M  V30 39 O 9.8319 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 26 2 CFG=3
M  V30 5 2 4 18
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=3
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 3 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 36 CFG=1
M  V30 23 1 18 22
M  V30 24 1 19 20
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 1 30 34
M  V30 37 1 31 32
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 37 38
M  V30 41 2 37 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 16 17 22 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3043957-94-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3043957-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41787975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diazabicyclic Smac mimetics as inhibitors of IAP proteins
and their use in the treatment HIV infections and cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marx, Leo; Adam, Aurelien; Wiedemann, Norbert; Bravo, Juan; Muzerelle,
Mathilde; Fuchss, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024121395 A1 2024-06-13

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Propen-1-yl)benzenamine
C9H11N
32704-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 N 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(2-Propen-1-yl)phenyl]formamide
C10H11NO
1379221-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 C 0.7700 4.0011 0.0 0
M  V30 3 C 0.0000 5.3349 0.0 0
M  V30 4 N 5.3900 4.0011 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32704-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1379221-13-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-725968
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 2-allylaniline (400 mg, 3.0 mmol) in toluene (9 mL) was
added formic acid (97%, 1.0 mL), and the mixture was stirred at 110 °C
for 10 h. Volatiles were removed from the resulting mixture. The crude
solid was purified by flash chromatography on silica gel (n-hexane/EtOAc
as an eluent) to give the desired products 1x. White solid, yield 416mg,
2.58 mmol, 86%. N- (2-Allylphenyl)formamide (1x). 1H NMR (CDCl3, 400 MHz,
1:0.65 mixture of rotamers): δ 8.48 (1HM, d, J = 11.3 Hz), 8.37 (1Hm, d,
J = 1.6 Hz), 8.13 (1HM, br s), 7.89 (1Hm, d, J = 7.9 Hz), 7.56 (1Hm, br
s), 7.28- 7.10 (4HM+3Hm, m), 6.00- 5.89 (1HM+1Hm, m), 5.18- 5.12
(1HM+1Hm, m), 5.04 (1Hm,dq, J = 17.2, 1.7 Hz), 5.02 (1HM, dq, J = 17.2,
1.7 Hz),3.42- 3.37 (2HM+2Hm, m); 13C NMR (CDCl3, 100 MHz, 1: 0.65 mixture
of rotamers): δ 163.3, 159.3, 135.6, 135.4, 135.0, 134.7, 131.5, 130.8,
130.1, 130.0, 127.6, 127.3, 126.3, 125.6, 123.7, 121.5, 116.8, 116.6,
36.1, 35.9; HRMS (EI):Calcd for C10H11NO [M]+ 161.0835, Found: 161.0840;
IR (cm- 1): ν 3237, 3121, 2884, 1655, 1584, 1527, 1453, 1391, 1252, 1156,
995 917, 751, 473.
$DTYPE RXN:VAR(1):NOTES
$DATUM 1:0.65 rotamers
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regiodivergent Access to Five- and Six-Membered Benzo-Fused Lactams:
Ru-Catalyzed Olefin Hydrocarbamoylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Bin; Park, Yoonsu; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2014), 136(3), 1125-1131

$RFMT $RIREG SCHEME405 STEP1
$RXN



  3  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-5-[(1R,4aS,8aS)-2-[(Acetyloxy)methyl]-1,4,4a,5,6,7,8,8a-octahydro-5,5,8a...
C22H34O4
556810-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 7.7001 0.0 0
M  V30 2 C 6.8514 6.9301 0.0 0
M  V30 3 C 8.1851 6.1601 0.0 0
M  V30 4 C 9.5188 6.9301 0.0 0
M  V30 5 C 10.8526 6.1601 0.0 0
M  V30 6 C 9.5188 8.4702 0.0 0
M  V30 7 C 12.1863 6.9301 0.0 0
M  V30 8 O 12.1863 8.4702 0.0 0
M  V30 9 O 13.5199 6.1601 0.0 0
M  V30 10 C 6.8514 3.8501 0.0 0
M  V30 11 O 6.8514 2.3100 0.0 0
M  V30 12 C 8.1851 1.5400 0.0 0
M  V30 13 C 8.1851 0.0000 0.0 0
M  V30 14 O 9.5188 2.3100 0.0 0
M  V30 15 C 0.0000 7.1975 0.0 0
M  V30 16 C 0.9899 5.4830 0.0 0
M  V30 17 C 4.1840 6.9301 0.0 0 CFG=2
M  V30 18 C 5.5178 6.1601 0.0 0 CFG=1
M  V30 19 C 2.8503 6.1601 0.0 0 CFG=2
M  V30 20 C 4.1840 8.4702 0.0 0
M  V30 21 C 5.5178 4.6201 0.0 0
M  V30 22 C 2.8503 4.6201 0.0 0
M  V30 23 C 1.5166 6.9301 0.0 0
M  V30 24 C 2.8503 9.2402 0.0 0
M  V30 25 C 4.1840 3.8501 0.0 0
M  V30 26 C 1.5166 8.4702 0.0 0
M  V30 27 H 1.5166 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 18 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 21
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 23
M  V30 16 1 16 23
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 19 27 CFG=3
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Diazomethane
CH2N2
334-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 0.0000 0.0 0 CHG=1 VAL=4
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-5-[(1R,3R,4aS,8aS)-3-(formyloxy)decahydro-5,5,8a-trimethyl-2-meth...
C22H34O4
556811-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 7.7001 0.0 0
M  V30 2 C 6.8514 6.9301 0.0 0
M  V30 3 C 8.1851 6.1601 0.0 0
M  V30 4 C 9.5188 6.9301 0.0 0
M  V30 5 C 10.8526 6.1601 0.0 0
M  V30 6 C 9.5188 8.4702 0.0 0
M  V30 7 C 12.1862 6.9301 0.0 0
M  V30 8 O 13.5199 6.1601 0.0 0
M  V30 9 O 12.1862 8.4702 0.0 0
M  V30 10 C 14.8536 6.9301 0.0 0
M  V30 11 C 0.0000 7.1975 0.0 0
M  V30 12 C 0.9899 5.4830 0.0 0
M  V30 13 C 6.8514 3.8501 0.0 0
M  V30 14 O 4.1840 2.3100 0.0 0
M  V30 15 C 2.8503 1.5400 0.0 0
M  V30 16 O 2.8503 0.0000 0.0 0
M  V30 17 C 4.1840 6.9301 0.0 0 CFG=1
M  V30 18 C 2.8503 6.1601 0.0 0 CFG=2
M  V30 19 C 5.5178 6.1601 0.0 0 CFG=1
M  V30 20 C 4.1840 8.4702 0.0 0
M  V30 21 C 2.8503 4.6201 0.0 0
M  V30 22 C 1.5166 6.9301 0.0 0
M  V30 23 C 5.5178 4.6201 0.0 0
M  V30 24 C 2.8503 9.2402 0.0 0
M  V30 25 C 4.1840 3.8501 0.0 0 CFG=1
M  V30 26 C 1.5166 8.4702 0.0 0
M  V30 27 H 1.5166 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 19 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 1 12 22
M  V30 13 2 13 23
M  V30 14 1 14 15
M  V30 15 1 25 14 CFG=3
M  V30 16 2 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 18 27 CFG=3
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 18 19 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 556810-99-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 334-88-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 556811-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-019-CAS-182337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Side-chain migration reactions and ring B aromatization in labdanes:
scope and limitations. Synthesis of isofregenedane type
tetrahydronaphthalenic diterpenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marcos, I. S.; Basabe, P.; Laderas, M.; Diez, D.; Jorge, A.; Rodilla, J.
M.; Moro, R. F.; Lithgow, A. M.; Barata, I. G.; Urones, J. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(13), 2333-2343

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
1,1′-Dimethyl 4,4′-dithiobis[3-nitrobenzoate]
C16H12N2O8S2
35350-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4702 4.0012 0.0 0
M  V30 2 S 9.2402 5.3348 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0 VAL=5
M  V30 4 O 6.1601 0.0000 0.0 0
M  V30 5 O 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 4.0012 0.0 0
M  V30 7 O 1.5400 5.3348 0.0 0
M  V30 8 O 1.5400 2.6675 0.0 0
M  V30 9 C 0.0000 5.3348 0.0 0
M  V30 10 N 10.7802 8.0023 0.0 0 VAL=5
M  V30 11 O 11.5503 9.3360 0.0 0
M  V30 12 O 9.2402 8.0023 0.0 0
M  V30 13 C 15.4003 5.3348 0.0 0
M  V30 14 O 16.1704 4.0012 0.0 0
M  V30 15 O 16.1704 6.6685 0.0 0
M  V30 16 C 17.7104 4.0012 0.0 0
M  V30 17 C 6.9302 4.0012 0.0 0
M  V30 18 C 6.1601 2.6675 0.0 0
M  V30 19 C 6.1601 5.3348 0.0 0
M  V30 20 C 4.6201 2.6675 0.0 0
M  V30 21 C 4.6201 5.3348 0.0 0
M  V30 22 C 3.8501 4.0012 0.0 0
M  V30 23 C 10.7802 5.3348 0.0 0
M  V30 24 C 11.5503 6.6685 0.0 0
M  V30 25 C 11.5503 4.0012 0.0 0
M  V30 26 C 13.0903 6.6685 0.0 0
M  V30 27 C 13.0903 4.0012 0.0 0
M  V30 28 C 13.8603 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 23
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 28
M  V30 17 1 14 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzothiazolecarboxylic acid, methyl ester
C9H7NO2S
478169-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 3.8500 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 3.7036 4.6200 0.0 0
M  V30 10 S 0.9052 4.3259 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 35350-37-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-65-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14087166
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-31-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Treatment of diseases with alpha-7 NACh receptor full agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Groppi, Vincent Edward, Jr.; Rogers, Bruce Nelsen; Rudmann, Daniel
Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004064836 A2 2004-08-05

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenoxybenzenamine
C12H11NO
3586-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.0800 0.0 0
M  V30 2 N 9.3358 3.0800 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 C 5.3347 0.7700 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 1.3336 3.0800 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 6
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Phenoxyphenyl)formamide
C13H11NO2
247055-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 N 9.3360 3.0801 0.0 0
M  V30 3 C 10.6697 2.3101 0.0 0
M  V30 4 O 12.0033 3.0801 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 8.0022 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 2 3 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3586-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 247055-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36058931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM product obtained as mixture of rotamers with 1:1 ratio,reaction in a
sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cell-based optimization of covalent reversible ketoamide inhibitors
bridging the unprimed to the primed site of the proteasome β5 subunit
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stubba, Daniel; Bensinger, Dennis; Steinbacher, Janika; Proskurjakov,
Lilia; Salcedo Gomez, Alvaro; Schmidt, Uwe; Roth, Stefan; Schmitz, Katja;
Schmidt, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2019), 14(23), 2005-2022

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Formic acid
CH2O2
64-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-amino-4-fluoro-, methyl ester
C8H8FNO2
369-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-3-(formylamino)benzoate
C9H8FNO3
1480858-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 2.3100 0.0 0
M  V30 2 O 8.0022 3.0800 0.0 0
M  V30 3 O 6.6684 0.7700 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 N 1.3337 2.3100 0.0 0
M  V30 6 C 1.3337 0.7700 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 F 1.3337 5.3901 0.0 0
M  V30 9 C 5.3348 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 369-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1480858-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19947904
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 97
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrrolotriazolylpyridinylbenzamide
derivatives and analogs for use as ASK1 active regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Xinye; Pan, Shengqiang; Ma, Facheng; Zhang, Yingxun; Wang, Xiaojun;
Zhang, Yingjun; Jin, Chuanfei; Zhang, Ji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034096 A1 2019-02-21

